| Outgoing Relation(s) |
| organic molecular entity (CHEBI:50860) has part carbon atom (CHEBI:27594) |
| organic molecular entity (CHEBI:50860) is a carbon group molecular entity (CHEBI:33582) |
| Incoming Relation(s) |
| -methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (CHEBI:232987) is a organic molecular entity (CHEBI:50860) |
| .alpha.1-proteinase inhibitor human (CHEBI:757317) is a organic molecular entity (CHEBI:50860) |
| (-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (CHEBI:232834) is a organic molecular entity (CHEBI:50860) |
| (-)-acanthoic acid (CHEBI:233299) is a organic molecular entity (CHEBI:50860) |
| (-)-bicuculline methochloride (CHEBI:234611) is a organic molecular entity (CHEBI:50860) |
| (-)-cyatha-3,12-diene (CHEBI:193155) is a organic molecular entity (CHEBI:50860) |
| (-)-Epigallocatechin-3-(3-O-methyl) gallate (CHEBI:136603) is a organic molecular entity (CHEBI:50860) |
| (-)-latifolian A trifluoroacetate (CHEBI:68905) is a organic molecular entity (CHEBI:50860) |
| (+)-24-dammarene-3alpha,12beta,20s-triol (CHEBI:230740) is a organic molecular entity (CHEBI:50860) |
| (+)-8-O-demethylmaritidine Trifluoroacetic acid (CHEBI:68300) is a organic molecular entity (CHEBI:50860) |
| (+)-Alloaromadendrene (CHEBI:228351) is a organic molecular entity (CHEBI:50860) |
| (+)-cymbodiacetal (CHEBI:232368) is a organic molecular entity (CHEBI:50860) |
| (+)-epibatidine (CHEBI:232109) is a organic molecular entity (CHEBI:50860) |
| (+)-isomalbrancheamide B(1+) (CHEBI:145678) is a organic molecular entity (CHEBI:50860) |
| (+)-isomalbrancheamide C(1+) (CHEBI:145680) is a organic molecular entity (CHEBI:50860) |
| (+)-isomalbrancheamide D(1+) (CHEBI:145930) is a organic molecular entity (CHEBI:50860) |
| (+)-malbrancheamide B(1+) (CHEBI:145677) is a organic molecular entity (CHEBI:50860) |
| (+)-malbrancheamide C(1+) (CHEBI:145679) is a organic molecular entity (CHEBI:50860) |
| (+)-malbrancheamide D(1+) (CHEBI:145929) is a organic molecular entity (CHEBI:50860) |
| (+)-malbrancheamide(1+) (CHEBI:145651) is a organic molecular entity (CHEBI:50860) |
| (+)-premalbrancheamide(1+) (CHEBI:145658) is a organic molecular entity (CHEBI:50860) |
| (+/-)11(12)-dihet (CHEBI:230582) is a organic molecular entity (CHEBI:50860) |
| (E)-{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene}amine (CHEBI:228144) is a organic molecular entity (CHEBI:50860) |
| (S)-carazolol(1+) (CHEBI:188146) is a organic molecular entity (CHEBI:50860) |
| (S)-malyl α-D-glucosaminide(1−) (CHEBI:64871) is a organic molecular entity (CHEBI:50860) |
| (S)-norcodamine(1+) (CHEBI:143271) is a organic molecular entity (CHEBI:50860) |
| (Z)-2-((N-methylformamido)methylene)-5-hydroxybutanolactone (CHEBI:141413) is a organic molecular entity (CHEBI:50860) |
| (−)-variculatriene B (CHEBI:177892) is a organic molecular entity (CHEBI:50860) |
| (1-HYDROXY-2-IMIDAZO[1,2-A]PYRIDIN-3-YLETHANE-1,1-DIYL)BIS(PHOSPHONIC ACID) (CHEBI:43806) is a organic molecular entity (CHEBI:50860) |
| (1S,10aS)-3-(CONH2)-1-(Me2N)-3,3a,4,6-(HO)4-2,5-dioxo-1H,10aH,11H,11aH-cyclopenta[b]anthracene (CHEBI:144803) is a organic molecular entity (CHEBI:50860) |
| (1S,8R,14S)-6,9-dioxo-15,17-diazatetracyclo[12.2.2.13,7.18,12]icosa-3(20),4,6,10,12(19)-tetraen-17-ium-7-ide (CHEBI:146147) is a organic molecular entity (CHEBI:50860) |
| (1S,8aS)-octahydroindolizin-1-ol(1+) (CHEBI:167676) is a organic molecular entity (CHEBI:50860) |
| (14E,18E)-lycopadiene (CHEBI:142539) is a organic molecular entity (CHEBI:50860) |
| (17z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomovitamin d3 / (17z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a,24b-dihomocholecalciferol (CHEBI:230750) is a organic molecular entity (CHEBI:50860) |
| (1E,4E)-1-(2-hydroxyphenyl)-5-(2-methoxyphenyl)penta-1,4-dien-3-one (CHEBI:234066) is a organic molecular entity (CHEBI:50860) |
| (1E,4E)-1,5-dipyridin-3-ylpenta-1,4-dien-3-one (CHEBI:234067) is a organic molecular entity (CHEBI:50860) |
| (1E,4Z,6E)-5-hydroxy-1,7-bis(4-methoxyphenyl)hepta-1,4,6-trien-3-one (CHEBI:233290) is a organic molecular entity (CHEBI:50860) |
| (1R,2R)-2-PCCA (CHEBI:197393) is a organic molecular entity (CHEBI:50860) |
| (1R,3S,5Z)-5-[(2Z)-2-[(1R,3Ar,7aS)-1-[(2S)-1-[3-(2-hydroxypropan-2-yl)phenoxy]propan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol (CHEBI:230972) is a organic molecular entity (CHEBI:50860) |
| (1R,7S,13S,15S)-2,15-Dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one (CHEBI:230844) is a organic molecular entity (CHEBI:50860) |
| (2-carboxyethyl)(dimethyl)sulfonium (CHEBI:230554) is a organic molecular entity (CHEBI:50860) |
| (2E,6E,10E)-geranylgeranial (CHEBI:189549) is a organic molecular entity (CHEBI:50860) |
| (2E)-3-(4-hydroxyphenyl)-2-isocyanoprop-2-enoate (CHEBI:140648) is a organic molecular entity (CHEBI:50860) |
| (2R,3R)-nemonapride(1+) (CHEBI:188145) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-[(E)-{[(2R,3S,4R,5R)-2,3,4,5-tetrahydroxyoxan-2-yl]methylidene}amino]propanoate (CHEBI:228148) is a organic molecular entity (CHEBI:50860) |
| (2S)-3-(1H-indol-3-yl)-2-isocyanopropanoate (CHEBI:140652) is a organic molecular entity (CHEBI:50860) |
| (2S)-3-(4-hydroxyphenyl)-2-isocyanopropanoate (CHEBI:140647) is a organic molecular entity (CHEBI:50860) |
| (20r,24r)-20-fluoro-1alpha,24-dihydroxy-26,27-cyclovitamin d3 / (20r,24r)-20-fluoro-1alpha,24-dihydroxy-26,27-cyclocholecalciferol (CHEBI:230607) is a organic molecular entity (CHEBI:50860) |
| (24r)-25-fluoro-1alpha,24-dihydroxy-24-methylvitamin d3 / (24r)-25-fluoro-1alpha,24-dihydroxy-24-methylcholecalciferol (CHEBI:230614) is a organic molecular entity (CHEBI:50860) |
| (2E,4E,6Z,8E)-3-Methyl-7-(p-tolyl)-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid (CHEBI:195416) is a organic molecular entity (CHEBI:50860) |
| (2E)-3-(2-chlorophenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one (CHEBI:232632) is a organic molecular entity (CHEBI:50860) |
| (2E)-Octadecenoyl-[acp] (CHEBI:80388) is a organic molecular entity (CHEBI:50860) |
| (2S,3R,4S)-2-[(1E)-buta-1,3-dienyl]-4-[(1E,3E)-penta-1,3-dienyl]tetrahydrofuran-3-ol (CHEBI:68770) is a organic molecular entity (CHEBI:50860) |
| (2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-N-[2-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]-3-methylpentanamide (CHEBI:192546) is a organic molecular entity (CHEBI:50860) |
| (2S)-1-[(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid (CHEBI:230411) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-3-((E)-but-2-enyloxy)propanoic acid (CHEBI:233031) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-3-[4-(3-oxobutanoyl)phenyl]propanoic acid (CHEBI:232821) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-3-[4-(cyclopentylmethoxy)phenyl]propanoic acid (CHEBI:233117) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-Amino-3-[4-[(2S)-2-amino-4-methylsulfanylbutanoyl]oxyphenyl]propanoic acid (CHEBI:230827) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-3-pent-4-enoxypropanoic acid (CHEBI:233030) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-(but-3-ynoxycarbonylamino)hexanoic acid (CHEBI:233092) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-[(2S)-2-aminopent-4-ynoyl]oxyhexanoic acid (CHEBI:233071) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-[(4-iodophenyl)methoxycarbonylamino]hexanoic acid (CHEBI:233094) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-[[(2R,3S)-3-ethynyloxolane-2-carbonyl]amino]hexanoic acid (CHEBI:232655) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-[[(2S)-2-aminopent-4-ynoyl]amino]hexanoic acid (CHEBI:233070) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-[2-(furan-2-yl)ethoxycarbonylamino]hexanoic acid (CHEBI:233120) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-[methyl-[(2-nitrophenyl)methoxycarbonyl]amino]hexanoic acid (CHEBI:233065) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-amino-6-{[(prop-2-yn-1-yloxy)carbonyl]amino}hexanoic acid (CHEBI:232656) is a organic molecular entity (CHEBI:50860) |
| (2S)-2-Aminohept-6-enoic acid (CHEBI:232649) is a organic molecular entity (CHEBI:50860) |
| (3-((3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienamido)propanoyl)-D-asparagine (CHEBI:167187) is a organic molecular entity (CHEBI:50860) |
| (3-((3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienamido)propanoyl)-D-asparaginyl-D-asparagine (CHEBI:167188) is a organic molecular entity (CHEBI:50860) |
| (3-(3-Methyl-3H diazirine-3-yl))-propaminocarbonyl- N6-L-lysine (CHEBI:233064) is a organic molecular entity (CHEBI:50860) |
| (3AS,4R,5S,6S,8R,9R,9AR,10R)-5-HYDROXY-4,6,9,10-TETRAMETHYL-1-OXO-6-VINYLDECAHYDRO-3A,9-PROPANOCYCLOPENTA[8]ANNULEN-8-YL {[(3-EXO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL]THIO}ACETATE (CHEBI:42737) is a organic molecular entity (CHEBI:50860) |
| (3E)-3-[(1-benzylindol-3-yl)methylidene]-1-methylindol-2-one (CHEBI:232421) is a organic molecular entity (CHEBI:50860) |
| (3E)-3-[(2,4,6-trimethoxyphenyl)methylidene]-1H-indol-2-one (CHEBI:195200) is a organic molecular entity (CHEBI:50860) |
| (3R, 6R)-Pleostene (CHEBI:228357) is a organic molecular entity (CHEBI:50860) |
| (3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienoic acid (CHEBI:167185) is a organic molecular entity (CHEBI:50860) |
| (3R,5R,7S,8E,10E,12E)-3-amino-5,7-dihydroxyoctadeca-8,10,12-trienoic acid (CHEBI:167189) is a organic molecular entity (CHEBI:50860) |
| (3S,3'R,4xi)-beta,beta-Carotene-3,3',4-triol (CHEBI:230431) is a organic molecular entity (CHEBI:50860) |
| (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER (CHEBI:42089) is a organic molecular entity (CHEBI:50860) |
| (3S)-3-Hydroxyacyl-hydrolipoate (CHEBI:210) is a organic molecular entity (CHEBI:50860) |
| (3S)-3-Hydroxyacyl-N-acylthioethanolamine (CHEBI:209) is a organic molecular entity (CHEBI:50860) |
| (4-aminophenyl)(7-benzyl-3,7-diazabicyclo[3.3.1]non-3-yl)methanone (CHEBI:230794) is a organic molecular entity (CHEBI:50860) |
| (4E,8E)-10-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate (CHEBI:167390) is a organic molecular entity (CHEBI:50860) |
| (4E,8E)-10-(4,6-dihydroxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate (CHEBI:167389) is a organic molecular entity (CHEBI:50860) |
| (4aR,10bS)-oxomaritidine(1+) (CHEBI:146209) is a organic molecular entity (CHEBI:50860) |
| (4aS,5R,10bR)-(+)-siculine Trifluoroacetic acid (CHEBI:68302) is a organic molecular entity (CHEBI:50860) |
| (4e,10e,12e)-nonadec-4,10,12-trien-6,8-diyn-2-one (CHEBI:230805) is a organic molecular entity (CHEBI:50860) |
| (4E)-unsatiated ceramide (CHEBI:195634) is a organic molecular entity (CHEBI:50860) |
| (4S)-4-hydroxy-5-octoxy-5-oxopentanoic acid (CHEBI:233976) is a organic molecular entity (CHEBI:50860) |
| (5-acetamido-4,6-diacetyloxyoxan-2-yl)methyl acetate (CHEBI:235315) is a organic molecular entity (CHEBI:50860) |
| (5S)-hydroperoxy-(6E,8Z)-icosadienoate(1−) (CHEBI:145836) is a organic molecular entity (CHEBI:50860) |
| (5Z,8R,9Z,11Z,14Z)-8,9-epoxyicosatetraenoate (CHEBI:134054) is a organic molecular entity (CHEBI:50860) |
| (5R,12R,14S)-dolasta-1(15),8-diene (CHEBI:192990) is a organic molecular entity (CHEBI:50860) |
| (5r,6s,7s)-6-methoxy-5-methyl-7-(methylamino)-6,7,8,9,15,16-hexahydro-5h,14h-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-14-one (CHEBI:230631) is a organic molecular entity (CHEBI:50860) |
| (5R)-5,6-dihydro-5-(thymidin-7-yl)thymidine (in double-helical DNA) (CHEBI:85625) is a organic molecular entity (CHEBI:50860) |
| (5Z)-7-{(1R,2R,3R,5S)-3,5-DIHYDROXY-2-[(1E,3S)-3-HYDROXY-5-PHENYLPENT-1-ENYL]CYCLOPENTYL}-N-ETHYLHEPT-5-ENAMIDE (CHEBI:39562) is a organic molecular entity (CHEBI:50860) |
| (6r)-1alpha,25-dihydroxyvitamin d3 6,19-sulfur dioxide adduct / (6r)-1alpha,25-dihydroxycholecalciferol 6,19-sulfur dioxide adduct (CHEBI:230558) is a organic molecular entity (CHEBI:50860) |
| (7-Hydroxycoumarin-4-yl)ethylGly (CHEBI:232936) is a organic molecular entity (CHEBI:50860) |
| (7Z,11Z)-nonacosadiene (CHEBI:232873) is a organic molecular entity (CHEBI:50860) |
| (7Z,11Z)-pentacosa-7,11-diene (CHEBI:233576) is a organic molecular entity (CHEBI:50860) |
| (8Z,11Z,14Z,17Z)-icosatetraenoyl-carnitine (CHEBI:140811) is a organic molecular entity (CHEBI:50860) |
| (9R)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20-dione (CHEBI:43938) is a organic molecular entity (CHEBI:50860) |
| (ADP-D-ribosyl)(n)-acceptor (CHEBI:133202) is a organic molecular entity (CHEBI:50860) |
| (ADP-D-ribosyl)(n+1)-acceptor (CHEBI:133203) is a organic molecular entity (CHEBI:50860) |
| (E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-YL)benzylidene]piperidin-2-one (CHEBI:195213) is a organic molecular entity (CHEBI:50860) |
| (E)-2',4,4',6'-Tetrahydroxy-3',5'-diprenylchalcone (CHEBI:228266) is a organic molecular entity (CHEBI:50860) |
| (E)-3-(3-Bromo-4,5-dihydroxyphenyl)-N-(3,4,5-trihydroxybenzyl)prop-2-enethioamide (CHEBI:234077) is a organic molecular entity (CHEBI:50860) |
| (E)-4-((5-amino-2-hydroxyphenyl)diazenyl)benzenesulfonic acid (CHEBI:747750) is a organic molecular entity (CHEBI:50860) |
| (E)-4-amino-2-((3-amino-2-hydroxyphenyl)diazenyl)phenol (CHEBI:747752) is a organic molecular entity (CHEBI:50860) |
| (E)-5-amino-3-imino-4-oxo-6-(phenyldiazenyl)
-3,4-dihydronaphthalene-2,7-disulfonic acid (CHEBI:747421) is a organic molecular entity (CHEBI:50860) |
| (E)-7,8-diamino-2-((4-((2-methoxyethyl)sulfonyl)phenyl)diazenyl)
naphthalene-1,3,6-triol (CHEBI:747413) is a organic molecular entity (CHEBI:50860) |
| (E)-dauca-4(11),8-diene (CHEBI:228359) is a organic molecular entity (CHEBI:50860) |
| (E)-octylphenazolone (CHEBI:747681) is a organic molecular entity (CHEBI:50860) |
| (ethanolamineP) mannose (a1-2) (ethanolamineP) mannose (a1-6) (ethanolamineP) mannose (a1-4) glucosaminyl-acyl-PI (CHEBI:77364) is a organic molecular entity (CHEBI:50860) |
| (GlcNAc)2 (Man)8 (CHEBI:91277) is a organic molecular entity (CHEBI:50860) |
| (N-Acetyl-beta-D-glucosaminyl-1,2)-alpha-D-mannosyl-1,3-(beta-N-acetyl-D-glucosaminyl-1,2-alpha-D-mannosyl-1,6)-beta-D-mannosyl-R (CHEBI:289) is a organic molecular entity (CHEBI:50860) |
| (R)-(-)-cembrene A (CHEBI:228349) is a organic molecular entity (CHEBI:50860) |
| (R)-(-)-niguldipine hydrochloride (CHEBI:231360) is a organic molecular entity (CHEBI:50860) |
| (R)-(+)-8-Hydroxy-DPAT hydrobromide (CHEBI:196978) is a organic molecular entity (CHEBI:50860) |
| (R)-3-Hydroxydodecanoyl-[acp] (CHEBI:325) is a organic molecular entity (CHEBI:50860) |
| (R)-3-Hydroxyhexanoyl-[acp] (CHEBI:326) is a organic molecular entity (CHEBI:50860) |
| (R)-Chiral alcohol (CHEBI:81701) is a organic molecular entity (CHEBI:50860) |
| (R)-Hemiketal (CHEBI:81703) is a organic molecular entity (CHEBI:50860) |
| (R)-N6-(S8-acetyldihydrolipoyl)-L-lysine residue (CHEBI:229464) is a organic molecular entity (CHEBI:50860) |
| (R)-Trolox-L-carnosine (CHEBI:235480) is a organic molecular entity (CHEBI:50860) |
| (RS)-α-methyl-4-phosphonophenylglycine (CHEBI:233978) is a organic molecular entity (CHEBI:50860) |
| (RS)-α-methyl-4-tetrazolylphenylglycine (CHEBI:233163) is a organic molecular entity (CHEBI:50860) |
| (S)-(+)-cembrene A (CHEBI:192752) is a organic molecular entity (CHEBI:50860) |
| (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE (CHEBI:46035) is a organic molecular entity (CHEBI:50860) |
| (S)-2-amino-3-(4-but-2-ynyloxy-phenyl)-propionic acid (CHEBI:233118) is a organic molecular entity (CHEBI:50860) |
| (S)-3-hydroxyhexacosanoyl-CoA(4-) (CHEBI:140720) is a organic molecular entity (CHEBI:50860) |
| (s)-3-methylthiohexyl hexanoate (CHEBI:230605) is a organic molecular entity (CHEBI:50860) |
| (s)-actinidine (CHEBI:230732) is a organic molecular entity (CHEBI:50860) |
| (S)-Hydroxynitrile (CHEBI:81967) is a organic molecular entity (CHEBI:50860) |
| (S)-Trolox-L-carnosine (CHEBI:235479) is a organic molecular entity (CHEBI:50860) |
| (z)-2,3-dichloroacrylic acid (CHEBI:230649) is a organic molecular entity (CHEBI:50860) |
| (Z)-5-amino-3-imino-4,7-dioxo-6-(2-phenylhydrazono)-3,4,6,7-tetrahydronaphthalene-2-sulfonic acid (CHEBI:747427) is a organic molecular entity (CHEBI:50860) |
| (Z)-eunicellane benditerpe-2,6,15-triene (CHEBI:228348) is a organic molecular entity (CHEBI:50860) |
| (Z)-icos-13-enamide (CHEBI:229513) is a organic molecular entity (CHEBI:50860) |
| (Z)-pentacos-7-ene (CHEBI:232651) is a organic molecular entity (CHEBI:50860) |
| (α-D-glucosyl)3-(α-D-mannosyl)8-β-D-mannosyldiacetylchitobiosyldiphosphodolichol (CHEBI:459) is a organic molecular entity (CHEBI:50860) |
| (β-D-glucosyl)-O-mycofactocinol (CHEBI:156520) is a organic molecular entity (CHEBI:50860) |
| (ω−1)-methyl-branched lipid (CHEBI:136963) is a organic molecular entity (CHEBI:50860) |
| [(3S,4R,8R,9E)-10-methyl-5-methylidene-6,14-dioxo-7,13-dioxatricyclo[10.2.1.04,8]pentadeca-1(15),9-dien-3-yl] (Z)-2-methylbut-2-enoate (CHEBI:232588) is a organic molecular entity (CHEBI:50860) |
| [(ppy)2Ir(dmn)]Cl (CHEBI:133489) is a organic molecular entity (CHEBI:50860) |
| [[(3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-ylidene]amino] N-(4-chlorophenyl)carbamate (CHEBI:235473) is a organic molecular entity (CHEBI:50860) |
| [N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]3 (CHEBI:143021) is a organic molecular entity (CHEBI:50860) |
| [N-(2,3-dihydroxybenzoyl)-L-seryl]2-N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine (CHEBI:143023) is a organic molecular entity (CHEBI:50860) |
| [14]-Gingerol (CHEBI:231136) is a organic molecular entity (CHEBI:50860) |
| [2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID (CHEBI:45809) is a organic molecular entity (CHEBI:50860) |
| [Cytochrome c] S-methionine (CHEBI:10144) is a organic molecular entity (CHEBI:50860) |
| [Cytochrome c]-N(omega)-methylarginine (CHEBI:79975) is a organic molecular entity (CHEBI:50860) |
| [Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylbutanoyl)dihydrolipoyllysine (CHEBI:80224) is a organic molecular entity (CHEBI:50860) |
| [Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(2-methylpropanoyl)dihydrolipoyllysine (CHEBI:80222) is a organic molecular entity (CHEBI:50860) |
| [Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase] S-(3-methylbutanoyl)dihydrolipoyllysine (CHEBI:80221) is a organic molecular entity (CHEBI:50860) |
| [Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine (CHEBI:80404) is a organic molecular entity (CHEBI:50860) |
| [Dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine (CHEBI:80403) is a organic molecular entity (CHEBI:50860) |
| [FeCl2(TMG5NMe2asme)] (CHEBI:747278) is a organic molecular entity (CHEBI:50860) |
| [Myeline basic protein] L-arginine (CHEBI:10166) is a organic molecular entity (CHEBI:50860) |
| [Myeline basic protein] N-methyl-L-arginine (CHEBI:10167) is a organic molecular entity (CHEBI:50860) |
| [Pyruvate formate-lyase]-glycine (CHEBI:10174) is a organic molecular entity (CHEBI:50860) |
| [Pyruvate formate-lyase]-glycine radical (CHEBI:10175) is a organic molecular entity (CHEBI:50860) |
| [Ribulose-1,5-bisphosphate-carboxylase]-lysine (CHEBI:10179) is a organic molecular entity (CHEBI:50860) |
| [Ribulose-1,5-bisphosphate-carboxylase]-N6-methyl-L-lysine (CHEBI:10178) is a organic molecular entity (CHEBI:50860) |
| [β-GlcNAc-(1→4)-Mur2Ac(oyl-L-Ala-γ-D-Glu-L-Lys-D-Ala-D-Ala)]n (CHEBI:76535) is a organic molecular entity (CHEBI:50860) |
| [β-GlcNAc-(1→4)-Mur2Ac(oyl-L-Ala-γ-D-Glu-L-Lys-D-Ala-D-Ala)]n (1−) (CHEBI:76539) is a organic molecular entity (CHEBI:50860) |
| all-trans-retro-retinol (CHEBI:176883) is a organic molecular entity (CHEBI:50860) |
| C-terminal amide O-palmitoyl-L-threonine residue (CHEBI:143620) is a organic molecular entity (CHEBI:50860) |
| meta-phosphoric acid (CHEBI:195297) is a organic molecular entity (CHEBI:50860) |
| N-(2,3-dihydroxybenzoyl)-L-serine trimer (CHEBI:143020) is a organic molecular entity (CHEBI:50860) |
| N-(2,3-dihydroxybenzoyl)-L-seryl-[N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]2 (CHEBI:143022) is a organic molecular entity (CHEBI:50860) |
| N-(acyl)-sphingosyl-1,3-cyclicphosphate(1−) (CHEBI:143892) is a organic molecular entity (CHEBI:50860) |
| N-(acyl)-sphingosylphosphoethanolamine zwitterion (CHEBI:143891) is a organic molecular entity (CHEBI:50860) |
| N-(tetradecanoyl)sphing-4-enine (CHEBI:34863) is a organic molecular entity (CHEBI:50860) |
| N-(ultra-long-chain-acyl)-sphingoid base (CHEBI:144713) is a organic molecular entity (CHEBI:50860) |
| N-(very-long-chain fatty acyl)-sphingoid base (CHEBI:144712) is a organic molecular entity (CHEBI:50860) |
| N-[(3S)-3-amino-3-carboxypropyl]-D-histidine dizwitterion (CHEBI:141808) is a organic molecular entity (CHEBI:50860) |
| N-[(3S)-3-amino-3-carboxypropyl]-L-histidine dizwitterion (CHEBI:143196) is a organic molecular entity (CHEBI:50860) |
| N-12-oxomyristoyl-L-cysteine residue (CHEBI:143562) is a organic molecular entity (CHEBI:50860) |
| N-12R-hydroxymyristoyl-L-cysteine residue (CHEBI:143561) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142642) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144911) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144910) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144480) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142883) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142884) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142629) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-α-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144995) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-α-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144994) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-D-galactosaminyl-(1→3)-(α-L-fucosyl-(1→2))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144493) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-D-galactosaminyl-(1→3)-(α-L-fucosyl-(1→2))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144492) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-D-galactosaminyl-(1→3)-(α-L-fucosyl-(1→2))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144496) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-D-galactosaminyl-(1→3)-(α-L-fucosyl-(1→2))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144495) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144468) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144467) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-(d18:1(4E)) (CHEBI:144443) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144448) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144563) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144562) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144770) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144564) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144725) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144727) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144726) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144769) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144768) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:145087) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:145086) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:145089) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:145088) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:145081) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:145083) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:145082) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144507) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144506) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144792) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144791) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-D-galactosamine(2−) (CHEBI:156407) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:141724) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:141725) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:141728) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:141729) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:141727) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(4−) (CHEBI:141711) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(4−) (CHEBI:141712) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(4−) (CHEBI:141714) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(4−) (CHEBI:141715) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(4−) (CHEBI:141713) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(5−) (CHEBI:141697) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(5−) (CHEBI:141703) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(5−) (CHEBI:141705) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(5−) (CHEBI:141706) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(5−) (CHEBI:141704) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141647) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141649) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141650) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141648) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:145006) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:145005) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:145008) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:145007) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-D-galactosamine(1−) (CHEBI:156406) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144654) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144657) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144656) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141636) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (CHEBI:141638) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141637) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:141739) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:141741) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:141742) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:141740) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(4−) (CHEBI:141716) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(4−) (CHEBI:141718) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(4−) (CHEBI:141719) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(4−) (CHEBI:141717) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142030) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142032) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142031) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142034) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142035) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142033) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141678) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141680) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141681) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141679) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-galactosaminyl-(1→4)-[α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:142333) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-galactosaminyl-(1→4)-[α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:142335) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-galactosaminyl-(1→4)-[α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(3−) (CHEBI:142334) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-galactosaminyl-(1→4)-[α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:142337) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-galactosaminyl-(1→4)-[α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:142338) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-galactosaminyl-(1→4)-[α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:142336) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144885) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144884) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144887) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144886) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144736) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144735) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144738) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144737) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144731) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144730) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144733) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144732) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144420) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144418) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144764) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144763) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:144502) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:144501) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:144852) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:144851) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:145075) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:145074) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:145077) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:145076) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144854) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144855) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144857) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144856) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:144497) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144499) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144498) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144850) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144849) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-Fuc-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144932) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-Fuc-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144931) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-Fuc-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144934) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-Fuc-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144933) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144471) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144470) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144909) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144908) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144453) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144740) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144739) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144511) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144756) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144755) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (1−) (CHEBI:141685) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (1−) (CHEBI:141687) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (1−) (CHEBI:141686) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1↔1')-ceramide(d18:0) (1−) (CHEBI:141689) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1↔1')-ceramide(d20:0) (1−) (CHEBI:141691) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141692) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1↔1')-ceramide(t18:0) (1−) (CHEBI:141690) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144961) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144959) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144964) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144962) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144952) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144938) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144954) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144953) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144880) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144879) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144882) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144881) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144457) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144456) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144847) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144846) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144416) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144417) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144789) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→6)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144788) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:141720) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:141722) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:141723) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:141721) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(4−) (CHEBI:141707) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(4−) (CHEBI:141709) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(5−) (CHEBI:141710) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(4−) (CHEBI:141708) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(5−) (CHEBI:141693) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(5−) (CHEBI:141695) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(5−) (CHEBI:141696) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(5−) (CHEBI:141694) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141655) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141657) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141658) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141656) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:144976) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:144975) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:144978) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:144977) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:144510) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:144509) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:144692) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:144691) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141663) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141665) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141666) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141664) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:144695) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:144698) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:144696) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:144809) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:144808) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:144811) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-α-neuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:144810) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144544) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144543) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144545) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:142147) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:142149) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142148) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (CHEBI:142151) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:142152) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142150) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphingosine (CHEBI:140617) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144627) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144626) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144628) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141799) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:141798) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141801) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141802) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141800) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142013) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142015) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142014) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142017) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142018) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142016) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:141814) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141837) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:141836) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141839) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141840) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141838) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141682) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141684) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141683) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141659) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141661) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141662) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141660) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:141748) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:141749) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:141751) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:141752) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:141750) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142007) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142009) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142008) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142011) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142012) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142010) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:141972) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141978) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:141977) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141980) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141981) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141979) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142036) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142038) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142037) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142041) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142042) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142040) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:141804) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141807) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:141806) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141812) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141813) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141810) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:141629) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (CHEBI:141631) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:141632) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:141630) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142963) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144609) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144790) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144610) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144629) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)/16:0) (CHEBI:142985) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144772) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-β-galactosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144771) is a organic molecular entity (CHEBI:50860) |
| N-acyl-S-1,2-diacyl-sn-glyceryl-L-cysteine residue (CHEBI:140657) is a organic molecular entity (CHEBI:50860) |
| N-acyl-1-O-alkyl-2-acyl-sn-glycero-3-phosphoethanolamine(1−) (CHEBI:140514) is a organic molecular entity (CHEBI:50860) |
| N-arachidonoyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine(1−) (CHEBI:140532) is a organic molecular entity (CHEBI:50860) |
| N-arachidonoylethanolamine phosphate(2−) (CHEBI:131894) is a organic molecular entity (CHEBI:50860) |
| N-aryl-1-palmitoyl-sn-glycero-3-phosphoethanolamine(1−) (CHEBI:145396) is a organic molecular entity (CHEBI:50860) |
| N-aryl-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine(1−) (CHEBI:145395) is a organic molecular entity (CHEBI:50860) |
| N-hexadecanoyl-(2S)-hydroxyglycinate (CHEBI:142695) is a organic molecular entity (CHEBI:50860) |
| N-hexanoyl-sphingosine-1,3-cyclophosphate(1−) (CHEBI:143883) is a organic molecular entity (CHEBI:50860) |
| N-lauroyl-heptadecasphingosine-1-phosphoethanolamine zwitterion (CHEBI:143864) is a organic molecular entity (CHEBI:50860) |
| N-lauroyl-heptadecasphingosine-1,3-cyclophosphate(1−) (CHEBI:143865) is a organic molecular entity (CHEBI:50860) |
| N-lauroyl-sphingosine-1,3-cyclophosphate(1−) (CHEBI:143884) is a organic molecular entity (CHEBI:50860) |
| N-methyldopaminechrome (CHEBI:189001) is a organic molecular entity (CHEBI:50860) |
| N-oleoylethanolamine phosphate(2−) (CHEBI:145465) is a organic molecular entity (CHEBI:50860) |
| N-palmitoyl-L-cysteine residue (CHEBI:143147) is a organic molecular entity (CHEBI:50860) |
| N-stearoyl-sphingoid base (CHEBI:144711) is a organic molecular entity (CHEBI:50860) |
| N-ω-(L-glutamyl)-O-acylsphingosine residue (CHEBI:143560) is a organic molecular entity (CHEBI:50860) |
| N1-(3,4-dihydroxybenzoyl)-N8-citryl-spermidine (1−) (CHEBI:149593) is a organic molecular entity (CHEBI:50860) |
| N1-(3,4-dihydroxybenzoyl)-N8,N'8-citryl-bis(spermidine) (2+) (CHEBI:149594) is a organic molecular entity (CHEBI:50860) |
| N4-{β-D-GlcNAc-(1→2)-[β-D-GlcNAc-(1→4)]-α-D-Man-(1→3)-[β-D-GlcNAc-(1→2)-{β-D-GlcNAc-(1→6)}-α-D-Man-(1→6)]-β-D-Man-(1→4)-β-D-GlcNAc-(1→4)-β-D-GlcNAc}-Asn residue (CHEBI:187875) is a organic molecular entity (CHEBI:50860) |
| N5-[(S)-citryl]-D-ornithine(2−) (CHEBI:142972) is a organic molecular entity (CHEBI:50860) |
| N6-[(2S,3R)-2-amino-8-carboxyoctan-3-yl]-L-lysine(1+) residue (CHEBI:149472) is a organic molecular entity (CHEBI:50860) |
| N8,N'8-citryl-bis(spermidine) (+3) (CHEBI:149592) is a organic molecular entity (CHEBI:50860) |
| Nδ-methyl-L-argininium (CHEBI:144928) is a organic molecular entity (CHEBI:50860) |
| p-N,N-bis(2-chloroethyl)amino-D-phenylalanine (CHEBI:25814) is a organic molecular entity (CHEBI:50860) |
| S-(12-hydroxyfarnesyl)-L-cysteine residue (CHEBI:143699) is a organic molecular entity (CHEBI:50860) |
| S-(15-deoxy-Δ12,14-prostaglandin J2-9-yl)cysteine residue(1−) (CHEBI:143698) is a organic molecular entity (CHEBI:50860) |
| S-(diphytanylglyceryl)-L-cysteine residue (CHEBI:143704) is a organic molecular entity (CHEBI:50860) |
| S-arachidonoyl-L-cysteine group (CHEBI:143202) is a organic molecular entity (CHEBI:50860) |
| S-myristoyl-L-cysteine group (CHEBI:143199) is a organic molecular entity (CHEBI:50860) |
| S-oleoyl-L-cysteine group (CHEBI:143201) is a organic molecular entity (CHEBI:50860) |
| S-palmitoleoyl-L-cysteine group (CHEBI:143203) is a organic molecular entity (CHEBI:50860) |
| S-stearoyl-L-cysteine group (CHEBI:143200) is a organic molecular entity (CHEBI:50860) |
| S-substituted L-cysteinylglycine zwitterion (CHEBI:143103) is a organic molecular entity (CHEBI:50860) |
| S-succinyl-L-cysteine(2−) (CHEBI:143133) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141114) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141116) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142159) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142167) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142160) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142169) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142170) is a organic molecular entity (CHEBI:50860) |
| SO3-3-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142168) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141165) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141166) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141167) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141161) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141162) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141163) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141157) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1 (4E)) (CHEBI:141158) is a organic molecular entity (CHEBI:50860) |
| SO3-3β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141159) is a organic molecular entity (CHEBI:50860) |
| SO3-6-O-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142965) is a organic molecular entity (CHEBI:50860) |
| SO3-6-O-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142966) is a organic molecular entity (CHEBI:50860) |
| cis-3-O-feruloylquinic acid (CHEBI:176886) is a organic molecular entity (CHEBI:50860) |
| D-fuculose (CHEBI:194176) is a organic molecular entity (CHEBI:50860) |
| L-arginyl-L-glutamic acid monoacetate (CHEBI:63333) is a organic molecular entity (CHEBI:50860) |
| L-lysine zwitterion (CHEBI:133538) is a organic molecular entity (CHEBI:50860) |
| 1-((2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl)-L-proline (CHEBI:42302) is a organic molecular entity (CHEBI:50860) |
| 1-(1,3-Benzothiazol-2-yl)-3-[3-(1,3-benzothiazol-2-ylcarbamoylamino)-4-methylphenyl]urea (CHEBI:232636) is a organic molecular entity (CHEBI:50860) |
| 1-(10Z)-heptadecenoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol(1−) (CHEBI:75120) is a organic molecular entity (CHEBI:50860) |
| 1-(11Z-icosenoyl)glycerol (CHEBI:142496) is a organic molecular entity (CHEBI:50860) |
| 1-(2-methoxy-nonadecanyl)-sn-glycero-3-phosphoethanolamine (CHEBI:230655) is a organic molecular entity (CHEBI:50860) |
| 1-(4-METHOXYPHENYL)-7-OXO-6-[4-(2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-3-CARBOXAMIDE (CHEBI:49620) is a organic molecular entity (CHEBI:50860) |
| 1-(9Z-hexadecenoyl)-2-tetradecanoyl-glycero-3-phosphoethanolamine (CHEBI:195407) is a organic molecular entity (CHEBI:50860) |
| 1-(cyclohexen-1-yl)pyrrolidine (CHEBI:233089) is a organic molecular entity (CHEBI:50860) |
| 1-(diaminomethylidene)-2-(4-hydroxyphenyl)guanidine (CHEBI:234069) is a organic molecular entity (CHEBI:50860) |
| 1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL (CHEBI:45684) is a organic molecular entity (CHEBI:50860) |
| 1-(isothiocyanatomethyl)-4-methoxybenzene (CHEBI:230766) is a organic molecular entity (CHEBI:50860) |
| 1-(N-hydroxylamino)naphthalene (CHEBI:760556) is a organic molecular entity (CHEBI:50860) |
| 1-[(4-fluorophenyl)methyl]-2,2-dioxothieno[3,2-c]thiazin-4-one (CHEBI:232981) is a organic molecular entity (CHEBI:50860) |
| 1-[2-[4-(4-methoxyphenyl)piperazin-1-yl]ethyl]-N-methyl-3,4-dihydro-1H-isochromene-6-carboxamide (CHEBI:140906) is a organic molecular entity (CHEBI:50860) |
| 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-3-methyl-4-(trifluoromethylsulfanyl)pyrazole (CHEBI:232108) is a organic molecular entity (CHEBI:50860) |
| 1-O-(1Z-hexadecenyl)-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphocholine (CHEBI:142763) is a organic molecular entity (CHEBI:50860) |
| 1-O-(1Z-hexadecenyl)-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (CHEBI:142762) is a organic molecular entity (CHEBI:50860) |
| 1-O-(6'-(N-methylphosphoethanolaminyl)-β-D-glucopyranosyl)-(N-acyl-4R-hydroxy-15-methyl-hexadecasphinganine) zwitterion (CHEBI:196954) is a organic molecular entity (CHEBI:50860) |
| 1-O-octadecyl-sn-glycero-3-phosphocholine (CHEBI:75216) is a organic molecular entity (CHEBI:50860) |
| 1-acyl-2-decanoyl-sn-glycero-3-phosphate(2−) (CHEBI:64866) is a organic molecular entity (CHEBI:50860) |
| 1-acyl-2-palmitoleoyl-sn-glycero-3-phosphoserine(1−) (CHEBI:75241) is a organic molecular entity (CHEBI:50860) |
| 1-alpha 23,25,26-trihydroxy vitamin D3 (CHEBI:233815) is a organic molecular entity (CHEBI:50860) |
| 1-alpha-23,25-dihydroxy vitamin D3 (CHEBI:233813) is a organic molecular entity (CHEBI:50860) |
| 1-alpha-25,26-dihydroxy-vitamin D3 (CHEBI:233814) is a organic molecular entity (CHEBI:50860) |
| 1-amino-2-naphthol (CHEBI:760553) is a organic molecular entity (CHEBI:50860) |
| 1-Amino-4-methylpiperazine (CHEBI:230450) is a organic molecular entity (CHEBI:50860) |
| 1-benzyl-3-(2-methylphenyl)-3,7-dihydro-1H-purine-2,6-dione (CHEBI:235307) is a organic molecular entity (CHEBI:50860) |
| 1-deoxy-D-tagatose (CHEBI:194172) is a organic molecular entity (CHEBI:50860) |
| 1-deoxy-L-fructose (CHEBI:194162) is a organic molecular entity (CHEBI:50860) |
| 1-deoxy-sphingosine (CHEBI:233818) is a organic molecular entity (CHEBI:50860) |
| 1-dimethylarsinoyl-pentadecane (CHEBI:230792) is a organic molecular entity (CHEBI:50860) |
| 1-epijosephinine Trifluoroacetic acid (CHEBI:68309) is a organic molecular entity (CHEBI:50860) |
| 1-ethyl-1H-imidazole (CHEBI:747843) is a organic molecular entity (CHEBI:50860) |
| 1-methyl-3-octylimidazolium tetrafluoroborate (CHEBI:233407) is a organic molecular entity (CHEBI:50860) |
| 1-myristoyl-sn-glycero-2,3-cyclic-phosphate(1−) (CHEBI:143882) is a organic molecular entity (CHEBI:50860) |
| 1-Naphthaleneacetic acid sodium salt (CHEBI:81811) is a organic molecular entity (CHEBI:50860) |
| 1-o-(2r-hydroxy-nonadecyl)-sn-glycerol (CHEBI:230705) is a organic molecular entity (CHEBI:50860) |
| 1-O-acetylbulbisine Trifluoroacetic acid (CHEBI:68317) is a organic molecular entity (CHEBI:50860) |
| 1-octadecanoyl-2-(15-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine zwitterion (CHEBI:146277) is a organic molecular entity (CHEBI:50860) |
| 1-octanoyl-sn-glycero-2,3-cyclic-phosphate(1−) (CHEBI:143876) is a organic molecular entity (CHEBI:50860) |
| 1-octanoyl-sn-glycero-3-phosphocholine zwitterion (CHEBI:143866) is a organic molecular entity (CHEBI:50860) |
| 1-oleoyl-2-acyl-sn-glycero-3-phosphoglycerol(1−) (CHEBI:145392) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-sn-glycero-2,3-cyclic-phosphate(1−) (CHEBI:143893) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(10-hydroperoxy-8E-octadecenoyl)-sn-glycero-3-phosphocholine (CHEBI:77749) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(10-hydroxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1−) (CHEBI:143094) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphate(2−) (CHEBI:142761) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phospho-(1'-sn-glycerol)(1−) (CHEBI:142759) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(5-hydroxyvaleroyl)-sn-glycero-3-phosphoethanolamine (CHEBI:142751) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphate(2−) (CHEBI:142760) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phospho-(1'-sn-glycerol)(1−) (CHEBI:142758) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphoethanolamine (CHEBI:142750) is a organic molecular entity (CHEBI:50860) |
| 1-palmitoyl-2-(9,10-epoxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1−) (CHEBI:143092) is a organic molecular entity (CHEBI:50860) |
| 1-radyl-2-acyl-sn-glycerolipid (CHEBI:144315) is a organic molecular entity (CHEBI:50860) |
| 1-salicylate O-glucuronide(1-) (CHEBI:176976) is a organic molecular entity (CHEBI:50860) |
| 1-stearoyl-2-(9,10-epoxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1−) (CHEBI:143087) is a organic molecular entity (CHEBI:50860) |
| 1-stearoyl,2-(10-hydroxyoctadecanoyl)-sn-glycero-3-phospho-L-serine(1−) (CHEBI:143088) is a organic molecular entity (CHEBI:50860) |
| 1,1'-(OXYDIMETHYLENE)BIS(4-FORMYLPYRIDINIUM)DIOXIME (CHEBI:44691) is a organic molecular entity (CHEBI:50860) |
| 1,10-di-epi-cubenol (CHEBI:192989) is a organic molecular entity (CHEBI:50860) |
| 1,2-alpha-D-Mannosylheteroglycan (CHEBI:509) is a organic molecular entity (CHEBI:50860) |
| 1,2-di-[(9Z)-hexadecenoyl]-sn-glycero-3-phosphoethanolamine zwitterion (CHEBI:138145) is a organic molecular entity (CHEBI:50860) |
| 1,2-diacyl-sn-glycerolipid (CHEBI:144368) is a organic molecular entity (CHEBI:50860) |
| 1,2-didodecanoyl-sn-glycero-3-phosphoethanolamine (CHEBI:183653) is a organic molecular entity (CHEBI:50860) |
| 1,2-dihexanoyl-3-oleoyl-sn-glycerol (CHEBI:140527) is a organic molecular entity (CHEBI:50860) |
| 1,2-diphytanoyl-sn-glycero-3-phosphocholine (CHEBI:183654) is a organic molecular entity (CHEBI:50860) |
| 1,2,4-triazole acetic acid (CHEBI:747847) is a organic molecular entity (CHEBI:50860) |
| 1,2,4,8-tetramethylbicyclo[6.3.0]undeca-2,4-diene (CHEBI:192758) is a organic molecular entity (CHEBI:50860) |
| 1,3,5-Tricaffeoylquinic acid (CHEBI:232586) is a organic molecular entity (CHEBI:50860) |
| 1,4-cyclohexanedimethanamine (CHEBI:747249) is a organic molecular entity (CHEBI:50860) |
| 1,4-cyclohexanedimethanol (CHEBI:747245) is a organic molecular entity (CHEBI:50860) |
| 1,4-di(hydroxymethyl)benzene (CHEBI:747252) is a organic molecular entity (CHEBI:50860) |
| 1,4-dicyanobenzene (CHEBI:747247) is a organic molecular entity (CHEBI:50860) |
| 1,4-naphthoquinon-2-yl-L-tryptophan (CHEBI:232157) is a organic molecular entity (CHEBI:50860) |
| 1,5-Dicaffeoylquinic acid (CHEBI:142446) is a organic molecular entity (CHEBI:50860) |
| 1'-Hydroxy-gamma-carotene glucoside ester (CHEBI:80138) is a organic molecular entity (CHEBI:50860) |
| 10-DEBC hydrochloride (CHEBI:231361) is a organic molecular entity (CHEBI:50860) |
| 10-deoxymethymycin(1+) (CHEBI:63307) is a organic molecular entity (CHEBI:50860) |
| 10-epi-alpha-cubebene (CHEBI:192985) is a organic molecular entity (CHEBI:50860) |
| 10-epi-beta-cubebene (CHEBI:192986) is a organic molecular entity (CHEBI:50860) |
| 10-formyltetrahydrofolyl-(Glu)5 (CHEBI:195342) is a organic molecular entity (CHEBI:50860) |
| 10-Hydroxypentadecanoylcarnitine (CHEBI:230427) is a organic molecular entity (CHEBI:50860) |
| 10(S),17(S)-dihydroxy-omega 6-docosapentaenoic acid (CHEBI:138674) is a organic molecular entity (CHEBI:50860) |
| 1018 iss (CHEBI:757138) is a organic molecular entity (CHEBI:50860) |
| 10Z,13Z-nonadecadienoic acid (CHEBI:232468) is a organic molecular entity (CHEBI:50860) |
| 11-azaartemisinin (CHEBI:234134) is a organic molecular entity (CHEBI:50860) |
| 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE (CHEBI:44659) is a organic molecular entity (CHEBI:50860) |
| 11-dodecen-1-ol (CHEBI:230798) is a organic molecular entity (CHEBI:50860) |
| 11a-hydroxy-oxytetracycline zwitterion (CHEBI:144646) is a organic molecular entity (CHEBI:50860) |
| 12-bromo-octadecanoic acid (CHEBI:230599) is a organic molecular entity (CHEBI:50860) |
| 12-Methoxydodecanoate (CHEBI:232426) is a organic molecular entity (CHEBI:50860) |
| 12a-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE (CHEBI:230874) is a organic molecular entity (CHEBI:50860) |
| 12a-hydroxyrotenone (CHEBI:68051) is a organic molecular entity (CHEBI:50860) |
| 13-cis-4-oxoretinoate (CHEBI:190136) is a organic molecular entity (CHEBI:50860) |
| 13-keto-9z-octadecenoic acid (CHEBI:230577) is a organic molecular entity (CHEBI:50860) |
| 13(R)-HODE(1−) (CHEBI:136655) is a organic molecular entity (CHEBI:50860) |
| 14,18 (CHEBI:754375) is a organic molecular entity (CHEBI:50860) |
| 14:4(2e,4e,8e,10e)(6me[s],9me,12me[s]) (CHEBI:230596) is a organic molecular entity (CHEBI:50860) |
| 14(Z)-Tricosenoic acid (CHEBI:231752) is a organic molecular entity (CHEBI:50860) |
| 14g2a (CHEBI:754222) is a organic molecular entity (CHEBI:50860) |
| 15-oxo-EDE(1−) (CHEBI:134546) is a organic molecular entity (CHEBI:50860) |
| 16-bromo-9e-hexadecenoic acid (CHEBI:230662) is a organic molecular entity (CHEBI:50860) |
| 16-bromo-hexadecanoic acid (CHEBI:230564) is a organic molecular entity (CHEBI:50860) |
| 16-oxo phytanic acid (CHEBI:233720) is a organic molecular entity (CHEBI:50860) |
| 17-phenyl heptadecanoic acid (CHEBI:230660) is a organic molecular entity (CHEBI:50860) |
| 17a,20a-dihydroxy-5a-pregnan-3-one (CHEBI:233716) is a organic molecular entity (CHEBI:50860) |
| 18-Carbamoyl-3,5,7,9,11,13,15,17-octaoxo-octadecanoyl-[acp] (CHEBI:31060) is a organic molecular entity (CHEBI:50860) |
| 18-Carbamoyl-9-hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp] (CHEBI:31061) is a organic molecular entity (CHEBI:50860) |
| 18-methyl-5z,8z,11z,14z-nonadecatetraenoic acid (CHEBI:230597) is a organic molecular entity (CHEBI:50860) |
| 19-O-acetylchaetoglobosin B (CHEBI:68753) is a organic molecular entity (CHEBI:50860) |
| 19-O-acetylchaetoglobosin D (CHEBI:68751) is a organic molecular entity (CHEBI:50860) |
| 19-oxodesacetylcinobufagin (CHEBI:230557) is a organic molecular entity (CHEBI:50860) |
| 1a,1b-dihomo-15-deoxy-delta-12,14-pgj2 (CHEBI:230782) is a organic molecular entity (CHEBI:50860) |
| 1alpha,25-dihydroxy-19-nor-22-oxavitamin d3 / 1alpha,25-dihydroxy-19-nor-22-oxacholecalciferol (CHEBI:230584) is a organic molecular entity (CHEBI:50860) |
| 1alpha,25-dihydroxy-19-norvitamin d3 / 1alpha,25-dihydroxy-19-norcholecalciferol (CHEBI:230738) is a organic molecular entity (CHEBI:50860) |
| 1alpha,25-dihydroxy-26,27-dimethyl-20,21,22,22,23,23-hexadehydro-24a-homovitamin D3 (CHEBI:230549) is a organic molecular entity (CHEBI:50860) |
| 1D-myo-Inositol bisdiphosphate tetrakisphosphate (CHEBI:81476) is a organic molecular entity (CHEBI:50860) |
| 1d09c3 (CHEBI:754294) is a organic molecular entity (CHEBI:50860) |
| 1H-pyrrolo[3,2-b]pyridine-3-carboxylic acid (CHEBI:234101) is a organic molecular entity (CHEBI:50860) |
| 1H-pyrrolo[3,2-c]pyridine-4-carboxylic acid (CHEBI:234111) is a organic molecular entity (CHEBI:50860) |
| 1α,25-dihydroxy-2β-(1,3-dihydroxypropoxy)vitamin D3 (CHEBI:146141) is a organic molecular entity (CHEBI:50860) |
| 2-((E)-(2-hydroxy-3-((E)-methyldiazenyl)phenyl)diazenyl)-4-nitrophenol (CHEBI:747751) is a organic molecular entity (CHEBI:50860) |
| 2-(2-Isopropyl-5-methylphenoxy)acetic acid (CHEBI:229531) is a organic molecular entity (CHEBI:50860) |
| 2-(2-nitrothiophen-3-yl)pyrimidine (CHEBI:234097) is a organic molecular entity (CHEBI:50860) |
| 2-(2-phenylcyclobutyl)phenol (CHEBI:230800) is a organic molecular entity (CHEBI:50860) |
| 2-(3,4-dichlorophenyl)ethanamine (CHEBI:232143) is a organic molecular entity (CHEBI:50860) |
| 2-(5-nitrothiophen-3-yl)pyrimidine (CHEBI:234096) is a organic molecular entity (CHEBI:50860) |
| 2-(6-(4-(2-Chloro-5-fluorophenoxy)piperidin-1-yl)pyridazin-3-yl)-5-methyl-1,3,4-oxadiazole (CHEBI:233365) is a organic molecular entity (CHEBI:50860) |
| 2-(6-chloro-5,7-dimethyl-3-oxo-1,4-benzoxazin-4-yl)acetic acid (CHEBI:232950) is a organic molecular entity (CHEBI:50860) |
| 2-(8-[5]-ladderane-octanyl)-sn-glycerol (CHEBI:230603) is a organic molecular entity (CHEBI:50860) |
| 2-(alpha-D-Glucosyl)-sn-glycerol (CHEBI:134177) is a organic molecular entity (CHEBI:50860) |
| 2-(Alpha-Hydroxybenzyl)Heptanal (CHEBI:195337) is a organic molecular entity (CHEBI:50860) |
| 2-(aminomethyl)benzene-1,3-diol (CHEBI:231851) is a organic molecular entity (CHEBI:50860) |
| 2-(benzylamino)-N-pyridin-2-yl-2-sulfanylideneacetamide (CHEBI:234414) is a organic molecular entity (CHEBI:50860) |
| 2-(diethylamino)-N-(3-phenylmethoxyphenyl)acetamide (CHEBI:232622) is a organic molecular entity (CHEBI:50860) |
| 2-(dimethylsulfonio)ethyl (2r)-2-(docosanoyloxy)-3-(icosanoyloxy)propyl phosphate (CHEBI:230804) is a organic molecular entity (CHEBI:50860) |
| 2-(hydroxymethyl)-2-(4-methylpent-3-en-1-yl)-2h-chromen-8-ol (CHEBI:230696) is a organic molecular entity (CHEBI:50860) |
| 2-(methoxymethyl)-1H-pyrimido[1,2-a]benzimidazol-4-one (CHEBI:232498) is a organic molecular entity (CHEBI:50860) |
| 2-(nonylsulfonylamino)benzoic acid (CHEBI:747873) is a organic molecular entity (CHEBI:50860) |
| 2-(phenylsulfonyl)ethyl hydrogen sulfate (CHEBI:747424) is a organic molecular entity (CHEBI:50860) |
| 2-[(L-alanin-3-ylcarbamoyl)methyl]-2-hydroxybutanedioate(2−) (CHEBI:142969) is a organic molecular entity (CHEBI:50860) |
| 2-[(L-alanin-3-ylcarbamoyl)methyl]-3-(2-aminoethylcarbamoyl)-2-hydroxypropanoate (CHEBI:142971) is a organic molecular entity (CHEBI:50860) |
| 2-[(2-aminoethylcarbamoyl)methyl]-2-hydroxybutanedioate (CHEBI:142970) is a organic molecular entity (CHEBI:50860) |
| 2-[(5-tert-butyl-2-methylphenyl)sulfonylamino]benzoic acid (CHEBI:233223) is a organic molecular entity (CHEBI:50860) |
| 2-[4-(2H-tetrazol-5-yl)anilino]propanoic acid (CHEBI:233977) is a organic molecular entity (CHEBI:50860) |
| 2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID (CHEBI:45377) is a organic molecular entity (CHEBI:50860) |
| 2-O-[6-O-octanoyl-α-D-glucopyranosyl-(1→6)-α-D-glucopyranosyl]-D-glycerate (CHEBI:141058) is a organic molecular entity (CHEBI:50860) |
| 2-O-[α-D-glucopyranosyl-(1→6)-α-D-glucopyranosyl]-D-glycerate (CHEBI:141056) is a organic molecular entity (CHEBI:50860) |
| 2-trans,4-cis-decadienoylcarnitine (CHEBI:156419) is a organic molecular entity (CHEBI:50860) |
| 2-AAPA (CHEBI:234428) is a organic molecular entity (CHEBI:50860) |
| 2-acetyl-4(5)-tetrahydroxybutyl imidazole (CHEBI:233845) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-(α-D-mannosyl-(1→2)-α-D-mannosyl-(1→6)-α-D-mannosyl-(1→4)-α-D-glucosaminyl)-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144074) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144054) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[6-phosphoethanolamine-α-D-mannosyl-(1→2)-6-phosphoethanolamine-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144080) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[6-phosphoethanolamine-α-D-mannosyl-(1→2)-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144079) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[α-D-mannosyl-(1→2)-6-phosphoethanolamine-α-D-mannosyl-(1→2)-6-phosphoethanolamine-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144092) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[α-D-mannosyl-(1→2)-6-phosphoethanolamine-α-D-mannosyl-(1→2)-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144091) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[α-D-mannosyl-(1→2)-α-D-mannosyl-(1→2)-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144090) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[α-D-mannosyl-(1→2)-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144035) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144036) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-[α-D-mannosyl-(1→6)-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144028) is a organic molecular entity (CHEBI:50860) |
| 2-acyl-6-α-D-glucosaminyl-1-(1,2-diacyl-sn-glycero-3-phospho)-1D-myo-inositol zwitterion (CHEBI:144033) is a organic molecular entity (CHEBI:50860) |
| 2-acylphloroglucinol 1-O-β-D-glucoside (CHEBI:141060) is a organic molecular entity (CHEBI:50860) |
| 2-Alkylmalic acid (CHEBI:80994) is a organic molecular entity (CHEBI:50860) |
| 2-amino-2-deoxy-D-mannitol (CHEBI:192771) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-3-(1H-1,2,4-triazol-1-yl)propanoic acid (CHEBI:747846) is a organic molecular entity (CHEBI:50860) |
| 2-amino-3-(6-hydroxy-2-naphthyl)-propanoic acid (CHEBI:232941) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-3-[4-(2-aminoethoxy)phenyl]propanoic acid (CHEBI:233116) is a organic molecular entity (CHEBI:50860) |
| 2-amino-3-hydroxyoctadecyl beta-d-glucopyranoside (CHEBI:230572) is a organic molecular entity (CHEBI:50860) |
| 2-amino-5-chloro-cis,cis-muconate 6-semialdehyde zwitterion (CHEBI:75057) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-6-((R)-tetrahydrofuran-2-carboxyamido)-hexanoic acid (2Thf-Lys) (CHEBI:233039) is a organic molecular entity (CHEBI:50860) |
| 2-amino-6-(but-3-enyloxy)carbonylamino-hexanoic-acid (CHEBI:232666) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-6-(but-3-ynoxycarbonylamino)hexanoic acid (CHEBI:232668) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-6-(cyclopentanecarboxyamino)hexanoicacid(Cpn-Lys) (CHEBI:233038) is a organic molecular entity (CHEBI:50860) |
| 2-amino-6-(pent-4-enyloxy)carbonylamino-hexanoic acid (CHEBI:232667) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-6-(pent-4-ynoxycarbonylamino)hexanoic acid (CHEBI:232669) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-6-[(4-iodophenyl)methoxycarbonylamino]hexanoic acid (CHEBI:232670) is a organic molecular entity (CHEBI:50860) |
| 2-amino-6-diazo-5-oxohexanoic acid (CHEBI:232155) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-7-octenoic acid (CHEBI:234154) is a organic molecular entity (CHEBI:50860) |
| 2-Amino-8-oxononanoic acid (CHEBI:233098) is a organic molecular entity (CHEBI:50860) |
| 2-Aminodecanoic acid (CHEBI:233025) is a organic molecular entity (CHEBI:50860) |
| 2-Aminononanoic acid (CHEBI:233024) is a organic molecular entity (CHEBI:50860) |
| 2-aminooct-7-enoic acid (CHEBI:233029) is a organic molecular entity (CHEBI:50860) |
| 2-aminophenol-4-sulfonic acid (CHEBI:760555) is a organic molecular entity (CHEBI:50860) |
| 2-azelaoyl-sn-glycero-3-phosphocholine(1−) (CHEBI:145780) is a organic molecular entity (CHEBI:50860) |
| 2-Azidoethyl 2-Acetamido-2-deoxy-beta-D-glucopyranoside (CHEBI:229508) is a organic molecular entity (CHEBI:50860) |
| 2-chloradenosine (CHEBI:235318) is a organic molecular entity (CHEBI:50860) |
| 2-chloro-stearic acid (CHEBI:230606) is a organic molecular entity (CHEBI:50860) |
| 2-Chlorophenylhydrazine hydrochloride (CHEBI:1046) is a organic molecular entity (CHEBI:50860) |
| 2-Cl-IB-MECA (CHEBI:747623) is a organic molecular entity (CHEBI:50860) |
| 2-ethyl-4-methylimidazole (CHEBI:747839) is a organic molecular entity (CHEBI:50860) |
| 2-ethyl-5-oxohexanoic acid (CHEBI:233711) is a organic molecular entity (CHEBI:50860) |
| 2-ethylhexanoic acid glucuronide (CHEBI:233712) is a organic molecular entity (CHEBI:50860) |
| 2-glutaroyl-sn-glycero-3-phosphocholine(1−) (CHEBI:145781) is a organic molecular entity (CHEBI:50860) |
| 2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID (CHEBI:45504) is a organic molecular entity (CHEBI:50860) |
| 2-Hydroxy-3-methyl-beta-keto-L-tyrosyl-[pcp] (CHEBI:31081) is a organic molecular entity (CHEBI:50860) |
| 2-Hydroxy-beta-keto-L-tyrosyl-[pcp] (CHEBI:31083) is a organic molecular entity (CHEBI:50860) |
| 2-hydroxyatorvastatin lactone (CHEBI:180932) is a organic molecular entity (CHEBI:50860) |
| 2-hydroxyethyl furan-5-carboxylic acid (CHEBI:747907) is a organic molecular entity (CHEBI:50860) |
| 2-iodopalmitaldehyde (CHEBI:230644) is a organic molecular entity (CHEBI:50860) |
| 2-methoxy-N-[(1-phenylcyclopentyl)methyl]benzamide (CHEBI:233046) is a organic molecular entity (CHEBI:50860) |
| 2-methyl-3-hydroxy indole (CHEBI:68776) is a organic molecular entity (CHEBI:50860) |
| 2-methyl-7-(2-methyloctan-2-yl)-2H-chromen-5-ol (CHEBI:234402) is a organic molecular entity (CHEBI:50860) |
| 2-methyl-7-pentyl-2H-chromen-5-ol (CHEBI:234404) is a organic molecular entity (CHEBI:50860) |
| 2-methyldocosane (CHEBI:233465) is a organic molecular entity (CHEBI:50860) |
| 2-methyloctacosane (CHEBI:233574) is a organic molecular entity (CHEBI:50860) |
| 2-Methylthio-ATP (CHEBI:231750) is a organic molecular entity (CHEBI:50860) |
| 2-O-(2-hydroxyethyl) 5-O-methyl furan-2,5-dicarboxylate (CHEBI:747908) is a organic molecular entity (CHEBI:50860) |
| 2-O-acetylbulbisine Trifluoroacetic acid (CHEBI:68316) is a organic molecular entity (CHEBI:50860) |
| 2-O-acetylcrinamabine Trifluoroacetic acid (CHEBI:68314) is a organic molecular entity (CHEBI:50860) |
| 2-O-methyl-d-xylopyranose (CHEBI:195333) is a organic molecular entity (CHEBI:50860) |
| 2-oleoyl-sn-glycero-3-phospho-(1'-sn-glycerol) (CHEBI:141490) is a organic molecular entity (CHEBI:50860) |
| 2-oxoclopidogrel (CHEBI:230580) is a organic molecular entity (CHEBI:50860) |
| 2-PROPYLPENTANAMIDE (CHEBI:46316) is a organic molecular entity (CHEBI:50860) |
| 2-Pyrroline-2-carboxyl-[pcp] (CHEBI:31088) is a organic molecular entity (CHEBI:50860) |
| 2-selenouridine 5'-monophosphate zwitterion residue (CHEBI:232024) is a organic molecular entity (CHEBI:50860) |
| 2,10-dihydroxy-4,6,8-decatriynoic acid (CHEBI:230812) is a organic molecular entity (CHEBI:50860) |
| 2,2-dimethyl-7-(2-methyloctan-2-yl)-2H-chromen-5-ol (CHEBI:234401) is a organic molecular entity (CHEBI:50860) |
| 2,2-dimethyl-7-pentyl-2H-chromen-5-ol (CHEBI:234403) is a organic molecular entity (CHEBI:50860) |
| 2,2,2-trichloro-1-(2,3,4,5,6-pentafluorophenyl)ethanol (CHEBI:233267) is a organic molecular entity (CHEBI:50860) |
| 2,2,2-trichloro-1-(4-fluorophenyl)ethanol (CHEBI:233268) is a organic molecular entity (CHEBI:50860) |
| 2,2,2-trichloro-1-[4-(trifluoromethyl)phenyl]ethanol (CHEBI:233269) is a organic molecular entity (CHEBI:50860) |
| 2,2,3,3-tetrafluoro-3-(trifluoromethoxy)propanoic acid (CHEBI:231617) is a organic molecular entity (CHEBI:50860) |
| 2,2',2''-((2R,5R,8S,11R)-11-((2R,4S,5E,7E,9E)-2,4-dihydroxypentadeca-5,7,9-trien-1-yl)-3,6,9,13,17-pentaoxo-1,4,7,10,14-pentaazacycloheptadecane-2,5,8-triyl)triacetamide (CHEBI:167190) is a organic molecular entity (CHEBI:50860) |
| 2,3-DCPE hydrochloride (CHEBI:231349) is a organic molecular entity (CHEBI:50860) |
| 2,3-dinor-5,6-dihydro-8-epi-prostaglandin F2α(1−) (CHEBI:234500) is a organic molecular entity (CHEBI:50860) |
| 2,3-Ene acid (CHEBI:891) is a organic molecular entity (CHEBI:50860) |
| 2,3,4,5,-TetraFluoro-D-phenylalanine (CHEBI:747856) is a organic molecular entity (CHEBI:50860) |
| 2,3,5,6-tetrafluorophenyl isothiocyanate (CHEBI:234094) is a organic molecular entity (CHEBI:50860) |
| 2,4-Diaminophenol (CHEBI:747613) is a organic molecular entity (CHEBI:50860) |
| 2,4-Diaminoresorcinol (CHEBI:747612) is a organic molecular entity (CHEBI:50860) |
| 2,4-DIoxo acid (CHEBI:902) is a organic molecular entity (CHEBI:50860) |
| 2,4-pentadecadienal (CHEBI:230718) is a organic molecular entity (CHEBI:50860) |
| 2,5-dihydroxybenzoic acid-5-O-glucoside (CHEBI:176885) is a organic molecular entity (CHEBI:50860) |
| 2,5-dimethyl-2e-tridecenoic acid (CHEBI:230710) is a organic molecular entity (CHEBI:50860) |
| 2,5-dimethylcelecoxib (CHEBI:232608) is a organic molecular entity (CHEBI:50860) |
| 2,6-Dichlorophenolindophenol sodium salt (CHEBI:948) is a organic molecular entity (CHEBI:50860) |
| 2,6-Difluoro-p-benzoylPhe (CHEBI:232825) is a organic molecular entity (CHEBI:50860) |
| 2,6-dimethylcyclohexanone (CHEBI:234093) is a organic molecular entity (CHEBI:50860) |
| 2,6,7-trihydroxybenzothiazole (CHEBI:747046) is a organic molecular entity (CHEBI:50860) |
| 2,7-dihydroxy-6-methylbenzothiazole (CHEBI:747044) is a organic molecular entity (CHEBI:50860) |
| 2,8-diaminonaphthalen-1-ol (CHEBI:747422) is a organic molecular entity (CHEBI:50860) |
| 2'-aTCOK (CHEBI:233438) is a organic molecular entity (CHEBI:50860) |
| 2'-chloro-deoxyinosine 5'-monophosphate(2−) (CHEBI:231723) is a organic molecular entity (CHEBI:50860) |
| 2'-deoxyribose 5'-monophosphate residue (CHEBI:139094) is a organic molecular entity (CHEBI:50860) |
| 2'-Hydroxy caffeic acid (CHEBI:81490) is a organic molecular entity (CHEBI:50860) |
| 2'-Hydroxy-MDCA (CHEBI:81492) is a organic molecular entity (CHEBI:50860) |
| 2'-Hydroxyferulic acid (CHEBI:81491) is a organic molecular entity (CHEBI:50860) |
| 2',4'-Dihydroxycinnamic acid (CHEBI:81493) is a organic molecular entity (CHEBI:50860) |
| 20-dihydrochaetoglobosin A (CHEBI:68754) is a organic molecular entity (CHEBI:50860) |
| 20-dihydrodydrogesterone (CHEBI:230689) is a organic molecular entity (CHEBI:50860) |
| 20-Hydroxy prostaglandin F2alpha (CHEBI:229535) is a organic molecular entity (CHEBI:50860) |
| 24-Norursa-3,12-dien-11-one (CHEBI:230346) is a organic molecular entity (CHEBI:50860) |
| 24(28)-Dehydromakisterone (CHEBI:231175) is a organic molecular entity (CHEBI:50860) |
| 25-hydroxy-16,17,23,23,24,24-hexadehydrovitamin d3 / 25-hydroxy-16,17,23,23,24,24-hexadehydrocholecalciferol (CHEBI:230583) is a organic molecular entity (CHEBI:50860) |
| 25-hydroxy-16,17,23,24-tetradehydrovitamin d3 / 25-hydroxy-16,17,23,24-tetradehydrocholecalciferol (CHEBI:230555) is a organic molecular entity (CHEBI:50860) |
| 25-O-Deacetylrifabutin (CHEBI:186416) is a organic molecular entity (CHEBI:50860) |
| 26,27-bisnor-22-dehydro-cholesterol (CHEBI:230712) is a organic molecular entity (CHEBI:50860) |
| 26,27-diethyl-1alpha,25-dihydroxy-22-thiavitamin d3 / 26,27-diethyl-1alpha,25-dihydroxy-22-thiacholecalciferol (CHEBI:230762) is a organic molecular entity (CHEBI:50860) |
| 2BAct (CHEBI:747375) is a organic molecular entity (CHEBI:50860) |
| 2S2-6S4 (CHEBI:233782) is a organic molecular entity (CHEBI:50860) |
| 3-((3R,5R,7S,8E,10E,12E)-3-amino-5-hydroxy-7-methoxyoctadeca-8,10,12-trienamido)propanoic acid (CHEBI:167186) is a organic molecular entity (CHEBI:50860) |
| 3-(2-furyl)alanine (CHEBI:233114) is a organic molecular entity (CHEBI:50860) |
| 3-(2-Thienyl)alanine (CHEBI:233112) is a organic molecular entity (CHEBI:50860) |
| 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone (CHEBI:747830) is a organic molecular entity (CHEBI:50860) |
| 3-(6-methylpyridin-2-yl)-N-phenyl-4-(quinolin-4-yl)-1H-pyrazole-1-carbothioamide (CHEBI:233322) is a organic molecular entity (CHEBI:50860) |
| 3-(but-3-en-1-yn-1-yl)-6-methyl-1,2-dithiine (CHEBI:230565) is a organic molecular entity (CHEBI:50860) |
| 3-(p-tolyl diazenyl)pentane-2,4-dione (CHEBI:747039) is a organic molecular entity (CHEBI:50860) |
| 3-[(2S,9R,10R,11S,14R,15S)-14-Hydroxy-9-methoxycarbonyl-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-en-14-yl]propanoic acid (CHEBI:183915) is a organic molecular entity (CHEBI:50860) |
| 3-[(6-acetyl-2-naphthalenyl)amino]Alanine (CHEBI:232653) is a organic molecular entity (CHEBI:50860) |
| 3-[[(3S)-1,2,3,4-tetrahydroisoquinoline-3-carbonyl]amino]propanoic acid (CHEBI:232581) is a organic molecular entity (CHEBI:50860) |
| 3-[[[[[(5S)-5-Amino-5-carboxypentyl]amino]carbonyl]oxy]methyl]-2,5-dihydro-2,2,5,5-tetramethyl-1H-pyrrol-1-yloxy (CHEBI:233119) is a organic molecular entity (CHEBI:50860) |
| 3-[3-(TERT-BUTYLTHIO)-1-(4-CHLOROBENZYL)-5-(QUINOLIN-2-YLMETHOXY)-1H-INDOL-2-YL]-2,2-DIMETHYLPROPANOIC ACID (CHEBI:47084) is a organic molecular entity (CHEBI:50860) |
| 3-{(e)-2-[3,5-dihydroxy-4-(3-methyl-2-buten-1-yl)phenyl]vinyl}-2,6-dihydroxyphenyl hydrogen sulfate (CHEBI:230680) is a organic molecular entity (CHEBI:50860) |
| 3-{[(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(nonanoyloxy)propyl nonanoate (CHEBI:230639) is a organic molecular entity (CHEBI:50860) |
| 3-{3,5-dimethyl-4-[3-(3-methylisoxazol-5-yl)propoxy]phenyl}-5-trifluoromethyl-1,2,4-oxadiazole (CHEBI:46479) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(3-O-sulfo)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142171) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(3-O-sulfo)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142173) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(3-O-sulfo)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142172) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(3-O-sulfo)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142175) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(3-O-sulfo)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142176) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(3-O-sulfo)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142174) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142297) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142299) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142298) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142325) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142326) is a organic molecular entity (CHEBI:50860) |
| 3-O-sulfo-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142324) is a organic molecular entity (CHEBI:50860) |
| 3-acetyl-4a,6,7,9,12a-pentahydroxy-4,5-dioxo-1,4,4a,5,12,12a-hexahydrotetracen-2-olate (CHEBI:146218) is a organic molecular entity (CHEBI:50860) |
| 3-Acetylenic fatty acyl thioesters (CHEBI:1444) is a organic molecular entity (CHEBI:50860) |
| 3-acetylpyridine adenine dinucleotide (CHEBI:166857) is a organic molecular entity (CHEBI:50860) |
| 3-Alkylmalic acid (CHEBI:80995) is a organic molecular entity (CHEBI:50860) |
| 3-Amino-3-(5-chloro-3,4-dihydroxyphenyl)propanoyl-[pcp] (CHEBI:1451) is a organic molecular entity (CHEBI:50860) |
| 3-amino-4-hydroxybenzenesulfonamide (CHEBI:760554) is a organic molecular entity (CHEBI:50860) |
| 3-aminopropyl N-(6-acetylnaphthalen-2-yl)-N-methylcarbamate (CHEBI:233289) is a organic molecular entity (CHEBI:50860) |
| 3-Azido-L-tyrosine (CHEBI:232942) is a organic molecular entity (CHEBI:50860) |
| 3-CPMT (CHEBI:231368) is a organic molecular entity (CHEBI:50860) |
| 3-Decanoyl-[acyl-carrier protein] (CHEBI:1480) is a organic molecular entity (CHEBI:50860) |
| 3-demethyl-ubiquinone-7(1−) (CHEBI:231822) is a organic molecular entity (CHEBI:50860) |
| 3-demethylubiquinone-10(1−) (CHEBI:231824) is a organic molecular entity (CHEBI:50860) |
| 3-demethylubiquinone-6(1−) (CHEBI:231821) is a organic molecular entity (CHEBI:50860) |
| 3-demethylubiquinone-8(1−) (CHEBI:231823) is a organic molecular entity (CHEBI:50860) |
| 3-Dimethylallyl-beta-hydroxy-L-tyrosyl-[pcp] (CHEBI:31114) is a organic molecular entity (CHEBI:50860) |
| 3-ethyl-7,11-dimethyltrideca-1,3z,6e,10-tetraene (CHEBI:230744) is a organic molecular entity (CHEBI:50860) |
| 3-Fluoro-4-nitro-p-benzoyl-L-phenylalanine (CHEBI:232828) is a organic molecular entity (CHEBI:50860) |
| 3-Hydroxy-2-Ethylhexenoic acid Coenzyme A (CHEBI:233769) is a organic molecular entity (CHEBI:50860) |
| 3-hydroxy-3'-nitro-2-naphthanilide (CHEBI:234060) is a organic molecular entity (CHEBI:50860) |
| 3-hydroxydesloratadine (CHEBI:746954) is a organic molecular entity (CHEBI:50860) |
| 3-Hydroxykynurenine glucoside (CHEBI:195248) is a organic molecular entity (CHEBI:50860) |
| 3-hydroxymonocarboxylic acid (CHEBI:1549) is a organic molecular entity (CHEBI:50860) |
| 3-hydroxyoct-3-enoylglycine (CHEBI:187355) is a organic molecular entity (CHEBI:50860) |
| 3-Hydroxyoctadecanoyl-[acp] (CHEBI:80387) is a organic molecular entity (CHEBI:50860) |
| 3-hydroxypropenoate(1-) (CHEBI:155969) is a organic molecular entity (CHEBI:50860) |
| 3-mercaptolactate-cysteine disulfide (CHEBI:140724) is a organic molecular entity (CHEBI:50860) |
| 3-mercaptolactic acid-cysteine disulfide (CHEBI:140723) is a organic molecular entity (CHEBI:50860) |
| 3-methyl-1-oxo-2-[3-oxo-3-(pyrrolidin-1-yl)propyl]-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile (CHEBI:158799) is a organic molecular entity (CHEBI:50860) |
| 3-Methyl-beta-keto-L-tyrosyl-[pcp] (CHEBI:31118) is a organic molecular entity (CHEBI:50860) |
| 3-methyladenine DNA (CHEBI:137218) is a organic molecular entity (CHEBI:50860) |
| 3-methylcrotonylcarnitine (CHEBI:233821) is a organic molecular entity (CHEBI:50860) |
| 3-Nitrooxypropanol (CHEBI:232818) is a organic molecular entity (CHEBI:50860) |
| 3-O-acetyl-8-O-demethylmaritidine Trifluoroacetic acid (CHEBI:68315) is a organic molecular entity (CHEBI:50860) |
| 3-oxo-(2S,6R,10R)-trimethyl-hendecanoyl-CoA(4-) (CHEBI:747147) is a organic molecular entity (CHEBI:50860) |
| 3-Oxo-2-Ethylhexanoic acid Coenzyme A (CHEBI:233770) is a organic molecular entity (CHEBI:50860) |
| 3-Oxodecanoyl-[acp] (CHEBI:1634) is a organic molecular entity (CHEBI:50860) |
| 3-Oxododecanoyl-[acp] (CHEBI:1637) is a organic molecular entity (CHEBI:50860) |
| 3-Oxohexanoyl-[acp] (CHEBI:1642) is a organic molecular entity (CHEBI:50860) |
| 3-Oxooctanoyl-[acp] (CHEBI:1646) is a organic molecular entity (CHEBI:50860) |
| 3-Oxostearoyl-[acp] (CHEBI:80386) is a organic molecular entity (CHEBI:50860) |
| 3-Oxotetradecanoyl-[acp] (CHEBI:1655) is a organic molecular entity (CHEBI:50860) |
| 3-Phosphoadenylylselenate(4-) (CHEBI:140698) is a organic molecular entity (CHEBI:50860) |
| 3-propylphenol (CHEBI:233241) is a organic molecular entity (CHEBI:50860) |
| 3,3-bis(trifluoromethyl)bicyclo[2.2.1]heptane-2,2-dicarbonitrile (CHEBI:232164) is a organic molecular entity (CHEBI:50860) |
| 3,4-dehydrobrevicomin (CHEBI:233448) is a organic molecular entity (CHEBI:50860) |
| 3,4-dichloroamphetamine (CHEBI:234126) is a organic molecular entity (CHEBI:50860) |
| 3,4-difluorobenzylidene curcumin (CHEBI:231749) is a organic molecular entity (CHEBI:50860) |
| 3,4-Dihydroxy-L-phenylalanyl-[pcp] (CHEBI:1378) is a organic molecular entity (CHEBI:50860) |
| 3,4-methylenedioxyphenylalanine (CHEBI:233115) is a organic molecular entity (CHEBI:50860) |
| 3,4-methylenedioxypyrovalerone (CHEBI:233286) is a organic molecular entity (CHEBI:50860) |
| 3,4,5-trifluorophenylalanine (CHEBI:747857) is a organic molecular entity (CHEBI:50860) |
| 3,4,5-Trimethoxybenzoic acid acylated spermidine (CHEBI:234023) is a organic molecular entity (CHEBI:50860) |
| 3,5-cholestadien-7-one (CHEBI:230561) is a organic molecular entity (CHEBI:50860) |
| 3,5-Dibromo-N'-((2,5-dimethyl-1-(3-nitrophenyl)-1H-pyrrol-3-yl)methylene)-4-hydroxybenzohydrazide (CHEBI:229459) is a organic molecular entity (CHEBI:50860) |
| 3,5-dimethyl-1-oxo-2-[3-oxo-3-(pyrrolidin-1-yl)propyl]-1,5-dihydrobenzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile (CHEBI:158993) is a organic molecular entity (CHEBI:50860) |
| 3,5-Dioxo acid (CHEBI:1410) is a organic molecular entity (CHEBI:50860) |
| 3,5-dithiocyanatopyridine-2,6-diamine (CHEBI:232487) is a organic molecular entity (CHEBI:50860) |
| 3,5,6-triamino-4,7-dihydroxynaphthalene-2-sulfonic acid (CHEBI:747428) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,11,13,15-Heptaoxo-9-hydroxy-heptadecanoyl-[acp] (CHEBI:31091) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,11,13,15-Heptaoxo-9-hydroxy-hexadecanoyl-[acp] (CHEBI:31092) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,11,13,15-Heptaoxo-9-hydroxy-octadecanoyl-[acp] (CHEBI:31093) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15-Heptaoxo-heptadecanoyl-[acp] (CHEBI:31100) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15-Heptaoxo-hexadecanoyl-[acp] (CHEBI:31101) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15-Heptaoxo-octadecanoyl-[acp] (CHEBI:31102) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15,17-Octaoxo-eicosanoyl-[acp] (CHEBI:31097) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15,17-Octaoxo-nonadecanoyl-[acp] (CHEBI:31098) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15,17-Octaoxo-octadecanoyl-[acp] (CHEBI:31099) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15,17,19-Nonaoxo-docosanoyl-[acp] (CHEBI:31094) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15,17,19-Nonaoxo-eicosanoyl-[acp] (CHEBI:31095) is a organic molecular entity (CHEBI:50860) |
| 3,5,7,9,11,13,15,17,19-Nonaoxo-henicosanoyl-[acp] (CHEBI:31096) is a organic molecular entity (CHEBI:50860) |
| 3,6,9,12,15-octadecapentaenoic acid (CHEBI:230569) is a organic molecular entity (CHEBI:50860) |
| 3'-O-salicyl-AMP(2−) (CHEBI:142981) is a organic molecular entity (CHEBI:50860) |
| 3'-hydro-2'-hydroxy-β-oxodihydrochalcone (CHEBI:142482) is a organic molecular entity (CHEBI:50860) |
| 3'-hydroxyflavone (CHEBI:63326) is a organic molecular entity (CHEBI:50860) |
| 3'-n-acetyl-4'-o-(14-methylheptadecanoyl)fusarochromanone (CHEBI:230571) is a organic molecular entity (CHEBI:50860) |
| 3',3'-cUAMP(2−) (CHEBI:143809) is a organic molecular entity (CHEBI:50860) |
| 3',4'-dimethoxyflavone (CHEBI:232299) is a organic molecular entity (CHEBI:50860) |
| 3'SLN (CHEBI:156513) is a organic molecular entity (CHEBI:50860) |
| 33-Deoxy-33-hydroperoxyfurohyperforin (CHEBI:176807) is a organic molecular entity (CHEBI:50860) |
| 3BDO (CHEBI:232795) is a organic molecular entity (CHEBI:50860) |
| 3beta-(p-chlorophenyl)tropane-2beta-carboxylic acid, 4'-azido-3'-iodophenylethyl ester (CHEBI:188463) is a organic molecular entity (CHEBI:50860) |
| 3beta,11beta-Diacetoxy-1alpha-hydroxykaura-16-ene-6,15-dione (CHEBI:5921) is a organic molecular entity (CHEBI:50860) |
| 3e,9z,12z,15z-octadecatetraenoic acid (CHEBI:230563) is a organic molecular entity (CHEBI:50860) |
| 4-((E)-(2-hydroxy-5-nitrophenyl)diazenyl)-2-((E)-methyldiazenyl)benzene-1,3-diol (CHEBI:747749) is a organic molecular entity (CHEBI:50860) |
| 4-(2-amino-6,7-dihydro-5H-pyrimido[5,4-c]carbazol-10-yl)-2-methylbut-3-yn-2-ol (CHEBI:194086) is a organic molecular entity (CHEBI:50860) |
| 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (CHEBI:233276) is a organic molecular entity (CHEBI:50860) |
| 4-(4-benzylpiperazin-1-yl)-6,7-dimethoxyquinazoline (CHEBI:233298) is a organic molecular entity (CHEBI:50860) |
| 4-(4-Fluoronaphthalen-1-yl)-6-isopropylpyrimidin-2-amine (CHEBI:232982) is a organic molecular entity (CHEBI:50860) |
| 4-(5-(4-Chlorophenyl)-3-(2-(4-phenoxybenzylidene)hydrazine-1-carbonyl)-1h-pyrazol-1-yl)benzenesulfonamide (CHEBI:747877) is a organic molecular entity (CHEBI:50860) |
| 4-(5-PYRIDIN-4-YL-1H-1,2,4-TRIAZOL-3-YL)PYRIDINE-2-CARBONITRILE (CHEBI:42614) is a organic molecular entity (CHEBI:50860) |
| 4-(6-methyl-s-tetrazin-3-yl)amino-L-phenylalanine (CHEBI:232937) is a organic molecular entity (CHEBI:50860) |
| 4-(methylsulfonyl)aniline (CHEBI:747036) is a organic molecular entity (CHEBI:50860) |
| 4-(N-Ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino)pyrimidinium chloride (CHEBI:197388) is a organic molecular entity (CHEBI:50860) |
| 4-(N-Maleimido)benzyltrimethylammonium iodide (CHEBI:34381) is a organic molecular entity (CHEBI:50860) |
| 4-(N-Maleimido)phenyltrimethylammonium iodide (CHEBI:34382) is a organic molecular entity (CHEBI:50860) |
| 4-[(E)-2-isocyanoethenyl]phenol (CHEBI:140650) is a organic molecular entity (CHEBI:50860) |
| 4-[4-[4-[2-[(4-fluorophenyl)methylamino]ethyl]piperazin-1-yl]phenyl]benzene-1,2-diol (CHEBI:234561) is a organic molecular entity (CHEBI:50860) |
| 4-{(e)-2-[(1,2-dicarboxyethyl)amino]vinyl}-2,3-dihydro-2,6-pyridinedicarboxylic acid (CHEBI:230760) is a organic molecular entity (CHEBI:50860) |
| 4-{[(2S,5S)-5-[(4-hydroxyphenyl)methyl]-2,5-dihydropyrazin-2-yl]methyl}phenol(1+) (CHEBI:145881) is a organic molecular entity (CHEBI:50860) |
| 4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile (CHEBI:49903) is a organic molecular entity (CHEBI:50860) |
| 4-O-feruloylquinic acid (CHEBI:176888) is a organic molecular entity (CHEBI:50860) |
| 4-amino-3-all-trans-hexaprenylbenzoate (CHEBI:142618) is a organic molecular entity (CHEBI:50860) |
| 4-amino-5-hydroxy-3-(2-(4-((2-hydroxyethyl)sulfonyl)phenyl)hydrazinyl)-6-(2-(4-sulfophenyl)hydrazinyl)naphthalene-2,7-disulfonic acid (CHEBI:747419) is a organic molecular entity (CHEBI:50860) |
| 4-amino-5-hydroxy-3-all-trans-hexaprenylbenzoate (CHEBI:142619) is a organic molecular entity (CHEBI:50860) |
| 4-amino-5-hydroxy-3,6-bis((E)-(4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)diazenyl)naphthalene-2,7-disulfonic acid (CHEBI:747411) is a organic molecular entity (CHEBI:50860) |
| 4-aminobenzenesulfurous acid (CHEBI:747425) is a organic molecular entity (CHEBI:50860) |
| 4-Aminobutyryl-[acp] (CHEBI:81452) is a organic molecular entity (CHEBI:50860) |
| 4-bromo-2-[4-(3-methoxyphenyl)-2,2-dimethyl-5,6-dihydro-1H-pyrimidin-6-yl]phenol (CHEBI:232897) is a organic molecular entity (CHEBI:50860) |
| 4-Dedimethylamino sancycline (CHEBI:230426) is a organic molecular entity (CHEBI:50860) |
| 4-deoxy-6-O-methyl-L-threo-hex-4-enopyranuronate (CHEBI:145031) is a organic molecular entity (CHEBI:50860) |
| 4-Deoxy-alpha-L-erythro-hex-4-enopyranuronoside (CHEBI:1822) is a organic molecular entity (CHEBI:50860) |
| 4-fluoro-2-(trifluoromethyl)aniline (CHEBI:230764) is a organic molecular entity (CHEBI:50860) |
| 4-fluoro-p-benzoyl-DL-phenylalanine (CHEBI:232458) is a organic molecular entity (CHEBI:50860) |
| 4-Fluoro-p-benzoyl-L-phenylalanine (CHEBI:232823) is a organic molecular entity (CHEBI:50860) |
| 4-HNEM (CHEBI:189058) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxy-15-methylhexadecasphinganine-phosphocholine (CHEBI:140519) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxy-15-methylhexadecasphinganine-phosphocholine(1+) (CHEBI:140520) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxy-2-deoxyguanosine (CHEBI:233804) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxyantipyrine (CHEBI:232156) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxyatorvastatin lactone (CHEBI:180934) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxybenzyl isothiocyanate rhamnoside (CHEBI:230714) is a organic molecular entity (CHEBI:50860) |
| 4-Hydroxydiphenylamine (CHEBI:233240) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxymytiloxanthin (CHEBI:230675) is a organic molecular entity (CHEBI:50860) |
| 4-hydroxytamoxifen (CHEBI:231618) is a organic molecular entity (CHEBI:50860) |
| 4-Imidazolone-5-propanoate(1-) (CHEBI:140725) is a organic molecular entity (CHEBI:50860) |
| 4-Iodo-p-benzoyl-L-phenylalanine (CHEBI:232645) is a organic molecular entity (CHEBI:50860) |
| 4-Methoxy potassium salicylate (CHEBI:81692) is a organic molecular entity (CHEBI:50860) |
| 4-methylcyclohexan-1-ol (CHEBI:232315) is a organic molecular entity (CHEBI:50860) |
| 4-methylthioamphetamine (CHEBI:233986) is a organic molecular entity (CHEBI:50860) |
| 4-Nitro-p-benzoyl-L-phenylalanine (CHEBI:232827) is a organic molecular entity (CHEBI:50860) |
| 4-Nitroanilide (CHEBI:1909) is a organic molecular entity (CHEBI:50860) |
| 4-Octyl itaconate (CHEBI:233645) is a organic molecular entity (CHEBI:50860) |
| 4-pentynoyl-Coenzyme A (CHEBI:187666) is a organic molecular entity (CHEBI:50860) |
| 4-Substituted anilide (CHEBI:1931) is a organic molecular entity (CHEBI:50860) |
| 4-Substituted aniline (CHEBI:1932) is a organic molecular entity (CHEBI:50860) |
| 4-Substituted phenylacetate (CHEBI:1933) is a organic molecular entity (CHEBI:50860) |
| 4-Substituted phenylacetonitrile (CHEBI:1934) is a organic molecular entity (CHEBI:50860) |
| 4-sulfamoylbenzoate (CHEBI:747038) is a organic molecular entity (CHEBI:50860) |
| 4-tert-butyl-N-(2,3-dimethylphenyl)-1,3-thiazol-2-amine (CHEBI:233243) is a organic molecular entity (CHEBI:50860) |
| 4-tert-butylbenzaldehyde (CHEBI:232598) is a organic molecular entity (CHEBI:50860) |
| 4-thiouracil (CHEBI:232485) is a organic molecular entity (CHEBI:50860) |
| 4,4-difluoro-1alpha,25-dihydroxyvitamin d3 / 4,4-difluoro-1alpha,25-dihydroxycholecalciferol (CHEBI:230578) is a organic molecular entity (CHEBI:50860) |
| 4,5-Diaminofluorescein (CHEBI:229536) is a organic molecular entity (CHEBI:50860) |
| 4,5-diepi-aristolochene (CHEBI:232332) is a organic molecular entity (CHEBI:50860) |
| 4,5-dihydro-6beta-hydroxy-20alpha-dihydro-prednisolone (CHEBI:180926) is a organic molecular entity (CHEBI:50860) |
| 4,5-dihydro-6beta-hydroxy-20beta-dihydro-prednisolone (CHEBI:180927) is a organic molecular entity (CHEBI:50860) |
| 4,5-dihydro-6beta-hydroxyprednisolone (CHEBI:180925) is a organic molecular entity (CHEBI:50860) |
| 4,5-Dimethoxy-2 nitrobenzylserine (CHEBI:232944) is a organic molecular entity (CHEBI:50860) |
| 4,7-dihydroxynaphthalen-2-olate (CHEBI:747430) is a organic molecular entity (CHEBI:50860) |
| 4,9-anhydro-10-hemiketal-5-deoxyTTX (CHEBI:147353) is a organic molecular entity (CHEBI:50860) |
| 4,9,12,12-tetramethyl-5-oxatricyclo[8.2.0.04,6]dodecane (CHEBI:234388) is a organic molecular entity (CHEBI:50860) |
| 4'-hydroxy-5-carboxy-lumiracoxib (CHEBI:230774) is a organic molecular entity (CHEBI:50860) |
| 4'-hydroxyasperentin (CHEBI:68793) is a organic molecular entity (CHEBI:50860) |
| 4',6'-Diamidino-2-phenylindole (CHEBI:230448) is a organic molecular entity (CHEBI:50860) |
| 42O (CHEBI:232418) is a organic molecular entity (CHEBI:50860) |
| 4a-dehydroxycrinamabine Trifluoroacetic acid (CHEBI:68303) is a organic molecular entity (CHEBI:50860) |
| 4b5 (CHEBI:754221) is a organic molecular entity (CHEBI:50860) |
| 4beta-hydroxyobovatachromene (CHEBI:230551) is a organic molecular entity (CHEBI:50860) |
| 4E,8-Nonadienal (CHEBI:230343) is a organic molecular entity (CHEBI:50860) |
| 4E2RCat (CHEBI:189654) is a organic molecular entity (CHEBI:50860) |
| 4g7xh22 (CHEBI:754376) is a organic molecular entity (CHEBI:50860) |
| 4μ8C (CHEBI:233999) is a organic molecular entity (CHEBI:50860) |
| 5-((carboxymethyl)-carbamoyl)furan-2-carboxylic acid (CHEBI:748859) is a organic molecular entity (CHEBI:50860) |
| 5-(4-Cyclohexylphenyl)-3-(3-(fluoromethyl)azetidine-1-carbonyl)-2-(3-methylpyrazin-2-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one (CHEBI:234079) is a organic molecular entity (CHEBI:50860) |
| 5-(Methoxycarbonyl)furan-2-carboxylic acid (CHEBI:747909) is a organic molecular entity (CHEBI:50860) |
| 5-(methylcarbamoyl)furan-2-carboxylic acid (CHEBI:748867) is a organic molecular entity (CHEBI:50860) |
| 5-(N-ethyl-N-isopropyl) amiloride (CHEBI:233428) is a organic molecular entity (CHEBI:50860) |
| 5-(octadiynyl)-cytosine (CHEBI:228265) is a organic molecular entity (CHEBI:50860) |
| 5-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidine-2,4-dione (CHEBI:233244) is a organic molecular entity (CHEBI:50860) |
| 5-Akloxymethylfurfural (CHEBI:748814) is a organic molecular entity (CHEBI:50860) |
| 5-Benzyl-1-hydroxypyridin-2(1H)-one (CHEBI:189825) is a organic molecular entity (CHEBI:50860) |
| 5-bromo-3-[(4-hydroxyphenyl)methylidene]-1H-indol-2-one (CHEBI:233350) is a organic molecular entity (CHEBI:50860) |
| 5-bromoskatole (CHEBI:746861) is a organic molecular entity (CHEBI:50860) |
| 5-carboxy-lumiracoxib (CHEBI:230683) is a organic molecular entity (CHEBI:50860) |
| 5-Chloro-3,4-dihydroxy-L-phenylalanyl-[pcp] (CHEBI:2043) is a organic molecular entity (CHEBI:50860) |
| 5-chloromethylfurfural (CHEBI:748830) is a organic molecular entity (CHEBI:50860) |
| 5-deoxy-5-(7,8-dimethyl-2,4-dioxo-3,4,4a,5-tetrahydrobenzo[g]pteridin-10(2h)-yl)-d-ribitol (CHEBI:230553) is a organic molecular entity (CHEBI:50860) |
| 5-ethyl-4-methyl-2-pentylthiazole (CHEBI:230729) is a organic molecular entity (CHEBI:50860) |
| 5-hydroxy-2-deoxyguanosine (CHEBI:233805) is a organic molecular entity (CHEBI:50860) |
| 5-Hydroxy-guaiacyl lignin (CHEBI:80099) is a organic molecular entity (CHEBI:50860) |
| 5-hydroxydecanoate (CHEBI:234041) is a organic molecular entity (CHEBI:50860) |
| 5-hydroxymethyluridine-2'-deoxy-5'-phosphate(2−) (CHEBI:90409) is a organic molecular entity (CHEBI:50860) |
| 5-L-Glutamyl-D-glutamyl-peptide (CHEBI:80660) is a organic molecular entity (CHEBI:50860) |
| 5-Mercapto-norvaline (CHEBI:233026) is a organic molecular entity (CHEBI:50860) |
| 5-methoxy-6-methyl-2-aminoindan (CHEBI:234127) is a organic molecular entity (CHEBI:50860) |
| 5-Methyl-pyrrole-2-carboxyl-[pcp] (CHEBI:31137) is a organic molecular entity (CHEBI:50860) |
| 5-methylaminomethyl-2-(Se-phospho)selenouridine 5'-monophosphate(2−) residue (CHEBI:143702) is a organic molecular entity (CHEBI:50860) |
| 5-methyltricosane (CHEBI:232476) is a organic molecular entity (CHEBI:50860) |
| 5-Ph-IAA (CHEBI:232046) is a organic molecular entity (CHEBI:50860) |
| 5-Ph-IAA-AM (CHEBI:233292) is a organic molecular entity (CHEBI:50860) |
| 5-Substituted dCMP (CHEBI:2125) is a organic molecular entity (CHEBI:50860) |
| 5,10-methylenetetrahydrosulfopterin (CHEBI:140606) is a organic molecular entity (CHEBI:50860) |
| 5,5,5-trifluoropentanoyl-CoA(4−) (CHEBI:747884) is a organic molecular entity (CHEBI:50860) |
| 5,6-diamino-3-imino-4-oxo-3,4-dihydro
naphthalene-2,7-disulfonic acid (CHEBI:747423) is a organic molecular entity (CHEBI:50860) |
| 5,6,8,9-tetrachloro-tetradecanoic acid (CHEBI:230586) is a organic molecular entity (CHEBI:50860) |
| 5,7-diethyl-9-methyl-3e,5e,7e,9e-tridecatetraene (CHEBI:230567) is a organic molecular entity (CHEBI:50860) |
| 5'-end (5'-triphosphoguanosine)-(2'-O-methyl-adenosine)(3−) residue (CHEBI:156478) is a organic molecular entity (CHEBI:50860) |
| 5'-end (5'-triphosphoguanosine)-(2'-O-methyl-guanosine)(3−) residue (CHEBI:156479) is a organic molecular entity (CHEBI:50860) |
| 5'-end (5'-triphosphoguanosine)-(2'-O-methyl-purine ribonucleoside)(3−) residue (CHEBI:156477) is a organic molecular entity (CHEBI:50860) |
| 5'-end phospho-(2'-O-methyl-adenosine)(1-) residue (CHEBI:234149) is a organic molecular entity (CHEBI:50860) |
| 5'-end ribonucleotide 3'-phosphate(1−) residue (CHEBI:231872) is a organic molecular entity (CHEBI:50860) |
| 5'''-methyl chlorobiocin-like antibiotic (CHEBI:86405) is a organic molecular entity (CHEBI:50860) |
| 5H-Tetrazol-5-Amine (CHEBI:229356) is a organic molecular entity (CHEBI:50860) |
| 6 thiodeoxyguanosine diphosphate (3-) (CHEBI:180690) is a organic molecular entity (CHEBI:50860) |
| 6 thiodeoxyguanosine monophosphate (2-) (CHEBI:180689) is a organic molecular entity (CHEBI:50860) |
| 6 thioguanosine triphosphate(4-) (CHEBI:180688) is a organic molecular entity (CHEBI:50860) |
| 6-(4-hydroxybenzyl)-4-methyl-1-hydroxypyridin-2(1H)-one (CHEBI:189827) is a organic molecular entity (CHEBI:50860) |
| 6-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydroimidazo[1,2-c]pyrimidin-5-one (CHEBI:230117) is a organic molecular entity (CHEBI:50860) |
| 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-α-D-mannosyl-(1→2)-6-phosphoethanolamine-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-inositol residue (CHEBI:233253) is a organic molecular entity (CHEBI:50860) |
| 6-[amino acid carboxyl end amidated-6-phosphoethanolamine-α-D-mannosyl-(1→2)-α-D-mannosyl-(1→6)-2-phosphoethanolamine-α-D-mannosyl-(1→4)-α-D-glucosaminyl]-1-(1-radyl,2-stearoyl-sn-glycero-3-phospho)-1D-myo-inositol residue (CHEBI:233421) is a organic molecular entity (CHEBI:50860) |
| 6-amino-2-methyl-2-heptanyl (1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)acetate (CHEBI:230658) is a organic molecular entity (CHEBI:50860) |
| 6-Amino-7-bromo-5,8-quinolinedione (CHEBI:232631) is a organic molecular entity (CHEBI:50860) |
| 6-aminophenanthridine (CHEBI:232357) is a organic molecular entity (CHEBI:50860) |
| 6-Benzyl-1-hydroxypyridin-2(1H)-one (CHEBI:189828) is a organic molecular entity (CHEBI:50860) |
| 6-Benzyl-4-isopropyl-1-hydroxypyridin-2(1H)-one (CHEBI:189829) is a organic molecular entity (CHEBI:50860) |
| 6-bromo-2-phenyl-2H-chromene (CHEBI:231418) is a organic molecular entity (CHEBI:50860) |
| 6-bromo-5-nitroindirubin-3'-acetoxime (CHEBI:233418) is a organic molecular entity (CHEBI:50860) |
| 6-Bromo-8-hydroxyconicamin (CHEBI:194577) is a organic molecular entity (CHEBI:50860) |
| 6-bromo-eicosa-5e,9z-dienoic acid (CHEBI:230721) is a organic molecular entity (CHEBI:50860) |
| 6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide;dihydrochloride (CHEBI:140953) is a organic molecular entity (CHEBI:50860) |
| 6-demethylgriseofulvin (CHEBI:230810) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-allose (CHEBI:194168) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-altrose (CHEBI:194167) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-glucose (CHEBI:194166) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-gulose (CHEBI:194173) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-idose (CHEBI:194174) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-psicose (CHEBI:194165) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-sorbose (CHEBI:194170) is a organic molecular entity (CHEBI:50860) |
| 6-deoxy-L-talose (CHEBI:194171) is a organic molecular entity (CHEBI:50860) |
| 6-FAM-mAmArCmAmA-Dabcyl (CHEBI:171662) is a organic molecular entity (CHEBI:50860) |
| 6-Hydroxygenistein (CHEBI:747154) is a organic molecular entity (CHEBI:50860) |
| 6-hydroxymelatonin-sulfate(1-) (CHEBI:746997) is a organic molecular entity (CHEBI:50860) |
| 6-Methylpenicillin (CHEBI:2216) is a organic molecular entity (CHEBI:50860) |
| 6-Sulfanyl-L-norleucine (CHEBI:233027) is a organic molecular entity (CHEBI:50860) |
| 6-thiodeoxyguanosine triphosphate (4-) (CHEBI:180691) is a organic molecular entity (CHEBI:50860) |
| 6-Thioguanosine diphosphate(3-) (CHEBI:180687) is a organic molecular entity (CHEBI:50860) |
| 6-Thioguanosine monophosphate(2-) (CHEBI:180686) is a organic molecular entity (CHEBI:50860) |
| 6-thioinosine-5'-monophosphate(2−) (CHEBI:180684) is a organic molecular entity (CHEBI:50860) |
| 6-Thioxanthine 5'-monophosphate(2-) (CHEBI:180685) is a organic molecular entity (CHEBI:50860) |
| 6,5-dichloroindirubin (CHEBI:233427) is a organic molecular entity (CHEBI:50860) |
| 6'SLDN (CHEBI:156514) is a organic molecular entity (CHEBI:50860) |
| 6a,7-didehydro-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate (CHEBI:68904) is a organic molecular entity (CHEBI:50860) |
| 6alpha-hydroxy-20beta-dihydro-prednisolone (CHEBI:180922) is a organic molecular entity (CHEBI:50860) |
| 6alpha-hydroxycinobufagin (CHEBI:230568) is a organic molecular entity (CHEBI:50860) |
| 6beta-hydroxy-20alpha-dihydro-prednisolone (CHEBI:180924) is a organic molecular entity (CHEBI:50860) |
| 6beta-hydroxy-20beta-dihydro-prednisolone (CHEBI:180923) is a organic molecular entity (CHEBI:50860) |
| 6PPDQ (CHEBI:233238) is a organic molecular entity (CHEBI:50860) |
| 7-chloro-4-phenylselanylquinoline (CHEBI:232152) is a organic molecular entity (CHEBI:50860) |
| 7-desacetoxy-6,7-dehydrogedunin (CHEBI:231343) is a organic molecular entity (CHEBI:50860) |
| 7-hydroxy-2,6-dimethylbenzothiazole (CHEBI:747045) is a organic molecular entity (CHEBI:50860) |
| 7-hydroxy-6-(3-oxobut-1-en-1-yl)-2H-chromen-2-one (CHEBI:168006) is a organic molecular entity (CHEBI:50860) |
| 7-methoxycrinamabine Trifluoroacetic acid (CHEBI:68308) is a organic molecular entity (CHEBI:50860) |
| 7-methyl-2'-deoxyguanosine 5'-phosphate(1-) (CHEBI:746876) is a organic molecular entity (CHEBI:50860) |
| 7-MethylCoumarinyl-ethylGly (CHEBI:232935) is a organic molecular entity (CHEBI:50860) |
| 7-MethylCoumarinylethylGly (CHEBI:232648) is a organic molecular entity (CHEBI:50860) |
| 7-methyloctanoyl carnitine (CHEBI:140732) is a organic molecular entity (CHEBI:50860) |
| 7-oxo-gamma-aminoisobutyrolithocholic acid (CHEBI:232239) is a organic molecular entity (CHEBI:50860) |
| 7-oxoalaninolithocholic acid (CHEBI:232240) is a organic molecular entity (CHEBI:50860) |
| 7-oxoargininolithocholic acid (CHEBI:232236) is a organic molecular entity (CHEBI:50860) |
| 7-oxoasparaginolithocholic acid (CHEBI:232233) is a organic molecular entity (CHEBI:50860) |
| 7-oxoaspartylolithocholic acid (CHEBI:232232) is a organic molecular entity (CHEBI:50860) |
| 7-oxoglutaminolithocholic acid (CHEBI:232234) is a organic molecular entity (CHEBI:50860) |
| 7-oxoglutamylolithochoic acid (CHEBI:232237) is a organic molecular entity (CHEBI:50860) |
| 7-oxohistidinolithocholic acid (CHEBI:232231) is a organic molecular entity (CHEBI:50860) |
| 7-oxoisoleucinolithocholic acid (CHEBI:232246) is a organic molecular entity (CHEBI:50860) |
| 7-oxoleucinolithocholic acid (CHEBI:232247) is a organic molecular entity (CHEBI:50860) |
| 7-oxomethioninolithocholic acid (CHEBI:232243) is a organic molecular entity (CHEBI:50860) |
| 7-oxophenylalaninolithocholic acid (CHEBI:232248) is a organic molecular entity (CHEBI:50860) |
| 7-oxoprolinolithocholic acid (CHEBI:232242) is a organic molecular entity (CHEBI:50860) |
| 7-oxoserinolithocholic acid (CHEBI:232235) is a organic molecular entity (CHEBI:50860) |
| 7-oxothreoninolithocholic acid (CHEBI:232238) is a organic molecular entity (CHEBI:50860) |
| 7-oxotryptophanolithocholic acid (CHEBI:232245) is a organic molecular entity (CHEBI:50860) |
| 7-oxotyraminolithocholic acid (CHEBI:232249) is a organic molecular entity (CHEBI:50860) |
| 7-oxotyrosinolithocholic acid (CHEBI:232241) is a organic molecular entity (CHEBI:50860) |
| 7-oxovalinolithocholic acid (CHEBI:232244) is a organic molecular entity (CHEBI:50860) |
| 7,11,15-Trimethyl-3-methylene-hexadeca-1,6,10,14-tetraene (CHEBI:192745) is a organic molecular entity (CHEBI:50860) |
| 7,12-Decaketide intermediate 1 (CHEBI:81682) is a organic molecular entity (CHEBI:50860) |
| 7,8-dihydroxy-3-methyl-1H-isochromen-4-one (CHEBI:232595) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Decaketide intermediate 1 (CHEBI:81676) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Decaketide intermediate 2 (CHEBI:81677) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Decaketide intermediate 3 (CHEBI:81678) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Decaketide intermediate 4 (CHEBI:81679) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Decaketide intermediate 5 (CHEBI:81680) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Decaketide intermediate 6 (CHEBI:81681) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Octaketide intermediate 1 (CHEBI:81673) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Octaketide intermediate 2 (CHEBI:81674) is a organic molecular entity (CHEBI:50860) |
| 7,9,12-Octaketide intermediate 3 (CHEBI:81675) is a organic molecular entity (CHEBI:50860) |
| 7MeG5'-ppp5'ACCCCC (CHEBI:149612) is a organic molecular entity (CHEBI:50860) |
| 7β-isopropylchenodeoxycholic acid (CHEBI:747206) is a organic molecular entity (CHEBI:50860) |
| 8-(6-aminohexylamino)-2'-O-methyl 3',5'-cyclic AMP (CHEBI:64404) is a organic molecular entity (CHEBI:50860) |
| 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione (CHEBI:49403) is a organic molecular entity (CHEBI:50860) |
| 8-[(6-IODO-1,3-BENZODIOXOL-5-YL)THIO]-9-[3-(ISOPROPYLAMINO)PROPYL]-9H-PURIN-6-AMINE (CHEBI:42928) is a organic molecular entity (CHEBI:50860) |
| 8-hydroxy-2-deoxyguanosine reduced (CHEBI:233806) is a organic molecular entity (CHEBI:50860) |
| 8-hydroxyefavirenz (CHEBI:746953) is a organic molecular entity (CHEBI:50860) |
| 8-O-demethyloxomaritidine Trifluoroacetic acid (CHEBI:68319) is a organic molecular entity (CHEBI:50860) |
| 8-oxo-7,8-dihydro-2-deoxyguanosine (CHEBI:233807) is a organic molecular entity (CHEBI:50860) |
| 8-oxo-GMP(2−) (CHEBI:145694) is a organic molecular entity (CHEBI:50860) |
| 8,9-Dihydro-8-hydroxybarettin (CHEBI:194575) is a organic molecular entity (CHEBI:50860) |
| 8,9-dihydrobarettin (CHEBI:195169) is a organic molecular entity (CHEBI:50860) |
| 81c6 131i (CHEBI:754339) is a organic molecular entity (CHEBI:50860) |
| 8h9 131i (CHEBI:754153) is a organic molecular entity (CHEBI:50860) |
| 9-(3,5-dimethylfuran-2-yl)-nonanoic acid (CHEBI:230623) is a organic molecular entity (CHEBI:50860) |
| 9-O-acetyl-3-deoxy-D-glycero-α-D-galacto-nononic acid anion (CHEBI:233184) is a organic molecular entity (CHEBI:50860) |
| 9-O-adenylylspectinomycin zwitterion (CHEBI:146261) is a organic molecular entity (CHEBI:50860) |
| 9-chloro-10-hydroxy-octadecanoic acid (CHEBI:230560) is a organic molecular entity (CHEBI:50860) |
| 9-epi-(E)-caryophylene (CHEBI:192813) is a organic molecular entity (CHEBI:50860) |
| 9-Glycineamido-20(S)-camptothecin.HCl (CHEBI:232986) is a organic molecular entity (CHEBI:50860) |
| 9-Hydroxy-3,5,7,11,13,15,17-octaoxo-eicosanoyl-[acp] (CHEBI:31150) is a organic molecular entity (CHEBI:50860) |
| 9-Hydroxy-3,5,7,11,13,15,17-octaoxo-nonadecanoyl-[acp] (CHEBI:31151) is a organic molecular entity (CHEBI:50860) |
| 9-Hydroxy-3,5,7,11,13,15,17-octaoxo-octadecanoyl-[acp] (CHEBI:31152) is a organic molecular entity (CHEBI:50860) |
| 9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-docosanoyl-[acp] (CHEBI:31147) is a organic molecular entity (CHEBI:50860) |
| 9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-eicosanoyl-[acp] (CHEBI:31148) is a organic molecular entity (CHEBI:50860) |
| 9-Hydroxy-3,5,7,11,13,15,17,19-nonaoxo-henicosanoyl-[acp] (CHEBI:31149) is a organic molecular entity (CHEBI:50860) |
| 9,14-Decaketide intermediate 1 (CHEBI:81683) is a organic molecular entity (CHEBI:50860) |
| 90y-ct84.66 (CHEBI:754191) is a organic molecular entity (CHEBI:50860) |
| 9b (CHEBI:194225) is a organic molecular entity (CHEBI:50860) |
| 9c (CHEBI:194226) is a organic molecular entity (CHEBI:50860) |
| 9d (CHEBI:194227) is a organic molecular entity (CHEBI:50860) |
| 9e (CHEBI:194228) is a organic molecular entity (CHEBI:50860) |
| 9f (CHEBI:194229) is a organic molecular entity (CHEBI:50860) |
| 9g (CHEBI:194230) is a organic molecular entity (CHEBI:50860) |
| 9h (CHEBI:194231) is a organic molecular entity (CHEBI:50860) |
| 9i (CHEBI:194232) is a organic molecular entity (CHEBI:50860) |
| 9j (CHEBI:194233) is a organic molecular entity (CHEBI:50860) |
| 9k (CHEBI:194234) is a organic molecular entity (CHEBI:50860) |
| 9l (CHEBI:194235) is a organic molecular entity (CHEBI:50860) |
| 9m (CHEBI:194236) is a organic molecular entity (CHEBI:50860) |
| 9Z-pentacosene (CHEBI:234029) is a organic molecular entity (CHEBI:50860) |
| a ring-opened 7-methylguanine in DNA (CHEBI:137936) is a organic molecular entity (CHEBI:50860) |
| A-366 (CHEBI:746980) is a organic molecular entity (CHEBI:50860) |
| A-438079 hydrochloride hydrate (CHEBI:229530) is a organic molecular entity (CHEBI:50860) |
| A-485 (CHEBI:233363) is a organic molecular entity (CHEBI:50860) |
| A-7 hydrochloride (CHEBI:231363) is a organic molecular entity (CHEBI:50860) |
| A-971432 (CHEBI:746979) is a organic molecular entity (CHEBI:50860) |
| a-muuroladiene (CHEBI:192740) is a organic molecular entity (CHEBI:50860) |
| a27.15 (CHEBI:754277) is a organic molecular entity (CHEBI:50860) |
| a33 131i (CHEBI:754377) is a organic molecular entity (CHEBI:50860) |
| A38 (CHEBI:231671) is a organic molecular entity (CHEBI:50860) |
| A54145 (CHEBI:80116) is a organic molecular entity (CHEBI:50860) |
| AA147 (CHEBI:747295) is a organic molecular entity (CHEBI:50860) |
| ab-101 (CHEBI:757139) is a organic molecular entity (CHEBI:50860) |
| abafilcon a (CHEBI:753230) is a organic molecular entity (CHEBI:50860) |
| abagovomab (CHEBI:750061) is a organic molecular entity (CHEBI:50860) |
| abaloparatide (CHEBI:755265) is a organic molecular entity (CHEBI:50860) |
| abatacept (CHEBI:749599) is a organic molecular entity (CHEBI:50860) |
| abbv-257 (CHEBI:757140) is a organic molecular entity (CHEBI:50860) |
| abbv-3373 (CHEBI:757047) is a organic molecular entity (CHEBI:50860) |
| abciximab (CHEBI:749549) is a organic molecular entity (CHEBI:50860) |
| ABD646 (CHEBI:746930) is a organic molecular entity (CHEBI:50860) |
| abdavomeran (CHEBI:758338) is a organic molecular entity (CHEBI:50860) |
| abelacimab (CHEBI:758262) is a organic molecular entity (CHEBI:50860) |
| Abemaciclib (CHEBI:233362) is a organic molecular entity (CHEBI:50860) |
| abenacianine (CHEBI:760002) is a organic molecular entity (CHEBI:50860) |
| abetimus (CHEBI:753180) is a organic molecular entity (CHEBI:50860) |
| abetimus sodium (CHEBI:753761) is a organic molecular entity (CHEBI:50860) |
| abgn-107 (CHEBI:757141) is a organic molecular entity (CHEBI:50860) |
| abicipar pegol (CHEBI:757142) is a organic molecular entity (CHEBI:50860) |
| abipapogene suvaplasmid (CHEBI:760113) is a organic molecular entity (CHEBI:50860) |
| abiprubart (CHEBI:759500) is a organic molecular entity (CHEBI:50860) |
| abituzumab (CHEBI:754362) is a organic molecular entity (CHEBI:50860) |
| abm-1310 (CHEBI:760473) is a organic molecular entity (CHEBI:50860) |
| abobotulinumtoxina (CHEBI:753524) is a organic molecular entity (CHEBI:50860) |
| abrilumab (CHEBI:755177) is a organic molecular entity (CHEBI:50860) |
| abrineurin (CHEBI:753231) is a organic molecular entity (CHEBI:50860) |
| ABT-100 (CHEBI:232865) is a organic molecular entity (CHEBI:50860) |
| abt-560 (CHEBI:755821) is a organic molecular entity (CHEBI:50860) |
| abt-806i (CHEBI:758263) is a organic molecular entity (CHEBI:50860) |
| abx-il8 (CHEBI:754360) is a organic molecular entity (CHEBI:50860) |
| abx-ma1 (CHEBI:754295) is a organic molecular entity (CHEBI:50860) |
| AC-55541 (CHEBI:189649) is a organic molecular entity (CHEBI:50860) |
| AC-93253 iodide (CHEBI:233224) is a organic molecular entity (CHEBI:50860) |
| acacia (CHEBI:753181) is a organic molecular entity (CHEBI:50860) |
| acapatamab (CHEBI:758565) is a organic molecular entity (CHEBI:50860) |
| acasunlimab (CHEBI:758906) is a organic molecular entity (CHEBI:50860) |
| acazicolcept (CHEBI:758877) is a organic molecular entity (CHEBI:50860) |
| Aceglatone (CHEBI:31160) is a organic molecular entity (CHEBI:50860) |
| acemta#1 (CHEBI:747148) is a organic molecular entity (CHEBI:50860) |
| acemta#2 (CHEBI:747149) is a organic molecular entity (CHEBI:50860) |
| Acetic acid, 2-(prop-2-ynylamino)- (CHEBI:233327) is a organic molecular entity (CHEBI:50860) |
| Acetyl-[pcp] (CHEBI:2410) is a organic molecular entity (CHEBI:50860) |
| acetylcysteine zidrimer (CHEBI:759722) is a organic molecular entity (CHEBI:50860) |
| Acetylkitasamycin (CHEBI:31165) is a organic molecular entity (CHEBI:50860) |
| Acetylpheneturide (CHEBI:31166) is a organic molecular entity (CHEBI:50860) |
| acetyltannic acid (CHEBI:753824) is a organic molecular entity (CHEBI:50860) |
| AChE-IN-72 (CHEBI:234406) is a organic molecular entity (CHEBI:50860) |
| Achimugu mEC2 (CHEBI:195188) is a organic molecular entity (CHEBI:50860) |
| Acid amide (CHEBI:2427) is a organic molecular entity (CHEBI:50860) |
| acid anhydride (CHEBI:36606) is a organic molecular entity (CHEBI:50860) |
| Acid Red-182 (CHEBI:747101) is a organic molecular entity (CHEBI:50860) |
| acimtamig (CHEBI:759698) is a organic molecular entity (CHEBI:50860) |
| aclerastide (CHEBI:757371) is a organic molecular entity (CHEBI:50860) |
| acofilcon a (CHEBI:755572) is a organic molecular entity (CHEBI:50860) |
| Acora-3,7(14)-diene (CHEBI:228361) is a organic molecular entity (CHEBI:50860) |
| acp-001 (CHEBI:757144) is a organic molecular entity (CHEBI:50860) |
| Acriflavine (CHEBI:2432) is a organic molecular entity (CHEBI:50860) |
| acriflavine hydrochloride (CHEBI:759075) is a organic molecular entity (CHEBI:50860) |
| Acrinol (CHEBI:31172) is a organic molecular entity (CHEBI:50860) |
| acrixolimab (CHEBI:758690) is a organic molecular entity (CHEBI:50860) |
| act-1 peptide (CHEBI:757394) is a organic molecular entity (CHEBI:50860) |
| actaplanin (CHEBI:753215) is a organic molecular entity (CHEBI:50860) |
| actinium ac 225 dotatate (CHEBI:760328) is a organic molecular entity (CHEBI:50860) |
| actinium dotatate (CHEBI:760539) is a organic molecular entity (CHEBI:50860) |
| actinomycin X2 (CHEBI:180658) is a organic molecular entity (CHEBI:50860) |
| Activin A (CHEBI:81351) is a organic molecular entity (CHEBI:50860) |
| Activin AB (CHEBI:81586) is a organic molecular entity (CHEBI:50860) |
| Activin B (CHEBI:81587) is a organic molecular entity (CHEBI:50860) |
| actovegin (CHEBI:753804) is a organic molecular entity (CHEBI:50860) |
| actoxumab (CHEBI:753619) is a organic molecular entity (CHEBI:50860) |
| Acyl-D-Ala-D-Ala (CHEBI:2456) is a organic molecular entity (CHEBI:50860) |
| acylaminosugars (CHEBI:157764) is a organic molecular entity (CHEBI:50860) |
| ad-159 (CHEBI:754236) is a organic molecular entity (CHEBI:50860) |
| ad-214 (CHEBI:759664) is a organic molecular entity (CHEBI:50860) |
| ad-439 (CHEBI:754237) is a organic molecular entity (CHEBI:50860) |
| ad26.rsv.pref (CHEBI:759665) is a organic molecular entity (CHEBI:50860) |
| AD57 (CHEBI:233980) is a organic molecular entity (CHEBI:50860) |
| AD80 (CHEBI:232151) is a organic molecular entity (CHEBI:50860) |
| ada-011 (CHEBI:760474) is a organic molecular entity (CHEBI:50860) |
| adagloxad simolenin (CHEBI:755770) is a organic molecular entity (CHEBI:50860) |
| Adagrasib (CHEBI:233309) is a organic molecular entity (CHEBI:50860) |
| adakitug (CHEBI:759251) is a organic molecular entity (CHEBI:50860) |
| adalimumab (CHEBI:749494) is a organic molecular entity (CHEBI:50860) |
| adalimumab fosimdesonide (CHEBI:759347) is a organic molecular entity (CHEBI:50860) |
| adargileukin alfa (CHEBI:753525) is a organic molecular entity (CHEBI:50860) |
| adargiminase (CHEBI:760114) is a organic molecular entity (CHEBI:50860) |
| adc3680 (CHEBI:755585) is a organic molecular entity (CHEBI:50860) |
| adct-701 (CHEBI:760475) is a organic molecular entity (CHEBI:50860) |
| adebrelimab (CHEBI:757272) is a organic molecular entity (CHEBI:50860) |
| adecatumumab (CHEBI:753036) is a organic molecular entity (CHEBI:50860) |
| adefovir monophosphate (CHEBI:230667) is a organic molecular entity (CHEBI:50860) |
| adekalant (CHEBI:753216) is a organic molecular entity (CHEBI:50860) |
| adelavin (CHEBI:753805) is a organic molecular entity (CHEBI:50860) |
| Adenosine 5'-phosphate disodium (CHEBI:81690) is a organic molecular entity (CHEBI:50860) |
| adenovirus type 26 encoding ebola virus glycoprotein (CHEBI:760292) is a organic molecular entity (CHEBI:50860) |
| adenovirus type 26 encoding sars-cov-2 spike glycoprotein (CHEBI:760295) is a organic molecular entity (CHEBI:50860) |
| Adenylylselenate(2-) (CHEBI:140726) is a organic molecular entity (CHEBI:50860) |
| ADG (CHEBI:190446) is a organic molecular entity (CHEBI:50860) |
| adg-106 (CHEBI:757993) is a organic molecular entity (CHEBI:50860) |
| adhibin (CHEBI:234351) is a organic molecular entity (CHEBI:50860) |
| adimlecleucel (CHEBI:756487) is a organic molecular entity (CHEBI:50860) |
| adintrevimab (CHEBI:758505) is a organic molecular entity (CHEBI:50860) |
| Adrenomedullin (CHEBI:80339) is a organic molecular entity (CHEBI:50860) |
| Adrenomedullin 2 (CHEBI:80340) is a organic molecular entity (CHEBI:50860) |
| Adrenorphin (CHEBI:80322) is a organic molecular entity (CHEBI:50860) |
| Adropin (34-76) (CHEBI:233311) is a organic molecular entity (CHEBI:50860) |
| adu-s100 (CHEBI:757145) is a organic molecular entity (CHEBI:50860) |
| aducanumab (CHEBI:755082) is a organic molecular entity (CHEBI:50860) |
| aeg-35156 (CHEBI:760504) is a organic molecular entity (CHEBI:50860) |
| aem-28 (CHEBI:759666) is a organic molecular entity (CHEBI:50860) |
| Aeol 10150 (CHEBI:232405) is a organic molecular entity (CHEBI:50860) |
| afamitresgene autoleucel (CHEBI:758561) is a organic molecular entity (CHEBI:50860) |
| afasevikumab (CHEBI:754257) is a organic molecular entity (CHEBI:50860) |
| afelimomab (CHEBI:753806) is a organic molecular entity (CHEBI:50860) |
| aficamten (CHEBI:747213) is a organic molecular entity (CHEBI:50860) |
| afimkibart (CHEBI:760115) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 endo glutathione conjugate (CHEBI:78581) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 endo-cysteinyl-conjugate (CHEBI:78578) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 endo-cysteinylglycine conjugate (CHEBI:78579) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 endo-N-acetylcysteine conjugate (CHEBI:78580) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 exo glutathione conjugate (CHEBI:78587) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 exo-cysteinyl-conjugate (CHEBI:78583) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 exo-cysteinylglycine conjugate (CHEBI:78584) is a organic molecular entity (CHEBI:50860) |
| Aflatoxin B1 exo-N-acetylcysteine conjugate (CHEBI:78585) is a organic molecular entity (CHEBI:50860) |
| aflibercept (CHEBI:750062) is a organic molecular entity (CHEBI:50860) |
| Afloqualone (CHEBI:31177) is a organic molecular entity (CHEBI:50860) |
| afm-11 (CHEBI:757313) is a organic molecular entity (CHEBI:50860) |
| afovirsen (CHEBI:753269) is a organic molecular entity (CHEBI:50860) |
| afovirsen sodium (CHEBI:753162) is a organic molecular entity (CHEBI:50860) |
| ag-270 (CHEBI:758485) is a organic molecular entity (CHEBI:50860) |
| ag0302-covid19 (CHEBI:758264) is a organic molecular entity (CHEBI:50860) |
| agalsidase alfa (CHEBI:753217) is a organic molecular entity (CHEBI:50860) |
| agalsidase beta (CHEBI:753807) is a organic molecular entity (CHEBI:50860) |
| aganirsen (CHEBI:753286) is a organic molecular entity (CHEBI:50860) |
| AGI-5198 (CHEBI:230488) is a organic molecular entity (CHEBI:50860) |
| aglatimagene besadenovec (CHEBI:755409) is a organic molecular entity (CHEBI:50860) |
| aglycone (CHEBI:166892) is a organic molecular entity (CHEBI:50860) |
| agn-211745 (CHEBI:758322) is a organic molecular entity (CHEBI:50860) |
| Agouti related protein (87-132) (CHEBI:80317) is a organic molecular entity (CHEBI:50860) |
| ags-16c3f (CHEBI:757936) is a organic molecular entity (CHEBI:50860) |
| ags62p1 (CHEBI:757331) is a organic molecular entity (CHEBI:50860) |
| aguracingene cadoparvovec (CHEBI:758575) is a organic molecular entity (CHEBI:50860) |
| ahn-12 (CHEBI:754266) is a organic molecular entity (CHEBI:50860) |
| air polymer-type a (CHEBI:757769) is a organic molecular entity (CHEBI:50860) |
| air, medical (CHEBI:753808) is a organic molecular entity (CHEBI:50860) |
| ak-01 (CHEBI:757859) is a organic molecular entity (CHEBI:50860) |
| AK-toxin I (CHEBI:80727) is a organic molecular entity (CHEBI:50860) |
| Akt1/2 kinase inhibitor (CHEBI:232778) is a organic molecular entity (CHEBI:50860) |
| al-78898a (CHEBI:757938) is a organic molecular entity (CHEBI:50860) |
| al-901 (CHEBI:754245) is a organic molecular entity (CHEBI:50860) |
| alacizumab pegol (CHEBI:750063) is a organic molecular entity (CHEBI:50860) |
| alamecin (CHEBI:753218) is a organic molecular entity (CHEBI:50860) |
| alamethicin F50 (CHEBI:156525) is a organic molecular entity (CHEBI:50860) |
| alaninochenodeoxycholic acid (CHEBI:232203) is a organic molecular entity (CHEBI:50860) |
| alaninocholic acid (CHEBI:232258) is a organic molecular entity (CHEBI:50860) |
| alaninodeoxycholic acid (CHEBI:232221) is a organic molecular entity (CHEBI:50860) |
| alaninolithocholic acid (CHEBI:232185) is a organic molecular entity (CHEBI:50860) |
| alaninoursodeoxycholic acid (CHEBI:232277) is a organic molecular entity (CHEBI:50860) |
| alanylasparagine (CHEBI:230637) is a organic molecular entity (CHEBI:50860) |
| albinterferon alfa-2b (CHEBI:752889) is a organic molecular entity (CHEBI:50860) |
| albipagrastim alfa (CHEBI:760003) is a organic molecular entity (CHEBI:50860) |
| albireticulene (CHEBI:193156) is a organic molecular entity (CHEBI:50860) |
| albumin human (CHEBI:749447) is a organic molecular entity (CHEBI:50860) |
| albumin tannate (CHEBI:753183) is a organic molecular entity (CHEBI:50860) |
| albumin, aggregated (CHEBI:753809) is a organic molecular entity (CHEBI:50860) |
| albumin, aggregated iodinated i 131 (CHEBI:754103) is a organic molecular entity (CHEBI:50860) |
| albumin, aggregated iodinated i 131 serum (CHEBI:753810) is a organic molecular entity (CHEBI:50860) |
| albumin, chromated cr 51 serum (CHEBI:749451) is a organic molecular entity (CHEBI:50860) |
| albumin, iodinated i 125 (CHEBI:753762) is a organic molecular entity (CHEBI:50860) |
| albumin, iodinated i 125 serum (CHEBI:749448) is a organic molecular entity (CHEBI:50860) |
| albumin, iodinated i 131 (CHEBI:753182) is a organic molecular entity (CHEBI:50860) |
| albumin, iodinated i 131 serum (CHEBI:749449) is a organic molecular entity (CHEBI:50860) |
| albusomatropin (CHEBI:757539) is a organic molecular entity (CHEBI:50860) |
| albutrepenonacog alfa (CHEBI:759759) is a organic molecular entity (CHEBI:50860) |
| alcestobart (CHEBI:760116) is a organic molecular entity (CHEBI:50860) |
| aldafermin (CHEBI:757478) is a organic molecular entity (CHEBI:50860) |
| aldastotug (CHEBI:760004) is a organic molecular entity (CHEBI:50860) |
| aldesleukin (CHEBI:749478) is a organic molecular entity (CHEBI:50860) |
| aldoxorubicin (CHEBI:231680) is a organic molecular entity (CHEBI:50860) |
| alefacept (CHEBI:749492) is a organic molecular entity (CHEBI:50860) |
| alemtuzumab (CHEBI:749551) is a organic molecular entity (CHEBI:50860) |
| alemtuzumab beta (CHEBI:759417) is a organic molecular entity (CHEBI:50860) |
| aleplasinin (CHEBI:230707) is a organic molecular entity (CHEBI:50860) |
| aletekitug (CHEBI:760117) is a organic molecular entity (CHEBI:50860) |
| Alexa Fluor 633 (CHEBI:137393) is a organic molecular entity (CHEBI:50860) |
| alexitol sodium (CHEBI:756030) is a organic molecular entity (CHEBI:50860) |
| alexomycin (CHEBI:753219) is a organic molecular entity (CHEBI:50860) |
| alextatug (CHEBI:759501) is a organic molecular entity (CHEBI:50860) |
| alferminogene tadenovec (CHEBI:752890) is a organic molecular entity (CHEBI:50860) |
| alfimeprase (CHEBI:753811) is a organic molecular entity (CHEBI:50860) |
| alg-991 (CHEBI:754367) is a organic molecular entity (CHEBI:50860) |
| algenpantucel-l (CHEBI:753657) is a organic molecular entity (CHEBI:50860) |
| alglucerase (CHEBI:749440) is a organic molecular entity (CHEBI:50860) |
| alglucosidase alfa (CHEBI:749600) is a organic molecular entity (CHEBI:50860) |
| aliarin 4'-methyl ether (CHEBI:230615) is a organic molecular entity (CHEBI:50860) |
| alicaforsen (CHEBI:753309) is a organic molecular entity (CHEBI:50860) |
| alicaforsen sodium (CHEBI:753812) is a organic molecular entity (CHEBI:50860) |
| aliphatic compound (CHEBI:33653) is a organic molecular entity (CHEBI:50860) |
| Aliphatic hydroxy acid (CHEBI:2573) is a organic molecular entity (CHEBI:50860) |
| Aliphatic oxo acid (CHEBI:80996) is a organic molecular entity (CHEBI:50860) |
| alipogene tiparvovec (CHEBI:753292) is a organic molecular entity (CHEBI:50860) |
| alirocumab (CHEBI:754310) is a organic molecular entity (CHEBI:50860) |
| alisvetcel (CHEBI:759502) is a organic molecular entity (CHEBI:50860) |
| alkavervir (CHEBI:749542) is a organic molecular entity (CHEBI:50860) |
| alkyl 4-(hydroxymethyl)benzoates (CHEBI:747253) is a organic molecular entity (CHEBI:50860) |
| Alkylamide (CHEBI:2586) is a organic molecular entity (CHEBI:50860) |
| Alkyldiaminoethylglycine hydrochloride (CHEBI:81709) is a organic molecular entity (CHEBI:50860) |
| Alkylnitrile (CHEBI:2590) is a organic molecular entity (CHEBI:50860) |
| alkylpolyaminoethylglycine (CHEBI:753813) is a organic molecular entity (CHEBI:50860) |
| alkylpolyaminoethylglycine hydrochloride (CHEBI:753764) is a organic molecular entity (CHEBI:50860) |
| Allatostatin I (CHEBI:80151) is a organic molecular entity (CHEBI:50860) |
| allo-aromadendr-9-ene (CHEBI:192812) is a organic molecular entity (CHEBI:50860) |
| allogeneic t cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (deltalngfr) and the herpes simplex i virus thymidine kinase (hsv-tk mut2) (CHEBI:759778) is a organic molecular entity (CHEBI:50860) |
| allomune (CHEBI:754175) is a organic molecular entity (CHEBI:50860) |
| allyl lactate (CHEBI:747276) is a organic molecular entity (CHEBI:50860) |
| almagodrate (CHEBI:753220) is a organic molecular entity (CHEBI:50860) |
| almond oil (CHEBI:753221) is a organic molecular entity (CHEBI:50860) |
| alnuctamab (CHEBI:760476) is a organic molecular entity (CHEBI:50860) |
| alnugranogene aldeparvovec (CHEBI:759348) is a organic molecular entity (CHEBI:50860) |
| aloe (CHEBI:753222) is a organic molecular entity (CHEBI:50860) |
| alofilcon a (CHEBI:753814) is a organic molecular entity (CHEBI:50860) |
| alomfilimab (CHEBI:758366) is a organic molecular entity (CHEBI:50860) |
| aloxiprin (CHEBI:753223) is a organic molecular entity (CHEBI:50860) |
| alpelisib (CHEBI:231324) is a organic molecular entity (CHEBI:50860) |
| alpha amylase (CHEBI:753815) is a organic molecular entity (CHEBI:50860) |
| alpha-Aminoadipoyl-S-acyl enzyme (CHEBI:10211) is a organic molecular entity (CHEBI:50860) |
| alpha-cembratrien-ol (CHEBI:192753) is a organic molecular entity (CHEBI:50860) |
| alpha-D-galactosyl-(1→4)-beta-D-galactosyl-(1→1)-N-acylsphingosine (CHEBI:195431) is a organic molecular entity (CHEBI:50860) |
| alpha-D-galactosyl-(1→4)-beta-D-glucosyl-(1→1)-N-acylsphingosine (CHEBI:195427) is a organic molecular entity (CHEBI:50860) |
| alpha-D-Mannosyl-1,3-(R1)-beta-D-mannosyl-R2 (CHEBI:10263) is a organic molecular entity (CHEBI:50860) |
| alpha-D-Ribose 5-phosphate(2-) (CHEBI:140679) is a organic molecular entity (CHEBI:50860) |
| alpha-Endorphin (CHEBI:80245) is a organic molecular entity (CHEBI:50860) |
| alpha-Linolenoyl-ACP (CHEBI:80358) is a organic molecular entity (CHEBI:50860) |
| alpha-N-Acetyl-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->3)-beta-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-xylosylproteoglycan (CHEBI:80007) is a organic molecular entity (CHEBI:50860) |
| alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-D-glucosaminyl-glycoprotein (CHEBI:10311) is a organic molecular entity (CHEBI:50860) |
| alpha-Neoendorphin (CHEBI:80261) is a organic molecular entity (CHEBI:50860) |
| alpha-springene (CHEBI:192746) is a organic molecular entity (CHEBI:50860) |
| alpha-tocotrienoxyl radical (CHEBI:235533) is a organic molecular entity (CHEBI:50860) |
| alphafilcon a (CHEBI:753816) is a organic molecular entity (CHEBI:50860) |
| alpitatug (CHEBI:760118) is a organic molecular entity (CHEBI:50860) |
| Alprostadil alfadex (CHEBI:34532) is a organic molecular entity (CHEBI:50860) |
| ALRESTATIN (CHEBI:40701) is a organic molecular entity (CHEBI:50860) |
| alsecovatein (CHEBI:759485) is a organic molecular entity (CHEBI:50860) |
| alseroxylon (CHEBI:749481) is a organic molecular entity (CHEBI:50860) |
| alsevalimab (CHEBI:758018) is a organic molecular entity (CHEBI:50860) |
| ALT001 (CHEBI:234585) is a organic molecular entity (CHEBI:50860) |
| alteplase (CHEBI:749459) is a organic molecular entity (CHEBI:50860) |
| altumomab (CHEBI:753280) is a organic molecular entity (CHEBI:50860) |
| aluminum carbonate, basic (CHEBI:753916) is a organic molecular entity (CHEBI:50860) |
| aluminum chlorohydrate (CHEBI:753917) is a organic molecular entity (CHEBI:50860) |
| aluminum chlorohydrex (CHEBI:753267) is a organic molecular entity (CHEBI:50860) |
| aluminum chlorohydrex polyethylene glycol (CHEBI:753778) is a organic molecular entity (CHEBI:50860) |
| aluminum chlorohydrex propylene glycol (CHEBI:753779) is a organic molecular entity (CHEBI:50860) |
| aluminum dichlorohydrate (CHEBI:753918) is a organic molecular entity (CHEBI:50860) |
| aluminum dichlorohydrex polyethylene glycol (CHEBI:753780) is a organic molecular entity (CHEBI:50860) |
| aluminum dichlorohydrex propylene glycol (CHEBI:753186) is a organic molecular entity (CHEBI:50860) |
| aluminum hydroxide, dried (CHEBI:753919) is a organic molecular entity (CHEBI:50860) |
| aluminum phthalocyanine (CHEBI:195321) is a organic molecular entity (CHEBI:50860) |
| Aluminum Phthalocyanine tetrasulfate (CHEBI:195322) is a organic molecular entity (CHEBI:50860) |
| aluminum sesquichlorohydrate (CHEBI:753920) is a organic molecular entity (CHEBI:50860) |
| aluminum sesquichlorohydrex polyethylene glycol (CHEBI:753782) is a organic molecular entity (CHEBI:50860) |
| aluminum sesquichlorohydrex propylene glycol (CHEBI:753776) is a organic molecular entity (CHEBI:50860) |
| aluminum silicate, synthetic (CHEBI:753921) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium octachlorohydrate (CHEBI:753777) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium octachlorohydrex gly (CHEBI:753922) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium pentachlorohydrate (CHEBI:753763) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium pentachlorohydrex gly (CHEBI:753767) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium tetrachlorohydrate (CHEBI:753268) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium tetrachlorohydrex gly (CHEBI:753768) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium trichlorohydrate (CHEBI:753769) is a organic molecular entity (CHEBI:50860) |
| aluminum zirconium trichlorohydrex gly (CHEBI:753923) is a organic molecular entity (CHEBI:50860) |
| aluminum-27(3+) (CHEBI:176600) is a organic molecular entity (CHEBI:50860) |
| alusulf (CHEBI:753446) is a organic molecular entity (CHEBI:50860) |
| alvamemugene sulseparvovec (CHEBI:759349) is a organic molecular entity (CHEBI:50860) |
| alvircept sudotox (CHEBI:753766) is a organic molecular entity (CHEBI:50860) |
| ALX 5407 hydrochloride (CHEBI:231644) is a organic molecular entity (CHEBI:50860) |
| alx-009 (CHEBI:757147) is a organic molecular entity (CHEBI:50860) |
| alx-0171 (CHEBI:757148) is a organic molecular entity (CHEBI:50860) |
| ama0076 (CHEBI:755448) is a organic molecular entity (CHEBI:50860) |
| amalgucin (CHEBI:753924) is a organic molecular entity (CHEBI:50860) |
| Amaranth (CHEBI:34533) is a organic molecular entity (CHEBI:50860) |
| amatuximab (CHEBI:750064) is a organic molecular entity (CHEBI:50860) |
| AMB639752 (CHEBI:232952) is a organic molecular entity (CHEBI:50860) |
| amediplase (CHEBI:753339) is a organic molecular entity (CHEBI:50860) |
| amezosvatein (CHEBI:760119) is a organic molecular entity (CHEBI:50860) |
| amfilcon a (CHEBI:753925) is a organic molecular entity (CHEBI:50860) |
| AMG 900 (CHEBI:747721) is a organic molecular entity (CHEBI:50860) |
| amg-108 (CHEBI:754248) is a organic molecular entity (CHEBI:50860) |
| amg-167 (CHEBI:754332) is a organic molecular entity (CHEBI:50860) |
| amg-224 (CHEBI:757994) is a organic molecular entity (CHEBI:50860) |
| amg-404 (CHEBI:757996) is a organic molecular entity (CHEBI:50860) |
| amg-557 (CHEBI:754119) is a organic molecular entity (CHEBI:50860) |
| amg-729 (CHEBI:754170) is a organic molecular entity (CHEBI:50860) |
| amg-780 (CHEBI:754343) is a organic molecular entity (CHEBI:50860) |
| amg-811 (CHEBI:754242) is a organic molecular entity (CHEBI:50860) |
| amg-820 (CHEBI:754158) is a organic molecular entity (CHEBI:50860) |
| amg-888 (CHEBI:754208) is a organic molecular entity (CHEBI:50860) |
| amg553 (CHEBI:758197) is a organic molecular entity (CHEBI:50860) |
| amicloral (CHEBI:751735) is a organic molecular entity (CHEBI:50860) |
| amicoumacin A 2-phosphate(1−) (CHEBI:144859) is a organic molecular entity (CHEBI:50860) |
| amicoumacin A(1+) (CHEBI:144858) is a organic molecular entity (CHEBI:50860) |
| amilomer (CHEBI:753340) is a organic molecular entity (CHEBI:50860) |
| amilomotide (CHEBI:753310) is a organic molecular entity (CHEBI:50860) |
| amimestrocel (CHEBI:760120) is a organic molecular entity (CHEBI:50860) |
| Amino acid(Tyr-, Trp-, Phe-, Leu-) (CHEBI:2645) is a organic molecular entity (CHEBI:50860) |
| amino acids (CHEBI:749563) is a organic molecular entity (CHEBI:50860) |
| Aminomalonyl-[acp] (CHEBI:81869) is a organic molecular entity (CHEBI:50860) |
| Aminosalicylate sodium anhydrous (CHEBI:2661) is a organic molecular entity (CHEBI:50860) |
| amivantamab (CHEBI:757222) is a organic molecular entity (CHEBI:50860) |
| amlenetug (CHEBI:758044) is a organic molecular entity (CHEBI:50860) |
| amlintide (CHEBI:753926) is a organic molecular entity (CHEBI:50860) |
| amlisimod (CHEBI:757844) is a organic molecular entity (CHEBI:50860) |
| amlitelimab (CHEBI:758042) is a organic molecular entity (CHEBI:50860) |
| ammonio methacrylate copolymer (CHEBI:753927) is a organic molecular entity (CHEBI:50860) |
| ammonium pyrrolidinedithiocarbamate (CHEBI:234321) is a organic molecular entity (CHEBI:50860) |
| Ammonium sulfamate (CHEBI:81950) is a organic molecular entity (CHEBI:50860) |
| amolimogene bepiplasmid (CHEBI:753037) is a organic molecular entity (CHEBI:50860) |
| amostomig (CHEBI:760005) is a organic molecular entity (CHEBI:50860) |
| amp-110 (CHEBI:757149) is a organic molecular entity (CHEBI:50860) |
| amp-224 (CHEBI:757045) is a organic molecular entity (CHEBI:50860) |
| amtabafusp alfa (CHEBI:760121) is a organic molecular entity (CHEBI:50860) |
| amubarvimab (CHEBI:758274) is a organic molecular entity (CHEBI:50860) |
| amulirafusp alfa (CHEBI:760006) is a organic molecular entity (CHEBI:50860) |
| amv-564 (CHEBI:757027) is a organic molecular entity (CHEBI:50860) |
| amylase (pancrelipase) (CHEBI:749434) is a organic molecular entity (CHEBI:50860) |
| Amylin (CHEBI:80342) is a organic molecular entity (CHEBI:50860) |
| an aldono-1,5-lactone (CHEBI:140380) is a organic molecular entity (CHEBI:50860) |
| an aldopyranose (CHEBI:140379) is a organic molecular entity (CHEBI:50860) |
| an α-mycolate (CHEBI:87903) is a organic molecular entity (CHEBI:50860) |
| an α-mycolic acid (CHEBI:87902) is a organic molecular entity (CHEBI:50860) |
| Anakinra (CHEBI:231683) is a organic molecular entity (CHEBI:50860) |
| Anap (CHEBI:233032) is a organic molecular entity (CHEBI:50860) |
| anaritide acetate (CHEBI:753847) is a organic molecular entity (CHEBI:50860) |
| anatumomab mafenatox (CHEBI:753246) is a organic molecular entity (CHEBI:50860) |
| anbalcabtagene autoleucel (CHEBI:759350) is a organic molecular entity (CHEBI:50860) |
| ancer-20 (CHEBI:753247) is a organic molecular entity (CHEBI:50860) |
| ancestim (CHEBI:753882) is a organic molecular entity (CHEBI:50860) |
| ancrod (CHEBI:753447) is a organic molecular entity (CHEBI:50860) |
| andecaliximab (CHEBI:755953) is a organic molecular entity (CHEBI:50860) |
| andexanet alfa (CHEBI:755267) is a organic molecular entity (CHEBI:50860) |
| andusomeran (CHEBI:759493) is a organic molecular entity (CHEBI:50860) |
| Anecortave acetate (CHEBI:31215) is a organic molecular entity (CHEBI:50860) |
| anetumab ravtansine (CHEBI:754368) is a organic molecular entity (CHEBI:50860) |
| anfibatide (CHEBI:757150) is a organic molecular entity (CHEBI:50860) |
| Angiotensin (1-5) (CHEBI:80129) is a organic molecular entity (CHEBI:50860) |
| Angiotensin IV (CHEBI:80127) is a organic molecular entity (CHEBI:50860) |
| Angiotensinogen (CHEBI:2720) is a organic molecular entity (CHEBI:50860) |
| angl#1 (CHEBI:140483) is a organic molecular entity (CHEBI:50860) |
| angl#10 (CHEBI:747150) is a organic molecular entity (CHEBI:50860) |
| angl#101 (CHEBI:747151) is a organic molecular entity (CHEBI:50860) |
| angl#2 (CHEBI:140484) is a organic molecular entity (CHEBI:50860) |
| anifrolumab (CHEBI:755000) is a organic molecular entity (CHEBI:50860) |
| anise oil (CHEBI:753883) is a organic molecular entity (CHEBI:50860) |
| anistreplase (CHEBI:753248) is a organic molecular entity (CHEBI:50860) |
| anitocabtagene autoleucel (CHEBI:759418) is a organic molecular entity (CHEBI:50860) |
| anivamersen (CHEBI:753663) is a organic molecular entity (CHEBI:50860) |
| anivamersen sodium (CHEBI:752913) is a organic molecular entity (CHEBI:50860) |
| anivovetmab (CHEBI:758691) is a organic molecular entity (CHEBI:50860) |
| Anle138b (CHEBI:232606) is a organic molecular entity (CHEBI:50860) |
| annexin a5 (CHEBI:758841) is a organic molecular entity (CHEBI:50860) |
| Annomuricatin B (CHEBI:230094) is a organic molecular entity (CHEBI:50860) |
| anoxomer (CHEBI:753884) is a organic molecular entity (CHEBI:50860) |
| anpocogin (CHEBI:757501) is a organic molecular entity (CHEBI:50860) |
| anrukinzumab (CHEBI:750065) is a organic molecular entity (CHEBI:50860) |
| anselamimab (CHEBI:759706) is a organic molecular entity (CHEBI:50860) |
| ansipastobart (CHEBI:760007) is a organic molecular entity (CHEBI:50860) |
| ansuvimab (CHEBI:757877) is a organic molecular entity (CHEBI:50860) |
| anthrax vaccine absorbed (CHEBI:753527) is a organic molecular entity (CHEBI:50860) |
| anti-cd18 (CHEBI:754165) is a organic molecular entity (CHEBI:50860) |
| anti-gd2 monoclonal antibody 3f8 (CHEBI:754219) is a organic molecular entity (CHEBI:50860) |
| anti-inhibitor coagulant complex (CHEBI:757383) is a organic molecular entity (CHEBI:50860) |
| anti-melanoma mab fragments (CHEBI:759787) is a organic molecular entity (CHEBI:50860) |
| anti-psgl-1 antibody selk2 (CHEBI:758078) is a organic molecular entity (CHEBI:50860) |
| anti-sclerostin (CHEBI:754333) is a organic molecular entity (CHEBI:50860) |
| anti-tac 90 y-hat (CHEBI:754189) is a organic molecular entity (CHEBI:50860) |
| Antibiotic K41 (CHEBI:80120) is a organic molecular entity (CHEBI:50860) |
| anticoagulant citrate dextrose solution (CHEBI:753885) is a organic molecular entity (CHEBI:50860) |
| anticoagulant citrate phosphate dextrose adenine solution (CHEBI:753886) is a organic molecular entity (CHEBI:50860) |
| anticoagulant citrate phosphate dextrose solution (CHEBI:753887) is a organic molecular entity (CHEBI:50860) |
| anticoagulant heparin solution (CHEBI:753249) is a organic molecular entity (CHEBI:50860) |
| anticoagulant rodenticide (CHEBI:188151) is a organic molecular entity (CHEBI:50860) |
| anticoagulant sodium citrate solution (CHEBI:753765) is a organic molecular entity (CHEBI:50860) |
| antihemophilic factor, pegylated (mw 20000) human sequence recombinant (CHEBI:758057) is a organic molecular entity (CHEBI:50860) |
| antilymphocyte immunoglobulin (horse) (CHEBI:753888) is a organic molecular entity (CHEBI:50860) |
| antimony (CHEBI:757118) is a organic molecular entity (CHEBI:50860) |
| antimony cation (5+) (CHEBI:756904) is a organic molecular entity (CHEBI:50860) |
| Antimony trioxide (CHEBI:82289) is a organic molecular entity (CHEBI:50860) |
| Antimony trisulfide (CHEBI:82390) is a organic molecular entity (CHEBI:50860) |
| antirabies serum (CHEBI:753889) is a organic molecular entity (CHEBI:50860) |
| antithrombin alfa (CHEBI:749445) is a organic molecular entity (CHEBI:50860) |
| antithrombin gamma (CHEBI:757939) is a organic molecular entity (CHEBI:50860) |
| antithrombin iii human (CHEBI:753528) is a organic molecular entity (CHEBI:50860) |
| antivenin (crotalidae) polyvalent (CHEBI:753774) is a organic molecular entity (CHEBI:50860) |
| antivenin (latrodectus mactans) (CHEBI:753781) is a organic molecular entity (CHEBI:50860) |
| antivenin (micrurus fulvius) (CHEBI:753890) is a organic molecular entity (CHEBI:50860) |
| anumigilimab (CHEBI:758344) is a organic molecular entity (CHEBI:50860) |
| anvatabart opadotin (CHEBI:757330) is a organic molecular entity (CHEBI:50860) |
| anvatabart pactil (CHEBI:759313) is a organic molecular entity (CHEBI:50860) |
| anx-005 (CHEBI:758328) is a organic molecular entity (CHEBI:50860) |
| anzurstobart (CHEBI:758893) is a organic molecular entity (CHEBI:50860) |
| ap-NADH (CHEBI:166858) is a organic molecular entity (CHEBI:50860) |
| AP21967 (CHEBI:194456) is a organic molecular entity (CHEBI:50860) |
| apabetalone (CHEBI:235514) is a organic molecular entity (CHEBI:50860) |
| apadamtase alfa (CHEBI:758079) is a organic molecular entity (CHEBI:50860) |
| Apafant (CHEBI:31226) is a organic molecular entity (CHEBI:50860) |
| apatorsen (CHEBI:755090) is a organic molecular entity (CHEBI:50860) |
| apatorsen sodium (CHEBI:755089) is a organic molecular entity (CHEBI:50860) |
| apelin (CHEBI:758265) is a organic molecular entity (CHEBI:50860) |
| Apelin-36 (CHEBI:80132) is a organic molecular entity (CHEBI:50860) |
| apg-1387 (CHEBI:757940) is a organic molecular entity (CHEBI:50860) |
| apg-2575 (CHEBI:758266) is a organic molecular entity (CHEBI:50860) |
| apilimod (CHEBI:230506) is a organic molecular entity (CHEBI:50860) |
| apitegromab (CHEBI:757824) is a organic molecular entity (CHEBI:50860) |
| apl-501 (CHEBI:757850) is a organic molecular entity (CHEBI:50860) |
| aplidic acid b (CHEBI:230653) is a organic molecular entity (CHEBI:50860) |
| aplindore (CHEBI:230598) is a organic molecular entity (CHEBI:50860) |
| aplitabart (CHEBI:760008) is a organic molecular entity (CHEBI:50860) |
| apn1125 (CHEBI:755419) is a organic molecular entity (CHEBI:50860) |
| Apo-[carboxylase] (CHEBI:2777) is a organic molecular entity (CHEBI:50860) |
| apolizumab (CHEBI:753250) is a organic molecular entity (CHEBI:50860) |
| apomab (CHEBI:754118) is a organic molecular entity (CHEBI:50860) |
| apple juice (CHEBI:756755) is a organic molecular entity (CHEBI:50860) |
| apricot kernel water (CHEBI:753891) is a organic molecular entity (CHEBI:50860) |
| aprinocarsen (CHEBI:753279) is a organic molecular entity (CHEBI:50860) |
| aprinocarsen sodium (CHEBI:753892) is a organic molecular entity (CHEBI:50860) |
| aprotinin (CHEBI:749537) is a organic molecular entity (CHEBI:50860) |
| aprutumab ixadotin (CHEBI:758195) is a organic molecular entity (CHEBI:50860) |
| apvo-414 (CHEBI:758014) is a organic molecular entity (CHEBI:50860) |
| apvo-436 (CHEBI:757999) is a organic molecular entity (CHEBI:50860) |
| aq-13 (CHEBI:757151) is a organic molecular entity (CHEBI:50860) |
| aquacobalamin (CHEBI:758087) is a organic molecular entity (CHEBI:50860) |
| ar-105 (CHEBI:757152) is a organic molecular entity (CHEBI:50860) |
| ar-177 (CHEBI:757548) is a organic molecular entity (CHEBI:50860) |
| ar-20.5 (CHEBI:754187) is a organic molecular entity (CHEBI:50860) |
| AR-A014418 (CHEBI:232162) is a organic molecular entity (CHEBI:50860) |
| AR-C155858 (CHEBI:234387) is a organic molecular entity (CHEBI:50860) |
| Ar4Cer (CHEBI:34539) is a organic molecular entity (CHEBI:50860) |
| Ar5Cer (CHEBI:34540) is a organic molecular entity (CHEBI:50860) |
| Aranidipine (CHEBI:31232) is a organic molecular entity (CHEBI:50860) |
| arc-19499 (CHEBI:757328) is a organic molecular entity (CHEBI:50860) |
| archexin (CHEBI:757513) is a organic molecular entity (CHEBI:50860) |
| arcitumomab (CHEBI:753251) is a organic molecular entity (CHEBI:50860) |
| ardacin (CHEBI:753252) is a organic molecular entity (CHEBI:50860) |
| ardenermin (CHEBI:753189) is a organic molecular entity (CHEBI:50860) |
| ardeparin sodium (CHEBI:749480) is a organic molecular entity (CHEBI:50860) |
| arecoline hydrobromide (CHEBI:233150) is a organic molecular entity (CHEBI:50860) |
| Arenomycin B (CHEBI:80124) is a organic molecular entity (CHEBI:50860) |
| Arg-Gly-Asp-Ser peptide (CHEBI:232857) is a organic molecular entity (CHEBI:50860) |
| argatroban (CHEBI:48720) is a organic molecular entity (CHEBI:50860) |
| argininochenodeoxycholic acid (CHEBI:232195) is a organic molecular entity (CHEBI:50860) |
| argininodeoxycholic acid (CHEBI:232213) is a organic molecular entity (CHEBI:50860) |
| argininolithocholic acid (CHEBI:232176) is a organic molecular entity (CHEBI:50860) |
| argininoursodeoxycholic acid (CHEBI:232269) is a organic molecular entity (CHEBI:50860) |
| argipressin tannate (CHEBI:753893) is a organic molecular entity (CHEBI:50860) |
| argx-119 (CHEBI:760477) is a organic molecular entity (CHEBI:50860) |
| arimoclomol (CHEBI:747211) is a organic molecular entity (CHEBI:50860) |
| aristolochate-I(1-) (CHEBI:746938) is a organic molecular entity (CHEBI:50860) |
| Arkin (TN) (CHEBI:31237) is a organic molecular entity (CHEBI:50860) |
| arlocabtagene autoleucel (CHEBI:760346) is a organic molecular entity (CHEBI:50860) |
| armocibart (CHEBI:760122) is a organic molecular entity (CHEBI:50860) |
| aromatic elixir (CHEBI:753894) is a organic molecular entity (CHEBI:50860) |
| aroplatin (CHEBI:756768) is a organic molecular entity (CHEBI:50860) |
| arry-300 (CHEBI:755594) is a organic molecular entity (CHEBI:50860) |
| arsenic-75(3-) (CHEBI:176619) is a organic molecular entity (CHEBI:50860) |
| arsenic-75(3+) (CHEBI:176620) is a organic molecular entity (CHEBI:50860) |
| arsenic-75(5+) (CHEBI:176621) is a organic molecular entity (CHEBI:50860) |
| artegraft (CHEBI:753253) is a organic molecular entity (CHEBI:50860) |
| ARV-825 (CHEBI:230507) is a organic molecular entity (CHEBI:50860) |
| arvenacogene sanparvovec (CHEBI:760123) is a organic molecular entity (CHEBI:50860) |
| arvenin i (CHEBI:230752) is a organic molecular entity (CHEBI:50860) |
| Arylamide (CHEBI:2862) is a organic molecular entity (CHEBI:50860) |
| arylboronic acid (CHEBI:747242) is a organic molecular entity (CHEBI:50860) |
| arylboronic ester (CHEBI:747243) is a organic molecular entity (CHEBI:50860) |
| Arylhydroxamate (CHEBI:2864) is a organic molecular entity (CHEBI:50860) |
| as-1403 (CHEBI:754183) is a organic molecular entity (CHEBI:50860) |
| as-1409 (CHEBI:754216) is a organic molecular entity (CHEBI:50860) |
| as-703988 (CHEBI:755536) is a organic molecular entity (CHEBI:50860) |
| ASC-JM-17 (CHEBI:232815) is a organic molecular entity (CHEBI:50860) |
| ascr#11-CoA (CHEBI:139619) is a organic molecular entity (CHEBI:50860) |
| ascr#11-CoA(4-) (CHEBI:139620) is a organic molecular entity (CHEBI:50860) |
| ascr#11(1-) (CHEBI:139618) is a organic molecular entity (CHEBI:50860) |
| ascr#12-CoA (CHEBI:139622) is a organic molecular entity (CHEBI:50860) |
| ascr#12-CoA(4-) (CHEBI:139623) is a organic molecular entity (CHEBI:50860) |
| ascr#13-CoA (CHEBI:139625) is a organic molecular entity (CHEBI:50860) |
| ascr#13-CoA(4-) (CHEBI:139626) is a organic molecular entity (CHEBI:50860) |
| ascr#13(1-) (CHEBI:139624) is a organic molecular entity (CHEBI:50860) |
| ascr#14-CoA (CHEBI:139628) is a organic molecular entity (CHEBI:50860) |
| ascr#14-CoA(4-) (CHEBI:139629) is a organic molecular entity (CHEBI:50860) |
| ascr#15-CoA (CHEBI:139631) is a organic molecular entity (CHEBI:50860) |
| ascr#15-CoA(4-) (CHEBI:139632) is a organic molecular entity (CHEBI:50860) |
| ascr#15(1-) (CHEBI:139630) is a organic molecular entity (CHEBI:50860) |
| ascr#16-CoA (CHEBI:139634) is a organic molecular entity (CHEBI:50860) |
| ascr#16-CoA(4-) (CHEBI:139635) is a organic molecular entity (CHEBI:50860) |
| ascr#17-CoA (CHEBI:139637) is a organic molecular entity (CHEBI:50860) |
| ascr#17-CoA(4-) (CHEBI:139638) is a organic molecular entity (CHEBI:50860) |
| ascr#17(1-) (CHEBI:139636) is a organic molecular entity (CHEBI:50860) |
| ascr#18-CoA (CHEBI:139640) is a organic molecular entity (CHEBI:50860) |
| ascr#18-CoA(4-) (CHEBI:139641) is a organic molecular entity (CHEBI:50860) |
| ascr#18(1−) (CHEBI:139639) is a organic molecular entity (CHEBI:50860) |
| ascr#19-CoA (CHEBI:139643) is a organic molecular entity (CHEBI:50860) |
| ascr#19-CoA(4-) (CHEBI:139644) is a organic molecular entity (CHEBI:50860) |
| ascr#19(1-) (CHEBI:139642) is a organic molecular entity (CHEBI:50860) |
| ascr#20-CoA (CHEBI:139648) is a organic molecular entity (CHEBI:50860) |
| ascr#20-CoA(4-) (CHEBI:139649) is a organic molecular entity (CHEBI:50860) |
| ascr#20(1-) (CHEBI:139647) is a organic molecular entity (CHEBI:50860) |
| ascr#21(1-) (CHEBI:139650) is a organic molecular entity (CHEBI:50860) |
| ascr#22(1-) (CHEBI:139653) is a organic molecular entity (CHEBI:50860) |
| ascr#23-CoA (CHEBI:139657) is a organic molecular entity (CHEBI:50860) |
| ascr#23-CoA(4-) (CHEBI:139658) is a organic molecular entity (CHEBI:50860) |
| ascr#23(1-) (CHEBI:139656) is a organic molecular entity (CHEBI:50860) |
| ascr#24-CoA (CHEBI:139660) is a organic molecular entity (CHEBI:50860) |
| ascr#24-CoA(4-) (CHEBI:139661) is a organic molecular entity (CHEBI:50860) |
| ascr#24(1-) (CHEBI:139659) is a organic molecular entity (CHEBI:50860) |
| ascr#25-CoA (CHEBI:139663) is a organic molecular entity (CHEBI:50860) |
| ascr#25-CoA(4-) (CHEBI:139664) is a organic molecular entity (CHEBI:50860) |
| ascr#25(1-) (CHEBI:139662) is a organic molecular entity (CHEBI:50860) |
| ascr#26-CoA (CHEBI:139666) is a organic molecular entity (CHEBI:50860) |
| ascr#26-CoA(4-) (CHEBI:139667) is a organic molecular entity (CHEBI:50860) |
| ascr#26(1-) (CHEBI:139665) is a organic molecular entity (CHEBI:50860) |
| ascr#27-CoA (CHEBI:139669) is a organic molecular entity (CHEBI:50860) |
| ascr#27-CoA(4-) (CHEBI:139670) is a organic molecular entity (CHEBI:50860) |
| ascr#27(1-) (CHEBI:139668) is a organic molecular entity (CHEBI:50860) |
| ascr#28-CoA (CHEBI:139672) is a organic molecular entity (CHEBI:50860) |
| ascr#28-CoA(4-) (CHEBI:139673) is a organic molecular entity (CHEBI:50860) |
| ascr#28(1-) (CHEBI:139671) is a organic molecular entity (CHEBI:50860) |
| ascr#29-CoA (CHEBI:139675) is a organic molecular entity (CHEBI:50860) |
| ascr#29-CoA(4-) (CHEBI:139676) is a organic molecular entity (CHEBI:50860) |
| ascr#29(1-) (CHEBI:139674) is a organic molecular entity (CHEBI:50860) |
| ascr#3(1-) (CHEBI:139677) is a organic molecular entity (CHEBI:50860) |
| ascr#30-CoA (CHEBI:139679) is a organic molecular entity (CHEBI:50860) |
| ascr#30-CoA(4-) (CHEBI:139680) is a organic molecular entity (CHEBI:50860) |
| ascr#30(1-) (CHEBI:139678) is a organic molecular entity (CHEBI:50860) |
| ascr#31-CoA (CHEBI:139682) is a organic molecular entity (CHEBI:50860) |
| ascr#31-CoA(4-) (CHEBI:139683) is a organic molecular entity (CHEBI:50860) |
| ascr#31(1-) (CHEBI:139681) is a organic molecular entity (CHEBI:50860) |
| ascr#32-CoA (CHEBI:139685) is a organic molecular entity (CHEBI:50860) |
| ascr#32-CoA(4-) (CHEBI:139686) is a organic molecular entity (CHEBI:50860) |
| ascr#32(1-) (CHEBI:139684) is a organic molecular entity (CHEBI:50860) |
| ascr#33-CoA (CHEBI:139688) is a organic molecular entity (CHEBI:50860) |
| ascr#33-CoA(4-) (CHEBI:139689) is a organic molecular entity (CHEBI:50860) |
| ascr#33(1-) (CHEBI:139687) is a organic molecular entity (CHEBI:50860) |
| ascr#34-CoA (CHEBI:139691) is a organic molecular entity (CHEBI:50860) |
| ascr#34-CoA(4-) (CHEBI:139692) is a organic molecular entity (CHEBI:50860) |
| ascr#34(1-) (CHEBI:139690) is a organic molecular entity (CHEBI:50860) |
| ascr#35-CoA (CHEBI:139694) is a organic molecular entity (CHEBI:50860) |
| ascr#35-CoA(4-) (CHEBI:139695) is a organic molecular entity (CHEBI:50860) |
| ascr#35(1-) (CHEBI:139693) is a organic molecular entity (CHEBI:50860) |
| ascr#36-CoA (CHEBI:139697) is a organic molecular entity (CHEBI:50860) |
| ascr#36-CoA(4-) (CHEBI:139698) is a organic molecular entity (CHEBI:50860) |
| ascr#36(1-) (CHEBI:139696) is a organic molecular entity (CHEBI:50860) |
| ascr#37-CoA (CHEBI:139700) is a organic molecular entity (CHEBI:50860) |
| ascr#37-CoA(4-) (CHEBI:139701) is a organic molecular entity (CHEBI:50860) |
| ascr#37(1-) (CHEBI:139699) is a organic molecular entity (CHEBI:50860) |
| ascr#38-CoA (CHEBI:139703) is a organic molecular entity (CHEBI:50860) |
| ascr#38-CoA(4-) (CHEBI:139704) is a organic molecular entity (CHEBI:50860) |
| ascr#38(1-) (CHEBI:139702) is a organic molecular entity (CHEBI:50860) |
| ascr#5-CoA (CHEBI:139708) is a organic molecular entity (CHEBI:50860) |
| ascr#5-CoA(4-) (CHEBI:139709) is a organic molecular entity (CHEBI:50860) |
| ascr#5(1-) (CHEBI:139707) is a organic molecular entity (CHEBI:50860) |
| ascr#7(1-) (CHEBI:139710) is a organic molecular entity (CHEBI:50860) |
| ascr#8(1-) (CHEBI:139713) is a organic molecular entity (CHEBI:50860) |
| ascr#9-CoA (CHEBI:139715) is a organic molecular entity (CHEBI:50860) |
| ascr#9-CoA(4-) (CHEBI:139716) is a organic molecular entity (CHEBI:50860) |
| ascrinvacumab (CHEBI:754143) is a organic molecular entity (CHEBI:50860) |
| aselizumab (CHEBI:753529) is a organic molecular entity (CHEBI:50860) |
| asfotase alfa (CHEBI:753299) is a organic molecular entity (CHEBI:50860) |
| asg-5me (CHEBI:754334) is a organic molecular entity (CHEBI:50860) |
| ask-8007 (CHEBI:754303) is a organic molecular entity (CHEBI:50860) |
| asm-024 (CHEBI:755753) is a organic molecular entity (CHEBI:50860) |
| asnuciclib (CHEBI:232811) is a organic molecular entity (CHEBI:50860) |
| asp-1948 (CHEBI:758330) is a organic molecular entity (CHEBI:50860) |
| asp-1951 (CHEBI:758331) is a organic molecular entity (CHEBI:50860) |
| asp-8374 (CHEBI:757332) is a organic molecular entity (CHEBI:50860) |
| asp7991 (CHEBI:755461) is a organic molecular entity (CHEBI:50860) |
| aspalon (CHEBI:753895) is a organic molecular entity (CHEBI:50860) |
| asparaginase (CHEBI:753896) is a organic molecular entity (CHEBI:50860) |
| asparaginase erwinia chrysanthemi (CHEBI:750222) is a organic molecular entity (CHEBI:50860) |
| asparaginochenodeoxycholic acid (CHEBI:232196) is a organic molecular entity (CHEBI:50860) |
| asparaginocholic acid (CHEBI:232251) is a organic molecular entity (CHEBI:50860) |
| asparaginodeoxycholic acid (CHEBI:232215) is a organic molecular entity (CHEBI:50860) |
| asparaginolithocholic acid (CHEBI:232181) is a organic molecular entity (CHEBI:50860) |
| asparaginoursodeoxycholic acid (CHEBI:232270) is a organic molecular entity (CHEBI:50860) |
| asparagylocholic acid (CHEBI:232255) is a organic molecular entity (CHEBI:50860) |
| aspartylochenodeoxycholic acid (CHEBI:232200) is a organic molecular entity (CHEBI:50860) |
| aspartylodeoxycholic acid (CHEBI:232218) is a organic molecular entity (CHEBI:50860) |
| aspartylolithocholic acid (CHEBI:232178) is a organic molecular entity (CHEBI:50860) |
| aspartyloursodeoxycholic acid (CHEBI:232273) is a organic molecular entity (CHEBI:50860) |
| aspergildiene A (CHEBI:189072) is a organic molecular entity (CHEBI:50860) |
| aspergildiene B (CHEBI:189073) is a organic molecular entity (CHEBI:50860) |
| aspergildiene C (CHEBI:189074) is a organic molecular entity (CHEBI:50860) |
| aspergildiene D (CHEBI:189075) is a organic molecular entity (CHEBI:50860) |
| aspergiltriene A (CHEBI:189071) is a organic molecular entity (CHEBI:50860) |
| aspidosperma (CHEBI:754104) is a organic molecular entity (CHEBI:50860) |
| Astaxanthin diester (CHEBI:80527) is a organic molecular entity (CHEBI:50860) |
| astegolimab (CHEBI:757874) is a organic molecular entity (CHEBI:50860) |
| asthremedin (CHEBI:753254) is a organic molecular entity (CHEBI:50860) |
| astifilcon a (CHEBI:753897) is a organic molecular entity (CHEBI:50860) |
| astodrimer (CHEBI:755008) is a organic molecular entity (CHEBI:50860) |
| astodrimer sodium (CHEBI:755009) is a organic molecular entity (CHEBI:50860) |
| astuprotimut-r (CHEBI:753649) is a organic molecular entity (CHEBI:50860) |
| asunaron (CHEBI:753255) is a organic molecular entity (CHEBI:50860) |
| asunercept (CHEBI:757324) is a organic molecular entity (CHEBI:50860) |
| asvasiran sodium (CHEBI:755165) is a organic molecular entity (CHEBI:50860) |
| AT 116, benzylamine salt (CHEBI:232633) is a organic molecular entity (CHEBI:50860) |
| atacicept (CHEBI:750066) is a organic molecular entity (CHEBI:50860) |
| atenastobart (CHEBI:760124) is a organic molecular entity (CHEBI:50860) |
| atesidorsen (CHEBI:756465) is a organic molecular entity (CHEBI:50860) |
| atesidorsen sodium (CHEBI:756478) is a organic molecular entity (CHEBI:50860) |
| atexakin alfa (CHEBI:753898) is a organic molecular entity (CHEBI:50860) |
| atezolizumab (CHEBI:755740) is a organic molecular entity (CHEBI:50860) |
| atidarsagene autotemcel (CHEBI:758569) is a organic molecular entity (CHEBI:50860) |
| atigotatug (CHEBI:760009) is a organic molecular entity (CHEBI:50860) |
| atinumab (CHEBI:750067) is a organic molecular entity (CHEBI:50860) |
| atirmociclib (CHEBI:747454) is a organic molecular entity (CHEBI:50860) |
| atisnolerbart (CHEBI:759351) is a organic molecular entity (CHEBI:50860) |
| atlafilcon a (CHEBI:753899) is a organic molecular entity (CHEBI:50860) |
| atoltivimab (CHEBI:757590) is a organic molecular entity (CHEBI:50860) |
| atorolimumab (CHEBI:753256) is a organic molecular entity (CHEBI:50860) |
| atractylenolide I (CHEBI:747480) is a organic molecular entity (CHEBI:50860) |
| Atractyloside (CHEBI:2913) is a organic molecular entity (CHEBI:50860) |
| Atrial natriuretic peptide (CHEBI:80233) is a organic molecular entity (CHEBI:50860) |
| atropine methonitrate (CHEBI:2918) is a organic molecular entity (CHEBI:50860) |
| atropine sulfate (CHEBI:233047) is a organic molecular entity (CHEBI:50860) |
| atsm copper (ii) (CHEBI:756864) is a organic molecular entity (CHEBI:50860) |
| attapulgite, activated (CHEBI:753758) is a organic molecular entity (CHEBI:50860) |
| atu-027 (CHEBI:757333) is a organic molecular entity (CHEBI:50860) |
| atuliflapon (CHEBI:758509) is a organic molecular entity (CHEBI:50860) |
| Atuveciclib Racemate (CHEBI:233410) is a organic molecular entity (CHEBI:50860) |
| atyr-1940 (CHEBI:757025) is a organic molecular entity (CHEBI:50860) |
| aucubin (CHEBI:69796) is a organic molecular entity (CHEBI:50860) |
| aurantoic acid (CHEBI:230612) is a organic molecular entity (CHEBI:50860) |
| aurograb (CHEBI:754330) is a organic molecular entity (CHEBI:50860) |
| austrobuxusin h (CHEBI:230742) is a organic molecular entity (CHEBI:50860) |
| AUTEN-67 (CHEBI:232158) is a organic molecular entity (CHEBI:50860) |
| AUTEN-99 hydrobromide (CHEBI:233148) is a organic molecular entity (CHEBI:50860) |
| autogene cevumeran (CHEBI:758268) is a organic molecular entity (CHEBI:50860) |
| autologous adipose-derived stromal vascular fraction (CHEBI:760478) is a organic molecular entity (CHEBI:50860) |
| autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence (CHEBI:759774) is a organic molecular entity (CHEBI:50860) |
| autologous cord blood (CHEBI:757942) is a organic molecular entity (CHEBI:50860) |
| autologous cultured chondrocytes (CHEBI:759773) is a organic molecular entity (CHEBI:50860) |
| autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous cd54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (CHEBI:759750) is a organic molecular entity (CHEBI:50860) |
| av-203 (CHEBI:754210) is a organic molecular entity (CHEBI:50860) |
| ava-6000 (CHEBI:758882) is a organic molecular entity (CHEBI:50860) |
| avacincaptad pegol (CHEBI:760479) is a organic molecular entity (CHEBI:50860) |
| avacincaptad pegol sodium (CHEBI:757327) is a organic molecular entity (CHEBI:50860) |
| avalglucosidase alfa (CHEBI:757819) is a organic molecular entity (CHEBI:50860) |
| avalotcagene ontaparvovec (CHEBI:758158) is a organic molecular entity (CHEBI:50860) |
| avasopasem manganese (CHEBI:757387) is a organic molecular entity (CHEBI:50860) |
| avdoralimab (CHEBI:757944) is a organic molecular entity (CHEBI:50860) |
| ave-9633 (CHEBI:754130) is a organic molecular entity (CHEBI:50860) |
| ave-9940 (CHEBI:755468) is a organic molecular entity (CHEBI:50860) |
| ave0847 (CHEBI:755558) is a organic molecular entity (CHEBI:50860) |
| ave8134 (CHEBI:755582) is a organic molecular entity (CHEBI:50860) |
| avelumab (CHEBI:755952) is a organic molecular entity (CHEBI:50860) |
| avexitide (CHEBI:757379) is a organic molecular entity (CHEBI:50860) |
| avexitide acetate (CHEBI:757583) is a organic molecular entity (CHEBI:50860) |
| avi-7288 (CHEBI:757153) is a organic molecular entity (CHEBI:50860) |
| avi-7537 (CHEBI:757154) is a organic molecular entity (CHEBI:50860) |
| avicatonin (CHEBI:753224) is a organic molecular entity (CHEBI:50860) |
| avid-200 (CHEBI:758001) is a organic molecular entity (CHEBI:50860) |
| avidin (CHEBI:757044) is a organic molecular entity (CHEBI:50860) |
| avidin periodate oxidized (CHEBI:757335) is a organic molecular entity (CHEBI:50860) |
| aviscumine (CHEBI:753179) is a organic molecular entity (CHEBI:50860) |
| avitotamig (CHEBI:760347) is a organic molecular entity (CHEBI:50860) |
| avizakimab (CHEBI:758006) is a organic molecular entity (CHEBI:50860) |
| avoparcin (CHEBI:753225) is a organic molecular entity (CHEBI:50860) |
| avoplacel (CHEBI:758140) is a organic molecular entity (CHEBI:50860) |
| avotermin (CHEBI:753759) is a organic molecular entity (CHEBI:50860) |
| avp-21d9 (CHEBI:754147) is a organic molecular entity (CHEBI:50860) |
| axatilimab (CHEBI:758080) is a organic molecular entity (CHEBI:50860) |
| Axenomycin (CHEBI:80118) is a organic molecular entity (CHEBI:50860) |
| axicabtagene ciloleucel (CHEBI:756472) is a organic molecular entity (CHEBI:50860) |
| axp-107-11 (CHEBI:755520) is a organic molecular entity (CHEBI:50860) |
| AZ191 (CHEBI:746975) is a organic molecular entity (CHEBI:50860) |
| AZ6983 (CHEBI:231677) is a organic molecular entity (CHEBI:50860) |
| az9773 (CHEBI:754344) is a organic molecular entity (CHEBI:50860) |
| azagly-nafarelin (CHEBI:760258) is a organic molecular entity (CHEBI:50860) |
| azalomycin (CHEBI:753226) is a organic molecular entity (CHEBI:50860) |
| Azaspiracid-2 (CHEBI:145155) is a organic molecular entity (CHEBI:50860) |
| azd-0156 (CHEBI:757336) is a organic molecular entity (CHEBI:50860) |
| azd-0284 (CHEBI:758508) is a organic molecular entity (CHEBI:50860) |
| azd-4785 (CHEBI:757337) is a organic molecular entity (CHEBI:50860) |
| azd-5312 (CHEBI:757338) is a organic molecular entity (CHEBI:50860) |
| azd-6918 (CHEBI:755559) is a organic molecular entity (CHEBI:50860) |
| azd2423 (CHEBI:755524) is a organic molecular entity (CHEBI:50860) |
| azd2516 (CHEBI:755586) is a organic molecular entity (CHEBI:50860) |
| azd3161 (CHEBI:755515) is a organic molecular entity (CHEBI:50860) |
| azd3199 (CHEBI:755462) is a organic molecular entity (CHEBI:50860) |
| AZD4573 (CHEBI:233359) is a organic molecular entity (CHEBI:50860) |
| azd8108 (CHEBI:755822) is a organic molecular entity (CHEBI:50860) |
| azd8683 (CHEBI:755525) is a organic molecular entity (CHEBI:50860) |
| azercabtagene zapreleucel (CHEBI:759034) is a organic molecular entity (CHEBI:50860) |
| azerutamig (CHEBI:760125) is a organic molecular entity (CHEBI:50860) |
| azficel-t (CHEBI:752908) is a organic molecular entity (CHEBI:50860) |
| AzHeK (CHEBI:747499) is a organic molecular entity (CHEBI:50860) |
| azidoglyburide (CHEBI:87302) is a organic molecular entity (CHEBI:50860) |
| Azidohomoalanine (CHEBI:233440) is a organic molecular entity (CHEBI:50860) |
| Azidonorleucine (CHEBI:233439) is a organic molecular entity (CHEBI:50860) |
| azintuxizumab vedotin (CHEBI:757300) is a organic molecular entity (CHEBI:50860) |
| azirkitug (CHEBI:760010) is a organic molecular entity (CHEBI:50860) |
| azodicarbonamide (CHEBI:156571) is a organic molecular entity (CHEBI:50860) |
| azoramide (CHEBI:233464) is a organic molecular entity (CHEBI:50860) |
| azoximer bromide (CHEBI:758270) is a organic molecular entity (CHEBI:50860) |
| Azoxymethane (CHEBI:232612) is a organic molecular entity (CHEBI:50860) |
| azuresin (CHEBI:753817) is a organic molecular entity (CHEBI:50860) |
| azx-100 (CHEBI:757339) is a organic molecular entity (CHEBI:50860) |
| B-sitosterol (CHEBI:176889) is a organic molecular entity (CHEBI:50860) |
| Bacillomycin D (CHEBI:31250) is a organic molecular entity (CHEBI:50860) |
| bacillus anthracis protective antigen, adsorbed (CHEBI:760404) is a organic molecular entity (CHEBI:50860) |
| bacitracin methylene disalicylate (CHEBI:753757) is a organic molecular entity (CHEBI:50860) |
| bacterial virulence gene B (CHEBI:73170) is a organic molecular entity (CHEBI:50860) |
| Bacterio-chlorophyll c (CHEBI:2976) is a organic molecular entity (CHEBI:50860) |
| Bacteriochlorophyll d (CHEBI:81553) is a organic molecular entity (CHEBI:50860) |
| bafisontamab (CHEBI:757952) is a organic molecular entity (CHEBI:50860) |
| balafilcon a (CHEBI:753227) is a organic molecular entity (CHEBI:50860) |
| baliforsen (CHEBI:756491) is a organic molecular entity (CHEBI:50860) |
| baloramotide (CHEBI:757502) is a organic molecular entity (CHEBI:50860) |
| balstilimab (CHEBI:757315) is a organic molecular entity (CHEBI:50860) |
| baltaleucel-t (CHEBI:756485) is a organic molecular entity (CHEBI:50860) |
| balugrastim (CHEBI:753526) is a organic molecular entity (CHEBI:50860) |
| baluretgene parvec (CHEBI:760394) is a organic molecular entity (CHEBI:50860) |
| bambermycins (CHEBI:753818) is a organic molecular entity (CHEBI:50860) |
| bamethan (CHEBI:37936) is a organic molecular entity (CHEBI:50860) |
| baminercept (CHEBI:750068) is a organic molecular entity (CHEBI:50860) |
| bamlanivimab (CHEBI:758271) is a organic molecular entity (CHEBI:50860) |
| bamosiran (CHEBI:757528) is a organic molecular entity (CHEBI:50860) |
| bandage, adhesive (CHEBI:753819) is a organic molecular entity (CHEBI:50860) |
| bandage, gauze (CHEBI:753228) is a organic molecular entity (CHEBI:50860) |
| bapineuzumab (CHEBI:753530) is a organic molecular entity (CHEBI:50860) |
| barecetamab (CHEBI:758362) is a organic molecular entity (CHEBI:50860) |
| barettin (CHEBI:194574) is a organic molecular entity (CHEBI:50860) |
| barzolvolimab (CHEBI:758842) is a organic molecular entity (CHEBI:50860) |
| basic fibroblast growth factor (human) (CHEBI:760509) is a organic molecular entity (CHEBI:50860) |
| basiliximab (CHEBI:63583) is a organic molecular entity (CHEBI:50860) |
| basiliximab sarotalocan (CHEBI:759419) is a organic molecular entity (CHEBI:50860) |
| bathophenanthrolinedisulfonic acid disodium salt trihydrate (CHEBI:234116) is a organic molecular entity (CHEBI:50860) |
| Bathorhodopsin (CHEBI:2998) is a organic molecular entity (CHEBI:50860) |
| batiraxcept (CHEBI:757943) is a organic molecular entity (CHEBI:50860) |
| batoclimab (CHEBI:758391) is a organic molecular entity (CHEBI:50860) |
| batroxobin (CHEBI:753820) is a organic molecular entity (CHEBI:50860) |
| bavebegene tovacivec (CHEBI:760126) is a organic molecular entity (CHEBI:50860) |
| Bavisant (CHEBI:747878) is a organic molecular entity (CHEBI:50860) |
| bavituximab (CHEBI:750069) is a organic molecular entity (CHEBI:50860) |
| bavunalimab (CHEBI:759014) is a organic molecular entity (CHEBI:50860) |
| Bax Channel Blocker (CHEBI:231620) is a organic molecular entity (CHEBI:50860) |
| baxdrostat (CHEBI:747471) is a organic molecular entity (CHEBI:50860) |
| Bay 65-1942 (CHEBI:230517) is a organic molecular entity (CHEBI:50860) |
| bay-1093884 (CHEBI:757341) is a organic molecular entity (CHEBI:50860) |
| bay-2287411 (CHEBI:757343) is a organic molecular entity (CHEBI:50860) |
| BAY-293 (CHEBI:232851) is a organic molecular entity (CHEBI:50860) |
| BAY-364 (CHEBI:234579) is a organic molecular entity (CHEBI:50860) |
| BAY-850 (CHEBI:234078) is a organic molecular entity (CHEBI:50860) |
| BAY-876 (CHEBI:747819) is a organic molecular entity (CHEBI:50860) |
| bazlitoran (CHEBI:757422) is a organic molecular entity (CHEBI:50860) |
| bazlitoran sodium (CHEBI:756736) is a organic molecular entity (CHEBI:50860) |
| bb-1701 (CHEBI:759668) is a organic molecular entity (CHEBI:50860) |
| bbv-152 antigen adjuvated with algel-imdg (CHEBI:758512) is a organic molecular entity (CHEBI:50860) |
| bc8 131i (CHEBI:754369) is a organic molecular entity (CHEBI:50860) |
| bcg live (CHEBI:753038) is a organic molecular entity (CHEBI:50860) |
| bcg vaccine (CHEBI:753821) is a organic molecular entity (CHEBI:50860) |
| BD1063 dihydrochloride (CHEBI:746974) is a organic molecular entity (CHEBI:50860) |
| bebtelovimab (CHEBI:758522) is a organic molecular entity (CHEBI:50860) |
| becaplermin (CHEBI:749433) is a organic molecular entity (CHEBI:50860) |
| beclanorsen (CHEBI:760529) is a organic molecular entity (CHEBI:50860) |
| Becocalcidiol (CHEBI:231099) is a organic molecular entity (CHEBI:50860) |
| becotatug (CHEBI:758363) is a organic molecular entity (CHEBI:50860) |
| becotatug vedotin (CHEBI:760127) is a organic molecular entity (CHEBI:50860) |
| bectumomab (CHEBI:753229) is a organic molecular entity (CHEBI:50860) |
| bedinvetmab (CHEBI:759755) is a organic molecular entity (CHEBI:50860) |
| beef tallow (CHEBI:753732) is a organic molecular entity (CHEBI:50860) |
| begelomab (CHEBI:755945) is a organic molecular entity (CHEBI:50860) |
| beinaglutide (CHEBI:758843) is a organic molecular entity (CHEBI:50860) |
| belacabnagene franleucel (CHEBI:760011) is a organic molecular entity (CHEBI:50860) |
| belagenpumatucel-l (CHEBI:753531) is a organic molecular entity (CHEBI:50860) |
| belantamab (CHEBI:757614) is a organic molecular entity (CHEBI:50860) |
| belantamab mafodotin (CHEBI:757615) is a organic molecular entity (CHEBI:50860) |
| belapectin (CHEBI:757052) is a organic molecular entity (CHEBI:50860) |
| belatacept (CHEBI:750070) is a organic molecular entity (CHEBI:50860) |
| belcesiran (CHEBI:758272) is a organic molecular entity (CHEBI:50860) |
| belimumab (CHEBI:750192) is a organic molecular entity (CHEBI:50860) |
| belladonna (CHEBI:753822) is a organic molecular entity (CHEBI:50860) |
| belladonna leaf (CHEBI:753532) is a organic molecular entity (CHEBI:50860) |
| belladonna root (CHEBI:753760) is a organic molecular entity (CHEBI:50860) |
| belrestotug (CHEBI:758518) is a organic molecular entity (CHEBI:50860) |
| beludavimab (CHEBI:758531) is a organic molecular entity (CHEBI:50860) |
| belzupacap sarotalocan (CHEBI:758507) is a organic molecular entity (CHEBI:50860) |
| bemarituzumab (CHEBI:758486) is a organic molecular entity (CHEBI:50860) |
| bemdaneprocel (CHEBI:759352) is a organic molecular entity (CHEBI:50860) |
| bemiltenase alfa (CHEBI:759503) is a organic molecular entity (CHEBI:50860) |
| bemiparin (CHEBI:755829) is a organic molecular entity (CHEBI:50860) |
| bemiparin sodium (CHEBI:753733) is a organic molecular entity (CHEBI:50860) |
| bempegaldesleukin (CHEBI:757481) is a organic molecular entity (CHEBI:50860) |
| bempikibart (CHEBI:758874) is a organic molecular entity (CHEBI:50860) |
| Benexate hydrochloride (CHEBI:31258) is a organic molecular entity (CHEBI:50860) |
| benexate hydrochloride betadex (CHEBI:753823) is a organic molecular entity (CHEBI:50860) |
| benmelstobart (CHEBI:759730) is a organic molecular entity (CHEBI:50860) |
| benralizumab (CHEBI:750071) is a organic molecular entity (CHEBI:50860) |
| Bentazone-sodium (CHEBI:81854) is a organic molecular entity (CHEBI:50860) |
| bentoquatam (CHEBI:749460) is a organic molecular entity (CHEBI:50860) |
| bentracimab (CHEBI:757825) is a organic molecular entity (CHEBI:50860) |
| benzalkonium(1+) (CHEBI:232885) is a organic molecular entity (CHEBI:50860) |
| benzin, petroleum (CHEBI:753831) is a organic molecular entity (CHEBI:50860) |
| Benzonitrile, 3-amino-4-((2-((dimethylamino)methyl)phenyl)thio)- (CHEBI:230438) is a organic molecular entity (CHEBI:50860) |
| benzothiazolylcysteine zwitterion (CHEBI:746958) is a organic molecular entity (CHEBI:50860) |
| benzoylphenylurea (CHEBI:233279) is a organic molecular entity (CHEBI:50860) |
| benzyl lactamide (CHEBI:747277) is a organic molecular entity (CHEBI:50860) |
| benzyl lactate (CHEBI:747275) is a organic molecular entity (CHEBI:50860) |
| Benzyl violet 4B (CHEBI:82293) is a organic molecular entity (CHEBI:50860) |
| beperminogene perplasmid (CHEBI:753314) is a organic molecular entity (CHEBI:50860) |
| bepirovirsen (CHEBI:758350) is a organic molecular entity (CHEBI:50860) |
| bepirovirsen sodium (CHEBI:759004) is a organic molecular entity (CHEBI:50860) |
| bepranemab (CHEBI:758084) is a organic molecular entity (CHEBI:50860) |
| beractant (CHEBI:749531) is a organic molecular entity (CHEBI:50860) |
| berahyaluronidase alfa (CHEBI:759420) is a organic molecular entity (CHEBI:50860) |
| Berberine chloride (TN) (CHEBI:31271) is a organic molecular entity (CHEBI:50860) |
| berberine tannate (CHEBI:753996) is a organic molecular entity (CHEBI:50860) |
| berdazimer sodium (CHEBI:757487) is a organic molecular entity (CHEBI:50860) |
| beremagene geperpavec (CHEBI:757826) is a organic molecular entity (CHEBI:50860) |
| beretemcel (CHEBI:760012) is a organic molecular entity (CHEBI:50860) |
| Bergstromic acid (CHEBI:197303) is a organic molecular entity (CHEBI:50860) |
| bermekimab (CHEBI:754385) is a organic molecular entity (CHEBI:50860) |
| beroctocog alfa (CHEBI:753313) is a organic molecular entity (CHEBI:50860) |
| Berthelotic acid (CHEBI:195356) is a organic molecular entity (CHEBI:50860) |
| bertilimumab (CHEBI:753997) is a organic molecular entity (CHEBI:50860) |
| besilesomab (CHEBI:753039) is a organic molecular entity (CHEBI:50860) |
| besvatresgene autoleucel (CHEBI:759421) is a organic molecular entity (CHEBI:50860) |
| beta-(3-Pyridyl)-DL-alanine (CHEBI:233113) is a organic molecular entity (CHEBI:50860) |
| beta-cembratrien-ol (CHEBI:192754) is a organic molecular entity (CHEBI:50860) |
| beta-Chloro-alpha-phenylbenzeneethanamine hydrochloride (CHEBI:79912) is a organic molecular entity (CHEBI:50860) |
| beta-D-galactosyl-(1→4)-beta-D-glucosyl-(1↔1)-N-acylsphingoid (CHEBI:195546) is a organic molecular entity (CHEBI:50860) |
| beta-D-GalNAc-(1→4)-beta-D-GlcA2S-(1→3)-beta-D-GalNAc6S-(1→4)-beta-D-GlcA-(1→3)-beta-D-Gal-(1→3)-beta-D-Gal-(1→4)-beta-D-Xyl-yl group (CHEBI:233527) is a organic molecular entity (CHEBI:50860) |
| beta-D-GalNAc-(1→4)-beta-D-IdoA-(1→3)-beta-D-GalNAc4,6S-(1→4)-beta-D-GlcA-(1→3)-beta-D-Gal-(1→3)-beta-D-Gal-(1→4)-beta-D-Xyl-yl group (CHEBI:233538) is a organic molecular entity (CHEBI:50860) |
| beta-D-Glucuronosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosylproteoglycan (CHEBI:79984) is a organic molecular entity (CHEBI:50860) |
| beta-D-Glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosylproteoglycan (CHEBI:79982) is a organic molecular entity (CHEBI:50860) |
| beta-D-Glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminylproteoglycan (CHEBI:79979) is a organic molecular entity (CHEBI:50860) |
| beta-Hydroxy-L-tyrosyl-[pcp] (CHEBI:32324) is a organic molecular entity (CHEBI:50860) |
| beta-Keto-L-tyrosyl-[pcp] (CHEBI:32326) is a organic molecular entity (CHEBI:50860) |
| beta-L-Dioxolane-cytidine (CHEBI:230309) is a organic molecular entity (CHEBI:50860) |
| beta-Lipotropin (CHEBI:80247) is a organic molecular entity (CHEBI:50860) |
| beta-Melanotropin (CHEBI:80348) is a organic molecular entity (CHEBI:50860) |
| beta-Neoendorphin (CHEBI:80262) is a organic molecular entity (CHEBI:50860) |
| beta-Nicotinamide mononucleotide (CHEBI:231660) is a organic molecular entity (CHEBI:50860) |
| beta-Substituted alpha-L-amino acid (CHEBI:10446) is a organic molecular entity (CHEBI:50860) |
| betaenone B (CHEBI:145054) is a organic molecular entity (CHEBI:50860) |
| betaenone C (CHEBI:145053) is a organic molecular entity (CHEBI:50860) |
| betanidin quinone(2-) (CHEBI:140727) is a organic molecular entity (CHEBI:50860) |
| betasizofiran (CHEBI:753382) is a organic molecular entity (CHEBI:50860) |
| betfisolimab (CHEBI:758692) is a organic molecular entity (CHEBI:50860) |
| betibeglogene autotemcel (CHEBI:757810) is a organic molecular entity (CHEBI:50860) |
| betinukibart (CHEBI:760128) is a organic molecular entity (CHEBI:50860) |
| bevacizumab (CHEBI:749495) is a organic molecular entity (CHEBI:50860) |
| bevacizumab 111in (CHEBI:755755) is a organic molecular entity (CHEBI:50860) |
| bevacizumab gamma (CHEBI:759422) is a organic molecular entity (CHEBI:50860) |
| bevifimod (CHEBI:757497) is a organic molecular entity (CHEBI:50860) |
| bevonescein (CHEBI:759049) is a organic molecular entity (CHEBI:50860) |
| bevufenogene nofeparvovec (CHEBI:759008) is a organic molecular entity (CHEBI:50860) |
| bexatamig (CHEBI:760013) is a organic molecular entity (CHEBI:50860) |
| bexmarilimab (CHEBI:758017) is a organic molecular entity (CHEBI:50860) |
| bezeotermin alfa (CHEBI:760129) is a organic molecular entity (CHEBI:50860) |
| bezeparsen (CHEBI:759353) is a organic molecular entity (CHEBI:50860) |
| bezetabart (CHEBI:759504) is a organic molecular entity (CHEBI:50860) |
| bezetabart debotansine (CHEBI:759505) is a organic molecular entity (CHEBI:50860) |
| bezlotoxumab (CHEBI:753618) is a organic molecular entity (CHEBI:50860) |
| BGP-15 (CHEBI:232856) is a organic molecular entity (CHEBI:50860) |
| bhas#1 (CHEBI:139717) is a organic molecular entity (CHEBI:50860) |
| bhas#1-CoA (CHEBI:139736) is a organic molecular entity (CHEBI:50860) |
| bhas#1-CoA(4-) (CHEBI:139737) is a organic molecular entity (CHEBI:50860) |
| bhas#1(1-) (CHEBI:139718) is a organic molecular entity (CHEBI:50860) |
| bhas#10-CoA (CHEBI:139720) is a organic molecular entity (CHEBI:50860) |
| bhas#10-CoA(4-) (CHEBI:139721) is a organic molecular entity (CHEBI:50860) |
| bhas#10(1-) (CHEBI:139719) is a organic molecular entity (CHEBI:50860) |
| bhas#12 (CHEBI:139722) is a organic molecular entity (CHEBI:50860) |
| bhas#12-CoA (CHEBI:139724) is a organic molecular entity (CHEBI:50860) |
| bhas#12-CoA(4-) (CHEBI:139725) is a organic molecular entity (CHEBI:50860) |
| bhas#12(1-) (CHEBI:139723) is a organic molecular entity (CHEBI:50860) |
| bhas#14 (CHEBI:139726) is a organic molecular entity (CHEBI:50860) |
| bhas#14-CoA (CHEBI:139728) is a organic molecular entity (CHEBI:50860) |
| bhas#14-CoA(4-) (CHEBI:139729) is a organic molecular entity (CHEBI:50860) |
| bhas#14(1-) (CHEBI:139727) is a organic molecular entity (CHEBI:50860) |
| bhas#16-CoA (CHEBI:139731) is a organic molecular entity (CHEBI:50860) |
| bhas#16-CoA(4-) (CHEBI:139732) is a organic molecular entity (CHEBI:50860) |
| bhas#16(1-) (CHEBI:139730) is a organic molecular entity (CHEBI:50860) |
| bhas#18-CoA (CHEBI:139734) is a organic molecular entity (CHEBI:50860) |
| bhas#18-CoA(4-) (CHEBI:139735) is a organic molecular entity (CHEBI:50860) |
| bhas#18(1-) (CHEBI:139733) is a organic molecular entity (CHEBI:50860) |
| bhas#20-CoA (CHEBI:139739) is a organic molecular entity (CHEBI:50860) |
| bhas#20-CoA(4-) (CHEBI:139740) is a organic molecular entity (CHEBI:50860) |
| bhas#20(1-) (CHEBI:139738) is a organic molecular entity (CHEBI:50860) |
| bhas#22-CoA (CHEBI:139742) is a organic molecular entity (CHEBI:50860) |
| bhas#22-CoA(4-) (CHEBI:139743) is a organic molecular entity (CHEBI:50860) |
| bhas#22(1-) (CHEBI:139741) is a organic molecular entity (CHEBI:50860) |
| bhas#24-CoA (CHEBI:139745) is a organic molecular entity (CHEBI:50860) |
| bhas#24-CoA(4-) (CHEBI:139746) is a organic molecular entity (CHEBI:50860) |
| bhas#24(1-) (CHEBI:139744) is a organic molecular entity (CHEBI:50860) |
| bhas#26-CoA (CHEBI:139748) is a organic molecular entity (CHEBI:50860) |
| bhas#26-CoA(4-) (CHEBI:139749) is a organic molecular entity (CHEBI:50860) |
| bhas#26(1-) (CHEBI:139747) is a organic molecular entity (CHEBI:50860) |
| bhas#28-CoA (CHEBI:139751) is a organic molecular entity (CHEBI:50860) |
| bhas#28-CoA(4-) (CHEBI:139752) is a organic molecular entity (CHEBI:50860) |
| bhas#28(1-) (CHEBI:139750) is a organic molecular entity (CHEBI:50860) |
| bhas#30-CoA (CHEBI:139754) is a organic molecular entity (CHEBI:50860) |
| bhas#30-CoA(4-) (CHEBI:139755) is a organic molecular entity (CHEBI:50860) |
| bhas#30(1-) (CHEBI:139753) is a organic molecular entity (CHEBI:50860) |
| bhas#32-CoA (CHEBI:139757) is a organic molecular entity (CHEBI:50860) |
| bhas#32-CoA(4-) (CHEBI:139758) is a organic molecular entity (CHEBI:50860) |
| bhas#32(1-) (CHEBI:139756) is a organic molecular entity (CHEBI:50860) |
| bhas#34-CoA (CHEBI:139760) is a organic molecular entity (CHEBI:50860) |
| bhas#34-CoA(4-) (CHEBI:139761) is a organic molecular entity (CHEBI:50860) |
| bhas#34(1-) (CHEBI:139759) is a organic molecular entity (CHEBI:50860) |
| bhas#36-CoA (CHEBI:139763) is a organic molecular entity (CHEBI:50860) |
| bhas#36-CoA(4-) (CHEBI:139764) is a organic molecular entity (CHEBI:50860) |
| bhas#36(1-) (CHEBI:139762) is a organic molecular entity (CHEBI:50860) |
| bhas#38-CoA (CHEBI:139766) is a organic molecular entity (CHEBI:50860) |
| bhas#38-CoA(4-) (CHEBI:139767) is a organic molecular entity (CHEBI:50860) |
| bhas#38(1-) (CHEBI:139765) is a organic molecular entity (CHEBI:50860) |
| bhas#9 (CHEBI:139768) is a organic molecular entity (CHEBI:50860) |
| bhas#9-CoA (CHEBI:139770) is a organic molecular entity (CHEBI:50860) |
| bhas#9-CoA(4-) (CHEBI:139771) is a organic molecular entity (CHEBI:50860) |
| bhas#9(1-) (CHEBI:139769) is a organic molecular entity (CHEBI:50860) |
| bhos#1 (CHEBI:139772) is a organic molecular entity (CHEBI:50860) |
| bhos#1-CoA (CHEBI:139791) is a organic molecular entity (CHEBI:50860) |
| bhos#1-CoA(4-) (CHEBI:139792) is a organic molecular entity (CHEBI:50860) |
| bhos#1(1-) (CHEBI:139773) is a organic molecular entity (CHEBI:50860) |
| bhos#10-CoA (CHEBI:139775) is a organic molecular entity (CHEBI:50860) |
| bhos#10-CoA(4-) (CHEBI:139776) is a organic molecular entity (CHEBI:50860) |
| bhos#10(1-) (CHEBI:139774) is a organic molecular entity (CHEBI:50860) |
| bhos#12 (CHEBI:139777) is a organic molecular entity (CHEBI:50860) |
| bhos#12-CoA (CHEBI:139779) is a organic molecular entity (CHEBI:50860) |
| bhos#12-CoA(4-) (CHEBI:139780) is a organic molecular entity (CHEBI:50860) |
| bhos#12(1-) (CHEBI:139778) is a organic molecular entity (CHEBI:50860) |
| bhos#14 (CHEBI:139781) is a organic molecular entity (CHEBI:50860) |
| bhos#14-CoA (CHEBI:139783) is a organic molecular entity (CHEBI:50860) |
| bhos#14-CoA(4-) (CHEBI:139784) is a organic molecular entity (CHEBI:50860) |
| bhos#14(1-) (CHEBI:139782) is a organic molecular entity (CHEBI:50860) |
| bhos#16-CoA (CHEBI:139786) is a organic molecular entity (CHEBI:50860) |
| bhos#16-CoA(4-) (CHEBI:139787) is a organic molecular entity (CHEBI:50860) |
| bhos#16(1-) (CHEBI:139785) is a organic molecular entity (CHEBI:50860) |
| bhos#18-CoA (CHEBI:139789) is a organic molecular entity (CHEBI:50860) |
| bhos#18-CoA(4-) (CHEBI:139790) is a organic molecular entity (CHEBI:50860) |
| bhos#18(1-) (CHEBI:139788) is a organic molecular entity (CHEBI:50860) |
| bhos#20-CoA (CHEBI:139794) is a organic molecular entity (CHEBI:50860) |
| bhos#20-CoA(4-) (CHEBI:139795) is a organic molecular entity (CHEBI:50860) |
| bhos#20(1-) (CHEBI:139793) is a organic molecular entity (CHEBI:50860) |
| bhos#22-CoA (CHEBI:139797) is a organic molecular entity (CHEBI:50860) |
| bhos#22-CoA(4-) (CHEBI:139798) is a organic molecular entity (CHEBI:50860) |
| bhos#22(1-) (CHEBI:139796) is a organic molecular entity (CHEBI:50860) |
| bhos#24-CoA (CHEBI:139800) is a organic molecular entity (CHEBI:50860) |
| bhos#24-CoA(4-) (CHEBI:139801) is a organic molecular entity (CHEBI:50860) |
| bhos#24(1-) (CHEBI:139799) is a organic molecular entity (CHEBI:50860) |
| bhos#26-CoA (CHEBI:139803) is a organic molecular entity (CHEBI:50860) |
| bhos#26-CoA(4-) (CHEBI:139804) is a organic molecular entity (CHEBI:50860) |
| bhos#26(1-) (CHEBI:139802) is a organic molecular entity (CHEBI:50860) |
| bhos#28-CoA (CHEBI:139806) is a organic molecular entity (CHEBI:50860) |
| bhos#28-CoA(4-) (CHEBI:139807) is a organic molecular entity (CHEBI:50860) |
| bhos#28(1-) (CHEBI:139805) is a organic molecular entity (CHEBI:50860) |
| bhos#30-CoA (CHEBI:139809) is a organic molecular entity (CHEBI:50860) |
| bhos#30-CoA(4-) (CHEBI:139810) is a organic molecular entity (CHEBI:50860) |
| bhos#30(1-) (CHEBI:139808) is a organic molecular entity (CHEBI:50860) |
| bhos#32-CoA (CHEBI:139812) is a organic molecular entity (CHEBI:50860) |
| bhos#32-CoA(4-) (CHEBI:139813) is a organic molecular entity (CHEBI:50860) |
| bhos#32(1-) (CHEBI:139811) is a organic molecular entity (CHEBI:50860) |
| bhos#34-CoA (CHEBI:139815) is a organic molecular entity (CHEBI:50860) |
| bhos#34-CoA(4-) (CHEBI:139816) is a organic molecular entity (CHEBI:50860) |
| bhos#34(1-) (CHEBI:139814) is a organic molecular entity (CHEBI:50860) |
| bhos#36-CoA (CHEBI:139818) is a organic molecular entity (CHEBI:50860) |
| bhos#36-CoA(4-) (CHEBI:139819) is a organic molecular entity (CHEBI:50860) |
| bhos#36(1-) (CHEBI:139817) is a organic molecular entity (CHEBI:50860) |
| bhos#38-CoA (CHEBI:139821) is a organic molecular entity (CHEBI:50860) |
| bhos#38-CoA(4-) (CHEBI:139822) is a organic molecular entity (CHEBI:50860) |
| bhos#38(1-) (CHEBI:139820) is a organic molecular entity (CHEBI:50860) |
| bhos#9 (CHEBI:139823) is a organic molecular entity (CHEBI:50860) |
| bhos#9-CoA (CHEBI:139825) is a organic molecular entity (CHEBI:50860) |
| bhos#9-CoA(4-) (CHEBI:139826) is a organic molecular entity (CHEBI:50860) |
| bhos#9(1-) (CHEBI:139824) is a organic molecular entity (CHEBI:50860) |
| bhq-880 (CHEBI:754198) is a organic molecular entity (CHEBI:50860) |
| bi-1206 (CHEBI:757946) is a organic molecular entity (CHEBI:50860) |
| bi-505 (CHEBI:754268) is a organic molecular entity (CHEBI:50860) |
| bi-811283 (CHEBI:755617) is a organic molecular entity (CHEBI:50860) |
| BI-831266 (CHEBI:232850) is a organic molecular entity (CHEBI:50860) |
| bi-836826 (CHEBI:758005) is a organic molecular entity (CHEBI:50860) |
| bi113823 (CHEBI:755611) is a organic molecular entity (CHEBI:50860) |
| biciromab (CHEBI:753383) is a organic molecular entity (CHEBI:50860) |
| biciromab brallobarbital (CHEBI:754137) is a organic molecular entity (CHEBI:50860) |
| Bicyclo [6.1.0] nonyne-lysine (CHEBI:232659) is a organic molecular entity (CHEBI:50860) |
| bidoleucel (CHEBI:759423) is a organic molecular entity (CHEBI:50860) |
| bidridistrogene xeboparvovec (CHEBI:758146) is a organic molecular entity (CHEBI:50860) |
| bifarcept (CHEBI:753384) is a organic molecular entity (CHEBI:50860) |
| bifidobacterium spp. (CHEBI:757348) is a organic molecular entity (CHEBI:50860) |
| bifonsecin B (CHEBI:145921) is a organic molecular entity (CHEBI:50860) |
| bifunctional epoxide hydrolase 2 (CHEBI:757526) is a organic molecular entity (CHEBI:50860) |
| Big endothelin (CHEBI:80239) is a organic molecular entity (CHEBI:50860) |
| biib-015 (CHEBI:754335) is a organic molecular entity (CHEBI:50860) |
| biib-022 (CHEBI:754181) is a organic molecular entity (CHEBI:50860) |
| biib-023 (CHEBI:754351) is a organic molecular entity (CHEBI:50860) |
| biib-068 (CHEBI:758334) is a organic molecular entity (CHEBI:50860) |
| biib-080 (CHEBI:759702) is a organic molecular entity (CHEBI:50860) |
| biib061 (CHEBI:755926) is a organic molecular entity (CHEBI:50860) |
| bile salts (CHEBI:753636) is a organic molecular entity (CHEBI:50860) |
| bimagrumab (CHEBI:755179) is a organic molecular entity (CHEBI:50860) |
| bimekizumab (CHEBI:757155) is a organic molecular entity (CHEBI:50860) |
| binetrakin (CHEBI:753385) is a organic molecular entity (CHEBI:50860) |
| biniramycin (CHEBI:753998) is a organic molecular entity (CHEBI:50860) |
| bintrafusp alfa (CHEBI:757448) is a organic molecular entity (CHEBI:50860) |
| bio-11006 (CHEBI:757156) is a organic molecular entity (CHEBI:50860) |
| bioconjugate (CHEBI:64985) is a organic molecular entity (CHEBI:50860) |
| biological indicator for dry-heat sterilization, paper strip (CHEBI:753999) is a organic molecular entity (CHEBI:50860) |
| biological indicator for ethylene oxide sterilization, paper strip (CHEBI:754000) is a organic molecular entity (CHEBI:50860) |
| biological indicator for steam sterilization, paper strip (CHEBI:753775) is a organic molecular entity (CHEBI:50860) |
| biological indicator for steam sterilization, self-contained (CHEBI:754001) is a organic molecular entity (CHEBI:50860) |
| biomacromolecule (CHEBI:33694) is a organic molecular entity (CHEBI:50860) |
| Biotinyl-[protein] (CHEBI:81472) is a organic molecular entity (CHEBI:50860) |
| birabresib (CHEBI:230508) is a organic molecular entity (CHEBI:50860) |
| birch triterpenes (CHEBI:758152) is a organic molecular entity (CHEBI:50860) |
| birinkibart (CHEBI:760130) is a organic molecular entity (CHEBI:50860) |
| biropepimut-s (CHEBI:756486) is a organic molecular entity (CHEBI:50860) |
| birtamimab (CHEBI:755936) is a organic molecular entity (CHEBI:50860) |
| bis(2-hydroxyethyl) terephthalamide (CHEBI:747240) is a organic molecular entity (CHEBI:50860) |
| bis(2-hydroxyethyl)furan-2,5-dicarboxylate (CHEBI:747695) is a organic molecular entity (CHEBI:50860) |
| Bis(3-azidopyridinium)-1,10-decane perchlorate (CHEBI:34574) is a organic molecular entity (CHEBI:50860) |
| bisacodyl tannex (CHEBI:754002) is a organic molecular entity (CHEBI:50860) |
| Bisbentiamine (CHEBI:31288) is a organic molecular entity (CHEBI:50860) |
| bisfarnesyl ether (CHEBI:192992) is a organic molecular entity (CHEBI:50860) |
| bismuth aluminate (CHEBI:754003) is a organic molecular entity (CHEBI:50860) |
| bismuth carbonate (CHEBI:753853) is a organic molecular entity (CHEBI:50860) |
| bismuth magnesium aluminosilicate (CHEBI:753858) is a organic molecular entity (CHEBI:50860) |
| bismuth oxide (CHEBI:757021) is a organic molecular entity (CHEBI:50860) |
| bismuth subcitrate (CHEBI:750171) is a organic molecular entity (CHEBI:50860) |
| bismuth subcitrate potassium (CHEBI:749392) is a organic molecular entity (CHEBI:50860) |
| Bismuth subnitrate (CHEBI:31293) is a organic molecular entity (CHEBI:50860) |
| bismuth tribromophenate (CHEBI:758088) is a organic molecular entity (CHEBI:50860) |
| bismuth, [milk of] (CHEBI:753850) is a organic molecular entity (CHEBI:50860) |
| bismuthate (CHEBI:750416) is a organic molecular entity (CHEBI:50860) |
| Bisoxatin acetate (CHEBI:31294) is a organic molecular entity (CHEBI:50860) |
| bits-7201a (CHEBI:757349) is a organic molecular entity (CHEBI:50860) |
| bitter tincture (CHEBI:754004) is a organic molecular entity (CHEBI:50860) |
| Bitumens (CHEBI:82295) is a organic molecular entity (CHEBI:50860) |
| bivalirudin trifluoroacetate (CHEBI:759085) is a organic molecular entity (CHEBI:50860) |
| bivatuzumab (CHEBI:753386) is a organic molecular entity (CHEBI:50860) |
| bivatuzumab mertansine (CHEBI:754141) is a organic molecular entity (CHEBI:50860) |
| biw-8962 (CHEBI:754223) is a organic molecular entity (CHEBI:50860) |
| bixalomer (CHEBI:756710) is a organic molecular entity (CHEBI:50860) |
| bizalimogene ralaplasmid (CHEBI:756753) is a organic molecular entity (CHEBI:50860) |
| bizaxofusp (CHEBI:757451) is a organic molecular entity (CHEBI:50860) |
| bkas#1 (CHEBI:139827) is a organic molecular entity (CHEBI:50860) |
| bkas#1-CoA (CHEBI:139849) is a organic molecular entity (CHEBI:50860) |
| bkas#1-CoA(4-) (CHEBI:139850) is a organic molecular entity (CHEBI:50860) |
| bkas#1(1-) (CHEBI:139828) is a organic molecular entity (CHEBI:50860) |
| bkas#10 (CHEBI:139829) is a organic molecular entity (CHEBI:50860) |
| bkas#10-CoA (CHEBI:139831) is a organic molecular entity (CHEBI:50860) |
| bkas#10-CoA(4-) (CHEBI:139832) is a organic molecular entity (CHEBI:50860) |
| bkas#10(1-) (CHEBI:139830) is a organic molecular entity (CHEBI:50860) |
| bkas#12 (CHEBI:139833) is a organic molecular entity (CHEBI:50860) |
| bkas#12-CoA (CHEBI:139835) is a organic molecular entity (CHEBI:50860) |
| bkas#12-CoA(4-) (CHEBI:139836) is a organic molecular entity (CHEBI:50860) |
| bkas#12(1-) (CHEBI:139834) is a organic molecular entity (CHEBI:50860) |
| bkas#14 (CHEBI:139837) is a organic molecular entity (CHEBI:50860) |
| bkas#14-CoA (CHEBI:139839) is a organic molecular entity (CHEBI:50860) |
| bkas#14-CoA(4-) (CHEBI:139840) is a organic molecular entity (CHEBI:50860) |
| bkas#14(1-) (CHEBI:139838) is a organic molecular entity (CHEBI:50860) |
| bkas#16 (CHEBI:139841) is a organic molecular entity (CHEBI:50860) |
| bkas#16-CoA (CHEBI:139843) is a organic molecular entity (CHEBI:50860) |
| bkas#16-CoA(4-) (CHEBI:139844) is a organic molecular entity (CHEBI:50860) |
| bkas#16(1-) (CHEBI:139842) is a organic molecular entity (CHEBI:50860) |
| bkas#18 (CHEBI:139845) is a organic molecular entity (CHEBI:50860) |
| bkas#18-CoA (CHEBI:139847) is a organic molecular entity (CHEBI:50860) |
| bkas#18-CoA(4-) (CHEBI:139848) is a organic molecular entity (CHEBI:50860) |
| bkas#18(1-) (CHEBI:139846) is a organic molecular entity (CHEBI:50860) |
| bkas#20 (CHEBI:139851) is a organic molecular entity (CHEBI:50860) |
| bkas#20-CoA (CHEBI:139853) is a organic molecular entity (CHEBI:50860) |
| bkas#20-CoA(4-) (CHEBI:139854) is a organic molecular entity (CHEBI:50860) |
| bkas#20(1-) (CHEBI:139852) is a organic molecular entity (CHEBI:50860) |
| bkas#22 (CHEBI:139855) is a organic molecular entity (CHEBI:50860) |
| bkas#22-CoA (CHEBI:139858) is a organic molecular entity (CHEBI:50860) |
| bkas#22-CoA(4-) (CHEBI:139859) is a organic molecular entity (CHEBI:50860) |
| bkas#22(1-) (CHEBI:139856) is a organic molecular entity (CHEBI:50860) |
| bkas#24 (CHEBI:139860) is a organic molecular entity (CHEBI:50860) |
| bkas#24-CoA (CHEBI:139862) is a organic molecular entity (CHEBI:50860) |
| bkas#24-CoA(4-) (CHEBI:139863) is a organic molecular entity (CHEBI:50860) |
| bkas#24(1-) (CHEBI:139861) is a organic molecular entity (CHEBI:50860) |
| bkas#26 (CHEBI:139864) is a organic molecular entity (CHEBI:50860) |
| bkas#26-CoA (CHEBI:139866) is a organic molecular entity (CHEBI:50860) |
| bkas#26-CoA(4-) (CHEBI:139867) is a organic molecular entity (CHEBI:50860) |
| bkas#26(1-) (CHEBI:139865) is a organic molecular entity (CHEBI:50860) |
| bkas#28 (CHEBI:139868) is a organic molecular entity (CHEBI:50860) |
| bkas#28-CoA (CHEBI:139870) is a organic molecular entity (CHEBI:50860) |
| bkas#28-CoA(4-) (CHEBI:139871) is a organic molecular entity (CHEBI:50860) |
| bkas#28(1-) (CHEBI:139869) is a organic molecular entity (CHEBI:50860) |
| bkas#30 (CHEBI:139872) is a organic molecular entity (CHEBI:50860) |
| bkas#30-CoA (CHEBI:139874) is a organic molecular entity (CHEBI:50860) |
| bkas#30-CoA(4-) (CHEBI:139875) is a organic molecular entity (CHEBI:50860) |
| bkas#30(1-) (CHEBI:139873) is a organic molecular entity (CHEBI:50860) |
| bkas#32 (CHEBI:139876) is a organic molecular entity (CHEBI:50860) |
| bkas#32-CoA (CHEBI:139878) is a organic molecular entity (CHEBI:50860) |
| bkas#32-CoA(4-) (CHEBI:139879) is a organic molecular entity (CHEBI:50860) |
| bkas#32(1-) (CHEBI:139877) is a organic molecular entity (CHEBI:50860) |
| bkas#34 (CHEBI:139880) is a organic molecular entity (CHEBI:50860) |
| bkas#34-CoA (CHEBI:139882) is a organic molecular entity (CHEBI:50860) |
| bkas#34-CoA(4-) (CHEBI:139883) is a organic molecular entity (CHEBI:50860) |
| bkas#34(1-) (CHEBI:139881) is a organic molecular entity (CHEBI:50860) |
| bkas#36 (CHEBI:139884) is a organic molecular entity (CHEBI:50860) |
| bkas#36-CoA (CHEBI:139886) is a organic molecular entity (CHEBI:50860) |
| bkas#36-CoA(4-) (CHEBI:139887) is a organic molecular entity (CHEBI:50860) |
| bkas#36(1-) (CHEBI:139885) is a organic molecular entity (CHEBI:50860) |
| bkas#38 (CHEBI:139888) is a organic molecular entity (CHEBI:50860) |
| bkas#38-CoA (CHEBI:139890) is a organic molecular entity (CHEBI:50860) |
| bkas#38-CoA(4-) (CHEBI:139891) is a organic molecular entity (CHEBI:50860) |
| bkas#38(1-) (CHEBI:139889) is a organic molecular entity (CHEBI:50860) |
| bkas#9 (CHEBI:139892) is a organic molecular entity (CHEBI:50860) |
| bkas#9-CoA (CHEBI:139894) is a organic molecular entity (CHEBI:50860) |
| bkas#9-CoA(4-) (CHEBI:139895) is a organic molecular entity (CHEBI:50860) |
| bkas#9(1-) (CHEBI:139893) is a organic molecular entity (CHEBI:50860) |
| bkos#1 (CHEBI:139896) is a organic molecular entity (CHEBI:50860) |
| bkos#1-CoA (CHEBI:139918) is a organic molecular entity (CHEBI:50860) |
| bkos#1-CoA(4-) (CHEBI:139919) is a organic molecular entity (CHEBI:50860) |
| bkos#1(1-) (CHEBI:139897) is a organic molecular entity (CHEBI:50860) |
| bkos#10 (CHEBI:139898) is a organic molecular entity (CHEBI:50860) |
| bkos#10-CoA (CHEBI:139900) is a organic molecular entity (CHEBI:50860) |
| bkos#10-CoA(4-) (CHEBI:139901) is a organic molecular entity (CHEBI:50860) |
| bkos#10(1-) (CHEBI:139899) is a organic molecular entity (CHEBI:50860) |
| bkos#12 (CHEBI:139902) is a organic molecular entity (CHEBI:50860) |
| bkos#12-CoA (CHEBI:139904) is a organic molecular entity (CHEBI:50860) |
| bkos#12-CoA(4-) (CHEBI:139905) is a organic molecular entity (CHEBI:50860) |
| bkos#12(1-) (CHEBI:139903) is a organic molecular entity (CHEBI:50860) |
| bkos#14 (CHEBI:139906) is a organic molecular entity (CHEBI:50860) |
| bkos#14-CoA (CHEBI:139908) is a organic molecular entity (CHEBI:50860) |
| bkos#14-CoA(4-) (CHEBI:139909) is a organic molecular entity (CHEBI:50860) |
| bkos#14(1-) (CHEBI:139907) is a organic molecular entity (CHEBI:50860) |
| bkos#16 (CHEBI:139910) is a organic molecular entity (CHEBI:50860) |
| bkos#16-CoA (CHEBI:139912) is a organic molecular entity (CHEBI:50860) |
| bkos#16-CoA(4-) (CHEBI:139913) is a organic molecular entity (CHEBI:50860) |
| bkos#16(1-) (CHEBI:139911) is a organic molecular entity (CHEBI:50860) |
| bkos#18 (CHEBI:139914) is a organic molecular entity (CHEBI:50860) |
| bkos#18-CoA (CHEBI:139916) is a organic molecular entity (CHEBI:50860) |
| bkos#18-CoA(4-) (CHEBI:139917) is a organic molecular entity (CHEBI:50860) |
| bkos#18(1-) (CHEBI:139915) is a organic molecular entity (CHEBI:50860) |
| bkos#20 (CHEBI:139920) is a organic molecular entity (CHEBI:50860) |
| bkos#20-CoA (CHEBI:139922) is a organic molecular entity (CHEBI:50860) |
| bkos#20-CoA(4-) (CHEBI:139923) is a organic molecular entity (CHEBI:50860) |
| bkos#20(1-) (CHEBI:139921) is a organic molecular entity (CHEBI:50860) |
| bkos#22 (CHEBI:139924) is a organic molecular entity (CHEBI:50860) |
| bkos#22-CoA (CHEBI:139926) is a organic molecular entity (CHEBI:50860) |
| bkos#22-CoA(4-) (CHEBI:139927) is a organic molecular entity (CHEBI:50860) |
| bkos#22(1-) (CHEBI:139925) is a organic molecular entity (CHEBI:50860) |
| bkos#24 (CHEBI:139928) is a organic molecular entity (CHEBI:50860) |
| bkos#24-CoA (CHEBI:139930) is a organic molecular entity (CHEBI:50860) |
| bkos#24-CoA(4-) (CHEBI:139931) is a organic molecular entity (CHEBI:50860) |
| bkos#24(1-) (CHEBI:139929) is a organic molecular entity (CHEBI:50860) |
| bkos#26 (CHEBI:139932) is a organic molecular entity (CHEBI:50860) |
| bkos#26-CoA (CHEBI:139934) is a organic molecular entity (CHEBI:50860) |
| bkos#26-CoA(4-) (CHEBI:139935) is a organic molecular entity (CHEBI:50860) |
| bkos#26(1-) (CHEBI:139933) is a organic molecular entity (CHEBI:50860) |
| bkos#28 (CHEBI:139936) is a organic molecular entity (CHEBI:50860) |
| bkos#28-CoA (CHEBI:139938) is a organic molecular entity (CHEBI:50860) |
| bkos#28-CoA(4-) (CHEBI:139939) is a organic molecular entity (CHEBI:50860) |
| bkos#28(1-) (CHEBI:139937) is a organic molecular entity (CHEBI:50860) |
| bkos#30 (CHEBI:139940) is a organic molecular entity (CHEBI:50860) |
| bkos#30-CoA (CHEBI:139942) is a organic molecular entity (CHEBI:50860) |
| bkos#30-CoA(4-) (CHEBI:139943) is a organic molecular entity (CHEBI:50860) |
| bkos#30(1-) (CHEBI:139941) is a organic molecular entity (CHEBI:50860) |
| bkos#32 (CHEBI:139944) is a organic molecular entity (CHEBI:50860) |
| bkos#32-CoA (CHEBI:139946) is a organic molecular entity (CHEBI:50860) |
| bkos#32-CoA(4-) (CHEBI:139947) is a organic molecular entity (CHEBI:50860) |
| bkos#32(1-) (CHEBI:139945) is a organic molecular entity (CHEBI:50860) |
| bkos#34 (CHEBI:139948) is a organic molecular entity (CHEBI:50860) |
| bkos#34-CoA (CHEBI:139950) is a organic molecular entity (CHEBI:50860) |
| bkos#34-CoA(4-) (CHEBI:139951) is a organic molecular entity (CHEBI:50860) |
| bkos#34(1-) (CHEBI:139949) is a organic molecular entity (CHEBI:50860) |
| bkos#36 (CHEBI:139952) is a organic molecular entity (CHEBI:50860) |
| bkos#36-CoA (CHEBI:139954) is a organic molecular entity (CHEBI:50860) |
| bkos#36-CoA(4-) (CHEBI:139955) is a organic molecular entity (CHEBI:50860) |
| bkos#36(1-) (CHEBI:139953) is a organic molecular entity (CHEBI:50860) |
| bkos#38 (CHEBI:139956) is a organic molecular entity (CHEBI:50860) |
| bkos#38-CoA (CHEBI:139958) is a organic molecular entity (CHEBI:50860) |
| bkos#38-CoA(4-) (CHEBI:139959) is a organic molecular entity (CHEBI:50860) |
| bkos#38(1-) (CHEBI:139957) is a organic molecular entity (CHEBI:50860) |
| bl22 (CHEBI:754178) is a organic molecular entity (CHEBI:50860) |
| blastomycin (CHEBI:754005) is a organic molecular entity (CHEBI:50860) |
| Bleomycin A (CHEBI:80092) is a organic molecular entity (CHEBI:50860) |
| Bleomycin B (CHEBI:80093) is a organic molecular entity (CHEBI:50860) |
| bleselumab (CHEBI:756509) is a organic molecular entity (CHEBI:50860) |
| blinatumomab (CHEBI:750072) is a organic molecular entity (CHEBI:50860) |
| blisibimod (CHEBI:752919) is a organic molecular entity (CHEBI:50860) |
| BlocLys (CHEBI:233073) is a organic molecular entity (CHEBI:50860) |
| Blonanserin (CHEBI:31296) is a organic molecular entity (CHEBI:50860) |
| blontuvetmab (CHEBI:755406) is a organic molecular entity (CHEBI:50860) |
| blood cells, red (CHEBI:753202) is a organic molecular entity (CHEBI:50860) |
| blood group specific substances a, b, and ab (CHEBI:753855) is a organic molecular entity (CHEBI:50860) |
| blood grouping serum, anti-a (CHEBI:754006) is a organic molecular entity (CHEBI:50860) |
| blood grouping serum, anti-b (CHEBI:753861) is a organic molecular entity (CHEBI:50860) |
| blood grouping serums (CHEBI:753197) is a organic molecular entity (CHEBI:50860) |
| blood grouping serums anti-d, anti-c, anti-e, anti-c, anti-e (CHEBI:753854) is a organic molecular entity (CHEBI:50860) |
| blood, whole (CHEBI:753387) is a organic molecular entity (CHEBI:50860) |
| blosozumab (CHEBI:750073) is a organic molecular entity (CHEBI:50860) |
| bluetongue virus vaccine, serotype 8 (inactivated) (CHEBI:759782) is a organic molecular entity (CHEBI:50860) |
| bluetongue-virus serotype-1 antigen (CHEBI:759769) is a organic molecular entity (CHEBI:50860) |
| Bm3 (CHEBI:177889) is a organic molecular entity (CHEBI:50860) |
| BMH-21 (CHEBI:232779) is a organic molecular entity (CHEBI:50860) |
| BMPPB-32 (CHEBI:232837) is a organic molecular entity (CHEBI:50860) |
| BMS 753 (CHEBI:230490) is a organic molecular entity (CHEBI:50860) |
| bms-698769 (CHEBI:755560) is a organic molecular entity (CHEBI:50860) |
| bms-770767 (CHEBI:758487) is a organic molecular entity (CHEBI:50860) |
| bms-817378 (CHEBI:755434) is a organic molecular entity (CHEBI:50860) |
| bms-936559 (CHEBI:757157) is a organic molecular entity (CHEBI:50860) |
| bms-962476 (CHEBI:757158) is a organic molecular entity (CHEBI:50860) |
| bms-986120 (CHEBI:758273) is a organic molecular entity (CHEBI:50860) |
| bms-986148 (CHEBI:760480) is a organic molecular entity (CHEBI:50860) |
| bms-986156 (CHEBI:757043) is a organic molecular entity (CHEBI:50860) |
| bms-986178 (CHEBI:757159) is a organic molecular entity (CHEBI:50860) |
| bms-986179 (CHEBI:757160) is a organic molecular entity (CHEBI:50860) |
| bms-986184 (CHEBI:758844) is a organic molecular entity (CHEBI:50860) |
| bms-986258 (CHEBI:757162) is a organic molecular entity (CHEBI:50860) |
| bms-986318 (CHEBI:758488) is a organic molecular entity (CHEBI:50860) |
| BMS-986365 (CHEBI:747790) is a organic molecular entity (CHEBI:50860) |
| BMS641 (CHEBI:230489) is a organic molecular entity (CHEBI:50860) |
| BMS961 (CHEBI:230491) is a organic molecular entity (CHEBI:50860) |
| BMX-001 (CHEBI:232540) is a organic molecular entity (CHEBI:50860) |
| bmx-010 (CHEBI:757163) is a organic molecular entity (CHEBI:50860) |
| bnc-105p (CHEBI:757352) is a organic molecular entity (CHEBI:50860) |
| bnc-210 (CHEBI:758336) is a organic molecular entity (CHEBI:50860) |
| bnt-152 mrna (CHEBI:759703) is a organic molecular entity (CHEBI:50860) |
| bnt-153 mrna (CHEBI:759704) is a organic molecular entity (CHEBI:50860) |
| bnt-162a1 (CHEBI:758337) is a organic molecular entity (CHEBI:50860) |
| Boc-Lys-OH (CHEBI:233075) is a organic molecular entity (CHEBI:50860) |
| bococizumab (CHEBI:755175) is a organic molecular entity (CHEBI:50860) |
| bofanglutide (CHEBI:760014) is a organic molecular entity (CHEBI:50860) |
| Bombesin (CHEBI:80229) is a organic molecular entity (CHEBI:50860) |
| bomtabegagene bavoparvovec (CHEBI:758562) is a organic molecular entity (CHEBI:50860) |
| bone morphogenetic protein 2 (CHEBI:760481) is a organic molecular entity (CHEBI:50860) |
| bordetella pertussis filamentous hemagglutinin (CHEBI:760262) is a organic molecular entity (CHEBI:50860) |
| bordetella pertussis pertactin autotransporter (CHEBI:760264) is a organic molecular entity (CHEBI:50860) |
| bordetella pertussis toxin (CHEBI:760263) is a organic molecular entity (CHEBI:50860) |
| bornyl acetate (CHEBI:232534) is a organic molecular entity (CHEBI:50860) |
| boroglycerin (CHEBI:754007) is a organic molecular entity (CHEBI:50860) |
| boron-11(3-) (CHEBI:176596) is a organic molecular entity (CHEBI:50860) |
| boron-11(3+) (CHEBI:176597) is a organic molecular entity (CHEBI:50860) |
| bos-589 (CHEBI:758198) is a organic molecular entity (CHEBI:50860) |
| bosakitug (CHEBI:759669) is a organic molecular entity (CHEBI:50860) |
| boserolimab (CHEBI:758931) is a organic molecular entity (CHEBI:50860) |
| botaretigene sparoparvovec (CHEBI:758989) is a organic molecular entity (CHEBI:50860) |
| botensilimab (CHEBI:758321) is a organic molecular entity (CHEBI:50860) |
| Botulinum toxin type A (CHEBI:3160) is a organic molecular entity (CHEBI:50860) |
| botulism antitoxin (CHEBI:754008) is a organic molecular entity (CHEBI:50860) |
| bouvardin (CHEBI:233285) is a organic molecular entity (CHEBI:50860) |
| bovactant (CHEBI:753388) is a organic molecular entity (CHEBI:50860) |
| bovine concentrated lactoserum containing specific immunoglobulins g against e. coli f5 (k99) adhesin (CHEBI:759790) is a organic molecular entity (CHEBI:50860) |
| bovine fibrin (CHEBI:754009) is a organic molecular entity (CHEBI:50860) |
| BPC (CHEBI:157699) is a organic molecular entity (CHEBI:50860) |
| bpi-3016 (CHEBI:757042) is a organic molecular entity (CHEBI:50860) |
| bpi-9016 (CHEBI:755531) is a organic molecular entity (CHEBI:50860) |
| BQCA (CHEBI:232407) is a organic molecular entity (CHEBI:50860) |
| Brain natriuretic peptide (CHEBI:80234) is a organic molecular entity (CHEBI:50860) |
| Bravizine: N-[4-[(4-hydroxy-3-tert-butylphenyl)methyl]-1-piperazinyl]benzamide (CHEBI:746918) is a organic molecular entity (CHEBI:50860) |
| brazikumab (CHEBI:755951) is a organic molecular entity (CHEBI:50860) |
| BRD proteins degrader (CHEBI:189679) is a organic molecular entity (CHEBI:50860) |
| BRD0705 (CHEBI:747872) is a organic molecular entity (CHEBI:50860) |
| bre-3 90y (CHEBI:754186) is a organic molecular entity (CHEBI:50860) |
| bremzalerbart (CHEBI:759354) is a organic molecular entity (CHEBI:50860) |
| brenetafusp (CHEBI:759424) is a organic molecular entity (CHEBI:50860) |
| brentuximab vedotin (CHEBI:750074) is a organic molecular entity (CHEBI:50860) |
| brexucabtagene autoleucel (CHEBI:758090) is a organic molecular entity (CHEBI:50860) |
| briakinumab (CHEBI:750075) is a organic molecular entity (CHEBI:50860) |
| brigatinib (CHEBI:232810) is a organic molecular entity (CHEBI:50860) |
| Brilliant Blue (CHEBI:82411) is a organic molecular entity (CHEBI:50860) |
| brinolase (CHEBI:753389) is a organic molecular entity (CHEBI:50860) |
| brinretigene vesgedparvovec (CHEBI:759506) is a organic molecular entity (CHEBI:50860) |
| briobacept (CHEBI:752891) is a organic molecular entity (CHEBI:50860) |
| briquilimab (CHEBI:758693) is a organic molecular entity (CHEBI:50860) |
| brivekimig (CHEBI:760015) is a organic molecular entity (CHEBI:50860) |
| brivestobart (CHEBI:760131) is a organic molecular entity (CHEBI:50860) |
| brivoligide (CHEBI:756734) is a organic molecular entity (CHEBI:50860) |
| brivoligide sodium (CHEBI:756733) is a organic molecular entity (CHEBI:50860) |
| BRL 32872 (CHEBI:34551) is a organic molecular entity (CHEBI:50860) |
| brm-421 (CHEBI:759705) is a organic molecular entity (CHEBI:50860) |
| BRM014 (CHEBI:232613) is a organic molecular entity (CHEBI:50860) |
| brodalumab (CHEBI:750076) is a organic molecular entity (CHEBI:50860) |
| brogidirsen (CHEBI:758935) is a organic molecular entity (CHEBI:50860) |
| brolucizumab (CHEBI:755824) is a organic molecular entity (CHEBI:50860) |
| Bromazepam (CHEBI:31302) is a organic molecular entity (CHEBI:50860) |
| bromelains (CHEBI:753928) is a organic molecular entity (CHEBI:50860) |
| broncasma berna (CHEBI:753929) is a organic molecular entity (CHEBI:50860) |
| brontictuzumab (CHEBI:755546) is a organic molecular entity (CHEBI:50860) |
| broxaldine (CHEBI:232618) is a organic molecular entity (CHEBI:50860) |
| Bryostatin (CHEBI:233364) is a organic molecular entity (CHEBI:50860) |
| bt1-322 (CHEBI:754174) is a organic molecular entity (CHEBI:50860) |
| BT1583 (CHEBI:80110) is a organic molecular entity (CHEBI:50860) |
| bti-410 (CHEBI:757408) is a organic molecular entity (CHEBI:50860) |
| bu12 90y (CHEBI:754168) is a organic molecular entity (CHEBI:50860) |
| Buccalin (CHEBI:80136) is a organic molecular entity (CHEBI:50860) |
| bucelipase alfa (CHEBI:753287) is a organic molecular entity (CHEBI:50860) |
| Bucetin (CHEBI:31311) is a organic molecular entity (CHEBI:50860) |
| Bucillamine (CHEBI:31312) is a organic molecular entity (CHEBI:50860) |
| budigalimab (CHEBI:757299) is a organic molecular entity (CHEBI:50860) |
| budoprutug (CHEBI:759507) is a organic molecular entity (CHEBI:50860) |
| Bufencarb (CHEBI:82088) is a organic molecular entity (CHEBI:50860) |
| Bufferin (CHEBI:31318) is a organic molecular entity (CHEBI:50860) |
| bufilcon a (CHEBI:753930) is a organic molecular entity (CHEBI:50860) |
| Bukeic acid (CHEBI:197311) is a organic molecular entity (CHEBI:50860) |
| bulbisine Trifluoroacetic acid (CHEBI:68306) is a organic molecular entity (CHEBI:50860) |
| bulevirtide (CHEBI:757164) is a organic molecular entity (CHEBI:50860) |
| bulevirtide acetate (CHEBI:759763) is a organic molecular entity (CHEBI:50860) |
| bultal (CHEBI:753341) is a organic molecular entity (CHEBI:50860) |
| bulumtatug (CHEBI:760132) is a organic molecular entity (CHEBI:50860) |
| bulumtatug fuvedotin (CHEBI:760133) is a organic molecular entity (CHEBI:50860) |
| bumetanide(1-) (CHEBI:746982) is a organic molecular entity (CHEBI:50860) |
| burfiralimab (CHEBI:758694) is a organic molecular entity (CHEBI:50860) |
| burosumab (CHEBI:755802) is a organic molecular entity (CHEBI:50860) |
| Buserelin acetate (CHEBI:31324) is a organic molecular entity (CHEBI:50860) |
| butirosin sulfate (CHEBI:759895) is a organic molecular entity (CHEBI:50860) |
| butoxycaine (CHEBI:30269) is a organic molecular entity (CHEBI:50860) |
| Butylparaben (CHEBI:88542) is a organic molecular entity (CHEBI:50860) |
| Butyryl-[acp] (CHEBI:3247) is a organic molecular entity (CHEBI:50860) |
| BV02 (CHEBI:232849) is a organic molecular entity (CHEBI:50860) |
| C-peptide (CHEBI:80332) is a organic molecular entity (CHEBI:50860) |
| C-Protein (CHEBI:3254) is a organic molecular entity (CHEBI:50860) |
| C-terminal amino acid- phosphatidylethanolamine amidated glycine residue(1−) (CHEBI:172941) is a organic molecular entity (CHEBI:50860) |
| C-terminal amino acid- phosphatidylserine amidated glycine residue(2−) (CHEBI:172942) is a organic molecular entity (CHEBI:50860) |
| C-terminal amino acid-glycine residue(1−) (CHEBI:172940) is a organic molecular entity (CHEBI:50860) |
| C-Type natriuretic peptide (CHEBI:80235) is a organic molecular entity (CHEBI:50860) |
| C8 β-D-glucosyl N-acylsphingosine (CHEBI:65222) is a organic molecular entity (CHEBI:50860) |
| c01275 (CHEBI:754251) is a organic molecular entity (CHEBI:50860) |
| C12-C14-Alkyl(ethylbenzyl)dimethylammonium chloride (CHEBI:234578) is a organic molecular entity (CHEBI:50860) |
| C15810 (CHEBI:80100) is a organic molecular entity (CHEBI:50860) |
| C15813 (CHEBI:80101) is a organic molecular entity (CHEBI:50860) |
| C15814 (CHEBI:80102) is a organic molecular entity (CHEBI:50860) |
| C15815 (CHEBI:80103) is a organic molecular entity (CHEBI:50860) |
| C16 (CHEBI:232603) is a organic molecular entity (CHEBI:50860) |
| c16g2 (CHEBI:757165) is a organic molecular entity (CHEBI:50860) |
| C26-CoA (CHEBI:31330) is a organic molecular entity (CHEBI:50860) |
| C5a anaphylatoxin (CHEBI:80542) is a organic molecular entity (CHEBI:50860) |
| C9-C9a linked PQQ (CHEBI:85623) is a organic molecular entity (CHEBI:50860) |
| ca-170 (CHEBI:758845) is a organic molecular entity (CHEBI:50860) |
| ca2 (CHEBI:754345) is a organic molecular entity (CHEBI:50860) |
| cabiotraxetan lutetium lu-177 (CHEBI:757296) is a organic molecular entity (CHEBI:50860) |
| cabiralizumab (CHEBI:757166) is a organic molecular entity (CHEBI:50860) |
| cabotamig (CHEBI:759508) is a organic molecular entity (CHEBI:50860) |
| cabotegravir glucuronide(1-) (CHEBI:746993) is a organic molecular entity (CHEBI:50860) |
| cabozanitib M2A (CHEBI:746996) is a organic molecular entity (CHEBI:50860) |
| cabufocon a (CHEBI:753931) is a organic molecular entity (CHEBI:50860) |
| cabufocon b (CHEBI:753342) is a organic molecular entity (CHEBI:50860) |
| cacao butter (CHEBI:753857) is a organic molecular entity (CHEBI:50860) |
| cactinomycin (CHEBI:753932) is a organic molecular entity (CHEBI:50860) |
| cadapersen (CHEBI:760134) is a organic molecular entity (CHEBI:50860) |
| cadexomer (CHEBI:753195) is a organic molecular entity (CHEBI:50860) |
| cadexomer iodine (CHEBI:753851) is a organic molecular entity (CHEBI:50860) |
| cadina-3,5-diene (CHEBI:192987) is a organic molecular entity (CHEBI:50860) |
| cadmium acetate (CHEBI:232796) is a organic molecular entity (CHEBI:50860) |
| cadmium-111(2+) (CHEBI:176629) is a organic molecular entity (CHEBI:50860) |
| cadonilimab (CHEBI:757937) is a organic molecular entity (CHEBI:50860) |
| Cadralazine (CHEBI:31331) is a organic molecular entity (CHEBI:50860) |
| cafelkibart (CHEBI:760016) is a organic molecular entity (CHEBI:50860) |
| caffeoyl-4'-hydroxyphenyllactate (CHEBI:746866) is a organic molecular entity (CHEBI:50860) |
| cafusertib (CHEBI:755591) is a organic molecular entity (CHEBI:50860) |
| cagrilintide (CHEBI:758489) is a organic molecular entity (CHEBI:50860) |
| cal (CHEBI:754324) is a organic molecular entity (CHEBI:50860) |
| cal-263 (CHEBI:755537) is a organic molecular entity (CHEBI:50860) |
| calamine (CHEBI:756047) is a organic molecular entity (CHEBI:50860) |
| calaspargase pegol (CHEBI:753666) is a organic molecular entity (CHEBI:50860) |
| calcitonin eel (CHEBI:757404) is a organic molecular entity (CHEBI:50860) |
| Calcitonin gene-related peptide 1 (CHEBI:80337) is a organic molecular entity (CHEBI:50860) |
| Calcitonin gene-related peptide 2 (CHEBI:80338) is a organic molecular entity (CHEBI:50860) |
| Calcitonin receptor-stimulating peptide 1 (CHEBI:80341) is a organic molecular entity (CHEBI:50860) |
| calcium alginate (CHEBI:755858) is a organic molecular entity (CHEBI:50860) |
| Calcium formate (CHEBI:81851) is a organic molecular entity (CHEBI:50860) |
| Calcium iodide (CHEBI:81718) is a organic molecular entity (CHEBI:50860) |
| Calcium ionophore I (CHEBI:233049) is a organic molecular entity (CHEBI:50860) |
| Calcium L-aspartate (CHEBI:31337) is a organic molecular entity (CHEBI:50860) |
| Calcium lactate (CHEBI:3315) is a organic molecular entity (CHEBI:50860) |
| Calcium levulinate anhydrous (CHEBI:81717) is a organic molecular entity (CHEBI:50860) |
| calcium polycarbophil (CHEBI:753933) is a organic molecular entity (CHEBI:50860) |
| calcium polystyrene sulfonate (CHEBI:753934) is a organic molecular entity (CHEBI:50860) |
| Calcium sulfide (CHEBI:81055) is a organic molecular entity (CHEBI:50860) |
| calcium-43(2+) (CHEBI:176609) is a organic molecular entity (CHEBI:50860) |
| calfactant (CHEBI:749466) is a organic molecular entity (CHEBI:50860) |
| calmangafodipir (CHEBI:757167) is a organic molecular entity (CHEBI:50860) |
| calotatug (CHEBI:760017) is a organic molecular entity (CHEBI:50860) |
| calotatug ginistinag (CHEBI:760018) is a organic molecular entity (CHEBI:50860) |
| calpurbatug (CHEBI:759355) is a organic molecular entity (CHEBI:50860) |
| camalprin alfa (CHEBI:760019) is a organic molecular entity (CHEBI:50860) |
| camellia oil (CHEBI:753343) is a organic molecular entity (CHEBI:50860) |
| camidanlumab (CHEBI:756743) is a organic molecular entity (CHEBI:50860) |
| camidanlumab tesirine (CHEBI:757310) is a organic molecular entity (CHEBI:50860) |
| camizestrant (CHEBI:747259) is a organic molecular entity (CHEBI:50860) |
| camoteskimab (CHEBI:754354) is a organic molecular entity (CHEBI:50860) |
| camrelizumab (CHEBI:757168) is a organic molecular entity (CHEBI:50860) |
| canakinumab (CHEBI:749608) is a organic molecular entity (CHEBI:50860) |
| CANBEF-13 (CHEBI:156509) is a organic molecular entity (CHEBI:50860) |
| candelilla wax (CHEBI:753040) is a organic molecular entity (CHEBI:50860) |
| canerpaturev (CHEBI:756732) is a organic molecular entity (CHEBI:50860) |
| canine parainfluenza type-2 virus, strain cpiv-2 bio 15 (live attenuated) (CHEBI:759777) is a organic molecular entity (CHEBI:50860) |
| canine parainfluenza virus, leptospira and rabies virus (CHEBI:759765) is a organic molecular entity (CHEBI:50860) |
| canoctakin (CHEBI:757490) is a organic molecular entity (CHEBI:50860) |
| canrivitug (CHEBI:759486) is a organic molecular entity (CHEBI:50860) |
| cantharides tincture (CHEBI:753935) is a organic molecular entity (CHEBI:50860) |
| cantuzumab mertansine (CHEBI:750077) is a organic molecular entity (CHEBI:50860) |
| cantuzumab ravtansine (CHEBI:750078) is a organic molecular entity (CHEBI:50860) |
| canvuparatide (CHEBI:760135) is a organic molecular entity (CHEBI:50860) |
| Capecchic acid (CHEBI:197309) is a organic molecular entity (CHEBI:50860) |
| caplacizumab (CHEBI:754365) is a organic molecular entity (CHEBI:50860) |
| capnoidine (CHEBI:68991) is a organic molecular entity (CHEBI:50860) |
| capromab (CHEBI:753277) is a organic molecular entity (CHEBI:50860) |
| capromab pendetide (CHEBI:749507) is a organic molecular entity (CHEBI:50860) |
| Caprylic/Capric triglyceride (CHEBI:232552) is a organic molecular entity (CHEBI:50860) |
| caprylocaproyl polyoxylglycerides (CHEBI:753533) is a organic molecular entity (CHEBI:50860) |
| capsicum (CHEBI:753236) is a organic molecular entity (CHEBI:50860) |
| capsicum oleoresin (CHEBI:753237) is a organic molecular entity (CHEBI:50860) |
| captopril(1-) (CHEBI:746988) is a organic molecular entity (CHEBI:50860) |
| capzimin dimer (CHEBI:232854) is a organic molecular entity (CHEBI:50860) |
| caramel (CHEBI:753257) is a organic molecular entity (CHEBI:50860) |
| caraway (CHEBI:753187) is a organic molecular entity (CHEBI:50860) |
| caraway oil (CHEBI:753900) is a organic molecular entity (CHEBI:50860) |
| carbetimer (CHEBI:753258) is a organic molecular entity (CHEBI:50860) |
| Carbidopa-levodopa (CHEBI:3396) is a organic molecular entity (CHEBI:50860) |
| carbocyclic thromboxane A2(1−) (CHEBI:138322) is a organic molecular entity (CHEBI:50860) |
| carbogen (CHEBI:757169) is a organic molecular entity (CHEBI:50860) |
| carbomer 1342 (CHEBI:753904) is a organic molecular entity (CHEBI:50860) |
| carbomer 910 (CHEBI:753901) is a organic molecular entity (CHEBI:50860) |
| carbomer 934 (CHEBI:753259) is a organic molecular entity (CHEBI:50860) |
| carbomer 934p (CHEBI:753902) is a organic molecular entity (CHEBI:50860) |
| carbomer 940 (CHEBI:753903) is a organic molecular entity (CHEBI:50860) |
| carbomer 941 (CHEBI:753260) is a organic molecular entity (CHEBI:50860) |
| carbomer copolymer (CHEBI:753905) is a organic molecular entity (CHEBI:50860) |
| carbomer homopolymer type b (allyl pentaerythritol crosslinked) (CHEBI:757355) is a organic molecular entity (CHEBI:50860) |
| carbomer interpolymer (CHEBI:753770) is a organic molecular entity (CHEBI:50860) |
| carbon monoxide c 11 (CHEBI:755010) is a organic molecular entity (CHEBI:50860) |
| carbon, activated (CHEBI:753771) is a organic molecular entity (CHEBI:50860) |
| Carboquone (CHEBI:31356) is a organic molecular entity (CHEBI:50860) |
| Carboxybiotinyl-[protein] (CHEBI:81473) is a organic molecular entity (CHEBI:50860) |
| carboxymethylcellulose calcium (CHEBI:753906) is a organic molecular entity (CHEBI:50860) |
| carboxymethylcellulose sodium (CHEBI:753907) is a organic molecular entity (CHEBI:50860) |
| carboxymethylcellulose sodium 12 (CHEBI:753188) is a organic molecular entity (CHEBI:50860) |
| carboxymethylcellulose sodium salt (CHEBI:234035) is a organic molecular entity (CHEBI:50860) |
| carboxymethylcellulose sodium, low-substituted (CHEBI:753534) is a organic molecular entity (CHEBI:50860) |
| cardamom oil (CHEBI:753261) is a organic molecular entity (CHEBI:50860) |
| cardamom seed (CHEBI:753908) is a organic molecular entity (CHEBI:50860) |
| carlecortemcel-l (CHEBI:752892) is a organic molecular entity (CHEBI:50860) |
| carlumab (CHEBI:750079) is a organic molecular entity (CHEBI:50860) |
| Carmoisine (CHEBI:82414) is a organic molecular entity (CHEBI:50860) |
| carotuximab (CHEBI:754157) is a organic molecular entity (CHEBI:50860) |
| Carpipramine maleate (CHEBI:31361) is a organic molecular entity (CHEBI:50860) |
| carrimycin (CHEBI:758276) is a organic molecular entity (CHEBI:50860) |
| carvacrol ether (CHEBI:233135) is a organic molecular entity (CHEBI:50860) |
| casanthranol (CHEBI:753909) is a organic molecular entity (CHEBI:50860) |
| cascara sagrada (CHEBI:753262) is a organic molecular entity (CHEBI:50860) |
| casdatifan (CHEBI:760136) is a organic molecular entity (CHEBI:50860) |
| casdozokitug (CHEBI:759356) is a organic molecular entity (CHEBI:50860) |
| Casein Kinase I Inhibitor, D4476 (CHEBI:195199) is a organic molecular entity (CHEBI:50860) |
| casimersen (CHEBI:757041) is a organic molecular entity (CHEBI:50860) |
| Casiopeina II-gly (CHEBI:232493) is a organic molecular entity (CHEBI:50860) |
| casirivimab (CHEBI:758154) is a organic molecular entity (CHEBI:50860) |
| castor oil, hydrogenated (CHEBI:753910) is a organic molecular entity (CHEBI:50860) |
| cat-203 (CHEBI:754156) is a organic molecular entity (CHEBI:50860) |
| catalpol (CHEBI:69797) is a organic molecular entity (CHEBI:50860) |
| catridecacog (CHEBI:753274) is a organic molecular entity (CHEBI:50860) |
| catumaxomab (CHEBI:753535) is a organic molecular entity (CHEBI:50860) |
| cavrotolimod (CHEBI:758277) is a organic molecular entity (CHEBI:50860) |
| caxmotabart (CHEBI:760137) is a organic molecular entity (CHEBI:50860) |
| caxmotabart entudotin (CHEBI:760138) is a organic molecular entity (CHEBI:50860) |
| CB-103 (CHEBI:232592) is a organic molecular entity (CHEBI:50860) |
| cb-189625 (CHEBI:755835) is a organic molecular entity (CHEBI:50860) |
| CB-5083 (CHEBI:232521) is a organic molecular entity (CHEBI:50860) |
| CBP/p300-IN-10 (CHEBI:235415) is a organic molecular entity (CHEBI:50860) |
| CBS 113A (CHEBI:34598) is a organic molecular entity (CHEBI:50860) |
| cbs-9106 (CHEBI:757523) is a organic molecular entity (CHEBI:50860) |
| cbx-129801 (CHEBI:758007) is a organic molecular entity (CHEBI:50860) |
| cc-90005 (CHEBI:758490) is a organic molecular entity (CHEBI:50860) |
| cc-90006 (CHEBI:757948) is a organic molecular entity (CHEBI:50860) |
| cc-94676 (CHEBI:758846) is a organic molecular entity (CHEBI:50860) |
| ccr5mab004 (CHEBI:754171) is a organic molecular entity (CHEBI:50860) |
| CCT129202 (CHEBI:747722) is a organic molecular entity (CHEBI:50860) |
| CCT137690 (CHEBI:747738) is a organic molecular entity (CHEBI:50860) |
| cd24fc (CHEBI:757170) is a organic molecular entity (CHEBI:50860) |
| cd40 ligand (CHEBI:757171) is a organic molecular entity (CHEBI:50860) |
| cdp-484 (CHEBI:754249) is a organic molecular entity (CHEBI:50860) |
| cdp-850 (CHEBI:754271) is a organic molecular entity (CHEBI:50860) |
| cdp-860 (CHEBI:754311) is a organic molecular entity (CHEBI:50860) |
| CDP-DG(20:2(11Z,14Z)/PGF1alpha) (CHEBI:230824) is a organic molecular entity (CHEBI:50860) |
| CDP-DG(i-19:0/PGE2) (CHEBI:230417) is a organic molecular entity (CHEBI:50860) |
| CDP-DG(PGE1/i-20:0) (CHEBI:230871) is a organic molecular entity (CHEBI:50860) |
| CDP-DG(PGF1alpha/20:3(5Z,8Z,11Z)) (CHEBI:230090) is a organic molecular entity (CHEBI:50860) |
| CDP-DG(PGJ2/18:1(11Z)) (CHEBI:230118) is a organic molecular entity (CHEBI:50860) |
| cdx-014 (CHEBI:757172) is a organic molecular entity (CHEBI:50860) |
| cdx-1135 (CHEBI:757173) is a organic molecular entity (CHEBI:50860) |
| cdx-1140 (CHEBI:757174) is a organic molecular entity (CHEBI:50860) |
| cdx-301 (CHEBI:758278) is a organic molecular entity (CHEBI:50860) |
| cdx-3379 (CHEBI:758194) is a organic molecular entity (CHEBI:50860) |
| Ceapin-A7 (CHEBI:747296) is a organic molecular entity (CHEBI:50860) |
| cebsulfase alfa (CHEBI:758912) is a organic molecular entity (CHEBI:50860) |
| cedefingol (CHEBI:230579) is a organic molecular entity (CHEBI:50860) |
| cedelizumab (CHEBI:753263) is a organic molecular entity (CHEBI:50860) |
| Cefacetrile sodium (CHEBI:31364) is a organic molecular entity (CHEBI:50860) |
| Cefetamet pivoxil hydrochloride (CHEBI:31369) is a organic molecular entity (CHEBI:50860) |
| Cefoperazone sodium (CHEBI:3494) is a organic molecular entity (CHEBI:50860) |
| Cefovecin sodium (CHEBI:31375) is a organic molecular entity (CHEBI:50860) |
| Cefoxitin sodium (CHEBI:3501) is a organic molecular entity (CHEBI:50860) |
| Cefpimizole sodium (CHEBI:31376) is a organic molecular entity (CHEBI:50860) |
| Cefsulodin sodium (CHEBI:31380) is a organic molecular entity (CHEBI:50860) |
| Ceftiofur sodium (CHEBI:31383) is a organic molecular entity (CHEBI:50860) |
| Cefuroxime sodium (CHEBI:3517) is a organic molecular entity (CHEBI:50860) |
| cellaburate (CHEBI:753041) is a organic molecular entity (CHEBI:50860) |
| cellacefate (CHEBI:753264) is a organic molecular entity (CHEBI:50860) |
| cellulase (CHEBI:753911) is a organic molecular entity (CHEBI:50860) |
| Cellulose acetate phthalate (CHEBI:31386) is a organic molecular entity (CHEBI:50860) |
| cellulose sodium phosphate (CHEBI:749458) is a organic molecular entity (CHEBI:50860) |
| cellulose, oxidized (CHEBI:753265) is a organic molecular entity (CHEBI:50860) |
| cellulose, oxidized regenerated (CHEBI:753912) is a organic molecular entity (CHEBI:50860) |
| celmoleukin (CHEBI:753185) is a organic molecular entity (CHEBI:50860) |
| celucloral (CHEBI:753773) is a organic molecular entity (CHEBI:50860) |
| cemacabtagene ansegedleucel (CHEBI:759509) is a organic molecular entity (CHEBI:50860) |
| cemavafusp (CHEBI:759425) is a organic molecular entity (CHEBI:50860) |
| cembrene A (CHEBI:192711) is a organic molecular entity (CHEBI:50860) |
| cemdisiran (CHEBI:757175) is a organic molecular entity (CHEBI:50860) |
| cemiplimab (CHEBI:757176) is a organic molecular entity (CHEBI:50860) |
| cendakimab (CHEBI:757304) is a organic molecular entity (CHEBI:50860) |
| cenderetide (CHEBI:753536) is a organic molecular entity (CHEBI:50860) |
| cenderitide (CHEBI:753660) is a organic molecular entity (CHEBI:50860) |
| cenegermin (CHEBI:757294) is a organic molecular entity (CHEBI:50860) |
| cenersen (CHEBI:753273) is a organic molecular entity (CHEBI:50860) |
| cenersen sodium (CHEBI:754920) is a organic molecular entity (CHEBI:50860) |
| Cenobamate (CHEBI:234112) is a organic molecular entity (CHEBI:50860) |
| cenplacel-l (CHEBI:752909) is a organic molecular entity (CHEBI:50860) |
| centella asiatica extract (CHEBI:758999) is a organic molecular entity (CHEBI:50860) |
| Centrinone (CHEBI:747302) is a organic molecular entity (CHEBI:50860) |
| cenzileucel (CHEBI:759357) is a organic molecular entity (CHEBI:50860) |
| cep-40783 (CHEBI:758392) is a organic molecular entity (CHEBI:50860) |
| cepadacursen sodium (CHEBI:758163) is a organic molecular entity (CHEBI:50860) |
| cepeginterferon alfa-2b (CHEBI:753080) is a organic molecular entity (CHEBI:50860) |
| cepeprubart (CHEBI:759510) is a organic molecular entity (CHEBI:50860) |
| cer-002 (CHEBI:755390) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/21:0) (CHEBI:143608) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/22:0(OH)) (CHEBI:143607) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/22:0) (CHEBI:143604) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/23:0) (CHEBI:143609) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/24:0) (CHEBI:143605) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/25:0) (CHEBI:143610) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:0(15Me)/26:0) (CHEBI:143606) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/16:0(2OH[R])) (CHEBI:143832) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/17:0(2OH[R])) (CHEBI:143841) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/18:0(2OH[R])) (CHEBI:143833) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/19:0(2OH[R])) (CHEBI:143842) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/20:0(2OH[R])) (CHEBI:143834) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/21:0(2OH[R])) (CHEBI:143843) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/22:0(2OH[R])) (CHEBI:143835) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/23:0(2OH[R])) (CHEBI:143844) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/24:0(2OH[R])) (CHEBI:143836) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/25:0(2OH[R])) (CHEBI:143845) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/26:0(2OH[R])) (CHEBI:143837) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/27:0(2OH[R])) (CHEBI:143846) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/28:0(2OH[R])) (CHEBI:143838) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/29:0(2OH[R])) (CHEBI:143847) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/29:0) (CHEBI:143840) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/30:0(2OH[R])) (CHEBI:143839) is a organic molecular entity (CHEBI:50860) |
| Cer(d16:1(4E)(1OH,3OH)(15Me)/30:0) (CHEBI:143831) is a organic molecular entity (CHEBI:50860) |
| Cer(d18:1/20:4(6E,8Z,11Z,14Z)-OH(5S)) (CHEBI:231109) is a organic molecular entity (CHEBI:50860) |
| ceralasertib (CHEBI:231342) is a organic molecular entity (CHEBI:50860) |
| Cerebellin (CHEBI:80137) is a organic molecular entity (CHEBI:50860) |
| cergutuzumab (CHEBI:756497) is a organic molecular entity (CHEBI:50860) |
| cergutuzumab amunaleukin (CHEBI:756500) is a organic molecular entity (CHEBI:50860) |
| cerium oxalate (CHEBI:756545) is a organic molecular entity (CHEBI:50860) |
| cerliponase alfa (CHEBI:755374) is a organic molecular entity (CHEBI:50860) |
| cernitin pollen extract (CHEBI:753913) is a organic molecular entity (CHEBI:50860) |
| certepetide (CHEBI:759716) is a organic molecular entity (CHEBI:50860) |
| certolizumab (CHEBI:757040) is a organic molecular entity (CHEBI:50860) |
| certolizumab pegol (CHEBI:63585) is a organic molecular entity (CHEBI:50860) |
| certoparin (CHEBI:757177) is a organic molecular entity (CHEBI:50860) |
| certoparin sodium (CHEBI:753914) is a organic molecular entity (CHEBI:50860) |
| cesium cs-131 (CHEBI:756857) is a organic molecular entity (CHEBI:50860) |
| cesnicabtagene autoleucel (CHEBI:760020) is a organic molecular entity (CHEBI:50860) |
| cetermin (CHEBI:753266) is a organic molecular entity (CHEBI:50860) |
| cetomacrogol 1000 (CHEBI:753915) is a organic molecular entity (CHEBI:50860) |
| cetrelimab (CHEBI:757427) is a organic molecular entity (CHEBI:50860) |
| Cetrimide (CHEBI:3565) is a organic molecular entity (CHEBI:50860) |
| cetrimide cation(1+) (CHEBI:232882) is a organic molecular entity (CHEBI:50860) |
| cetuximab (CHEBI:749550) is a organic molecular entity (CHEBI:50860) |
| cetuximab beta (CHEBI:760139) is a organic molecular entity (CHEBI:50860) |
| cetuximab sarotalocan (CHEBI:757507) is a organic molecular entity (CHEBI:50860) |
| cetyl esters wax (CHEBI:753832) is a organic molecular entity (CHEBI:50860) |
| cetyldimethylethylammonium(1+) (CHEBI:232881) is a organic molecular entity (CHEBI:50860) |
| cevaretigene ritoparvovec (CHEBI:757840) is a organic molecular entity (CHEBI:50860) |
| cevostamab (CHEBI:757345) is a organic molecular entity (CHEBI:50860) |
| cg250 111in (CHEBI:755771) is a organic molecular entity (CHEBI:50860) |
| cg250 124i (CHEBI:755721) is a organic molecular entity (CHEBI:50860) |
| cg250 177lu (CHEBI:755783) is a organic molecular entity (CHEBI:50860) |
| CGP 54626 hydrochloride (CHEBI:234136) is a organic molecular entity (CHEBI:50860) |
| CH3-R (CHEBI:3274) is a organic molecular entity (CHEBI:50860) |
| chaetochalasin A (CHEBI:68750) is a organic molecular entity (CHEBI:50860) |
| chaetocin (CHEBI:68747) is a organic molecular entity (CHEBI:50860) |
| chaetocin B (CHEBI:68759) is a organic molecular entity (CHEBI:50860) |
| chaetocin C (CHEBI:68760) is a organic molecular entity (CHEBI:50860) |
| chaetoglocin C (CHEBI:68768) is a organic molecular entity (CHEBI:50860) |
| chaetomanone (CHEBI:68781) is a organic molecular entity (CHEBI:50860) |
| chamomile (CHEBI:753833) is a organic molecular entity (CHEBI:50860) |
| Chandalone (CHEBI:230421) is a organic molecular entity (CHEBI:50860) |
| characterised viable autologous cartilage cells expanded ex vivo expressing specific marker proteins (CHEBI:760259) is a organic molecular entity (CHEBI:50860) |
| CHEBI:55424-chloramide (CHEBI:157776) is a organic molecular entity (CHEBI:50860) |
| CHEBI:55478-chloramide (CHEBI:157777) is a organic molecular entity (CHEBI:50860) |
| chemerin-9 (CHEBI:234354) is a organic molecular entity (CHEBI:50860) |
| Chenodeoxycholylalanine (CHEBI:230097) is a organic molecular entity (CHEBI:50860) |
| cherry juice (CHEBI:753190) is a organic molecular entity (CHEBI:50860) |
| chetoseminudin A (CHEBI:68745) is a organic molecular entity (CHEBI:50860) |
| chetoseminudin B (CHEBI:68809) is a organic molecular entity (CHEBI:50860) |
| chetoseminudin C (CHEBI:68746) is a organic molecular entity (CHEBI:50860) |
| chetracin A (CHEBI:68757) is a organic molecular entity (CHEBI:50860) |
| Chevreulic acid (CHEBI:195352) is a organic molecular entity (CHEBI:50860) |
| chf-6467 (CHEBI:760508) is a organic molecular entity (CHEBI:50860) |
| chikungunya virus, live attenuated (CHEBI:760405) is a organic molecular entity (CHEBI:50860) |
| chimeric yellow fever dengue virus, live attenuated (CHEBI:760288) is a organic molecular entity (CHEBI:50860) |
| chimpanzee adenovirus encoding sars-cov-2 spike glycoprotein (CHEBI:760294) is a organic molecular entity (CHEBI:50860) |
| CHIR99021 HCl (CHEBI:747739) is a organic molecular entity (CHEBI:50860) |
| chitosan low molecular weight (20-200 mpa.s) (CHEBI:757949) is a organic molecular entity (CHEBI:50860) |
| Chivosazole C (CHEBI:80059) is a organic molecular entity (CHEBI:50860) |
| chloriodized oil (CHEBI:753238) is a organic molecular entity (CHEBI:50860) |
| chlorobiocin-like antibiotic (CHEBI:86404) is a organic molecular entity (CHEBI:50860) |
| chlorophyllin (CHEBI:232141) is a organic molecular entity (CHEBI:50860) |
| chlorophyllin copper complex (CHEBI:753834) is a organic molecular entity (CHEBI:50860) |
| chlorotoxin (CHEBI:757536) is a organic molecular entity (CHEBI:50860) |
| Chlorpheniramine maleate (CHEBI:3645) is a organic molecular entity (CHEBI:50860) |
| Chlorphonium chloride (CHEBI:81903) is a organic molecular entity (CHEBI:50860) |
| CHM-1 (CHEBI:231703) is a organic molecular entity (CHEBI:50860) |
| cho-h01 (CHEBI:757178) is a organic molecular entity (CHEBI:50860) |
| Cholecystokinin-33 (CHEBI:80345) is a organic molecular entity (CHEBI:50860) |
| Cholecystokinin-8 (CHEBI:80327) is a organic molecular entity (CHEBI:50860) |
| CholEsteryl BODIPY 542/563 C11 (CHEBI:141516) is a organic molecular entity (CHEBI:50860) |
| cholestyramine (CHEBI:749501) is a organic molecular entity (CHEBI:50860) |
| choline magnesium trisalicylate (CHEBI:757179) is a organic molecular entity (CHEBI:50860) |
| chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells (CHEBI:759789) is a organic molecular entity (CHEBI:50860) |
| chondroitin sulfate sodium (CHEBI:753835) is a organic molecular entity (CHEBI:50860) |
| choriogonadotropin alfa (CHEBI:749511) is a organic molecular entity (CHEBI:50860) |
| Chorionic gonadotropin (CHEBI:81570) is a organic molecular entity (CHEBI:50860) |
| chrexanthomycin A (CHEBI:233194) is a organic molecular entity (CHEBI:50860) |
| chrexanthomycin B (CHEBI:233195) is a organic molecular entity (CHEBI:50860) |
| chrexanthomycin C (CHEBI:233196) is a organic molecular entity (CHEBI:50860) |
| chromic chloride (CHEBI:749266) is a organic molecular entity (CHEBI:50860) |
| chromic phosphate (CHEBI:754409) is a organic molecular entity (CHEBI:50860) |
| chromic phosphate p 32 (CHEBI:749297) is a organic molecular entity (CHEBI:50860) |
| chromium (CHEBI:749398) is a organic molecular entity (CHEBI:50860) |
| chromium cr 51 edetate (CHEBI:755920) is a organic molecular entity (CHEBI:50860) |
| chromium edetate (CHEBI:756538) is a organic molecular entity (CHEBI:50860) |
| chromium picolinate (CHEBI:755205) is a organic molecular entity (CHEBI:50860) |
| chrysodiene (CHEBI:192982) is a organic molecular entity (CHEBI:50860) |
| Chrysoidine (CHEBI:82424) is a organic molecular entity (CHEBI:50860) |
| chs-114 (CHEBI:760482) is a organic molecular entity (CHEBI:50860) |
| chtnt-1 131i (CHEBI:754202) is a organic molecular entity (CHEBI:50860) |
| chymotrypsin (CHEBI:749539) is a organic molecular entity (CHEBI:50860) |
| CI Acid Orange 20 (CHEBI:82426) is a organic molecular entity (CHEBI:50860) |
| CI Acid Orange 3 (CHEBI:82425) is a organic molecular entity (CHEBI:50860) |
| CI Acid red 114 (CHEBI:82302) is a organic molecular entity (CHEBI:50860) |
| CI Basic red 9 (CHEBI:82303) is a organic molecular entity (CHEBI:50860) |
| cibisatamab (CHEBI:757510) is a organic molecular entity (CHEBI:50860) |
| cibotercept (CHEBI:759511) is a organic molecular entity (CHEBI:50860) |
| cibrigirsen (CHEBI:759512) is a organic molecular entity (CHEBI:50860) |
| Cichorioside J (CHEBI:230409) is a organic molecular entity (CHEBI:50860) |
| Ciclesonide (CHEBI:31397) is a organic molecular entity (CHEBI:50860) |
| CID 139371523 (CHEBI:233326) is a organic molecular entity (CHEBI:50860) |
| CID 661578 (CHEBI:233083) is a organic molecular entity (CHEBI:50860) |
| cideferron (CHEBI:753836) is a organic molecular entity (CHEBI:50860) |
| ciduvectamig (CHEBI:759358) is a organic molecular entity (CHEBI:50860) |
| cifurtilimab (CHEBI:758695) is a organic molecular entity (CHEBI:50860) |
| cilastatin zwitterion(-) (CHEBI:746944) is a organic molecular entity (CHEBI:50860) |
| ciletatug (CHEBI:760140) is a organic molecular entity (CHEBI:50860) |
| ciletatug vedotin (CHEBI:760141) is a organic molecular entity (CHEBI:50860) |
| cilgavimab (CHEBI:758164) is a organic molecular entity (CHEBI:50860) |
| ciliary neurotrophic factor (CHEBI:757486) is a organic molecular entity (CHEBI:50860) |
| cilmostim (CHEBI:753239) is a organic molecular entity (CHEBI:50860) |
| ciltacabtagene autoleucel (CHEBI:758570) is a organic molecular entity (CHEBI:50860) |
| cimaglermin alfa (CHEBI:755083) is a organic molecular entity (CHEBI:50860) |
| cimdelirsen (CHEBI:758165) is a organic molecular entity (CHEBI:50860) |
| cimderlirsen sodium (CHEBI:758166) is a organic molecular entity (CHEBI:50860) |
| cinaxadamtase alfa (CHEBI:759033) is a organic molecular entity (CHEBI:50860) |
| cinhyaluronate sodium (CHEBI:757522) is a organic molecular entity (CHEBI:50860) |
| Cinnamic acid acylated spermidine (CHEBI:234018) is a organic molecular entity (CHEBI:50860) |
| cinnamon (CHEBI:753837) is a organic molecular entity (CHEBI:50860) |
| cinnamon oil (CHEBI:753838) is a organic molecular entity (CHEBI:50860) |
| cinpanemab (CHEBI:755925) is a organic molecular entity (CHEBI:50860) |
| cinrebafusp alfa (CHEBI:757260) is a organic molecular entity (CHEBI:50860) |
| cintredekin besudotox (CHEBI:753537) is a organic molecular entity (CHEBI:50860) |
| cipaglucosidase alfa (CHEBI:757827) is a organic molecular entity (CHEBI:50860) |
| ciracigene golparvovec (CHEBI:760021) is a organic molecular entity (CHEBI:50860) |
| cirevetmab (CHEBI:758696) is a organic molecular entity (CHEBI:50860) |
| cirmtuzumab (CHEBI:757180) is a organic molecular entity (CHEBI:50860) |
| cirolemycin (CHEBI:753240) is a organic molecular entity (CHEBI:50860) |
| cis-11,12-methyleneoctadecanoate (CHEBI:140681) is a organic molecular entity (CHEBI:50860) |
| cis-11,12-methyleneoctadecanoic acid (CHEBI:140680) is a organic molecular entity (CHEBI:50860) |
| cis-11,12-methyleneoctadecanoyl-carnitine (CHEBI:140684) is a organic molecular entity (CHEBI:50860) |
| cis-11,12-methyleneoctadecanoyl-CoA (CHEBI:140682) is a organic molecular entity (CHEBI:50860) |
| cis-11,12-methyleneoctadecanoyl-CoA(4-) (CHEBI:140683) is a organic molecular entity (CHEBI:50860) |
| cis-9,10-methylenehexadecanoate (CHEBI:140686) is a organic molecular entity (CHEBI:50860) |
| cis-9,10-methylenehexadecanoic acid (CHEBI:140685) is a organic molecular entity (CHEBI:50860) |
| cis-9,10-methylenehexadecanoyl carnitine (CHEBI:140689) is a organic molecular entity (CHEBI:50860) |
| cis-9,10-methylenehexadecanoyl-CoA (CHEBI:140687) is a organic molecular entity (CHEBI:50860) |
| cis-9,10-methylenehexadecanoyl-CoA(4-) (CHEBI:140688) is a organic molecular entity (CHEBI:50860) |
| cis-dodec-5-enoyl-CoA(4-) (CHEBI:230464) is a organic molecular entity (CHEBI:50860) |
| cis-hydroxy perhexiline (CHEBI:230593) is a organic molecular entity (CHEBI:50860) |
| cis-muurola-4(15)5-diene (CHEBI:192988) is a organic molecular entity (CHEBI:50860) |
| CIS-N-TERT-BUTYL-DECAHYDRO-2-[2(R)-HYDROXY-4-PHENYL-3(S)-[[N-2-QUINOLYLCARBONYL-L-ASPARAGINYL]AMINO]BUTYL]-(4AS)-ISOQUINOLINE-3(S)-CARBOXAMIDE (CHEBI:45279) is a organic molecular entity (CHEBI:50860) |
| cis-norbixin (CHEBI:233982) is a organic molecular entity (CHEBI:50860) |
| cis-permethrin (CHEBI:233594) is a organic molecular entity (CHEBI:50860) |
| citatuzumab bogatox (CHEBI:750080) is a organic molecular entity (CHEBI:50860) |
| Citric acid monohydrate (CHEBI:31404) is a organic molecular entity (CHEBI:50860) |
| citrusinine ii (CHEBI:230775) is a organic molecular entity (CHEBI:50860) |
| cixutumumab (CHEBI:750081) is a organic molecular entity (CHEBI:50860) |
| cizutamig (CHEBI:760142) is a organic molecular entity (CHEBI:50860) |
| cjm-112 (CHEBI:757360) is a organic molecular entity (CHEBI:50860) |
| cl-184 (CHEBI:754326) is a organic molecular entity (CHEBI:50860) |
| CL316243 (CHEBI:232554) is a organic molecular entity (CHEBI:50860) |
| clazakizumab (CHEBI:753543) is a organic molecular entity (CHEBI:50860) |
| cleisthantin derivative (CHEBI:156524) is a organic molecular entity (CHEBI:50860) |
| clemidsogene lanparvovec (CHEBI:759513) is a organic molecular entity (CHEBI:50860) |
| clenoliximab (CHEBI:753194) is a organic molecular entity (CHEBI:50860) |
| Clerodanoid 482 (CHEBI:197375) is a organic molecular entity (CHEBI:50860) |
| Clerodanoid 484 (CHEBI:197376) is a organic molecular entity (CHEBI:50860) |
| clervonafusp alfa (CHEBI:757845) is a organic molecular entity (CHEBI:50860) |
| clesitamig (CHEBI:760143) is a organic molecular entity (CHEBI:50860) |
| clesrovimab (CHEBI:757229) is a organic molecular entity (CHEBI:50860) |
| Clidanac (CHEBI:31411) is a organic molecular entity (CHEBI:50860) |
| climacostol (CHEBI:232341) is a organic molecular entity (CHEBI:50860) |
| Clinofibrate (CHEBI:31412) is a organic molecular entity (CHEBI:50860) |
| clivatuzumab tetraxetan (CHEBI:755269) is a organic molecular entity (CHEBI:50860) |
| Clobetasone butyrate (CHEBI:31415) is a organic molecular entity (CHEBI:50860) |
| Clofenamide (CHEBI:31418) is a organic molecular entity (CHEBI:50860) |
| Clorexolone (CHEBI:31421) is a organic molecular entity (CHEBI:50860) |
| Clotiazepam (CHEBI:31425) is a organic molecular entity (CHEBI:50860) |
| clove oil (CHEBI:753245) is a organic molecular entity (CHEBI:50860) |
| clover, red (CHEBI:753846) is a organic molecular entity (CHEBI:50860) |
| Cloxyfonac-sodium (CHEBI:81983) is a organic molecular entity (CHEBI:50860) |
| cm-082 (CHEBI:755634) is a organic molecular entity (CHEBI:50860) |
| cm-101 (CHEBI:760483) is a organic molecular entity (CHEBI:50860) |
| cmb-401 (CHEBI:754138) is a organic molecular entity (CHEBI:50860) |
| cmd-193 (CHEBI:754285) is a organic molecular entity (CHEBI:50860) |
| CMN 131 (CHEBI:80010) is a organic molecular entity (CHEBI:50860) |
| CMP-9-O-acetyl-3-deoxy-D-glycero-β-D-galacto-non-2-ulopyranosonate(2−) (CHEBI:233183) is a organic molecular entity (CHEBI:50860) |
| CMS-121 (CHEBI:230492) is a organic molecular entity (CHEBI:50860) |
| Cnidilide (CHEBI:80808) is a organic molecular entity (CHEBI:50860) |
| cnto-5825 (CHEBI:754253) is a organic molecular entity (CHEBI:50860) |
| co-danthramer (CHEBI:753198) is a organic molecular entity (CHEBI:50860) |
| co-magaldrox (CHEBI:753849) is a organic molecular entity (CHEBI:50860) |
| co-simalcite (CHEBI:753841) is a organic molecular entity (CHEBI:50860) |
| coagulation factor ix human (CHEBI:757413) is a organic molecular entity (CHEBI:50860) |
| coagulation factor ix recombinant human (CHEBI:754094) is a organic molecular entity (CHEBI:50860) |
| coagulation factor vii human (CHEBI:760401) is a organic molecular entity (CHEBI:50860) |
| Coagulation Factor VIIa (CHEBI:3777) is a organic molecular entity (CHEBI:50860) |
| coagulation factor x human (CHEBI:757381) is a organic molecular entity (CHEBI:50860) |
| Coagulation Factor Xa (CHEBI:3783) is a organic molecular entity (CHEBI:50860) |
| coal tar (CHEBI:753233) is a organic molecular entity (CHEBI:50860) |
| Coal tar creosote (CHEBI:82278) is a organic molecular entity (CHEBI:50860) |
| Coal-tar pitch (CHEBI:80501) is a organic molecular entity (CHEBI:50860) |
| cobalamin concentrate (CHEBI:753715) is a organic molecular entity (CHEBI:50860) |
| cobalt-59(2+) (CHEBI:176615) is a organic molecular entity (CHEBI:50860) |
| cobalt-59(3+) (CHEBI:176616) is a organic molecular entity (CHEBI:50860) |
| cobaltous chloride (CHEBI:750272) is a organic molecular entity (CHEBI:50860) |
| cobaltous chloride co 57 (CHEBI:749267) is a organic molecular entity (CHEBI:50860) |
| cobaltous chloride co 60 (CHEBI:749374) is a organic molecular entity (CHEBI:50860) |
| cobitolimod (CHEBI:757039) is a organic molecular entity (CHEBI:50860) |
| cobitolimod sodium (CHEBI:759010) is a organic molecular entity (CHEBI:50860) |
| cobnabexagene anvuparvovec (CHEBI:759000) is a organic molecular entity (CHEBI:50860) |
| cobolimab (CHEBI:757537) is a organic molecular entity (CHEBI:50860) |
| cobomarsen (CHEBI:756476) is a organic molecular entity (CHEBI:50860) |
| cobomarsen sodium (CHEBI:756477) is a organic molecular entity (CHEBI:50860) |
| Cocaine- and Amphetamine- regulated transcript (1-39) (CHEBI:80252) is a organic molecular entity (CHEBI:50860) |
| Cocaine- and Amphetamine- regulated transcript (42-89) (CHEBI:80253) is a organic molecular entity (CHEBI:50860) |
| coccidioidin (CHEBI:753828) is a organic molecular entity (CHEBI:50860) |
| cochliodinol (CHEBI:68808) is a organic molecular entity (CHEBI:50860) |
| coco diethanolamide (CHEBI:757022) is a organic molecular entity (CHEBI:50860) |
| cocoa (CHEBI:753234) is a organic molecular entity (CHEBI:50860) |
| cocoa butter (CHEBI:753829) is a organic molecular entity (CHEBI:50860) |
| cod liver oil (CHEBI:753235) is a organic molecular entity (CHEBI:50860) |
| cod liver oil, nondestearinated (CHEBI:753830) is a organic molecular entity (CHEBI:50860) |
| coda-001 (CHEBI:757476) is a organic molecular entity (CHEBI:50860) |
| codeine polistirex (CHEBI:749483) is a organic molecular entity (CHEBI:50860) |
| codrituzumab (CHEBI:757508) is a organic molecular entity (CHEBI:50860) |
| cofetuzumab (CHEBI:756464) is a organic molecular entity (CHEBI:50860) |
| cofetuzumab pelidotin (CHEBI:756466) is a organic molecular entity (CHEBI:50860) |
| cofirasersen (CHEBI:758358) is a organic molecular entity (CHEBI:50860) |
| col-1 (CHEBI:754275) is a organic molecular entity (CHEBI:50860) |
| cold cream (CHEBI:753859) is a organic molecular entity (CHEBI:50860) |
| Colestilan (CHEBI:31428) is a organic molecular entity (CHEBI:50860) |
| colestilan chloride (CHEBI:750473) is a organic molecular entity (CHEBI:50860) |
| colextran (CHEBI:753241) is a organic molecular entity (CHEBI:50860) |
| colistin sulfate (CHEBI:759883) is a organic molecular entity (CHEBI:50860) |
| collagenase clostridium histolyticum (CHEBI:753652) is a organic molecular entity (CHEBI:50860) |
| collodion (CHEBI:753848) is a organic molecular entity (CHEBI:50860) |
| coltuximab ravtansine (CHEBI:754139) is a organic molecular entity (CHEBI:50860) |
| colulintide (CHEBI:760383) is a organic molecular entity (CHEBI:50860) |
| com-701 (CHEBI:758008) is a organic molecular entity (CHEBI:50860) |
| comekibart (CHEBI:760022) is a organic molecular entity (CHEBI:50860) |
| comfilcon a (CHEBI:753538) is a organic molecular entity (CHEBI:50860) |
| Compound 1 (CHEBI:747297) is a organic molecular entity (CHEBI:50860) |
| Compound 77 (CHEBI:150010) is a organic molecular entity (CHEBI:50860) |
| compound 78 (CHEBI:150009) is a organic molecular entity (CHEBI:50860) |
| Compound D (CHEBI:228264) is a organic molecular entity (CHEBI:50860) |
| Compound-21 (CHEBI:747459) is a organic molecular entity (CHEBI:50860) |
| comsaleucel (CHEBI:760144) is a organic molecular entity (CHEBI:50860) |
| conatumumab (CHEBI:750082) is a organic molecular entity (CHEBI:50860) |
| conbercept (CHEBI:753301) is a organic molecular entity (CHEBI:50860) |
| concizumab (CHEBI:757182) is a organic molecular entity (CHEBI:50860) |
| condoliase (CHEBI:752918) is a organic molecular entity (CHEBI:50860) |
| condurango fluidextract (CHEBI:753839) is a organic molecular entity (CHEBI:50860) |
| conestat alfa (CHEBI:753329) is a organic molecular entity (CHEBI:50860) |
| conicasterol c (CHEBI:230703) is a organic molecular entity (CHEBI:50860) |
| contusugene ladenovec (CHEBI:753539) is a organic molecular entity (CHEBI:50860) |
| copper (CHEBI:748257) is a organic molecular entity (CHEBI:50860) |
| copper (64cu) adarulatide tetraxetan (CHEBI:760023) is a organic molecular entity (CHEBI:50860) |
| Copper gluconate (CHEBI:31431) is a organic molecular entity (CHEBI:50860) |
| copper histidine (CHEBI:757183) is a organic molecular entity (CHEBI:50860) |
| Copper hydroxide (CHEBI:81907) is a organic molecular entity (CHEBI:50860) |
| copper oleinate (CHEBI:750190) is a organic molecular entity (CHEBI:50860) |
| copper oxodotreotide (CHEBI:757642) is a organic molecular entity (CHEBI:50860) |
| copper oxodotreotide cu-64 (CHEBI:756834) is a organic molecular entity (CHEBI:50860) |
| coramitug (CHEBI:759514) is a organic molecular entity (CHEBI:50860) |
| Core protein (CHEBI:81639) is a organic molecular entity (CHEBI:50860) |
| coresevin m (CHEBI:754213) is a organic molecular entity (CHEBI:50860) |
| Coreynic acid (CHEBI:197307) is a organic molecular entity (CHEBI:50860) |
| coriander oil (CHEBI:753840) is a organic molecular entity (CHEBI:50860) |
| corifollitropin alfa (CHEBI:753193) is a organic molecular entity (CHEBI:50860) |
| Corin (CHEBI:232604) is a organic molecular entity (CHEBI:50860) |
| cornusiin E(4−) (CHEBI:145907) is a organic molecular entity (CHEBI:50860) |
| corticorelin ovine triflutate (CHEBI:749441) is a organic molecular entity (CHEBI:50860) |
| corticotropin zinc hydroxide (CHEBI:749432) is a organic molecular entity (CHEBI:50860) |
| Corticotropin-like intermediary peptide (CHEBI:80346) is a organic molecular entity (CHEBI:50860) |
| Cortistatin-17 (CHEBI:80251) is a organic molecular entity (CHEBI:50860) |
| Cortistatin-29 (CHEBI:80250) is a organic molecular entity (CHEBI:50860) |
| cosfroviximab (CHEBI:756484) is a organic molecular entity (CHEBI:50860) |
| cosibelimab (CHEBI:757181) is a organic molecular entity (CHEBI:50860) |
| cotoretigene toliparvovec (CHEBI:757820) is a organic molecular entity (CHEBI:50860) |
| cotton, purified (CHEBI:753242) is a organic molecular entity (CHEBI:50860) |
| cottonseed oil (CHEBI:753842) is a organic molecular entity (CHEBI:50860) |
| coumaphos oxon (CHEBI:234570) is a organic molecular entity (CHEBI:50860) |
| cox-2 (CHEBI:757185) is a organic molecular entity (CHEBI:50860) |
| CP 55940 (CHEBI:234379) is a organic molecular entity (CHEBI:50860) |
| cp-459632 (CHEBI:755561) is a organic molecular entity (CHEBI:50860) |
| CP2 (CHEBI:231659) is a organic molecular entity (CHEBI:50860) |
| CP681301 (CHEBI:232980) is a organic molecular entity (CHEBI:50860) |
| CpG-oligodeoxynucleotide (CHEBI:232583) is a organic molecular entity (CHEBI:50860) |
| CPH4 (CHEBI:193163) is a organic molecular entity (CHEBI:50860) |
| CPI-203 (CHEBI:746981) is a organic molecular entity (CHEBI:50860) |
| cr 1447 (CHEBI:755458) is a organic molecular entity (CHEBI:50860) |
| cranberry liquid preparation (CHEBI:753843) is a organic molecular entity (CHEBI:50860) |
| crebankitug (CHEBI:760024) is a organic molecular entity (CHEBI:50860) |
| crefmirlimab (CHEBI:758574) is a organic molecular entity (CHEBI:50860) |
| crenezumab (CHEBI:750083) is a organic molecular entity (CHEBI:50860) |
| Crenigacestat (CHEBI:232469) is a organic molecular entity (CHEBI:50860) |
| creosote carbonate (CHEBI:753243) is a organic molecular entity (CHEBI:50860) |
| cretostimogene grenadenorepvec (CHEBI:759015) is a organic molecular entity (CHEBI:50860) |
| crexavibart (CHEBI:758890) is a organic molecular entity (CHEBI:50860) |
| Criegeenic acid (CHEBI:197321) is a organic molecular entity (CHEBI:50860) |
| crilanomer (CHEBI:753191) is a organic molecular entity (CHEBI:50860) |
| crinamabine Trifluoroacetic acid (CHEBI:68313) is a organic molecular entity (CHEBI:50860) |
| crisantaspase (CHEBI:753844) is a organic molecular entity (CHEBI:50860) |
| crizanlizumab (CHEBI:757186) is a organic molecular entity (CHEBI:50860) |
| crofelemer (CHEBI:753192) is a organic molecular entity (CHEBI:50860) |
| crofilcon a (CHEBI:753244) is a organic molecular entity (CHEBI:50860) |
| croscarmellose sodium (CHEBI:753845) is a organic molecular entity (CHEBI:50860) |
| crosigalcogene omlixparvovec (CHEBI:759359) is a organic molecular entity (CHEBI:50860) |
| crospovidone (CHEBI:753772) is a organic molecular entity (CHEBI:50860) |
| crotedumab (CHEBI:755769) is a organic molecular entity (CHEBI:50860) |
| crovalimab (CHEBI:757815) is a organic molecular entity (CHEBI:50860) |
| cryopreserved human fibroblast-derived dermal substitute (CHEBI:753540) is a organic molecular entity (CHEBI:50860) |
| cryostor cs10 (CHEBI:758847) is a organic molecular entity (CHEBI:50860) |
| cryptenamine acetates (CHEBI:749479) is a organic molecular entity (CHEBI:50860) |
| cryptenamine tannates (CHEBI:749552) is a organic molecular entity (CHEBI:50860) |
| cs-1003 (CHEBI:758010) is a organic molecular entity (CHEBI:50860) |
| cs-8080 (CHEBI:755533) is a organic molecular entity (CHEBI:50860) |
| CS-D (CHEBI:167154) is a organic molecular entity (CHEBI:50860) |
| csl-360 (CHEBI:754161) is a organic molecular entity (CHEBI:50860) |
| CTX-0391034 (CHEBI:231661) is a organic molecular entity (CHEBI:50860) |
| CU-CPT22 (CHEBI:233358) is a organic molecular entity (CHEBI:50860) |
| CU-O LINKAGE (CHEBI:47286) is a organic molecular entity (CHEBI:50860) |
| Cu(II)ATSM (CHEBI:232495) is a organic molecular entity (CHEBI:50860) |
| cubebol (CHEBI:192809) is a organic molecular entity (CHEBI:50860) |
| cudarolimab (CHEBI:758025) is a organic molecular entity (CHEBI:50860) |
| Cudc-101 (CHEBI:747759) is a organic molecular entity (CHEBI:50860) |
| cugrastomig (CHEBI:760025) is a organic molecular entity (CHEBI:50860) |
| cumulene (CHEBI:37608) is a organic molecular entity (CHEBI:50860) |
| cunermuspir (CHEBI:760418) is a organic molecular entity (CHEBI:50860) |
| cupric chloride (CHEBI:748881) is a organic molecular entity (CHEBI:50860) |
| cupric chloride anhydrous (CHEBI:749273) is a organic molecular entity (CHEBI:50860) |
| cupric chloride cu-64 (CHEBI:759909) is a organic molecular entity (CHEBI:50860) |
| cupric sulfate (CHEBI:748005) is a organic molecular entity (CHEBI:50860) |
| cupric yersiniabactin (CHEBI:232568) is a organic molecular entity (CHEBI:50860) |
| curcuminoids (CHEBI:757459) is a organic molecular entity (CHEBI:50860) |
| curdlan sulfate (CHEBI:757187) is a organic molecular entity (CHEBI:50860) |
| cusatuzumab (CHEBI:757329) is a organic molecular entity (CHEBI:50860) |
| custirsen (CHEBI:753297) is a organic molecular entity (CHEBI:50860) |
| custirsen sodium (CHEBI:754917) is a organic molecular entity (CHEBI:50860) |
| CV 2961 (CHEBI:79977) is a organic molecular entity (CHEBI:50860) |
| cv-8102 (CHEBI:758515) is a organic molecular entity (CHEBI:50860) |
| cvx-060 (CHEBI:757950) is a organic molecular entity (CHEBI:50860) |
| cvx-241 (CHEBI:758279) is a organic molecular entity (CHEBI:50860) |
| CX-4945 (CHEBI:232617) is a organic molecular entity (CHEBI:50860) |
| CX-6258 (CHEBI:233305) is a organic molecular entity (CHEBI:50860) |
| cx1739 (CHEBI:755851) is a organic molecular entity (CHEBI:50860) |
| Cyanidin-3-O-(trans-p-coumaroyl)-diglucoside (CHEBI:746931) is a organic molecular entity (CHEBI:50860) |
| cyanidin-3-O-xyloside (CHEBI:746932) is a organic molecular entity (CHEBI:50860) |
| cyanocobalamin (CHEBI:754405) is a organic molecular entity (CHEBI:50860) |
| cyanocobalamin co 57 (CHEBI:750451) is a organic molecular entity (CHEBI:50860) |
| cyanocobalamin co 58 (CHEBI:750807) is a organic molecular entity (CHEBI:50860) |
| cyanocobalamin co 60 (CHEBI:750635) is a organic molecular entity (CHEBI:50860) |
| Cyanoglycoside (CHEBI:3980) is a organic molecular entity (CHEBI:50860) |
| Cyc-116 (CHEBI:747760) is a organic molecular entity (CHEBI:50860) |
| Cyclamate (CHEBI:82431) is a organic molecular entity (CHEBI:50860) |
| Cyclic secondary alcohol (CHEBI:3993) is a organic molecular entity (CHEBI:50860) |
| cyclo(1, 12)-Pen-K34-I-D-D-I30-T88-D-Y-I-S84-C-OH (CHEBI:488395) is a organic molecular entity (CHEBI:50860) |
| cyclo(L-Phe-L-Pro) (CHEBI:69440) is a organic molecular entity (CHEBI:50860) |
| Cyclo(Pro-Pro) (CHEBI:228280) is a organic molecular entity (CHEBI:50860) |
| Cyclofenil (CHEBI:31446) is a organic molecular entity (CHEBI:50860) |
| cyclofilcon a (CHEBI:753151) is a organic molecular entity (CHEBI:50860) |
| cycloguanil hydrochloride (CHEBI:79772) is a organic molecular entity (CHEBI:50860) |
| cyclohexyladenosine (CHEBI:232101) is a organic molecular entity (CHEBI:50860) |
| cyclolavandulyl diphosphate (CHEBI:193154) is a organic molecular entity (CHEBI:50860) |
| Cyclolinopeptide B (CHEBI:230354) is a organic molecular entity (CHEBI:50860) |
| Cyclopropanecarboxamide, 1,2,2,3,3-pentamethyl- (CHEBI:230447) is a organic molecular entity (CHEBI:50860) |
| cycloxaprid (CHEBI:232852) is a organic molecular entity (CHEBI:50860) |
| CYM-5478 (CHEBI:233320) is a organic molecular entity (CHEBI:50860) |
| cynarine (CHEBI:50167) is a organic molecular entity (CHEBI:50860) |
| cypothrin (CHEBI:230746) is a organic molecular entity (CHEBI:50860) |
| Cys-Ala thioether (CHEBI:132412) is a organic molecular entity (CHEBI:50860) |
| Cys-Asn thioether (CHEBI:132414) is a organic molecular entity (CHEBI:50860) |
| Cys-Glu thioether (CHEBI:132408) is a organic molecular entity (CHEBI:50860) |
| Cys-Met thioether (CHEBI:132410) is a organic molecular entity (CHEBI:50860) |
| Cys-Phe thioether (CHEBI:132409) is a organic molecular entity (CHEBI:50860) |
| Cys-Ser thioether (CHEBI:132411) is a organic molecular entity (CHEBI:50860) |
| Cys-Thr thioether (CHEBI:132254) is a organic molecular entity (CHEBI:50860) |
| Cys-Tyr thioether (CHEBI:132413) is a organic molecular entity (CHEBI:50860) |
| cyt-500 177lu (CHEBI:754318) is a organic molecular entity (CHEBI:50860) |
| cytidine 5'-({hydroxy[(S)-2-hydroxypropyl]phosphonoyl}phosphate)(2−) (CHEBI:142877) is a organic molecular entity (CHEBI:50860) |
| cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}(2−) (CHEBI:142876) is a organic molecular entity (CHEBI:50860) |
| Cytochrome c-552 (CHEBI:4065) is a organic molecular entity (CHEBI:50860) |
| Cytochrome cL (CHEBI:81596) is a organic molecular entity (CHEBI:50860) |
| D and C Red No. 9 (CHEBI:82435) is a organic molecular entity (CHEBI:50860) |
| D-2-(5-BromoThienyl)-alanine (CHEBI:233111) is a organic molecular entity (CHEBI:50860) |
| d-3263 (CHEBI:755793) is a organic molecular entity (CHEBI:50860) |
| D-520 (CHEBI:232847) is a organic molecular entity (CHEBI:50860) |
| D-CPT tartrate (CHEBI:232147) is a organic molecular entity (CHEBI:50860) |
| D-Cys-epsilon-Lys ("(S,S)") (CHEBI:233055) is a organic molecular entity (CHEBI:50860) |
| D-Glucamine (CHEBI:231253) is a organic molecular entity (CHEBI:50860) |
| D-glucosyl-N-acylsphingoid (CHEBI:195532) is a organic molecular entity (CHEBI:50860) |
| D-glycero-D-altro-octulose (CHEBI:192770) is a organic molecular entity (CHEBI:50860) |
| D-glycero-D-ido-octulose (CHEBI:194175) is a organic molecular entity (CHEBI:50860) |
| D-ido-heptulose (CHEBI:192772) is a organic molecular entity (CHEBI:50860) |
| D-NAME (CHEBI:232149) is a organic molecular entity (CHEBI:50860) |
| D-NAME hydrochloride (CHEBI:233136) is a organic molecular entity (CHEBI:50860) |
| D-Ornithine hydrochloride (CHEBI:4221) is a organic molecular entity (CHEBI:50860) |
| D-ribose-L-cysteine (CHEBI:233278) is a organic molecular entity (CHEBI:50860) |
| dabocemagene autoficel (CHEBI:758173) is a organic molecular entity (CHEBI:50860) |
| dacetuzumab (CHEBI:750084) is a organic molecular entity (CHEBI:50860) |
| dacliximab (CHEBI:753272) is a organic molecular entity (CHEBI:50860) |
| daclizumab (CHEBI:749553) is a organic molecular entity (CHEBI:50860) |
| dADG (CHEBI:190447) is a organic molecular entity (CHEBI:50860) |
| dADG monophosphate (CHEBI:190448) is a organic molecular entity (CHEBI:50860) |
| dalantercept (CHEBI:754386) is a organic molecular entity (CHEBI:50860) |
| dalazatide (CHEBI:757189) is a organic molecular entity (CHEBI:50860) |
| dalmitamig (CHEBI:760348) is a organic molecular entity (CHEBI:50860) |
| dalnacogene ponparvovec (CHEBI:760145) is a organic molecular entity (CHEBI:50860) |
| dalnicastobart (CHEBI:759360) is a organic molecular entity (CHEBI:50860) |
| dalotuzumab (CHEBI:750085) is a organic molecular entity (CHEBI:50860) |
| dalpiciclib (CHEBI:747469) is a organic molecular entity (CHEBI:50860) |
| dalteparin sodium (CHEBI:749547) is a organic molecular entity (CHEBI:50860) |
| dalucabtagene autoleucel (CHEBI:758697) is a organic molecular entity (CHEBI:50860) |
| dalutrafusp alfa (CHEBI:758848) is a organic molecular entity (CHEBI:50860) |
| damistimagene matitucel (CHEBI:756516) is a organic molecular entity (CHEBI:50860) |
| damoctocog alfa pegol (CHEBI:759752) is a organic molecular entity (CHEBI:50860) |
| danaparoid sodium (CHEBI:749568) is a organic molecular entity (CHEBI:50860) |
| danburstotug (CHEBI:758311) is a organic molecular entity (CHEBI:50860) |
| danicopan (CHEBI:231416) is a organic molecular entity (CHEBI:50860) |
| daniluromer (CHEBI:759426) is a organic molecular entity (CHEBI:50860) |
| daniplestim (CHEBI:753199) is a organic molecular entity (CHEBI:50860) |
| DansylAla (CHEBI:232943) is a organic molecular entity (CHEBI:50860) |
| danvatirsen (CHEBI:757190) is a organic molecular entity (CHEBI:50860) |
| danvatirsen sodium (CHEBI:756750) is a organic molecular entity (CHEBI:50860) |
| danvilostomig (CHEBI:759361) is a organic molecular entity (CHEBI:50860) |
| dapiclermin (CHEBI:753042) is a organic molecular entity (CHEBI:50860) |
| dapiglutide (CHEBI:759670) is a organic molecular entity (CHEBI:50860) |
| dapirolizumab pegol (CHEBI:754264) is a organic molecular entity (CHEBI:50860) |
| daplusiran (CHEBI:759016) is a organic molecular entity (CHEBI:50860) |
| daratumumab (CHEBI:750086) is a organic molecular entity (CHEBI:50860) |
| darbepoetin alfa (CHEBI:749503) is a organic molecular entity (CHEBI:50860) |
| dargistotug (CHEBI:759362) is a organic molecular entity (CHEBI:50860) |
| darleukin (CHEBI:757191) is a organic molecular entity (CHEBI:50860) |
| Darovasertib (CHEBI:233324) is a organic molecular entity (CHEBI:50860) |
| darvadstrocel (CHEBI:757587) is a organic molecular entity (CHEBI:50860) |
| das-181 (CHEBI:757363) is a organic molecular entity (CHEBI:50860) |
| dasiglucagon (CHEBI:757192) is a organic molecular entity (CHEBI:50860) |
| dasiglucagon hydrochloride (CHEBI:758180) is a organic molecular entity (CHEBI:50860) |
| dasiprotimut-t (CHEBI:754994) is a organic molecular entity (CHEBI:50860) |
| datopotamab (CHEBI:759324) is a organic molecular entity (CHEBI:50860) |
| datopotamab deruxtecan (CHEBI:757370) is a organic molecular entity (CHEBI:50860) |
| davamotecan pegadexamer (CHEBI:758514) is a organic molecular entity (CHEBI:50860) |
| davanat (CHEBI:757390) is a organic molecular entity (CHEBI:50860) |
| davoceticept (CHEBI:758878) is a organic molecular entity (CHEBI:50860) |
| davutamig (CHEBI:759041) is a organic molecular entity (CHEBI:50860) |
| daxdilimab (CHEBI:757828) is a organic molecular entity (CHEBI:50860) |
| daxibotulinumtoxina (CHEBI:755826) is a organic molecular entity (CHEBI:50860) |
| dazagamglogene autogedtemcel (CHEBI:759515) is a organic molecular entity (CHEBI:50860) |
| dazodalibep (CHEBI:757829) is a organic molecular entity (CHEBI:50860) |
| dazukibart (CHEBI:757253) is a organic molecular entity (CHEBI:50860) |
| DB213 (CHEBI:233081) is a organic molecular entity (CHEBI:50860) |
| db959 (CHEBI:755500) is a organic molecular entity (CHEBI:50860) |
| DBeQ (CHEBI:231699) is a organic molecular entity (CHEBI:50860) |
| dBET6 (CHEBI:189651) is a organic molecular entity (CHEBI:50860) |
| dCDG (CHEBI:190451) is a organic molecular entity (CHEBI:50860) |
| dCDG monophosphate (CHEBI:190452) is a organic molecular entity (CHEBI:50860) |
| dCeMM1 (CHEBI:232050) is a organic molecular entity (CHEBI:50860) |
| dCeMM2 (CHEBI:232051) is a organic molecular entity (CHEBI:50860) |
| dCeMM3 (CHEBI:232057) is a organic molecular entity (CHEBI:50860) |
| dcll-9718s (CHEBI:759708) is a organic molecular entity (CHEBI:50860) |
| dDG (CHEBI:190454) is a organic molecular entity (CHEBI:50860) |
| dDG monophosphate (CHEBI:190455) is a organic molecular entity (CHEBI:50860) |
| de-104 (CHEBI:755487) is a organic molecular entity (CHEBI:50860) |
| deamino-α-neuraminate(1−) (CHEBI:232096) is a organic molecular entity (CHEBI:50860) |
| debamestrocel (CHEBI:759043) is a organic molecular entity (CHEBI:50860) |
| Decane-1,3,7,10-tetramine (CHEBI:234486) is a organic molecular entity (CHEBI:50860) |
| decavitamin (CHEBI:753369) is a organic molecular entity (CHEBI:50860) |
| decorin (CHEBI:758280) is a organic molecular entity (CHEBI:50860) |
| defatted powder of arachis hypogaea l., semen (peanuts) (CHEBI:759770) is a organic molecular entity (CHEBI:50860) |
| defibrotide (CHEBI:753370) is a organic molecular entity (CHEBI:50860) |
| defibrotide sodium (CHEBI:755739) is a organic molecular entity (CHEBI:50860) |
| Dehydropeptide (CHEBI:4369) is a organic molecular entity (CHEBI:50860) |
| dehydroprobetaenone I (CHEBI:145061) is a organic molecular entity (CHEBI:50860) |
| delandistrogene moxeparvovec (CHEBI:758147) is a organic molecular entity (CHEBI:50860) |
| delcasertib (CHEBI:752914) is a organic molecular entity (CHEBI:50860) |
| delcasertib acetate (CHEBI:753669) is a organic molecular entity (CHEBI:50860) |
| deligoparin sodium (CHEBI:753976) is a organic molecular entity (CHEBI:50860) |
| delmitide (CHEBI:753541) is a organic molecular entity (CHEBI:50860) |
| delmitide acetate (CHEBI:753542) is a organic molecular entity (CHEBI:50860) |
| delpacibart (CHEBI:759363) is a organic molecular entity (CHEBI:50860) |
| delpacibart braxlosiran (CHEBI:760146) is a organic molecular entity (CHEBI:50860) |
| delpacibart etedesiran (CHEBI:759364) is a organic molecular entity (CHEBI:50860) |
| delpacibart zotadirsen (CHEBI:760147) is a organic molecular entity (CHEBI:50860) |
| delta-2-carene (CHEBI:192814) is a organic molecular entity (CHEBI:50860) |
| deltafilcon a (CHEBI:753371) is a organic molecular entity (CHEBI:50860) |
| deltafilcon b (CHEBI:753977) is a organic molecular entity (CHEBI:50860) |
| demcizumab (CHEBI:754200) is a organic molecular entity (CHEBI:50860) |
| demethylluteothin(1−) (CHEBI:142870) is a organic molecular entity (CHEBI:50860) |
| demplatin pegraglumer (CHEBI:757475) is a organic molecular entity (CHEBI:50860) |
| denatonium benzoate (CHEBI:232400) is a organic molecular entity (CHEBI:50860) |
| dendrotrifidic acid (CHEBI:230641) is a organic molecular entity (CHEBI:50860) |
| denecimig (CHEBI:759365) is a organic molecular entity (CHEBI:50860) |
| denenicokin (CHEBI:752898) is a organic molecular entity (CHEBI:50860) |
| dengue virus, live attenuated (CHEBI:760290) is a organic molecular entity (CHEBI:50860) |
| Denifanstat (CHEBI:233413) is a organic molecular entity (CHEBI:50860) |
| denikitug (CHEBI:760026) is a organic molecular entity (CHEBI:50860) |
| denileukin diftitox (CHEBI:749427) is a organic molecular entity (CHEBI:50860) |
| denintuzumab (CHEBI:755408) is a organic molecular entity (CHEBI:50860) |
| denintuzumab mafodotin (CHEBI:755601) is a organic molecular entity (CHEBI:50860) |
| denofungin (CHEBI:753978) is a organic molecular entity (CHEBI:50860) |
| denosumab (CHEBI:749681) is a organic molecular entity (CHEBI:50860) |
| denrakibart (CHEBI:760148) is a organic molecular entity (CHEBI:50860) |
| DENSPM (CHEBI:231415) is a organic molecular entity (CHEBI:50860) |
| deoxyartemisinin (CHEBI:234135) is a organic molecular entity (CHEBI:50860) |
| deoxysappanone B 7,3'-dimethyl ether acetate (CHEBI:235314) is a organic molecular entity (CHEBI:50860) |
| depatuxizumab (CHEBI:755780) is a organic molecular entity (CHEBI:50860) |
| depatuxizumab mafodotin (CHEBI:755768) is a organic molecular entity (CHEBI:50860) |
| depelestat (CHEBI:753043) is a organic molecular entity (CHEBI:50860) |
| depemokimab (CHEBI:758351) is a organic molecular entity (CHEBI:50860) |
| depreotide trifluoroacetate (CHEBI:759762) is a organic molecular entity (CHEBI:50860) |
| deramiocel (CHEBI:760149) is a organic molecular entity (CHEBI:50860) |
| Dermaseptin (CHEBI:80155) is a organic molecular entity (CHEBI:50860) |
| Dermateic acid (CHEBI:197317) is a organic molecular entity (CHEBI:50860) |
| descartes 30 (CHEBI:758281) is a organic molecular entity (CHEBI:50860) |
| desmethyl-dehydrogriseofulvin (CHEBI:193067) is a organic molecular entity (CHEBI:50860) |
| desmethylprodine (CHEBI:233164) is a organic molecular entity (CHEBI:50860) |
| desmoteplase (CHEBI:753979) is a organic molecular entity (CHEBI:50860) |
| Desmycocin (CHEBI:4452) is a organic molecular entity (CHEBI:50860) |
| desoxyribonuclease (CHEBI:749527) is a organic molecular entity (CHEBI:50860) |
| desulfo-Glucosinolate (CHEBI:80991) is a organic molecular entity (CHEBI:50860) |
| detalimogene voraplasmid (CHEBI:759042) is a organic molecular entity (CHEBI:50860) |
| detralfate (CHEBI:753372) is a organic molecular entity (CHEBI:50860) |
| detumomab (CHEBI:753980) is a organic molecular entity (CHEBI:50860) |
| devextinetug (CHEBI:758894) is a organic molecular entity (CHEBI:50860) |
| Dexamethasone 17-propionate (CHEBI:31470) is a organic molecular entity (CHEBI:50860) |
| Dexamethasone palmitate (CHEBI:31471) is a organic molecular entity (CHEBI:50860) |
| Dexchlorpheniramine maleate (CHEBI:4465) is a organic molecular entity (CHEBI:50860) |
| dextran 1 (CHEBI:753044) is a organic molecular entity (CHEBI:50860) |
| dextran 40 (CHEBI:754059) is a organic molecular entity (CHEBI:50860) |
| dextran 70 (CHEBI:753420) is a organic molecular entity (CHEBI:50860) |
| dextran 75 (CHEBI:753856) is a organic molecular entity (CHEBI:50860) |
| dextran sulfate sodium (5000 mw) (CHEBI:758028) is a organic molecular entity (CHEBI:50860) |
| dextranomer (CHEBI:753207) is a organic molecular entity (CHEBI:50860) |
| dextrates (CHEBI:753864) is a organic molecular entity (CHEBI:50860) |
| dextriferron (CHEBI:753204) is a organic molecular entity (CHEBI:50860) |
| dextromethorphan polistirex (CHEBI:749482) is a organic molecular entity (CHEBI:50860) |
| dextrose excipient (CHEBI:754060) is a organic molecular entity (CHEBI:50860) |
| dezamizumab (CHEBI:757396) is a organic molecular entity (CHEBI:50860) |
| df-1001 (CHEBI:759709) is a organic molecular entity (CHEBI:50860) |
| DFL23916 (CHEBI:235317) is a organic molecular entity (CHEBI:50860) |
| dfo-atezolizumab zr-89 (CHEBI:760501) is a organic molecular entity (CHEBI:50860) |
| dfp-13318 (CHEBI:758936) is a organic molecular entity (CHEBI:50860) |
| dfPreQ1 (CHEBI:190460) is a organic molecular entity (CHEBI:50860) |
| dfPreQ1 monophosphate (CHEBI:190462) is a organic molecular entity (CHEBI:50860) |
| DG (CHEBI:190453) is a organic molecular entity (CHEBI:50860) |
| DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) (CHEBI:230361) is a organic molecular entity (CHEBI:50860) |
| DG(14:0/PGF1alpha/0:0) (CHEBI:230428) is a organic molecular entity (CHEBI:50860) |
| DG(14:0/TXB2/0:0) (CHEBI:230423) is a organic molecular entity (CHEBI:50860) |
| DG(18:1(12Z)-2OH(9,10)/8:0/0:0) (CHEBI:230439) is a organic molecular entity (CHEBI:50860) |
| DG(2:0/18:1(12Z)-2OH(9,10)/0:0) (CHEBI:231144) is a organic molecular entity (CHEBI:50860) |
| DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/16:0/0:0) (CHEBI:230425) is a organic molecular entity (CHEBI:50860) |
| DG(8:0/18:1(12Z)-O(9S,10R)/0:0) (CHEBI:230435) is a organic molecular entity (CHEBI:50860) |
| dG+ (CHEBI:190142) is a organic molecular entity (CHEBI:50860) |
| dG+ monophosphate (CHEBI:190143) is a organic molecular entity (CHEBI:50860) |
| dhes-0815a (CHEBI:757364) is a organic molecular entity (CHEBI:50860) |
| Di-2,5-cyclohexadien-1-ylsilane (CHEBI:188835) is a organic molecular entity (CHEBI:50860) |
| di-leu16-il2 (CHEBI:758282) is a organic molecular entity (CHEBI:50860) |
| diacetylated monoglycerides (CHEBI:754061) is a organic molecular entity (CHEBI:50860) |
| Diacylglyceryl-N,N,N-trimethylhomoserine (CHEBI:81558) is a organic molecular entity (CHEBI:50860) |
| Diacylglycerylhomoserine (CHEBI:81557) is a organic molecular entity (CHEBI:50860) |
| Dialicor (CHEBI:31473) is a organic molecular entity (CHEBI:50860) |
| diaminopropylterephthalamide (CHEBI:747250) is a organic molecular entity (CHEBI:50860) |
| diammonium glycyrrhizinate (CHEBI:757193) is a organic molecular entity (CHEBI:50860) |
| dianexin (CHEBI:754995) is a organic molecular entity (CHEBI:50860) |
| diapep-277 (CHEBI:757365) is a organic molecular entity (CHEBI:50860) |
| diastase (CHEBI:753421) is a organic molecular entity (CHEBI:50860) |
| dibotatug (CHEBI:760027) is a organic molecular entity (CHEBI:50860) |
| dibotermin alfa (CHEBI:754062) is a organic molecular entity (CHEBI:50860) |
| dibutyryl-cAMP (CHEBI:197402) is a organic molecular entity (CHEBI:50860) |
| diclofenac etalhyaluronate (CHEBI:756737) is a organic molecular entity (CHEBI:50860) |
| diclofenac etalhyaluronate sodium (CHEBI:756738) is a organic molecular entity (CHEBI:50860) |
| dicobalt edetate (CHEBI:755930) is a organic molecular entity (CHEBI:50860) |
| Didecyldimethylammonium chloride (CHEBI:79935) is a organic molecular entity (CHEBI:50860) |
| Didemnin C (CHEBI:231128) is a organic molecular entity (CHEBI:50860) |
| diethyl 3,5,6-trichloropyridin-2-yl phosphate (CHEBI:747840) is a organic molecular entity (CHEBI:50860) |
| diethylene glycol stearates (CHEBI:753544) is a organic molecular entity (CHEBI:50860) |
| difluorodiphenyltrichloroethane (CHEBI:233159) is a organic molecular entity (CHEBI:50860) |
| difopein (CHEBI:194558) is a organic molecular entity (CHEBI:50860) |
| digadoglucitol (CHEBI:759516) is a organic molecular entity (CHEBI:50860) |
| digalloyl trioleate (CHEBI:753422) is a organic molecular entity (CHEBI:50860) |
| digitalis (CHEBI:754063) is a organic molecular entity (CHEBI:50860) |
| dihydromyrcene (CHEBI:232106) is a organic molecular entity (CHEBI:50860) |
| dihydrovittatine Trifluoroacetic acid (CHEBI:68304) is a organic molecular entity (CHEBI:50860) |
| Dihydroxyaluminum (CHEBI:81047) is a organic molecular entity (CHEBI:50860) |
| dihydrozeatin-7-n-glucoside (CHEBI:230786) is a organic molecular entity (CHEBI:50860) |
| dilanubicel (CHEBI:756745) is a organic molecular entity (CHEBI:50860) |
| dilpacimab (CHEBI:757806) is a organic molecular entity (CHEBI:50860) |
| dimefilcon a (CHEBI:754010) is a organic molecular entity (CHEBI:50860) |
| Dimefline hydrochloride (CHEBI:31495) is a organic molecular entity (CHEBI:50860) |
| dimefocon a (CHEBI:754011) is a organic molecular entity (CHEBI:50860) |
| Dimetacrine tartrate (CHEBI:31497) is a organic molecular entity (CHEBI:50860) |
| dimethicone (CHEBI:753206) is a organic molecular entity (CHEBI:50860) |
| dimethicone 350 (CHEBI:753203) is a organic molecular entity (CHEBI:50860) |
| dimethyl cyclohexanedicarboxylate (CHEBI:747241) is a organic molecular entity (CHEBI:50860) |
| dimethyl phosphite (CHEBI:230736) is a organic molecular entity (CHEBI:50860) |
| dimethyl-hexadecanoic acid (CHEBI:136923) is a organic molecular entity (CHEBI:50860) |
| dimethylcurcumin (CHEBI:233431) is a organic molecular entity (CHEBI:50860) |
| dimetilan (CHEBI:233357) is a organic molecular entity (CHEBI:50860) |
| dimpropyridaz (CHEBI:233329) is a organic molecular entity (CHEBI:50860) |
| dimyristoyl lecithin (CHEBI:749486) is a organic molecular entity (CHEBI:50860) |
| dinapinone A (CHEBI:145923) is a organic molecular entity (CHEBI:50860) |
| Dinheic acid (CHEBI:195343) is a organic molecular entity (CHEBI:50860) |
| Dinoprost tromethamine (CHEBI:31502) is a organic molecular entity (CHEBI:50860) |
| dinutuximab (CHEBI:755169) is a organic molecular entity (CHEBI:50860) |
| dinutuximab beta (CHEBI:759751) is a organic molecular entity (CHEBI:50860) |
| diohippuric acid i 125 (CHEBI:756675) is a organic molecular entity (CHEBI:50860) |
| diohippuric acid i 131 (CHEBI:756688) is a organic molecular entity (CHEBI:50860) |
| Diosgenin glycoside (CHEBI:81096) is a organic molecular entity (CHEBI:50860) |
| diosquinone (CHEBI:232378) is a organic molecular entity (CHEBI:50860) |
| dioxyline phosphate (CHEBI:753862) is a organic molecular entity (CHEBI:50860) |
| Dipeptide (Xaa-Pro) (CHEBI:4635) is a organic molecular entity (CHEBI:50860) |
| diphenyl diselenide (CHEBI:232541) is a organic molecular entity (CHEBI:50860) |
| diphenylpyraline teoclate (CHEBI:31509) is a organic molecular entity (CHEBI:50860) |
| diphtheria antitoxin (CHEBI:753390) is a organic molecular entity (CHEBI:50860) |
| diphtheria toxin for schick test (CHEBI:754012) is a organic molecular entity (CHEBI:50860) |
| diphtheria toxoid (CHEBI:754013) is a organic molecular entity (CHEBI:50860) |
| diphtheria toxoid adsorbed (CHEBI:754014) is a organic molecular entity (CHEBI:50860) |
| diridavumab (CHEBI:755176) is a organic molecular entity (CHEBI:50860) |
| dirloctocogene samoparvovec (CHEBI:758159) is a organic molecular entity (CHEBI:50860) |
| discoidol (CHEBI:192996) is a organic molecular entity (CHEBI:50860) |
| disialyl-Lewis A antigen (CHEBI:140915) is a organic molecular entity (CHEBI:50860) |
| disitamab (CHEBI:760396) is a organic molecular entity (CHEBI:50860) |
| disitamab vedotin (CHEBI:758849) is a organic molecular entity (CHEBI:50860) |
| disitertide (CHEBI:753326) is a organic molecular entity (CHEBI:50860) |
| Disodium 2-hydroxypentanedioate (CHEBI:228282) is a organic molecular entity (CHEBI:50860) |
| Disodium;[(3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate (CHEBI:228281) is a organic molecular entity (CHEBI:50860) |
| Disperse Black 9 (CHEBI:232794) is a organic molecular entity (CHEBI:50860) |
| DISTAMYCIN A (CHEBI:41958) is a organic molecular entity (CHEBI:50860) |
| Disufenton sodium (CHEBI:233414) is a organic molecular entity (CHEBI:50860) |
| divozilimab (CHEBI:759671) is a organic molecular entity (CHEBI:50860) |
| dkn-01 (CHEBI:757037) is a organic molecular entity (CHEBI:50860) |
| dl-alpha-Tocopheryl sodium phosphate (CHEBI:81288) is a organic molecular entity (CHEBI:50860) |
| DL-epinastine hydrochloride (CHEBI:31533) is a organic molecular entity (CHEBI:50860) |
| dl-Methylephedrine hydrochloride (CHEBI:79398) is a organic molecular entity (CHEBI:50860) |
| dmPreQ1 (CHEBI:190457) is a organic molecular entity (CHEBI:50860) |
| dmPreQ1 monophosphate (CHEBI:190458) is a organic molecular entity (CHEBI:50860) |
| dmuc-4064a (CHEBI:757368) is a organic molecular entity (CHEBI:50860) |
| DNA 3'-a,b-unsaturated aldehyde (CHEBI:137036) is a organic molecular entity (CHEBI:50860) |
| DNA 5'-phosphate (CHEBI:4294) is a organic molecular entity (CHEBI:50860) |
| DNA 8-oxoguanine (CHEBI:137052) is a organic molecular entity (CHEBI:50860) |
| DNA with 3-terminal trans-a,b-unsaturated sugar (CHEBI:137051) is a organic molecular entity (CHEBI:50860) |
| DNA without the base (CHEBI:137219) is a organic molecular entity (CHEBI:50860) |
| Docarpamine (CHEBI:31513) is a organic molecular entity (CHEBI:50860) |
| dociparstat sodium (CHEBI:756488) is a organic molecular entity (CHEBI:50860) |
| docosenoate (CHEBI:78076) is a organic molecular entity (CHEBI:50860) |
| domagrozumab (CHEBI:755407) is a organic molecular entity (CHEBI:50860) |
| domvanalimab (CHEBI:758283) is a organic molecular entity (CHEBI:50860) |
| donanemab (CHEBI:756751) is a organic molecular entity (CHEBI:50860) |
| donaperminogene seltoplasmid (CHEBI:756523) is a organic molecular entity (CHEBI:50860) |
| donidalorsen (CHEBI:758141) is a organic molecular entity (CHEBI:50860) |
| donidalorsen sodium (CHEBI:758142) is a organic molecular entity (CHEBI:50860) |
| donislecel (CHEBI:757830) is a organic molecular entity (CHEBI:50860) |
| donitabart (CHEBI:760028) is a organic molecular entity (CHEBI:50860) |
| donzakimig (CHEBI:759517) is a organic molecular entity (CHEBI:50860) |
| dopaminochenodeoxycholic acid (CHEBI:232202) is a organic molecular entity (CHEBI:50860) |
| dopaminocholic acid (CHEBI:232257) is a organic molecular entity (CHEBI:50860) |
| doreptide (CHEBI:754015) is a organic molecular entity (CHEBI:50860) |
| dorgenmeltucel-l (CHEBI:755257) is a organic molecular entity (CHEBI:50860) |
| dorlimomab aritox (CHEBI:754016) is a organic molecular entity (CHEBI:50860) |
| dornase alfa (CHEBI:749545) is a organic molecular entity (CHEBI:50860) |
| dorocubicel (CHEBI:759518) is a organic molecular entity (CHEBI:50860) |
| doruxapapogene ralaplasmid (CHEBI:760379) is a organic molecular entity (CHEBI:50860) |
| dostarlimab (CHEBI:757538) is a organic molecular entity (CHEBI:50860) |
| dotamtate (CHEBI:757629) is a organic molecular entity (CHEBI:50860) |
| dotamtate pb-212 (CHEBI:756841) is a organic molecular entity (CHEBI:50860) |
| dotmp sm-153 (CHEBI:758467) is a organic molecular entity (CHEBI:50860) |
| dotriacontahexaenoate (CHEBI:78083) is a organic molecular entity (CHEBI:50860) |
| dotriacontatetraenoate (CHEBI:78081) is a organic molecular entity (CHEBI:50860) |
| Doxylamine succinate (CHEBI:82461) is a organic molecular entity (CHEBI:50860) |
| DPLA (CHEBI:77067) is a organic molecular entity (CHEBI:50860) |
| dPreQ0 (CHEBI:190144) is a organic molecular entity (CHEBI:50860) |
| dPreQ0 monophosphate (CHEBI:190445) is a organic molecular entity (CHEBI:50860) |
| dpreQ1 (CHEBI:190449) is a organic molecular entity (CHEBI:50860) |
| dPreQ1 monophosphate (CHEBI:190450) is a organic molecular entity (CHEBI:50860) |
| DPTIP (CHEBI:747374) is a organic molecular entity (CHEBI:50860) |
| Dpvdavp (CHEBI:230095) is a organic molecular entity (CHEBI:50860) |
| drf-10945 (CHEBI:755616) is a organic molecular entity (CHEBI:50860) |
| Drimenyl diphosphate (CHEBI:228356) is a organic molecular entity (CHEBI:50860) |
| drisapersen (CHEBI:753672) is a organic molecular entity (CHEBI:50860) |
| drisapersen sodium (CHEBI:753673) is a organic molecular entity (CHEBI:50860) |
| drotokibart (CHEBI:760150) is a organic molecular entity (CHEBI:50860) |
| drotrecogin alfa (activated) (CHEBI:753962) is a organic molecular entity (CHEBI:50860) |
| droxifilcon a (CHEBI:753963) is a organic molecular entity (CHEBI:50860) |
| drozitumab (CHEBI:750087) is a organic molecular entity (CHEBI:50860) |
| dry distillation tar of defatting soybean (CHEBI:753948) is a organic molecular entity (CHEBI:50860) |
| ds-2325a (CHEBI:758850) is a organic molecular entity (CHEBI:50860) |
| ds-3078a (CHEBI:755392) is a organic molecular entity (CHEBI:50860) |
| ds-7423 (CHEBI:755538) is a organic molecular entity (CHEBI:50860) |
| ds-8273a (CHEBI:757851) is a organic molecular entity (CHEBI:50860) |
| dsta-4637s (CHEBI:757372) is a organic molecular entity (CHEBI:50860) |
| dTAG-13 (CHEBI:234353) is a organic molecular entity (CHEBI:50860) |
| DTAGv-1 (CHEBI:233323) is a organic molecular entity (CHEBI:50860) |
| dTDP-6-deoxy-β-L-talose(2−) (CHEBI:68576) is a organic molecular entity (CHEBI:50860) |
| Dulaglutide (CHEBI:83033) is a organic molecular entity (CHEBI:50860) |
| dulanermin (CHEBI:752893) is a organic molecular entity (CHEBI:50860) |
| duligotuzumab (CHEBI:755171) is a organic molecular entity (CHEBI:50860) |
| dumorelin (CHEBI:753351) is a organic molecular entity (CHEBI:50860) |
| dupilumab (CHEBI:753623) is a organic molecular entity (CHEBI:50860) |
| Duplicate chrysazin (CHEBI:68799) is a organic molecular entity (CHEBI:50860) |
| Duplicate chrysophanol (CHEBI:68782) is a organic molecular entity (CHEBI:50860) |
| Duplicate eugenitin (CHEBI:68812) is a organic molecular entity (CHEBI:50860) |
| Duplicate orcinol (CHEBI:68796) is a organic molecular entity (CHEBI:50860) |
| Duplicate orsellinic acid (CHEBI:68795) is a organic molecular entity (CHEBI:50860) |
| Duplicate sterigmatocystin (CHEBI:68810) is a organic molecular entity (CHEBI:50860) |
| durcabtagene autoleucel (CHEBI:759427) is a organic molecular entity (CHEBI:50860) |
| durvalumab (CHEBI:755270) is a organic molecular entity (CHEBI:50860) |
| dusigitumab (CHEBI:754180) is a organic molecular entity (CHEBI:50860) |
| dusting powder, absorbable (CHEBI:753949) is a organic molecular entity (CHEBI:50860) |
| duteplase (CHEBI:753352) is a organic molecular entity (CHEBI:50860) |
| duvakitug (CHEBI:759428) is a organic molecular entity (CHEBI:50860) |
| duvalgagene otiparvovec (CHEBI:760029) is a organic molecular entity (CHEBI:50860) |
| duvortuxizumab (CHEBI:756517) is a organic molecular entity (CHEBI:50860) |
| dv-281 (CHEBI:758012) is a organic molecular entity (CHEBI:50860) |
| dvx-201 (CHEBI:758902) is a organic molecular entity (CHEBI:50860) |
| Dyerbergeic acid (CHEBI:197319) is a organic molecular entity (CHEBI:50860) |
| Dynorphin B (CHEBI:80347) is a organic molecular entity (CHEBI:50860) |
| e-3179 (CHEBI:230590) is a organic molecular entity (CHEBI:50860) |
| e-7974 (CHEBI:758347) is a organic molecular entity (CHEBI:50860) |
| E-Halidrysone A (CHEBI:144085) is a organic molecular entity (CHEBI:50860) |
| E-Isohalidrysone A (CHEBI:144083) is a organic molecular entity (CHEBI:50860) |
| e2.3 (CHEBI:754278) is a organic molecular entity (CHEBI:50860) |
| EB1002 (CHEBI:233646) is a organic molecular entity (CHEBI:50860) |
| Ebastine (CHEBI:31528) is a organic molecular entity (CHEBI:50860) |
| ebdarokimab (CHEBI:758323) is a organic molecular entity (CHEBI:50860) |
| ebrasodebart (CHEBI:760030) is a organic molecular entity (CHEBI:50860) |
| ebribafusp alfa (CHEBI:760031) is a organic molecular entity (CHEBI:50860) |
| ecallantide (CHEBI:749611) is a organic molecular entity (CHEBI:50860) |
| echinacea angustifolia (CHEBI:753950) is a organic molecular entity (CHEBI:50860) |
| echinacea angustifolia, powdered (CHEBI:753951) is a organic molecular entity (CHEBI:50860) |
| echinacea pallida (CHEBI:753353) is a organic molecular entity (CHEBI:50860) |
| echinacea pallida, powdered (CHEBI:753952) is a organic molecular entity (CHEBI:50860) |
| echinacea purpurea root (CHEBI:753354) is a organic molecular entity (CHEBI:50860) |
| echinacea purpurea, powdered (CHEBI:753953) is a organic molecular entity (CHEBI:50860) |
| echinacea, unspecified (CHEBI:757374) is a organic molecular entity (CHEBI:50860) |
| eciskafusp alfa (CHEBI:759672) is a organic molecular entity (CHEBI:50860) |
| eclutatug (CHEBI:760151) is a organic molecular entity (CHEBI:50860) |
| ecnoglutide (CHEBI:758698) is a organic molecular entity (CHEBI:50860) |
| ECO 02301 (CHEBI:80047) is a organic molecular entity (CHEBI:50860) |
| ecogramostim (CHEBI:753159) is a organic molecular entity (CHEBI:50860) |
| ecromeximab (CHEBI:753954) is a organic molecular entity (CHEBI:50860) |
| eculizumab (CHEBI:749604) is a organic molecular entity (CHEBI:50860) |
| edaravone sulfate(1-) (CHEBI:746959) is a organic molecular entity (CHEBI:50860) |
| ederimotide (CHEBI:759429) is a organic molecular entity (CHEBI:50860) |
| edi-200 (CHEBI:757375) is a organic molecular entity (CHEBI:50860) |
| edifoligide (CHEBI:753304) is a organic molecular entity (CHEBI:50860) |
| edifoligide sodium (CHEBI:753955) is a organic molecular entity (CHEBI:50860) |
| edobacomab (CHEBI:753355) is a organic molecular entity (CHEBI:50860) |
| edodekin alfa (CHEBI:753956) is a organic molecular entity (CHEBI:50860) |
| edotreotide gallium ga-68 (CHEBI:756835) is a organic molecular entity (CHEBI:50860) |
| edotreotide yttrium (CHEBI:748708) is a organic molecular entity (CHEBI:50860) |
| edotreotide yttrium y-90 (CHEBI:756837) is a organic molecular entity (CHEBI:50860) |
| edrecolomab (CHEBI:753866) is a organic molecular entity (CHEBI:50860) |
| efalizumab (CHEBI:749493) is a organic molecular entity (CHEBI:50860) |
| efanesoctocog alfa (CHEBI:758851) is a organic molecular entity (CHEBI:50860) |
| efarindodekin alfa (CHEBI:760152) is a organic molecular entity (CHEBI:50860) |
| efavaleukin alfa (CHEBI:757611) is a organic molecular entity (CHEBI:50860) |
| efbalropendekin alfa (CHEBI:759430) is a organic molecular entity (CHEBI:50860) |
| efbemalenograstim alfa (CHEBI:757380) is a organic molecular entity (CHEBI:50860) |
| efdelikofusp alfa (CHEBI:760153) is a organic molecular entity (CHEBI:50860) |
| efdoralprin alfa (CHEBI:760154) is a organic molecular entity (CHEBI:50860) |
| efepoetin alfa (CHEBI:757951) is a organic molecular entity (CHEBI:50860) |
| efercoleukin alfa (CHEBI:759519) is a organic molecular entity (CHEBI:50860) |
| Effector protein (CHEBI:192507) is a organic molecular entity (CHEBI:50860) |
| efgartigimod alfa (CHEBI:757026) is a organic molecular entity (CHEBI:50860) |
| efgitasialase alfa (CHEBI:760155) is a organic molecular entity (CHEBI:50860) |
| efgivanermin alfa (CHEBI:757454) is a organic molecular entity (CHEBI:50860) |
| efimosfermin alfa (CHEBI:760032) is a organic molecular entity (CHEBI:50860) |
| efineptakin alfa (CHEBI:758062) is a organic molecular entity (CHEBI:50860) |
| efinopegdutide (CHEBI:757051) is a organic molecular entity (CHEBI:50860) |
| efizonerimod alfa (CHEBI:756511) is a organic molecular entity (CHEBI:50860) |
| eflapegrastim (CHEBI:755956) is a organic molecular entity (CHEBI:50860) |
| eflepedocokin alfa (CHEBI:758015) is a organic molecular entity (CHEBI:50860) |
| Efloxate (CHEBI:31531) is a organic molecular entity (CHEBI:50860) |
| efmarodocokin alfa (CHEBI:758156) is a organic molecular entity (CHEBI:50860) |
| efmedaglutide alfa (CHEBI:760156) is a organic molecular entity (CHEBI:50860) |
| efmitermant alfa (CHEBI:757307) is a organic molecular entity (CHEBI:50860) |
| efmoroctocog alfa (CHEBI:757376) is a organic molecular entity (CHEBI:50860) |
| efocipegtrutide (CHEBI:758732) is a organic molecular entity (CHEBI:50860) |
| efparepoetin alfa (CHEBI:760033) is a organic molecular entity (CHEBI:50860) |
| efpegerglucagon (CHEBI:759520) is a organic molecular entity (CHEBI:50860) |
| efpeglenatide (CHEBI:758352) is a organic molecular entity (CHEBI:50860) |
| efrofilcon a (CHEBI:758633) is a organic molecular entity (CHEBI:50860) |
| efruxifermin (CHEBI:757878) is a organic molecular entity (CHEBI:50860) |
| efsubaglutide alfa (CHEBI:760157) is a organic molecular entity (CHEBI:50860) |
| efsudenermin alfa (CHEBI:760158) is a organic molecular entity (CHEBI:50860) |
| eftilagimod alfa (CHEBI:758030) is a organic molecular entity (CHEBI:50860) |
| eftozanermin alfa (CHEBI:757821) is a organic molecular entity (CHEBI:50860) |
| eftrenonacog alfa (CHEBI:758070) is a organic molecular entity (CHEBI:50860) |
| efungumab (CHEBI:750088) is a organic molecular entity (CHEBI:50860) |
| efzilonkofusp alfa (CHEBI:760159) is a organic molecular entity (CHEBI:50860) |
| efzimfotase alfa (CHEBI:759431) is a organic molecular entity (CHEBI:50860) |
| egaptivon pegol (CHEBI:753319) is a organic molecular entity (CHEBI:50860) |
| eglatoprutug (CHEBI:759366) is a organic molecular entity (CHEBI:50860) |
| EHop-016 (CHEBI:232966) is a organic molecular entity (CHEBI:50860) |
| eIF4A3-IN-2 (CHEBI:747632) is a organic molecular entity (CHEBI:50860) |
| eladocagene exuparvovec (CHEBI:757596) is a organic molecular entity (CHEBI:50860) |
| elapegademase (CHEBI:756508) is a organic molecular entity (CHEBI:50860) |
| elapomestrocel (CHEBI:758699) is a organic molecular entity (CHEBI:50860) |
| elarekibep (CHEBI:758938) is a organic molecular entity (CHEBI:50860) |
| elasomeran (CHEBI:758372) is a organic molecular entity (CHEBI:50860) |
| elastase (CHEBI:753415) is a organic molecular entity (CHEBI:50860) |
| Elastin (CHEBI:4767) is a organic molecular entity (CHEBI:50860) |
| elastofilcon a (CHEBI:753981) is a organic molecular entity (CHEBI:50860) |
| eldelumab (CHEBI:754387) is a organic molecular entity (CHEBI:50860) |
| eldexomer (CHEBI:753196) is a organic molecular entity (CHEBI:50860) |
| eldocasiran (CHEBI:759367) is a organic molecular entity (CHEBI:50860) |
| elebsiran (CHEBI:759732) is a organic molecular entity (CHEBI:50860) |
| elemental carbon (CHEBI:33415) is a organic molecular entity (CHEBI:50860) |
| eleuthero (CHEBI:753201) is a organic molecular entity (CHEBI:50860) |
| eleuthero, powdered (CHEBI:753860) is a organic molecular entity (CHEBI:50860) |
| Elexacaftor (CHEBI:234518) is a organic molecular entity (CHEBI:50860) |
| elezanumab (CHEBI:757194) is a organic molecular entity (CHEBI:50860) |
| elgemtumab (CHEBI:757438) is a organic molecular entity (CHEBI:50860) |
| elivaldogene autotemcel (CHEBI:757831) is a organic molecular entity (CHEBI:50860) |
| elivaldogene tavalentivec (CHEBI:756526) is a organic molecular entity (CHEBI:50860) |
| elm (CHEBI:753373) is a organic molecular entity (CHEBI:50860) |
| eloralintide (CHEBI:760373) is a organic molecular entity (CHEBI:50860) |
| elosulfase alfa (CHEBI:753624) is a organic molecular entity (CHEBI:50860) |
| elotuzumab (CHEBI:750089) is a organic molecular entity (CHEBI:50860) |
| elranatamab (CHEBI:757254) is a organic molecular entity (CHEBI:50860) |
| elritercept (CHEBI:759432) is a organic molecular entity (CHEBI:50860) |
| elsiglutide (CHEBI:753305) is a organic molecular entity (CHEBI:50860) |
| elsilimomab (CHEBI:753545) is a organic molecular entity (CHEBI:50860) |
| elsunersen (CHEBI:760034) is a organic molecular entity (CHEBI:50860) |
| eltivutabart (CHEBI:760160) is a organic molecular entity (CHEBI:50860) |
| eltrapuldencel-t (CHEBI:755378) is a organic molecular entity (CHEBI:50860) |
| eltrekibart (CHEBI:759325) is a organic molecular entity (CHEBI:50860) |
| eltrombopag olamine (CHEBI:234330) is a organic molecular entity (CHEBI:50860) |
| eluforsen (CHEBI:758060) is a organic molecular entity (CHEBI:50860) |
| eluvixtamab (CHEBI:757995) is a organic molecular entity (CHEBI:50860) |
| elx-02 (CHEBI:757195) is a organic molecular entity (CHEBI:50860) |
| elzocabtagene autoleucel (CHEBI:760035) is a organic molecular entity (CHEBI:50860) |
| emactuzumab (CHEBI:755600) is a organic molecular entity (CHEBI:50860) |
| emapalumab (CHEBI:756460) is a organic molecular entity (CHEBI:50860) |
| Emapunil (CHEBI:232500) is a organic molecular entity (CHEBI:50860) |
| emd-1201081 (CHEBI:757420) is a organic molecular entity (CHEBI:50860) |
| emd-273063 (CHEBI:754218) is a organic molecular entity (CHEBI:50860) |
| emepronium carrageenate (CHEBI:753982) is a organic molecular entity (CHEBI:50860) |
| emerfetamab (CHEBI:758571) is a organic molecular entity (CHEBI:50860) |
| emfilermin (CHEBI:753374) is a organic molecular entity (CHEBI:50860) |
| emfizatamab (CHEBI:758700) is a organic molecular entity (CHEBI:50860) |
| emi-137 (CHEBI:757196) is a organic molecular entity (CHEBI:50860) |
| emibetuzumab (CHEBI:755262) is a organic molecular entity (CHEBI:50860) |
| emicizumab (CHEBI:755960) is a organic molecular entity (CHEBI:50860) |
| emiglitate (CHEBI:230574) is a organic molecular entity (CHEBI:50860) |
| emilimogene sigulactibac (CHEBI:758701) is a organic molecular entity (CHEBI:50860) |
| emiltatug (CHEBI:760036) is a organic molecular entity (CHEBI:50860) |
| emiltatug ledadotin (CHEBI:760037) is a organic molecular entity (CHEBI:50860) |
| emiplacel (CHEBI:756749) is a organic molecular entity (CHEBI:50860) |
| emirodatamab (CHEBI:757319) is a organic molecular entity (CHEBI:50860) |
| emoctakin (CHEBI:753983) is a organic molecular entity (CHEBI:50860) |
| Emorfazone (CHEBI:31535) is a organic molecular entity (CHEBI:50860) |
| empasiprubart (CHEBI:759368) is a organic molecular entity (CHEBI:50860) |
| empegfilgrastim (CHEBI:759999) is a organic molecular entity (CHEBI:50860) |
| emugrobart (CHEBI:760161) is a organic molecular entity (CHEBI:50860) |
| emunkitug (CHEBI:760162) is a organic molecular entity (CHEBI:50860) |
| EN460 (CHEBI:234114) is a organic molecular entity (CHEBI:50860) |
| enadenotucirev (CHEBI:757197) is a organic molecular entity (CHEBI:50860) |
| enalaprilat zwitterion(1-) (CHEBI:746985) is a organic molecular entity (CHEBI:50860) |
| enapotamab vedotin (CHEBI:757414) is a organic molecular entity (CHEBI:50860) |
| enavatuzumab (CHEBI:750090) is a organic molecular entity (CHEBI:50860) |
| enavermotide (CHEBI:759521) is a organic molecular entity (CHEBI:50860) |
| encoberminogene rezmadenovec (CHEBI:759020) is a organic molecular entity (CHEBI:50860) |
| endo-BCN-L-Lysine (CHEBI:233067) is a organic molecular entity (CHEBI:50860) |
| Endokinin A/B (CHEBI:80313) is a organic molecular entity (CHEBI:50860) |
| Endokinin C (CHEBI:80314) is a organic molecular entity (CHEBI:50860) |
| Endokinin D (CHEBI:80315) is a organic molecular entity (CHEBI:50860) |
| Endomorphin-1 (CHEBI:80156) is a organic molecular entity (CHEBI:50860) |
| Endomorphin-2 (CHEBI:80157) is a organic molecular entity (CHEBI:50860) |
| endomycin (CHEBI:753984) is a organic molecular entity (CHEBI:50860) |
| endosidin 2 (CHEBI:233265) is a organic molecular entity (CHEBI:50860) |
| endostatin (CHEBI:757198) is a organic molecular entity (CHEBI:50860) |
| endostatin, n-terminal-mggshhhhh (CHEBI:757377) is a organic molecular entity (CHEBI:50860) |
| Endothal-disodium (CHEBI:81916) is a organic molecular entity (CHEBI:50860) |
| Endothelin-1 (CHEBI:80240) is a organic molecular entity (CHEBI:50860) |
| Endothelin-2 (CHEBI:80242) is a organic molecular entity (CHEBI:50860) |
| Endothelin-3 (CHEBI:80243) is a organic molecular entity (CHEBI:50860) |
| eneboparatide (CHEBI:758884) is a organic molecular entity (CHEBI:50860) |
| enekinragene inzadenovec (CHEBI:758903) is a organic molecular entity (CHEBI:50860) |
| enfilcon a (CHEBI:753045) is a organic molecular entity (CHEBI:50860) |
| enfortumab (CHEBI:755263) is a organic molecular entity (CHEBI:50860) |
| enfortumab vedotin (CHEBI:755272) is a organic molecular entity (CHEBI:50860) |
| engabexagene cincesparvovec (CHEBI:758702) is a organic molecular entity (CHEBI:50860) |
| englumafusp alfa (CHEBI:758944) is a organic molecular entity (CHEBI:50860) |
| enibarcimab (CHEBI:758320) is a organic molecular entity (CHEBI:50860) |
| enistimagene setitucel (CHEBI:756515) is a organic molecular entity (CHEBI:50860) |
| enlicovatein (CHEBI:759487) is a organic molecular entity (CHEBI:50860) |
| enlimomab (CHEBI:753985) is a organic molecular entity (CHEBI:50860) |
| enlimomab pegol (CHEBI:753375) is a organic molecular entity (CHEBI:50860) |
| enlonstobart (CHEBI:759728) is a organic molecular entity (CHEBI:50860) |
| enoblituzumab (CHEBI:755603) is a organic molecular entity (CHEBI:50860) |
| Enocitabine (CHEBI:31537) is a organic molecular entity (CHEBI:50860) |
| enokizumab (CHEBI:750091) is a organic molecular entity (CHEBI:50860) |
| enomimeran (CHEBI:759044) is a organic molecular entity (CHEBI:50860) |
| enoticumab (CHEBI:754201) is a organic molecular entity (CHEBI:50860) |
| enoxaparin sodium (CHEBI:749476) is a organic molecular entity (CHEBI:50860) |
| Enpiroline (CHEBI:232635) is a organic molecular entity (CHEBI:50860) |
| enramycin (CHEBI:753986) is a organic molecular entity (CHEBI:50860) |
| enristomig (CHEBI:759327) is a organic molecular entity (CHEBI:50860) |
| ensereptide (CHEBI:758939) is a organic molecular entity (CHEBI:50860) |
| ensituximab (CHEBI:750092) is a organic molecular entity (CHEBI:50860) |
| ensovibep (CHEBI:758491) is a organic molecular entity (CHEBI:50860) |
| entacingene turiparvovec (CHEBI:757841) is a organic molecular entity (CHEBI:50860) |
| Entecavir triphosphate (CHEBI:619285) is a organic molecular entity (CHEBI:50860) |
| entolimod (CHEBI:753631) is a organic molecular entity (CHEBI:50860) |
| envafolimab (CHEBI:757431) is a organic molecular entity (CHEBI:50860) |
| Envelope glycoprotein E2 (CHEBI:81640) is a organic molecular entity (CHEBI:50860) |
| envuretcel (CHEBI:759522) is a organic molecular entity (CHEBI:50860) |
| enzyme bound BLM intermediate (CHEBI:132419) is a organic molecular entity (CHEBI:50860) |
| enzyme bound TLM intermediate (CHEBI:132417) is a organic molecular entity (CHEBI:50860) |
| Enzyme bound ZBM intermediate (CHEBI:132421) is a organic molecular entity (CHEBI:50860) |
| Enzyme N6-(dihydrolipoyl)lysine (CHEBI:80219) is a organic molecular entity (CHEBI:50860) |
| Enzyme N6-(lipoyl)lysine (CHEBI:80218) is a organic molecular entity (CHEBI:50860) |
| eo-3021 (CHEBI:760484) is a organic molecular entity (CHEBI:50860) |
| epacmarstobart (CHEBI:758909) is a organic molecular entity (CHEBI:50860) |
| epafipase (CHEBI:753376) is a organic molecular entity (CHEBI:50860) |
| epcoritamab (CHEBI:758284) is a organic molecular entity (CHEBI:50860) |
| epetirimod (CHEBI:197374) is a organic molecular entity (CHEBI:50860) |
| epi-589 (CHEBI:757036) is a organic molecular entity (CHEBI:50860) |
| Epitalon (CHEBI:230091) is a organic molecular entity (CHEBI:50860) |
| Epitiostanol (CHEBI:31546) is a organic molecular entity (CHEBI:50860) |
| epitumomab (CHEBI:753377) is a organic molecular entity (CHEBI:50860) |
| epitumomab cituxetan (CHEBI:753546) is a organic molecular entity (CHEBI:50860) |
| epivittatine Trifluoroacetic acid (CHEBI:68311) is a organic molecular entity (CHEBI:50860) |
| eplontersen (CHEBI:757832) is a organic molecular entity (CHEBI:50860) |
| eplontersen sodium (CHEBI:757833) is a organic molecular entity (CHEBI:50860) |
| epoetin alfa (CHEBI:749425) is a organic molecular entity (CHEBI:50860) |
| epoetin beta (CHEBI:753987) is a organic molecular entity (CHEBI:50860) |
| epoetin delta (CHEBI:753988) is a organic molecular entity (CHEBI:50860) |
| epoetin epsilon (CHEBI:753022) is a organic molecular entity (CHEBI:50860) |
| epoetin gamma (CHEBI:753200) is a organic molecular entity (CHEBI:50860) |
| epoetin kappa (CHEBI:753270) is a organic molecular entity (CHEBI:50860) |
| epoetin omega (CHEBI:753865) is a organic molecular entity (CHEBI:50860) |
| epoetin theta (CHEBI:753281) is a organic molecular entity (CHEBI:50860) |
| epoetin zeta (CHEBI:753547) is a organic molecular entity (CHEBI:50860) |
| epofolate (CHEBI:757200) is a organic molecular entity (CHEBI:50860) |
| epoxybetaenone (CHEBI:145069) is a organic molecular entity (CHEBI:50860) |
| epratuzumab (CHEBI:753378) is a organic molecular entity (CHEBI:50860) |
| epratuzumab 90y (CHEBI:753335) is a organic molecular entity (CHEBI:50860) |
| epratuzumab-cys-tesirine (CHEBI:757311) is a organic molecular entity (CHEBI:50860) |
| epsametostat (CHEBI:760038) is a organic molecular entity (CHEBI:50860) |
| eptacog alfa (activated) (CHEBI:753315) is a organic molecular entity (CHEBI:50860) |
| eptacog alfa pegol (activated) (CHEBI:753283) is a organic molecular entity (CHEBI:50860) |
| eptacog beta (activated) (CHEBI:759761) is a organic molecular entity (CHEBI:50860) |
| eptinezumab (CHEBI:755917) is a organic molecular entity (CHEBI:50860) |
| eptotermin alfa (CHEBI:753548) is a organic molecular entity (CHEBI:50860) |
| EPZ015666 (CHEBI:197422) is a organic molecular entity (CHEBI:50860) |
| equecabtagene autoleucel (CHEBI:759369) is a organic molecular entity (CHEBI:50860) |
| equine umbilical cord mesenchymal stem cells (CHEBI:759791) is a organic molecular entity (CHEBI:50860) |
| ER 27319 maleate (CHEBI:231345) is a organic molecular entity (CHEBI:50860) |
| eras-801 (CHEBI:760485) is a organic molecular entity (CHEBI:50860) |
| Erdafitinib (CHEBI:232556) is a organic molecular entity (CHEBI:50860) |
| erenumab (CHEBI:755924) is a organic molecular entity (CHEBI:50860) |
| erepdekinra (CHEBI:759370) is a organic molecular entity (CHEBI:50860) |
| erfonrilimab (CHEBI:758365) is a organic molecular entity (CHEBI:50860) |
| ergoloid (CHEBI:230734) is a organic molecular entity (CHEBI:50860) |
| Ergotamine tartrate (CHEBI:4827) is a organic molecular entity (CHEBI:50860) |
| eriodictyon (CHEBI:753989) is a organic molecular entity (CHEBI:50860) |
| Erionite (CHEBI:82272) is a organic molecular entity (CHEBI:50860) |
| erlizumab (CHEBI:753990) is a organic molecular entity (CHEBI:50860) |
| ersodetug (CHEBI:759433) is a organic molecular entity (CHEBI:50860) |
| ersofermin (CHEBI:753205) is a organic molecular entity (CHEBI:50860) |
| ertumaxomab (CHEBI:753046) is a organic molecular entity (CHEBI:50860) |
| ery-974 (CHEBI:757378) is a organic molecular entity (CHEBI:50860) |
| erythrinin c (CHEBI:230767) is a organic molecular entity (CHEBI:50860) |
| Erythronic acid lactone (CHEBI:229488) is a organic molecular entity (CHEBI:50860) |
| erzotabart (CHEBI:759711) is a organic molecular entity (CHEBI:50860) |
| eschscholtzxanthone (CHEBI:230748) is a organic molecular entity (CHEBI:50860) |
| escin (CHEBI:757953) is a organic molecular entity (CHEBI:50860) |
| esepapogene zalarnarepvec (CHEBI:759371) is a organic molecular entity (CHEBI:50860) |
| Esmeraldin A (CHEBI:31557) is a organic molecular entity (CHEBI:50860) |
| esonadogene imvoparvovec (CHEBI:759434) is a organic molecular entity (CHEBI:50860) |
| Ester of phosphinic acid (CHEBI:4860) is a organic molecular entity (CHEBI:50860) |
| esterifilcon a (CHEBI:753826) is a organic molecular entity (CHEBI:50860) |
| estrogens, conjugated (CHEBI:749574) is a organic molecular entity (CHEBI:50860) |
| estrogens, conjugated synthetic a (CHEBI:749535) is a organic molecular entity (CHEBI:50860) |
| estrogens, esterified (CHEBI:749546) is a organic molecular entity (CHEBI:50860) |
| etafilcon a (CHEBI:753232) is a organic molecular entity (CHEBI:50860) |
| etakafusp alfa (CHEBI:760039) is a organic molecular entity (CHEBI:50860) |
| etalanetug (CHEBI:760363) is a organic molecular entity (CHEBI:50860) |
| etanercept (CHEBI:4875) is a organic molecular entity (CHEBI:50860) |
| etaracizumab (CHEBI:759087) is a organic molecular entity (CHEBI:50860) |
| etentamig (CHEBI:759663) is a organic molecular entity (CHEBI:50860) |
| eteplirsen (CHEBI:753271) is a organic molecular entity (CHEBI:50860) |
| etesevimab (CHEBI:758369) is a organic molecular entity (CHEBI:50860) |
| ethacrynate sodium (CHEBI:749259) is a organic molecular entity (CHEBI:50860) |
| ethenzamide (CHEBI:31564) is a organic molecular entity (CHEBI:50860) |
| ethiodized oil (CHEBI:749453) is a organic molecular entity (CHEBI:50860) |
| ethiodized oil i 131 (CHEBI:753827) is a organic molecular entity (CHEBI:50860) |
| ethyl 2-hydroxybutanoate (CHEBI:232871) is a organic molecular entity (CHEBI:50860) |
| ethyl 4-(3-oxo-2,3-dihydroisothiazol-2-yl)benzoate (CHEBI:195296) is a organic molecular entity (CHEBI:50860) |
| Ethyl 5-(furan-2-carboxamido)-3-methyl-4-thiocyanatothiophene-2-carboxylate (CHEBI:233366) is a organic molecular entity (CHEBI:50860) |
| ethyl 5r,6r-epoxy-7-eicosynoate (CHEBI:230769) is a organic molecular entity (CHEBI:50860) |
| Ethyl icosapentate (CHEBI:31570) is a organic molecular entity (CHEBI:50860) |
| Ethyl loflazepate (CHEBI:31573) is a organic molecular entity (CHEBI:50860) |
| Ethyl selenac (CHEBI:82466) is a organic molecular entity (CHEBI:50860) |
| Ethyl tellurac (CHEBI:82566) is a organic molecular entity (CHEBI:50860) |
| ethylcellulose (CHEBI:753117) is a organic molecular entity (CHEBI:50860) |
| Ethylendiamine dihydroiodide (CHEBI:81719) is a organic molecular entity (CHEBI:50860) |
| ethylene glycol stearates (CHEBI:753549) is a organic molecular entity (CHEBI:50860) |
| Ethylenebismaleimide (CHEBI:233215) is a organic molecular entity (CHEBI:50860) |
| ethylglyoxal (CHEBI:747042) is a organic molecular entity (CHEBI:50860) |
| etigilimab (CHEBI:757612) is a organic molecular entity (CHEBI:50860) |
| etimumotide (CHEBI:759435) is a organic molecular entity (CHEBI:50860) |
| etirinotecan pegol (CHEBI:755091) is a organic molecular entity (CHEBI:50860) |
| etirinotecan pegol tetrahydrochloride (CHEBI:755092) is a organic molecular entity (CHEBI:50860) |
| etirinotecan pegol tetratriflutate (CHEBI:755096) is a organic molecular entity (CHEBI:50860) |
| etivelcabtagene erigedleucel (CHEBI:760163) is a organic molecular entity (CHEBI:50860) |
| Etizolam (CHEBI:31583) is a organic molecular entity (CHEBI:50860) |
| etokimab (CHEBI:757055) is a organic molecular entity (CHEBI:50860) |
| Etomidoline (CHEBI:31584) is a organic molecular entity (CHEBI:50860) |
| etomoxir (CHEBI:232547) is a organic molecular entity (CHEBI:50860) |
| etranacogene dezaparvovec (CHEBI:759012) is a organic molecular entity (CHEBI:50860) |
| etrolizumab (CHEBI:750093) is a organic molecular entity (CHEBI:50860) |
| eucalyptin (CHEBI:230595) is a organic molecular entity (CHEBI:50860) |
| eucalyptus oil (CHEBI:753379) is a organic molecular entity (CHEBI:50860) |
| eufauserase (CHEBI:753991) is a organic molecular entity (CHEBI:50860) |
| euphausia extract (CHEBI:753992) is a organic molecular entity (CHEBI:50860) |
| eurestobart (CHEBI:759436) is a organic molecular entity (CHEBI:50860) |
| evabotulinumtoxina (CHEBI:753674) is a organic molecular entity (CHEBI:50860) |
| Evadol hydrochloride (CHEBI:79862) is a organic molecular entity (CHEBI:50860) |
| evalstotug (CHEBI:759523) is a organic molecular entity (CHEBI:50860) |
| evazarsen (CHEBI:759017) is a organic molecular entity (CHEBI:50860) |
| evazarsen sodium (CHEBI:759018) is a organic molecular entity (CHEBI:50860) |
| evencaleucel (CHEBI:758703) is a organic molecular entity (CHEBI:50860) |
| evexomostat (CHEBI:758528) is a organic molecular entity (CHEBI:50860) |
| evinacumab (CHEBI:755506) is a organic molecular entity (CHEBI:50860) |
| evolocumab (CHEBI:755001) is a organic molecular entity (CHEBI:50860) |
| evorpacept (CHEBI:757318) is a organic molecular entity (CHEBI:50860) |
| evruleucel (CHEBI:759319) is a organic molecular entity (CHEBI:50860) |
| evt401 (CHEBI:755848) is a organic molecular entity (CHEBI:50860) |
| evunzekibart (CHEBI:758881) is a organic molecular entity (CHEBI:50860) |
| ex vivo expanded autologous human corneal epithelial cells containing stem cells (CHEBI:759780) is a organic molecular entity (CHEBI:50860) |
| exagamglogene autotemcel (CHEBI:759035) is a organic molecular entity (CHEBI:50860) |
| exatecan alideximer (CHEBI:753295) is a organic molecular entity (CHEBI:50860) |
| exbivirumab (CHEBI:753047) is a organic molecular entity (CHEBI:50860) |
| exebacase (CHEBI:757359) is a organic molecular entity (CHEBI:50860) |
| Exendin-2 (CHEBI:80356) is a organic molecular entity (CHEBI:50860) |
| exlinkibart (CHEBI:759372) is a organic molecular entity (CHEBI:50860) |
| exo-BCN-L-Lysine (CHEBI:233066) is a organic molecular entity (CHEBI:50860) |
| ezabenlimab (CHEBI:758492) is a organic molecular entity (CHEBI:50860) |
| ezaladcigene resoparvovec (CHEBI:758148) is a organic molecular entity (CHEBI:50860) |
| F-14512 (CHEBI:232860) is a organic molecular entity (CHEBI:50860) |
| f105 (CHEBI:754235) is a organic molecular entity (CHEBI:50860) |
| f16il2 (CHEBI:754340) is a organic molecular entity (CHEBI:50860) |
| f16sip 131i (CHEBI:754341) is a organic molecular entity (CHEBI:50860) |
| f19 131i (CHEBI:754378) is a organic molecular entity (CHEBI:50860) |
| F420(ox.) (CHEBI:141634) is a organic molecular entity (CHEBI:50860) |
| F420(red.) (CHEBI:141635) is a organic molecular entity (CHEBI:50860) |
| factor ix complex (CHEBI:753993) is a organic molecular entity (CHEBI:50860) |
| factor viii fraction (CHEBI:753994) is a organic molecular entity (CHEBI:50860) |
| Factor X (CHEBI:4964) is a organic molecular entity (CHEBI:50860) |
| FAHFA anion (CHEBI:197342) is a organic molecular entity (CHEBI:50860) |
| falbikitug (CHEBI:759700) is a organic molecular entity (CHEBI:50860) |
| falcarindiol (CHEBI:69236) is a organic molecular entity (CHEBI:50860) |
| Falecalcitriol (CHEBI:31590) is a organic molecular entity (CHEBI:50860) |
| falimarev (cea, muc-1, fowlpox virus) (CHEBI:753550) is a organic molecular entity (CHEBI:50860) |
| famzeretcel (CHEBI:759373) is a organic molecular entity (CHEBI:50860) |
| fanastomig (CHEBI:759524) is a organic molecular entity (CHEBI:50860) |
| fapi ga-68 (CHEBI:758251) is a organic molecular entity (CHEBI:50860) |
| fapi-46 ga-68 (CHEBI:758904) is a organic molecular entity (CHEBI:50860) |
| faralimomab (CHEBI:753380) is a organic molecular entity (CHEBI:50860) |
| faricimab (CHEBI:757201) is a organic molecular entity (CHEBI:50860) |
| farletuzumab (CHEBI:750094) is a organic molecular entity (CHEBI:50860) |
| farletuzumab ecteribulin (CHEBI:758523) is a organic molecular entity (CHEBI:50860) |
| Faropenem sodium (CHEBI:31591) is a organic molecular entity (CHEBI:50860) |
| farrerol (CHEBI:67897) is a organic molecular entity (CHEBI:50860) |
| fasinumab (CHEBI:754301) is a organic molecular entity (CHEBI:50860) |
| fat, hard (CHEBI:753381) is a organic molecular entity (CHEBI:50860) |
| favezelimab (CHEBI:757230) is a organic molecular entity (CHEBI:50860) |
| faz-053 (CHEBI:758016) is a organic molecular entity (CHEBI:50860) |
| fazirsiran (CHEBI:758997) is a organic molecular entity (CHEBI:50860) |
| fazirsiran sodium (CHEBI:758998) is a organic molecular entity (CHEBI:50860) |
| fazpilodemab (CHEBI:757346) is a organic molecular entity (CHEBI:50860) |
| fb-825 (CHEBI:757382) is a organic molecular entity (CHEBI:50860) |
| fbt-a05 (CHEBI:754177) is a organic molecular entity (CHEBI:50860) |
| FD44 (CHEBI:233406) is a organic molecular entity (CHEBI:50860) |
| fe 202767 (CHEBI:755495) is a organic molecular entity (CHEBI:50860) |
| Fe(III)-[N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]2(2−) (CHEBI:143776) is a organic molecular entity (CHEBI:50860) |
| Fe(III)-{N-(2,3-dihydroxybenzoyl)-L-seryl-[N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serine]2}(4−) (CHEBI:143773) is a organic molecular entity (CHEBI:50860) |
| Fe(III)-{N-(2,3-dihydroxybenzoyl)-L-seryl-N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serinate}(2−) (CHEBI:143775) is a organic molecular entity (CHEBI:50860) |
| Fe(III)-{di[N-(2,3-dihydroxybenzoyl)-L-seryl]-N-(C-5-[deoxy-β-D-glucosyl]-2,3-dihydroxybenzoyl)-L-serinate}(4−) (CHEBI:143774) is a organic molecular entity (CHEBI:50860) |
| fecal microbiota spores, live (CHEBI:760410) is a organic molecular entity (CHEBI:50860) |
| feladilimab (CHEBI:757399) is a organic molecular entity (CHEBI:50860) |
| feline interleukin-2 recombinant canarypox virus (vcp1338 virus) (CHEBI:759793) is a organic molecular entity (CHEBI:50860) |
| felmetatug (CHEBI:760164) is a organic molecular entity (CHEBI:50860) |
| felmetatug vedotin (CHEBI:760165) is a organic molecular entity (CHEBI:50860) |
| felvizumab (CHEBI:753995) is a organic molecular entity (CHEBI:50860) |
| felzartamab (CHEBI:758052) is a organic molecular entity (CHEBI:50860) |
| Fenaminosulf (CHEBI:82078) is a organic molecular entity (CHEBI:50860) |
| fencabtagene autoleucel (CHEBI:759525) is a organic molecular entity (CHEBI:50860) |
| Fenebrutinib (CHEBI:234073) is a organic molecular entity (CHEBI:50860) |
| fennel oil (CHEBI:753344) is a organic molecular entity (CHEBI:50860) |
| Fenuron-TCA (CHEBI:82202) is a organic molecular entity (CHEBI:50860) |
| fepixnebart (CHEBI:758046) is a organic molecular entity (CHEBI:50860) |
| Feprazone (CHEBI:31603) is a organic molecular entity (CHEBI:50860) |
| fequesetide (CHEBI:759374) is a organic molecular entity (CHEBI:50860) |
| fermagate (CHEBI:757202) is a organic molecular entity (CHEBI:50860) |
| ferric carboxymaltose (CHEBI:753551) is a organic molecular entity (CHEBI:50860) |
| ferric citrate (CHEBI:755280) is a organic molecular entity (CHEBI:50860) |
| ferric citrate (59fe) [injection] (CHEBI:755939) is a organic molecular entity (CHEBI:50860) |
| ferric citrate [injection] (CHEBI:756529) is a organic molecular entity (CHEBI:50860) |
| ferric citrate anhydrous (CHEBI:756552) is a organic molecular entity (CHEBI:50860) |
| ferric derisomaltose (CHEBI:757594) is a organic molecular entity (CHEBI:50860) |
| ferric gluconate trihydrate (CHEBI:758348) is a organic molecular entity (CHEBI:50860) |
| ferric maltol (CHEBI:757527) is a organic molecular entity (CHEBI:50860) |
| ferric oxyhydroxide (CHEBI:758535) is a organic molecular entity (CHEBI:50860) |
| ferric pyrophosphate citrate (CHEBI:755915) is a organic molecular entity (CHEBI:50860) |
| ferric sodium citrate (CHEBI:755774) is a organic molecular entity (CHEBI:50860) |
| ferric sulfate (CHEBI:758632) is a organic molecular entity (CHEBI:50860) |
| ferriheme c di-L-cysteine(1-) residue (CHEBI:229946) is a organic molecular entity (CHEBI:50860) |
| ferristene (CHEBI:753825) is a organic molecular entity (CHEBI:50860) |
| Ferritin (CHEBI:82594) is a organic molecular entity (CHEBI:50860) |
| ferroglycine sulfate (CHEBI:757130) is a organic molecular entity (CHEBI:50860) |
| ferrous ascorbate (CHEBI:755787) is a organic molecular entity (CHEBI:50860) |
| ferrous aspartate (CHEBI:755757) is a organic molecular entity (CHEBI:50860) |
| ferrous bisglycinate (CHEBI:757203) is a organic molecular entity (CHEBI:50860) |
| ferrous cation (CHEBI:760534) is a organic molecular entity (CHEBI:50860) |
| ferrous chloride (CHEBI:755201) is a organic molecular entity (CHEBI:50860) |
| ferrous citrate (CHEBI:754591) is a organic molecular entity (CHEBI:50860) |
| ferrous citrate fe 59 (CHEBI:752127) is a organic molecular entity (CHEBI:50860) |
| ferrous gluconate anhydrous (CHEBI:756557) is a organic molecular entity (CHEBI:50860) |
| ferrous glycine sulfate (CHEBI:755725) is a organic molecular entity (CHEBI:50860) |
| ferrous iodine (CHEBI:755807) is a organic molecular entity (CHEBI:50860) |
| ferrous succinate (CHEBI:755744) is a organic molecular entity (CHEBI:50860) |
| ferrous sulfate (CHEBI:749323) is a organic molecular entity (CHEBI:50860) |
| ferrous sulfate sesquihydrate (CHEBI:760470) is a organic molecular entity (CHEBI:50860) |
| ferrous tartrate (CHEBI:755842) is a organic molecular entity (CHEBI:50860) |
| Fertilitatic acid (CHEBI:195354) is a organic molecular entity (CHEBI:50860) |
| ferucarbotran (CHEBI:753363) is a organic molecular entity (CHEBI:50860) |
| ferumoxides (CHEBI:749534) is a organic molecular entity (CHEBI:50860) |
| ferumoxsil (CHEBI:749564) is a organic molecular entity (CHEBI:50860) |
| ferumoxtran-10 (CHEBI:753477) is a organic molecular entity (CHEBI:50860) |
| ferumoxytol (CHEBI:749612) is a organic molecular entity (CHEBI:50860) |
| ferutinin (CHEBI:230617) is a organic molecular entity (CHEBI:50860) |
| fesomersen (CHEBI:759039) is a organic molecular entity (CHEBI:50860) |
| fesomersen sodium (CHEBI:758886) is a organic molecular entity (CHEBI:50860) |
| Feteic acid (CHEBI:197316) is a organic molecular entity (CHEBI:50860) |
| feverfew (CHEBI:753364) is a organic molecular entity (CHEBI:50860) |
| fexofenadine zwitterion (CHEBI:746987) is a organic molecular entity (CHEBI:50860) |
| fezakinumab (CHEBI:750095) is a organic molecular entity (CHEBI:50860) |
| fgi-101-1a6 (CHEBI:754350) is a organic molecular entity (CHEBI:50860) |
| FHD-286 (CHEBI:233318) is a organic molecular entity (CHEBI:50860) |
| FHD-609 (CHEBI:233319) is a organic molecular entity (CHEBI:50860) |
| fianlimab (CHEBI:757504) is a organic molecular entity (CHEBI:50860) |
| fianlimab dfo zr-89 (CHEBI:760502) is a organic molecular entity (CHEBI:50860) |
| Fibrinogen binding inhibitor peptide (CHEBI:80159) is a organic molecular entity (CHEBI:50860) |
| Fibrinogen binding peptide (CHEBI:80160) is a organic molecular entity (CHEBI:50860) |
| fibrinogen i 125 (CHEBI:749446) is a organic molecular entity (CHEBI:50860) |
| fibrinogen, human (CHEBI:753967) is a organic molecular entity (CHEBI:50860) |
| fibrinolysin, human (CHEBI:749519) is a organic molecular entity (CHEBI:50860) |
| Fibrinopeptide B (CHEBI:5057) is a organic molecular entity (CHEBI:50860) |
| fibroblast growth factor-1 (CHEBI:757384) is a organic molecular entity (CHEBI:50860) |
| Fibronectin (CHEBI:5058) is a organic molecular entity (CHEBI:50860) |
| ficerafusp alfa (CHEBI:758887) is a organic molecular entity (CHEBI:50860) |
| ficlatuzumab (CHEBI:750096) is a organic molecular entity (CHEBI:50860) |
| fidanacogene elaparvovec (CHEBI:756514) is a organic molecular entity (CHEBI:50860) |
| Fidarestat (CHEBI:31611) is a organic molecular entity (CHEBI:50860) |
| figitumumab (CHEBI:750097) is a organic molecular entity (CHEBI:50860) |
| filgrastim (CHEBI:749461) is a organic molecular entity (CHEBI:50860) |
| fimaporfin (CHEBI:757320) is a organic molecular entity (CHEBI:50860) |
| fimasartan potassium trihydrate (CHEBI:757023) is a organic molecular entity (CHEBI:50860) |
| Fimepinostat (CHEBI:747806) is a organic molecular entity (CHEBI:50860) |
| Finerenone (CHEBI:747008) is a organic molecular entity (CHEBI:50860) |
| finotonlimab (CHEBI:758393) is a organic molecular entity (CHEBI:50860) |
| firastotug (CHEBI:759697) is a organic molecular entity (CHEBI:50860) |
| firicabtagene autoleucel (CHEBI:759526) is a organic molecular entity (CHEBI:50860) |
| firtecan pegol (CHEBI:757748) is a organic molecular entity (CHEBI:50860) |
| fish oil (CHEBI:755949) is a organic molecular entity (CHEBI:50860) |
| fish oil triglycerides (CHEBI:757013) is a organic molecular entity (CHEBI:50860) |
| fitusiran (CHEBI:757204) is a organic molecular entity (CHEBI:50860) |
| fiztasovimab (CHEBI:758704) is a organic molecular entity (CHEBI:50860) |
| FK866 (CHEBI:231701) is a organic molecular entity (CHEBI:50860) |
| flanvotumab (CHEBI:753671) is a organic molecular entity (CHEBI:50860) |
| flavipin (CHEBI:68742) is a organic molecular entity (CHEBI:50860) |
| flavocoxid (CHEBI:758852) is a organic molecular entity (CHEBI:50860) |
| flavonoids (CHEBI:72544) is a organic molecular entity (CHEBI:50860) |
| fletikumab (CHEBI:755264) is a organic molecular entity (CHEBI:50860) |
| Floctafenine (CHEBI:31612) is a organic molecular entity (CHEBI:50860) |
| Flopropione (CHEBI:31614) is a organic molecular entity (CHEBI:50860) |
| Florbenazine (CHEBI:230930) is a organic molecular entity (CHEBI:50860) |
| flotetuzumab (CHEBI:756518) is a organic molecular entity (CHEBI:50860) |
| flotufolastat gallium (CHEBI:759814) is a organic molecular entity (CHEBI:50860) |
| Fluo-4 AM (CHEBI:233001) is a organic molecular entity (CHEBI:50860) |
| Fluo-8 AM (CHEBI:233002) is a organic molecular entity (CHEBI:50860) |
| Fluocinonide (CHEBI:5109) is a organic molecular entity (CHEBI:50860) |
| Flupyrsulfuron-methyl sodium (CHEBI:82014) is a organic molecular entity (CHEBI:50860) |
| fluralaner (CHEBI:233405) is a organic molecular entity (CHEBI:50860) |
| Flurbiprofen axetil (CHEBI:31627) is a organic molecular entity (CHEBI:50860) |
| flurimedrimer (18f) (CHEBI:759437) is a organic molecular entity (CHEBI:50860) |
| Flutazolam (CHEBI:31628) is a organic molecular entity (CHEBI:50860) |
| Flutoprazepam (CHEBI:31629) is a organic molecular entity (CHEBI:50860) |
| flysyn (CHEBI:758191) is a organic molecular entity (CHEBI:50860) |
| fn-1501 (CHEBI:757954) is a organic molecular entity (CHEBI:50860) |
| focofilcon a (CHEBI:754076) is a organic molecular entity (CHEBI:50860) |
| Foigeic acid (CHEBI:195346) is a organic molecular entity (CHEBI:50860) |
| folinate(2-) (CHEBI:746989) is a organic molecular entity (CHEBI:50860) |
| follitropin (CHEBI:757385) is a organic molecular entity (CHEBI:50860) |
| follitropin alfa (CHEBI:749583) is a organic molecular entity (CHEBI:50860) |
| follitropin beta (CHEBI:759804) is a organic molecular entity (CHEBI:50860) |
| follitropin delta (CHEBI:759747) is a organic molecular entity (CHEBI:50860) |
| fomivirsen (CHEBI:749580) is a organic molecular entity (CHEBI:50860) |
| fomivirsen sodium (CHEBI:749516) is a organic molecular entity (CHEBI:50860) |
| fontolizumab (CHEBI:753427) is a organic molecular entity (CHEBI:50860) |
| foralumab (CHEBI:750098) is a organic molecular entity (CHEBI:50860) |
| foravirumab (CHEBI:750099) is a organic molecular entity (CHEBI:50860) |
| fordadistrogene movaparvovec (CHEBI:757834) is a organic molecular entity (CHEBI:50860) |
| forimtamig (CHEBI:759375) is a organic molecular entity (CHEBI:50860) |
| formofilcon a (CHEBI:755005) is a organic molecular entity (CHEBI:50860) |
| formofilcon b (CHEBI:755093) is a organic molecular entity (CHEBI:50860) |
| Formylisoglutamine(1-) (CHEBI:140737) is a organic molecular entity (CHEBI:50860) |
| Fosfomycin calcium (CHEBI:79400) is a organic molecular entity (CHEBI:50860) |
| fosmetpantotenate (CHEBI:232816) is a organic molecular entity (CHEBI:50860) |
| fp-1039 (CHEBI:757205) is a organic molecular entity (CHEBI:50860) |
| fpreQ1 (CHEBI:190459) is a organic molecular entity (CHEBI:50860) |
| fpt-155 (CHEBI:757857) is a organic molecular entity (CHEBI:50860) |
| Fredricksonic acid (CHEBI:197318) is a organic molecular entity (CHEBI:50860) |
| fremanezumab (CHEBI:757206) is a organic molecular entity (CHEBI:50860) |
| freneslerbart (CHEBI:759376) is a organic molecular entity (CHEBI:50860) |
| frenlosirsen (CHEBI:758167) is a organic molecular entity (CHEBI:50860) |
| frenlosirsen sodium (CHEBI:758359) is a organic molecular entity (CHEBI:50860) |
| fresolimumab (CHEBI:750100) is a organic molecular entity (CHEBI:50860) |
| frexalimab (CHEBI:758705) is a organic molecular entity (CHEBI:50860) |
| froniglutide (CHEBI:759673) is a organic molecular entity (CHEBI:50860) |
| frovocimab (CHEBI:757440) is a organic molecular entity (CHEBI:50860) |
| frunevetmab (CHEBI:756492) is a organic molecular entity (CHEBI:50860) |
| fs-102 (CHEBI:757386) is a organic molecular entity (CHEBI:50860) |
| fs-120 (CHEBI:758349) is a organic molecular entity (CHEBI:50860) |
| Fucosyldisialyllacto-N-hexaose I (CHEBI:195319) is a organic molecular entity (CHEBI:50860) |
| Fudosteine (CHEBI:31637) is a organic molecular entity (CHEBI:50860) |
| fulipiftide (CHEBI:760397) is a organic molecular entity (CHEBI:50860) |
| fulranumab (CHEBI:750101) is a organic molecular entity (CHEBI:50860) |
| Fumarate acylated putrescine (CHEBI:234020) is a organic molecular entity (CHEBI:50860) |
| fungimycin (CHEBI:753428) is a organic molecular entity (CHEBI:50860) |
| furosemide(1-) (CHEBI:746948) is a organic molecular entity (CHEBI:50860) |
| Fursultiamine hydrochloride (CHEBI:81714) is a organic molecular entity (CHEBI:50860) |
| fusafungine (CHEBI:754077) is a organic molecular entity (CHEBI:50860) |
| fusicocccadiene (CHEBI:177895) is a organic molecular entity (CHEBI:50860) |
| futuximab (CHEBI:754204) is a organic molecular entity (CHEBI:50860) |
| fx-005 (CHEBI:755522) is a organic molecular entity (CHEBI:50860) |
| g-3215 (CHEBI:760511) is a organic molecular entity (CHEBI:50860) |
| g17dt immunogen (CHEBI:758853) is a organic molecular entity (CHEBI:50860) |
| gacovetug (CHEBI:760166) is a organic molecular entity (CHEBI:50860) |
| gadodenterate (CHEBI:753552) is a organic molecular entity (CHEBI:50860) |
| gadofosveset (CHEBI:750267) is a organic molecular entity (CHEBI:50860) |
| gadofosveset trisodium (CHEBI:750264) is a organic molecular entity (CHEBI:50860) |
| gadolinium (CHEBI:749665) is a organic molecular entity (CHEBI:50860) |
| gadoquatrane (CHEBI:760361) is a organic molecular entity (CHEBI:50860) |
| gadoxanum (CHEBI:754078) is a organic molecular entity (CHEBI:50860) |
| gadoxetate disodium (CHEBI:750455) is a organic molecular entity (CHEBI:50860) |
| gadoxetic acid (CHEBI:754929) is a organic molecular entity (CHEBI:50860) |
| gadozelite (CHEBI:754079) is a organic molecular entity (CHEBI:50860) |
| Galactose oligosaccharide (CHEBI:5257) is a organic molecular entity (CHEBI:50860) |
| galageenan (CHEBI:753429) is a organic molecular entity (CHEBI:50860) |
| Galanin (CHEBI:80161) is a organic molecular entity (CHEBI:50860) |
| Galanin-like peptide (CHEBI:80268) is a organic molecular entity (CHEBI:50860) |
| galanthamine Trifluoroacetic acid (CHEBI:68318) is a organic molecular entity (CHEBI:50860) |
| Galantide (CHEBI:80163) is a organic molecular entity (CHEBI:50860) |
| galasomite (CHEBI:753430) is a organic molecular entity (CHEBI:50860) |
| galcanezumab (CHEBI:755804) is a organic molecular entity (CHEBI:50860) |
| galegenimab (CHEBI:758526) is a organic molecular entity (CHEBI:50860) |
| galgenprostucel-l (CHEBI:753048) is a organic molecular entity (CHEBI:50860) |
| galinpepimut-s (CHEBI:755957) is a organic molecular entity (CHEBI:50860) |
| galiximab (CHEBI:754080) is a organic molecular entity (CHEBI:50860) |
| gallium (CHEBI:749395) is a organic molecular entity (CHEBI:50860) |
| gallium (68ga) rofapitide tetraxetan (CHEBI:759170) is a organic molecular entity (CHEBI:50860) |
| gallium citrate (CHEBI:754399) is a organic molecular entity (CHEBI:50860) |
| gallium citrate ga 67 (CHEBI:749353) is a organic molecular entity (CHEBI:50860) |
| gallium maltolate (CHEBI:760422) is a organic molecular entity (CHEBI:50860) |
| gallium oxodotreotide (CHEBI:748710) is a organic molecular entity (CHEBI:50860) |
| gallium rofapitidexetan (CHEBI:759810) is a organic molecular entity (CHEBI:50860) |
| galsulfase (CHEBI:749598) is a organic molecular entity (CHEBI:50860) |
| galvokimig (CHEBI:759527) is a organic molecular entity (CHEBI:50860) |
| galyfilcon a (CHEBI:755475) is a organic molecular entity (CHEBI:50860) |
| gamma-aminobutyrolithocholic acid (CHEBI:232183) is a organic molecular entity (CHEBI:50860) |
| gamma-aminobutyroursodeoxycholic acid (CHEBI:232276) is a organic molecular entity (CHEBI:50860) |
| gamma-Endorphin (CHEBI:80246) is a organic molecular entity (CHEBI:50860) |
| gamma-glutamyl-beta-cyanoalanine(1-) (CHEBI:140738) is a organic molecular entity (CHEBI:50860) |
| gamma-L-Glutamyl-[acp] (CHEBI:81451) is a organic molecular entity (CHEBI:50860) |
| gamma-L-Glutamyl-4-amino-2-hydroxybutyryl-[acp] (CHEBI:81454) is a organic molecular entity (CHEBI:50860) |
| gamma-L-Glutamyl-4-aminobutyryl-[acp] (CHEBI:81453) is a organic molecular entity (CHEBI:50860) |
| gamma-Lipotropin (CHEBI:80248) is a organic molecular entity (CHEBI:50860) |
| gamma-Melanotropin (CHEBI:80349) is a organic molecular entity (CHEBI:50860) |
| ganciclovir triphosphate(4-) (CHEBI:760570) is a organic molecular entity (CHEBI:50860) |
| gancotamab (CHEBI:755935) is a organic molecular entity (CHEBI:50860) |
| Ganglioside GA2 (d18:1/16:0) (CHEBI:230437) is a organic molecular entity (CHEBI:50860) |
| ganipatide (CHEBI:759528) is a organic molecular entity (CHEBI:50860) |
| ganitumab (CHEBI:750102) is a organic molecular entity (CHEBI:50860) |
| gantenerumab (CHEBI:750103) is a organic molecular entity (CHEBI:50860) |
| ganulameran (CHEBI:758339) is a organic molecular entity (CHEBI:50860) |
| garetosmab (CHEBI:757584) is a organic molecular entity (CHEBI:50860) |
| garivulimab (CHEBI:758333) is a organic molecular entity (CHEBI:50860) |
| garlic (CHEBI:753431) is a organic molecular entity (CHEBI:50860) |
| garnocestim (CHEBI:753432) is a organic molecular entity (CHEBI:50860) |
| gas gangrene antitoxin, pentavalent (CHEBI:754081) is a organic molecular entity (CHEBI:50860) |
| gastric mucin (CHEBI:753479) is a organic molecular entity (CHEBI:50860) |
| Gastrin-releasing peptide (CHEBI:80328) is a organic molecular entity (CHEBI:50860) |
| gataparsen (CHEBI:754918) is a organic molecular entity (CHEBI:50860) |
| gataparsen sodium (CHEBI:754919) is a organic molecular entity (CHEBI:50860) |
| gatipotuzumab (CHEBI:757035) is a organic molecular entity (CHEBI:50860) |
| gatralimab (CHEBI:760515) is a organic molecular entity (CHEBI:50860) |
| gauze, absorbent (CHEBI:753478) is a organic molecular entity (CHEBI:50860) |
| gauze, petrolatum (CHEBI:753011) is a organic molecular entity (CHEBI:50860) |
| gavilimomab (CHEBI:754082) is a organic molecular entity (CHEBI:50860) |
| gavocabtagene autoleucel (CHEBI:758566) is a organic molecular entity (CHEBI:50860) |
| GayathriK_2023_C_1 (CHEBI:195236) is a organic molecular entity (CHEBI:50860) |
| gc1118 (CHEBI:758193) is a organic molecular entity (CHEBI:50860) |
| GCN2iB (CHEBI:747100) is a organic molecular entity (CHEBI:50860) |
| gdc-0334 (CHEBI:758493) is a organic molecular entity (CHEBI:50860) |
| gdc-0927 (CHEBI:757207) is a organic molecular entity (CHEBI:50860) |
| gebasaxturev (CHEBI:759001) is a organic molecular entity (CHEBI:50860) |
| Gedatolisib (CHEBI:747853) is a organic molecular entity (CHEBI:50860) |
| gedivumab (CHEBI:757463) is a organic molecular entity (CHEBI:50860) |
| Gefarnate (CHEBI:31646) is a organic molecular entity (CHEBI:50860) |
| gefurulimab (CHEBI:758880) is a organic molecular entity (CHEBI:50860) |
| gelatin film, absorbable (CHEBI:754083) is a organic molecular entity (CHEBI:50860) |
| gelatin sponge, absorbable (CHEBI:753013) is a organic molecular entity (CHEBI:50860) |
| gelsolin (CHEBI:760528) is a organic molecular entity (CHEBI:50860) |
| gemibotulinumtoxin a (CHEBI:757835) is a organic molecular entity (CHEBI:50860) |
| gemtuzumab (CHEBI:753322) is a organic molecular entity (CHEBI:50860) |
| gemtuzumab ozogamicin (CHEBI:749520) is a organic molecular entity (CHEBI:50860) |
| gen-1053 (CHEBI:760513) is a organic molecular entity (CHEBI:50860) |
| genetically modified recombinant shiga-toxin-2e antigen (CHEBI:759772) is a organic molecular entity (CHEBI:50860) |
| gengleucel (CHEBI:759529) is a organic molecular entity (CHEBI:50860) |
| gentamicin (CHEBI:759884) is a organic molecular entity (CHEBI:50860) |
| gentamicin C1(5+) (CHEBI:230466) is a organic molecular entity (CHEBI:50860) |
| gentulizumab (CHEBI:759674) is a organic molecular entity (CHEBI:50860) |
| Geobarrettin A (CHEBI:194559) is a organic molecular entity (CHEBI:50860) |
| Geobarrettin B (CHEBI:194572) is a organic molecular entity (CHEBI:50860) |
| Geobarrettin C (CHEBI:194573) is a organic molecular entity (CHEBI:50860) |
| gersizangitide (CHEBI:758706) is a organic molecular entity (CHEBI:50860) |
| Gestonorone caproate (CHEBI:31650) is a organic molecular entity (CHEBI:50860) |
| gevokizumab (CHEBI:750104) is a organic molecular entity (CHEBI:50860) |
| GGTI 298 trifluoroacetate (CHEBI:232872) is a organic molecular entity (CHEBI:50860) |
| gi heptapeptide (CHEBI:757208) is a organic molecular entity (CHEBI:50860) |
| gi-101 (CHEBI:759675) is a organic molecular entity (CHEBI:50860) |
| gilavebexagene anvuparvovec (CHEBI:759022) is a organic molecular entity (CHEBI:50860) |
| giloralimab (CHEBI:757991) is a organic molecular entity (CHEBI:50860) |
| gilvetmab (CHEBI:756489) is a organic molecular entity (CHEBI:50860) |
| Gimeracil (CHEBI:31652) is a organic molecular entity (CHEBI:50860) |
| gimistotug (CHEBI:760040) is a organic molecular entity (CHEBI:50860) |
| gimsilumab (CHEBI:754226) is a organic molecular entity (CHEBI:50860) |
| gindameran (CHEBI:759309) is a organic molecular entity (CHEBI:50860) |
| ginger (CHEBI:753433) is a organic molecular entity (CHEBI:50860) |
| ginger, powdered (CHEBI:754084) is a organic molecular entity (CHEBI:50860) |
| ginkgo (CHEBI:753434) is a organic molecular entity (CHEBI:50860) |
| ginseng, american (CHEBI:754085) is a organic molecular entity (CHEBI:50860) |
| ginseng, asian (CHEBI:753435) is a organic molecular entity (CHEBI:50860) |
| GIPC-anchor amidated glycine residue(1−) (CHEBI:143805) is a organic molecular entity (CHEBI:50860) |
| girentuximab (CHEBI:750105) is a organic molecular entity (CHEBI:50860) |
| giroctocogene fitelparvovec (CHEBI:757601) is a organic molecular entity (CHEBI:50860) |
| gitalin (CHEBI:753436) is a organic molecular entity (CHEBI:50860) |
| givastomig (CHEBI:759530) is a organic molecular entity (CHEBI:50860) |
| givilmeran (CHEBI:760167) is a organic molecular entity (CHEBI:50860) |
| givosiran (CHEBI:757209) is a organic molecular entity (CHEBI:50860) |
| givosiran sodium (CHEBI:757770) is a organic molecular entity (CHEBI:50860) |
| GJ1012 C (CHEBI:177899) is a organic molecular entity (CHEBI:50860) |
| Gla protein (CHEBI:5366) is a organic molecular entity (CHEBI:50860) |
| Gla protein precursor (CHEBI:5367) is a organic molecular entity (CHEBI:50860) |
| gla-af (CHEBI:759676) is a organic molecular entity (CHEBI:50860) |
| glatiramer acetate (CHEBI:749565) is a organic molecular entity (CHEBI:50860) |
| glaze, pharmaceutical (CHEBI:754086) is a organic molecular entity (CHEBI:50860) |
| GlcNAc-beta1,3-Gal-R (CHEBI:140876) is a organic molecular entity (CHEBI:50860) |
| GlcNAc(b1-3)[GlcNAc(b1-6)]Gal(b1-4)Glc (CHEBI:195330) is a organic molecular entity (CHEBI:50860) |
| glembatumumab (CHEBI:753650) is a organic molecular entity (CHEBI:50860) |
| glembatumumab vedotin (CHEBI:750106) is a organic molecular entity (CHEBI:50860) |
| glemtimbetasin (CHEBI:760168) is a organic molecular entity (CHEBI:50860) |
| glenzocimab (CHEBI:758285) is a organic molecular entity (CHEBI:50860) |
| glepaglutide (CHEBI:757210) is a organic molecular entity (CHEBI:50860) |
| gleptoferron (CHEBI:753012) is a organic molecular entity (CHEBI:50860) |
| glial cell line-derived neurotrophic factor (CHEBI:760486) is a organic molecular entity (CHEBI:50860) |
| Glicentin (CHEBI:80272) is a organic molecular entity (CHEBI:50860) |
| gliricidin (CHEBI:230756) is a organic molecular entity (CHEBI:50860) |
| globulin serum, anti-human (CHEBI:754037) is a organic molecular entity (CHEBI:50860) |
| glofitamab (CHEBI:757511) is a organic molecular entity (CHEBI:50860) |
| glpg-0555 (CHEBI:755539) is a organic molecular entity (CHEBI:50860) |
| glpg-3970 (CHEBI:758907) is a organic molecular entity (CHEBI:50860) |
| Glucagon hydrochloride (CHEBI:34776) is a organic molecular entity (CHEBI:50860) |
| Glucagon-like peptide 1 (CHEBI:80270) is a organic molecular entity (CHEBI:50860) |
| Glucagon-like peptide 2 (CHEBI:80271) is a organic molecular entity (CHEBI:50860) |
| glucagon-like peptide ii (CHEBI:757388) is a organic molecular entity (CHEBI:50860) |
| glucarpidase (CHEBI:750223) is a organic molecular entity (CHEBI:50860) |
| glucose isomerase from streptomyces rubiginosus (CHEBI:230629) is a organic molecular entity (CHEBI:50860) |
| glucose oxidase (CHEBI:753644) is a organic molecular entity (CHEBI:50860) |
| Glucose-dependent insulinotropic peptide (CHEBI:80165) is a organic molecular entity (CHEBI:50860) |
| glucosylceramide (d18:1/24:0) (CHEBI:142699) is a organic molecular entity (CHEBI:50860) |
| glucuronate acceptor (CHEBI:132368) is a organic molecular entity (CHEBI:50860) |
| gluose enzymatic test strip (CHEBI:754038) is a organic molecular entity (CHEBI:50860) |
| glusoferron (CHEBI:753405) is a organic molecular entity (CHEBI:50860) |
| glutamate decarboxylase 2 (CHEBI:758071) is a organic molecular entity (CHEBI:50860) |
| glutaminochenodeoxycholic acid (CHEBI:232197) is a organic molecular entity (CHEBI:50860) |
| glutaminocholic acid (CHEBI:232252) is a organic molecular entity (CHEBI:50860) |
| glutaminodeoxycholic acid (CHEBI:232216) is a organic molecular entity (CHEBI:50860) |
| glutaminolithocholic acid (CHEBI:232177) is a organic molecular entity (CHEBI:50860) |
| glutaminoursodeoxycholic acid (CHEBI:232271) is a organic molecular entity (CHEBI:50860) |
| glutamylochenodeoxycholic acid (CHEBI:232199) is a organic molecular entity (CHEBI:50860) |
| glutamylocholic acid (CHEBI:232254) is a organic molecular entity (CHEBI:50860) |
| glutamylodeoxycholic acid (CHEBI:232219) is a organic molecular entity (CHEBI:50860) |
| glutamylolithocholic acid (CHEBI:232180) is a organic molecular entity (CHEBI:50860) |
| glutamyloursodeoxycholic acid (CHEBI:232275) is a organic molecular entity (CHEBI:50860) |
| glutaral disinfectant (CHEBI:754039) is a organic molecular entity (CHEBI:50860) |
| Gluten exorphin A5 (CHEBI:187780) is a organic molecular entity (CHEBI:50860) |
| Glybuzole (CHEBI:31657) is a organic molecular entity (CHEBI:50860) |
| Glycerol monoester (CHEBI:5452) is a organic molecular entity (CHEBI:50860) |
| glycerophosphoinositol monophosphate (CHEBI:83188) is a organic molecular entity (CHEBI:50860) |
| glyceryl allyl Ether (CHEBI:747437) is a organic molecular entity (CHEBI:50860) |
| glyceryl laurate (CHEBI:760524) is a organic molecular entity (CHEBI:50860) |
| Glycino 3β-cholesterol ester group (CHEBI:143135) is a organic molecular entity (CHEBI:50860) |
| Glycolide (CHEBI:140598) is a organic molecular entity (CHEBI:50860) |
| Glycopeptidelipid (CHEBI:80114) is a organic molecular entity (CHEBI:50860) |
| Glycoprotein with the oligosaccharide chain attached by N-glycosyllinkage to protein L-asparagine (CHEBI:5489) is a organic molecular entity (CHEBI:50860) |
| Glycoside of aldohexose (CHEBI:5496) is a organic molecular entity (CHEBI:50860) |
| Glycyl amino acid (CHEBI:5500) is a organic molecular entity (CHEBI:50860) |
| Glycyl-proline-1-naphthylamide (CHEBI:230443) is a organic molecular entity (CHEBI:50860) |
| glycyrrhiza (CHEBI:754040) is a organic molecular entity (CHEBI:50860) |
| Glycyrrhizinate dipotassium (CHEBI:79402) is a organic molecular entity (CHEBI:50860) |
| glyphosate-isopropylammonium (CHEBI:81834) is a organic molecular entity (CHEBI:50860) |
| Glyphosate-monoammonium (CHEBI:81835) is a organic molecular entity (CHEBI:50860) |
| gma-161 (CHEBI:757391) is a organic molecular entity (CHEBI:50860) |
| gnkg-168 (CHEBI:757392) is a organic molecular entity (CHEBI:50860) |
| GO-203 (CHEBI:231751) is a organic molecular entity (CHEBI:50860) |
| gocatamig (CHEBI:760041) is a organic molecular entity (CHEBI:50860) |
| goflikicept (CHEBI:758390) is a organic molecular entity (CHEBI:50860) |
| gold (CHEBI:755184) is a organic molecular entity (CHEBI:50860) |
| gold au 198 (CHEBI:755921) is a organic molecular entity (CHEBI:50860) |
| gold sodium thiosulfate anhydrous (CHEBI:756532) is a organic molecular entity (CHEBI:50860) |
| goldenseal (CHEBI:753879) is a organic molecular entity (CHEBI:50860) |
| goldenseal, powdered (CHEBI:753481) is a organic molecular entity (CHEBI:50860) |
| golimumab (CHEBI:749607) is a organic molecular entity (CHEBI:50860) |
| golmestrocel (CHEBI:759531) is a organic molecular entity (CHEBI:50860) |
| golnerminogene pradenovec (CHEBI:753648) is a organic molecular entity (CHEBI:50860) |
| golocdacimab (CHEBI:758930) is a organic molecular entity (CHEBI:50860) |
| golodirsen (CHEBI:757211) is a organic molecular entity (CHEBI:50860) |
| Gonadotropin-releasing hormone II (CHEBI:80298) is a organic molecular entity (CHEBI:50860) |
| gonadotropin, chorionic (CHEBI:749576) is a organic molecular entity (CHEBI:50860) |
| gonadotropin, serum (CHEBI:754041) is a organic molecular entity (CHEBI:50860) |
| gorivitug (CHEBI:759312) is a organic molecular entity (CHEBI:50860) |
| Goserelin (CHEBI:5523) is a organic molecular entity (CHEBI:50860) |
| gosuranemab (CHEBI:756522) is a organic molecular entity (CHEBI:50860) |
| gotistobart (CHEBI:759677) is a organic molecular entity (CHEBI:50860) |
| govafilcon a (CHEBI:753014) is a organic molecular entity (CHEBI:50860) |
| gp-100 antigen (CHEBI:757393) is a organic molecular entity (CHEBI:50860) |
| GP369 (CHEBI:156377) is a organic molecular entity (CHEBI:50860) |
| gpi-0100 (CHEBI:758286) is a organic molecular entity (CHEBI:50860) |
| graftskin (CHEBI:753049) is a organic molecular entity (CHEBI:50860) |
| gramicidin (CHEBI:749506) is a organic molecular entity (CHEBI:50860) |
| Gramicidin A (CHEBI:80115) is a organic molecular entity (CHEBI:50860) |
| Granuliberin R (CHEBI:80170) is a organic molecular entity (CHEBI:50860) |
| grapefruit juice (CHEBI:756756) is a organic molecular entity (CHEBI:50860) |
| graphite oxide (CHEBI:132888) is a organic molecular entity (CHEBI:50860) |
| grc-15300 (CHEBI:755796) is a organic molecular entity (CHEBI:50860) |
| grc-17536 (CHEBI:755795) is a organic molecular entity (CHEBI:50860) |
| green soap (CHEBI:753555) is a organic molecular entity (CHEBI:50860) |
| gremubamab (CHEBI:757455) is a organic molecular entity (CHEBI:50860) |
| greziprubart (CHEBI:760169) is a organic molecular entity (CHEBI:50860) |
| gruticibart (CHEBI:759320) is a organic molecular entity (CHEBI:50860) |
| GS-5759 (CHEBI:231668) is a organic molecular entity (CHEBI:50860) |
| gs-cda1 (CHEBI:754155) is a organic molecular entity (CHEBI:50860) |
| GS-nitroimidazole (CHEBI:180931) is a organic molecular entity (CHEBI:50860) |
| Gsh-prostaglandin A1 (CHEBI:5548) is a organic molecular entity (CHEBI:50860) |
| gsk-1070806 (CHEBI:754355) is a organic molecular entity (CHEBI:50860) |
| gsk-1614235 (CHEBI:757395) is a organic molecular entity (CHEBI:50860) |
| gsk-1795091 (CHEBI:758519) is a organic molecular entity (CHEBI:50860) |
| gsk-1995057 (CHEBI:754347) is a organic molecular entity (CHEBI:50860) |
| gsk-2330811 (CHEBI:760514) is a organic molecular entity (CHEBI:50860) |
| GSK-256066 (CHEBI:231666) is a organic molecular entity (CHEBI:50860) |
| gsk-2586881 (CHEBI:757325) is a organic molecular entity (CHEBI:50860) |
| gsk-3050002 (CHEBI:757397) is a organic molecular entity (CHEBI:50860) |
| gsk-3174998 (CHEBI:757398) is a organic molecular entity (CHEBI:50860) |
| gsk-610677 (CHEBI:755395) is a organic molecular entity (CHEBI:50860) |
| gsk-679586a (CHEBI:754252) is a organic molecular entity (CHEBI:50860) |
| GSK-J4 hydrochloride (CHEBI:747761) is a organic molecular entity (CHEBI:50860) |
| GSK-LSD1 (CHEBI:232752) is a organic molecular entity (CHEBI:50860) |
| gsk159802 (CHEBI:755455) is a organic molecular entity (CHEBI:50860) |
| GSK1702934A (CHEBI:232878) is a organic molecular entity (CHEBI:50860) |
| GSK2193874 (CHEBI:232516) is a organic molecular entity (CHEBI:50860) |
| GSK2606414 (CHEBI:232161) is a organic molecular entity (CHEBI:50860) |
| gsk2618960 (CHEBI:760412) is a organic molecular entity (CHEBI:50860) |
| gsk2849466 (CHEBI:755433) is a organic molecular entity (CHEBI:50860) |
| gsk2881078 (CHEBI:755499) is a organic molecular entity (CHEBI:50860) |
| GSK503 (CHEBI:231340) is a organic molecular entity (CHEBI:50860) |
| GSK547 (CHEBI:230494) is a organic molecular entity (CHEBI:50860) |
| GSK591 (CHEBI:230495) is a organic molecular entity (CHEBI:50860) |
| GSK805 (CHEBI:230496) is a organic molecular entity (CHEBI:50860) |
| GSK864 (CHEBI:233361) is a organic molecular entity (CHEBI:50860) |
| gsk933776 (CHEBI:754145) is a organic molecular entity (CHEBI:50860) |
| GT-951 (CHEBI:232863) is a organic molecular entity (CHEBI:50860) |
| gti-2040 (CHEBI:757212) is a organic molecular entity (CHEBI:50860) |
| GTS467 (CHEBI:232975) is a organic molecular entity (CHEBI:50860) |
| guadecitabine (CHEBI:231603) is a organic molecular entity (CHEBI:50860) |
| guaiac (CHEBI:753406) is a organic molecular entity (CHEBI:50860) |
| Guanacasta-1,3-diene (CHEBI:228350) is a organic molecular entity (CHEBI:50860) |
| Guangxitoxin 1E (CHEBI:233846) is a organic molecular entity (CHEBI:50860) |
| guanosine-5'-triphosphate(3-) group (CHEBI:192284) is a organic molecular entity (CHEBI:50860) |
| Guanylin (CHEBI:80237) is a organic molecular entity (CHEBI:50860) |
| guar gum (CHEBI:753416) is a organic molecular entity (CHEBI:50860) |
| Guinea Green B (CHEBI:82471) is a organic molecular entity (CHEBI:50860) |
| gulgafafusp alfa (CHEBI:759438) is a organic molecular entity (CHEBI:50860) |
| gumokimab (CHEBI:758875) is a organic molecular entity (CHEBI:50860) |
| guselkumab (CHEBI:754996) is a organic molecular entity (CHEBI:50860) |
| gutta percha (CHEBI:753471) is a organic molecular entity (CHEBI:50860) |
| gv-971 (CHEBI:758287) is a organic molecular entity (CHEBI:50860) |
| GW3965 hydrochloride (CHEBI:232793) is a organic molecular entity (CHEBI:50860) |
| GW4869 (CHEBI:231549) is a organic molecular entity (CHEBI:50860) |
| GW5074 (CHEBI:231667) is a organic molecular entity (CHEBI:50860) |
| GWARJD07 (CHEBI:195491) is a organic molecular entity (CHEBI:50860) |
| gwn-323 (CHEBI:757402) is a organic molecular entity (CHEBI:50860) |
| H-Gly-Ser-Pro-Met-Phe-Val-NH2 (CHEBI:229509) is a organic molecular entity (CHEBI:50860) |
| H-L-Cys(MDNPE)-OH (CHEBI:233121) is a organic molecular entity (CHEBI:50860) |
| H-Lys(4-nitro-Z)-OH (CHEBI:233096) is a organic molecular entity (CHEBI:50860) |
| h11 scfv (CHEBI:754126) is a organic molecular entity (CHEBI:50860) |
| H2NTP (CHEBI:193162) is a organic molecular entity (CHEBI:50860) |
| h3b-8800 (CHEBI:758494) is a organic molecular entity (CHEBI:50860) |
| H3K27Ac (CHEBI:85044) is a organic molecular entity (CHEBI:50860) |
| H3K27Me3 (CHEBI:85045) is a organic molecular entity (CHEBI:50860) |
| HA Binder_1-scrm (CHEBI:190677) is a organic molecular entity (CHEBI:50860) |
| HA Binder_10K (CHEBI:190682) is a organic molecular entity (CHEBI:50860) |
| HA Binder_17X-3 (CHEBI:190678) is a organic molecular entity (CHEBI:50860) |
| HA Binder_2nd de novo (CHEBI:190681) is a organic molecular entity (CHEBI:50860) |
| HA Binder_4 (CHEBI:190683) is a organic molecular entity (CHEBI:50860) |
| HA Binder_6b (CHEBI:190684) is a organic molecular entity (CHEBI:50860) |
| HA Binder_6f-2 (CHEBI:190679) is a organic molecular entity (CHEBI:50860) |
| HA Binder_7c (CHEBI:190685) is a organic molecular entity (CHEBI:50860) |
| HA Binder_8h-2 (CHEBI:190680) is a organic molecular entity (CHEBI:50860) |
| HA Binder_BHP3 (CHEBI:190686) is a organic molecular entity (CHEBI:50860) |
| HA Binder_BHP4 (CHEBI:190687) is a organic molecular entity (CHEBI:50860) |
| hAChE-IN-8 (CHEBI:233297) is a organic molecular entity (CHEBI:50860) |
| hachimycin (CHEBI:753209) is a organic molecular entity (CHEBI:50860) |
| haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen (CHEBI:757493) is a organic molecular entity (CHEBI:50860) |
| haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen (CHEBI:757407) is a organic molecular entity (CHEBI:50860) |
| hafnium oxide (CHEBI:757474) is a organic molecular entity (CHEBI:50860) |
| Halazepam (CHEBI:5603) is a organic molecular entity (CHEBI:50860) |
| Halcinonide (CHEBI:31663) is a organic molecular entity (CHEBI:50860) |
| halisulfate 1, (rel)- (CHEBI:69280) is a organic molecular entity (CHEBI:50860) |
| Halisulfate 2 (CHEBI:69283) is a organic molecular entity (CHEBI:50860) |
| Haloalcohol (CHEBI:5609) is a organic molecular entity (CHEBI:50860) |
| Haloaromatic compound (CHEBI:5611) is a organic molecular entity (CHEBI:50860) |
| halocynthiaxanthin (CHEBI:230562) is a organic molecular entity (CHEBI:50860) |
| Haloperidol decanoate (CHEBI:31664) is a organic molecular entity (CHEBI:50860) |
| Halopredone acetate (CHEBI:31665) is a organic molecular entity (CHEBI:50860) |
| Haloxazolam (CHEBI:31666) is a organic molecular entity (CHEBI:50860) |
| hamayne Trifluoroacetic acid (CHEBI:68307) is a organic molecular entity (CHEBI:50860) |
| hamycin (CHEBI:753463) is a organic molecular entity (CHEBI:50860) |
| hawthorn leaf with flower (CHEBI:754053) is a organic molecular entity (CHEBI:50860) |
| hawthorn leaf with flower, powdered (CHEBI:753468) is a organic molecular entity (CHEBI:50860) |
| hb-201 (CHEBI:760487) is a organic molecular entity (CHEBI:50860) |
| hb-202 (CHEBI:760488) is a organic molecular entity (CHEBI:50860) |
| hbas#3(1-) (CHEBI:140799) is a organic molecular entity (CHEBI:50860) |
| HC Yellow 13 (CHEBI:747841) is a organic molecular entity (CHEBI:50860) |
| HC-030031 (CHEBI:232895) is a organic molecular entity (CHEBI:50860) |
| hcbe-11 (CHEBI:754288) is a organic molecular entity (CHEBI:50860) |
| HE800 exopolysaccharide (CHEBI:229540) is a organic molecular entity (CHEBI:50860) |
| hefi-1 (CHEBI:754122) is a organic molecular entity (CHEBI:50860) |
| hefilcon a (CHEBI:753211) is a organic molecular entity (CHEBI:50860) |
| hefilcon c (CHEBI:753208) is a organic molecular entity (CHEBI:50860) |
| HELLO123 (CHEBI:231869) is a organic molecular entity (CHEBI:50860) |
| Helospectin I (CHEBI:80174) is a organic molecular entity (CHEBI:50860) |
| Helospectin II (CHEBI:80176) is a organic molecular entity (CHEBI:50860) |
| hemay-022 (CHEBI:755466) is a organic molecular entity (CHEBI:50860) |
| heme arginate (CHEBI:756785) is a organic molecular entity (CHEBI:50860) |
| hemocoagulase (CHEBI:753871) is a organic molecular entity (CHEBI:50860) |
| hemoglobin betafumaril, bovine (CHEBI:760261) is a organic molecular entity (CHEBI:50860) |
| hemoglobin crosfumaril (CHEBI:753873) is a organic molecular entity (CHEBI:50860) |
| hemoglobin glutamer (CHEBI:754054) is a organic molecular entity (CHEBI:50860) |
| hemoglobin glutamer-200 (bovine) (CHEBI:753556) is a organic molecular entity (CHEBI:50860) |
| hemoglobin glutamer-250 (bovine) (CHEBI:753557) is a organic molecular entity (CHEBI:50860) |
| hemoglobin glutamer-256 (CHEBI:753558) is a organic molecular entity (CHEBI:50860) |
| hemoglobin raffimer (CHEBI:753874) is a organic molecular entity (CHEBI:50860) |
| hemoglobin sucistil (bovine) (CHEBI:758707) is a organic molecular entity (CHEBI:50860) |
| hemopexin (human) (CHEBI:759707) is a organic molecular entity (CHEBI:50860) |
| hepalatide (CHEBI:758288) is a organic molecular entity (CHEBI:50860) |
| Heparin binding peptide (CHEBI:80178) is a organic molecular entity (CHEBI:50860) |
| heparin calcium (CHEBI:749487) is a organic molecular entity (CHEBI:50860) |
| Heparinase I (CHEBI:231867) is a organic molecular entity (CHEBI:50860) |
| Heparosan primer (5-mer) (CHEBI:197337) is a organic molecular entity (CHEBI:50860) |
| Heparosan primer (6-mer) (CHEBI:197336) is a organic molecular entity (CHEBI:50860) |
| Heparosan primer (7-mer) (CHEBI:197338) is a organic molecular entity (CHEBI:50860) |
| hepatitis b immune globulin (CHEBI:753475) is a organic molecular entity (CHEBI:50860) |
| hepatitis b virus hbsag surface protein antigen (CHEBI:757403) is a organic molecular entity (CHEBI:50860) |
| hepatitis b virus s protein, pre-s1 protein and pre-s2 protein virus like particles (CHEBI:760260) is a organic molecular entity (CHEBI:50860) |
| hepatitis b virus vaccine inactivated (CHEBI:754055) is a organic molecular entity (CHEBI:50860) |
| hepatopoietin-a (CHEBI:757500) is a organic molecular entity (CHEBI:50860) |
| hepcidin (CHEBI:757822) is a organic molecular entity (CHEBI:50860) |
| hepcidin acetate (CHEBI:757823) is a organic molecular entity (CHEBI:50860) |
| Heporasan primer 9 (4-mer) (CHEBI:197335) is a organic molecular entity (CHEBI:50860) |
| Hepronicate (CHEBI:31668) is a organic molecular entity (CHEBI:50860) |
| heptane-1,1-diamine (CHEBI:232150) is a organic molecular entity (CHEBI:50860) |
| hetastarch (CHEBI:753417) is a organic molecular entity (CHEBI:50860) |
| heteroorganic entity (CHEBI:33285) is a organic molecular entity (CHEBI:50860) |
| hetrombopag olamine (CHEBI:757213) is a organic molecular entity (CHEBI:50860) |
| hexadecadienoate (CHEBI:78096) is a organic molecular entity (CHEBI:50860) |
| hexadecenoate (CHEBI:78095) is a organic molecular entity (CHEBI:50860) |
| Hexadecenoyl-[acyl-carrier protein] (CHEBI:80547) is a organic molecular entity (CHEBI:50860) |
| Hexaflurate (CHEBI:82182) is a organic molecular entity (CHEBI:50860) |
| Hexanoyl-[acp] (CHEBI:5704) is a organic molecular entity (CHEBI:50860) |
| hexanoyl-sn-glycero-3-phosphoethanolamine zwitterion (CHEBI:138267) is a organic molecular entity (CHEBI:50860) |
| hexasodium fytate (CHEBI:235478) is a organic molecular entity (CHEBI:50860) |
| hexasodium phytate (CHEBI:758529) is a organic molecular entity (CHEBI:50860) |
| hexavitamin (CHEBI:753418) is a organic molecular entity (CHEBI:50860) |
| HexCer(d16:1(4E,15Me)/21:0(OH)) (CHEBI:143601) is a organic molecular entity (CHEBI:50860) |
| HexCer(d16:1(4E,15Me)/22:0(OH)) (CHEBI:143598) is a organic molecular entity (CHEBI:50860) |
| HexCer(d16:1(4E,15Me)/23:0(OH)) (CHEBI:143602) is a organic molecular entity (CHEBI:50860) |
| HexCer(d16:1(4E,15Me)/24:0(OH)) (CHEBI:143599) is a organic molecular entity (CHEBI:50860) |
| HexCer(d16:1(4E,15Me)/25:0(OH)) (CHEBI:143603) is a organic molecular entity (CHEBI:50860) |
| HexCer(d16:1(4E,15Me)/26:0(OH)) (CHEBI:143600) is a organic molecular entity (CHEBI:50860) |
| hexoprenaline (CHEBI:37950) is a organic molecular entity (CHEBI:50860) |
| HF13141-15 (CHEBI:747875) is a organic molecular entity (CHEBI:50860) |
| hgs-1025 (CHEBI:754172) is a organic molecular entity (CHEBI:50860) |
| hilafilcon a (CHEBI:754056) is a organic molecular entity (CHEBI:50860) |
| hilafilcon b (CHEBI:754057) is a organic molecular entity (CHEBI:50860) |
| hiltonol (CHEBI:757034) is a organic molecular entity (CHEBI:50860) |
| hioxifilcon a (CHEBI:753419) is a organic molecular entity (CHEBI:50860) |
| hioxifilcon d (CHEBI:753559) is a organic molecular entity (CHEBI:50860) |
| Histatin 5 (CHEBI:80179) is a organic molecular entity (CHEBI:50860) |
| histidinochenodeoxycholic acid (CHEBI:232194) is a organic molecular entity (CHEBI:50860) |
| histidinocholic acid (CHEBI:232250) is a organic molecular entity (CHEBI:50860) |
| histidinodeoxycholic acid (CHEBI:232214) is a organic molecular entity (CHEBI:50860) |
| histidinolithocholic acid (CHEBI:232175) is a organic molecular entity (CHEBI:50860) |
| histidinoursodeoxycholic acid (CHEBI:232268) is a organic molecular entity (CHEBI:50860) |
| Histone H4 (CHEBI:234588) is a organic molecular entity (CHEBI:50860) |
| Histone L-arginine (CHEBI:5735) is a organic molecular entity (CHEBI:50860) |
| Histone N-methyl-L-arginine (CHEBI:5736) is a organic molecular entity (CHEBI:50860) |
| Histone-L-lysine (CHEBI:5738) is a organic molecular entity (CHEBI:50860) |
| histoplasmin (CHEBI:754058) is a organic molecular entity (CHEBI:50860) |
| hkt-288 (CHEBI:757409) is a organic molecular entity (CHEBI:50860) |
| HLo7 (CHEBI:5592) is a organic molecular entity (CHEBI:50860) |
| hmpl-453 (CHEBI:758199) is a organic molecular entity (CHEBI:50860) |
| HMTase Inhibitor IX (CHEBI:233480) is a organic molecular entity (CHEBI:50860) |
| hnk20 (CHEBI:754329) is a organic molecular entity (CHEBI:50860) |
| hofocon a (CHEBI:753553) is a organic molecular entity (CHEBI:50860) |
| hokt3 (CHEBI:754121) is a organic molecular entity (CHEBI:50860) |
| Holo-Lys2 (CHEBI:5743) is a organic molecular entity (CHEBI:50860) |
| Holo-transferrin (CHEBI:746965) is a organic molecular entity (CHEBI:50860) |
| Holothurin (CHEBI:80869) is a organic molecular entity (CHEBI:50860) |
| homatropine hydrobromide (CHEBI:5748) is a organic molecular entity (CHEBI:50860) |
| Homoamino acid (CHEBI:80997) is a organic molecular entity (CHEBI:50860) |
| homocarbonyltopsentin (CHEBI:233156) is a organic molecular entity (CHEBI:50860) |
| honey (CHEBI:753365) is a organic molecular entity (CHEBI:50860) |
| horse chestnut (CHEBI:753968) is a organic molecular entity (CHEBI:50860) |
| horse chestnut extract, powdered (CHEBI:753969) is a organic molecular entity (CHEBI:50860) |
| horse chestnut, powdered (CHEBI:753366) is a organic molecular entity (CHEBI:50860) |
| horse-chestnut leaf extract (CHEBI:753970) is a organic molecular entity (CHEBI:50860) |
| HPA-12 (CHEBI:233449) is a organic molecular entity (CHEBI:50860) |
| hpg-1860 (CHEBI:760516) is a organic molecular entity (CHEBI:50860) |
| hpn-424 (CHEBI:758353) is a organic molecular entity (CHEBI:50860) |
| HQ-Ala (CHEBI:232824) is a organic molecular entity (CHEBI:50860) |
| HSB-13 (CHEBI:234266) is a organic molecular entity (CHEBI:50860) |
| ht-2157 (CHEBI:757214) is a organic molecular entity (CHEBI:50860) |
| hu3f4 (CHEBI:754220) is a organic molecular entity (CHEBI:50860) |
| hu3s193 (CHEBI:754286) is a organic molecular entity (CHEBI:50860) |
| hu8f4 (CHEBI:757997) is a organic molecular entity (CHEBI:50860) |
| hua33 (CHEBI:754229) is a organic molecular entity (CHEBI:50860) |
| huhmfg1 (CHEBI:754374) is a organic molecular entity (CHEBI:50860) |
| huj591 111in (CHEBI:754391) is a organic molecular entity (CHEBI:50860) |
| huj591 177lu (CHEBI:754392) is a organic molecular entity (CHEBI:50860) |
| humab 216 (CHEBI:754384) is a organic molecular entity (CHEBI:50860) |
| human c1-esterase inhibitor (CHEBI:757024) is a organic molecular entity (CHEBI:50860) |
| human coagulation factor viii (CHEBI:753184) is a organic molecular entity (CHEBI:50860) |
| Human Heregulin-b1 (CHEBI:231555) is a organic molecular entity (CHEBI:50860) |
| human immunoglobulin g (CHEBI:749498) is a organic molecular entity (CHEBI:50860) |
| human menopausal gonadotrophins (CHEBI:753863) is a organic molecular entity (CHEBI:50860) |
| human neuregulin-1 recombinant (177-237) (CHEBI:758072) is a organic molecular entity (CHEBI:50860) |
| human papillomavirus, l1 protein virus like particles (CHEBI:760273) is a organic molecular entity (CHEBI:50860) |
| human recombinant bone morphogenetic protein 4 (CHEBI:758024) is a organic molecular entity (CHEBI:50860) |
| human serum albumin, recombinant rice-derived (CHEBI:760525) is a organic molecular entity (CHEBI:50860) |
| Humanin (CHEBI:80290) is a organic molecular entity (CHEBI:50860) |
| humax-il15 (CHEBI:754256) is a organic molecular entity (CHEBI:50860) |
| humik-beta-1 (CHEBI:754358) is a organic molecular entity (CHEBI:50860) |
| hupam4 (CHEBI:754188) is a organic molecular entity (CHEBI:50860) |
| huratoxin (CHEBI:70549) is a organic molecular entity (CHEBI:50860) |
| hyalosidase (CHEBI:753210) is a organic molecular entity (CHEBI:50860) |
| Hyaluronan_High_Sulfate (CHEBI:194334) is a organic molecular entity (CHEBI:50860) |
| Hyaluronan_Low_Sulfate (CHEBI:194333) is a organic molecular entity (CHEBI:50860) |
| hyaluronate sodium (CHEBI:757753) is a organic molecular entity (CHEBI:50860) |
| hyaluronic acid (non-animal stabilized) (CHEBI:758058) is a organic molecular entity (CHEBI:50860) |
| Hyaluronidase (CHEBI:231673) is a organic molecular entity (CHEBI:50860) |
| hyaluronidase (human recombinant) (CHEBI:749530) is a organic molecular entity (CHEBI:50860) |
| hyaluronidase (ovine) (CHEBI:753560) is a organic molecular entity (CHEBI:50860) |
| hybufocon a (CHEBI:755474) is a organic molecular entity (CHEBI:50860) |
| hydralazine polistirex (CHEBI:753462) is a organic molecular entity (CHEBI:50860) |
| hydrargaphen (CHEBI:755948) is a organic molecular entity (CHEBI:50860) |
| hydrastinine (CHEBI:233287) is a organic molecular entity (CHEBI:50860) |
| hydrazine sulfate (CHEBI:232153) is a organic molecular entity (CHEBI:50860) |
| hydrocodone polistirex (CHEBI:749484) is a organic molecular entity (CHEBI:50860) |
| Hydrocortisone Sodium Succinate (CHEBI:5782) is a organic molecular entity (CHEBI:50860) |
| Hydrocotarnine hydrochloride (CHEBI:79397) is a organic molecular entity (CHEBI:50860) |
| hydrofilcon a (CHEBI:753367) is a organic molecular entity (CHEBI:50860) |
| hydrogen (CHEBI:757215) is a organic molecular entity (CHEBI:50860) |
| hydropyrene (CHEBI:142541) is a organic molecular entity (CHEBI:50860) |
| Hydroxychlorobactene glucoside ester (CHEBI:80175) is a organic molecular entity (CHEBI:50860) |
| hydroxyethyl cellulose (CHEBI:753971) is a organic molecular entity (CHEBI:50860) |
| hydroxyethyl starch 130/0.4 (CHEBI:753645) is a organic molecular entity (CHEBI:50860) |
| Hydroxylamine hydrochloride (CHEBI:5807) is a organic molecular entity (CHEBI:50860) |
| Hydroxymalonyl-[acp] (CHEBI:81868) is a organic molecular entity (CHEBI:50860) |
| Hydroxypro-Xaa (CHEBI:5811) is a organic molecular entity (CHEBI:50860) |
| HYDROXYPROPYL BETADEX (CHEBI:195327) is a organic molecular entity (CHEBI:50860) |
| hydroxypropyl cellulose (CHEBI:749526) is a organic molecular entity (CHEBI:50860) |
| hydroxypropyl methylcellulose 1828 (CHEBI:753972) is a organic molecular entity (CHEBI:50860) |
| hydroxypropyl methylcellulose phthalate 200731 (CHEBI:753973) is a organic molecular entity (CHEBI:50860) |
| hydroxypropyl methylcellulose phthalate 220824 (CHEBI:753467) is a organic molecular entity (CHEBI:50860) |
| Hydroxypropylmethylcellulose phthalate (CHEBI:31678) is a organic molecular entity (CHEBI:50860) |
| hydroxystearin sulfate (CHEBI:753368) is a organic molecular entity (CHEBI:50860) |
| hyetellose (CHEBI:753974) is a organic molecular entity (CHEBI:50860) |
| hylan g-f 20 (CHEBI:757216) is a organic molecular entity (CHEBI:50860) |
| hymetellose (CHEBI:753975) is a organic molecular entity (CHEBI:50860) |
| Hyoscyamine methylbromide (CHEBI:31681) is a organic molecular entity (CHEBI:50860) |
| hyoscyamine sulfate dihydrate (CHEBI:28486) is a organic molecular entity (CHEBI:50860) |
| Hypadil (TN) (CHEBI:31682) is a organic molecular entity (CHEBI:50860) |
| hyprolose (CHEBI:753345) is a organic molecular entity (CHEBI:50860) |
| hypromellose (CHEBI:753867) is a organic molecular entity (CHEBI:50860) |
| hypromellose acetate succinate (CHEBI:753561) is a organic molecular entity (CHEBI:50860) |
| hypromellose phthalate (CHEBI:753868) is a organic molecular entity (CHEBI:50860) |
| Hypromellosum (CHEBI:230936) is a organic molecular entity (CHEBI:50860) |
| I-BRD9 (CHEBI:747477) is a organic molecular entity (CHEBI:50860) |
| iacs-010759 (CHEBI:758380) is a organic molecular entity (CHEBI:50860) |
| IACS-10759 Hydrochloride (CHEBI:231619) is a organic molecular entity (CHEBI:50860) |
| Iadademstat (CHEBI:234592) is a organic molecular entity (CHEBI:50860) |
| ianalumab (CHEBI:757852) is a organic molecular entity (CHEBI:50860) |
| Ianthelline (CHEBI:195168) is a organic molecular entity (CHEBI:50860) |
| ibalizumab (CHEBI:750107) is a organic molecular entity (CHEBI:50860) |
| IBANDRONATE (CHEBI:41060) is a organic molecular entity (CHEBI:50860) |
| ibentatug (CHEBI:759532) is a organic molecular entity (CHEBI:50860) |
| iberiotoxin (CHEBI:233564) is a organic molecular entity (CHEBI:50860) |
| ibi-188 (CHEBI:758026) is a organic molecular entity (CHEBI:50860) |
| ibi-939 (CHEBI:758355) is a organic molecular entity (CHEBI:50860) |
| iboctadekin (CHEBI:753050) is a organic molecular entity (CHEBI:50860) |
| ibritumomab tiuxetan (CHEBI:749464) is a organic molecular entity (CHEBI:50860) |
| Ibuprofen piconol (CHEBI:31685) is a organic molecular entity (CHEBI:50860) |
| ic14 (CHEBI:754163) is a organic molecular entity (CHEBI:50860) |
| icas#3(1-) (CHEBI:140802) is a organic molecular entity (CHEBI:50860) |
| icas#7(1-) (CHEBI:140803) is a organic molecular entity (CHEBI:50860) |
| icerguastat (CHEBI:233229) is a organic molecular entity (CHEBI:50860) |
| ichorcumab (CHEBI:757428) is a organic molecular entity (CHEBI:50860) |
| ichthammol (CHEBI:753936) is a organic molecular entity (CHEBI:50860) |
| icm3 (CHEBI:754267) is a organic molecular entity (CHEBI:50860) |
| icodextrin (CHEBI:749502) is a organic molecular entity (CHEBI:50860) |
| Icofungipen (CHEBI:230412) is a organic molecular entity (CHEBI:50860) |
| icosadienoate (CHEBI:78073) is a organic molecular entity (CHEBI:50860) |
| icosatrienoate (CHEBI:78072) is a organic molecular entity (CHEBI:50860) |
| icosenoate (CHEBI:78075) is a organic molecular entity (CHEBI:50860) |
| iCRT3 (CHEBI:232963) is a organic molecular entity (CHEBI:50860) |
| iCRT5 (CHEBI:232949) is a organic molecular entity (CHEBI:50860) |
| icrucumab (CHEBI:750108) is a organic molecular entity (CHEBI:50860) |
| ictasol (CHEBI:753346) is a organic molecular entity (CHEBI:50860) |
| ID-8 (CHEBI:231604) is a organic molecular entity (CHEBI:50860) |
| idarucizumab (CHEBI:755412) is a organic molecular entity (CHEBI:50860) |
| Idasanutlin (CHEBI:232616) is a organic molecular entity (CHEBI:50860) |
| idec-159 (CHEBI:754336) is a organic molecular entity (CHEBI:50860) |
| idec-159 111in (CHEBI:754393) is a organic molecular entity (CHEBI:50860) |
| idec-159 90y (CHEBI:754394) is a organic molecular entity (CHEBI:50860) |
| idecabtagene vicleucel (CHEBI:757606) is a organic molecular entity (CHEBI:50860) |
| idestopoetin alfa (CHEBI:758174) is a organic molecular entity (CHEBI:50860) |
| IdoA2S-GlcNS6S tetrasaccharide (CHEBI:150007) is a organic molecular entity (CHEBI:50860) |
| IdoA2S-GlcNS6S trisaccharide (CHEBI:150008) is a organic molecular entity (CHEBI:50860) |
| IDPN (CHEBI:231607) is a organic molecular entity (CHEBI:50860) |
| idrabiotaparinux sodium (CHEBI:757217) is a organic molecular entity (CHEBI:50860) |
| idursulfase (CHEBI:749602) is a organic molecular entity (CHEBI:50860) |
| idursulfase beta (CHEBI:757415) is a organic molecular entity (CHEBI:50860) |
| idusulfase (CHEBI:753317) is a organic molecular entity (CHEBI:50860) |
| ieramilimab (CHEBI:757434) is a organic molecular entity (CHEBI:50860) |
| ifinatamab (CHEBI:758708) is a organic molecular entity (CHEBI:50860) |
| ifinatamab deruxtecan (CHEBI:758901) is a organic molecular entity (CHEBI:50860) |
| Iganidipine (CHEBI:230432) is a organic molecular entity (CHEBI:50860) |
| iGb5Cer (CHEBI:35084) is a organic molecular entity (CHEBI:50860) |
| iglu#2 (CHEBI:140486) is a organic molecular entity (CHEBI:50860) |
| ign-002 (CHEBI:757858) is a organic molecular entity (CHEBI:50860) |
| ign-101 (CHEBI:754125) is a organic molecular entity (CHEBI:50860) |
| ign-311 (CHEBI:754282) is a organic molecular entity (CHEBI:50860) |
| ign-523 (CHEBI:758029) is a organic molecular entity (CHEBI:50860) |
| igovomab (CHEBI:753937) is a organic molecular entity (CHEBI:50860) |
| igovomab 125i (CHEBI:753298) is a organic molecular entity (CHEBI:50860) |
| igrelimogene litadenorepvec (CHEBI:759377) is a organic molecular entity (CHEBI:50860) |
| Iguratimod (CHEBI:31689) is a organic molecular entity (CHEBI:50860) |
| IHSF115 (CHEBI:232602) is a organic molecular entity (CHEBI:50860) |
| II2Xylbeta-Ml4Cer (CHEBI:34797) is a organic molecular entity (CHEBI:50860) |
| Ile-Ile-Ile-Pro (CHEBI:230918) is a organic molecular entity (CHEBI:50860) |
| ilodecakin (CHEBI:753938) is a organic molecular entity (CHEBI:50860) |
| ilofotase alfa (CHEBI:757968) is a organic molecular entity (CHEBI:50860) |
| iltamiocel (CHEBI:758143) is a organic molecular entity (CHEBI:50860) |
| iluzanebart (CHEBI:759731) is a organic molecular entity (CHEBI:50860) |
| ima-026 (CHEBI:757956) is a organic molecular entity (CHEBI:50860) |
| imalumab (CHEBI:758196) is a organic molecular entity (CHEBI:50860) |
| imaprelimab (CHEBI:758384) is a organic molecular entity (CHEBI:50860) |
| imc-1c11 (CHEBI:754124) is a organic molecular entity (CHEBI:50860) |
| imc-3c5 (CHEBI:754353) is a organic molecular entity (CHEBI:50860) |
| imc-cs4 (CHEBI:754159) is a organic molecular entity (CHEBI:50860) |
| imc-eb10 (CHEBI:754162) is a organic molecular entity (CHEBI:50860) |
| imc-gp100 (CHEBI:754228) is a organic molecular entity (CHEBI:50860) |
| imciromab (CHEBI:753275) is a organic molecular entity (CHEBI:50860) |
| imciromab pentetate (CHEBI:753939) is a organic molecular entity (CHEBI:50860) |
| imcnyeso (CHEBI:757218) is a organic molecular entity (CHEBI:50860) |
| imcy-0098 (CHEBI:760489) is a organic molecular entity (CHEBI:50860) |
| imd-1041 (CHEBI:755496) is a organic molecular entity (CHEBI:50860) |
| imd-2560 (CHEBI:755485) is a organic molecular entity (CHEBI:50860) |
| imdevimab (CHEBI:758155) is a organic molecular entity (CHEBI:50860) |
| imdusiran (CHEBI:759340) is a organic molecular entity (CHEBI:50860) |
| imdusiran sodium (CHEBI:759341) is a organic molecular entity (CHEBI:50860) |
| imelciment (CHEBI:760042) is a organic molecular entity (CHEBI:50860) |
| imeroprubart (CHEBI:760170) is a organic molecular entity (CHEBI:50860) |
| imetelstat (CHEBI:752899) is a organic molecular entity (CHEBI:50860) |
| imetelstat sodium (CHEBI:753646) is a organic molecular entity (CHEBI:50860) |
| imgatuzumab (CHEBI:754205) is a organic molecular entity (CHEBI:50860) |
| imgn-388 (CHEBI:754370) is a organic molecular entity (CHEBI:50860) |
| imgn-779 (CHEBI:757419) is a organic molecular entity (CHEBI:50860) |
| imidacloprid-olefin (CHEBI:233429) is a organic molecular entity (CHEBI:50860) |
| imidecyl iodine (CHEBI:753869) is a organic molecular entity (CHEBI:50860) |
| imifoplatin (CHEBI:758555) is a organic molecular entity (CHEBI:50860) |
| imiglucerase (CHEBI:749442) is a organic molecular entity (CHEBI:50860) |
| imilecleucel-t (CHEBI:754909) is a organic molecular entity (CHEBI:50860) |
| imine (CHEBI:24783) is a organic molecular entity (CHEBI:50860) |
| Imipenem-cilastatin (CHEBI:5880) is a organic molecular entity (CHEBI:50860) |
| imisopasem manganese (CHEBI:232553) is a organic molecular entity (CHEBI:50860) |
| imlifidase (CHEBI:757410) is a organic molecular entity (CHEBI:50860) |
| imm-0306 (CHEBI:758357) is a organic molecular entity (CHEBI:50860) |
| immune globulin intravenous pentetate (CHEBI:753940) is a organic molecular entity (CHEBI:50860) |
| immunocytokine nhs-il12 (CHEBI:757479) is a organic molecular entity (CHEBI:50860) |
| immurait-ll2 (CHEBI:754287) is a organic molecular entity (CHEBI:50860) |
| imneskibart (CHEBI:760364) is a organic molecular entity (CHEBI:50860) |
| imsamotide (CHEBI:759439) is a organic molecular entity (CHEBI:50860) |
| imsidolimab (CHEBI:758327) is a organic molecular entity (CHEBI:50860) |
| imvotamab (CHEBI:757955) is a organic molecular entity (CHEBI:50860) |
| imzokitug (CHEBI:760365) is a organic molecular entity (CHEBI:50860) |
| inactivated bluetongue virus, serotype 1, strain btv-1/alg2006/01 e1 (CHEBI:759781) is a organic molecular entity (CHEBI:50860) |
| inactivated bluetongue virus, serotype 8, strain btv-8/bel2006/02 (CHEBI:759748) is a organic molecular entity (CHEBI:50860) |
| inactivated chimaeric flavivirus strain yf-wn (CHEBI:759749) is a organic molecular entity (CHEBI:50860) |
| inaleucel (CHEBI:759378) is a organic molecular entity (CHEBI:50860) |
| inalimarev (cea, muc-1, vaccinia virus) (CHEBI:753562) is a organic molecular entity (CHEBI:50860) |
| inaticabtagene autoleucel (CHEBI:759440) is a organic molecular entity (CHEBI:50860) |
| inbakicept (CHEBI:757817) is a organic molecular entity (CHEBI:50860) |
| incb-047986 (CHEBI:755527) is a organic molecular entity (CHEBI:50860) |
| incb-086550 (CHEBI:758521) is a organic molecular entity (CHEBI:50860) |
| incb-13739 (CHEBI:758915) is a organic molecular entity (CHEBI:50860) |
| incb-40093 (CHEBI:755435) is a organic molecular entity (CHEBI:50860) |
| inclacumab (CHEBI:754273) is a organic molecular entity (CHEBI:50860) |
| inclisiran (CHEBI:176399) is a organic molecular entity (CHEBI:50860) |
| inclisiran sodium (CHEBI:758637) is a organic molecular entity (CHEBI:50860) |
| incobotulinumtoxina (CHEBI:753051) is a organic molecular entity (CHEBI:50860) |
| incomplete freund's adjuvant (CHEBI:758289) is a organic molecular entity (CHEBI:50860) |
| indantadol (CHEBI:755852) is a organic molecular entity (CHEBI:50860) |
| indatuximab ravtansine (CHEBI:750109) is a organic molecular entity (CHEBI:50860) |
| indemakitug (CHEBI:760171) is a organic molecular entity (CHEBI:50860) |
| indenebart (CHEBI:760372) is a organic molecular entity (CHEBI:50860) |
| indium chloride (CHEBI:749818) is a organic molecular entity (CHEBI:50860) |
| indium chlorides in 113m (CHEBI:753347) is a organic molecular entity (CHEBI:50860) |
| indium in 111 altumomab pentetate (CHEBI:753941) is a organic molecular entity (CHEBI:50860) |
| indium in 111 capromab pendetide (CHEBI:753727) is a organic molecular entity (CHEBI:50860) |
| indium in 111 chloride (CHEBI:749368) is a organic molecular entity (CHEBI:50860) |
| indium in 111 ibritumomab tiuxetan (CHEBI:753563) is a organic molecular entity (CHEBI:50860) |
| indium in 111 oxyquinoline (CHEBI:749250) is a organic molecular entity (CHEBI:50860) |
| indium in 111 pentetate (CHEBI:749401) is a organic molecular entity (CHEBI:50860) |
| indium in 111 pentetreotide (CHEBI:749290) is a organic molecular entity (CHEBI:50860) |
| indium in 111 satumomab pendetide (CHEBI:750167) is a organic molecular entity (CHEBI:50860) |
| indium oxyquinoline (CHEBI:754413) is a organic molecular entity (CHEBI:50860) |
| indium pentetate (CHEBI:754930) is a organic molecular entity (CHEBI:50860) |
| indium pentetreotide (CHEBI:754402) is a organic molecular entity (CHEBI:50860) |
| Indium phosphide (CHEBI:82281) is a organic molecular entity (CHEBI:50860) |
| Indolicidin (CHEBI:80180) is a organic molecular entity (CHEBI:50860) |
| indolmycin B (CHEBI:746870) is a organic molecular entity (CHEBI:50860) |
| indusatumab vedotin (CHEBI:757468) is a organic molecular entity (CHEBI:50860) |
| inebilizumab (CHEBI:754166) is a organic molecular entity (CHEBI:50860) |
| inetagugene geperpavec (CHEBI:758149) is a organic molecular entity (CHEBI:50860) |
| inezetamab (CHEBI:758709) is a organic molecular entity (CHEBI:50860) |
| infliximab (CHEBI:749571) is a organic molecular entity (CHEBI:50860) |
| influenza a virus hemagglutinin (CHEBI:760291) is a organic molecular entity (CHEBI:50860) |
| influenza a virus, inactivated hemagglutinin (CHEBI:760275) is a organic molecular entity (CHEBI:50860) |
| influenza a virus, inactivated neuraminidase (CHEBI:760276) is a organic molecular entity (CHEBI:50860) |
| influenza a virus, inactivated whole virion (CHEBI:760274) is a organic molecular entity (CHEBI:50860) |
| influenza a virus, live attenuated (CHEBI:760283) is a organic molecular entity (CHEBI:50860) |
| influenza a virus, split virion (CHEBI:760277) is a organic molecular entity (CHEBI:50860) |
| influenza b virus hemagglutinin (CHEBI:760302) is a organic molecular entity (CHEBI:50860) |
| influenza b virus, inactivated hemagglutinin (CHEBI:760298) is a organic molecular entity (CHEBI:50860) |
| influenza b virus, inactivated neuraminidase (CHEBI:760299) is a organic molecular entity (CHEBI:50860) |
| influenza b virus, live attenuated (CHEBI:760301) is a organic molecular entity (CHEBI:50860) |
| influenza b virus, split virion (CHEBI:760300) is a organic molecular entity (CHEBI:50860) |
| influenza virus vaccine (CHEBI:753942) is a organic molecular entity (CHEBI:50860) |
| ing-1 (CHEBI:754127) is a organic molecular entity (CHEBI:50860) |
| ingitamig (CHEBI:760380) is a organic molecular entity (CHEBI:50860) |
| inodiftagene vixteplasmid (CHEBI:757957) is a organic molecular entity (CHEBI:50860) |
| inolimomab (CHEBI:753348) is a organic molecular entity (CHEBI:50860) |
| inositol-1-phospho-N-(2-hydroxy-very-long-chain fatty acyl)-4R-hydroxysphingoid base(1−) (CHEBI:144720) is a organic molecular entity (CHEBI:50860) |
| inotersen (CHEBI:757219) is a organic molecular entity (CHEBI:50860) |
| inotersen sodium (CHEBI:757015) is a organic molecular entity (CHEBI:50860) |
| inotuzumab (CHEBI:757033) is a organic molecular entity (CHEBI:50860) |
| inotuzumab ozogamicin (CHEBI:753564) is a organic molecular entity (CHEBI:50860) |
| inpegsomatropin (CHEBI:759441) is a organic molecular entity (CHEBI:50860) |
| Insularoside 3',6''-diglucoside (CHEBI:197419) is a organic molecular entity (CHEBI:50860) |
| insulin [injection], biphasic (CHEBI:753878) is a organic molecular entity (CHEBI:50860) |
| insulin argine (CHEBI:753466) is a organic molecular entity (CHEBI:50860) |
| insulin aspart (CHEBI:749465) is a organic molecular entity (CHEBI:50860) |
| insulin aspart protamine recombinant (CHEBI:749468) is a organic molecular entity (CHEBI:50860) |
| insulin defalan (CHEBI:753870) is a organic molecular entity (CHEBI:50860) |
| insulin degludec (CHEBI:752911) is a organic molecular entity (CHEBI:50860) |
| insulin efsitora alfa (CHEBI:758924) is a organic molecular entity (CHEBI:50860) |
| insulin glargine (CHEBI:749436) is a organic molecular entity (CHEBI:50860) |
| insulin glulisine (CHEBI:749555) is a organic molecular entity (CHEBI:50860) |
| insulin human (CHEBI:749524) is a organic molecular entity (CHEBI:50860) |
| insulin human zinc (CHEBI:753881) is a organic molecular entity (CHEBI:50860) |
| insulin human, isophane (CHEBI:753880) is a organic molecular entity (CHEBI:50860) |
| insulin icodec (CHEBI:758054) is a organic molecular entity (CHEBI:50860) |
| insulin lispro (CHEBI:232799) is a organic molecular entity (CHEBI:50860) |
| insulin lispro protamine recombinant (CHEBI:749469) is a organic molecular entity (CHEBI:50860) |
| insulin peglispro (CHEBI:753523) is a organic molecular entity (CHEBI:50860) |
| insulin pork (CHEBI:749491) is a organic molecular entity (CHEBI:50860) |
| insulin purified beef (CHEBI:749473) is a organic molecular entity (CHEBI:50860) |
| insulin purified pork (CHEBI:749557) is a organic molecular entity (CHEBI:50860) |
| insulin susp isophane beef (CHEBI:749462) is a organic molecular entity (CHEBI:50860) |
| insulin susp isophane recombinant human (CHEBI:749569) is a organic molecular entity (CHEBI:50860) |
| insulin susp isophane semisynthetic purified human (CHEBI:749437) is a organic molecular entity (CHEBI:50860) |
| insulin tregopil (CHEBI:753293) is a organic molecular entity (CHEBI:50860) |
| insulin zinc (CHEBI:753457) is a organic molecular entity (CHEBI:50860) |
| insulin zinc susp recombinant human (CHEBI:749572) is a organic molecular entity (CHEBI:50860) |
| insulin zinc, extended (CHEBI:753458) is a organic molecular entity (CHEBI:50860) |
| insulin zinc, prompt (CHEBI:753459) is a organic molecular entity (CHEBI:50860) |
| Insulin-like 3 (CHEBI:80336) is a organic molecular entity (CHEBI:50860) |
| Insulin-like growth factor I (CHEBI:80343) is a organic molecular entity (CHEBI:50860) |
| Insulin-like growth factor II (CHEBI:80344) is a organic molecular entity (CHEBI:50860) |
| Insulin-like peptide 5 (CHEBI:80363) is a organic molecular entity (CHEBI:50860) |
| insulin, biphasic isophane [injection] (CHEBI:753728) is a organic molecular entity (CHEBI:50860) |
| insulin, dalanated (CHEBI:753943) is a organic molecular entity (CHEBI:50860) |
| insulin, globin zinc (CHEBI:753214) is a organic molecular entity (CHEBI:50860) |
| insulin, isophane (CHEBI:753875) is a organic molecular entity (CHEBI:50860) |
| insulin, neutral (CHEBI:753876) is a organic molecular entity (CHEBI:50860) |
| insulin, neutral [injection] of purified porcine (CHEBI:753456) is a organic molecular entity (CHEBI:50860) |
| insulin, protamine zinc (CHEBI:753944) is a organic molecular entity (CHEBI:50860) |
| INT-2 (CHEBI:156241) is a organic molecular entity (CHEBI:50860) |
| interferon (CHEBI:52999) is a organic molecular entity (CHEBI:50860) |
| interferon alfa (CHEBI:753470) is a organic molecular entity (CHEBI:50860) |
| interferon alfa (ball-1) (CHEBI:753349) is a organic molecular entity (CHEBI:50860) |
| Interferon alfa-2a (CHEBI:5937) is a organic molecular entity (CHEBI:50860) |
| interferon alfa-2b (CHEBI:749428) is a organic molecular entity (CHEBI:50860) |
| interferon alfa-2b kinoid (CHEBI:758356) is a organic molecular entity (CHEBI:50860) |
| interferon alfa-n1 (CHEBI:753472) is a organic molecular entity (CHEBI:50860) |
| interferon alfa-n3 (CHEBI:753945) is a organic molecular entity (CHEBI:50860) |
| interferon alfacon-1 (CHEBI:749570) is a organic molecular entity (CHEBI:50860) |
| interferon beta (CHEBI:753473) is a organic molecular entity (CHEBI:50860) |
| interferon beta-1a (CHEBI:749518) is a organic molecular entity (CHEBI:50860) |
| Interferon beta-1b (CHEBI:5938) is a organic molecular entity (CHEBI:50860) |
| interferon gamma-1a (CHEBI:753474) is a organic molecular entity (CHEBI:50860) |
| Interferon gamma-1b (CHEBI:5939) is a organic molecular entity (CHEBI:50860) |
| interleukin 15, recombinant non-glycosylated (CHEBI:757416) is a organic molecular entity (CHEBI:50860) |
| interleukin-10 (CHEBI:757220) is a organic molecular entity (CHEBI:50860) |
| interleukin-12 human recombinant (CHEBI:758911) is a organic molecular entity (CHEBI:50860) |
| interleukin-7 (CHEBI:757221) is a organic molecular entity (CHEBI:50860) |
| intetumumab (CHEBI:750110) is a organic molecular entity (CHEBI:50860) |
| intismeran autogene (CHEBI:760172) is a organic molecular entity (CHEBI:50860) |
| intrinsic factor (CHEBI:749477) is a organic molecular entity (CHEBI:50860) |
| invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein (CHEBI:758034) is a organic molecular entity (CHEBI:50860) |
| invikafusp alfa (CHEBI:760043) is a organic molecular entity (CHEBI:50860) |
| inz-701 (CHEBI:758290) is a organic molecular entity (CHEBI:50860) |
| Iobenzamic acid (CHEBI:31700) is a organic molecular entity (CHEBI:50860) |
| Iocarmic acid (CHEBI:31702) is a organic molecular entity (CHEBI:50860) |
| iodine (131i) metuximab (CHEBI:758923) is a organic molecular entity (CHEBI:50860) |
| Iodine aqueous (CHEBI:5948) is a organic molecular entity (CHEBI:50860) |
| iodine i 124 girentuximab (CHEBI:753654) is a organic molecular entity (CHEBI:50860) |
| iodine i 131 apamistamab (CHEBI:757423) is a organic molecular entity (CHEBI:50860) |
| iodine i 131 derlotuximab biotin (CHEBI:755377) is a organic molecular entity (CHEBI:50860) |
| iodine i124 evuzamitide (CHEBI:759330) is a organic molecular entity (CHEBI:50860) |
| iodine povacrylex (CHEBI:749577) is a organic molecular entity (CHEBI:50860) |
| iodized oil (CHEBI:753946) is a organic molecular entity (CHEBI:50860) |
| iodobehenate calcium (CHEBI:753872) is a organic molecular entity (CHEBI:50860) |
| iodolecithine (CHEBI:753947) is a organic molecular entity (CHEBI:50860) |
| Iodopsin (CHEBI:5949) is a organic molecular entity (CHEBI:50860) |
| Iodosulfuron-methyl-sodium (CHEBI:81741) is a organic molecular entity (CHEBI:50860) |
| Iodoxamic acid (CHEBI:31707) is a organic molecular entity (CHEBI:50860) |
| Iofetamine hydrochloride I 123 (CHEBI:31708) is a organic molecular entity (CHEBI:50860) |
| iometopane (CHEBI:232145) is a organic molecular entity (CHEBI:50860) |
| Iotalamic acid (CHEBI:31713) is a organic molecular entity (CHEBI:50860) |
| Iotrolan (CHEBI:31715) is a organic molecular entity (CHEBI:50860) |
| Iotroxic acid (CHEBI:31716) is a organic molecular entity (CHEBI:50860) |
| ipafricept (CHEBI:755261) is a organic molecular entity (CHEBI:50860) |
| IPAG (CHEBI:231348) is a organic molecular entity (CHEBI:50860) |
| ipecac (CHEBI:753350) is a organic molecular entity (CHEBI:50860) |
| iph-2101 (CHEBI:754280) is a organic molecular entity (CHEBI:50860) |
| ipilimumab (CHEBI:231679) is a organic molecular entity (CHEBI:50860) |
| ipl-344 (CHEBI:758361) is a organic molecular entity (CHEBI:50860) |
| iratumumab (CHEBI:753565) is a organic molecular entity (CHEBI:50860) |
| irgd (CHEBI:757856) is a organic molecular entity (CHEBI:50860) |
| irl-201104 (CHEBI:760519) is a organic molecular entity (CHEBI:50860) |
| iron dextran (CHEBI:78291) is a organic molecular entity (CHEBI:50860) |
| iron isomaltoside 1000 (CHEBI:757469) is a organic molecular entity (CHEBI:50860) |
| Iron sorbitex (CHEBI:82478) is a organic molecular entity (CHEBI:50860) |
| iron sucrose (CHEBI:749322) is a organic molecular entity (CHEBI:50860) |
| iron tetraphenylporphyrin (CHEBI:176789) is a organic molecular entity (CHEBI:50860) |
| iron-57(2+) (CHEBI:176613) is a organic molecular entity (CHEBI:50860) |
| iron-57(3+) (CHEBI:176614) is a organic molecular entity (CHEBI:50860) |
| Iron-dextrin complex (CHEBI:82477) is a organic molecular entity (CHEBI:50860) |
| iroplact (CHEBI:753482) is a organic molecular entity (CHEBI:50860) |
| irsenontrine (CHEBI:747609) is a organic molecular entity (CHEBI:50860) |
| irucalantide (CHEBI:759533) is a organic molecular entity (CHEBI:50860) |
| irx-2 (CHEBI:757958) is a organic molecular entity (CHEBI:50860) |
| irx4310 (CHEBI:755498) is a organic molecular entity (CHEBI:50860) |
| isatuximab (CHEBI:755476) is a organic molecular entity (CHEBI:50860) |
| iscalimab (CHEBI:757616) is a organic molecular entity (CHEBI:50860) |
| isepamicin (CHEBI:37951) is a organic molecular entity (CHEBI:50860) |
| isis-2503 (CHEBI:758035) is a organic molecular entity (CHEBI:50860) |
| isis-333611 (CHEBI:757425) is a organic molecular entity (CHEBI:50860) |
| isis-463588 (CHEBI:758036) is a organic molecular entity (CHEBI:50860) |
| islatravir (CHEBI:747369) is a organic molecular entity (CHEBI:50860) |
| ismomultin alfa (CHEBI:753566) is a organic molecular entity (CHEBI:50860) |
| iso-alcoholic elixir (CHEBI:753358) is a organic molecular entity (CHEBI:50860) |
| iso-debromo-laurinterol (CHEBI:230677) is a organic molecular entity (CHEBI:50860) |
| isoaspartate (CHEBI:85309) is a organic molecular entity (CHEBI:50860) |
| Isobazzanene (CHEBI:228358) is a organic molecular entity (CHEBI:50860) |
| isogravacridonechlorine (CHEBI:230576) is a organic molecular entity (CHEBI:50860) |
| isoheptadecanoyl carnitine (CHEBI:140731) is a organic molecular entity (CHEBI:50860) |
| isoleucinochenodeoxycholic acid (CHEBI:232209) is a organic molecular entity (CHEBI:50860) |
| isoleucinocholic acid (CHEBI:232264) is a organic molecular entity (CHEBI:50860) |
| isoleucinodeoxycholic acid (CHEBI:232227) is a organic molecular entity (CHEBI:50860) |
| isoleucinolithocholic acid (CHEBI:232190) is a organic molecular entity (CHEBI:50860) |
| isoleucinoursodeoxycholic acid (CHEBI:232283) is a organic molecular entity (CHEBI:50860) |
| Isometamidium chloride (CHEBI:6028) is a organic molecular entity (CHEBI:50860) |
| Isoosajin (CHEBI:232614) is a organic molecular entity (CHEBI:50860) |
| isopentadecanoyl carnitine (CHEBI:140730) is a organic molecular entity (CHEBI:50860) |
| Isopomiferin (CHEBI:232470) is a organic molecular entity (CHEBI:50860) |
| isoprenoid (CHEBI:24913) is a organic molecular entity (CHEBI:50860) |
| Isosilybin B (CHEBI:228202) is a organic molecular entity (CHEBI:50860) |
| Isosorbide (CHEBI:6060) is a organic molecular entity (CHEBI:50860) |
| isowighteone hydrate (CHEBI:69750) is a organic molecular entity (CHEBI:50860) |
| ISOX DUAL (CHEBI:233360) is a organic molecular entity (CHEBI:50860) |
| ispectamab debotansine (CHEBI:758710) is a organic molecular entity (CHEBI:50860) |
| ispectamab tazide (CHEBI:759379) is a organic molecular entity (CHEBI:50860) |
| ISRIB (CHEBI:232338) is a organic molecular entity (CHEBI:50860) |
| Istaroxime (CHEBI:747876) is a organic molecular entity (CHEBI:50860) |
| istiratumab (CHEBI:756473) is a organic molecular entity (CHEBI:50860) |
| isunakinra (CHEBI:755505) is a organic molecular entity (CHEBI:50860) |
| it-139 (CHEBI:756899) is a organic molecular entity (CHEBI:50860) |
| itanistomig (CHEBI:760173) is a organic molecular entity (CHEBI:50860) |
| itepekimab (CHEBI:758066) is a organic molecular entity (CHEBI:50860) |
| itolizumab (CHEBI:750111) is a organic molecular entity (CHEBI:50860) |
| IU1 (CHEBI:232499) is a organic molecular entity (CHEBI:50860) |
| ivonescimab (CHEBI:760362) is a organic molecular entity (CHEBI:50860) |
| ivuxolimab (CHEBI:757321) is a organic molecular entity (CHEBI:50860) |
| IXA21 (CHEBI:746970) is a organic molecular entity (CHEBI:50860) |
| IXA554 (CHEBI:746972) is a organic molecular entity (CHEBI:50860) |
| IXA62 (CHEBI:746966) is a organic molecular entity (CHEBI:50860) |
| IXA624 (CHEBI:746973) is a organic molecular entity (CHEBI:50860) |
| IXA76 (CHEBI:746971) is a organic molecular entity (CHEBI:50860) |
| ixekizumab (CHEBI:750112) is a organic molecular entity (CHEBI:50860) |
| ixmyelocel-t (CHEBI:753670) is a organic molecular entity (CHEBI:50860) |
| ixoberogene soroparvovec (CHEBI:759005) is a organic molecular entity (CHEBI:50860) |
| izalontamab (CHEBI:758950) is a organic molecular entity (CHEBI:50860) |
| izalontamab brengitecan (CHEBI:759534) is a organic molecular entity (CHEBI:50860) |
| izastobart (CHEBI:759535) is a organic molecular entity (CHEBI:50860) |
| izeltabart (CHEBI:759380) is a organic molecular entity (CHEBI:50860) |
| izeltabart tapatansine (CHEBI:758914) is a organic molecular entity (CHEBI:50860) |
| izenivetmab (CHEBI:758711) is a organic molecular entity (CHEBI:50860) |
| izokibep (CHEBI:757143) is a organic molecular entity (CHEBI:50860) |
| izuralimab (CHEBI:758576) is a organic molecular entity (CHEBI:50860) |
| j591 (CHEBI:754316) is a organic molecular entity (CHEBI:50860) |
| j591 177lu (CHEBI:754323) is a organic molecular entity (CHEBI:50860) |
| Jamaicamide (CHEBI:80111) is a organic molecular entity (CHEBI:50860) |
| japanese encephalitis virus, inactivated (CHEBI:760278) is a organic molecular entity (CHEBI:50860) |
| jnj-17216498 (CHEBI:755424) is a organic molecular entity (CHEBI:50860) |
| JS-K (CHEBI:232953) is a organic molecular entity (CHEBI:50860) |
| jte-151 (CHEBI:755593) is a organic molecular entity (CHEBI:50860) |
| juglanin B (CHEBI:66127) is a organic molecular entity (CHEBI:50860) |
| junipegenin a (CHEBI:230758) is a organic molecular entity (CHEBI:50860) |
| juniper tar (CHEBI:753359) is a organic molecular entity (CHEBI:50860) |
| JW-65 (CHEBI:747373) is a organic molecular entity (CHEBI:50860) |
| JZL184 (CHEBI:232864) is a organic molecular entity (CHEBI:50860) |
| k-877 (CHEBI:755628) is a organic molecular entity (CHEBI:50860) |
| kabiramide C (CHEBI:68063) is a organic molecular entity (CHEBI:50860) |
| kai-1678 (CHEBI:757223) is a organic molecular entity (CHEBI:50860) |
| kallidinogenase (CHEBI:753964) is a organic molecular entity (CHEBI:50860) |
| kallikrein-1 (CHEBI:757535) is a organic molecular entity (CHEBI:50860) |
| kasal (CHEBI:753454) is a organic molecular entity (CHEBI:50860) |
| Kassinin (CHEBI:80145) is a organic molecular entity (CHEBI:50860) |
| Katacalcin (CHEBI:80147) is a organic molecular entity (CHEBI:50860) |
| kazinol h (CHEBI:230600) is a organic molecular entity (CHEBI:50860) |
| kb-001 (CHEBI:754308) is a organic molecular entity (CHEBI:50860) |
| kb-004 (CHEBI:754209) is a organic molecular entity (CHEBI:50860) |
| KB-R7943 (CHEBI:232494) is a organic molecular entity (CHEBI:50860) |
| KBH (CHEBI:232964) is a organic molecular entity (CHEBI:50860) |
| kbp5209 (CHEBI:758192) is a organic molecular entity (CHEBI:50860) |
| kbpa-101 (CHEBI:754307) is a organic molecular entity (CHEBI:50860) |
| kd-247 (CHEBI:754238) is a organic molecular entity (CHEBI:50860) |
| kd3010 (CHEBI:755467) is a organic molecular entity (CHEBI:50860) |
| keliximab (CHEBI:753455) is a organic molecular entity (CHEBI:50860) |
| Kemptide (CHEBI:80146) is a organic molecular entity (CHEBI:50860) |
| keyhole limpet hemocyanin (CHEBI:759678) is a organic molecular entity (CHEBI:50860) |
| khk-2866 (CHEBI:754230) is a organic molecular entity (CHEBI:50860) |
| KHS101 (CHEBI:231700) is a organic molecular entity (CHEBI:50860) |
| KIN1148 (CHEBI:232549) is a organic molecular entity (CHEBI:50860) |
| kisspeptin (CHEBI:758292) is a organic molecular entity (CHEBI:50860) |
| Kisspeptin-10 (CHEBI:80307) is a organic molecular entity (CHEBI:50860) |
| Kisspeptin-13 (CHEBI:80306) is a organic molecular entity (CHEBI:50860) |
| Kisspeptin-14 (CHEBI:80305) is a organic molecular entity (CHEBI:50860) |
| Kitasamycin tartrate (CHEBI:34804) is a organic molecular entity (CHEBI:50860) |
| KL001 (CHEBI:232813) is a organic molecular entity (CHEBI:50860) |
| klysimplexin R (CHEBI:192713) is a organic molecular entity (CHEBI:50860) |
| kn-026 (CHEBI:758041) is a organic molecular entity (CHEBI:50860) |
| kolfocon a (CHEBI:753360) is a organic molecular entity (CHEBI:50860) |
| konjac mannan (CHEBI:757389) is a organic molecular entity (CHEBI:50860) |
| KPT-276 (CHEBI:232870) is a organic molecular entity (CHEBI:50860) |
| Krm 1657 (CHEBI:34806) is a organic molecular entity (CHEBI:50860) |
| krn-330 (CHEBI:754142) is a organic molecular entity (CHEBI:50860) |
| KRN2 (CHEBI:233647) is a organic molecular entity (CHEBI:50860) |
| krypton clathrate kr 85 (CHEBI:754921) is a organic molecular entity (CHEBI:50860) |
| KU-0058948 (CHEBI:235312) is a organic molecular entity (CHEBI:50860) |
| KYT 0353 (CHEBI:231341) is a organic molecular entity (CHEBI:50860) |
| L-6-bromohypaphorine (CHEBI:194578) is a organic molecular entity (CHEBI:50860) |
| L-744832 (CHEBI:232858) is a organic molecular entity (CHEBI:50860) |
| L-DOPA-2,5,6-d3 (CHEBI:233994) is a organic molecular entity (CHEBI:50860) |
| l-dos47 (CHEBI:757959) is a organic molecular entity (CHEBI:50860) |
| L-fructose 1-phosphate (CHEBI:194164) is a organic molecular entity (CHEBI:50860) |
| L-galactosamine (CHEBI:194169) is a organic molecular entity (CHEBI:50860) |
| L-glucosamine (CHEBI:194163) is a organic molecular entity (CHEBI:50860) |
| L-Phenylalanine, 4-[3-(trifluoromethyl)-3H-diazirin-3-yl]- (CHEBI:232457) is a organic molecular entity (CHEBI:50860) |
| L-Prolyl-[pcp] (CHEBI:31756) is a organic molecular entity (CHEBI:50860) |
| L-Tyrosyl-[pcp] (CHEBI:31758) is a organic molecular entity (CHEBI:50860) |
| L-α-hydroxyglutaric acid disodium salt (CHEBI:233138) is a organic molecular entity (CHEBI:50860) |
| l19il2 (CHEBI:754357) is a organic molecular entity (CHEBI:50860) |
| l19sip 131i (CHEBI:754215) is a organic molecular entity (CHEBI:50860) |
| l19tnfa (CHEBI:754346) is a organic molecular entity (CHEBI:50860) |
| labafenogene marselecobac (CHEBI:759442) is a organic molecular entity (CHEBI:50860) |
| labd-13-en-8,15-diol (CHEBI:192824) is a organic molecular entity (CHEBI:50860) |
| labetuzumab (CHEBI:753465) is a organic molecular entity (CHEBI:50860) |
| labetuzumab govitecan (CHEBI:755376) is a organic molecular entity (CHEBI:50860) |
| lactalfate (CHEBI:753361) is a organic molecular entity (CHEBI:50860) |
| lactase (CHEBI:753469) is a organic molecular entity (CHEBI:50860) |
| Lactenosin (CHEBI:6352) is a organic molecular entity (CHEBI:50860) |
| Lacto-N-decaose (CHEBI:195317) is a organic molecular entity (CHEBI:50860) |
| Lacto-N-neodecaose (CHEBI:195318) is a organic molecular entity (CHEBI:50860) |
| lactobacillus acidophilus (CHEBI:753965) is a organic molecular entity (CHEBI:50860) |
| lactoferrin, bovine (CHEBI:758892) is a organic molecular entity (CHEBI:50860) |
| lactose monohydrate (CHEBI:759844) is a organic molecular entity (CHEBI:50860) |
| lactose, anhydrous (CHEBI:759088) is a organic molecular entity (CHEBI:50860) |
| lacutamab (CHEBI:757424) is a organic molecular entity (CHEBI:50860) |
| lademirsen (CHEBI:757506) is a organic molecular entity (CHEBI:50860) |
| lademirsen sodium (CHEBI:756752) is a organic molecular entity (CHEBI:50860) |
| ladiratuzumab vedotin (CHEBI:757520) is a organic molecular entity (CHEBI:50860) |
| Lafutidine (CHEBI:31759) is a organic molecular entity (CHEBI:50860) |
| lafuvitug (CHEBI:759696) is a organic molecular entity (CHEBI:50860) |
| lalikinogene sifuplasmid (CHEBI:760381) is a organic molecular entity (CHEBI:50860) |
| lampalizumab (CHEBI:754212) is a organic molecular entity (CHEBI:50860) |
| lanadelumab (CHEBI:755504) is a organic molecular entity (CHEBI:50860) |
| lancastotug (CHEBI:759536) is a organic molecular entity (CHEBI:50860) |
| landogrozumab (CHEBI:755447) is a organic molecular entity (CHEBI:50860) |
| lanerkitug (CHEBI:760044) is a organic molecular entity (CHEBI:50860) |
| lanimostim (CHEBI:753567) is a organic molecular entity (CHEBI:50860) |
| Lankacidin C (CHEBI:80085) is a organic molecular entity (CHEBI:50860) |
| lanolin (CHEBI:753362) is a organic molecular entity (CHEBI:50860) |
| lanolin alcohols (CHEBI:753966) is a organic molecular entity (CHEBI:50860) |
| lanolin, modified (CHEBI:753729) is a organic molecular entity (CHEBI:50860) |
| lanoteplase (CHEBI:753464) is a organic molecular entity (CHEBI:50860) |
| lansoprazole sulfide (CHEBI:230581) is a organic molecular entity (CHEBI:50860) |
| lanthanum carbonate (CHEBI:750449) is a organic molecular entity (CHEBI:50860) |
| lapuleucel-t (CHEBI:753568) is a organic molecular entity (CHEBI:50860) |
| larcaviximab (CHEBI:756463) is a organic molecular entity (CHEBI:50860) |
| lard (CHEBI:753160) is a organic molecular entity (CHEBI:50860) |
| laricovatein (CHEBI:759488) is a organic molecular entity (CHEBI:50860) |
| larnefpendekin alfa (CHEBI:760174) is a organic molecular entity (CHEBI:50860) |
| laronidase (CHEBI:749444) is a organic molecular entity (CHEBI:50860) |
| laruparetigene zovaparvovec (CHEBI:758990) is a organic molecular entity (CHEBI:50860) |
| lasmecabtagene timgedleucel (CHEBI:760175) is a organic molecular entity (CHEBI:50860) |
| lat-8881 (CHEBI:760521) is a organic molecular entity (CHEBI:50860) |
| latiglutenase (CHEBI:755170) is a organic molecular entity (CHEBI:50860) |
| latikafusp (CHEBI:758712) is a organic molecular entity (CHEBI:50860) |
| latovetcel (CHEBI:759537) is a organic molecular entity (CHEBI:50860) |
| latozinemab (CHEBI:758325) is a organic molecular entity (CHEBI:50860) |
| Lauric diethanolamine (CHEBI:229527) is a organic molecular entity (CHEBI:50860) |
| lavender oil (CHEBI:753213) is a organic molecular entity (CHEBI:50860) |
| Lavoisieric acid (CHEBI:197300) is a organic molecular entity (CHEBI:50860) |
| lby-135 (CHEBI:754117) is a organic molecular entity (CHEBI:50860) |
| LCS3 (CHEBI:232545) is a organic molecular entity (CHEBI:50860) |
| LDN-193189 (CHEBI:747377) is a organic molecular entity (CHEBI:50860) |
| lead (212pb) bamzireotide navoxetan (CHEBI:759985) is a organic molecular entity (CHEBI:50860) |
| lead (212pb) lapemelanotide zapixetan (CHEBI:759986) is a organic molecular entity (CHEBI:50860) |
| lead bamzireotide navoxetan (CHEBI:760536) is a organic molecular entity (CHEBI:50860) |
| lead lapemelanotide zapixetan (CHEBI:760537) is a organic molecular entity (CHEBI:50860) |
| lebrikizumab (CHEBI:750113) is a organic molecular entity (CHEBI:50860) |
| lecanemab (CHEBI:755918) is a organic molecular entity (CHEBI:50860) |
| lecilimogene autotemcel (CHEBI:758713) is a organic molecular entity (CHEBI:50860) |
| leconotide (CHEBI:753391) is a organic molecular entity (CHEBI:50860) |
| ledismase (CHEBI:754018) is a organic molecular entity (CHEBI:50860) |
| lefelsiran (CHEBI:759343) is a organic molecular entity (CHEBI:50860) |
| lefelsiran sodium (CHEBI:759342) is a organic molecular entity (CHEBI:50860) |
| lefitolimod (CHEBI:757224) is a organic molecular entity (CHEBI:50860) |
| leish-f3 (CHEBI:758293) is a organic molecular entity (CHEBI:50860) |
| leishmania infantum excreted secreted proteins (CHEBI:759767) is a organic molecular entity (CHEBI:50860) |
| lemalesomab (CHEBI:754019) is a organic molecular entity (CHEBI:50860) |
| lemon oil (CHEBI:753392) is a organic molecular entity (CHEBI:50860) |
| lemon tincture (CHEBI:753460) is a organic molecular entity (CHEBI:50860) |
| lemoxinol (CHEBI:753461) is a organic molecular entity (CHEBI:50860) |
| lemzoparlimab (CHEBI:758397) is a organic molecular entity (CHEBI:50860) |
| Lenacapavir (CHEBI:234519) is a organic molecular entity (CHEBI:50860) |
| lenefilcon a (CHEBI:753554) is a organic molecular entity (CHEBI:50860) |
| lenercept (CHEBI:753212) is a organic molecular entity (CHEBI:50860) |
| lenograstim (CHEBI:754020) is a organic molecular entity (CHEBI:50860) |
| lenomorelin (CHEBI:753291) is a organic molecular entity (CHEBI:50860) |
| lenperone (CHEBI:230698) is a organic molecular entity (CHEBI:50860) |
| lenvervimab (CHEBI:760512) is a organic molecular entity (CHEBI:50860) |
| lenzilumab (CHEBI:755801) is a organic molecular entity (CHEBI:50860) |
| leo-15520 (CHEBI:755449) is a organic molecular entity (CHEBI:50860) |
| lepodisiran (CHEBI:760356) is a organic molecular entity (CHEBI:50860) |
| lepodisiran sodium (CHEBI:760357) is a organic molecular entity (CHEBI:50860) |
| lerdelimumab (CHEBI:753877) is a organic molecular entity (CHEBI:50860) |
| leridistim (CHEBI:753393) is a organic molecular entity (CHEBI:50860) |
| lerodalcibep (CHEBI:758294) is a organic molecular entity (CHEBI:50860) |
| leronlimab (CHEBI:754173) is a organic molecular entity (CHEBI:50860) |
| lesabelimab (CHEBI:758714) is a organic molecular entity (CHEBI:50860) |
| lesigercept (CHEBI:760045) is a organic molecular entity (CHEBI:50860) |
| lesinidase alfa (CHEBI:756499) is a organic molecular entity (CHEBI:50860) |
| lesofavumab (CHEBI:757464) is a organic molecular entity (CHEBI:50860) |
| letetresgene autoleucel (CHEBI:758144) is a organic molecular entity (CHEBI:50860) |
| letibotulinumtoxina (CHEBI:755798) is a organic molecular entity (CHEBI:50860) |
| letolizumab (CHEBI:756482) is a organic molecular entity (CHEBI:50860) |
| leuciglumer (CHEBI:753394) is a organic molecular entity (CHEBI:50860) |
| leucinochenodeoxycholic acid (CHEBI:232210) is a organic molecular entity (CHEBI:50860) |
| leucinocholic acid (CHEBI:232265) is a organic molecular entity (CHEBI:50860) |
| leucinodeoxycholic acid (CHEBI:232228) is a organic molecular entity (CHEBI:50860) |
| leucinolithocholic acid (CHEBI:232191) is a organic molecular entity (CHEBI:50860) |
| leucinoursodeoxycholic acid (CHEBI:232284) is a organic molecular entity (CHEBI:50860) |
| Leucokinin VIII (CHEBI:80185) is a organic molecular entity (CHEBI:50860) |
| leukocyte typing serum (CHEBI:754021) is a organic molecular entity (CHEBI:50860) |
| Leumorphin (CHEBI:80260) is a organic molecular entity (CHEBI:50860) |
| Levamisole hydrochloride (CHEBI:6433) is a organic molecular entity (CHEBI:50860) |
| levilimab (CHEBI:758295) is a organic molecular entity (CHEBI:50860) |
| levocarnitine chloride (CHEBI:233463) is a organic molecular entity (CHEBI:50860) |
| levothyroxine sodium hydrate (CHEBI:6447) is a organic molecular entity (CHEBI:50860) |
| Lewis A antigen (CHEBI:140878) is a organic molecular entity (CHEBI:50860) |
| Lewis X antigen (CHEBI:140911) is a organic molecular entity (CHEBI:50860) |
| Lewis Y antigen (CHEBI:140912) is a organic molecular entity (CHEBI:50860) |
| lexanersen (CHEBI:758168) is a organic molecular entity (CHEBI:50860) |
| lexanersen sodium (CHEBI:758404) is a organic molecular entity (CHEBI:50860) |
| lexaptepid pegol (CHEBI:757484) is a organic molecular entity (CHEBI:50860) |
| lexatumumab (CHEBI:750114) is a organic molecular entity (CHEBI:50860) |
| lexgenleucel-t (CHEBI:752894) is a organic molecular entity (CHEBI:50860) |
| lfb-r603 (CHEBI:754176) is a organic molecular entity (CHEBI:50860) |
| lgx-806 (CHEBI:755548) is a organic molecular entity (CHEBI:50860) |
| lh (menotropins) (CHEBI:749582) is a organic molecular entity (CHEBI:50860) |
| lhc-165 (CHEBI:758043) is a organic molecular entity (CHEBI:50860) |
| liatermin (CHEBI:753356) is a organic molecular entity (CHEBI:50860) |
| libevitug (CHEBI:760046) is a organic molecular entity (CHEBI:50860) |
| libivirumab (CHEBI:753569) is a organic molecular entity (CHEBI:50860) |
| licaminlimab (CHEBI:759051) is a organic molecular entity (CHEBI:50860) |
| Lichenysin D (CHEBI:31774) is a organic molecular entity (CHEBI:50860) |
| licorice (CHEBI:753957) is a organic molecular entity (CHEBI:50860) |
| licryfilcon a (CHEBI:753958) is a organic molecular entity (CHEBI:50860) |
| licryfilcon b (CHEBI:753357) is a organic molecular entity (CHEBI:50860) |
| lidofilcon a (CHEBI:753959) is a organic molecular entity (CHEBI:50860) |
| lidofilcon b (CHEBI:753960) is a organic molecular entity (CHEBI:50860) |
| Liebigeic acid (CHEBI:195355) is a organic molecular entity (CHEBI:50860) |
| lifastuzumab (CHEBI:755545) is a organic molecular entity (CHEBI:50860) |
| lifastuzumab vedotin (CHEBI:757369) is a organic molecular entity (CHEBI:50860) |
| lifileucel (CHEBI:757607) is a organic molecular entity (CHEBI:50860) |
| ligelizumab (CHEBI:754247) is a organic molecular entity (CHEBI:50860) |
| lilotomab (CHEBI:758567) is a organic molecular entity (CHEBI:50860) |
| limaresiquimod (CHEBI:759538) is a organic molecular entity (CHEBI:50860) |
| lime, sulfurated (CHEBI:753961) is a organic molecular entity (CHEBI:50860) |
| linavonkibart (CHEBI:759381) is a organic molecular entity (CHEBI:50860) |
| linclatamig (CHEBI:760047) is a organic molecular entity (CHEBI:50860) |
| linoleoyl containing 1,2,3-triacyl-sn-glycerol (CHEBI:144774) is a organic molecular entity (CHEBI:50860) |
| linoleoyl polyoxylglycerides (CHEBI:753570) is a organic molecular entity (CHEBI:50860) |
| Linoleoyl-[acyl-carrier protein] (CHEBI:80357) is a organic molecular entity (CHEBI:50860) |
| linoserpaturev (CHEBI:760176) is a organic molecular entity (CHEBI:50860) |
| lintuzumab (CHEBI:754042) is a organic molecular entity (CHEBI:50860) |
| lintuzumab actinium ac-225 (CHEBI:757029) is a organic molecular entity (CHEBI:50860) |
| linvekinogene treniplasmid (CHEBI:759382) is a organic molecular entity (CHEBI:50860) |
| linvoseltamab (CHEBI:758940) is a organic molecular entity (CHEBI:50860) |
| lipase (pancrelipase) (CHEBI:749431) is a organic molecular entity (CHEBI:50860) |
| lipegfilgrastim (CHEBI:757744) is a organic molecular entity (CHEBI:50860) |
| lipid (CHEBI:18059) is a organic molecular entity (CHEBI:50860) |
| lipo-chitin oligosaccharide (CHEBI:67062) is a organic molecular entity (CHEBI:50860) |
| Lipomannan (CHEBI:142968) is a organic molecular entity (CHEBI:50860) |
| Lipoyl-[acp] (CHEBI:80400) is a organic molecular entity (CHEBI:50860) |
| liprotamase (CHEBI:753647) is a organic molecular entity (CHEBI:50860) |
| lipustobart (CHEBI:759383) is a organic molecular entity (CHEBI:50860) |
| lirentelimab (CHEBI:757316) is a organic molecular entity (CHEBI:50860) |
| lirilumab (CHEBI:754281) is a organic molecular entity (CHEBI:50860) |
| lisocabtagene maraleucel (CHEBI:756742) is a organic molecular entity (CHEBI:50860) |
| litenimod (CHEBI:753288) is a organic molecular entity (CHEBI:50860) |
| litgenprostucel-l (CHEBI:753571) is a organic molecular entity (CHEBI:50860) |
| lithocholic acid 3-o-glucuronide (CHEBI:230723) is a organic molecular entity (CHEBI:50860) |
| litifilimab (CHEBI:755908) is a organic molecular entity (CHEBI:50860) |
| Litorin (CHEBI:80360) is a organic molecular entity (CHEBI:50860) |
| livaraparin calcium (CHEBI:753407) is a organic molecular entity (CHEBI:50860) |
| live aroa gene deleted escherichia coli, type 078, strain ec34195 (CHEBI:759786) is a organic molecular entity (CHEBI:50860) |
| live attenuated aujeszkys disease virus, strain nia3-783 (CHEBI:759776) is a organic molecular entity (CHEBI:50860) |
| live attenuated muscovy duck parvovirus strain gm 199 (CHEBI:759779) is a organic molecular entity (CHEBI:50860) |
| live avian infectious bronchitis virus, strain d388 (CHEBI:759788) is a organic molecular entity (CHEBI:50860) |
| live myxoma-vectored rabbit-haemorrhagic-disease virus strain 009 (CHEBI:759771) is a organic molecular entity (CHEBI:50860) |
| live non-pathogenic escherichia coli o8: k87 (CHEBI:759783) is a organic molecular entity (CHEBI:50860) |
| liver extract (CHEBI:753480) is a organic molecular entity (CHEBI:50860) |
| Liver-expressed antimicrobial peptide 1 (CHEBI:80285) is a organic molecular entity (CHEBI:50860) |
| Liver-expressed antimicrobial peptide 2 (CHEBI:80286) is a organic molecular entity (CHEBI:50860) |
| livmoniplimab (CHEBI:759679) is a organic molecular entity (CHEBI:50860) |
| lixmabegagene relduparvovec (CHEBI:758715) is a organic molecular entity (CHEBI:50860) |
| lixudebart (CHEBI:759443) is a organic molecular entity (CHEBI:50860) |
| LL-37 (CHEBI:81664) is a organic molecular entity (CHEBI:50860) |
| LLY283 (CHEBI:232587) is a organic molecular entity (CHEBI:50860) |
| lmb-1 (CHEBI:754149) is a organic molecular entity (CHEBI:50860) |
| lmb-100 (CHEBI:757225) is a organic molecular entity (CHEBI:50860) |
| lmb-2 (CHEBI:754190) is a organic molecular entity (CHEBI:50860) |
| lmb-7 (CHEBI:754150) is a organic molecular entity (CHEBI:50860) |
| lmb-9 (CHEBI:754284) is a organic molecular entity (CHEBI:50860) |
| lmgp06020080 (CHEBI:230687) is a organic molecular entity (CHEBI:50860) |
| lmpk12010098 (CHEBI:230772) is a organic molecular entity (CHEBI:50860) |
| lmpk12050050 (CHEBI:230594) is a organic molecular entity (CHEBI:50860) |
| lmpk12050119 (CHEBI:230619) is a organic molecular entity (CHEBI:50860) |
| lmpk12050368 (CHEBI:230693) is a organic molecular entity (CHEBI:50860) |
| lmst01010143 (CHEBI:230573) is a organic molecular entity (CHEBI:50860) |
| lmst01010314 (CHEBI:230587) is a organic molecular entity (CHEBI:50860) |
| lmst01010385 (CHEBI:230559) is a organic molecular entity (CHEBI:50860) |
| lobeline hydrochloride (CHEBI:234117) is a organic molecular entity (CHEBI:50860) |
| lodapolimab (CHEBI:757444) is a organic molecular entity (CHEBI:50860) |
| lofacimig (CHEBI:760177) is a organic molecular entity (CHEBI:50860) |
| lokivetmab (CHEBI:759753) is a organic molecular entity (CHEBI:50860) |
| Lomotil (CHEBI:6519) is a organic molecular entity (CHEBI:50860) |
| lomvastomig (CHEBI:758074) is a organic molecular entity (CHEBI:50860) |
| lonapegsomatropin (CHEBI:757592) is a organic molecular entity (CHEBI:50860) |
| loncastuximab (CHEBI:756744) is a organic molecular entity (CHEBI:50860) |
| loncastuximab tesirine (CHEBI:757226) is a organic molecular entity (CHEBI:50860) |
| Long-chain carboxylate (CHEBI:6526) is a organic molecular entity (CHEBI:50860) |
| Long-chain ester (CHEBI:6527) is a organic molecular entity (CHEBI:50860) |
| lonigutamab (CHEBI:759680) is a organic molecular entity (CHEBI:50860) |
| Lonijaposide J (CHEBI:69648) is a organic molecular entity (CHEBI:50860) |
| lonimecgene renparvovec (CHEBI:760048) is a organic molecular entity (CHEBI:50860) |
| lonoctocog alfa (CHEBI:758075) is a organic molecular entity (CHEBI:50860) |
| lontucirev (CHEBI:753052) is a organic molecular entity (CHEBI:50860) |
| lontucirev (replicating adenovirus) (CHEBI:753572) is a organic molecular entity (CHEBI:50860) |
| lonvoguran (CHEBI:760049) is a organic molecular entity (CHEBI:50860) |
| loracarbef monohydrate (CHEBI:6537) is a organic molecular entity (CHEBI:50860) |
| lorecivivint (CHEBI:747481) is a organic molecular entity (CHEBI:50860) |
| lorigerlimab (CHEBI:758854) is a organic molecular entity (CHEBI:50860) |
| lorutengitide (CHEBI:760050) is a organic molecular entity (CHEBI:50860) |
| lorvotuzumab mertansine (CHEBI:750115) is a organic molecular entity (CHEBI:50860) |
| losatuxizumab vedotin (CHEBI:757989) is a organic molecular entity (CHEBI:50860) |
| lotivibart (CHEBI:760178) is a organic molecular entity (CHEBI:50860) |
| lotrafilcon a (CHEBI:753053) is a organic molecular entity (CHEBI:50860) |
| lotrafilcon b (CHEBI:753573) is a organic molecular entity (CHEBI:50860) |
| loviride (CHEBI:230669) is a organic molecular entity (CHEBI:50860) |
| lovotibeglogene autotemcel (CHEBI:758175) is a organic molecular entity (CHEBI:50860) |
| Lower primary alcohol (CHEBI:6547) is a organic molecular entity (CHEBI:50860) |
| Loxiglumide (CHEBI:31785) is a organic molecular entity (CHEBI:50860) |
| LPS O antigen repeat from P. aeruginosa serotype 10 (CHEBI:156535) is a organic molecular entity (CHEBI:50860) |
| LRRKtide amide (CHEBI:195429) is a organic molecular entity (CHEBI:50860) |
| lsalt peptide (CHEBI:759681) is a organic molecular entity (CHEBI:50860) |
| lti-03 (CHEBI:760490) is a organic molecular entity (CHEBI:50860) |
| lucatumumab (CHEBI:750116) is a organic molecular entity (CHEBI:50860) |
| lucicebtide (CHEBI:759539) is a organic molecular entity (CHEBI:50860) |
| lucinactant (CHEBI:750321) is a organic molecular entity (CHEBI:50860) |
| lucorafusp alfa (CHEBI:760051) is a organic molecular entity (CHEBI:50860) |
| lucoridalines (CHEBI:759333) is a organic molecular entity (CHEBI:50860) |
| LUF6000 (CHEBI:747580) is a organic molecular entity (CHEBI:50860) |
| lulizumab pegol (CHEBI:755180) is a organic molecular entity (CHEBI:50860) |
| lumasiran (CHEBI:757227) is a organic molecular entity (CHEBI:50860) |
| lumasiran sodium (CHEBI:758181) is a organic molecular entity (CHEBI:50860) |
| lumiliximab (CHEBI:754043) is a organic molecular entity (CHEBI:50860) |
| Lumirhodopsin (CHEBI:6562) is a organic molecular entity (CHEBI:50860) |
| lumistobart (CHEBI:760052) is a organic molecular entity (CHEBI:50860) |
| lumretuzumab (CHEBI:755855) is a organic molecular entity (CHEBI:50860) |
| lumrotatug (CHEBI:759540) is a organic molecular entity (CHEBI:50860) |
| lunaxafusp (CHEBI:759384) is a organic molecular entity (CHEBI:50860) |
| lunbotinib (CHEBI:760053) is a organic molecular entity (CHEBI:50860) |
| lunlekitug (CHEBI:760366) is a organic molecular entity (CHEBI:50860) |
| lunsekimig (CHEBI:759541) is a organic molecular entity (CHEBI:50860) |
| lupeol acetate (CHEBI:69744) is a organic molecular entity (CHEBI:50860) |
| lusacomfar alfa (CHEBI:758905) is a organic molecular entity (CHEBI:50860) |
| luspatercept (CHEBI:755086) is a organic molecular entity (CHEBI:50860) |
| lusvertikimab (CHEBI:758379) is a organic molecular entity (CHEBI:50860) |
| lutadenovec autogene (CHEBI:760179) is a organic molecular entity (CHEBI:50860) |
| lutetium (177lu) tezuvotide tetraxetan (CHEBI:759976) is a organic molecular entity (CHEBI:50860) |
| lutetium (lu177) lilotomab satetraxetan (CHEBI:758568) is a organic molecular entity (CHEBI:50860) |
| lutetium (lu177) rofapitide tetraxetan (CHEBI:759174) is a organic molecular entity (CHEBI:50860) |
| lutetium (lu177) rosopatamab tetraxetan (CHEBI:760054) is a organic molecular entity (CHEBI:50860) |
| lutetium chloride (CHEBI:759822) is a organic molecular entity (CHEBI:50860) |
| lutetium chloride lu-177 (CHEBI:759745) is a organic molecular entity (CHEBI:50860) |
| lutetium lu 177 zadavotide guraxetan (CHEBI:759628) is a organic molecular entity (CHEBI:50860) |
| lutetium lu-177 psma-r2 (CHEBI:760439) is a organic molecular entity (CHEBI:50860) |
| lutetium lu-177 vipivotide tetraxetan (CHEBI:757895) is a organic molecular entity (CHEBI:50860) |
| lutetium lu177 edotreotide (CHEBI:758987) is a organic molecular entity (CHEBI:50860) |
| lutetium oxodotreotide (CHEBI:757641) is a organic molecular entity (CHEBI:50860) |
| lutetium oxodotreotide lu-177 (CHEBI:757020) is a organic molecular entity (CHEBI:50860) |
| lutetium psma-r2 (CHEBI:760542) is a organic molecular entity (CHEBI:50860) |
| lutetium rofapitidexetan (CHEBI:759811) is a organic molecular entity (CHEBI:50860) |
| lutetium tezuvotidexetan (CHEBI:760535) is a organic molecular entity (CHEBI:50860) |
| lutikizumab (CHEBI:757992) is a organic molecular entity (CHEBI:50860) |
| lutropin alfa (CHEBI:749523) is a organic molecular entity (CHEBI:50860) |
| luvagrobart (CHEBI:759542) is a organic molecular entity (CHEBI:50860) |
| luveltamab tazevibulin (CHEBI:758716) is a organic molecular entity (CHEBI:50860) |
| luveltamab tazide (CHEBI:758717) is a organic molecular entity (CHEBI:50860) |
| luvomeran (CHEBI:760055) is a organic molecular entity (CHEBI:50860) |
| Luzopeptin (CHEBI:80122) is a organic molecular entity (CHEBI:50860) |
| LX-623 (CHEBI:232814) is a organic molecular entity (CHEBI:50860) |
| LY 272015 Hydrochloride (CHEBI:747852) is a organic molecular entity (CHEBI:50860) |
| ly-2382770 (CHEBI:754342) is a organic molecular entity (CHEBI:50860) |
| ly-2405319 (CHEBI:759717) is a organic molecular entity (CHEBI:50860) |
| ly-2599666 (CHEBI:757439) is a organic molecular entity (CHEBI:50860) |
| ly-2624587 (CHEBI:758045) is a organic molecular entity (CHEBI:50860) |
| ly-2780301 (CHEBI:755478) is a organic molecular entity (CHEBI:50860) |
| ly-2787106 (CHEBI:754233) is a organic molecular entity (CHEBI:50860) |
| ly-3007113 (CHEBI:755413) is a organic molecular entity (CHEBI:50860) |
| ly-3076226 (CHEBI:757441) is a organic molecular entity (CHEBI:50860) |
| ly-3164530 (CHEBI:757442) is a organic molecular entity (CHEBI:50860) |
| ly-3185643 (CHEBI:757443) is a organic molecular entity (CHEBI:50860) |
| ly-3321367 (CHEBI:757446) is a organic molecular entity (CHEBI:50860) |
| ly-3415244 (CHEBI:758047) is a organic molecular entity (CHEBI:50860) |
| ly2245461 (CHEBI:755613) is a organic molecular entity (CHEBI:50860) |
| ly2590443 (CHEBI:755523) is a organic molecular entity (CHEBI:50860) |
| ly2940094 (CHEBI:755624) is a organic molecular entity (CHEBI:50860) |
| ly2969822 (CHEBI:755551) is a organic molecular entity (CHEBI:50860) |
| lyapolate sodium (CHEBI:755637) is a organic molecular entity (CHEBI:50860) |
| lym-1 (CHEBI:754239) is a organic molecular entity (CHEBI:50860) |
| lymphocyte activation gene 3 protein (CHEBI:757433) is a organic molecular entity (CHEBI:50860) |
| lymphogranuloma venereum antigen (CHEBI:753010) is a organic molecular entity (CHEBI:50860) |
| lysinochenodeoxcholic acid dimer (CHEBI:232212) is a organic molecular entity (CHEBI:50860) |
| lysinocholic acid dimer (CHEBI:232267) is a organic molecular entity (CHEBI:50860) |
| lysinodeoxycholic acid dimer (CHEBI:232230) is a organic molecular entity (CHEBI:50860) |
| lysinoursodeoxycholic acid dimer (CHEBI:232287) is a organic molecular entity (CHEBI:50860) |
| lysostaphin (CHEBI:753395) is a organic molecular entity (CHEBI:50860) |
| lysozyme chloride (CHEBI:752967) is a organic molecular entity (CHEBI:50860) |
| m-1095 (CHEBI:757447) is a organic molecular entity (CHEBI:50860) |
| m-Benzenesulfonium diazonium chloride (CHEBI:35086) is a organic molecular entity (CHEBI:50860) |
| m-Iodobenzylguanidine-123I (CHEBI:32348) is a organic molecular entity (CHEBI:50860) |
| m170 (CHEBI:754298) is a organic molecular entity (CHEBI:50860) |
| m195 (CHEBI:754131) is a organic molecular entity (CHEBI:50860) |
| M3 acceptor complex (CHEBI:166860) is a organic molecular entity (CHEBI:50860) |
| m5a 90y (CHEBI:754194) is a organic molecular entity (CHEBI:50860) |
| mab-216 (CHEBI:754240) is a organic molecular entity (CHEBI:50860) |
| mab-425 (CHEBI:754206) is a organic molecular entity (CHEBI:50860) |
| macitegtagene autoleucel (CHEBI:760180) is a organic molecular entity (CHEBI:50860) |
| macrosalb (131i) (CHEBI:754022) is a organic molecular entity (CHEBI:50860) |
| macrosalb (99mtc) (CHEBI:753015) is a organic molecular entity (CHEBI:50860) |
| macupatide (CHEBI:760398) is a organic molecular entity (CHEBI:50860) |
| mafilcon a (CHEBI:753483) is a organic molecular entity (CHEBI:50860) |
| Mafoprazine mesylate (CHEBI:81707) is a organic molecular entity (CHEBI:50860) |
| maftivimab (CHEBI:757591) is a organic molecular entity (CHEBI:50860) |
| Magainin 1 (CHEBI:80186) is a organic molecular entity (CHEBI:50860) |
| Magainin 2 (CHEBI:80190) is a organic molecular entity (CHEBI:50860) |
| MAGE-3 (271 - 279) (CHEBI:80192) is a organic molecular entity (CHEBI:50860) |
| magnesium aluminometasilicate (CHEBI:754023) is a organic molecular entity (CHEBI:50860) |
| magnesium aluminosilicate (CHEBI:754114) is a organic molecular entity (CHEBI:50860) |
| magnesium aluminum silicate (CHEBI:754024) is a organic molecular entity (CHEBI:50860) |
| magnesium aspartate (CHEBI:754115) is a organic molecular entity (CHEBI:50860) |
| magnesium glycinate (CHEBI:753396) is a organic molecular entity (CHEBI:50860) |
| Magnesium Isoglycyrrhizinate (CHEBI:233492) is a organic molecular entity (CHEBI:50860) |
| Magnesium L-ascorbic acid-2-phosphate (CHEBI:81686) is a organic molecular entity (CHEBI:50860) |
| Magnesium peroxide (CHEBI:81304) is a organic molecular entity (CHEBI:50860) |
| magnesium silicate (CHEBI:754025) is a organic molecular entity (CHEBI:50860) |
| magnesium-25(2+) (CHEBI:176599) is a organic molecular entity (CHEBI:50860) |
| magnocurarine trifluoroacetate, rac- (CHEBI:68906) is a organic molecular entity (CHEBI:50860) |
| magrolimab (CHEBI:757412) is a organic molecular entity (CHEBI:50860) |
| mak-683 (CHEBI:758370) is a organic molecular entity (CHEBI:50860) |
| maleimide-thiol (CHEBI:230453) is a organic molecular entity (CHEBI:50860) |
| malethamer (CHEBI:752965) is a organic molecular entity (CHEBI:50860) |
| mallotus japonicus extract (CHEBI:753730) is a organic molecular entity (CHEBI:50860) |
| malonyl-CoA lithium salt (CHEBI:232859) is a organic molecular entity (CHEBI:50860) |
| malt extract (CHEBI:752964) is a organic molecular entity (CHEBI:50860) |
| manelimab (CHEBI:758002) is a organic molecular entity (CHEBI:50860) |
| mangaciclanol (CHEBI:760056) is a organic molecular entity (CHEBI:50860) |
| mangafodipir (CHEBI:749406) is a organic molecular entity (CHEBI:50860) |
| mangafodipir trisodium (CHEBI:750450) is a organic molecular entity (CHEBI:50860) |
| manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin (CHEBI:232620) is a organic molecular entity (CHEBI:50860) |
| manganese chloride (CHEBI:759091) is a organic molecular entity (CHEBI:50860) |
| manganese chloride anhydrous (CHEBI:749300) is a organic molecular entity (CHEBI:50860) |
| manganese sulfate (CHEBI:750456) is a organic molecular entity (CHEBI:50860) |
| manganese sulfate anhydrous (CHEBI:749276) is a organic molecular entity (CHEBI:50860) |
| manganese-55(2+) (CHEBI:176610) is a organic molecular entity (CHEBI:50860) |
| manganese-55(4+) (CHEBI:176611) is a organic molecular entity (CHEBI:50860) |
| manganese-55(7+) (CHEBI:176612) is a organic molecular entity (CHEBI:50860) |
| mangofilcon a (CHEBI:755007) is a organic molecular entity (CHEBI:50860) |
| Mannomustine dihydrochloride (CHEBI:82481) is a organic molecular entity (CHEBI:50860) |
| manusiran (CHEBI:759385) is a organic molecular entity (CHEBI:50860) |
| mapatumumab (CHEBI:753574) is a organic molecular entity (CHEBI:50860) |
| maplirpacept (CHEBI:758504) is a organic molecular entity (CHEBI:50860) |
| margetuximab (CHEBI:754997) is a organic molecular entity (CHEBI:50860) |
| maridebart (CHEBI:759444) is a organic molecular entity (CHEBI:50860) |
| maridebart cafraglutide (CHEBI:759445) is a organic molecular entity (CHEBI:50860) |
| maritime pine (CHEBI:754097) is a organic molecular entity (CHEBI:50860) |
| maritime pine extract (CHEBI:754098) is a organic molecular entity (CHEBI:50860) |
| maritinamine Trifluoroacetic acid (CHEBI:68301) is a organic molecular entity (CHEBI:50860) |
| marlumotide (CHEBI:759446) is a organic molecular entity (CHEBI:50860) |
| marnetegragene autotemcel (CHEBI:758563) is a organic molecular entity (CHEBI:50860) |
| marstacimab (CHEBI:756519) is a organic molecular entity (CHEBI:50860) |
| marzeptacog alfa (activated) (CHEBI:757494) is a organic molecular entity (CHEBI:50860) |
| mas-825 (CHEBI:759719) is a organic molecular entity (CHEBI:50860) |
| Mas17 (CHEBI:80199) is a organic molecular entity (CHEBI:50860) |
| Mas7 (CHEBI:80197) is a organic molecular entity (CHEBI:50860) |
| Mas8 (CHEBI:80198) is a organic molecular entity (CHEBI:50860) |
| maslimomab (CHEBI:753442) is a organic molecular entity (CHEBI:50860) |
| mastigophorene a (CHEBI:230609) is a organic molecular entity (CHEBI:50860) |
| Matereic acid (CHEBI:197298) is a organic molecular entity (CHEBI:50860) |
| matrix-m1 adjuvant (CHEBI:758296) is a organic molecular entity (CHEBI:50860) |
| matuzumab (CHEBI:753054) is a organic molecular entity (CHEBI:50860) |
| maveropepimut-s (CHEBI:757818) is a organic molecular entity (CHEBI:50860) |
| mavilimogene ralaplasmid (CHEBI:756754) is a organic molecular entity (CHEBI:50860) |
| mavrilimumab (CHEBI:750117) is a organic molecular entity (CHEBI:50860) |
| mavrostobart (CHEBI:760181) is a organic molecular entity (CHEBI:50860) |
| Maxacalcitol (CHEBI:31801) is a organic molecular entity (CHEBI:50860) |
| Mazaticol hydrochloride (CHEBI:31802) is a organic molecular entity (CHEBI:50860) |
| mazdutide (CHEBI:758925) is a organic molecular entity (CHEBI:50860) |
| Mazindol (CHEBI:6702) is a organic molecular entity (CHEBI:50860) |
| MB0-002 (CHEBI:156507) is a organic molecular entity (CHEBI:50860) |
| mbas#10(1-) (CHEBI:140806) is a organic molecular entity (CHEBI:50860) |
| mbas#3(1-) (CHEBI:140807) is a organic molecular entity (CHEBI:50860) |
| mbl-hcv-1 (CHEBI:754231) is a organic molecular entity (CHEBI:50860) |
| mbx-2044 (CHEBI:755421) is a organic molecular entity (CHEBI:50860) |
| MC2050 (CHEBI:232977) is a organic molecular entity (CHEBI:50860) |
| mcmv-3068a (CHEBI:757450) is a organic molecular entity (CHEBI:50860) |
| mcs-110 (CHEBI:754290) is a organic molecular entity (CHEBI:50860) |
| mdx-033 (CHEBI:754274) is a organic molecular entity (CHEBI:50860) |
| mdx-070 (CHEBI:754319) is a organic molecular entity (CHEBI:50860) |
| mdx-1303 (CHEBI:754148) is a organic molecular entity (CHEBI:50860) |
| mdx-1342 (CHEBI:754169) is a organic molecular entity (CHEBI:50860) |
| mdx-1411 (CHEBI:754276) is a organic molecular entity (CHEBI:50860) |
| mdx-210 (CHEBI:754133) is a organic molecular entity (CHEBI:50860) |
| mdx-220 (CHEBI:754337) is a organic molecular entity (CHEBI:50860) |
| mdx-447 (CHEBI:754207) is a organic molecular entity (CHEBI:50860) |
| mdx-cd4 (CHEBI:754259) is a organic molecular entity (CHEBI:50860) |
| me1-14 f(ab')2 (CHEBI:754314) is a organic molecular entity (CHEBI:50860) |
| Meanjinic acid (CHEBI:195347) is a organic molecular entity (CHEBI:50860) |
| measles immune globulin (CHEBI:754099) is a organic molecular entity (CHEBI:50860) |
| measles virus vaccine live (CHEBI:754100) is a organic molecular entity (CHEBI:50860) |
| measles virus, live attenuated (CHEBI:760268) is a organic molecular entity (CHEBI:50860) |
| Mebutamate (CHEBI:31804) is a organic molecular entity (CHEBI:50860) |
| mecapegfilgrastim (CHEBI:758855) is a organic molecular entity (CHEBI:50860) |
| mecasermin (CHEBI:749581) is a organic molecular entity (CHEBI:50860) |
| mecasermin rinfabate (CHEBI:749578) is a organic molecular entity (CHEBI:50860) |
| mecbotamab (CHEBI:758991) is a organic molecular entity (CHEBI:50860) |
| mecbotamab vedotin (CHEBI:758885) is a organic molecular entity (CHEBI:50860) |
| mecobalamin (CHEBI:754965) is a organic molecular entity (CHEBI:50860) |
| Medazepam (CHEBI:31807) is a organic molecular entity (CHEBI:50860) |
| medi-0639 (CHEBI:757453) is a organic molecular entity (CHEBI:50860) |
| medi-3617 (CHEBI:754144) is a organic molecular entity (CHEBI:50860) |
| medi-4212 (CHEBI:754243) is a organic molecular entity (CHEBI:50860) |
| medi-4276 (CHEBI:757456) is a organic molecular entity (CHEBI:50860) |
| medi-500 (CHEBI:754349) is a organic molecular entity (CHEBI:50860) |
| medi-547 (CHEBI:757960) is a organic molecular entity (CHEBI:50860) |
| medi-557 (CHEBI:754327) is a organic molecular entity (CHEBI:50860) |
| medi-564 (CHEBI:754328) is a organic molecular entity (CHEBI:50860) |
| medi-565 (CHEBI:754193) is a organic molecular entity (CHEBI:50860) |
| medi-570 (CHEBI:754241) is a organic molecular entity (CHEBI:50860) |
| medi-578 (CHEBI:754300) is a organic molecular entity (CHEBI:50860) |
| medi-639 (CHEBI:754199) is a organic molecular entity (CHEBI:50860) |
| medi-6469 (CHEBI:754304) is a organic molecular entity (CHEBI:50860) |
| medi-7219 (CHEBI:760523) is a organic molecular entity (CHEBI:50860) |
| medi-7247 (CHEBI:757457) is a organic molecular entity (CHEBI:50860) |
| medi-8852 (CHEBI:757458) is a organic molecular entity (CHEBI:50860) |
| medi-8968 (CHEBI:754356) is a organic molecular entity (CHEBI:50860) |
| medium-chain fatty acyl-AMP(1−) (CHEBI:141140) is a organic molecular entity (CHEBI:50860) |
| medium-chain triglycerides (CHEBI:757465) is a organic molecular entity (CHEBI:50860) |
| Mefruside (CHEBI:31809) is a organic molecular entity (CHEBI:50860) |
| meglumine antimonate (CHEBI:748808) is a organic molecular entity (CHEBI:50860) |
| melafocon a (CHEBI:754032) is a organic molecular entity (CHEBI:50860) |
| Melanin-concentrating hormone (CHEBI:80254) is a organic molecular entity (CHEBI:50860) |
| melanoma-associated antigen 3 (CHEBI:758928) is a organic molecular entity (CHEBI:50860) |
| Melanotan II (CHEBI:195326) is a organic molecular entity (CHEBI:50860) |
| melevodopa hydrochloride (CHEBI:232320) is a organic molecular entity (CHEBI:50860) |
| melilot extract (CHEBI:754033) is a organic molecular entity (CHEBI:50860) |
| melinacidin IV (CHEBI:68758) is a organic molecular entity (CHEBI:50860) |
| Melinamide (CHEBI:31814) is a organic molecular entity (CHEBI:50860) |
| melredableukin alfa (CHEBI:758942) is a organic molecular entity (CHEBI:50860) |
| melrilimab (CHEBI:757400) is a organic molecular entity (CHEBI:50860) |
| Menfegol (CHEBI:31817) is a organic molecular entity (CHEBI:50860) |
| meningococcal polysaccharide vaccine group a (CHEBI:754034) is a organic molecular entity (CHEBI:50860) |
| meningococcal polysaccharide vaccine group c (CHEBI:753722) is a organic molecular entity (CHEBI:50860) |
| menotropins (CHEBI:753399) is a organic molecular entity (CHEBI:50860) |
| mentha oil (CHEBI:753400) is a organic molecular entity (CHEBI:50860) |
| Menzeleic acid (CHEBI:195345) is a organic molecular entity (CHEBI:50860) |
| MEPB (CHEBI:232984) is a organic molecular entity (CHEBI:50860) |
| Mepitiostane (CHEBI:31818) is a organic molecular entity (CHEBI:50860) |
| mepolizumab (CHEBI:753401) is a organic molecular entity (CHEBI:50860) |
| Meprobamate (CHEBI:6761) is a organic molecular entity (CHEBI:50860) |
| Mercaptide (CHEBI:6764) is a organic molecular entity (CHEBI:50860) |
| mercaptosuccinicated polymer of succinate and 3-allyloxy-1,2-propanediol (CHEBI:747439) is a organic molecular entity (CHEBI:50860) |
| mercuric chloride (CHEBI:749787) is a organic molecular entity (CHEBI:50860) |
| mercuric iodide (CHEBI:749667) is a organic molecular entity (CHEBI:50860) |
| Mercuric oxide (CHEBI:81882) is a organic molecular entity (CHEBI:50860) |
| mercury, ammoniated (CHEBI:755743) is a organic molecular entity (CHEBI:50860) |
| mercury, metallic (CHEBI:755843) is a organic molecular entity (CHEBI:50860) |
| Merosterolic acid A (CHEBI:228355) is a organic molecular entity (CHEBI:50860) |
| Merosterolic acid B (CHEBI:228354) is a organic molecular entity (CHEBI:50860) |
| mesifilcon a (CHEBI:753402) is a organic molecular entity (CHEBI:50860) |
| mesmulogene ancovacivec (CHEBI:758394) is a organic molecular entity (CHEBI:50860) |
| meso-tetra(4-sulfonatophenyl)porphine zn(ii) (CHEBI:232359) is a organic molecular entity (CHEBI:50860) |
| Met-enkephalin-Arg-Gly-Leu (CHEBI:80264) is a organic molecular entity (CHEBI:50860) |
| Met-enkephalin-Arg-Phe (CHEBI:80265) is a organic molecular entity (CHEBI:50860) |
| Met-Xaa (CHEBI:6787) is a organic molecular entity (CHEBI:50860) |
| metallocene (CHEBI:33963) is a organic molecular entity (CHEBI:50860) |
| Metarhodopsin (CHEBI:6796) is a organic molecular entity (CHEBI:50860) |
| metelimumab (CHEBI:753403) is a organic molecular entity (CHEBI:50860) |
| metenkefalin (CHEBI:753282) is a organic molecular entity (CHEBI:50860) |
| metformin glycinate (CHEBI:753289) is a organic molecular entity (CHEBI:50860) |
| metformInium (CHEBI:230465) is a organic molecular entity (CHEBI:50860) |
| methacrylic acid copolymer (CHEBI:754036) is a organic molecular entity (CHEBI:50860) |
| Methacycline hydrochloride (CHEBI:6806) is a organic molecular entity (CHEBI:50860) |
| methafilcon b (CHEBI:753404) is a organic molecular entity (CHEBI:50860) |
| Methandrostenolone (CHEBI:6810) is a organic molecular entity (CHEBI:50860) |
| Methanetriol (CHEBI:167061) is a organic molecular entity (CHEBI:50860) |
| Metharbital (CHEBI:31827) is a organic molecular entity (CHEBI:50860) |
| methiazole (CHEBI:232489) is a organic molecular entity (CHEBI:50860) |
| methioninochenodeoxycholic acid (CHEBI:232206) is a organic molecular entity (CHEBI:50860) |
| methioninocholic acid (CHEBI:232261) is a organic molecular entity (CHEBI:50860) |
| methioninodeoxycholic acid (CHEBI:232224) is a organic molecular entity (CHEBI:50860) |
| methioninolithocholic acid (CHEBI:232187) is a organic molecular entity (CHEBI:50860) |
| methioninoursodeoxycholic acid (CHEBI:232280) is a organic molecular entity (CHEBI:50860) |
| methocidin (CHEBI:753156) is a organic molecular entity (CHEBI:50860) |
| methoxime (CHEBI:233582) is a organic molecular entity (CHEBI:50860) |
| methoxy polyethylene glycol-epoetin beta (CHEBI:755792) is a organic molecular entity (CHEBI:50860) |
| Methoxymalonyl-[acp] (CHEBI:81867) is a organic molecular entity (CHEBI:50860) |
| methoxymycolate type-1 (VI') (CHEBI:88028) is a organic molecular entity (CHEBI:50860) |
| Methsuximide (CHEBI:6846) is a organic molecular entity (CHEBI:50860) |
| methyl 10-hydroxy-8,9-epoxy-2z-decen-4,6-diynoate (CHEBI:230604) is a organic molecular entity (CHEBI:50860) |
| methyl 5-[2-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl]phenoxy]-4-oxopentanoate (CHEBI:234583) is a organic molecular entity (CHEBI:50860) |
| methyl 5r,6r-epoxy-9e-eicosen-7-ynoate (CHEBI:230588) is a organic molecular entity (CHEBI:50860) |
| Methyl galactose (CHEBI:229489) is a organic molecular entity (CHEBI:50860) |
| Methyl gambogate (CHEBI:232630) is a organic molecular entity (CHEBI:50860) |
| methyl isoquinoline-6-carboxylate (CHEBI:232582) is a organic molecular entity (CHEBI:50860) |
| Methyl streptonigrin (CHEBI:232715) is a organic molecular entity (CHEBI:50860) |
| methyl-6-hydroxyhexanoate (CHEBI:747562) is a organic molecular entity (CHEBI:50860) |
| methylated enzyme bound BLM intermediate (CHEBI:132420) is a organic molecular entity (CHEBI:50860) |
| methylated enzyme bound TLM intermediate (CHEBI:132418) is a organic molecular entity (CHEBI:50860) |
| methylated enzyme bound ZBM intermediate (CHEBI:132422) is a organic molecular entity (CHEBI:50860) |
| methylcellulose (CHEBI:754087) is a organic molecular entity (CHEBI:50860) |
| methylhildgardtol a (CHEBI:230807) is a organic molecular entity (CHEBI:50860) |
| methyllinderone (CHEBI:233555) is a organic molecular entity (CHEBI:50860) |
| Methylmethionine sulfonium salt (CHEBI:6884) is a organic molecular entity (CHEBI:50860) |
| methylphosphotriester-DNA (CHEBI:137177) is a organic molecular entity (CHEBI:50860) |
| Methylsulfomycin I (CHEBI:80069) is a organic molecular entity (CHEBI:50860) |
| Methyprylon (CHEBI:31837) is a organic molecular entity (CHEBI:50860) |
| metreleptin (CHEBI:752900) is a organic molecular entity (CHEBI:50860) |
| mevociclib (CHEBI:230486) is a organic molecular entity (CHEBI:50860) |
| mevonlerbart (CHEBI:759386) is a organic molecular entity (CHEBI:50860) |
| mezagitamab (CHEBI:757277) is a organic molecular entity (CHEBI:50860) |
| mf101 (CHEBI:755627) is a organic molecular entity (CHEBI:50860) |
| MG(5-iso PGF2VI/0:0/0:0) (CHEBI:230114) is a organic molecular entity (CHEBI:50860) |
| mgawn1 (CHEBI:754366) is a organic molecular entity (CHEBI:50860) |
| mgd-007 (CHEBI:757461) is a organic molecular entity (CHEBI:50860) |
| mgd-009 (CHEBI:758050) is a organic molecular entity (CHEBI:50860) |
| mgd-010 (CHEBI:757462) is a organic molecular entity (CHEBI:50860) |
| MHY1485 (CHEBI:747040) is a organic molecular entity (CHEBI:50860) |
| MI-463 (CHEBI:232862) is a organic molecular entity (CHEBI:50860) |
| mibavademab (CHEBI:758386) is a organic molecular entity (CHEBI:50860) |
| microcrystalline cellulose (CHEBI:757032) is a organic molecular entity (CHEBI:50860) |
| microcystin RR (CHEBI:133296) is a organic molecular entity (CHEBI:50860) |
| micvotabart (CHEBI:760057) is a organic molecular entity (CHEBI:50860) |
| micvotabart pelidotin (CHEBI:760058) is a organic molecular entity (CHEBI:50860) |
| Midecamycin (CHEBI:31845) is a organic molecular entity (CHEBI:50860) |
| Midecamycin acetate (CHEBI:31846) is a organic molecular entity (CHEBI:50860) |
| mifomelatide (CHEBI:760059) is a organic molecular entity (CHEBI:50860) |
| migafocon a (CHEBI:753055) is a organic molecular entity (CHEBI:50860) |
| migaldendranib (CHEBI:759544) is a organic molecular entity (CHEBI:50860) |
| mik-665 (CHEBI:757515) is a organic molecular entity (CHEBI:50860) |
| mik-beta-1 (CHEBI:754160) is a organic molecular entity (CHEBI:50860) |
| mikamycin (CHEBI:759082) is a organic molecular entity (CHEBI:50860) |
| milatuzumab (CHEBI:750118) is a organic molecular entity (CHEBI:50860) |
| milk thisle (CHEBI:754017) is a organic molecular entity (CHEBI:50860) |
| milk thistle (CHEBI:753575) is a organic molecular entity (CHEBI:50860) |
| milodistim (CHEBI:753408) is a organic molecular entity (CHEBI:50860) |
| milpocitide (CHEBI:759387) is a organic molecular entity (CHEBI:50860) |
| milsaperidone (CHEBI:747406) is a organic molecular entity (CHEBI:50860) |
| minabeolide-7 (CHEBI:230575) is a organic molecular entity (CHEBI:50860) |
| MIND4 (CHEBI:232555) is a organic molecular entity (CHEBI:50860) |
| MIND4-17 (CHEBI:232621) is a organic molecular entity (CHEBI:50860) |
| mineral oil (CHEBI:754044) is a organic molecular entity (CHEBI:50860) |
| mineral oil, light (CHEBI:754045) is a organic molecular entity (CHEBI:50860) |
| minolteparin sodium (CHEBI:754046) is a organic molecular entity (CHEBI:50860) |
| minretumomab (CHEBI:753723) is a organic molecular entity (CHEBI:50860) |
| mint-1526a (CHEBI:757467) is a organic molecular entity (CHEBI:50860) |
| mip-1095 i-131 (CHEBI:757295) is a organic molecular entity (CHEBI:50860) |
| mipafilcon a (CHEBI:754047) is a organic molecular entity (CHEBI:50860) |
| mipasetamab (CHEBI:759009) is a organic molecular entity (CHEBI:50860) |
| mipasetamab uzoptirine (CHEBI:758873) is a organic molecular entity (CHEBI:50860) |
| mipletamig (CHEBI:760060) is a organic molecular entity (CHEBI:50860) |
| Mirabamide E (CHEBI:68403) is a organic molecular entity (CHEBI:50860) |
| Mirabamide F (CHEBI:68404) is a organic molecular entity (CHEBI:50860) |
| miravirsen (CHEBI:753338) is a organic molecular entity (CHEBI:50860) |
| mirikizumab (CHEBI:756496) is a organic molecular entity (CHEBI:50860) |
| mirimostim (CHEBI:753409) is a organic molecular entity (CHEBI:50860) |
| mirococept (CHEBI:753056) is a organic molecular entity (CHEBI:50860) |
| mirvetuximab (CHEBI:755507) is a organic molecular entity (CHEBI:50860) |
| mirvetuximab soravtansine (CHEBI:755477) is a organic molecular entity (CHEBI:50860) |
| mirzotamab (CHEBI:758572) is a organic molecular entity (CHEBI:50860) |
| mirzotamab clezutoclax (CHEBI:757988) is a organic molecular entity (CHEBI:50860) |
| misitatug (CHEBI:760061) is a organic molecular entity (CHEBI:50860) |
| misitatug blivedotin (CHEBI:760062) is a organic molecular entity (CHEBI:50860) |
| misonidazole (CHEBI:230671) is a organic molecular entity (CHEBI:50860) |
| mitazalimab (CHEBI:757309) is a organic molecular entity (CHEBI:50860) |
| mitiglinide calcium dihydrate (CHEBI:757430) is a organic molecular entity (CHEBI:50860) |
| mitocarcin (CHEBI:753410) is a organic molecular entity (CHEBI:50860) |
| mitochondrial ribosomes (CHEBI:189681) is a organic molecular entity (CHEBI:50860) |
| mitochonic acid 5 (CHEBI:234581) is a organic molecular entity (CHEBI:50860) |
| mitocromin (CHEBI:754048) is a organic molecular entity (CHEBI:50860) |
| mitogillin (CHEBI:753411) is a organic molecular entity (CHEBI:50860) |
| mitomalcin (CHEBI:752968) is a organic molecular entity (CHEBI:50860) |
| mitomycin C(1−) (CHEBI:194095) is a organic molecular entity (CHEBI:50860) |
| Mitoquinone (CHEBI:233321) is a organic molecular entity (CHEBI:50860) |
| mitoquinone mesylate (CHEBI:234429) is a organic molecular entity (CHEBI:50860) |
| mitosper (CHEBI:754049) is a organic molecular entity (CHEBI:50860) |
| mitumomab (CHEBI:753412) is a organic molecular entity (CHEBI:50860) |
| mitumprotimut-t (CHEBI:752895) is a organic molecular entity (CHEBI:50860) |
| miv-711 (CHEBI:760491) is a organic molecular entity (CHEBI:50860) |
| mivalsecovatein (CHEBI:760182) is a organic molecular entity (CHEBI:50860) |
| mivelsiran (CHEBI:759543) is a organic molecular entity (CHEBI:50860) |
| mk-1029 (CHEBI:755425) is a organic molecular entity (CHEBI:50860) |
| mk-2201 (CHEBI:755414) is a organic molecular entity (CHEBI:50860) |
| mk-2225 (CHEBI:759682) is a organic molecular entity (CHEBI:50860) |
| mk-2640 (CHEBI:758495) is a organic molecular entity (CHEBI:50860) |
| mk-3415 (CHEBI:754154) is a organic molecular entity (CHEBI:50860) |
| mk-4721 (CHEBI:754315) is a organic molecular entity (CHEBI:50860) |
| MK-571 (CHEBI:234612) is a organic molecular entity (CHEBI:50860) |
| mk-8325 (CHEBI:757232) is a organic molecular entity (CHEBI:50860) |
| mk-8777 (CHEBI:755853) is a organic molecular entity (CHEBI:50860) |
| MK8722 (CHEBI:747625) is a organic molecular entity (CHEBI:50860) |
| ML-60218 (CHEBI:232880) is a organic molecular entity (CHEBI:50860) |
| ML-SA1 (CHEBI:232894) is a organic molecular entity (CHEBI:50860) |
| ML297 (CHEBI:232497) is a organic molecular entity (CHEBI:50860) |
| ML324 (CHEBI:746977) is a organic molecular entity (CHEBI:50860) |
| Ml4Cer (CHEBI:34854) is a organic molecular entity (CHEBI:50860) |
| mln-01 (CHEBI:754279) is a organic molecular entity (CHEBI:50860) |
| mln-2704 (CHEBI:754320) is a organic molecular entity (CHEBI:50860) |
| mln-591rl (CHEBI:754321) is a organic molecular entity (CHEBI:50860) |
| mln3126 (CHEBI:755549) is a organic molecular entity (CHEBI:50860) |
| mlnm-2201 (CHEBI:754164) is a organic molecular entity (CHEBI:50860) |
| mlpa(o-16:0) (CHEBI:230610) is a organic molecular entity (CHEBI:50860) |
| mm-111 (CHEBI:757031) is a organic molecular entity (CHEBI:50860) |
| MnTBAP (CHEBI:233143) is a organic molecular entity (CHEBI:50860) |
| mobenakin (CHEBI:753397) is a organic molecular entity (CHEBI:50860) |
| moc31-pe (CHEBI:754129) is a organic molecular entity (CHEBI:50860) |
| modakafusp alfa (CHEBI:757279) is a organic molecular entity (CHEBI:50860) |
| modified amino acid anion (CHEBI:63472) is a organic molecular entity (CHEBI:50860) |
| modified live porcine respiratory and reproductive syndrome virus, strain 96v198 (CHEBI:759792) is a organic molecular entity (CHEBI:50860) |
| modimelanotide (CHEBI:755463) is a organic molecular entity (CHEBI:50860) |
| modotuximab (CHEBI:756471) is a organic molecular entity (CHEBI:50860) |
| mogamulizumab (CHEBI:750119) is a organic molecular entity (CHEBI:50860) |
| molgramostim (CHEBI:754026) is a organic molecular entity (CHEBI:50860) |
| molybdenum-98(3+) (CHEBI:176627) is a organic molecular entity (CHEBI:50860) |
| molybdenum-98(6+) (CHEBI:176628) is a organic molecular entity (CHEBI:50860) |
| monalizumab (CHEBI:757233) is a organic molecular entity (CHEBI:50860) |
| Monanchocidin A, rel- (CHEBI:69398) is a organic molecular entity (CHEBI:50860) |
| Monanchocidin B, rel- (CHEBI:69399) is a organic molecular entity (CHEBI:50860) |
| Monanchocidin C, rel- (CHEBI:69400) is a organic molecular entity (CHEBI:50860) |
| Monanchocidin D, rel- (CHEBI:69401) is a organic molecular entity (CHEBI:50860) |
| Monanchocidin E, rel- (CHEBI:69402) is a organic molecular entity (CHEBI:50860) |
| monarsen (CHEBI:760507) is a organic molecular entity (CHEBI:50860) |
| mongersen sodium (CHEBI:755839) is a organic molecular entity (CHEBI:50860) |
| mono- and di-acetylated monoglycerides (CHEBI:754027) is a organic molecular entity (CHEBI:50860) |
| mono- and di-glycerides (CHEBI:754028) is a organic molecular entity (CHEBI:50860) |
| Mono-(alk-1-enyl)-glycerol (CHEBI:76580) is a organic molecular entity (CHEBI:50860) |
| mono-2-(ethylhexyl) adipate (CHEBI:233709) is a organic molecular entity (CHEBI:50860) |
| mono-dga-rfb4 (CHEBI:754179) is a organic molecular entity (CHEBI:50860) |
| Monoammonium glycyrrhizinate (CHEBI:81864) is a organic molecular entity (CHEBI:50860) |
| monocillin I (CHEBI:68804) is a organic molecular entity (CHEBI:50860) |
| monocobalt(III) bis((Z)-1-((2-oxido-5-sulfamoylphenyl)diazenyl)naphthalen-2-olate) (CHEBI:760552) is a organic molecular entity (CHEBI:50860) |
| monoctanoin (CHEBI:759881) is a organic molecular entity (CHEBI:50860) |
| Monocyte locomotion inhibitory factor (CHEBI:81638) is a organic molecular entity (CHEBI:50860) |
| monofluorinated methyl farnesoate (CHEBI:235476) is a organic molecular entity (CHEBI:50860) |
| monogalactosylglycerol (CHEBI:176882) is a organic molecular entity (CHEBI:50860) |
| Monopropionylcadaverine (CHEBI:230410) is a organic molecular entity (CHEBI:50860) |
| monosialotetrahexosylganglioside sodium (CHEBI:758856) is a organic molecular entity (CHEBI:50860) |
| monosodium L-glutamate hydrate (CHEBI:232425) is a organic molecular entity (CHEBI:50860) |
| monosodium mono(4,7-dioxidonaphthalene-2-sulfonate) (CHEBI:747431) is a organic molecular entity (CHEBI:50860) |
| monosodium urate (CHEBI:143125) is a organic molecular entity (CHEBI:50860) |
| monteplase (CHEBI:753398) is a organic molecular entity (CHEBI:50860) |
| Monuron-TCA (CHEBI:82210) is a organic molecular entity (CHEBI:50860) |
| morab-028 (CHEBI:754217) is a organic molecular entity (CHEBI:50860) |
| Morfamquat (CHEBI:6996) is a organic molecular entity (CHEBI:50860) |
| Morinidazole (CHEBI:230801) is a organic molecular entity (CHEBI:50860) |
| morinidazole sulfate(1-) (CHEBI:746961) is a organic molecular entity (CHEBI:50860) |
| moroctocog alfa (CHEBI:754029) is a organic molecular entity (CHEBI:50860) |
| morolimumab (CHEBI:754030) is a organic molecular entity (CHEBI:50860) |
| Morpholine (4-methoxyphenyl)(morpholino)phosphinodithioate (CHEBI:197330) is a organic molecular entity (CHEBI:50860) |
| morrhuate sodium (CHEBI:754031) is a organic molecular entity (CHEBI:50860) |
| Moscatilin (CHEBI:747854) is a organic molecular entity (CHEBI:50860) |
| mosnodenvir (CHEBI:746991) is a organic molecular entity (CHEBI:50860) |
| mosunetuzumab (CHEBI:757234) is a organic molecular entity (CHEBI:50860) |
| motavizumab (CHEBI:750120) is a organic molecular entity (CHEBI:50860) |
| motexafin lutetium (CHEBI:755564) is a organic molecular entity (CHEBI:50860) |
| Motilin (CHEBI:80269) is a organic molecular entity (CHEBI:50860) |
| moxetumomab pasudotox (CHEBI:750121) is a organic molecular entity (CHEBI:50860) |
| mozafancogene autotemcel (CHEBI:758564) is a organic molecular entity (CHEBI:50860) |
| mozistobart (CHEBI:760063) is a organic molecular entity (CHEBI:50860) |
| mozistobart zoratolimod (CHEBI:760064) is a organic molecular entity (CHEBI:50860) |
| mp-0250 (CHEBI:757471) is a organic molecular entity (CHEBI:50860) |
| MPLA (CHEBI:77066) is a organic molecular entity (CHEBI:50860) |
| mpreQ1 (CHEBI:190456) is a organic molecular entity (CHEBI:50860) |
| MPTP hydrochloride (CHEBI:233275) is a organic molecular entity (CHEBI:50860) |
| mr-1817 (CHEBI:755849) is a organic molecular entity (CHEBI:50860) |
| mra 003 us (CHEBI:754359) is a organic molecular entity (CHEBI:50860) |
| mrna-0184 (CHEBI:760492) is a organic molecular entity (CHEBI:50860) |
| MRS5698 (CHEBI:747579) is a organic molecular entity (CHEBI:50860) |
| mrx-2843 (CHEBI:758297) is a organic molecular entity (CHEBI:50860) |
| ms-1819 (CHEBI:757472) is a organic molecular entity (CHEBI:50860) |
| MS023 (CHEBI:230483) is a organic molecular entity (CHEBI:50860) |
| msc-2364447 (CHEBI:755508) is a organic molecular entity (CHEBI:50860) |
| mt-3724 (CHEBI:757235) is a organic molecular entity (CHEBI:50860) |
| MTK458 (CHEBI:747831) is a organic molecular entity (CHEBI:50860) |
| mu-11-1f4 124i (CHEBI:754146) is a organic molecular entity (CHEBI:50860) |
| mu-bc-1 (CHEBI:754302) is a organic molecular entity (CHEBI:50860) |
| mu-j591 (CHEBI:754322) is a organic molecular entity (CHEBI:50860) |
| Mubritinib (CHEBI:233310) is a organic molecular entity (CHEBI:50860) |
| mucopolysaccharide polysulfate (CHEBI:754088) is a organic molecular entity (CHEBI:50860) |
| mulnitorsen (CHEBI:758718) is a organic molecular entity (CHEBI:50860) |
| mumps skin test antigen (CHEBI:754089) is a organic molecular entity (CHEBI:50860) |
| mumps virus vaccine live (CHEBI:754090) is a organic molecular entity (CHEBI:50860) |
| mumps virus vaccine, inactivated (CHEBI:753731) is a organic molecular entity (CHEBI:50860) |
| mumps virus, live attenuated (CHEBI:760270) is a organic molecular entity (CHEBI:50860) |
| mupadolimab (CHEBI:758513) is a organic molecular entity (CHEBI:50860) |
| muparfostat (CHEBI:756699) is a organic molecular entity (CHEBI:50860) |
| muparfostat sodium (CHEBI:756698) is a organic molecular entity (CHEBI:50860) |
| muplestim (CHEBI:753437) is a organic molecular entity (CHEBI:50860) |
| murcidencel (CHEBI:759447) is a organic molecular entity (CHEBI:50860) |
| mureletecan (CHEBI:753438) is a organic molecular entity (CHEBI:50860) |
| murlentamab (CHEBI:758908) is a organic molecular entity (CHEBI:50860) |
| murodermin (CHEBI:754091) is a organic molecular entity (CHEBI:50860) |
| muromonab-cd3 (CHEBI:749554) is a organic molecular entity (CHEBI:50860) |
| muzastotug (CHEBI:759448) is a organic molecular entity (CHEBI:50860) |
| mvt-1075 (CHEBI:757236) is a organic molecular entity (CHEBI:50860) |
| mvt-5873 (CHEBI:757237) is a organic molecular entity (CHEBI:50860) |
| mycofactocin (CHEBI:167637) is a organic molecular entity (CHEBI:50860) |
| mycoplasma synoviae strain ms-h (CHEBI:759795) is a organic molecular entity (CHEBI:50860) |
| Mycosubtilin (CHEBI:29633) is a organic molecular entity (CHEBI:50860) |
| myeloperoxidase (CHEBI:752901) is a organic molecular entity (CHEBI:50860) |
| Myomodulin (CHEBI:80200) is a organic molecular entity (CHEBI:50860) |
| Myoseverin (CHEBI:232491) is a organic molecular entity (CHEBI:50860) |
| myrcludex b (CHEBI:757238) is a organic molecular entity (CHEBI:50860) |
| myristicin (CHEBI:68234) is a organic molecular entity (CHEBI:50860) |
| myrrh (CHEBI:754092) is a organic molecular entity (CHEBI:50860) |
| MZ1 (CHEBI:189652) is a organic molecular entity (CHEBI:50860) |
| N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine (CHEBI:747835) is a organic molecular entity (CHEBI:50860) |
| N-(2E)-TCO-L-lysine (CHEBI:232660) is a organic molecular entity (CHEBI:50860) |
| N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE (CHEBI:46084) is a organic molecular entity (CHEBI:50860) |
| N-(3-Aminopropyl)-N-methylcarbamic acid tert-butyl ester (CHEBI:230359) is a organic molecular entity (CHEBI:50860) |
| N-(3-chloro-4-fluorophenyl)-4-fluoro-3,5-dimethylbenzenesulfonamide (CHEBI:233317) is a organic molecular entity (CHEBI:50860) |
| N-(3,4-Dichlorobenzyl)-3-(6-fluoro-2-methylpyridin-3-yl)-5-((2-imino-3-methyl-2,3-dihydro-1H-imidazol-1-yl)methyl)benzamide (CHEBI:231431) is a organic molecular entity (CHEBI:50860) |
| N-(4-Aminobutylidene)-[eIF5A-precursor]-lysine (CHEBI:80130) is a organic molecular entity (CHEBI:50860) |
| N-(4-bromophenyl)-3-[(4-bromophenyl)sulfamoyl]benzamide (CHEBI:233979) is a organic molecular entity (CHEBI:50860) |
| N-(5-chloro-2-methylphenyl)-3-hydroxy-2-naphthalenecarboxamide (CHEBI:234065) is a organic molecular entity (CHEBI:50860) |
| n-(9z-hexadecenoyl)-homoserine lactone (CHEBI:230725) is a organic molecular entity (CHEBI:50860) |
| N-(Butoxymethyl)acrylamide (CHEBI:747834) is a organic molecular entity (CHEBI:50860) |
| N-(Isobutoxymethyl)acrylamide (CHEBI:747837) is a organic molecular entity (CHEBI:50860) |
| N-(tricosanoyl)-tetradecasphing-4-enine-1-phosphoethanolamine (CHEBI:197368) is a organic molecular entity (CHEBI:50860) |
| n-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-n-[4-hydroxy-1-methyl-2-(propyldithio)-1-butenyl]formamide (CHEBI:230701) is a organic molecular entity (CHEBI:50860) |
| N-[(E,2S,3R)-1,3-dihydroxytetradec-4-en-2-yl]acetamide (CHEBI:232609) is a organic molecular entity (CHEBI:50860) |
| N-[1-(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-p-aminobenzoate (CHEBI:177373) is a organic molecular entity (CHEBI:50860) |
| N-[1,3-bis(1,3-benzodioxol-5-yl)propan-2-yl]formamide (CHEBI:233198) is a organic molecular entity (CHEBI:50860) |
| N-[12-[(7-Nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-ceramide (CHEBI:143826) is a organic molecular entity (CHEBI:50860) |
| N-[2-(BENZHYDRYLOXY)ETHYL]-N,N-DIMETHYLAMINE (CHEBI:39792) is a organic molecular entity (CHEBI:50860) |
| N-[2-(diethylamino)ethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (CHEBI:234600) is a organic molecular entity (CHEBI:50860) |
| n-[4-(3-iodo-4-azidophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane (CHEBI:177885) is a organic molecular entity (CHEBI:50860) |
| N-[4-chloro-3-(trifluoromethyl)phenyl]-2-(4-ethoxy-2-hydroxybutoxy)benzamide (CHEBI:234584) is a organic molecular entity (CHEBI:50860) |
| N-[5-(5-methoxy-1,3-benzothiazol-2-yl)pyridin-3-yl]acetamide (CHEBI:233242) is a organic molecular entity (CHEBI:50860) |
| N-5-(hydroxymethyl)-2-furoylglycine (CHEBI:748848) is a organic molecular entity (CHEBI:50860) |
| N-Acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosyl-(1->4)-N-acetyl-alpha-D-glucosaminylproteoglycan (CHEBI:79980) is a organic molecular entity (CHEBI:50860) |
| N-Acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-glucuronosylproteoglycan (CHEBI:79981) is a organic molecular entity (CHEBI:50860) |
| N-Acetyl-beta-D-galactosaminyl-(1->4)-beta-D-glucuronosylproteoglycan (CHEBI:79983) is a organic molecular entity (CHEBI:50860) |
| N-acetyl-beta-D-galactosaminyl-(1→4)-beta-D-galactosyl-(1→4)-beta-D-glucosyl-(1↔1')-N-acylsphingosine (CHEBI:195476) is a organic molecular entity (CHEBI:50860) |
| N-Acetyl-L-cysteine ethyl ester (CHEBI:747653) is a organic molecular entity (CHEBI:50860) |
| N-Acetylcysteine amide (CHEBI:231847) is a organic molecular entity (CHEBI:50860) |
| N-Acetyldemethylphosphinothricinate (2-) (CHEBI:86401) is a organic molecular entity (CHEBI:50860) |
| N-acetylkynureninate(1-) (CHEBI:746924) is a organic molecular entity (CHEBI:50860) |
| N-acyl-1-O-galactosyl-15-methylhexadecasphing-4-enine (CHEBI:140530) is a organic molecular entity (CHEBI:50860) |
| N-Acyl-O-acetylneuraminate (CHEBI:7237) is a organic molecular entity (CHEBI:50860) |
| N-Acylmuramate (CHEBI:7239) is a organic molecular entity (CHEBI:50860) |
| N-Arachidonoyl Arginine (CHEBI:230415) is a organic molecular entity (CHEBI:50860) |
| N-Arachidonoyl Lysine (CHEBI:230414) is a organic molecular entity (CHEBI:50860) |
| N-Benzoyl-2'-deoxycytidine (CHEBI:229529) is a organic molecular entity (CHEBI:50860) |
| N-Docosahexaenoyl Alanine (CHEBI:230110) is a organic molecular entity (CHEBI:50860) |
| N-epsilon-((1-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethoxy)carbonyl)-L-lysine (CHEBI:233056) is a organic molecular entity (CHEBI:50860) |
| N-ethylpyrrolidine (CHEBI:234080) is a organic molecular entity (CHEBI:50860) |
| n-hexanoyl histidine (CHEBI:230552) is a organic molecular entity (CHEBI:50860) |
| n-hydroxy arachidonoyl amine (CHEBI:230691) is a organic molecular entity (CHEBI:50860) |
| N-hydroxy-4-((5-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)-1H-indol-1-yl) sulfonyl)benzamide (CHEBI:234427) is a organic molecular entity (CHEBI:50860) |
| N-hydroxy-4-((5-(3-(piperidin-1-yl)propoxy)-1H-indol-1-yl)sulfonyl)benzamide (CHEBI:234426) is a organic molecular entity (CHEBI:50860) |
| n-hydroxyapatite (CHEBI:747153) is a organic molecular entity (CHEBI:50860) |
| n-isobutyl-(2e,4e,14z)-eicosatrienamide (CHEBI:230585) is a organic molecular entity (CHEBI:50860) |
| N-Linoleoyl Tyrosine (CHEBI:231152) is a organic molecular entity (CHEBI:50860) |
| N-methyl-quinidine (CHEBI:231725) is a organic molecular entity (CHEBI:50860) |
| N-methylmaleimide (CHEBI:232160) is a organic molecular entity (CHEBI:50860) |
| N-Myristoyl Asparagine (CHEBI:231177) is a organic molecular entity (CHEBI:50860) |
| N-octyl-6-epi-valienamine (CHEBI:235472) is a organic molecular entity (CHEBI:50860) |
| n-phenyl-beta-d-glucopyranosylamine (CHEBI:230608) is a organic molecular entity (CHEBI:50860) |
| N-PROPARGYL-1(R)-AMINONDAN (CHEBI:45357) is a organic molecular entity (CHEBI:50860) |
| n-propionyl-CoA lithium salt (CHEBI:233091) is a organic molecular entity (CHEBI:50860) |
| n-sulfoglucosamine sulfohydrolase recombinant (CHEBI:757406) is a organic molecular entity (CHEBI:50860) |
| N-terminal trimethyl-α-amino-acid(1+) residue (CHEBI:146135) is a organic molecular entity (CHEBI:50860) |
| N,N-Bis(2-chloroethyl)-DL-alanine hydrochloride (CHEBI:79813) is a organic molecular entity (CHEBI:50860) |
| N,N-Diethyl-2-[4-[6-methoxy-2-(4-methoxyphenyl)-1H-inden-3-yl]phenoxy]ethanamine hydrochloride (CHEBI:79830) is a organic molecular entity (CHEBI:50860) |
| N,N-Diethylacrylamide (CHEBI:747838) is a organic molecular entity (CHEBI:50860) |
| N,N,N-Trimethylmethanaminium chloride (CHEBI:7070) is a organic molecular entity (CHEBI:50860) |
| N,N'-Bis(2-hydroxyethyl)-2-nitro-p-phenylenediamine (CHEBI:747842) is a organic molecular entity (CHEBI:50860) |
| N,N'-BIS(4-AMINO-2-METHYLQUINOLIN-6-YL)UREA (CHEBI:44628) is a organic molecular entity (CHEBI:50860) |
| N,N'-Methylenebisacrylamide (CHEBI:747836) is a organic molecular entity (CHEBI:50860) |
| N(6)-[(R)-S(8)-2-methylbutanoyldihydrolipoyl]-L-lysine residue (CHEBI:229216) is a organic molecular entity (CHEBI:50860) |
| N(6)-[(R)-S(8)-isovaleryldihydrolipoyl]-L-lysine residue (CHEBI:229215) is a organic molecular entity (CHEBI:50860) |
| N6-[1,1-(5-adenosylyl-α-D-ribose-1,2-di-O-yl)ethyl]-L-lysinium residue (CHEBI:183315) is a organic molecular entity (CHEBI:50860) |
| N1-acetyl,N8-glutarylspermidine (CHEBI:195633) is a organic molecular entity (CHEBI:50860) |
| N1-acetyl,N8-malonylspermidine (CHEBI:195638) is a organic molecular entity (CHEBI:50860) |
| N1-acetyl,N8-succinylspermidine (CHEBI:195636) is a organic molecular entity (CHEBI:50860) |
| N1-glutaryl,N8-acetylspermidine (CHEBI:195635) is a organic molecular entity (CHEBI:50860) |
| N1-glutarylspermidine (CHEBI:195641) is a organic molecular entity (CHEBI:50860) |
| N1-malonyl,N8-acetylspermidine (CHEBI:195639) is a organic molecular entity (CHEBI:50860) |
| N1-malonylspermidine (CHEBI:195645) is a organic molecular entity (CHEBI:50860) |
| N1-succinyl,N8-acetylspermidine (CHEBI:195637) is a organic molecular entity (CHEBI:50860) |
| N1-succinylspermidine (CHEBI:195643) is a organic molecular entity (CHEBI:50860) |
| N2-Acylated Arg-CH2Cl (CHEBI:7369) is a organic molecular entity (CHEBI:50860) |
| N2-Acylated Lys-CH2Cl (CHEBI:7370) is a organic molecular entity (CHEBI:50860) |
| N4-Acetylcytidine triphosphate (CHEBI:229512) is a organic molecular entity (CHEBI:50860) |
| N5-Alkylglutamine (CHEBI:7395) is a organic molecular entity (CHEBI:50860) |
| N6 -Allyloxycarbonyl-I-lysine (AlocLys) (CHEBI:233072) is a organic molecular entity (CHEBI:50860) |
| N6-(((1R,2R)-2-azidocyclopentyloxy)carbonyl)-L-lysine (ACPK) (CHEBI:233041) is a organic molecular entity (CHEBI:50860) |
| N6-(((4-nitrobenzyl)oxy)carbonyl)-L-lysine (CHEBI:232671) is a organic molecular entity (CHEBI:50860) |
| N6-((2-azidoethoxy)carbonyl)-L-lysine (CHEBI:233053) is a organic molecular entity (CHEBI:50860) |
| N6-((bicyclo[2.2.1]hept-5-en-2-ylmethoxy)carbonyl)-L-lysine (CHEBI:232662) is a organic molecular entity (CHEBI:50860) |
| N6-((Pent-4-yn-1-yloxy)carbonyl)-L-lysine (CHEBI:233093) is a organic molecular entity (CHEBI:50860) |
| N6-((S)-2-Amino-4-pentynoyl)lysine ditrifluoroacetate (CHEBI:232665) is a organic molecular entity (CHEBI:50860) |
| N6-(1-Methylcycloprop-2-enecarboxamido)lysine (CpK) (CHEBI:233069) is a organic molecular entity (CHEBI:50860) |
| N6-(Benzyloxycarbonyl)-L-lysine(ZLys) (CHEBI:233033) is a organic molecular entity (CHEBI:50860) |
| N6-(o-Azidobenzyloxycarbonyl)-L-lysine(AzZLys) (CHEBI:233035) is a organic molecular entity (CHEBI:50860) |
| N6-(Spiro[2.3]hex-1-ene-5-methoxycarbonyl)-L-lysine (CHEBI:233095) is a organic molecular entity (CHEBI:50860) |
| N6-(tert-Butoxycarbonyl)-L-lysine (BocLys) (CHEBI:233034) is a organic molecular entity (CHEBI:50860) |
| N6-(tert-Butoxycarbonyl)-N6-methyl-L-lysine (CHEBI:233063) is a organic molecular entity (CHEBI:50860) |
| N6-[(2-(3-Methyl-3H-diazirin-3-yl)ethoxy)carbonyl]-L-lysine (CHEBI:233057) is a organic molecular entity (CHEBI:50860) |
| N6-[(2-Propynyloxy)carbonyl]-L-lysine (CHEBI:233040) is a organic molecular entity (CHEBI:50860) |
| N6-5-Norbornene-2-yloxycarbonyl-L-lysine (CHEBI:233110) is a organic molecular entity (CHEBI:50860) |
| N6-Acryloyl-L-lysine (CHEBI:233076) is a organic molecular entity (CHEBI:50860) |
| N6-Alkylaminopurine-9-beta-D-glucoside (CHEBI:80655) is a organic molecular entity (CHEBI:50860) |
| N6-Butyryl-L-lysine (CHEBI:233108) is a organic molecular entity (CHEBI:50860) |
| N6-Crotonyl-L-lysine (CHEBI:232673) is a organic molecular entity (CHEBI:50860) |
| N6-Cyclopentyloxycarbon-yl-L-lysine (Cyc) (CHEBI:233037) is a organic molecular entity (CHEBI:50860) |
| N6-d-Cysteinyl-l-lysine (CHEBI:233662) is a organic molecular entity (CHEBI:50860) |
| N6-D-Prolyl-L-Lysine (CHEBI:232654) is a organic molecular entity (CHEBI:50860) |
| N6-L -Cysteinyl-L-lysine (CHEBI:233663) is a organic molecular entity (CHEBI:50860) |
| N6-monoubiquitinyl-[protein]-L-lysine (CHEBI:134522) is a organic molecular entity (CHEBI:50860) |
| N6-Propionyl-L-lysine (CHEBI:233107) is a organic molecular entity (CHEBI:50860) |
| N8-glutarylspermidine (CHEBI:195640) is a organic molecular entity (CHEBI:50860) |
| N8-malonylspermidine (CHEBI:195644) is a organic molecular entity (CHEBI:50860) |
| N8-succinylspermidine (CHEBI:195642) is a organic molecular entity (CHEBI:50860) |
| nacolomab tafenatox (CHEBI:753161) is a organic molecular entity (CHEBI:50860) |
| nadecnemab (CHEBI:758387) is a organic molecular entity (CHEBI:50860) |
| nadofaragene firadenovec (CHEBI:756521) is a organic molecular entity (CHEBI:50860) |
| nadravaleucel (CHEBI:759388) is a organic molecular entity (CHEBI:50860) |
| nadroparin calcium (CHEBI:754093) is a organic molecular entity (CHEBI:50860) |
| Naepl (CHEBI:229516) is a organic molecular entity (CHEBI:50860) |
| nagrestipen (CHEBI:753439) is a organic molecular entity (CHEBI:50860) |
| nalotimagene carmaleucel (CHEBI:756520) is a organic molecular entity (CHEBI:50860) |
| namilumab (CHEBI:750122) is a organic molecular entity (CHEBI:50860) |
| nangibotide (CHEBI:757239) is a organic molecular entity (CHEBI:50860) |
| nanrilkefusp alfa (CHEBI:758951) is a organic molecular entity (CHEBI:50860) |
| Naphazoline (CHEBI:7470) is a organic molecular entity (CHEBI:50860) |
| Naporafenib (CHEBI:747299) is a organic molecular entity (CHEBI:50860) |
| naptumomab estafenatox (CHEBI:750123) is a organic molecular entity (CHEBI:50860) |
| narafilcon b (CHEBI:752910) is a organic molecular entity (CHEBI:50860) |
| naratuximab emtansine (CHEBI:754132) is a organic molecular entity (CHEBI:50860) |
| narlumosbart (CHEBI:759683) is a organic molecular entity (CHEBI:50860) |
| narnatumab (CHEBI:750124) is a organic molecular entity (CHEBI:50860) |
| narsoplimab (CHEBI:757602) is a organic molecular entity (CHEBI:50860) |
| nartograstim (CHEBI:754070) is a organic molecular entity (CHEBI:50860) |
| nasaruplase (CHEBI:754071) is a organic molecular entity (CHEBI:50860) |
| nasaruplase beta (CHEBI:753425) is a organic molecular entity (CHEBI:50860) |
| nasaruplase gamma (CHEBI:759389) is a organic molecular entity (CHEBI:50860) |
| nastorazepide calcium (CHEBI:757547) is a organic molecular entity (CHEBI:50860) |
| natalizumab (CHEBI:749500) is a organic molecular entity (CHEBI:50860) |
| nateplase (CHEBI:753476) is a organic molecular entity (CHEBI:50860) |
| Nativitatic acid (CHEBI:197313) is a organic molecular entity (CHEBI:50860) |
| navenibart (CHEBI:760065) is a organic molecular entity (CHEBI:50860) |
| navepegritide (CHEBI:757982) is a organic molecular entity (CHEBI:50860) |
| navicixizumab (CHEBI:756467) is a organic molecular entity (CHEBI:50860) |
| naxitamab (CHEBI:757411) is a organic molecular entity (CHEBI:50860) |
| Nbeta-acetylstreptothricin E (CHEBI:67578) is a organic molecular entity (CHEBI:50860) |
| NBI-74330 (CHEBI:233356) is a organic molecular entity (CHEBI:50860) |
| nbl-015 (CHEBI:759684) is a organic molecular entity (CHEBI:50860) |
| nc-410 (CHEBI:759721) is a organic molecular entity (CHEBI:50860) |
| nd0801 (CHEBI:755794) is a organic molecular entity (CHEBI:50860) |
| NDP-N-methyl-L-glucosamine (CHEBI:7429) is a organic molecular entity (CHEBI:50860) |
| Ne-(1Methylcycloprop-2enecarboxamido)lysine (CHEBI:232663) is a organic molecular entity (CHEBI:50860) |
| Ne-(2-Nitrobenzyl)oxycarbonyl-Ne-methyl-L-lysine (CHEBI:232658) is a organic molecular entity (CHEBI:50860) |
| Ne-L-Thiapropyl-L-lysine (CHEBI:232664) is a organic molecular entity (CHEBI:50860) |
| Ne(((1R,2R)-2azidocyclopentyloxy)carbonyl)-L-lysine (CHEBI:232657) is a organic molecular entity (CHEBI:50860) |
| nebacumab (CHEBI:754072) is a organic molecular entity (CHEBI:50860) |
| nebokitug (CHEBI:760183) is a organic molecular entity (CHEBI:50860) |
| nebratamig (CHEBI:759449) is a organic molecular entity (CHEBI:50860) |
| Nec-1s (CHEBI:167705) is a organic molecular entity (CHEBI:50860) |
| necitumumab (CHEBI:750125) is a organic molecular entity (CHEBI:50860) |
| necuparanib (CHEBI:755254) is a organic molecular entity (CHEBI:50860) |
| necuparanib sodium (CHEBI:755259) is a organic molecular entity (CHEBI:50860) |
| nedemelteon (CHEBI:760184) is a organic molecular entity (CHEBI:50860) |
| nedosiran (CHEBI:758150) is a organic molecular entity (CHEBI:50860) |
| nedosiran sodium (CHEBI:757836) is a organic molecular entity (CHEBI:50860) |
| nefocon a (CHEBI:754073) is a organic molecular entity (CHEBI:50860) |
| nefonadogene vonzuparvovec (CHEBI:760185) is a organic molecular entity (CHEBI:50860) |
| negalstobart (CHEBI:759545) is a organic molecular entity (CHEBI:50860) |
| neihulizumab (CHEBI:757302) is a organic molecular entity (CHEBI:50860) |
| neisseria meningitidis adhesin a (CHEBI:760286) is a organic molecular entity (CHEBI:50860) |
| neisseria meningitidis factor h binding protein (CHEBI:760409) is a organic molecular entity (CHEBI:50860) |
| neisseria meningitidis neisserial heparin binding antigen (CHEBI:760285) is a organic molecular entity (CHEBI:50860) |
| neisseria meningitidis oligosaccharide conjugated to corynebacterium diphtheriae crm197 (CHEBI:760282) is a organic molecular entity (CHEBI:50860) |
| neisseria meningitidis outer membrane vesicles (CHEBI:760284) is a organic molecular entity (CHEBI:50860) |
| neisseria meningitidis polysaccharide conjugated to tetanus toxoid (CHEBI:760408) is a organic molecular entity (CHEBI:50860) |
| neldaleucel (CHEBI:760367) is a organic molecular entity (CHEBI:50860) |
| nelfilcon a (CHEBI:753426) is a organic molecular entity (CHEBI:50860) |
| nelistotug (CHEBI:759712) is a organic molecular entity (CHEBI:50860) |
| nelitolimod (CHEBI:760368) is a organic molecular entity (CHEBI:50860) |
| nelitolimod sodium (CHEBI:760369) is a organic molecular entity (CHEBI:50860) |
| nelmastobart (CHEBI:760517) is a organic molecular entity (CHEBI:50860) |
| neltependocel (CHEBI:759390) is a organic molecular entity (CHEBI:50860) |
| nemolizumab (CHEBI:757240) is a organic molecular entity (CHEBI:50860) |
| nemvaleukin alfa (CHEBI:758857) is a organic molecular entity (CHEBI:50860) |
| nendocabtagene onogedleucel (CHEBI:760066) is a organic molecular entity (CHEBI:50860) |
| neo-201 (CHEBI:757961) is a organic molecular entity (CHEBI:50860) |
| Neocarzilin (CHEBI:80121) is a organic molecular entity (CHEBI:50860) |
| neoechinulin A (CHEBI:68794) is a organic molecular entity (CHEBI:50860) |
| neomycin B(5+) (CHEBI:231552) is a organic molecular entity (CHEBI:50860) |
| neomycin palmitate (CHEBI:756129) is a organic molecular entity (CHEBI:50860) |
| neomycin undecylenate (CHEBI:756181) is a organic molecular entity (CHEBI:50860) |
| Neonatic acid (CHEBI:197297) is a organic molecular entity (CHEBI:50860) |
| nepidermin (CHEBI:753302) is a organic molecular entity (CHEBI:50860) |
| neprilysin (CHEBI:757241) is a organic molecular entity (CHEBI:50860) |
| nerelimomab (CHEBI:753520) is a organic molecular entity (CHEBI:50860) |
| nerve growth factor (CHEBI:757242) is a organic molecular entity (CHEBI:50860) |
| nesiritide citrate (CHEBI:754074) is a organic molecular entity (CHEBI:50860) |
| nesofilcon a (CHEBI:754908) is a organic molecular entity (CHEBI:50860) |
| nespecabtagene autoleucel (CHEBI:760186) is a organic molecular entity (CHEBI:50860) |
| nesvacumab (CHEBI:753626) is a organic molecular entity (CHEBI:50860) |
| netakimab (CHEBI:760001) is a organic molecular entity (CHEBI:50860) |
| netrafilcon a (CHEBI:754075) is a organic molecular entity (CHEBI:50860) |
| NeuGc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141172) is a organic molecular entity (CHEBI:50860) |
| Neuromedin B (CHEBI:80139) is a organic molecular entity (CHEBI:50860) |
| Neuromedin C (CHEBI:80140) is a organic molecular entity (CHEBI:50860) |
| Neuromedin N (CHEBI:80141) is a organic molecular entity (CHEBI:50860) |
| Neuromedin S (CHEBI:80321) is a organic molecular entity (CHEBI:50860) |
| Neuromedin U (CHEBI:80142) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide AF (CHEBI:80325) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide B-23 (CHEBI:80259) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide B-29 (CHEBI:80258) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide EI (CHEBI:80318) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide FF (CHEBI:80326) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide gamma (CHEBI:80310) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide GE (CHEBI:80255) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide K (CHEBI:80309) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide W-23 (CHEBI:80257) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide W-30 (CHEBI:80256) is a organic molecular entity (CHEBI:50860) |
| Neuropeptide Y (CHEBI:80201) is a organic molecular entity (CHEBI:50860) |
| Neurophysin I (CHEBI:80293) is a organic molecular entity (CHEBI:50860) |
| Neurophysin II (CHEBI:80294) is a organic molecular entity (CHEBI:50860) |
| nexiguran (CHEBI:759391) is a organic molecular entity (CHEBI:50860) |
| nezastomig (CHEBI:758069) is a organic molecular entity (CHEBI:50860) |
| nezutatug (CHEBI:759713) is a organic molecular entity (CHEBI:50860) |
| NF-κB Activation Inhibitor IV (CHEBI:233280) is a organic molecular entity (CHEBI:50860) |
| ng-641 (CHEBI:758858) is a organic molecular entity (CHEBI:50860) |
| ni-0801 (CHEBI:754197) is a organic molecular entity (CHEBI:50860) |
| Nicarbazin (CHEBI:81725) is a organic molecular entity (CHEBI:50860) |
| Niceritrol (CHEBI:31903) is a organic molecular entity (CHEBI:50860) |
| nickel-60(2+) (CHEBI:176617) is a organic molecular entity (CHEBI:50860) |
| Nicomol (CHEBI:31904) is a organic molecular entity (CHEBI:50860) |
| nicotine polacrilex (CHEBI:749467) is a organic molecular entity (CHEBI:50860) |
| nicotine sulfate (CHEBI:232650) is a organic molecular entity (CHEBI:50860) |
| nidanilimab (CHEBI:758932) is a organic molecular entity (CHEBI:50860) |
| nifungin (CHEBI:753155) is a organic molecular entity (CHEBI:50860) |
| nimacimab (CHEBI:757514) is a organic molecular entity (CHEBI:50860) |
| nimatpagene pariparvovec (CHEBI:759546) is a organic molecular entity (CHEBI:50860) |
| nimotuzumab (CHEBI:753337) is a organic molecular entity (CHEBI:50860) |
| ninsipapogene sibamarepvec (CHEBI:759392) is a organic molecular entity (CHEBI:50860) |
| ninsipapogene sibarnarepvec (CHEBI:760358) is a organic molecular entity (CHEBI:50860) |
| nipocalimab (CHEBI:757809) is a organic molecular entity (CHEBI:50860) |
| nirsevimab (CHEBI:757050) is a organic molecular entity (CHEBI:50860) |
| nisevokitug (CHEBI:757480) is a organic molecular entity (CHEBI:50860) |
| nisotirostide (CHEBI:759718) is a organic molecular entity (CHEBI:50860) |
| nisoxetine hydrochloride (CHEBI:232874) is a organic molecular entity (CHEBI:50860) |
| nitrile herbicide (CHEBI:188149) is a organic molecular entity (CHEBI:50860) |
| nitrofen (CHEBI:7590) is a organic molecular entity (CHEBI:50860) |
| Nitrosylsulfuric acid (CHEBI:230452) is a organic molecular entity (CHEBI:50860) |
| nivatrotamab (CHEBI:758298) is a organic molecular entity (CHEBI:50860) |
| nivegacetor (CHEBI:760187) is a organic molecular entity (CHEBI:50860) |
| nivisnebart (CHEBI:760188) is a organic molecular entity (CHEBI:50860) |
| nivobotulinumtoxina (CHEBI:756495) is a organic molecular entity (CHEBI:50860) |
| Nivolumab (CHEBI:231614) is a organic molecular entity (CHEBI:50860) |
| njh-395 (CHEBI:758053) is a organic molecular entity (CHEBI:50860) |
| nktr-171 (CHEBI:755516) is a organic molecular entity (CHEBI:50860) |
| nlg-802 (CHEBI:758375) is a organic molecular entity (CHEBI:50860) |
| NLRP3-IN-33 (CHEBI:233294) is a organic molecular entity (CHEBI:50860) |
| nm-21-1480 (CHEBI:758377) is a organic molecular entity (CHEBI:50860) |
| nms-1116354 (CHEBI:755576) is a organic molecular entity (CHEBI:50860) |
| NMS-873 (CHEBI:232809) is a organic molecular entity (CHEBI:50860) |
| NNC 05-2090 hydrochloride (CHEBI:231346) is a organic molecular entity (CHEBI:50860) |
| nnc0114-0006 (CHEBI:757243) is a organic molecular entity (CHEBI:50860) |
| nociceptin (CHEBI:80266) is a organic molecular entity (CHEBI:50860) |
| Nocistatin (CHEBI:80143) is a organic molecular entity (CHEBI:50860) |
| nogapendekin alfa (CHEBI:757146) is a organic molecular entity (CHEBI:50860) |
| nogapendekin alfa inbakicept (CHEBI:760245) is a organic molecular entity (CHEBI:50860) |
| nomacopan (CHEBI:757362) is a organic molecular entity (CHEBI:50860) |
| nomifensine maleate (CHEBI:234352) is a organic molecular entity (CHEBI:50860) |
| nomlabofusp (CHEBI:758896) is a organic molecular entity (CHEBI:50860) |
| Non-structural protein 4A (CHEBI:81642) is a organic molecular entity (CHEBI:50860) |
| Non-structural protein 5A (CHEBI:81643) is a organic molecular entity (CHEBI:50860) |
| Non-structural protein V (CHEBI:82132) is a organic molecular entity (CHEBI:50860) |
| nona-arginine (CHEBI:757482) is a organic molecular entity (CHEBI:50860) |
| nonacog beta pegol (CHEBI:753327) is a organic molecular entity (CHEBI:50860) |
| Nonaketamide monocyclic intermediate (CHEBI:81644) is a organic molecular entity (CHEBI:50860) |
| Nonaketamide tricyclic intermediate (CHEBI:81645) is a organic molecular entity (CHEBI:50860) |
| nonoxynol (CHEBI:753440) is a organic molecular entity (CHEBI:50860) |
| nonoxynol 10 (CHEBI:754095) is a organic molecular entity (CHEBI:50860) |
| nonoxynol 15 (CHEBI:753441) is a organic molecular entity (CHEBI:50860) |
| nonoxynol 30 (CHEBI:754096) is a organic molecular entity (CHEBI:50860) |
| Nonylphenol (CHEBI:79516) is a organic molecular entity (CHEBI:50860) |
| norgalanthamine Trifluoroacetic acid (CHEBI:68305) is a organic molecular entity (CHEBI:50860) |
| Nosantine (CHEBI:230933) is a organic molecular entity (CHEBI:50860) |
| novaferon (CHEBI:758299) is a organic molecular entity (CHEBI:50860) |
| Novobiocin sodium (CHEBI:31924) is a organic molecular entity (CHEBI:50860) |
| NP-313 (CHEBI:231339) is a organic molecular entity (CHEBI:50860) |
| NSC-277184 (CHEBI:232812) is a organic molecular entity (CHEBI:50860) |
| NSC139021 (CHEBI:232634) is a organic molecular entity (CHEBI:50860) |
| NSC294149 (CHEBI:232978) is a organic molecular entity (CHEBI:50860) |
| NSC363998 (CHEBI:232529) is a organic molecular entity (CHEBI:50860) |
| NSC80997 (CHEBI:232988) is a organic molecular entity (CHEBI:50860) |
| NSTX-3 (CHEBI:232846) is a organic molecular entity (CHEBI:50860) |
| NTX-301 (CHEBI:232584) is a organic molecular entity (CHEBI:50860) |
| nucresiran (CHEBI:760067) is a organic molecular entity (CHEBI:50860) |
| NudC Pyrophosphatase (CHEBI:231717) is a organic molecular entity (CHEBI:50860) |
| nulabeglogene autogedtemcel (CHEBI:758719) is a organic molecular entity (CHEBI:50860) |
| nurulimab (CHEBI:758003) is a organic molecular entity (CHEBI:50860) |
| nusinersen (CHEBI:755256) is a organic molecular entity (CHEBI:50860) |
| nusinersen sodium (CHEBI:755933) is a organic molecular entity (CHEBI:50860) |
| nutmeg oil (CHEBI:753423) is a organic molecular entity (CHEBI:50860) |
| nuvustotug (CHEBI:760189) is a organic molecular entity (CHEBI:50860) |
| nux vomica extract (CHEBI:752961) is a organic molecular entity (CHEBI:50860) |
| nv-128 (CHEBI:755479) is a organic molecular entity (CHEBI:50860) |
| NVP-2 (CHEBI:230487) is a organic molecular entity (CHEBI:50860) |
| nvx-cov2373 (CHEBI:758953) is a organic molecular entity (CHEBI:50860) |
| ny-eso-1 (CHEBI:757962) is a organic molecular entity (CHEBI:50860) |
| nzv-930 (CHEBI:758055) is a organic molecular entity (CHEBI:50860) |
| O-(N-acetyl-β-D-glucosaminyl)-residue (CHEBI:747467) is a organic molecular entity (CHEBI:50860) |
| O-[(2E)-2-Buten-1-yl]-L-serine (CHEBI:232652) is a organic molecular entity (CHEBI:50860) |
| O-3-butenyl-L-tyrosine (CHEBI:233948) is a organic molecular entity (CHEBI:50860) |
| O-4-pentenyl-L-tyrosine (CHEBI:233947) is a organic molecular entity (CHEBI:50860) |
| O-allyl-L-homoserine (CHEBI:234157) is a organic molecular entity (CHEBI:50860) |
| O-Allyl-L-tyrosine (CHEBI:232454) is a organic molecular entity (CHEBI:50860) |
| o-desmethylindomethacin (CHEBI:230589) is a organic molecular entity (CHEBI:50860) |
| o-eugenol (CHEBI:232404) is a organic molecular entity (CHEBI:50860) |
| O-methyl-sterigmatocystin (CHEBI:68811) is a organic molecular entity (CHEBI:50860) |
| o-Nitrobenzyl-2-fluoro-L-tyrosine (CHEBI:232646) is a organic molecular entity (CHEBI:50860) |
| o-Nitrobenzyl-2,6 difluoro-L-tyrosine (CHEBI:232932) is a organic molecular entity (CHEBI:50860) |
| o-Nitrobenzyl-2,6-difluoro-L-tyrosine (CHEBI:232647) is a organic molecular entity (CHEBI:50860) |
| o-Nitrobenzyl-3-fluoro-L-tyrosine (CHEBI:232931) is a organic molecular entity (CHEBI:50860) |
| o-Nitrobenzyl-O-tyrosine (CHEBI:232923) is a organic molecular entity (CHEBI:50860) |
| o-Nitrobenzyl-oxycarbonyl-N6-L-lysine (CHEBI:233054) is a organic molecular entity (CHEBI:50860) |
| O-Propargyl-L-tyrosine (CHEBI:232455) is a organic molecular entity (CHEBI:50860) |
| O-propargyl-puromycin (CHEBI:233230) is a organic molecular entity (CHEBI:50860) |
| O-tert-Butyl-L-tyrosine (CHEBI:233946) is a organic molecular entity (CHEBI:50860) |
| oatmeal, colloidal (CHEBI:754064) is a organic molecular entity (CHEBI:50860) |
| ob-002 (CHEBI:759685) is a organic molecular entity (CHEBI:50860) |
| Obatoclax (CHEBI:231698) is a organic molecular entity (CHEBI:50860) |
| obecabtagene autoleucel (CHEBI:759002) is a organic molecular entity (CHEBI:50860) |
| oberotatug (CHEBI:759450) is a organic molecular entity (CHEBI:50860) |
| oberotatug ravtansine (CHEBI:759451) is a organic molecular entity (CHEBI:50860) |
| obertamig (CHEBI:759452) is a organic molecular entity (CHEBI:50860) |
| Obestatin (CHEBI:80316) is a organic molecular entity (CHEBI:50860) |
| obeversen (CHEBI:758992) is a organic molecular entity (CHEBI:50860) |
| obeversen sodium (CHEBI:758993) is a organic molecular entity (CHEBI:50860) |
| obexelimab (CHEBI:757546) is a organic molecular entity (CHEBI:50860) |
| obi-888 (CHEBI:757963) is a organic molecular entity (CHEBI:50860) |
| obidoxime (CHEBI:233583) is a organic molecular entity (CHEBI:50860) |
| obiltoxaximab (CHEBI:755379) is a organic molecular entity (CHEBI:50860) |
| obinepitide (CHEBI:753318) is a organic molecular entity (CHEBI:50860) |
| obinutuzumab (CHEBI:750126) is a organic molecular entity (CHEBI:50860) |
| oblimersen (CHEBI:753308) is a organic molecular entity (CHEBI:50860) |
| oblimersen sodium (CHEBI:754116) is a organic molecular entity (CHEBI:50860) |
| obrixtamig (CHEBI:760068) is a organic molecular entity (CHEBI:50860) |
| Obscurin (CHEBI:80112) is a organic molecular entity (CHEBI:50860) |
| obudanersen (CHEBI:760395) is a organic molecular entity (CHEBI:50860) |
| obudanersen sodium (CHEBI:760518) is a organic molecular entity (CHEBI:50860) |
| ocankitug (CHEBI:760069) is a organic molecular entity (CHEBI:50860) |
| ocaratuzumab (CHEBI:754388) is a organic molecular entity (CHEBI:50860) |
| ociperlimab (CHEBI:758300) is a organic molecular entity (CHEBI:50860) |
| ocrase (CHEBI:754065) is a organic molecular entity (CHEBI:50860) |
| ocrelizumab (CHEBI:753057) is a organic molecular entity (CHEBI:50860) |
| ocriplasmin (CHEBI:750438) is a organic molecular entity (CHEBI:50860) |
| octadecenedioic acid (CHEBI:136827) is a organic molecular entity (CHEBI:50860) |
| Octaketide bicyclic intermediate (CHEBI:81699) is a organic molecular entity (CHEBI:50860) |
| Octaneuropeptide (CHEBI:80209) is a organic molecular entity (CHEBI:50860) |
| octocog alfa (CHEBI:757312) is a organic molecular entity (CHEBI:50860) |
| Octotiamine (CHEBI:31930) is a organic molecular entity (CHEBI:50860) |
| octyl α-ketoglutarate (CHEBI:233151) is a organic molecular entity (CHEBI:50860) |
| ocufilcon a (CHEBI:753721) is a organic molecular entity (CHEBI:50860) |
| ocufilcon b (CHEBI:754066) is a organic molecular entity (CHEBI:50860) |
| ocufilcon c (CHEBI:754067) is a organic molecular entity (CHEBI:50860) |
| ocufilcon d (CHEBI:753424) is a organic molecular entity (CHEBI:50860) |
| ocufilcon e (CHEBI:752966) is a organic molecular entity (CHEBI:50860) |
| ocufilcon f (CHEBI:752962) is a organic molecular entity (CHEBI:50860) |
| odesivimab (CHEBI:757595) is a organic molecular entity (CHEBI:50860) |
| odetiglucan (CHEBI:758859) is a organic molecular entity (CHEBI:50860) |
| ODN 2216 (CHEBI:231793) is a organic molecular entity (CHEBI:50860) |
| odronextamab (CHEBI:757503) is a organic molecular entity (CHEBI:50860) |
| odulimomab (CHEBI:754068) is a organic molecular entity (CHEBI:50860) |
| ofatumumab (CHEBI:749610) is a organic molecular entity (CHEBI:50860) |
| ofranergene obadenovec (CHEBI:755837) is a organic molecular entity (CHEBI:50860) |
| ogalvibart (CHEBI:758891) is a organic molecular entity (CHEBI:50860) |
| ointment, bland lubricating (CHEBI:752958) is a organic molecular entity (CHEBI:50860) |
| ointment, hydrophilic (CHEBI:752959) is a organic molecular entity (CHEBI:50860) |
| ointment, rose water (CHEBI:752960) is a organic molecular entity (CHEBI:50860) |
| ointment, white (CHEBI:753484) is a organic molecular entity (CHEBI:50860) |
| ointment, wilson's (CHEBI:754069) is a organic molecular entity (CHEBI:50860) |
| ointment, yellow (CHEBI:753485) is a organic molecular entity (CHEBI:50860) |
| olaptesed pegol (CHEBI:757964) is a organic molecular entity (CHEBI:50860) |
| olaratumab (CHEBI:231681) is a organic molecular entity (CHEBI:50860) |
| olatorepatide (CHEBI:760070) is a organic molecular entity (CHEBI:50860) |
| oleclumab (CHEBI:756498) is a organic molecular entity (CHEBI:50860) |
| olefinic compound (CHEBI:78840) is a organic molecular entity (CHEBI:50860) |
| olendalizumab (CHEBI:756507) is a organic molecular entity (CHEBI:50860) |
| oleovitamin a and d (CHEBI:753506) is a organic molecular entity (CHEBI:50860) |
| oleoyl polyoxylglycerides (CHEBI:753576) is a organic molecular entity (CHEBI:50860) |
| olesoxime (CHEBI:233408) is a organic molecular entity (CHEBI:50860) |
| olestra (CHEBI:758301) is a organic molecular entity (CHEBI:50860) |
| olezarsen (CHEBI:758324) is a organic molecular entity (CHEBI:50860) |
| olezarsen sodium (CHEBI:758169) is a organic molecular entity (CHEBI:50860) |
| Oliceridine (CHEBI:747294) is a organic molecular entity (CHEBI:50860) |
| oligonol (CHEBI:747298) is a organic molecular entity (CHEBI:50860) |
| olintatug (CHEBI:760071) is a organic molecular entity (CHEBI:50860) |
| olintatug tesirine (CHEBI:760072) is a organic molecular entity (CHEBI:50860) |
| olinvacimab (CHEBI:757534) is a organic molecular entity (CHEBI:50860) |
| olipudase alfa (CHEBI:755825) is a organic molecular entity (CHEBI:50860) |
| Olivanic acid (CHEBI:7768) is a organic molecular entity (CHEBI:50860) |
| olive oil (CHEBI:752944) is a organic molecular entity (CHEBI:50860) |
| olmesartan(1-) (CHEBI:746939) is a organic molecular entity (CHEBI:50860) |
| olocrolimus (CHEBI:755482) is a organic molecular entity (CHEBI:50860) |
| oloctinebart (CHEBI:759453) is a organic molecular entity (CHEBI:50860) |
| olokizumab (CHEBI:750127) is a organic molecular entity (CHEBI:50860) |
| olpasiran (CHEBI:758302) is a organic molecular entity (CHEBI:50860) |
| Olprinone hydrochloride (CHEBI:34902) is a organic molecular entity (CHEBI:50860) |
| olvimulogene nanivacirepvec (CHEBI:757807) is a organic molecular entity (CHEBI:50860) |
| omafilcon b (CHEBI:755095) is a organic molecular entity (CHEBI:50860) |
| omalizumab (CHEBI:749497) is a organic molecular entity (CHEBI:50860) |
| ombipepimut-s (CHEBI:756741) is a organic molecular entity (CHEBI:50860) |
| omburtamab (CHEBI:756739) is a organic molecular entity (CHEBI:50860) |
| omectatug (CHEBI:760190) is a organic molecular entity (CHEBI:50860) |
| omega-3 fatty acids (CHEBI:757488) is a organic molecular entity (CHEBI:50860) |
| omfiloctocog alfa (CHEBI:758077) is a organic molecular entity (CHEBI:50860) |
| omidubicel (CHEBI:757597) is a organic molecular entity (CHEBI:50860) |
| omidubicel non-cultured fraction (CHEBI:760407) is a organic molecular entity (CHEBI:50860) |
| Omilancor (CHEBI:233417) is a organic molecular entity (CHEBI:50860) |
| omodenbamab (CHEBI:757837) is a organic molecular entity (CHEBI:50860) |
| omoprubart (CHEBI:759547) is a organic molecular entity (CHEBI:50860) |
| ompekimig (CHEBI:760384) is a organic molecular entity (CHEBI:50860) |
| omramotide (CHEBI:759548) is a organic molecular entity (CHEBI:50860) |
| onabotulinumtoxina (CHEBI:749424) is a organic molecular entity (CHEBI:50860) |
| onacrisantaspase (CHEBI:759549) is a organic molecular entity (CHEBI:50860) |
| onamelatucel-l (CHEBI:753577) is a organic molecular entity (CHEBI:50860) |
| Onametostat (CHEBI:746978) is a organic molecular entity (CHEBI:50860) |
| onartuzumab (CHEBI:750128) is a organic molecular entity (CHEBI:50860) |
| onasemnogene abeparvovec (CHEBI:756746) is a organic molecular entity (CHEBI:50860) |
| onc-392 (CHEBI:757965) is a organic molecular entity (CHEBI:50860) |
| oncolysin b (CHEBI:754151) is a organic molecular entity (CHEBI:50860) |
| oncolysin cd6 (CHEBI:754270) is a organic molecular entity (CHEBI:50860) |
| oncolysin m (CHEBI:754296) is a organic molecular entity (CHEBI:50860) |
| oncolysin s (CHEBI:754371) is a organic molecular entity (CHEBI:50860) |
| one-carbon compound (CHEBI:64708) is a organic molecular entity (CHEBI:50860) |
| onercept (CHEBI:752945) is a organic molecular entity (CHEBI:50860) |
| onfekafusp alfa (CHEBI:757432) is a organic molecular entity (CHEBI:50860) |
| ongericimab (CHEBI:758039) is a organic molecular entity (CHEBI:50860) |
| ono-5334 (CHEBI:758496) is a organic molecular entity (CHEBI:50860) |
| Ono-AE1-329 (CHEBI:231670) is a organic molecular entity (CHEBI:50860) |
| onsifocon a (CHEBI:752946) is a organic molecular entity (CHEBI:50860) |
| ontamalimab (CHEBI:754289) is a organic molecular entity (CHEBI:50860) |
| ontasameran (CHEBI:759050) is a organic molecular entity (CHEBI:50860) |
| onterodrimer (CHEBI:758922) is a organic molecular entity (CHEBI:50860) |
| ontorpacept (CHEBI:759686) is a organic molecular entity (CHEBI:50860) |
| ontuxizumab (CHEBI:755003) is a organic molecular entity (CHEBI:50860) |
| onvapegleukin alfa (CHEBI:759550) is a organic molecular entity (CHEBI:50860) |
| onvatilimab (CHEBI:757426) is a organic molecular entity (CHEBI:50860) |
| onvitrelin ucalontide (CHEBI:757199) is a organic molecular entity (CHEBI:50860) |
| opacaline A (CHEBI:69417) is a organic molecular entity (CHEBI:50860) |
| opacaline B (CHEBI:69418) is a organic molecular entity (CHEBI:50860) |
| opacaline C (CHEBI:69419) is a organic molecular entity (CHEBI:50860) |
| opebacan (CHEBI:752947) is a organic molecular entity (CHEBI:50860) |
| opelkibart (CHEBI:759551) is a organic molecular entity (CHEBI:50860) |
| opelkibart elmanitin (CHEBI:759552) is a organic molecular entity (CHEBI:50860) |
| opemalirsen (CHEBI:759553) is a organic molecular entity (CHEBI:50860) |
| Ophiopogonin C (CHEBI:80884) is a organic molecular entity (CHEBI:50860) |
| opicinumab (CHEBI:755375) is a organic molecular entity (CHEBI:50860) |
| opilrelagene atradenorepvec (CHEBI:758720) is a organic molecular entity (CHEBI:50860) |
| opinercept (CHEBI:759998) is a organic molecular entity (CHEBI:50860) |
| Opipramol hydrochloride (CHEBI:31936) is a organic molecular entity (CHEBI:50860) |
| opium (CHEBI:752948) is a organic molecular entity (CHEBI:50860) |
| opium, powdered (CHEBI:752949) is a organic molecular entity (CHEBI:50860) |
| opolimogene capmilisbac (CHEBI:756748) is a organic molecular entity (CHEBI:50860) |
| oportuzumab monatox (CHEBI:750129) is a organic molecular entity (CHEBI:50860) |
| oprelvekin (CHEBI:749532) is a organic molecular entity (CHEBI:50860) |
| opugotamig (CHEBI:760073) is a organic molecular entity (CHEBI:50860) |
| opugotamig olatansine (CHEBI:760074) is a organic molecular entity (CHEBI:50860) |
| orange flower oil (CHEBI:753509) is a organic molecular entity (CHEBI:50860) |
| orange flower water (CHEBI:753510) is a organic molecular entity (CHEBI:50860) |
| orange juice (CHEBI:756757) is a organic molecular entity (CHEBI:50860) |
| orange oil (CHEBI:752977) is a organic molecular entity (CHEBI:50860) |
| orange peel, bitter (CHEBI:752950) is a organic molecular entity (CHEBI:50860) |
| orange spirit, compound (CHEBI:753001) is a organic molecular entity (CHEBI:50860) |
| Orbonaic acid (CHEBI:197302) is a organic molecular entity (CHEBI:50860) |
| ordesekimab (CHEBI:754255) is a organic molecular entity (CHEBI:50860) |
| oregovomab (CHEBI:752951) is a organic molecular entity (CHEBI:50860) |
| oremepermin alfa (CHEBI:759029) is a organic molecular entity (CHEBI:50860) |
| Orexin A (CHEBI:80319) is a organic molecular entity (CHEBI:50860) |
| Orexin B (CHEBI:80320) is a organic molecular entity (CHEBI:50860) |
| orforglipron (CHEBI:747472) is a organic molecular entity (CHEBI:50860) |
| organic acid (CHEBI:64709) is a organic molecular entity (CHEBI:50860) |
| organic amino compound (CHEBI:50047) is a organic molecular entity (CHEBI:50860) |
| organic fundamental parent (CHEBI:33245) is a organic molecular entity (CHEBI:50860) |
| organic hydroxy compound (CHEBI:33822) is a organic molecular entity (CHEBI:50860) |
| organic ion (CHEBI:25699) is a organic molecular entity (CHEBI:50860) |
| organic molecule (CHEBI:72695) is a organic molecular entity (CHEBI:50860) |
| organometallic compound (CHEBI:25707) is a organic molecular entity (CHEBI:50860) |
| organometalloidal compound (CHEBI:143084) is a organic molecular entity (CHEBI:50860) |
| organophosphonate(2−) (CHEBI:71285) is a organic molecular entity (CHEBI:50860) |
| organophosphorus herbicide (CHEBI:188148) is a organic molecular entity (CHEBI:50860) |
| organosilicon compound (CHEBI:25713) is a organic molecular entity (CHEBI:50860) |
| orgotein (CHEBI:753504) is a organic molecular entity (CHEBI:50860) |
| oric-101 (CHEBI:758497) is a organic molecular entity (CHEBI:50860) |
| orientiparcin (CHEBI:752952) is a organic molecular entity (CHEBI:50860) |
| orilanolimab (CHEBI:757532) is a organic molecular entity (CHEBI:50860) |
| ORM-10962 (CHEBI:232848) is a organic molecular entity (CHEBI:50860) |
| orn-0829 hydrate (CHEBI:758399) is a organic molecular entity (CHEBI:50860) |
| Ornoprostil (CHEBI:31937) is a organic molecular entity (CHEBI:50860) |
| Ortho-topolin riboside (CHEBI:233409) is a organic molecular entity (CHEBI:50860) |
| orticumab (CHEBI:754305) is a organic molecular entity (CHEBI:50860) |
| orvacabtagene autoleucel (CHEBI:757808) is a organic molecular entity (CHEBI:50860) |
| orvepitant (CHEBI:230796) is a organic molecular entity (CHEBI:50860) |
| oryzanol (CHEBI:757244) is a organic molecular entity (CHEBI:50860) |
| Osajin 4'-methyl ether (CHEBI:232615) is a organic molecular entity (CHEBI:50860) |
| Osalmid (CHEBI:31938) is a organic molecular entity (CHEBI:50860) |
| osas#1 (CHEBI:140786) is a organic molecular entity (CHEBI:50860) |
| osas#1(1-) (CHEBI:140795) is a organic molecular entity (CHEBI:50860) |
| osas#10 (CHEBI:140787) is a organic molecular entity (CHEBI:50860) |
| osas#10(1-) (CHEBI:140796) is a organic molecular entity (CHEBI:50860) |
| osas#9 (CHEBI:140788) is a organic molecular entity (CHEBI:50860) |
| osas#9(1-) (CHEBI:140797) is a organic molecular entity (CHEBI:50860) |
| osemitamab (CHEBI:758954) is a organic molecular entity (CHEBI:50860) |
| osencabtagene autoleucel (CHEBI:760075) is a organic molecular entity (CHEBI:50860) |
| osiramestrocel (CHEBI:760191) is a organic molecular entity (CHEBI:50860) |
| osocimab (CHEBI:757342) is a organic molecular entity (CHEBI:50860) |
| ostabolin-c (CHEBI:758533) is a organic molecular entity (CHEBI:50860) |
| Osutidine (CHEBI:31939) is a organic molecular entity (CHEBI:50860) |
| otekinogene vusaplasmid (CHEBI:760192) is a organic molecular entity (CHEBI:50860) |
| otelixizumab (CHEBI:750130) is a organic molecular entity (CHEBI:50860) |
| oteseconazole (CHEBI:188153) is a organic molecular entity (CHEBI:50860) |
| otilimab (CHEBI:754227) is a organic molecular entity (CHEBI:50860) |
| otlertuzumab (CHEBI:755081) is a organic molecular entity (CHEBI:50860) |
| ovandrotone albumin (CHEBI:752953) is a organic molecular entity (CHEBI:50860) |
| ox bile (CHEBI:752954) is a organic molecular entity (CHEBI:50860) |
| Oxabolone cipionate (CHEBI:31940) is a organic molecular entity (CHEBI:50860) |
| Oxapium iodide (CHEBI:31942) is a organic molecular entity (CHEBI:50860) |
| Oxazolam (CHEBI:31944) is a organic molecular entity (CHEBI:50860) |
| Oxeladin citrate (CHEBI:31945) is a organic molecular entity (CHEBI:50860) |
| oxelumab (CHEBI:753659) is a organic molecular entity (CHEBI:50860) |
| Oxendolone (CHEBI:31946) is a organic molecular entity (CHEBI:50860) |
| oxerutins (CHEBI:752955) is a organic molecular entity (CHEBI:50860) |
| oxidized 2-acylglycerol (CHEBI:167117) is a organic molecular entity (CHEBI:50860) |
| Oxidized azurin (CHEBI:7833) is a organic molecular entity (CHEBI:50860) |
| oxidized glycerolipid (CHEBI:176641) is a organic molecular entity (CHEBI:50860) |
| Oxidized reactive black 5 (CHEBI:80232) is a organic molecular entity (CHEBI:50860) |
| Oxidized thiol-containing reductant (CHEBI:79973) is a organic molecular entity (CHEBI:50860) |
| Oxidopamine Hydrochloride (CHEBI:232990) is a organic molecular entity (CHEBI:50860) |
| oximbomotide (CHEBI:759554) is a organic molecular entity (CHEBI:50860) |
| oxime (CHEBI:25750) is a organic molecular entity (CHEBI:50860) |
| Oxine-copper (CHEBI:82028) is a organic molecular entity (CHEBI:50860) |
| oxoplatinum (CHEBI:233162) is a organic molecular entity (CHEBI:50860) |
| oxychlorosene sodium (CHEBI:752956) is a organic molecular entity (CHEBI:50860) |
| Oxyfedrine hydrochloride (CHEBI:31950) is a organic molecular entity (CHEBI:50860) |
| oxyfilcon a (CHEBI:752957) is a organic molecular entity (CHEBI:50860) |
| oxylanthanum carbonate (CHEBI:760323) is a organic molecular entity (CHEBI:50860) |
| Oxymetebanol (CHEBI:31951) is a organic molecular entity (CHEBI:50860) |
| Oxyntomodulin (CHEBI:81576) is a organic molecular entity (CHEBI:50860) |
| Oxypertine (CHEBI:31952) is a organic molecular entity (CHEBI:50860) |
| Oxytetracycline hydrochloride (CHEBI:31953) is a organic molecular entity (CHEBI:50860) |
| Ozagrel hydrochloride (CHEBI:31954) is a organic molecular entity (CHEBI:50860) |
| ozanezumab (CHEBI:753627) is a organic molecular entity (CHEBI:50860) |
| Ozanimod (CHEBI:234516) is a organic molecular entity (CHEBI:50860) |
| ozarelix (CHEBI:753300) is a organic molecular entity (CHEBI:50860) |
| ozekibart (CHEBI:759310) is a organic molecular entity (CHEBI:50860) |
| ozogamicin (CHEBI:753082) is a organic molecular entity (CHEBI:50860) |
| ozoralizumab (CHEBI:750131) is a organic molecular entity (CHEBI:50860) |
| ozureprubart (CHEBI:760076) is a organic molecular entity (CHEBI:50860) |
| ozuriftamab (CHEBI:758994) is a organic molecular entity (CHEBI:50860) |
| ozuriftamab vedotin (CHEBI:758860) is a organic molecular entity (CHEBI:50860) |
| p-(2-tetrazole) -L-phenylalanine (CHEBI:232938) is a organic molecular entity (CHEBI:50860) |
| p-Acrylamido-(S)-L-phenylalanine (CHEBI:232939) is a organic molecular entity (CHEBI:50860) |
| p-Aminobenzamidine dihydrochloride (CHEBI:10618) is a organic molecular entity (CHEBI:50860) |
| p-Borono-L-phenylalanine (CHEBI:232826) is a organic molecular entity (CHEBI:50860) |
| P-CH-clothianidin (CHEBI:232536) is a organic molecular entity (CHEBI:50860) |
| p-chloroacetophenone (CHEBI:230611) is a organic molecular entity (CHEBI:50860) |
| p-Hydroxy-phenyllactic-acid (CHEBI:232831) is a organic molecular entity (CHEBI:50860) |
| p-isopge2-pc (CHEBI:230727) is a organic molecular entity (CHEBI:50860) |
| p-isopgf2-pc (CHEBI:230627) is a organic molecular entity (CHEBI:50860) |
| p-Methyl-L-phenylalanine (CHEBI:232833) is a organic molecular entity (CHEBI:50860) |
| p-OCF3-Phe (CHEBI:232830) is a organic molecular entity (CHEBI:50860) |
| p-Vinylsulfonamido (S)-L-phenylalanine (CHEBI:232940) is a organic molecular entity (CHEBI:50860) |
| p-xylylenediamine (CHEBI:747248) is a organic molecular entity (CHEBI:50860) |
| p2y purinoceptor 12 (CHEBI:758381) is a organic molecular entity (CHEBI:50860) |
| P55-TNFR (CHEBI:80210) is a organic molecular entity (CHEBI:50860) |
| P75-TNFR (CHEBI:80211) is a organic molecular entity (CHEBI:50860) |
| pa(12:0/17:1(9z)) (CHEBI:230788) is a organic molecular entity (CHEBI:50860) |
| pa(12:0/18:2(9z,12z)) (CHEBI:230621) is a organic molecular entity (CHEBI:50860) |
| PA(14:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) (CHEBI:230806) is a organic molecular entity (CHEBI:50860) |
| pa(14:1(9z)/14:1(9z)) (CHEBI:230790) is a organic molecular entity (CHEBI:50860) |
| PA(20:3(6,8,11)-OH(5)/14:0) (CHEBI:230924) is a organic molecular entity (CHEBI:50860) |
| PA(21:0/18:3(10,12,15)-OH(9)) (CHEBI:230446) is a organic molecular entity (CHEBI:50860) |
| PA(22:2(13Z,16Z)/PGE1) (CHEBI:230429) is a organic molecular entity (CHEBI:50860) |
| pa(22:6(4z,7z,10z,13z,16z,19z)/20:5(5z,8z,11z,14z,17z)) (CHEBI:230665) is a organic molecular entity (CHEBI:50860) |
| PA(6 keto-PGF1alpha/14:1(9Z)) (CHEBI:230838) is a organic molecular entity (CHEBI:50860) |
| PA(a-25:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) (CHEBI:230434) is a organic molecular entity (CHEBI:50860) |
| pa(o-20:0/0:0) (CHEBI:230633) is a organic molecular entity (CHEBI:50860) |
| pabinafusp alfa (CHEBI:758038) is a organic molecular entity (CHEBI:50860) |
| Pac-1 (CHEBI:231696) is a organic molecular entity (CHEBI:50860) |
| pac-14028 (CHEBI:755850) is a organic molecular entity (CHEBI:50860) |
| pacanalotamab (CHEBI:758160) is a organic molecular entity (CHEBI:50860) |
| pacibekitug (CHEBI:760077) is a organic molecular entity (CHEBI:50860) |
| paclitaxel obaluronate (CHEBI:758721) is a organic molecular entity (CHEBI:50860) |
| paclitaxel poliglumex (CHEBI:753579) is a organic molecular entity (CHEBI:50860) |
| pacmilimab (CHEBI:757038) is a organic molecular entity (CHEBI:50860) |
| padeliporfin (CHEBI:757787) is a organic molecular entity (CHEBI:50860) |
| padeliporfin potassium (CHEBI:757788) is a organic molecular entity (CHEBI:50860) |
| padoporfin (CHEBI:756713) is a organic molecular entity (CHEBI:50860) |
| paflufocon a (CHEBI:753083) is a organic molecular entity (CHEBI:50860) |
| paflufocon b (CHEBI:753084) is a organic molecular entity (CHEBI:50860) |
| paflufocon c (CHEBI:753085) is a organic molecular entity (CHEBI:50860) |
| paflufocon d (CHEBI:753086) is a organic molecular entity (CHEBI:50860) |
| paflufocon d-hem-iberfilcon a (CHEBI:753580) is a organic molecular entity (CHEBI:50860) |
| paflufocon e (CHEBI:753087) is a organic molecular entity (CHEBI:50860) |
| pagibaximab (CHEBI:753058) is a organic molecular entity (CHEBI:50860) |
| paguinal hydrochloride (CHEBI:753581) is a organic molecular entity (CHEBI:50860) |
| Pahutoxin (CHEBI:80781) is a organic molecular entity (CHEBI:50860) |
| palifermin (CHEBI:749597) is a organic molecular entity (CHEBI:50860) |
| palivizumab (CHEBI:749496) is a organic molecular entity (CHEBI:50860) |
| palmarumycin C8 (CHEBI:141339) is a organic molecular entity (CHEBI:50860) |
| Palmitoylphosphatidylcholine (CHEBI:7901) is a organic molecular entity (CHEBI:50860) |
| palopegteriparatide (CHEBI:759036) is a organic molecular entity (CHEBI:50860) |
| palsucibep pegol (CHEBI:758722) is a organic molecular entity (CHEBI:50860) |
| paluratide (CHEBI:760078) is a organic molecular entity (CHEBI:50860) |
| palustrol (CHEBI:231493) is a organic molecular entity (CHEBI:50860) |
| palverafusp alfa (CHEBI:760079) is a organic molecular entity (CHEBI:50860) |
| Palygorskite (CHEBI:82365) is a organic molecular entity (CHEBI:50860) |
| pAMF (CHEBI:232832) is a organic molecular entity (CHEBI:50860) |
| Pamicogrel (CHEBI:31957) is a organic molecular entity (CHEBI:50860) |
| pamiteplase (CHEBI:753088) is a organic molecular entity (CHEBI:50860) |
| pamlectabart (CHEBI:760193) is a organic molecular entity (CHEBI:50860) |
| pamlectabart tismanitin (CHEBI:760194) is a organic molecular entity (CHEBI:50860) |
| pamrevlumab (CHEBI:754196) is a organic molecular entity (CHEBI:50860) |
| pamvatamig (CHEBI:759555) is a organic molecular entity (CHEBI:50860) |
| pancreas powder, porcine (CHEBI:759766) is a organic molecular entity (CHEBI:50860) |
| Pancreatic polypeptide (CHEBI:80329) is a organic molecular entity (CHEBI:50860) |
| pancreatin (CHEBI:753089) is a organic molecular entity (CHEBI:50860) |
| pancrelipase (CHEBI:753090) is a organic molecular entity (CHEBI:50860) |
| pancreozymin (CHEBI:753508) is a organic molecular entity (CHEBI:50860) |
| pangumestrocel (CHEBI:760195) is a organic molecular entity (CHEBI:50860) |
| Panipenem (CHEBI:7911) is a organic molecular entity (CHEBI:50860) |
| panitumumab (CHEBI:749603) is a organic molecular entity (CHEBI:50860) |
| panobacumab (CHEBI:750132) is a organic molecular entity (CHEBI:50860) |
| Panthenyl ethyl ether (CHEBI:31960) is a organic molecular entity (CHEBI:50860) |
| papain (CHEBI:753091) is a organic molecular entity (CHEBI:50860) |
| para-amino-blebbistatin (CHEBI:747820) is a organic molecular entity (CHEBI:50860) |
| Paracetamol-Cys-Gly conjugate (CHEBI:180460) is a organic molecular entity (CHEBI:50860) |
| paraffin (CHEBI:753092) is a organic molecular entity (CHEBI:50860) |
| paraffin, synthetic (CHEBI:753093) is a organic molecular entity (CHEBI:50860) |
| paraformaldehyde (CHEBI:752978) is a organic molecular entity (CHEBI:50860) |
| paraquat dichloride hydrate (CHEBI:233354) is a organic molecular entity (CHEBI:50860) |
| Parathyroid hormone (CHEBI:80273) is a organic molecular entity (CHEBI:50860) |
| Parathyroid hormone-related peptide (1-36) (CHEBI:80274) is a organic molecular entity (CHEBI:50860) |
| paregoric (CHEBI:753094) is a organic molecular entity (CHEBI:50860) |
| paridiprubart (CHEBI:758933) is a organic molecular entity (CHEBI:50860) |
| pariglasgene brecaparvovec (CHEBI:759006) is a organic molecular entity (CHEBI:50860) |
| parnaparin (CHEBI:755724) is a organic molecular entity (CHEBI:50860) |
| parnaparin sodium (CHEBI:753095) is a organic molecular entity (CHEBI:50860) |
| parsatuzumab (CHEBI:754203) is a organic molecular entity (CHEBI:50860) |
| pascolizumab (CHEBI:753131) is a organic molecular entity (CHEBI:50860) |
| pasifolate exatecan (CHEBI:760374) is a organic molecular entity (CHEBI:50860) |
| pasritamig (CHEBI:760196) is a organic molecular entity (CHEBI:50860) |
| patecibart (CHEBI:759454) is a organic molecular entity (CHEBI:50860) |
| pateclizumab (CHEBI:750133) is a organic molecular entity (CHEBI:50860) |
| Patent blue (CHEBI:34906) is a organic molecular entity (CHEBI:50860) |
| patiromer (CHEBI:752917) is a organic molecular entity (CHEBI:50860) |
| patiromer calcium (CHEBI:752888) is a organic molecular entity (CHEBI:50860) |
| patiromer sorbitex calcium (CHEBI:759764) is a organic molecular entity (CHEBI:50860) |
| patisiran (CHEBI:756470) is a organic molecular entity (CHEBI:50860) |
| patisiran sodium (CHEBI:757014) is a organic molecular entity (CHEBI:50860) |
| patritumab (CHEBI:754211) is a organic molecular entity (CHEBI:50860) |
| patritumab deruxtecan (CHEBI:758083) is a organic molecular entity (CHEBI:50860) |
| Patroneic acid (CHEBI:197299) is a organic molecular entity (CHEBI:50860) |
| paulomycin (CHEBI:753683) is a organic molecular entity (CHEBI:50860) |
| pavurutamab (CHEBI:758161) is a organic molecular entity (CHEBI:50860) |
| Pb1 (CHEBI:177890) is a organic molecular entity (CHEBI:50860) |
| PB1-F2 (CHEBI:82128) is a organic molecular entity (CHEBI:50860) |
| pbf-680 (CHEBI:755490) is a organic molecular entity (CHEBI:50860) |
| PC (O-16:0/4:1) (CHEBI:140476) is a organic molecular entity (CHEBI:50860) |
| PC(DiMe(13,5)/TXB2) (CHEBI:230442) is a organic molecular entity (CHEBI:50860) |
| pd-360324 (CHEBI:754291) is a organic molecular entity (CHEBI:50860) |
| PE-GlcCer 16:0(3OH,4OH,14Me)/22:0(2OH) (CHEBI:229470) is a organic molecular entity (CHEBI:50860) |
| PE-GlcCer 16:0(3OH,4OH,14Me)/24:0(2OH) (CHEBI:229471) is a organic molecular entity (CHEBI:50860) |
| PE-HexCer 39:0;O4 (CHEBI:229483) is a organic molecular entity (CHEBI:50860) |
| PE-HexCer 40:0;O4 (CHEBI:229484) is a organic molecular entity (CHEBI:50860) |
| PE-HexCer 41:0;O4 (CHEBI:229485) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-GlcCer 16:0(3OH,4OH,14Me)/22:0(2OH) (CHEBI:229472) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-GlcCer 16:0(3OH,4OH,14Me)/23:0(2OH) (CHEBI:229473) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-GlcCer 16:0(3OH,4OH,14Me)/24:0(2OH) (CHEBI:229474) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 38:0;O4 (CHEBI:229475) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 39:0;O4 (CHEBI:229476) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 40:0;O4 (CHEBI:229477) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 41:0;O4 (CHEBI:229478) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 42:0;O4 (CHEBI:229479) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 43:0;O4 (CHEBI:229480) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 44:0;O4 (CHEBI:229481) is a organic molecular entity (CHEBI:50860) |
| PE-NMe-HexCer 45:0;O4 (CHEBI:229482) is a organic molecular entity (CHEBI:50860) |
| PE(0:0/14:0) (CHEBI:145244) is a organic molecular entity (CHEBI:50860) |
| PE(16:1(9Z)/14:0) zwitterion (CHEBI:195408) is a organic molecular entity (CHEBI:50860) |
| PE(16:1(9Z)/16:0) zwitterion (CHEBI:195410) is a organic molecular entity (CHEBI:50860) |
| PE(18:0/16:1(9Z)) zwitterion (CHEBI:195411) is a organic molecular entity (CHEBI:50860) |
| PE(20:1(11Z)/PGJ2) (CHEBI:230419) is a organic molecular entity (CHEBI:50860) |
| PE(DiMe(13,5)/PGF2alpha) (CHEBI:230304) is a organic molecular entity (CHEBI:50860) |
| PE(LTE4/DiMe(11,3)) (CHEBI:230941) is a organic molecular entity (CHEBI:50860) |
| PE(P-18:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) (CHEBI:230444) is a organic molecular entity (CHEBI:50860) |
| peanut oil (CHEBI:753684) is a organic molecular entity (CHEBI:50860) |
| peceleganan (CHEBI:758723) is a organic molecular entity (CHEBI:50860) |
| pectenolone (CHEBI:230678) is a organic molecular entity (CHEBI:50860) |
| peforelin (CHEBI:753059) is a organic molecular entity (CHEBI:50860) |
| pegacaristim (CHEBI:753132) is a organic molecular entity (CHEBI:50860) |
| pegademase bovine (CHEBI:749443) is a organic molecular entity (CHEBI:50860) |
| pegadricase (CHEBI:753661) is a organic molecular entity (CHEBI:50860) |
| pegaldesleukin (CHEBI:753007) is a organic molecular entity (CHEBI:50860) |
| pegapamodutide (CHEBI:756494) is a organic molecular entity (CHEBI:50860) |
| pegaptanib octasodium (CHEBI:753685) is a organic molecular entity (CHEBI:50860) |
| pegaptanib sodium (CHEBI:749454) is a organic molecular entity (CHEBI:50860) |
| pegargiminase (CHEBI:755172) is a organic molecular entity (CHEBI:50860) |
| pegaspargase (CHEBI:753505) is a organic molecular entity (CHEBI:50860) |
| pegbelfermin (CHEBI:757053) is a organic molecular entity (CHEBI:50860) |
| pegbovigrastim (CHEBI:755004) is a organic molecular entity (CHEBI:50860) |
| pegcetacoplan (CHEBI:757617) is a organic molecular entity (CHEBI:50860) |
| pegdinetanib (CHEBI:753334) is a organic molecular entity (CHEBI:50860) |
| pegenzileukin (CHEBI:758314) is a organic molecular entity (CHEBI:50860) |
| pegfilgrastim (CHEBI:749426) is a organic molecular entity (CHEBI:50860) |
| pegfosimer manganese (CHEBI:759455) is a organic molecular entity (CHEBI:50860) |
| pegilodecakin (CHEBI:756475) is a organic molecular entity (CHEBI:50860) |
| peginterferon alfa-2a (CHEBI:749533) is a organic molecular entity (CHEBI:50860) |
| peginterferon alfa-2b (CHEBI:63615) is a organic molecular entity (CHEBI:50860) |
| peginterferon alfacon-2 (CHEBI:760000) is a organic molecular entity (CHEBI:50860) |
| peginterferon beta-1a (CHEBI:753625) is a organic molecular entity (CHEBI:50860) |
| peginterferon lambda-1a (CHEBI:753662) is a organic molecular entity (CHEBI:50860) |
| pegipanermin (CHEBI:758520) is a organic molecular entity (CHEBI:50860) |
| peglicol 5 oleate (CHEBI:753746) is a organic molecular entity (CHEBI:50860) |
| pegloprastide (CHEBI:758883) is a organic molecular entity (CHEBI:50860) |
| pegloticase (CHEBI:749683) is a organic molecular entity (CHEBI:50860) |
| pegloxenatide (CHEBI:758524) is a organic molecular entity (CHEBI:50860) |
| pegmispotide (CHEBI:759556) is a organic molecular entity (CHEBI:50860) |
| pegmusirudin (CHEBI:753686) is a organic molecular entity (CHEBI:50860) |
| pegnartograstim (CHEBI:753006) is a organic molecular entity (CHEBI:50860) |
| pegnivacogin (CHEBI:752912) is a organic molecular entity (CHEBI:50860) |
| pegnivacogin sodium (CHEBI:753667) is a organic molecular entity (CHEBI:50860) |
| pegorgotein (CHEBI:753516) is a organic molecular entity (CHEBI:50860) |
| pegoterate (CHEBI:753519) is a organic molecular entity (CHEBI:50860) |
| pegoxol 7 stearate (CHEBI:753004) is a organic molecular entity (CHEBI:50860) |
| pegozafermin (CHEBI:757947) is a organic molecular entity (CHEBI:50860) |
| pegpleranib sodium (CHEBI:755260) is a organic molecular entity (CHEBI:50860) |
| pegrizeprument (CHEBI:760089) is a organic molecular entity (CHEBI:50860) |
| pegsebrenatide (CHEBI:758376) is a organic molecular entity (CHEBI:50860) |
| pegsitacianine (CHEBI:758378) is a organic molecular entity (CHEBI:50860) |
| pegsunercept (CHEBI:750134) is a organic molecular entity (CHEBI:50860) |
| pegtarazimod (CHEBI:759456) is a organic molecular entity (CHEBI:50860) |
| pegtarviliase (CHEBI:759687) is a organic molecular entity (CHEBI:50860) |
| pegteograstim (CHEBI:757246) is a organic molecular entity (CHEBI:50860) |
| pegtibatinase (CHEBI:757245) is a organic molecular entity (CHEBI:50860) |
| pegulicianine acetate (CHEBI:757843) is a organic molecular entity (CHEBI:50860) |
| pegunigalsidase alfa (CHEBI:757247) is a organic molecular entity (CHEBI:50860) |
| pegvisomant (CHEBI:749488) is a organic molecular entity (CHEBI:50860) |
| pegvorhyaluronidase alfa (CHEBI:756459) is a organic molecular entity (CHEBI:50860) |
| pegylated carboxyhemoglobin (bovine) (CHEBI:758383) is a organic molecular entity (CHEBI:50860) |
| pegzilarginase (CHEBI:757248) is a organic molecular entity (CHEBI:50860) |
| pelacarsen (CHEBI:757609) is a organic molecular entity (CHEBI:50860) |
| pelacarsen sodium (CHEBI:757610) is a organic molecular entity (CHEBI:50860) |
| pelareorep (CHEBI:755444) is a organic molecular entity (CHEBI:50860) |
| pelgifatamab (CHEBI:758724) is a organic molecular entity (CHEBI:50860) |
| peliomycin (CHEBI:753133) is a organic molecular entity (CHEBI:50860) |
| peltopepimut-s (CHEBI:759038) is a organic molecular entity (CHEBI:50860) |
| Pelubiprofen (CHEBI:31970) is a organic molecular entity (CHEBI:50860) |
| peluntamig (CHEBI:760197) is a organic molecular entity (CHEBI:50860) |
| Pembrolizumab (CHEBI:82976) is a organic molecular entity (CHEBI:50860) |
| Pemirolast potassium (CHEBI:31971) is a organic molecular entity (CHEBI:50860) |
| pemivibart (CHEBI:760399) is a organic molecular entity (CHEBI:50860) |
| pemlimogene merolisbac (CHEBI:756747) is a organic molecular entity (CHEBI:50860) |
| pemtumomab (CHEBI:754184) is a organic molecular entity (CHEBI:50860) |
| pemvidutide (CHEBI:758725) is a organic molecular entity (CHEBI:50860) |
| Penflutizide (CHEBI:31972) is a organic molecular entity (CHEBI:50860) |
| penicillinase (CHEBI:753687) is a organic molecular entity (CHEBI:50860) |
| penochalasin A (CHEBI:68806) is a organic molecular entity (CHEBI:50860) |
| penpulimab (CHEBI:757046) is a organic molecular entity (CHEBI:50860) |
| pentadeca-1z,7z,13z-trien-9,11-diyne (CHEBI:230591) is a organic molecular entity (CHEBI:50860) |
| pentafilcon a (CHEBI:753688) is a organic molecular entity (CHEBI:50860) |
| Pentafluoro-D-phenylalanine (CHEBI:747855) is a organic molecular entity (CHEBI:50860) |
| Pentagastrin (CHEBI:31974) is a organic molecular entity (CHEBI:50860) |
| pentaglutamyl folate (CHEBI:140748) is a organic molecular entity (CHEBI:50860) |
| pentaglutamyl folate(6-) (CHEBI:140749) is a organic molecular entity (CHEBI:50860) |
| pentastarch (CHEBI:753134) is a organic molecular entity (CHEBI:50860) |
| pentetate calcium trisodium yb-169 (CHEBI:749302) is a organic molecular entity (CHEBI:50860) |
| pentetate indium disodium (CHEBI:754721) is a organic molecular entity (CHEBI:50860) |
| pentetate indium disodium in 111 (CHEBI:752668) is a organic molecular entity (CHEBI:50860) |
| Pentetreotide (CHEBI:31975) is a organic molecular entity (CHEBI:50860) |
| Pentobarbital sodium (CHEBI:7984) is a organic molecular entity (CHEBI:50860) |
| pentosan polysulfate sodium (CHEBI:749457) is a organic molecular entity (CHEBI:50860) |
| pepinemab (CHEBI:757322) is a organic molecular entity (CHEBI:50860) |
| peppermint (CHEBI:753511) is a organic molecular entity (CHEBI:50860) |
| peppermint oil (CHEBI:753689) is a organic molecular entity (CHEBI:50860) |
| peppermint spirit (CHEBI:753002) is a organic molecular entity (CHEBI:50860) |
| peppermint water (CHEBI:753512) is a organic molecular entity (CHEBI:50860) |
| Peptide 2-[3-carboxy-3-(dimethylammonio)propyl]-L-histidine (CHEBI:80681) is a organic molecular entity (CHEBI:50860) |
| peptide b27pd (CHEBI:757340) is a organic molecular entity (CHEBI:50860) |
| peptide yy human (3-36) (CHEBI:757401) is a organic molecular entity (CHEBI:50860) |
| Peptide-L-methionine (R)-S-oxide (CHEBI:80004) is a organic molecular entity (CHEBI:50860) |
| Peptide(-Phe) (CHEBI:8000) is a organic molecular entity (CHEBI:50860) |
| Peptide(-Trp) (CHEBI:8001) is a organic molecular entity (CHEBI:50860) |
| Peptide(N-Glu, Asp, Cystine) (CHEBI:8004) is a organic molecular entity (CHEBI:50860) |
| perakizumab (CHEBI:754258) is a organic molecular entity (CHEBI:50860) |
| perenostobart (CHEBI:759393) is a organic molecular entity (CHEBI:50860) |
| peresolimab (CHEBI:758927) is a organic molecular entity (CHEBI:50860) |
| perfilcon a (CHEBI:753135) is a organic molecular entity (CHEBI:50860) |
| perfluoropolymethylisopropyl ether (CHEBI:749508) is a organic molecular entity (CHEBI:50860) |
| Perhexiline maleate (CHEBI:232991) is a organic molecular entity (CHEBI:50860) |
| Perlapine (CHEBI:31983) is a organic molecular entity (CHEBI:50860) |
| perlolyrine (CHEBI:69444) is a organic molecular entity (CHEBI:50860) |
| Peroxidase (CHEBI:8027) is a organic molecular entity (CHEBI:50860) |
| persic oil (CHEBI:753448) is a organic molecular entity (CHEBI:50860) |
| persicabtagene lemgedleucel (CHEBI:760198) is a organic molecular entity (CHEBI:50860) |
| pertechnetate (CHEBI:754396) is a organic molecular entity (CHEBI:50860) |
| pertussis immune globulin (CHEBI:754105) is a organic molecular entity (CHEBI:50860) |
| pertussis vaccine (CHEBI:754106) is a organic molecular entity (CHEBI:50860) |
| pertussis vaccine adsorbed (CHEBI:754107) is a organic molecular entity (CHEBI:50860) |
| pertuzumab (CHEBI:750362) is a organic molecular entity (CHEBI:50860) |
| pertuzumab zuvotolimod (CHEBI:758726) is a organic molecular entity (CHEBI:50860) |
| peruvian balsam (CHEBI:753449) is a organic molecular entity (CHEBI:50860) |
| Pervanadate (CHEBI:235319) is a organic molecular entity (CHEBI:50860) |
| pestalodiol (CHEBI:156305) is a organic molecular entity (CHEBI:50860) |
| petosemtamab (CHEBI:757228) is a organic molecular entity (CHEBI:50860) |
| petrafocon a-hem-larafilcon a (CHEBI:753582) is a organic molecular entity (CHEBI:50860) |
| petrelintide (CHEBI:759557) is a organic molecular entity (CHEBI:50860) |
| petrobactin(1+) (CHEBI:142778) is a organic molecular entity (CHEBI:50860) |
| petrolatum (CHEBI:753513) is a organic molecular entity (CHEBI:50860) |
| petrolatum, hydrophilic (CHEBI:753009) is a organic molecular entity (CHEBI:50860) |
| petrolatum, white (CHEBI:749575) is a organic molecular entity (CHEBI:50860) |
| pexastimogene devacirepvec (CHEBI:755087) is a organic molecular entity (CHEBI:50860) |
| pexelizumab (CHEBI:753003) is a organic molecular entity (CHEBI:50860) |
| pexipepimut-s (CHEBI:759040) is a organic molecular entity (CHEBI:50860) |
| pezadeftide (CHEBI:758727) is a organic molecular entity (CHEBI:50860) |
| pf-03446879 (CHEBI:754297) is a organic molecular entity (CHEBI:50860) |
| pf-03475952 (CHEBI:754265) is a organic molecular entity (CHEBI:50860) |
| pf-03732010 (CHEBI:754306) is a organic molecular entity (CHEBI:50860) |
| Pf-03814735 (CHEBI:747804) is a organic molecular entity (CHEBI:50860) |
| pf-04603629 (CHEBI:758498) is a organic molecular entity (CHEBI:50860) |
| pf-04605412 (CHEBI:754363) is a organic molecular entity (CHEBI:50860) |
| PF-04691502 (CHEBI:231357) is a organic molecular entity (CHEBI:50860) |
| pf-05019702 (CHEBI:755534) is a organic molecular entity (CHEBI:50860) |
| pf-05230907 (CHEBI:758303) is a organic molecular entity (CHEBI:50860) |
| pf-06263507 (CHEBI:757249) is a organic molecular entity (CHEBI:50860) |
| PF-06447475 (CHEBI:233295) is a organic molecular entity (CHEBI:50860) |
| pf-06671008 (CHEBI:757250) is a organic molecular entity (CHEBI:50860) |
| pf-06688992 (CHEBI:757966) is a organic molecular entity (CHEBI:50860) |
| pf-06747143 (CHEBI:757251) is a organic molecular entity (CHEBI:50860) |
| pf-06751979 (CHEBI:757252) is a organic molecular entity (CHEBI:50860) |
| Pf-06840003 (CHEBI:233415) is a organic molecular entity (CHEBI:50860) |
| pf-07258669 (CHEBI:758861) is a organic molecular entity (CHEBI:50860) |
| PF-4708671 (CHEBI:232526) is a organic molecular entity (CHEBI:50860) |
| pg-102 (CHEBI:754261) is a organic molecular entity (CHEBI:50860) |
| pg-110 (CHEBI:754299) is a organic molecular entity (CHEBI:50860) |
| pg-760564 (CHEBI:755619) is a organic molecular entity (CHEBI:50860) |
| pg(13:0/20:1(11z)) (CHEBI:230601) is a organic molecular entity (CHEBI:50860) |
| PG(18:3(6Z,9Z,12Z)/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) (CHEBI:230960) is a organic molecular entity (CHEBI:50860) |
| PG(a-21:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) (CHEBI:230841) is a organic molecular entity (CHEBI:50860) |
| PG(i-24:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) (CHEBI:230440) is a organic molecular entity (CHEBI:50860) |
| PG(i-24:0/TXB2) (CHEBI:231147) is a organic molecular entity (CHEBI:50860) |
| pg(o-16:0/15:1(9z)) (CHEBI:230716) is a organic molecular entity (CHEBI:50860) |
| PGP(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/PGF2alpha) (CHEBI:230937) is a organic molecular entity (CHEBI:50860) |
| pgt-121 (CHEBI:758059) is a organic molecular entity (CHEBI:50860) |
| PH4 (CHEBI:193164) is a organic molecular entity (CHEBI:50860) |
| Pha-680632 (CHEBI:747805) is a organic molecular entity (CHEBI:50860) |
| pha-794428 (CHEBI:760493) is a organic molecular entity (CHEBI:50860) |
| Phaeomelanin (CHEBI:81393) is a organic molecular entity (CHEBI:50860) |
| Phe-4-azobenzene (CHEBI:232820) is a organic molecular entity (CHEBI:50860) |
| Phe-Trp-Asn (CHEBI:161909) is a organic molecular entity (CHEBI:50860) |
| phe377 (CHEBI:755486) is a organic molecular entity (CHEBI:50860) |
| phemfilcon a (CHEBI:754108) is a organic molecular entity (CHEBI:50860) |
| Phen-DC 3 (CHEBI:235412) is a organic molecular entity (CHEBI:50860) |
| Phenanthroviridone aglycon (CHEBI:31986) is a organic molecular entity (CHEBI:50860) |
| Phenbenzamine hydrochloride (CHEBI:34913) is a organic molecular entity (CHEBI:50860) |
| Phenelzine sulfate (CHEBI:8061) is a organic molecular entity (CHEBI:50860) |
| Pheniramine maleate (CHEBI:31990) is a organic molecular entity (CHEBI:50860) |
| Phenmetrazine hydrochloride (CHEBI:8068) is a organic molecular entity (CHEBI:50860) |
| phenolphthalein, yellow (CHEBI:754109) is a organic molecular entity (CHEBI:50860) |
| Phenoxybenzamine hydrochloride (CHEBI:8078) is a organic molecular entity (CHEBI:50860) |
| Phenylalanine-4-azobenzene (CHEBI:232456) is a organic molecular entity (CHEBI:50860) |
| phenylalaninodeoxycholic acid (CHEBI:232229) is a organic molecular entity (CHEBI:50860) |
| phenylalaninolithocholic acid (CHEBI:232192) is a organic molecular entity (CHEBI:50860) |
| phenylalaninoursodeoxycholic acid (CHEBI:232285) is a organic molecular entity (CHEBI:50860) |
| phenylmercuric borate (CHEBI:755943) is a organic molecular entity (CHEBI:50860) |
| phenylpropane (CHEBI:166891) is a organic molecular entity (CHEBI:50860) |
| Phenylpropanol (CHEBI:31995) is a organic molecular entity (CHEBI:50860) |
| PhenylselenoCys (CHEBI:232933) is a organic molecular entity (CHEBI:50860) |
| phenytoin sodium (CHEBI:233284) is a organic molecular entity (CHEBI:50860) |
| philanthotoxin 433 (CHEBI:232580) is a organic molecular entity (CHEBI:50860) |
| phosphatidylethanolamine 20:4_22:2 (CHEBI:149575) is a organic molecular entity (CHEBI:50860) |
| phosphatidylinositol 4,5-bisphosphate (CHEBI:232300) is a organic molecular entity (CHEBI:50860) |
| phosphoethanolamine cellulose (CHEBI:232983) is a organic molecular entity (CHEBI:50860) |
| phosphoethanolamine-glycosyl-(1-radyl,2-acyl-sn-glycero-3-phospho)-1D-myo-2-acyl-inositol zwitterion (CHEBI:143784) is a organic molecular entity (CHEBI:50860) |
| phosphoethanolamine-glycosyl-inositol-phosphoceramide zwitterion (CHEBI:143881) is a organic molecular entity (CHEBI:50860) |
| phosphoribosylformylglycinamidine (CHEBI:230651) is a organic molecular entity (CHEBI:50860) |
| phosphorothioic acid, O,O-diethyl O-phenyl ester (CHEBI:232103) is a organic molecular entity (CHEBI:50860) |
| phosphorus-31(3-) (CHEBI:176601) is a organic molecular entity (CHEBI:50860) |
| phosphorus-31(3+) (CHEBI:176602) is a organic molecular entity (CHEBI:50860) |
| phosphorus-31(5+) (CHEBI:176603) is a organic molecular entity (CHEBI:50860) |
| physioneal (CHEBI:758499) is a organic molecular entity (CHEBI:50860) |
| phytene-1,2-diol (CHEBI:232590) is a organic molecular entity (CHEBI:50860) |
| pi-0824 (CHEBI:757255) is a organic molecular entity (CHEBI:50860) |
| pi(15:0/20:3(8z,11z,14z)) (CHEBI:230777) is a organic molecular entity (CHEBI:50860) |
| PI(18:0/LTE4) (CHEBI:230942) is a organic molecular entity (CHEBI:50860) |
| PI(20:0/PGF2alpha) (CHEBI:231107) is a organic molecular entity (CHEBI:50860) |
| PI(20:1(11Z)/5-iso PGF2VI) (CHEBI:230946) is a organic molecular entity (CHEBI:50860) |
| PI(22:3(10Z,13Z,16Z)/PGD2) (CHEBI:230441) is a organic molecular entity (CHEBI:50860) |
| PI(22:4(10Z,13Z,16Z,19Z)/PGF2alpha) (CHEBI:230124) is a organic molecular entity (CHEBI:50860) |
| PI(5-iso PGF2VI/16:0) (CHEBI:230938) is a organic molecular entity (CHEBI:50860) |
| PI(6 keto-PGF1alpha/22:3(10Z,13Z,16Z)) (CHEBI:231072) is a organic molecular entity (CHEBI:50860) |
| PI(PGE2/20:3(5Z,8Z,11Z)) (CHEBI:230926) is a organic molecular entity (CHEBI:50860) |
| PIAA (CHEBI:234613) is a organic molecular entity (CHEBI:50860) |
| picankibart (CHEBI:759457) is a organic molecular entity (CHEBI:50860) |
| picoplatin (CHEBI:755367) is a organic molecular entity (CHEBI:50860) |
| pidacmeran (CHEBI:758340) is a organic molecular entity (CHEBI:50860) |
| pidilizumab (CHEBI:753628) is a organic molecular entity (CHEBI:50860) |
| pifonakin (CHEBI:753497) is a organic molecular entity (CHEBI:50860) |
| pillar[5]arene (CHEBI:233288) is a organic molecular entity (CHEBI:50860) |
| pimivalimab (CHEBI:758364) is a organic molecular entity (CHEBI:50860) |
| pimrocktakin (bovine) (CHEBI:759394) is a organic molecular entity (CHEBI:50860) |
| pimurutamab (CHEBI:758022) is a organic molecular entity (CHEBI:50860) |
| Pinacidil (CHEBI:34923) is a organic molecular entity (CHEBI:50860) |
| pinatuzumab vedotin (CHEBI:755268) is a organic molecular entity (CHEBI:50860) |
| pine needle oil (CHEBI:753413) is a organic molecular entity (CHEBI:50860) |
| pine tar (CHEBI:754050) is a organic molecular entity (CHEBI:50860) |
| pinometostat (CHEBI:230493) is a organic molecular entity (CHEBI:50860) |
| PIP(18:1(11Z)/TXB2) (CHEBI:230087) is a organic molecular entity (CHEBI:50860) |
| PIP(18:3(6Z,9Z,12Z)/PGJ2) (CHEBI:230932) is a organic molecular entity (CHEBI:50860) |
| PIP(22:3(10Z,13Z,16Z)/6 keto-PGF1alpha) (CHEBI:230934) is a organic molecular entity (CHEBI:50860) |
| pipercyclobutanamide a (CHEBI:230784) is a organic molecular entity (CHEBI:50860) |
| piragliatin (CHEBI:230673) is a organic molecular entity (CHEBI:50860) |
| Pirenoxine (CHEBI:32013) is a organic molecular entity (CHEBI:50860) |
| piroxicam betadex (CHEBI:753414) is a organic molecular entity (CHEBI:50860) |
| piroximone (CHEBI:230602) is a organic molecular entity (CHEBI:50860) |
| pitozinameran (CHEBI:759495) is a organic molecular entity (CHEBI:50860) |
| pitrakinra (CHEBI:754051) is a organic molecular entity (CHEBI:50860) |
| Pituitary adenylate cyclase-activating peptide-27 (CHEBI:80303) is a organic molecular entity (CHEBI:50860) |
| Pituitary adenylate cyclase-activating peptide-38 (CHEBI:80302) is a organic molecular entity (CHEBI:50860) |
| pituitary, posterior (CHEBI:754052) is a organic molecular entity (CHEBI:50860) |
| pivekimab (CHEBI:759013) is a organic molecular entity (CHEBI:50860) |
| pivekimab sunirine (CHEBI:757418) is a organic molecular entity (CHEBI:50860) |
| pivicasiran (CHEBI:760199) is a organic molecular entity (CHEBI:50860) |
| pkddia-ps (CHEBI:230647) is a organic molecular entity (CHEBI:50860) |
| pl-225b (CHEBI:755415) is a organic molecular entity (CHEBI:50860) |
| Placental lactogen (CHEBI:81588) is a organic molecular entity (CHEBI:50860) |
| placulumab (CHEBI:753675) is a organic molecular entity (CHEBI:50860) |
| plague vaccine (CHEBI:752941) is a organic molecular entity (CHEBI:50860) |
| plamotamab (CHEBI:757542) is a organic molecular entity (CHEBI:50860) |
| plantago seed (CHEBI:753142) is a organic molecular entity (CHEBI:50860) |
| plasma protein fraction (CHEBI:753703) is a organic molecular entity (CHEBI:50860) |
| plasma, antihemophilic human (CHEBI:753702) is a organic molecular entity (CHEBI:50860) |
| plasmalyte a (CHEBI:758304) is a organic molecular entity (CHEBI:50860) |
| Plasminogen (CHEBI:8259) is a organic molecular entity (CHEBI:50860) |
| platelet concentrate (CHEBI:753704) is a organic molecular entity (CHEBI:50860) |
| platelets (CHEBI:753583) is a organic molecular entity (CHEBI:50860) |
| plauracin (CHEBI:752971) is a organic molecular entity (CHEBI:50860) |
| plazinemdor (CHEBI:758342) is a organic molecular entity (CHEBI:50860) |
| plb1003 (CHEBI:758200) is a organic molecular entity (CHEBI:50860) |
| plectranthus amboinicus extract (CHEBI:759003) is a organic molecular entity (CHEBI:50860) |
| plg-0206 (CHEBI:759723) is a organic molecular entity (CHEBI:50860) |
| plixacabtagene autoleucel (CHEBI:758728) is a organic molecular entity (CHEBI:50860) |
| PlocLys (CHEBI:233074) is a organic molecular entity (CHEBI:50860) |
| plonmarlimab (CHEBI:758395) is a organic molecular entity (CHEBI:50860) |
| plovamer (CHEBI:752907) is a organic molecular entity (CHEBI:50860) |
| plovamer acetate (CHEBI:753653) is a organic molecular entity (CHEBI:50860) |
| plozalizumab (CHEBI:755741) is a organic molecular entity (CHEBI:50860) |
| plozasiran (CHEBI:760349) is a organic molecular entity (CHEBI:50860) |
| plozasiran sodium (CHEBI:760350) is a organic molecular entity (CHEBI:50860) |
| Pluronic F-127 (CHEBI:233003) is a organic molecular entity (CHEBI:50860) |
| plusonermin (CHEBI:753143) is a organic molecular entity (CHEBI:50860) |
| plutavimab (CHEBI:758343) is a organic molecular entity (CHEBI:50860) |
| plx-7486 (CHEBI:755607) is a organic molecular entity (CHEBI:50860) |
| PLX5622 (CHEBI:230497) is a organic molecular entity (CHEBI:50860) |
| PM26 (CHEBI:176580) is a organic molecular entity (CHEBI:50860) |
| PNU-282987 (CHEBI:230498) is a organic molecular entity (CHEBI:50860) |
| pobrolitide (CHEBI:759558) is a organic molecular entity (CHEBI:50860) |
| pochonin D (CHEBI:68779) is a organic molecular entity (CHEBI:50860) |
| podentamig (CHEBI:760080) is a organic molecular entity (CHEBI:50860) |
| podophyllum (CHEBI:753503) is a organic molecular entity (CHEBI:50860) |
| podophyllum resin (CHEBI:753705) is a organic molecular entity (CHEBI:50860) |
| poison ivy extract, alum precipitated (CHEBI:752987) is a organic molecular entity (CHEBI:50860) |
| poison oak extract (CHEBI:752973) is a organic molecular entity (CHEBI:50860) |
| polacrilin (CHEBI:753491) is a organic molecular entity (CHEBI:50860) |
| polacrilin potassium (CHEBI:752974) is a organic molecular entity (CHEBI:50860) |
| polatuzumab vedotin (CHEBI:755266) is a organic molecular entity (CHEBI:50860) |
| policapram (CHEBI:753706) is a organic molecular entity (CHEBI:50860) |
| policosanol (CHEBI:755819) is a organic molecular entity (CHEBI:50860) |
| policresulen (CHEBI:752329) is a organic molecular entity (CHEBI:50860) |
| polidexide sulfate (CHEBI:752975) is a organic molecular entity (CHEBI:50860) |
| polifeprosan 20 (CHEBI:753492) is a organic molecular entity (CHEBI:50860) |
| poliglecaprone 25 (CHEBI:752994) is a organic molecular entity (CHEBI:50860) |
| poliglecaprone 90 (CHEBI:752985) is a organic molecular entity (CHEBI:50860) |
| poliglusam (CHEBI:753144) is a organic molecular entity (CHEBI:50860) |
| polignate sodium (CHEBI:753496) is a organic molecular entity (CHEBI:50860) |
| poliovirus vaccine inactivated (CHEBI:752989) is a organic molecular entity (CHEBI:50860) |
| poliovirus vaccine live oral (CHEBI:753707) is a organic molecular entity (CHEBI:50860) |
| polipropene 25 (CHEBI:752990) is a organic molecular entity (CHEBI:50860) |
| polisaponin (CHEBI:752983) is a organic molecular entity (CHEBI:50860) |
| poloxalene (CHEBI:753499) is a organic molecular entity (CHEBI:50860) |
| poloxyl lanolin (CHEBI:753500) is a organic molecular entity (CHEBI:50860) |
| poly (adp-ribose) polymerase 1 (CHEBI:757491) is a organic molecular entity (CHEBI:50860) |
| poly-beta-1,6-N-acetyl-D-glucosamine (CHEBI:67063) is a organic molecular entity (CHEBI:50860) |
| Poly(gamma-ethyl L-glutamate) (CHEBI:234576) is a organic molecular entity (CHEBI:50860) |
| poly[(GA)] (CHEBI:137464) is a organic molecular entity (CHEBI:50860) |
| polyamine-methylene resin (CHEBI:752988) is a organic molecular entity (CHEBI:50860) |
| polybenzarsol (CHEBI:753501) is a organic molecular entity (CHEBI:50860) |
| polybutester (CHEBI:753488) is a organic molecular entity (CHEBI:50860) |
| polybutilate (CHEBI:753495) is a organic molecular entity (CHEBI:50860) |
| polycarbophil (CHEBI:753708) is a organic molecular entity (CHEBI:50860) |
| polydioxanone (CHEBI:752986) is a organic molecular entity (CHEBI:50860) |
| polyenephosphatidyl choline (CHEBI:752982) is a organic molecular entity (CHEBI:50860) |
| polyestradiol phosphate (CHEBI:749485) is a organic molecular entity (CHEBI:50860) |
| polyethadene (CHEBI:753489) is a organic molecular entity (CHEBI:50860) |
| polyethylene excipient (CHEBI:752963) is a organic molecular entity (CHEBI:50860) |
| polyethylene glycol (CHEBI:749470) is a organic molecular entity (CHEBI:50860) |
| polyethylene glycol 1540 (CHEBI:753000) is a organic molecular entity (CHEBI:50860) |
| polyethylene glycol 3350 (CHEBI:749517) is a organic molecular entity (CHEBI:50860) |
| polyethylene glycol 4000 (CHEBI:753709) is a organic molecular entity (CHEBI:50860) |
| polyethylene glycol 6000 (CHEBI:752970) is a organic molecular entity (CHEBI:50860) |
| polyethylene glycol monomethyl ether (CHEBI:752976) is a organic molecular entity (CHEBI:50860) |
| polyferose (CHEBI:753486) is a organic molecular entity (CHEBI:50860) |
| polygeline (CHEBI:753145) is a organic molecular entity (CHEBI:50860) |
| polyglactin 370 (CHEBI:752981) is a organic molecular entity (CHEBI:50860) |
| polyglactin 910 (CHEBI:753498) is a organic molecular entity (CHEBI:50860) |
| polyglycolic acid (CHEBI:752992) is a organic molecular entity (CHEBI:50860) |
| polyglyconate (CHEBI:752993) is a organic molecular entity (CHEBI:50860) |
| polyisobutylene (CHEBI:753060) is a organic molecular entity (CHEBI:50860) |
| polylactide, l- (CHEBI:760527) is a organic molecular entity (CHEBI:50860) |
| polymacon (CHEBI:753146) is a organic molecular entity (CHEBI:50860) |
| polymetaphosphate p 32 (CHEBI:752972) is a organic molecular entity (CHEBI:50860) |
| Polymethylene polyphenyl isocyanate (CHEBI:82567) is a organic molecular entity (CHEBI:50860) |
| polymonine (CHEBI:752998) is a organic molecular entity (CHEBI:50860) |
| polymyxin b (CHEBI:759086) is a organic molecular entity (CHEBI:50860) |
| Polymyxin M (CHEBI:230420) is a organic molecular entity (CHEBI:50860) |
| polynoxylin (CHEBI:753494) is a organic molecular entity (CHEBI:50860) |
| polyoxyl 10 oleyl ether (CHEBI:753710) is a organic molecular entity (CHEBI:50860) |
| polyoxyl 20 cetostearyl ether (CHEBI:752979) is a organic molecular entity (CHEBI:50860) |
| polyoxyl 35 castor oil (CHEBI:752980) is a organic molecular entity (CHEBI:50860) |
| polyoxyl 40 hydrogenated castor oil (CHEBI:752996) is a organic molecular entity (CHEBI:50860) |
| polyoxyl 8 stearate (CHEBI:752991) is a organic molecular entity (CHEBI:50860) |
| polyoxyl lauryl ether (CHEBI:753584) is a organic molecular entity (CHEBI:50860) |
| polyoxyl oleate (CHEBI:753585) is a organic molecular entity (CHEBI:50860) |
| polyoxyl stearyl ether (CHEBI:753586) is a organic molecular entity (CHEBI:50860) |
| polyoxypropylene 15 stearyl ether (CHEBI:752997) is a organic molecular entity (CHEBI:50860) |
| Polyplatillen (CHEBI:81550) is a organic molecular entity (CHEBI:50860) |
| polypropylene glycol (CHEBI:753711) is a organic molecular entity (CHEBI:50860) |
| polysorbate 65 (CHEBI:752995) is a organic molecular entity (CHEBI:50860) |
| polysorbate 85 (CHEBI:752969) is a organic molecular entity (CHEBI:50860) |
| polytef (CHEBI:753487) is a organic molecular entity (CHEBI:50860) |
| polytetrafluoroethylene (CHEBI:749472) is a organic molecular entity (CHEBI:50860) |
| Polyurethane foam (CHEBI:82586) is a organic molecular entity (CHEBI:50860) |
| polyvinox (CHEBI:753147) is a organic molecular entity (CHEBI:50860) |
| polyvinyl acetate phthalate (CHEBI:752999) is a organic molecular entity (CHEBI:50860) |
| polyvinyl alcohol (CHEBI:755638) is a organic molecular entity (CHEBI:50860) |
| polzastobart (CHEBI:758921) is a organic molecular entity (CHEBI:50860) |
| Pomiferin-3',4'-dimethylether (CHEBI:232989) is a organic molecular entity (CHEBI:50860) |
| Pomiferin, triacetate (CHEBI:232992) is a organic molecular entity (CHEBI:50860) |
| pomlucabtagene autoleucel (CHEBI:759395) is a organic molecular entity (CHEBI:50860) |
| Ponceau 3R (CHEBI:82368) is a organic molecular entity (CHEBI:50860) |
| Ponceau SX (CHEBI:82522) is a organic molecular entity (CHEBI:50860) |
| Ponesimod (CHEBI:233412) is a organic molecular entity (CHEBI:50860) |
| ponezumab (CHEBI:750135) is a organic molecular entity (CHEBI:50860) |
| ponsegromab (CHEBI:758382) is a organic molecular entity (CHEBI:50860) |
| poractant alfa (CHEBI:749536) is a organic molecular entity (CHEBI:50860) |
| porgaviximab (CHEBI:756479) is a organic molecular entity (CHEBI:50860) |
| porofocon a (CHEBI:753148) is a organic molecular entity (CHEBI:50860) |
| porofocon b (CHEBI:753502) is a organic molecular entity (CHEBI:50860) |
| Porphyropsin (CHEBI:8338) is a organic molecular entity (CHEBI:50860) |
| porustobart (CHEBI:758910) is a organic molecular entity (CHEBI:50860) |
| posdinemab (CHEBI:758291) is a organic molecular entity (CHEBI:50860) |
| posnafusp alfa (CHEBI:760201) is a organic molecular entity (CHEBI:50860) |
| posoleucel (CHEBI:757838) is a organic molecular entity (CHEBI:50860) |
| potassic saline [injection], lactated (CHEBI:753712) is a organic molecular entity (CHEBI:50860) |
| Potassium 2,6-dihydroxytriazinecarboxylate (CHEBI:80230) is a organic molecular entity (CHEBI:50860) |
| Potassium bis(2-hydroxyethyl)dithiocarbamate (CHEBI:82523) is a organic molecular entity (CHEBI:50860) |
| potassium hydroxycitrate (CHEBI:232319) is a organic molecular entity (CHEBI:50860) |
| Potassium Iodate (CHEBI:234593) is a organic molecular entity (CHEBI:50860) |
| potassium phosphate, unspecified form (CHEBI:757495) is a organic molecular entity (CHEBI:50860) |
| potassium phthalimide (CHEBI:233325) is a organic molecular entity (CHEBI:50860) |
| potassium-39(1+) (CHEBI:176608) is a organic molecular entity (CHEBI:50860) |
| potravitug (CHEBI:760505) is a organic molecular entity (CHEBI:50860) |
| povetacicept (CHEBI:758879) is a organic molecular entity (CHEBI:50860) |
| povidone (CHEBI:753149) is a organic molecular entity (CHEBI:50860) |
| povidone i 125 (CHEBI:753493) is a organic molecular entity (CHEBI:50860) |
| povidone i 131 (CHEBI:753490) is a organic molecular entity (CHEBI:50860) |
| powdered cellulose (CHEBI:757358) is a organic molecular entity (CHEBI:50860) |
| powelline Trifluoroacetic acid (CHEBI:68312) is a organic molecular entity (CHEBI:50860) |
| pozelimab (CHEBI:757505) is a organic molecular entity (CHEBI:50860) |
| pozetaldogene ormesparvovec (CHEBI:759559) is a organic molecular entity (CHEBI:50860) |
| pp-f11n lutetium (CHEBI:758415) is a organic molecular entity (CHEBI:50860) |
| pp-f11n lutetium lu-177 (CHEBI:758207) is a organic molecular entity (CHEBI:50860) |
| pr1 leukemia peptide vaccine (CHEBI:757256) is a organic molecular entity (CHEBI:50860) |
| prabotulinumtoxin a (CHEBI:756735) is a organic molecular entity (CHEBI:50860) |
| prademagene zamikeracel (CHEBI:757811) is a organic molecular entity (CHEBI:50860) |
| pradusinstobart (CHEBI:759396) is a organic molecular entity (CHEBI:50860) |
| prafnosbart (CHEBI:758900) is a organic molecular entity (CHEBI:50860) |
| praluzatamab (CHEBI:758157) is a organic molecular entity (CHEBI:50860) |
| praluzatamab ravtansine (CHEBI:757188) is a organic molecular entity (CHEBI:50860) |
| prasinezumab (CHEBI:757498) is a organic molecular entity (CHEBI:50860) |
| pravibismane (CHEBI:759653) is a organic molecular entity (CHEBI:50860) |
| praziquantel (CHEBI:45267) is a organic molecular entity (CHEBI:50860) |
| precemtabart (CHEBI:760081) is a organic molecular entity (CHEBI:50860) |
| precemtabart tocentecan (CHEBI:760082) is a organic molecular entity (CHEBI:50860) |
| Prednisolone farnesylate (CHEBI:32043) is a organic molecular entity (CHEBI:50860) |
| preguanitoxin (CHEBI:233006) is a organic molecular entity (CHEBI:50860) |
| preguanitoxin N-oxide (CHEBI:233007) is a organic molecular entity (CHEBI:50860) |
| preimplantation factor (CHEBI:757533) is a organic molecular entity (CHEBI:50860) |
| Prenateic acid (CHEBI:197315) is a organic molecular entity (CHEBI:50860) |
| prep-001 (CHEBI:757257) is a organic molecular entity (CHEBI:50860) |
| Prexasertib (CHEBI:747627) is a organic molecular entity (CHEBI:50860) |
| prexigebersen (CHEBI:756461) is a organic molecular entity (CHEBI:50860) |
| pri-724 (CHEBI:757258) is a organic molecular entity (CHEBI:50860) |
| Prifinium bromide (CHEBI:32052) is a organic molecular entity (CHEBI:50860) |
| priliximab (CHEBI:753443) is a organic molecular entity (CHEBI:50860) |
| Primaquine Phosphate (CHEBI:232993) is a organic molecular entity (CHEBI:50860) |
| pritebegene zepadenovec (CHEBI:760202) is a organic molecular entity (CHEBI:50860) |
| pritumumab (CHEBI:753061) is a organic molecular entity (CHEBI:50860) |
| prizloncabtagene autoleucel (CHEBI:759458) is a organic molecular entity (CHEBI:50860) |
| pro-542 (CHEBI:754234) is a organic molecular entity (CHEBI:50860) |
| Pro-Xaa (CHEBI:8420) is a organic molecular entity (CHEBI:50860) |
| Proadrenomedullin N-terminal 20 peptide (CHEBI:81577) is a organic molecular entity (CHEBI:50860) |
| probetaenone I (CHEBI:145062) is a organic molecular entity (CHEBI:50860) |
| Procaine hydrochloride (CHEBI:8431) is a organic molecular entity (CHEBI:50860) |
| Procaterol hydrochloride (CHEBI:32056) is a organic molecular entity (CHEBI:50860) |
| prochaetoglobosin III (CHEBI:68755) is a organic molecular entity (CHEBI:50860) |
| prochaetoglobosin IV (CHEBI:68756) is a organic molecular entity (CHEBI:50860) |
| Prochlorperazine Edisylate (CHEBI:232994) is a organic molecular entity (CHEBI:50860) |
| produvofusp (CHEBI:760200) is a organic molecular entity (CHEBI:50860) |
| Proflavine hemisulfate (CHEBI:233302) is a organic molecular entity (CHEBI:50860) |
| Progigneic acid (CHEBI:197312) is a organic molecular entity (CHEBI:50860) |
| programmed cell death 1 ligand 1 (CHEBI:757492) is a organic molecular entity (CHEBI:50860) |
| proinsulin human (CHEBI:754101) is a organic molecular entity (CHEBI:50860) |
| Prolactin (CHEBI:81580) is a organic molecular entity (CHEBI:50860) |
| Prolactin-releasing peptide-20 (CHEBI:80301) is a organic molecular entity (CHEBI:50860) |
| Prolactin-releasing peptide-31 (CHEBI:80300) is a organic molecular entity (CHEBI:50860) |
| prolgolimab (CHEBI:759688) is a organic molecular entity (CHEBI:50860) |
| prolinochenodeoxycholic acid (CHEBI:232205) is a organic molecular entity (CHEBI:50860) |
| prolinocholic acid (CHEBI:232260) is a organic molecular entity (CHEBI:50860) |
| prolinodeoxycholic acid (CHEBI:232223) is a organic molecular entity (CHEBI:50860) |
| prolinolithocholic acid (CHEBI:232186) is a organic molecular entity (CHEBI:50860) |
| prolinoursodeoxycholic acid (CHEBI:232279) is a organic molecular entity (CHEBI:50860) |
| prolyl endopeptidase (CHEBI:758305) is a organic molecular entity (CHEBI:50860) |
| Prolyl-peptide (CHEBI:8458) is a organic molecular entity (CHEBI:50860) |
| promelase (CHEBI:754102) is a organic molecular entity (CHEBI:50860) |
| promolate (CHEBI:230780) is a organic molecular entity (CHEBI:50860) |
| pronase (CHEBI:753444) is a organic molecular entity (CHEBI:50860) |
| Pronetalol hydrochloride (CHEBI:82525) is a organic molecular entity (CHEBI:50860) |
| Propamocarb hydrochloride (CHEBI:81735) is a organic molecular entity (CHEBI:50860) |
| Propantheline chloride (CHEBI:8483) is a organic molecular entity (CHEBI:50860) |
| propolis wax (CHEBI:757496) is a organic molecular entity (CHEBI:50860) |
| propyl-2-propynylphenylphosphonate (CHEBI:232437) is a organic molecular entity (CHEBI:50860) |
| Propylene carbonate (CHEBI:231185) is a organic molecular entity (CHEBI:50860) |
| Propyliodone (CHEBI:32064) is a organic molecular entity (CHEBI:50860) |
| Proscillaridin (CHEBI:32065) is a organic molecular entity (CHEBI:50860) |
| Prostaglandin A2-d4 (CHEBI:186015) is a organic molecular entity (CHEBI:50860) |
| prostaglandin F2α-CoA(4−) (CHEBI:143532) is a organic molecular entity (CHEBI:50860) |
| PROTAC-O4I2 (CHEBI:234201) is a organic molecular entity (CHEBI:50860) |
| protamine hydrochloride (CHEBI:753137) is a organic molecular entity (CHEBI:50860) |
| protamine sulfate (CHEBI:749540) is a organic molecular entity (CHEBI:50860) |
| protease (pancrelipase) (CHEBI:749559) is a organic molecular entity (CHEBI:50860) |
| Protein 5-hydroxylysine (CHEBI:8527) is a organic molecular entity (CHEBI:50860) |
| Protein alanine (CHEBI:8559) is a organic molecular entity (CHEBI:50860) |
| Protein aspartate (CHEBI:8562) is a organic molecular entity (CHEBI:50860) |
| protein binder (CHEBI:189680) is a organic molecular entity (CHEBI:50860) |
| Protein C (CHEBI:82131) is a organic molecular entity (CHEBI:50860) |
| protein c concentrate (human) (CHEBI:759768) is a organic molecular entity (CHEBI:50860) |
| Protein Cys-Cys (CHEBI:8530) is a organic molecular entity (CHEBI:50860) |
| Protein glutamate methyl ester (CHEBI:8568) is a organic molecular entity (CHEBI:50860) |
| protein hydrolysate (CHEBI:749541) is a organic molecular entity (CHEBI:50860) |
| Protein L-isoaspartate methyl ester (CHEBI:8534) is a organic molecular entity (CHEBI:50860) |
| Protein L-selenocysteine (CHEBI:80757) is a organic molecular entity (CHEBI:50860) |
| Protein N6-(dihydrolipoyl)lysine (CHEBI:80760) is a organic molecular entity (CHEBI:50860) |
| Protein N6-(lipoyl)lysine (CHEBI:80399) is a organic molecular entity (CHEBI:50860) |
| Protein N6-(octanoyl)lysine (CHEBI:80398) is a organic molecular entity (CHEBI:50860) |
| Protein N6-methyl-L-lysine (CHEBI:8555) is a organic molecular entity (CHEBI:50860) |
| Protein N6,N6-dimethyl-L-lysine (CHEBI:8552) is a organic molecular entity (CHEBI:50860) |
| Protein N6,N6,N6-trimethyl-L-lysine (CHEBI:8551) is a organic molecular entity (CHEBI:50860) |
| Protein Nomega-Methyl-L-arginine (CHEBI:8556) is a organic molecular entity (CHEBI:50860) |
| Protein P (CHEBI:82129) is a organic molecular entity (CHEBI:50860) |
| protein s human (CHEBI:760402) is a organic molecular entity (CHEBI:50860) |
| Protein serine (CHEBI:8572) is a organic molecular entity (CHEBI:50860) |
| Protein serine D-xyloside (CHEBI:8573) is a organic molecular entity (CHEBI:50860) |
| Protein-omega-N-(ADP-D-ribosyl)-L-arginine (CHEBI:80241) is a organic molecular entity (CHEBI:50860) |
| Protein(N-Glu, Asp, Cystine) (CHEBI:8580) is a organic molecular entity (CHEBI:50860) |
| Prothrombin (CHEBI:8583) is a organic molecular entity (CHEBI:50860) |
| prothrombin complex concentrate (CHEBI:760520) is a organic molecular entity (CHEBI:50860) |
| prothrombin complex, activated (CHEBI:753694) is a organic molecular entity (CHEBI:50860) |
| Protizinic acid (CHEBI:32067) is a organic molecular entity (CHEBI:50860) |
| prt-2607 (CHEBI:755480) is a organic molecular entity (CHEBI:50860) |
| PRT382 (CHEBI:231664) is a organic molecular entity (CHEBI:50860) |
| prussian blue insoluble (CHEBI:750441) is a organic molecular entity (CHEBI:50860) |
| ps-516895 (CHEBI:755481) is a organic molecular entity (CHEBI:50860) |
| PS(16:1(9Z)/TXB2) (CHEBI:230436) is a organic molecular entity (CHEBI:50860) |
| ps(o-20:0/22:1(11z)) (CHEBI:230814) is a organic molecular entity (CHEBI:50860) |
| PS3061 (CHEBI:189655) is a organic molecular entity (CHEBI:50860) |
| pseudoephedrine polistirex (CHEBI:749560) is a organic molecular entity (CHEBI:50860) |
| pseudohalogen (CHEBI:36867) is a organic molecular entity (CHEBI:50860) |
| pseudopaline(2−) (CHEBI:143198) is a organic molecular entity (CHEBI:50860) |
| psyllium hemicellulose (CHEBI:753587) is a organic molecular entity (CHEBI:50860) |
| psyllium husk (CHEBI:753138) is a organic molecular entity (CHEBI:50860) |
| pt-217 (CHEBI:759724) is a organic molecular entity (CHEBI:50860) |
| PT-2385 (CHEBI:233314) is a organic molecular entity (CHEBI:50860) |
| Pteropterin (CHEBI:197369) is a organic molecular entity (CHEBI:50860) |
| pterosin j (CHEBI:230635) is a organic molecular entity (CHEBI:50860) |
| pti-6d2 (CHEBI:754292) is a organic molecular entity (CHEBI:50860) |
| pti-6d2 188re (CHEBI:754390) is a organic molecular entity (CHEBI:50860) |
| PTP1B inhibitor (CHEBI:232869) is a organic molecular entity (CHEBI:50860) |
| PTUBP (CHEBI:233137) is a organic molecular entity (CHEBI:50860) |
| PU139 (CHEBI:235414) is a organic molecular entity (CHEBI:50860) |
| pucotenlimab (CHEBI:758354) is a organic molecular entity (CHEBI:50860) |
| pulocimab (CHEBI:758506) is a organic molecular entity (CHEBI:50860) |
| pumactant (CHEBI:753695) is a organic molecular entity (CHEBI:50860) |
| pumice (CHEBI:753139) is a organic molecular entity (CHEBI:50860) |
| purines 2'-deoxy-D-ribonucleoside (CHEBI:142361) is a organic molecular entity (CHEBI:50860) |
| puxitatug (CHEBI:759459) is a organic molecular entity (CHEBI:50860) |
| puxitatug samrotecan (CHEBI:759460) is a organic molecular entity (CHEBI:50860) |
| pwt-33579 (CHEBI:755577) is a organic molecular entity (CHEBI:50860) |
| pwt-33587 (CHEBI:755416) is a organic molecular entity (CHEBI:50860) |
| pxs-5505 (CHEBI:758306) is a organic molecular entity (CHEBI:50860) |
| Pyranose (CHEBI:79986) is a organic molecular entity (CHEBI:50860) |
| Pyrantel pamoate (CHEBI:8655) is a organic molecular entity (CHEBI:50860) |
| pyrethrum extract (CHEBI:753696) is a organic molecular entity (CHEBI:50860) |
| Pyrimidine-4,6-dicarboxylic acid (CHEBI:233004) is a organic molecular entity (CHEBI:50860) |
| Pyrintegrin (CHEBI:233045) is a organic molecular entity (CHEBI:50860) |
| Pyrithiobac-sodium (CHEBI:81973) is a organic molecular entity (CHEBI:50860) |
| pyroxylin (CHEBI:753140) is a organic molecular entity (CHEBI:50860) |
| Pyrrole-2-carboxyl-[pcp] (CHEBI:32078) is a organic molecular entity (CHEBI:50860) |
| Q-VD-OPh (CHEBI:233568) is a organic molecular entity (CHEBI:50860) |
| Q-VD-OPh hydrate (CHEBI:232611) is a organic molecular entity (CHEBI:50860) |
| qaf805 (CHEBI:755514) is a organic molecular entity (CHEBI:50860) |
| qax-576 (CHEBI:754254) is a organic molecular entity (CHEBI:50860) |
| QBP1 (CHEBI:233157) is a organic molecular entity (CHEBI:50860) |
| QC6352 (CHEBI:232550) is a organic molecular entity (CHEBI:50860) |
| qrh-882260 (CHEBI:757967) is a organic molecular entity (CHEBI:50860) |
| qs-21 (CHEBI:757261) is a organic molecular entity (CHEBI:50860) |
| quaratusugene ozeplasmid (CHEBI:757879) is a organic molecular entity (CHEBI:50860) |
| quavonlimab (CHEBI:758307) is a organic molecular entity (CHEBI:50860) |
| quazomotide (CHEBI:759461) is a organic molecular entity (CHEBI:50860) |
| quercetin 3-O-(6''-malonyl)-B-D-glucoside (CHEBI:176890) is a organic molecular entity (CHEBI:50860) |
| quercetin-3'-O-sulfate (CHEBI:746960) is a organic molecular entity (CHEBI:50860) |
| quercus stenophylla extract (CHEBI:753745) is a organic molecular entity (CHEBI:50860) |
| quetmolimab (CHEBI:757373) is a organic molecular entity (CHEBI:50860) |
| quilizumab (CHEBI:754246) is a organic molecular entity (CHEBI:50860) |
| Quinacrine dihydrochloride dihydrate (CHEBI:233303) is a organic molecular entity (CHEBI:50860) |
| quinapril(1-) (CHEBI:746947) is a organic molecular entity (CHEBI:50860) |
| quinidine hydrochloride monohydrate (CHEBI:233595) is a organic molecular entity (CHEBI:50860) |
| quinidine polygalacturonate (CHEBI:28569) is a organic molecular entity (CHEBI:50860) |
| quinine tannate (CHEBI:752942) is a organic molecular entity (CHEBI:50860) |
| Quinupristin-dalfopristin (CHEBI:8733) is a organic molecular entity (CHEBI:50860) |
| quisovalimab (CHEBI:758511) is a organic molecular entity (CHEBI:50860) |
| Qx28 (CHEBI:231486) is a organic molecular entity (CHEBI:50860) |
| Qx66 (CHEBI:231485) is a organic molecular entity (CHEBI:50860) |
| R (CHEBI:8735) is a organic molecular entity (CHEBI:50860) |
| R-1487 hydrochloride (CHEBI:233225) is a organic molecular entity (CHEBI:50860) |
| r-333 (CHEBI:755489) is a organic molecular entity (CHEBI:50860) |
| R-CHOH-CO-CH2OH (CHEBI:8740) is a organic molecular entity (CHEBI:50860) |
| R-H (CHEBI:142491) is a organic molecular entity (CHEBI:50860) |
| R-S-Alanylglycine (CHEBI:8744) is a organic molecular entity (CHEBI:50860) |
| R1-Barrigenol (CHEBI:230314) is a organic molecular entity (CHEBI:50860) |
| RAB11-inhibitor-B6 (CHEBI:234563) is a organic molecular entity (CHEBI:50860) |
| RAB11-inhibitor-D5 (CHEBI:234562) is a organic molecular entity (CHEBI:50860) |
| RAB11-inhibitor-D6 (CHEBI:234564) is a organic molecular entity (CHEBI:50860) |
| rabies immune globulin (CHEBI:749475) is a organic molecular entity (CHEBI:50860) |
| rabies recombinant canarypox virus (vcp65) (CHEBI:759784) is a organic molecular entity (CHEBI:50860) |
| rabies vaccine (CHEBI:752943) is a organic molecular entity (CHEBI:50860) |
| rac-1,9,10-trihydroxy-2-methoxy-6-methylaporphinium trifluoroacetate (CHEBI:68903) is a organic molecular entity (CHEBI:50860) |
| rac-3'-hydroxy-N,N-dimethylcoclaurinium trifluoroacetate (CHEBI:68902) is a organic molecular entity (CHEBI:50860) |
| rac-N-methyllaudanosolinium trifluoroacetate (CHEBI:68901) is a organic molecular entity (CHEBI:50860) |
| Racepinephrine Hydrochloride (CHEBI:233315) is a organic molecular entity (CHEBI:50860) |
| racotumomab (CHEBI:750136) is a organic molecular entity (CHEBI:50860) |
| radavirsen (CHEBI:757334) is a organic molecular entity (CHEBI:50860) |
| rademikibart (CHEBI:759462) is a organic molecular entity (CHEBI:50860) |
| radium ra-223 (CHEBI:756909) is a organic molecular entity (CHEBI:50860) |
| Radium-224 (CHEBI:80503) is a organic molecular entity (CHEBI:50860) |
| Radium-226 (CHEBI:80504) is a organic molecular entity (CHEBI:50860) |
| Radium-228 (CHEBI:80505) is a organic molecular entity (CHEBI:50860) |
| radotermin (CHEBI:753588) is a organic molecular entity (CHEBI:50860) |
| radretumab (CHEBI:750137) is a organic molecular entity (CHEBI:50860) |
| rafivirumab (CHEBI:750138) is a organic molecular entity (CHEBI:50860) |
| ragifilimab (CHEBI:758031) is a organic molecular entity (CHEBI:50860) |
| ragistomig (CHEBI:759560) is a organic molecular entity (CHEBI:50860) |
| raguneprocel (CHEBI:758729) is a organic molecular entity (CHEBI:50860) |
| ralpancizumab (CHEBI:755178) is a organic molecular entity (CHEBI:50860) |
| raludotatug (CHEBI:759397) is a organic molecular entity (CHEBI:50860) |
| raludotatug deruxtecan (CHEBI:758899) is a organic molecular entity (CHEBI:50860) |
| ralzapastotug (CHEBI:758872) is a organic molecular entity (CHEBI:50860) |
| ramatercept (CHEBI:753622) is a organic molecular entity (CHEBI:50860) |
| Ramatroban (CHEBI:32087) is a organic molecular entity (CHEBI:50860) |
| ramipril dioxopiperazine (CHEBI:231706) is a organic molecular entity (CHEBI:50860) |
| ramiprilat dioxopiperazine(1-) (CHEBI:231707) is a organic molecular entity (CHEBI:50860) |
| ramucirumab (CHEBI:750139) is a organic molecular entity (CHEBI:50860) |
| ranagengliotucel-t (CHEBI:752896) is a organic molecular entity (CHEBI:50860) |
| Ranatensin (CHEBI:80361) is a organic molecular entity (CHEBI:50860) |
| ranibizumab (CHEBI:749601) is a organic molecular entity (CHEBI:50860) |
| Ranimustine (CHEBI:32089) is a organic molecular entity (CHEBI:50860) |
| ranirestat (CHEBI:233577) is a organic molecular entity (CHEBI:50860) |
| Ranitidine bismuth citrate (CHEBI:77596) is a organic molecular entity (CHEBI:50860) |
| ranpirnase (CHEBI:753445) is a organic molecular entity (CHEBI:50860) |
| RapaLink-1 (CHEBI:189661) is a organic molecular entity (CHEBI:50860) |
| rapcabtagene autoleucel (CHEBI:758730) is a organic molecular entity (CHEBI:50860) |
| rapirosiran (CHEBI:759329) is a organic molecular entity (CHEBI:50860) |
| rapirosiran sodium (CHEBI:759331) is a organic molecular entity (CHEBI:50860) |
| rasburicase (CHEBI:749439) is a organic molecular entity (CHEBI:50860) |
| rasdegafusp alfa (CHEBI:757357) is a organic molecular entity (CHEBI:50860) |
| raspberry syrup (CHEBI:752920) is a organic molecular entity (CHEBI:50860) |
| rauwolfia serpentina (CHEBI:755639) is a organic molecular entity (CHEBI:50860) |
| rav-12 (CHEBI:754325) is a organic molecular entity (CHEBI:50860) |
| ravagalimab (CHEBI:757618) is a organic molecular entity (CHEBI:50860) |
| ravatirelin (CHEBI:753294) is a organic molecular entity (CHEBI:50860) |
| Ravtansine (CHEBI:230408) is a organic molecular entity (CHEBI:50860) |
| ravulizumab (CHEBI:756469) is a organic molecular entity (CHEBI:50860) |
| raxibacumab (CHEBI:753589) is a organic molecular entity (CHEBI:50860) |
| raxorulimogene belzovacirepvec (CHEBI:759398) is a organic molecular entity (CHEBI:50860) |
| raxtozinameran (CHEBI:759496) is a organic molecular entity (CHEBI:50860) |
| rayon, purified (CHEBI:752921) is a organic molecular entity (CHEBI:50860) |
| rbt-9 (CHEBI:758774) is a organic molecular entity (CHEBI:50860) |
| rebisufligene etisparvovec (CHEBI:760377) is a organic molecular entity (CHEBI:50860) |
| rebonuputemcel (CHEBI:758573) is a organic molecular entity (CHEBI:50860) |
| recaticimab (CHEBI:758947) is a organic molecular entity (CHEBI:50860) |
| recibokibart (CHEBI:760203) is a organic molecular entity (CHEBI:50860) |
| recifercept (CHEBI:758308) is a organic molecular entity (CHEBI:50860) |
| recombinant human interleukin-15 (CHEBI:758309) is a organic molecular entity (CHEBI:50860) |
| recombinant human kallikrein-1 (CHEBI:757367) is a organic molecular entity (CHEBI:50860) |
| recombinant human lecithin:cholesterol acyltransferase (CHEBI:757308) is a organic molecular entity (CHEBI:50860) |
| recombinant human thrombopoietin (CHEBI:758500) is a organic molecular entity (CHEBI:50860) |
| recombinant inactivated avian influenza virus, h5n3 subtype (CHEBI:759785) is a organic molecular entity (CHEBI:50860) |
| Recombinant MCP-2(CCL8) (CHEBI:195369) is a organic molecular entity (CHEBI:50860) |
| recombinant methionyl human brain-derived neurotrophic factor (CHEBI:758056) is a organic molecular entity (CHEBI:50860) |
| recombinant omega interferon of feline origin (CHEBI:759757) is a organic molecular entity (CHEBI:50860) |
| Recombinant Tumor Necrosis Factor TNF alpha (Zebrafish) (CHEBI:197439) is a organic molecular entity (CHEBI:50860) |
| Recombinant Tumor Necrosis Factor-alpha (human) (CHEBI:197440) is a organic molecular entity (CHEBI:50860) |
| Recombinant Visfatin (CHEBI:195368) is a organic molecular entity (CHEBI:50860) |
| redalsomatropin alfa (CHEBI:760083) is a organic molecular entity (CHEBI:50860) |
| redasemtide (CHEBI:760494) is a organic molecular entity (CHEBI:50860) |
| Reduced azurin (CHEBI:8787) is a organic molecular entity (CHEBI:50860) |
| Reduced cytochrome cL (CHEBI:81597) is a organic molecular entity (CHEBI:50860) |
| Reduced Vitamin K (CHEBI:8784) is a organic molecular entity (CHEBI:50860) |
| refametinib (CHEBI:231602) is a organic molecular entity (CHEBI:50860) |
| refanezumab (CHEBI:755574) is a organic molecular entity (CHEBI:50860) |
| reflocibart (CHEBI:759561) is a organic molecular entity (CHEBI:50860) |
| regavirumab (CHEBI:752922) is a organic molecular entity (CHEBI:50860) |
| regdanvimab (CHEBI:758345) is a organic molecular entity (CHEBI:50860) |
| regn-1154 (CHEBI:754380) is a organic molecular entity (CHEBI:50860) |
| regn-1400 (CHEBI:758063) is a organic molecular entity (CHEBI:50860) |
| regn-3048 (CHEBI:758064) is a organic molecular entity (CHEBI:50860) |
| regn-3051 (CHEBI:758065) is a organic molecular entity (CHEBI:50860) |
| regn-4659 (CHEBI:758068) is a organic molecular entity (CHEBI:50860) |
| regn-728 (CHEBI:754381) is a organic molecular entity (CHEBI:50860) |
| regn-846 (CHEBI:754382) is a organic molecular entity (CHEBI:50860) |
| regramostim (CHEBI:752923) is a organic molecular entity (CHEBI:50860) |
| rel-sodium 2-((1S,4R,5aS,5bR,7aS,11aS,11bR,13R,13aS)-13-acetoxy-1,4-dimethoxy-5b,8,8,11a,13a-pentamethyl-3-oxo-5,5a,6,7,7a,8,9,10,11,11a,11b,12,13,13a-tetradecahydro-1H-phenanthro[2,1-e]isoindol-2(3H,4H,5bH)-yl)acetate (CHEBI:68046) is a organic molecular entity (CHEBI:50860) |
| relabotulinumtoxina (CHEBI:757816) is a organic molecular entity (CHEBI:50860) |
| relatlimab (CHEBI:756524) is a organic molecular entity (CHEBI:50860) |
| relaxin (CHEBI:752924) is a organic molecular entity (CHEBI:50860) |
| Relaxin-1 (CHEBI:80333) is a organic molecular entity (CHEBI:50860) |
| Relaxin-2 (CHEBI:80334) is a organic molecular entity (CHEBI:50860) |
| Relaxin-3 (CHEBI:80335) is a organic molecular entity (CHEBI:50860) |
| relebactam(1-) (CHEBI:746986) is a organic molecular entity (CHEBI:50860) |
| reloxaliase (CHEBI:757262) is a organic molecular entity (CHEBI:50860) |
| reluscovtogene ralaplasmid (CHEBI:758916) is a organic molecular entity (CHEBI:50860) |
| rememulgene arelactibac (CHEBI:760204) is a organic molecular entity (CHEBI:50860) |
| remestemcel-l (CHEBI:753062) is a organic molecular entity (CHEBI:50860) |
| remlarsen (CHEBI:757969) is a organic molecular entity (CHEBI:50860) |
| Remodelin (CHEBI:747163) is a organic molecular entity (CHEBI:50860) |
| remternetug (CHEBI:759045) is a organic molecular entity (CHEBI:50860) |
| remtolumab (CHEBI:757303) is a organic molecular entity (CHEBI:50860) |
| remumiocel (CHEBI:758731) is a organic molecular entity (CHEBI:50860) |
| remvulimorgene autoleucel (CHEBI:760084) is a organic molecular entity (CHEBI:50860) |
| remzistotug (CHEBI:759990) is a organic molecular entity (CHEBI:50860) |
| renizgamglogene autogedtemcel (CHEBI:759997) is a organic molecular entity (CHEBI:50860) |
| renizgamglogene autogedtencel (CHEBI:759562) is a organic molecular entity (CHEBI:50860) |
| rentosertib (CHEBI:747470) is a organic molecular entity (CHEBI:50860) |
| renvistobart (CHEBI:757161) is a organic molecular entity (CHEBI:50860) |
| reozalimab (CHEBI:758926) is a organic molecular entity (CHEBI:50860) |
| repagermanium (CHEBI:752925) is a organic molecular entity (CHEBI:50860) |
| repicericel (CHEBI:759563) is a organic molecular entity (CHEBI:50860) |
| repifermin (CHEBI:752984) is a organic molecular entity (CHEBI:50860) |
| Repirinast (CHEBI:32092) is a organic molecular entity (CHEBI:50860) |
| resamirigene bilparvovec (CHEBI:757588) is a organic molecular entity (CHEBI:50860) |
| Rescimetol (CHEBI:32093) is a organic molecular entity (CHEBI:50860) |
| resecabtagene autoleucel (CHEBI:760205) is a organic molecular entity (CHEBI:50860) |
| resimmune (CHEBI:757030) is a organic molecular entity (CHEBI:50860) |
| Resistin (CHEBI:81573) is a organic molecular entity (CHEBI:50860) |
| reslizumab (CHEBI:752926) is a organic molecular entity (CHEBI:50860) |
| respiratory syncytial virus pre-fusion glycoprotein f (CHEBI:760400) is a organic molecular entity (CHEBI:50860) |
| respiratory syncytial virus pre-fusion glycoprotein f mrna (CHEBI:760406) is a organic molecular entity (CHEBI:50860) |
| resugosbart (CHEBI:758948) is a organic molecular entity (CHEBI:50860) |
| retatrutide (CHEBI:759046) is a organic molecular entity (CHEBI:50860) |
| reteplase (CHEBI:752927) is a organic molecular entity (CHEBI:50860) |
| retifanlimab (CHEBI:757460) is a organic molecular entity (CHEBI:50860) |
| retinoic acid receptor .gamma. (CHEBI:758061) is a organic molecular entity (CHEBI:50860) |
| retlirafusp alfa (CHEBI:758949) is a organic molecular entity (CHEBI:50860) |
| revakinagene taroretcel (CHEBI:759332) is a organic molecular entity (CHEBI:50860) |
| revdofilimab (CHEBI:757990) is a organic molecular entity (CHEBI:50860) |
| reveglucosidase alfa (CHEBI:755781) is a organic molecular entity (CHEBI:50860) |
| reviparin sodium (CHEBI:752928) is a organic molecular entity (CHEBI:50860) |
| revusiran (CHEBI:757970) is a organic molecular entity (CHEBI:50860) |
| rexlemestrocel-l (CHEBI:755575) is a organic molecular entity (CHEBI:50860) |
| rezetamig (CHEBI:759564) is a organic molecular entity (CHEBI:50860) |
| rezorstobart (CHEBI:759565) is a organic molecular entity (CHEBI:50860) |
| rezpegaldesleukin (CHEBI:759019) is a organic molecular entity (CHEBI:50860) |
| RFamide-related peptide 1 (CHEBI:80323) is a organic molecular entity (CHEBI:50860) |
| RFamide-related peptide 2 (CHEBI:80267) is a organic molecular entity (CHEBI:50860) |
| RFamide-related peptide 3 (CHEBI:80324) is a organic molecular entity (CHEBI:50860) |
| rg-1512 (CHEBI:754272) is a organic molecular entity (CHEBI:50860) |
| rg-1550 (CHEBI:754185) is a organic molecular entity (CHEBI:50860) |
| rg-7167 (CHEBI:755608) is a organic molecular entity (CHEBI:50860) |
| rg-7256 (CHEBI:755451) is a organic molecular entity (CHEBI:50860) |
| rg-7376 (CHEBI:755452) is a organic molecular entity (CHEBI:50860) |
| rg-7594 (CHEBI:754383) is a organic molecular entity (CHEBI:50860) |
| rg-7598 (CHEBI:754134) is a organic molecular entity (CHEBI:50860) |
| rg-7600 (CHEBI:754135) is a organic molecular entity (CHEBI:50860) |
| rg-7636 (CHEBI:754136) is a organic molecular entity (CHEBI:50860) |
| rg-7652 (CHEBI:754309) is a organic molecular entity (CHEBI:50860) |
| rg-7741 (CHEBI:755510) is a organic molecular entity (CHEBI:50860) |
| rg-7795 (CHEBI:758326) is a organic molecular entity (CHEBI:50860) |
| rg-7841 (CHEBI:757366) is a organic molecular entity (CHEBI:50860) |
| rg6029 (CHEBI:755836) is a organic molecular entity (CHEBI:50860) |
| rg7185 (CHEBI:755383) is a organic molecular entity (CHEBI:50860) |
| rg7342 (CHEBI:755513) is a organic molecular entity (CHEBI:50860) |
| rg7893 (CHEBI:755820) is a organic molecular entity (CHEBI:50860) |
| rgls-4326 (CHEBI:758388) is a organic molecular entity (CHEBI:50860) |
| RGRN-305 (CHEBI:232048) is a organic molecular entity (CHEBI:50860) |
| rhenium re-186 obisbemeda (CHEBI:759695) is a organic molecular entity (CHEBI:50860) |
| rhigm12b7 (CHEBI:754152) is a organic molecular entity (CHEBI:50860) |
| rho (d) immune globulin (CHEBI:753690) is a organic molecular entity (CHEBI:50860) |
| Rhodoquinone-9 (CHEBI:140751) is a organic molecular entity (CHEBI:50860) |
| Rhodoquinonol-9 (CHEBI:140752) is a organic molecular entity (CHEBI:50860) |
| RHPS4 methosulfate (CHEBI:235413) is a organic molecular entity (CHEBI:50860) |
| RI (CHEBI:8753) is a organic molecular entity (CHEBI:50860) |
| ribaminol (CHEBI:753507) is a organic molecular entity (CHEBI:50860) |
| ribaxamase (CHEBI:756468) is a organic molecular entity (CHEBI:50860) |
| ribrecabtagene autoleucel (CHEBI:759566) is a organic molecular entity (CHEBI:50860) |
| Ricin (CHEBI:8852) is a organic molecular entity (CHEBI:50860) |
| ricinoleoyl-sn-glycero-3-phosphocholine (CHEBI:140446) is a organic molecular entity (CHEBI:50860) |
| Rifamycin S (CHEBI:34948) is a organic molecular entity (CHEBI:50860) |
| riferminogene pecaplasmid (CHEBI:753284) is a organic molecular entity (CHEBI:50860) |
| rildinadstrocel (CHEBI:759047) is a organic molecular entity (CHEBI:50860) |
| rilimogene galvacirepvec (CHEBI:755088) is a organic molecular entity (CHEBI:50860) |
| riliprubart (CHEBI:759726) is a organic molecular entity (CHEBI:50860) |
| rilogrotug (CHEBI:758269) is a organic molecular entity (CHEBI:50860) |
| rilonacept (CHEBI:749605) is a organic molecular entity (CHEBI:50860) |
| rilotumumab (CHEBI:750140) is a organic molecular entity (CHEBI:50860) |
| rilparencel (CHEBI:759399) is a organic molecular entity (CHEBI:50860) |
| riltovetbart (CHEBI:759400) is a organic molecular entity (CHEBI:50860) |
| rilunermin alfa (CHEBI:758733) is a organic molecular entity (CHEBI:50860) |
| rilvegostomig (CHEBI:759401) is a organic molecular entity (CHEBI:50860) |
| rimabotulinumtoxinb (CHEBI:749438) is a organic molecular entity (CHEBI:50860) |
| rimantadine (CHEBI:49886) is a organic molecular entity (CHEBI:50860) |
| Rimantadine hydrochloride (CHEBI:8865) is a organic molecular entity (CHEBI:50860) |
| rimtoregtide (CHEBI:758734) is a organic molecular entity (CHEBI:50860) |
| rinatabart (CHEBI:760085) is a organic molecular entity (CHEBI:50860) |
| rinatabart sesutecan (CHEBI:760086) is a organic molecular entity (CHEBI:50860) |
| rindopepimut (CHEBI:752906) is a organic molecular entity (CHEBI:50860) |
| rinfabate (CHEBI:753063) is a organic molecular entity (CHEBI:50860) |
| ring scan 111in (CHEBI:754338) is a organic molecular entity (CHEBI:50860) |
| ringer's injection (CHEBI:753691) is a organic molecular entity (CHEBI:50860) |
| rintatolimod (CHEBI:752905) is a organic molecular entity (CHEBI:50860) |
| rinucumab (CHEBI:755573) is a organic molecular entity (CHEBI:50860) |
| rinvecalinase alfa (CHEBI:759463) is a organic molecular entity (CHEBI:50860) |
| riofilcon a (CHEBI:755273) is a organic molecular entity (CHEBI:50860) |
| ripertamab (CHEBI:758076) is a organic molecular entity (CHEBI:50860) |
| risankizumab (CHEBI:756510) is a organic molecular entity (CHEBI:50860) |
| risdiplam (CHEBI:233561) is a organic molecular entity (CHEBI:50860) |
| rismorelin (CHEBI:753285) is a organic molecular entity (CHEBI:50860) |
| rismorelin porcine (CHEBI:753692) is a organic molecular entity (CHEBI:50860) |
| riticovatein (CHEBI:759489) is a organic molecular entity (CHEBI:50860) |
| Ritipenem acoxil hydrate (CHEBI:34951) is a organic molecular entity (CHEBI:50860) |
| rituximab (CHEBI:64357) is a organic molecular entity (CHEBI:50860) |
| rivogenlecleucel (CHEBI:756462) is a organic molecular entity (CHEBI:50860) |
| rivunatpagene miziparvovec (CHEBI:759402) is a organic molecular entity (CHEBI:50860) |
| rizolipase (CHEBI:753136) is a organic molecular entity (CHEBI:50860) |
| rm-2 (CHEBI:757637) is a organic molecular entity (CHEBI:50860) |
| rm-2 ga-68 (CHEBI:756836) is a organic molecular entity (CHEBI:50860) |
| Ro-3306 (CHEBI:747457) is a organic molecular entity (CHEBI:50860) |
| ro-5429083 (CHEBI:758073) is a organic molecular entity (CHEBI:50860) |
| ro-5458640 (CHEBI:754352) is a organic molecular entity (CHEBI:50860) |
| robatumumab (CHEBI:750141) is a organic molecular entity (CHEBI:50860) |
| rocakinogene sifuplasmid (CHEBI:758033) is a organic molecular entity (CHEBI:50860) |
| rocapuldencel-t (CHEBI:755473) is a organic molecular entity (CHEBI:50860) |
| rocatinlimab (CHEBI:758040) is a organic molecular entity (CHEBI:50860) |
| rocky mountain spotted fever vaccine (CHEBI:753693) is a organic molecular entity (CHEBI:50860) |
| roconkibart (CHEBI:759567) is a organic molecular entity (CHEBI:50860) |
| roflufocon a (CHEBI:753590) is a organic molecular entity (CHEBI:50860) |
| roflufocon b (CHEBI:753591) is a organic molecular entity (CHEBI:50860) |
| roflufocon c (CHEBI:753064) is a organic molecular entity (CHEBI:50860) |
| roflufocon d (CHEBI:753592) is a organic molecular entity (CHEBI:50860) |
| roflufocon e (CHEBI:753065) is a organic molecular entity (CHEBI:50860) |
| Roflumilast N-oxide (RNO) (CHEBI:746969) is a organic molecular entity (CHEBI:50860) |
| Rokitamycin (CHEBI:32103) is a organic molecular entity (CHEBI:50860) |
| roledumab (CHEBI:750142) is a organic molecular entity (CHEBI:50860) |
| rolipoltide (CHEBI:753276) is a organic molecular entity (CHEBI:50860) |
| rolistobart (CHEBI:759464) is a organic molecular entity (CHEBI:50860) |
| romazarit (CHEBI:230566) is a organic molecular entity (CHEBI:50860) |
| romilkimab (CHEBI:757516) is a organic molecular entity (CHEBI:50860) |
| romiplostim (CHEBI:749606) is a organic molecular entity (CHEBI:50860) |
| romlusevimab (CHEBI:758275) is a organic molecular entity (CHEBI:50860) |
| romosozumab (CHEBI:752916) is a organic molecular entity (CHEBI:50860) |
| Romurtide (CHEBI:32106) is a organic molecular entity (CHEBI:50860) |
| romyelocel-l (CHEBI:755166) is a organic molecular entity (CHEBI:50860) |
| rondaptivon pegol (CHEBI:759338) is a organic molecular entity (CHEBI:50860) |
| roneparstat (CHEBI:758107) is a organic molecular entity (CHEBI:50860) |
| rontalizumab (CHEBI:750143) is a organic molecular entity (CHEBI:50860) |
| ROOH (CHEBI:79974) is a organic molecular entity (CHEBI:50860) |
| ropeginterferon alfa-2b (CHEBI:757263) is a organic molecular entity (CHEBI:50860) |
| rose oil (CHEBI:753450) is a organic molecular entity (CHEBI:50860) |
| rose water, stronger (CHEBI:754110) is a organic molecular entity (CHEBI:50860) |
| rose-010 (CHEBI:758310) is a organic molecular entity (CHEBI:50860) |
| rosin (CHEBI:753451) is a organic molecular entity (CHEBI:50860) |
| rosmantuzumab (CHEBI:756512) is a organic molecular entity (CHEBI:50860) |
| rosnilimab (CHEBI:758862) is a organic molecular entity (CHEBI:50860) |
| rosomidnar (CHEBI:755765) is a organic molecular entity (CHEBI:50860) |
| rotavirus, live (CHEBI:760272) is a organic molecular entity (CHEBI:50860) |
| rotavirus, live attenuated (CHEBI:760265) is a organic molecular entity (CHEBI:50860) |
| rovalpituzumab (CHEBI:756474) is a organic molecular entity (CHEBI:50860) |
| rovalpituzumab tesirine (CHEBI:756493) is a organic molecular entity (CHEBI:50860) |
| rovanersen (CHEBI:758403) is a organic molecular entity (CHEBI:50860) |
| rovanersen sodium (CHEBI:758170) is a organic molecular entity (CHEBI:50860) |
| rovelizumab (CHEBI:754111) is a organic molecular entity (CHEBI:50860) |
| roxatidine (CHEBI:230550) is a organic molecular entity (CHEBI:50860) |
| rozanolixizumab (CHEBI:757264) is a organic molecular entity (CHEBI:50860) |
| rozibafusp alfa (CHEBI:758151) is a organic molecular entity (CHEBI:50860) |
| rozrolimupab (CHEBI:752902) is a organic molecular entity (CHEBI:50860) |
| RP-6306 (CHEBI:747624) is a organic molecular entity (CHEBI:50860) |
| rpr749 (CHEBI:755581) is a organic molecular entity (CHEBI:50860) |
| RRR-ALPHA-TOCOPHERYLQUINONE (CHEBI:46468) is a organic molecular entity (CHEBI:50860) |
| RS 17053 hydrochloride (CHEBI:231359) is a organic molecular entity (CHEBI:50860) |
| rslv-132 (CHEBI:757265) is a organic molecular entity (CHEBI:50860) |
| rst-001 (CHEBI:758863) is a organic molecular entity (CHEBI:50860) |
| RTI-112 (CHEBI:232744) is a organic molecular entity (CHEBI:50860) |
| RTI-121 (CHEBI:234124) is a organic molecular entity (CHEBI:50860) |
| RTI-31 (CHEBI:232619) is a organic molecular entity (CHEBI:50860) |
| RTI-32 (CHEBI:233984) is a organic molecular entity (CHEBI:50860) |
| RTI-83 (CHEBI:233985) is a organic molecular entity (CHEBI:50860) |
| rTRD01 (CHEBI:232954) is a organic molecular entity (CHEBI:50860) |
| rubella virus vaccine live (CHEBI:754112) is a organic molecular entity (CHEBI:50860) |
| rubella virus, live attenuated (CHEBI:760269) is a organic molecular entity (CHEBI:50860) |
| rubidium rb-82 (CHEBI:756912) is a organic molecular entity (CHEBI:50860) |
| rubidium-85(1+) (CHEBI:176625) is a organic molecular entity (CHEBI:50860) |
| rucosopasem manganese (CHEBI:758208) is a organic molecular entity (CHEBI:50860) |
| rugecitide (CHEBI:760522) is a organic molecular entity (CHEBI:50860) |
| rugonersen (CHEBI:759030) is a organic molecular entity (CHEBI:50860) |
| rugonersen sodium (CHEBI:759031) is a organic molecular entity (CHEBI:50860) |
| runimotamab (CHEBI:758341) is a organic molecular entity (CHEBI:50860) |
| ruplizumab (CHEBI:753697) is a organic molecular entity (CHEBI:50860) |
| rusfertide (CHEBI:758385) is a organic molecular entity (CHEBI:50860) |
| rusfertide acetate (CHEBI:758176) is a organic molecular entity (CHEBI:50860) |
| rutin hydrate (CHEBI:232410) is a organic molecular entity (CHEBI:50860) |
| ruxoprubart (CHEBI:760370) is a organic molecular entity (CHEBI:50860) |
| RV 538 (CHEBI:234003) is a organic molecular entity (CHEBI:50860) |
| rwj-800088 (CHEBI:759714) is a organic molecular entity (CHEBI:50860) |
| rxdx-103 (CHEBI:755456) is a organic molecular entity (CHEBI:50860) |
| S 1033 (CHEBI:79948) is a organic molecular entity (CHEBI:50860) |
| S-(alpha-chlorocarboxymethyl)glutathione (CHEBI:229639) is a organic molecular entity (CHEBI:50860) |
| s-222611 (CHEBI:755511) is a organic molecular entity (CHEBI:50860) |
| s-237648 (CHEBI:755428) is a organic molecular entity (CHEBI:50860) |
| s-55746 (CHEBI:758332) is a organic molecular entity (CHEBI:50860) |
| S-Alkyl-thiohydroximate (CHEBI:80993) is a organic molecular entity (CHEBI:50860) |
| s-isopropyl 3-methylbut-2-enethioate (CHEBI:230802) is a organic molecular entity (CHEBI:50860) |
| S-Palmitoylprotein (CHEBI:80958) is a organic molecular entity (CHEBI:50860) |
| S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine (CHEBI:134521) is a organic molecular entity (CHEBI:50860) |
| S. pneumoniae serotype 18C CPS (CHEBI:156533) is a organic molecular entity (CHEBI:50860) |
| S. pneumoniae serotype 6B CPS (CHEBI:156532) is a organic molecular entity (CHEBI:50860) |
| S107 (CHEBI:233562) is a organic molecular entity (CHEBI:50860) |
| S1QEL1.1 (CHEBI:232490) is a organic molecular entity (CHEBI:50860) |
| S1QEL2.2 (CHEBI:747478) is a organic molecular entity (CHEBI:50860) |
| S2172 (CHEBI:233401) is a organic molecular entity (CHEBI:50860) |
| S3QEL 1.2 (CHEBI:232783) is a organic molecular entity (CHEBI:50860) |
| S3QEL 2 (CHEBI:747479) is a organic molecular entity (CHEBI:50860) |
| S3QEL 2.2 (CHEBI:232784) is a organic molecular entity (CHEBI:50860) |
| S3QEL 3 (CHEBI:232785) is a organic molecular entity (CHEBI:50860) |
| S63845 (CHEBI:234577) is a organic molecular entity (CHEBI:50860) |
| S961 (CHEBI:234347) is a organic molecular entity (CHEBI:50860) |
| sab-176 (CHEBI:758864) is a organic molecular entity (CHEBI:50860) |
| sab-185 (CHEBI:758865) is a organic molecular entity (CHEBI:50860) |
| sabatolimab (CHEBI:758048) is a organic molecular entity (CHEBI:50860) |
| sabestomig (CHEBI:759465) is a organic molecular entity (CHEBI:50860) |
| sabirnetug (CHEBI:759466) is a organic molecular entity (CHEBI:50860) |
| Saccharated iron oxide (CHEBI:82530) is a organic molecular entity (CHEBI:50860) |
| saccharated pepsin (CHEBI:753698) is a organic molecular entity (CHEBI:50860) |
| Saccharin sodium (CHEBI:32112) is a organic molecular entity (CHEBI:50860) |
| sacituzumab (CHEBI:755856) is a organic molecular entity (CHEBI:50860) |
| sacituzumab govitecan (CHEBI:755547) is a organic molecular entity (CHEBI:50860) |
| sacituzumab tirumotecan (CHEBI:759568) is a organic molecular entity (CHEBI:50860) |
| sacrosidase (CHEBI:749561) is a organic molecular entity (CHEBI:50860) |
| saf312 (CHEBI:755388) is a organic molecular entity (CHEBI:50860) |
| safflower oil (CHEBI:749543) is a organic molecular entity (CHEBI:50860) |
| safimestomig (CHEBI:760206) is a organic molecular entity (CHEBI:50860) |
| SAFit2 (CHEBI:747378) is a organic molecular entity (CHEBI:50860) |
| SAG hydrochloride (CHEBI:232702) is a organic molecular entity (CHEBI:50860) |
| salanersen (CHEBI:760371) is a organic molecular entity (CHEBI:50860) |
| salicylic acid-2-O-glucoside (CHEBI:176884) is a organic molecular entity (CHEBI:50860) |
| salicylic acyl beta-D-glucuronide (1-) (CHEBI:176960) is a organic molecular entity (CHEBI:50860) |
| salmonella typhi ty2 vi polysaccharide antigen (CHEBI:758955) is a organic molecular entity (CHEBI:50860) |
| salpn (CHEBI:233502) is a organic molecular entity (CHEBI:50860) |
| salts, rehydration (CHEBI:753170) is a organic molecular entity (CHEBI:50860) |
| samalizumab (CHEBI:750144) is a organic molecular entity (CHEBI:50860) |
| samarium (CHEBI:757625) is a organic molecular entity (CHEBI:50860) |
| samarium dotmp (CHEBI:758581) is a organic molecular entity (CHEBI:50860) |
| samarium lexidronam pentasodium (CHEBI:754404) is a organic molecular entity (CHEBI:50860) |
| samarium sm 153 lexidronam pentasodium (CHEBI:750453) is a organic molecular entity (CHEBI:50860) |
| samarium sm-153 (CHEBI:756914) is a organic molecular entity (CHEBI:50860) |
| samatatug (CHEBI:760087) is a organic molecular entity (CHEBI:50860) |
| samatatug zovodotin (CHEBI:760088) is a organic molecular entity (CHEBI:50860) |
| samfilcon a (CHEBI:755006) is a organic molecular entity (CHEBI:50860) |
| samrotamab vedotin (CHEBI:757987) is a organic molecular entity (CHEBI:50860) |
| samrotecan (CHEBI:760382) is a organic molecular entity (CHEBI:50860) |
| Samuelssonic acid (CHEBI:197304) is a organic molecular entity (CHEBI:50860) |
| san-300 (CHEBI:757266) is a organic molecular entity (CHEBI:50860) |
| sapablursen (CHEBI:758360) is a organic molecular entity (CHEBI:50860) |
| sapablursen sodium (CHEBI:759011) is a organic molecular entity (CHEBI:50860) |
| sapecmeran autogene (CHEBI:760207) is a organic molecular entity (CHEBI:50860) |
| saposin c (non-glycosylated) (CHEBI:757855) is a organic molecular entity (CHEBI:50860) |
| sappanone A dimethyl ether (CHEBI:231354) is a organic molecular entity (CHEBI:50860) |
| Saquinavir mesylate (CHEBI:32121) is a organic molecular entity (CHEBI:50860) |
| sar-103168 (CHEBI:755620) is a organic molecular entity (CHEBI:50860) |
| sar-113945 (CHEBI:755385) is a organic molecular entity (CHEBI:50860) |
| sar-1349 (CHEBI:754167) is a organic molecular entity (CHEBI:50860) |
| sar-279356 (CHEBI:754313) is a organic molecular entity (CHEBI:50860) |
| sar-439459 (CHEBI:757518) is a organic molecular entity (CHEBI:50860) |
| sar-441236 (CHEBI:757519) is a organic molecular entity (CHEBI:50860) |
| sar-566658 (CHEBI:754372) is a organic molecular entity (CHEBI:50860) |
| sar-bbn (CHEBI:759819) is a organic molecular entity (CHEBI:50860) |
| sar-bbn cu-64 (CHEBI:759634) is a organic molecular entity (CHEBI:50860) |
| sar425899 (CHEBI:755550) is a organic molecular entity (CHEBI:50860) |
| Sarafotoxin S6b (CHEBI:80362) is a organic molecular entity (CHEBI:50860) |
| sargramostim (CHEBI:749544) is a organic molecular entity (CHEBI:50860) |
| sarilumab (CHEBI:753668) is a organic molecular entity (CHEBI:50860) |
| sars-cov (CHEBI:757971) is a organic molecular entity (CHEBI:50860) |
| sars-cov-2 virus spike protein (CHEBI:760296) is a organic molecular entity (CHEBI:50860) |
| sars-cov-2 virus, inactivated (CHEBI:760297) is a organic molecular entity (CHEBI:50860) |
| saruplase (CHEBI:753141) is a organic molecular entity (CHEBI:50860) |
| sasanlimab (CHEBI:757598) is a organic molecular entity (CHEBI:50860) |
| satralizumab (CHEBI:755907) is a organic molecular entity (CHEBI:50860) |
| satricabtagene autoleucel (CHEBI:759403) is a organic molecular entity (CHEBI:50860) |
| satumomab (CHEBI:753312) is a organic molecular entity (CHEBI:50860) |
| saw palmetto (CHEBI:753699) is a organic molecular entity (CHEBI:50860) |
| SB 258719 (CHEBI:234391) is a organic molecular entity (CHEBI:50860) |
| SB 290157 (CHEBI:197424) is a organic molecular entity (CHEBI:50860) |
| SB-269970 hydrochloride (CHEBI:232896) is a organic molecular entity (CHEBI:50860) |
| sb-85635 (CHEBI:755609) is a organic molecular entity (CHEBI:50860) |
| SB216641 (CHEBI:234390) is a organic molecular entity (CHEBI:50860) |
| sbr-759 (CHEBI:758946) is a organic molecular entity (CHEBI:50860) |
| sc-004 (CHEBI:757267) is a organic molecular entity (CHEBI:50860) |
| sc-005 (CHEBI:757972) is a organic molecular entity (CHEBI:50860) |
| sc-006 (CHEBI:757973) is a organic molecular entity (CHEBI:50860) |
| sc-007 (CHEBI:757268) is a organic molecular entity (CHEBI:50860) |
| sc-1 (CHEBI:754269) is a organic molecular entity (CHEBI:50860) |
| SC-26196 (CHEBI:232585) is a organic molecular entity (CHEBI:50860) |
| SC-4Mor (CHEBI:235411) is a organic molecular entity (CHEBI:50860) |
| SC-791 (CHEBI:232369) is a organic molecular entity (CHEBI:50860) |
| sc-80036 (CHEBI:755380) is a organic molecular entity (CHEBI:50860) |
| SC75741 (CHEBI:232877) is a organic molecular entity (CHEBI:50860) |
| SC79 (CHEBI:232492) is a organic molecular entity (CHEBI:50860) |
| scarlet fever streptococcus toxin (CHEBI:753700) is a organic molecular entity (CHEBI:50860) |
| sch-708980 (CHEBI:754250) is a organic molecular entity (CHEBI:50860) |
| SCH529074 (CHEBI:231690) is a organic molecular entity (CHEBI:50860) |
| schick test control (CHEBI:753701) is a organic molecular entity (CHEBI:50860) |
| SCO-L-Lysine (CHEBI:232661) is a organic molecular entity (CHEBI:50860) |
| scopolia extract (CHEBI:752929) is a organic molecular entity (CHEBI:50860) |
| SDM25N hydrochloride (CHEBI:231365) is a organic molecular entity (CHEBI:50860) |
| sea-bcma (CHEBI:757974) is a organic molecular entity (CHEBI:50860) |
| SEA0400 (CHEBI:233563) is a organic molecular entity (CHEBI:50860) |
| sebelipase alfa (CHEBI:755079) is a organic molecular entity (CHEBI:50860) |
| secretin synthetic human (CHEBI:749429) is a organic molecular entity (CHEBI:50860) |
| secretin synthetic porcine (CHEBI:749504) is a organic molecular entity (CHEBI:50860) |
| secukinumab (CHEBI:750145) is a organic molecular entity (CHEBI:50860) |
| sefaxersen (CHEBI:760351) is a organic molecular entity (CHEBI:50860) |
| sefaxersen sodium (CHEBI:760352) is a organic molecular entity (CHEBI:50860) |
| seglebegagene dasniparvovec (CHEBI:759404) is a organic molecular entity (CHEBI:50860) |
| selenium-82(2-) (CHEBI:176622) is a organic molecular entity (CHEBI:50860) |
| selenium-82(4+) (CHEBI:176623) is a organic molecular entity (CHEBI:50860) |
| selenium-82(6+) (CHEBI:176624) is a organic molecular entity (CHEBI:50860) |
| selicrelumab (CHEBI:754263) is a organic molecular entity (CHEBI:50860) |
| selvacovatein (CHEBI:759490) is a organic molecular entity (CHEBI:50860) |
| Semicarbazide hydrochloride (CHEBI:82532) is a organic molecular entity (CHEBI:50860) |
| semisynthetic derivative (CHEBI:72588) is a organic molecular entity (CHEBI:50860) |
| semorinemab (CHEBI:757512) is a organic molecular entity (CHEBI:50860) |
| semparatide acetate (CHEBI:753800) is a organic molecular entity (CHEBI:50860) |
| semuloparin (CHEBI:753656) is a organic molecular entity (CHEBI:50860) |
| semuloparin sodium (CHEBI:753658) is a organic molecular entity (CHEBI:50860) |
| semzuvolimab (CHEBI:757288) is a organic molecular entity (CHEBI:50860) |
| SEN180 (CHEBI:232946) is a organic molecular entity (CHEBI:50860) |
| senacnagene enfaleucel (CHEBI:760208) is a organic molecular entity (CHEBI:50860) |
| senega syrup (CHEBI:753124) is a organic molecular entity (CHEBI:50860) |
| Senicapoc (CHEBI:233644) is a organic molecular entity (CHEBI:50860) |
| seniprutug (CHEBI:759569) is a organic molecular entity (CHEBI:50860) |
| senlizumab (CHEBI:753017) is a organic molecular entity (CHEBI:50860) |
| senna (CHEBI:753515) is a organic molecular entity (CHEBI:50860) |
| senofilcon a (CHEBI:753593) is a organic molecular entity (CHEBI:50860) |
| senofilcon b (CHEBI:755274) is a organic molecular entity (CHEBI:50860) |
| senrebotase (CHEBI:755174) is a organic molecular entity (CHEBI:50860) |
| senvesiran (CHEBI:760209) is a organic molecular entity (CHEBI:50860) |
| sephb4-hsa (CHEBI:757499) is a organic molecular entity (CHEBI:50860) |
| Sepiolite (CHEBI:82533) is a organic molecular entity (CHEBI:50860) |
| sepofarsen (CHEBI:757975) is a organic molecular entity (CHEBI:50860) |
| seractide (CHEBI:136033) is a organic molecular entity (CHEBI:50860) |
| seractide acetate (CHEBI:749456) is a organic molecular entity (CHEBI:50860) |
| Seratrodast (CHEBI:32126) is a organic molecular entity (CHEBI:50860) |
| serclutamab (CHEBI:757880) is a organic molecular entity (CHEBI:50860) |
| serclutamab talirine (CHEBI:757881) is a organic molecular entity (CHEBI:50860) |
| serdemetan (CHEBI:231694) is a organic molecular entity (CHEBI:50860) |
| serelaxin (CHEBI:753336) is a organic molecular entity (CHEBI:50860) |
| seribantumab (CHEBI:755446) is a organic molecular entity (CHEBI:50860) |
| Serine acylated putrescine (CHEBI:234021) is a organic molecular entity (CHEBI:50860) |
| Serine protease NS3 (CHEBI:81641) is a organic molecular entity (CHEBI:50860) |
| serinochenodeoxycholic acid (CHEBI:232198) is a organic molecular entity (CHEBI:50860) |
| serinocholic acid (CHEBI:232253) is a organic molecular entity (CHEBI:50860) |
| serinodeoxycholic acid (CHEBI:232217) is a organic molecular entity (CHEBI:50860) |
| serinolithocholic acid (CHEBI:232179) is a organic molecular entity (CHEBI:50860) |
| serinoursodeoxycholic acid (CHEBI:232272) is a organic molecular entity (CHEBI:50860) |
| sermorelin acetate (CHEBI:749509) is a organic molecular entity (CHEBI:50860) |
| serplulimab (CHEBI:758023) is a organic molecular entity (CHEBI:50860) |
| serrapeptase (CHEBI:753801) is a organic molecular entity (CHEBI:50860) |
| sesame oil (CHEBI:753125) is a organic molecular entity (CHEBI:50860) |
| sesterbrasiliatriene (CHEBI:177896) is a organic molecular entity (CHEBI:50860) |
| setamevetcel (CHEBI:757593) is a organic molecular entity (CHEBI:50860) |
| SETDB1-TTD-IN-1 (CHEBI:234559) is a organic molecular entity (CHEBI:50860) |
| setidegrasib (CHEBI:760090) is a organic molecular entity (CHEBI:50860) |
| setmelanotide hydrochloride (CHEBI:757875) is a organic molecular entity (CHEBI:50860) |
| setrusumab (CHEBI:757353) is a organic molecular entity (CHEBI:50860) |
| seviprotimut-l (CHEBI:755168) is a organic molecular entity (CHEBI:50860) |
| sevirumab (CHEBI:753802) is a organic molecular entity (CHEBI:50860) |
| sevuparin (CHEBI:757269) is a organic molecular entity (CHEBI:50860) |
| seychellene (CHEBI:234606) is a organic molecular entity (CHEBI:50860) |
| Seylereic acid (CHEBI:195353) is a organic molecular entity (CHEBI:50860) |
| sfericase (CHEBI:753126) is a organic molecular entity (CHEBI:50860) |
| SGC0946 (CHEBI:232383) is a organic molecular entity (CHEBI:50860) |
| Sgk1-IN-2 (CHEBI:233306) is a organic molecular entity (CHEBI:50860) |
| sgn-1 (CHEBI:759725) is a organic molecular entity (CHEBI:50860) |
| sgn-15 (CHEBI:754283) is a organic molecular entity (CHEBI:50860) |
| sgn-30 (CHEBI:754123) is a organic molecular entity (CHEBI:50860) |
| sgn-cd123a (CHEBI:757270) is a organic molecular entity (CHEBI:50860) |
| sgn-cd352a (CHEBI:757271) is a organic molecular entity (CHEBI:50860) |
| sgn-cd70a (CHEBI:757976) is a organic molecular entity (CHEBI:50860) |
| Shale oils (CHEBI:80506) is a organic molecular entity (CHEBI:50860) |
| shellac (CHEBI:753517) is a organic molecular entity (CHEBI:50860) |
| shr-1501 (CHEBI:760495) is a organic molecular entity (CHEBI:50860) |
| sibeprenlimab (CHEBI:758086) is a organic molecular entity (CHEBI:50860) |
| sibrotuzumab (CHEBI:753803) is a organic molecular entity (CHEBI:50860) |
| siccayne (CHEBI:156304) is a organic molecular entity (CHEBI:50860) |
| sifalimumab (CHEBI:750146) is a organic molecular entity (CHEBI:50860) |
| sifarobocept (CHEBI:759570) is a organic molecular entity (CHEBI:50860) |
| sifilcon a (CHEBI:753066) is a organic molecular entity (CHEBI:50860) |
| sig12d loder (CHEBI:757977) is a organic molecular entity (CHEBI:50860) |
| sigvotatug (CHEBI:759571) is a organic molecular entity (CHEBI:50860) |
| sigvotatug vedotin (CHEBI:759572) is a organic molecular entity (CHEBI:50860) |
| silafilcon a (CHEBI:753127) is a organic molecular entity (CHEBI:50860) |
| silafocon a (CHEBI:753018) is a organic molecular entity (CHEBI:50860) |
| silevimig (CHEBI:759573) is a organic molecular entity (CHEBI:50860) |
| silibinin dihemisuccinate disodium (CHEBI:757436) is a organic molecular entity (CHEBI:50860) |
| siliceous earth, purified (CHEBI:753020) is a organic molecular entity (CHEBI:50860) |
| silk fibroin (CHEBI:760496) is a organic molecular entity (CHEBI:50860) |
| silmitasertib (CHEBI:232159) is a organic molecular entity (CHEBI:50860) |
| silodrate (CHEBI:753128) is a organic molecular entity (CHEBI:50860) |
| siltartoxatug (CHEBI:760091) is a organic molecular entity (CHEBI:50860) |
| silteplase (CHEBI:753676) is a organic molecular entity (CHEBI:50860) |
| siltuximab (CHEBI:750147) is a organic molecular entity (CHEBI:50860) |
| silver protein, mild (CHEBI:753016) is a organic molecular entity (CHEBI:50860) |
| simethicone (CHEBI:756708) is a organic molecular entity (CHEBI:50860) |
| simethicone-cellulose (CHEBI:749562) is a organic molecular entity (CHEBI:50860) |
| simeticone (CHEBI:753677) is a organic molecular entity (CHEBI:50860) |
| Simfibrate (CHEBI:32131) is a organic molecular entity (CHEBI:50860) |
| simlukafusp alfa (CHEBI:757509) is a organic molecular entity (CHEBI:50860) |
| simoctocog alfa (CHEBI:753306) is a organic molecular entity (CHEBI:50860) |
| simoladagene autotemcel (CHEBI:757608) is a organic molecular entity (CHEBI:50860) |
| simplexin (CHEBI:70548) is a organic molecular entity (CHEBI:50860) |
| simtuzumab (CHEBI:754389) is a organic molecular entity (CHEBI:50860) |
| Simurosertib (CHEBI:233316) is a organic molecular entity (CHEBI:50860) |
| Sinbaglustat (CHEBI:747619) is a organic molecular entity (CHEBI:50860) |
| sinecatechins (CHEBI:749579) is a organic molecular entity (CHEBI:50860) |
| sintilimab (CHEBI:757273) is a organic molecular entity (CHEBI:50860) |
| sipavibart (CHEBI:759701) is a organic molecular entity (CHEBI:50860) |
| siplizumab (CHEBI:753678) is a organic molecular entity (CHEBI:50860) |
| sipuleucel-t (CHEBI:749682) is a organic molecular entity (CHEBI:50860) |
| sirukumab (CHEBI:750148) is a organic molecular entity (CHEBI:50860) |
| sitagliptin(1+) (CHEBI:746990) is a organic molecular entity (CHEBI:50860) |
| sitimagene ceradenovec (CHEBI:753316) is a organic molecular entity (CHEBI:50860) |
| sitocabnagene loxiveleucel (CHEBI:760359) is a organic molecular entity (CHEBI:50860) |
| sitosterols (CHEBI:753129) is a organic molecular entity (CHEBI:50860) |
| sizavaleucel (CHEBI:759007) is a organic molecular entity (CHEBI:50860) |
| sizofiran (CHEBI:753019) is a organic molecular entity (CHEBI:50860) |
| SKF-81297 (CHEBI:231665) is a organic molecular entity (CHEBI:50860) |
| skin substitute, human fibroblast-derived temporary (CHEBI:753594) is a organic molecular entity (CHEBI:50860) |
| skin, sterile freeze-dried porcine dermal (CHEBI:753679) is a organic molecular entity (CHEBI:50860) |
| skin, sterile freeze-dried porcine epidermal (CHEBI:753005) is a organic molecular entity (CHEBI:50860) |
| skl-27969 (CHEBI:759729) is a organic molecular entity (CHEBI:50860) |
| SKQ-1 bromide (CHEBI:232599) is a organic molecular entity (CHEBI:50860) |
| SM(d17:1/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) (CHEBI:230962) is a organic molecular entity (CHEBI:50860) |
| SM(d18:1/PGJ2) (CHEBI:230445) is a organic molecular entity (CHEBI:50860) |
| SM(d19:0/PGJ2) (CHEBI:230416) is a organic molecular entity (CHEBI:50860) |
| SM(d19:1/LTE4) (CHEBI:230306) is a organic molecular entity (CHEBI:50860) |
| smallpox vaccine (CHEBI:753632) is a organic molecular entity (CHEBI:50860) |
| smc021 (CHEBI:755630) is a organic molecular entity (CHEBI:50860) |
| SMER 10 (CHEBI:235416) is a organic molecular entity (CHEBI:50860) |
| SMER 18 (CHEBI:235417) is a organic molecular entity (CHEBI:50860) |
| SMIFH2 (CHEBI:232351) is a organic molecular entity (CHEBI:50860) |
| SMS 201-995 (CHEBI:177082) is a organic molecular entity (CHEBI:50860) |
| SN-011 (CHEBI:747183) is a organic molecular entity (CHEBI:50860) |
| SNS-314 Mesylate (CHEBI:747807) is a organic molecular entity (CHEBI:50860) |
| SNX-2112 (CHEBI:231695) is a organic molecular entity (CHEBI:50860) |
| soap, green (CHEBI:753008) is a organic molecular entity (CHEBI:50860) |
| sobi-003 (CHEBI:757525) is a organic molecular entity (CHEBI:50860) |
| Sobuzoxane (CHEBI:32136) is a organic molecular entity (CHEBI:50860) |
| socazolimab (CHEBI:758532) is a organic molecular entity (CHEBI:50860) |
| sodium (E)-3-hydroxy-4-((1-hydroxy-8-sulfonaphthalen-2-yl)diazenyl)naphthalene-1-sulfonate (CHEBI:747105) is a organic molecular entity (CHEBI:50860) |
| Sodium (E)-3-hydroxy-4-((2-hydroxynaphthalen-1-yl)diazenyl)naphthalene-1-sulfonate (CHEBI:747102) is a organic molecular entity (CHEBI:50860) |
| sodium (E)-5-amino-3-imino-4-oxo-6-(phenyl
diazenyl)-3,4-dihydronaphthalene-2,7-disulfonate (CHEBI:747412) is a organic molecular entity (CHEBI:50860) |
| Sodium (E)-5-chloro-2-hydroxy-3-((5-hydroxy-3-methyl-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)diazenyl)benzenesulfonate (CHEBI:747103) is a organic molecular entity (CHEBI:50860) |
| Sodium 2-O-L-rhamnopyranosyl-4-deoxy-alpha-L-threo-hex-4-eno-pyranosiduronate (CHEBI:9176) is a organic molecular entity (CHEBI:50860) |
| sodium 2,6-dimethylbenzo[d]thiazole-7-sulfonate (CHEBI:747043) is a organic molecular entity (CHEBI:50860) |
| Sodium 3,5,6-triamino-4,7-dihydroxynaphthalen-2-olate (CHEBI:747429) is a organic molecular entity (CHEBI:50860) |
| sodium 4-((E)-(2,6-dihydroxy-3-((E)-(2-hydroxy-5-nitrophenyl)diazenyl)phenyl)diazenyl)benzenesulfonate (CHEBI:747104) is a organic molecular entity (CHEBI:50860) |
| sodium 4-amino-6-imino-5-oxo-3-(2-phenyl hydrazinyl)-7-sulfo-5,6-dihydronaphthalene-2-sulfonate (CHEBI:747426) is a organic molecular entity (CHEBI:50860) |
| sodium antimonylgluconate (CHEBI:753108) is a organic molecular entity (CHEBI:50860) |
| sodium aurotiosulfate (CHEBI:755955) is a organic molecular entity (CHEBI:50860) |
| Sodium chondroitin sulfate (CHEBI:81720) is a organic molecular entity (CHEBI:50860) |
| sodium chromate cr 51 (CHEBI:750444) is a organic molecular entity (CHEBI:50860) |
| Sodium diethyldithiocarbamate (CHEBI:82587) is a organic molecular entity (CHEBI:50860) |
| sodium ferric gluconate complex (CHEBI:749521) is a organic molecular entity (CHEBI:50860) |
| Sodium folinate (CHEBI:81303) is a organic molecular entity (CHEBI:50860) |
| sodium glucaldrate (CHEBI:753725) is a organic molecular entity (CHEBI:50860) |
| sodium glucaspaldrate (CHEBI:753109) is a organic molecular entity (CHEBI:50860) |
| Sodium glucuronate (CHEBI:32144) is a organic molecular entity (CHEBI:50860) |
| sodium glycerophosphate (CHEBI:759900) is a organic molecular entity (CHEBI:50860) |
| Sodium iodate (CHEBI:81708) is a organic molecular entity (CHEBI:50860) |
| Sodium iodoacetate (CHEBI:234594) is a organic molecular entity (CHEBI:50860) |
| sodium L-lactate (CHEBI:232798) is a organic molecular entity (CHEBI:50860) |
| sodium magnesium chlorophyllin (CHEBI:234098) is a organic molecular entity (CHEBI:50860) |
| Sodium oleate (CHEBI:81860) is a organic molecular entity (CHEBI:50860) |
| Sodium ortho-phenylphenate (CHEBI:82371) is a organic molecular entity (CHEBI:50860) |
| sodium palmitate (CHEBI:234557) is a organic molecular entity (CHEBI:50860) |
| sodium pentaborate (CHEBI:759689) is a organic molecular entity (CHEBI:50860) |
| sodium pertechnetate (CHEBI:754411) is a organic molecular entity (CHEBI:50860) |
| sodium pertechnetate tc 99m (CHEBI:750446) is a organic molecular entity (CHEBI:50860) |
| sodium polyphosphate (CHEBI:753110) is a organic molecular entity (CHEBI:50860) |
| sodium polystyrene sulfonate (CHEBI:749538) is a organic molecular entity (CHEBI:50860) |
| sodium psylliate [injection] (CHEBI:753783) is a organic molecular entity (CHEBI:50860) |
| Sodium salicylate (CHEBI:9180) is a organic molecular entity (CHEBI:50860) |
| sodium starch glycolate (CHEBI:753028) is a organic molecular entity (CHEBI:50860) |
| Sodium thiosalicylate (CHEBI:9182) is a organic molecular entity (CHEBI:50860) |
| sodium zirconium cyclosilicate (CHEBI:755275) is a organic molecular entity (CHEBI:50860) |
| sodium-23(1+) (CHEBI:176598) is a organic molecular entity (CHEBI:50860) |
| sodium(2R,3R,E)-9-(2,5-dihydroxyphenyl)-3,7-dimethyl-1-((1S,4aS,8aS)-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl)non-7-en-2-yl sulfate (CHEBI:69281) is a organic molecular entity (CHEBI:50860) |
| sodium(2R,3R,Z)-9-(2,5-dihydroxyphenyl)-3,7-dimethyl-1-((1S,4aS,8aS)-2,5,5,8a-tetramethyl-1,4,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)non-7-en-2-yl sulfate (CHEBI:69282) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((2S,3S,4R,5R)-3,4-dihydroxy-2,5-dimethoxytetrahydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69291) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((2S,5R)-2,5-dimethoxy-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69290) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((R)-5-methoxy-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69289) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((S)-2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69286) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-1-(2-((S)-5-methoxy-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-4b,8,8,10a-tetramethyldecahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69288) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(2-oxo-2,5-dihydro-1H-pyrrol-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69292) is a organic molecular entity (CHEBI:50860) |
| sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate (CHEBI:69287) is a organic molecular entity (CHEBI:50860) |
| sofituzumab (CHEBI:755605) is a organic molecular entity (CHEBI:50860) |
| sofituzumab vedotin (CHEBI:755602) is a organic molecular entity (CHEBI:50860) |
| solabafusp alfa (CHEBI:760210) is a organic molecular entity (CHEBI:50860) |
| solanezumab (CHEBI:750149) is a organic molecular entity (CHEBI:50860) |
| solbinsiran (CHEBI:759334) is a organic molecular entity (CHEBI:50860) |
| solbinsiran sodium (CHEBI:759335) is a organic molecular entity (CHEBI:50860) |
| solengepras (CHEBI:758516) is a organic molecular entity (CHEBI:50860) |
| solitomab (CHEBI:754128) is a organic molecular entity (CHEBI:50860) |
| solizmestrocel (CHEBI:759574) is a organic molecular entity (CHEBI:50860) |
| solnatide (CHEBI:757323) is a organic molecular entity (CHEBI:50860) |
| solnerstotug (CHEBI:760211) is a organic molecular entity (CHEBI:50860) |
| solrikitug (CHEBI:759575) is a organic molecular entity (CHEBI:50860) |
| somagrebove (CHEBI:753111) is a organic molecular entity (CHEBI:50860) |
| somalapor (CHEBI:753784) is a organic molecular entity (CHEBI:50860) |
| somatorelin (CHEBI:753785) is a organic molecular entity (CHEBI:50860) |
| somatosalm (CHEBI:753023) is a organic molecular entity (CHEBI:50860) |
| somatrem (CHEBI:749435) is a organic molecular entity (CHEBI:50860) |
| somatrogon (CHEBI:757274) is a organic molecular entity (CHEBI:50860) |
| somatropin (CHEBI:749556) is a organic molecular entity (CHEBI:50860) |
| somatropin pegol (CHEBI:753303) is a organic molecular entity (CHEBI:50860) |
| somavaratan (CHEBI:755799) is a organic molecular entity (CHEBI:50860) |
| somavubove (CHEBI:753633) is a organic molecular entity (CHEBI:50860) |
| somenopor (CHEBI:753024) is a organic molecular entity (CHEBI:50860) |
| sometribove (CHEBI:753112) is a organic molecular entity (CHEBI:50860) |
| sometripor (CHEBI:753634) is a organic molecular entity (CHEBI:50860) |
| somfasepor (CHEBI:753026) is a organic molecular entity (CHEBI:50860) |
| somidobove (CHEBI:753635) is a organic molecular entity (CHEBI:50860) |
| sonavibart (CHEBI:760375) is a organic molecular entity (CHEBI:50860) |
| sonefpeglutide (CHEBI:760092) is a organic molecular entity (CHEBI:50860) |
| sonepcizumab (CHEBI:754331) is a organic molecular entity (CHEBI:50860) |
| sonermin (CHEBI:753786) is a organic molecular entity (CHEBI:50860) |
| sonesitatug (CHEBI:760212) is a organic molecular entity (CHEBI:50860) |
| sonesitatug vedotin (CHEBI:760213) is a organic molecular entity (CHEBI:50860) |
| sonpiretigene isteparvovec (CHEBI:759467) is a organic molecular entity (CHEBI:50860) |
| sonruvetcel (CHEBI:760214) is a organic molecular entity (CHEBI:50860) |
| sontuzumab (CHEBI:753321) is a organic molecular entity (CHEBI:50860) |
| sorimcovatein (CHEBI:759491) is a organic molecular entity (CHEBI:50860) |
| Sorivudine (CHEBI:32152) is a organic molecular entity (CHEBI:50860) |
| sotatercept (CHEBI:750150) is a organic molecular entity (CHEBI:50860) |
| sotevtamab (CHEBI:760497) is a organic molecular entity (CHEBI:50860) |
| sothrombomodulin alfa (CHEBI:753311) is a organic molecular entity (CHEBI:50860) |
| sotiburafusp alfa (CHEBI:759468) is a organic molecular entity (CHEBI:50860) |
| sotigalimab (CHEBI:757326) is a organic molecular entity (CHEBI:50860) |
| sotrovimab (CHEBI:758401) is a organic molecular entity (CHEBI:50860) |
| Sotuletinib (CHEBI:746976) is a organic molecular entity (CHEBI:50860) |
| sovipostobart (CHEBI:759469) is a organic molecular entity (CHEBI:50860) |
| sovipostobart beta (CHEBI:760215) is a organic molecular entity (CHEBI:50860) |
| soy isoflavones (CHEBI:757483) is a organic molecular entity (CHEBI:50860) |
| soybean oil, hydrogenated (CHEBI:753595) is a organic molecular entity (CHEBI:50860) |
| soybean phospholipids (CHEBI:753113) is a organic molecular entity (CHEBI:50860) |
| soysterol (CHEBI:753787) is a organic molecular entity (CHEBI:50860) |
| sozinibercept (CHEBI:758735) is a organic molecular entity (CHEBI:50860) |
| SP2509 (CHEBI:176335) is a organic molecular entity (CHEBI:50860) |
| spartalizumab (CHEBI:757275) is a organic molecular entity (CHEBI:50860) |
| spearmint (CHEBI:753114) is a organic molecular entity (CHEBI:50860) |
| spearmint oil (CHEBI:753788) is a organic molecular entity (CHEBI:50860) |
| spermidine trihydrochloride (CHEBI:233088) is a organic molecular entity (CHEBI:50860) |
| spesolimab (CHEBI:757347) is a organic molecular entity (CHEBI:50860) |
| spevatamig (CHEBI:760216) is a organic molecular entity (CHEBI:50860) |
| spheroids of human autologous matrix-associated chondrocytes (CHEBI:759794) is a organic molecular entity (CHEBI:50860) |
| Sphinganine-C17 (CHEBI:747628) is a organic molecular entity (CHEBI:50860) |
| Spinetoram (CHEBI:82041) is a organic molecular entity (CHEBI:50860) |
| sprifermin (CHEBI:753290) is a organic molecular entity (CHEBI:50860) |
| spunoleucel (CHEBI:760353) is a organic molecular entity (CHEBI:50860) |
| sr-123781a (CHEBI:758081) is a organic molecular entity (CHEBI:50860) |
| SR-1815 (CHEBI:747379) is a organic molecular entity (CHEBI:50860) |
| SR8278 (CHEBI:747458) is a organic molecular entity (CHEBI:50860) |
| SRA12 (CHEBI:156240) is a organic molecular entity (CHEBI:50860) |
| SRA8 (CHEBI:156239) is a organic molecular entity (CHEBI:50860) |
| SRK2 (CHEBI:156238) is a organic molecular entity (CHEBI:50860) |
| SRT1720 HCl (CHEBI:747808) is a organic molecular entity (CHEBI:50860) |
| srx251 (CHEBI:755484) is a organic molecular entity (CHEBI:50860) |
| ss1(dsfv)-pe38 (CHEBI:754293) is a organic molecular entity (CHEBI:50860) |
| st. john's wort (CHEBI:753115) is a organic molecular entity (CHEBI:50860) |
| stamulumab (CHEBI:753067) is a organic molecular entity (CHEBI:50860) |
| stannic protoporfin (CHEBI:759306) is a organic molecular entity (CHEBI:50860) |
| stannous sulfur colloid (CHEBI:753029) is a organic molecular entity (CHEBI:50860) |
| stannsoporfin (CHEBI:756715) is a organic molecular entity (CHEBI:50860) |
| staphyloferrin A(5−) (CHEBI:142973) is a organic molecular entity (CHEBI:50860) |
| staphylopine(1−) (CHEBI:141669) is a organic molecular entity (CHEBI:50860) |
| stapokibart (CHEBI:758895) is a organic molecular entity (CHEBI:50860) |
| stapuldencel (CHEBI:755411) is a organic molecular entity (CHEBI:50860) |
| starch glycerite (CHEBI:753030) is a organic molecular entity (CHEBI:50860) |
| starch, corn (CHEBI:753068) is a organic molecular entity (CHEBI:50860) |
| starch, modified (CHEBI:753596) is a organic molecular entity (CHEBI:50860) |
| starch, potato (CHEBI:753597) is a organic molecular entity (CHEBI:50860) |
| starch, pregelatinized (CHEBI:753031) is a organic molecular entity (CHEBI:50860) |
| starch, pregelatinized modified (CHEBI:753598) is a organic molecular entity (CHEBI:50860) |
| starch, rice (CHEBI:753027) is a organic molecular entity (CHEBI:50860) |
| starch, tapioca (CHEBI:753069) is a organic molecular entity (CHEBI:50860) |
| starch, topical (CHEBI:753638) is a organic molecular entity (CHEBI:50860) |
| starch, wheat (CHEBI:753599) is a organic molecular entity (CHEBI:50860) |
| statolon (CHEBI:753639) is a organic molecular entity (CHEBI:50860) |
| stavudine (CHEBI:63581) is a organic molecular entity (CHEBI:50860) |
| stearoyl polyoxylglcerides (CHEBI:753600) is a organic molecular entity (CHEBI:50860) |
| Stearyltrimethylammonium chloride (CHEBI:81710) is a organic molecular entity (CHEBI:50860) |
| stem bromelain (CHEBI:757477) is a organic molecular entity (CHEBI:50860) |
| StemRegenin 1 (CHEBI:230484) is a organic molecular entity (CHEBI:50860) |
| stenfilcon a (CHEBI:755094) is a organic molecular entity (CHEBI:50860) |
| steviol acyl glucuronide (CHEBI:746992) is a organic molecular entity (CHEBI:50860) |
| sti-6643 (CHEBI:758501) is a organic molecular entity (CHEBI:50860) |
| stibophen (CHEBI:750189) is a organic molecular entity (CHEBI:50860) |
| stop-ALS-a (CHEBI:747566) is a organic molecular entity (CHEBI:50860) |
| storax (CHEBI:753116) is a organic molecular entity (CHEBI:50860) |
| streptococcus pneumoniae polysaccharide conjugated to corynebacterium diphtheriae crm197 (CHEBI:760403) is a organic molecular entity (CHEBI:50860) |
| streptococcus pneumoniae polysaccharide conjugated to corynebacterium diphtheriae toxoid (CHEBI:760279) is a organic molecular entity (CHEBI:50860) |
| streptococcus pneumoniae polysaccharide conjugated to haemophilus influenzae protein d (CHEBI:760281) is a organic molecular entity (CHEBI:50860) |
| streptococcus pneumoniae polysaccharide conjugated to tetanus toxoid (CHEBI:760280) is a organic molecular entity (CHEBI:50860) |
| streptodornase (CHEBI:753789) is a organic molecular entity (CHEBI:50860) |
| streptoduocin (CHEBI:759902) is a organic molecular entity (CHEBI:50860) |
| streptokinase (CHEBI:753157) is a organic molecular entity (CHEBI:50860) |
| streptovarycin (CHEBI:753790) is a organic molecular entity (CHEBI:50860) |
| Strobane (CHEBI:82539) is a organic molecular entity (CHEBI:50860) |
| strontium-88(2+) (CHEBI:176626) is a organic molecular entity (CHEBI:50860) |
| strychnine nitrate (CHEBI:234030) is a organic molecular entity (CHEBI:50860) |
| strychnine sulfate (CHEBI:233239) is a organic molecular entity (CHEBI:50860) |
| Stryphnusin (CHEBI:194557) is a organic molecular entity (CHEBI:50860) |
| stx-100 (CHEBI:754364) is a organic molecular entity (CHEBI:50860) |
| styronate resins (CHEBI:753734) is a organic molecular entity (CHEBI:50860) |
| sucantomotide (CHEBI:759576) is a organic molecular entity (CHEBI:50860) |
| Succinate acylated putrescine (CHEBI:234024) is a organic molecular entity (CHEBI:50860) |
| Succinate acylated spermidine (CHEBI:234019) is a organic molecular entity (CHEBI:50860) |
| Succinate_d4 (CHEBI:172952) is a organic molecular entity (CHEBI:50860) |
| Sucralfate (CHEBI:9313) is a organic molecular entity (CHEBI:50860) |
| sucralox (CHEBI:753163) is a organic molecular entity (CHEBI:50860) |
| sudismase (CHEBI:753164) is a organic molecular entity (CHEBI:50860) |
| sudocetaxel zendusortide (CHEBI:758736) is a organic molecular entity (CHEBI:50860) |
| sugar spheres (CHEBI:753518) is a organic molecular entity (CHEBI:50860) |
| sugar, compressible (CHEBI:753735) is a organic molecular entity (CHEBI:50860) |
| sugar, confectioner's (CHEBI:753025) is a organic molecular entity (CHEBI:50860) |
| sugar, invert (CHEBI:749573) is a organic molecular entity (CHEBI:50860) |
| sugemalimab (CHEBI:758009) is a organic molecular entity (CHEBI:50860) |
| suleparoid sodium (CHEBI:753165) is a organic molecular entity (CHEBI:50860) |
| sulesomab (CHEBI:753736) is a organic molecular entity (CHEBI:50860) |
| Sulfadimethoxine sodium (CHEBI:81722) is a organic molecular entity (CHEBI:50860) |
| Sulfamethoxazole sodium (CHEBI:81291) is a organic molecular entity (CHEBI:50860) |
| Sulfametomidine (CHEBI:32163) is a organic molecular entity (CHEBI:50860) |
| sulfanilate zinc (CHEBI:232366) is a organic molecular entity (CHEBI:50860) |
| sulfated D-galactosylceramide (CHEBI:195531) is a organic molecular entity (CHEBI:50860) |
| sulfated D-galactosylceramide(1-) (CHEBI:195555) is a organic molecular entity (CHEBI:50860) |
| Sulfated_hyaluronan_13sHA6 (CHEBI:194335) is a organic molecular entity (CHEBI:50860) |
| Sulfo-L-tyrosine (CHEBI:232819) is a organic molecular entity (CHEBI:50860) |
| sulfobutylether-beta-cyclodextrin (CHEBI:233221) is a organic molecular entity (CHEBI:50860) |
| sulfocon b (CHEBI:753737) is a organic molecular entity (CHEBI:50860) |
| Sulfur donor (CHEBI:80867) is a organic molecular entity (CHEBI:50860) |
| sulfur-34(2-) (CHEBI:176604) is a organic molecular entity (CHEBI:50860) |
| sulfur-34(2+) (CHEBI:176605) is a organic molecular entity (CHEBI:50860) |
| sulfur-34(4+) (CHEBI:176606) is a organic molecular entity (CHEBI:50860) |
| sulfur-34(6+) (CHEBI:176607) is a organic molecular entity (CHEBI:50860) |
| Sulfuric monoester (CHEBI:80697) is a organic molecular entity (CHEBI:50860) |
| sulglicotide (CHEBI:753100) is a organic molecular entity (CHEBI:50860) |
| sulodexide (CHEBI:753101) is a organic molecular entity (CHEBI:50860) |
| Sulpyrine (CHEBI:32169) is a organic molecular entity (CHEBI:50860) |
| Sultiame (CHEBI:32171) is a organic molecular entity (CHEBI:50860) |
| sunitinib malate (CHEBI:232546) is a organic molecular entity (CHEBI:50860) |
| Sunset Yellow FCF (CHEBI:82538) is a organic molecular entity (CHEBI:50860) |
| suptavumab (CHEBI:755803) is a organic molecular entity (CHEBI:50860) |
| surabgene lomparvovec (CHEBI:760093) is a organic molecular entity (CHEBI:50860) |
| suratadenoturev (CHEBI:759337) is a organic molecular entity (CHEBI:50860) |
| surfilcon a (CHEBI:753102) is a organic molecular entity (CHEBI:50860) |
| surfomer (CHEBI:753103) is a organic molecular entity (CHEBI:50860) |
| surgibone (CHEBI:753104) is a organic molecular entity (CHEBI:50860) |
| surovatamig (CHEBI:760217) is a organic molecular entity (CHEBI:50860) |
| survodutide (CHEBI:759470) is a organic molecular entity (CHEBI:50860) |
| surzebiclimab (CHEBI:757945) is a organic molecular entity (CHEBI:50860) |
| susoctocog alfa (CHEBI:759758) is a organic molecular entity (CHEBI:50860) |
| suspensolide (CHEBI:230625) is a organic molecular entity (CHEBI:50860) |
| sutacimig (CHEBI:760218) is a organic molecular entity (CHEBI:50860) |
| sutilains (CHEBI:749505) is a organic molecular entity (CHEBI:50860) |
| sutimlimab (CHEBI:757276) is a organic molecular entity (CHEBI:50860) |
| suture, absorbable surgical (CHEBI:753105) is a organic molecular entity (CHEBI:50860) |
| suture, nonabsorbable surgical (CHEBI:753106) is a organic molecular entity (CHEBI:50860) |
| Suvanine (CHEBI:69284) is a organic molecular entity (CHEBI:50860) |
| suvanine's sodium salt (CHEBI:69285) is a organic molecular entity (CHEBI:50860) |
| suvemcitug (CHEBI:759727) is a organic molecular entity (CHEBI:50860) |
| suvizumab (CHEBI:750151) is a organic molecular entity (CHEBI:50860) |
| suvodirsen (CHEBI:757599) is a organic molecular entity (CHEBI:50860) |
| suvodirsen sodium (CHEBI:757600) is a organic molecular entity (CHEBI:50860) |
| suvratoxumab (CHEBI:756480) is a organic molecular entity (CHEBI:50860) |
| suvutresgene autoleucel (CHEBI:759471) is a organic molecular entity (CHEBI:50860) |
| svn53-67/m57-klh peptide vaccine (CHEBI:758312) is a organic molecular entity (CHEBI:50860) |
| SW106065 (CHEBI:233416) is a organic molecular entity (CHEBI:50860) |
| swertia herb (CHEBI:753107) is a organic molecular entity (CHEBI:50860) |
| sym-021 (CHEBI:757529) is a organic molecular entity (CHEBI:50860) |
| sym-022 (CHEBI:757530) is a organic molecular entity (CHEBI:50860) |
| sym-023 (CHEBI:757531) is a organic molecular entity (CHEBI:50860) |
| Synta66 (CHEBI:231608) is a organic molecular entity (CHEBI:50860) |
| synthetic conjugated estrogens, b (CHEBI:749558) is a organic molecular entity (CHEBI:50860) |
| synthetic peptide analogue of gnrf conjugated to diptheria toxoid (CHEBI:759775) is a organic molecular entity (CHEBI:50860) |
| Syringopeptin (CHEBI:80113) is a organic molecular entity (CHEBI:50860) |
| syringylglycerol (CHEBI:176881) is a organic molecular entity (CHEBI:50860) |
| syrup (CHEBI:753637) is a organic molecular entity (CHEBI:50860) |
| T0467 (CHEBI:232528) is a organic molecular entity (CHEBI:50860) |
| t84.66 (CHEBI:754192) is a organic molecular entity (CHEBI:50860) |
| ta-5493 (CHEBI:755512) is a organic molecular entity (CHEBI:50860) |
| tabalumab (CHEBI:750152) is a organic molecular entity (CHEBI:50860) |
| tabelecleucel (CHEBI:756490) is a organic molecular entity (CHEBI:50860) |
| taberminogene vadenovec (CHEBI:753081) is a organic molecular entity (CHEBI:50860) |
| tabirafusp alfa (CHEBI:760219) is a organic molecular entity (CHEBI:50860) |
| tabirafusp alfa tedromer (CHEBI:760220) is a organic molecular entity (CHEBI:50860) |
| tadekinig alfa (CHEBI:753070) is a organic molecular entity (CHEBI:50860) |
| tadnersen sodium (CHEBI:758335) is a organic molecular entity (CHEBI:50860) |
| tadocizumab (CHEBI:750153) is a organic molecular entity (CHEBI:50860) |
| tafasitamab (CHEBI:757470) is a organic molecular entity (CHEBI:50860) |
| tafolecimab (CHEBI:758027) is a organic molecular entity (CHEBI:50860) |
| tagraxofusp (CHEBI:757048) is a organic molecular entity (CHEBI:50860) |
| tak-137 (CHEBI:757978) is a organic molecular entity (CHEBI:50860) |
| tak-164 (CHEBI:757278) is a organic molecular entity (CHEBI:50860) |
| tak-186 (CHEBI:759690) is a organic molecular entity (CHEBI:50860) |
| TAK-418 (CHEBI:230499) is a organic molecular entity (CHEBI:50860) |
| Tak-901 (CHEBI:747809) is a organic molecular entity (CHEBI:50860) |
| talacotuzumab (CHEBI:757280) is a organic molecular entity (CHEBI:50860) |
| talactoferrin alfa (CHEBI:753601) is a organic molecular entity (CHEBI:50860) |
| talazoparib (CHEBI:231344) is a organic molecular entity (CHEBI:50860) |
| Talc (CHEBI:32178) is a organic molecular entity (CHEBI:50860) |
| taldefgrobep alfa (CHEBI:757350) is a organic molecular entity (CHEBI:50860) |
| taliglucerase alfa (CHEBI:750322) is a organic molecular entity (CHEBI:50860) |
| talimogene laherparepvec (CHEBI:753665) is a organic molecular entity (CHEBI:50860) |
| talinexomer (CHEBI:755797) is a organic molecular entity (CHEBI:50860) |
| talizumab (CHEBI:752930) is a organic molecular entity (CHEBI:50860) |
| talogreptide mesaroxetan (CHEBI:760094) is a organic molecular entity (CHEBI:50860) |
| talquetamab (CHEBI:757979) is a organic molecular entity (CHEBI:50860) |
| tamtuvetmab (CHEBI:755857) is a organic molecular entity (CHEBI:50860) |
| taneptacogin alfa (CHEBI:753602) is a organic molecular entity (CHEBI:50860) |
| tanezumab (CHEBI:753521) is a organic molecular entity (CHEBI:50860) |
| tanfanercept (CHEBI:757876) is a organic molecular entity (CHEBI:50860) |
| taniborbactam (CHEBI:747455) is a organic molecular entity (CHEBI:50860) |
| taniraleucel (CHEBI:759316) is a organic molecular entity (CHEBI:50860) |
| tape, adhesive (CHEBI:752931) is a organic molecular entity (CHEBI:50860) |
| TAPI-1 (CHEBI:234202) is a organic molecular entity (CHEBI:50860) |
| taplitumomab paptox (CHEBI:752932) is a organic molecular entity (CHEBI:50860) |
| tarcocimab (CHEBI:759314) is a organic molecular entity (CHEBI:50860) |
| tarcocimab tedromer (CHEBI:758737) is a organic molecular entity (CHEBI:50860) |
| tarextumab (CHEBI:755271) is a organic molecular entity (CHEBI:50860) |
| tarlatamab (CHEBI:758866) is a organic molecular entity (CHEBI:50860) |
| tarperprumig (CHEBI:759699) is a organic molecular entity (CHEBI:50860) |
| tarumase (CHEBI:759577) is a organic molecular entity (CHEBI:50860) |
| Tas-116 (CHEBI:233475) is a organic molecular entity (CHEBI:50860) |
| tas-1553 (CHEBI:760530) is a organic molecular entity (CHEBI:50860) |
| tas-266 (CHEBI:758530) is a organic molecular entity (CHEBI:50860) |
| tasadenoturev (CHEBI:756525) is a organic molecular entity (CHEBI:50860) |
| tasonermin (CHEBI:752933) is a organic molecular entity (CHEBI:50860) |
| taspoglutide (CHEBI:752903) is a organic molecular entity (CHEBI:50860) |
| tasquinimod (CHEBI:231355) is a organic molecular entity (CHEBI:50860) |
| tavokinogene telseplasmid (CHEBI:757613) is a organic molecular entity (CHEBI:50860) |
| tavolimab (CHEBI:757452) is a organic molecular entity (CHEBI:50860) |
| TAXOTERE (CHEBI:46058) is a organic molecular entity (CHEBI:50860) |
| Tazanolast (CHEBI:32183) is a organic molecular entity (CHEBI:50860) |
| tazemetostat (CHEBI:231598) is a organic molecular entity (CHEBI:50860) |
| tazlestobart (CHEBI:760095) is a organic molecular entity (CHEBI:50860) |
| tb-402 (CHEBI:754214) is a organic molecular entity (CHEBI:50860) |
| tb-403 (CHEBI:754312) is a organic molecular entity (CHEBI:50860) |
| TCA-sodium (CHEBI:81976) is a organic molecular entity (CHEBI:50860) |
| tcn-032 (CHEBI:754361) is a organic molecular entity (CHEBI:50860) |
| tcn-202 (CHEBI:757980) is a organic molecular entity (CHEBI:50860) |
| TCO (CHEBI:233068) is a organic molecular entity (CHEBI:50860) |
| tebentafusp (CHEBI:757417) is a organic molecular entity (CHEBI:50860) |
| tebotelimab (CHEBI:758051) is a organic molecular entity (CHEBI:50860) |
| teceleukin (CHEBI:752934) is a organic molecular entity (CHEBI:50860) |
| tecemotide (CHEBI:755085) is a organic molecular entity (CHEBI:50860) |
| technetium (CHEBI:749410) is a organic molecular entity (CHEBI:50860) |
| technetium etifenin (CHEBI:756528) is a organic molecular entity (CHEBI:50860) |
| technetium galtifenin (CHEBI:756550) is a organic molecular entity (CHEBI:50860) |
| technetium trofolastat (CHEBI:758092) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) apcitide (CHEBI:749566) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) etarfolatide (CHEBI:755844) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) etifenin (CHEBI:755813) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) galtifenin (CHEBI:755759) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) human serum albumin [injection] (CHEBI:752935) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) phytate [injection] (CHEBI:752936) is a organic molecular entity (CHEBI:50860) |
| technetium (99mtc) pintumomab (CHEBI:752937) is a organic molecular entity (CHEBI:50860) |
| technetium bicisate (CHEBI:758104) is a organic molecular entity (CHEBI:50860) |
| technetium disofenin (CHEBI:754414) is a organic molecular entity (CHEBI:50860) |
| technetium etidronate (CHEBI:754400) is a organic molecular entity (CHEBI:50860) |
| technetium exametazime (CHEBI:754661) is a organic molecular entity (CHEBI:50860) |
| technetium furifosmin (CHEBI:758096) is a organic molecular entity (CHEBI:50860) |
| technetium gluceptate (CHEBI:754410) is a organic molecular entity (CHEBI:50860) |
| technetium lidofenin (CHEBI:754406) is a organic molecular entity (CHEBI:50860) |
| technetium mebrofenin (CHEBI:754401) is a organic molecular entity (CHEBI:50860) |
| technetium medronate (CHEBI:754415) is a organic molecular entity (CHEBI:50860) |
| technetium mertiatide (CHEBI:754723) is a organic molecular entity (CHEBI:50860) |
| technetium oxidronate (CHEBI:754407) is a organic molecular entity (CHEBI:50860) |
| technetium pentetate (CHEBI:754398) is a organic molecular entity (CHEBI:50860) |
| technetium pyrophosphate (CHEBI:754403) is a organic molecular entity (CHEBI:50860) |
| technetium sestamibi (CHEBI:760547) is a organic molecular entity (CHEBI:50860) |
| technetium succimer (CHEBI:754412) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m (pyro- and trimeta-) phosphates (CHEBI:749513) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m albumin aggregated (CHEBI:749452) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m albumin microaggregated (CHEBI:752938) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m antimony trisulfide colloid (CHEBI:752939) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m arcitumomab (CHEBI:750166) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m bicisate (CHEBI:749686) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m depreotide (CHEBI:749512) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m disofenin (CHEBI:749340) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m etidronate (CHEBI:749325) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m exametazime (CHEBI:752415) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m fanolesomab (CHEBI:752940) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m ferpentetate (CHEBI:749514) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m furifosmin (CHEBI:757747) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m gluceptate (CHEBI:749289) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m lidofenin (CHEBI:749292) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m mebrofenin (CHEBI:749240) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m medronate (CHEBI:749341) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m mertiatide (CHEBI:752673) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m nofetumomab merpentan (CHEBI:754140) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m oxidronate (CHEBI:749239) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m pentetate (CHEBI:750452) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m pyrophosphate (CHEBI:749221) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m red blood cells (CHEBI:749471) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m sulfur colloid (CHEBI:749474) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m teboroxime (CHEBI:757736) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m tetrofosmin (CHEBI:749329) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m tiatide (CHEBI:753152) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m tilmanocept (CHEBI:753664) is a organic molecular entity (CHEBI:50860) |
| technetium tc 99m trofolastat (CHEBI:757757) is a organic molecular entity (CHEBI:50860) |
| technetium tc-99m (CHEBI:756931) is a organic molecular entity (CHEBI:50860) |
| technetium tc-99m ethylene-dicysteine-deoxyglucose (CHEBI:757854) is a organic molecular entity (CHEBI:50860) |
| technetium tc-99m labeled carbon (CHEBI:759345) is a organic molecular entity (CHEBI:50860) |
| technetium tc-99m pertechnetate (CHEBI:756860) is a organic molecular entity (CHEBI:50860) |
| technetium tc-99m polyphosphate kit (CHEBI:749455) is a organic molecular entity (CHEBI:50860) |
| technetium tc-99m trofolastat chloride (CHEBI:757297) is a organic molecular entity (CHEBI:50860) |
| technetium teboroxime (CHEBI:758106) is a organic molecular entity (CHEBI:50860) |
| technetium tetrofosmin (CHEBI:754408) is a organic molecular entity (CHEBI:50860) |
| teclistamab (CHEBI:757981) is a organic molecular entity (CHEBI:50860) |
| tecogalan sodium (CHEBI:753716) is a organic molecular entity (CHEBI:50860) |
| tecotabart (CHEBI:760096) is a organic molecular entity (CHEBI:50860) |
| tecotabart vedotin (CHEBI:760097) is a organic molecular entity (CHEBI:50860) |
| tedromer (CHEBI:759315) is a organic molecular entity (CHEBI:50860) |
| tefibazumab (CHEBI:753071) is a organic molecular entity (CHEBI:50860) |
| teglicar (CHEBI:234386) is a organic molecular entity (CHEBI:50860) |
| tegoprubart (CHEBI:757941) is a organic molecular entity (CHEBI:50860) |
| tegrenmeran (CHEBI:759497) is a organic molecular entity (CHEBI:50860) |
| teicoplanin A3 (CHEBI:80013) is a organic molecular entity (CHEBI:50860) |
| telazorlimab (CHEBI:758019) is a organic molecular entity (CHEBI:50860) |
| telbermin (CHEBI:753514) is a organic molecular entity (CHEBI:50860) |
| telikibart (CHEBI:760221) is a organic molecular entity (CHEBI:50860) |
| telimomab aritox (CHEBI:753717) is a organic molecular entity (CHEBI:50860) |
| telisotuzumab (CHEBI:755631) is a organic molecular entity (CHEBI:50860) |
| telisotuzumab adizutecan (CHEBI:760098) is a organic molecular entity (CHEBI:50860) |
| telisotuzumab vedotin (CHEBI:756513) is a organic molecular entity (CHEBI:50860) |
| telitacicept (CHEBI:758867) is a organic molecular entity (CHEBI:50860) |
| temavirsen (CHEBI:756481) is a organic molecular entity (CHEBI:50860) |
| temavirsen sodium (CHEBI:756501) is a organic molecular entity (CHEBI:50860) |
| temelimab (CHEBI:758020) is a organic molecular entity (CHEBI:50860) |
| temtokibart (CHEBI:759472) is a organic molecular entity (CHEBI:50860) |
| Tenatoprazole (CHEBI:32191) is a organic molecular entity (CHEBI:50860) |
| tenatumomab (CHEBI:750154) is a organic molecular entity (CHEBI:50860) |
| tendamistat (CHEBI:753153) is a organic molecular entity (CHEBI:50860) |
| tenecteplase (CHEBI:753718) is a organic molecular entity (CHEBI:50860) |
| teneliximab (CHEBI:753154) is a organic molecular entity (CHEBI:50860) |
| tenilsetam (CHEBI:232422) is a organic molecular entity (CHEBI:50860) |
| teplizumab (CHEBI:750155) is a organic molecular entity (CHEBI:50860) |
| teprasiran (CHEBI:757049) is a organic molecular entity (CHEBI:50860) |
| teprasiran sodium (CHEBI:757586) is a organic molecular entity (CHEBI:50860) |
| teprotumumab (CHEBI:750156) is a organic molecular entity (CHEBI:50860) |
| tergenpumatucel-l (CHEBI:753630) is a organic molecular entity (CHEBI:50860) |
| Terguride (CHEBI:32193) is a organic molecular entity (CHEBI:50860) |
| teriparatide acetate (CHEBI:749430) is a organic molecular entity (CHEBI:50860) |
| Ternatin 4 (DA3) (CHEBI:189650) is a organic molecular entity (CHEBI:50860) |
| teropavimab (CHEBI:758868) is a organic molecular entity (CHEBI:50860) |
| teroxirone (CHEBI:747490) is a organic molecular entity (CHEBI:50860) |
| tertomotide (CHEBI:753296) is a organic molecular entity (CHEBI:50860) |
| tes-c21 (CHEBI:754244) is a organic molecular entity (CHEBI:50860) |
| Tesaglitazar (CHEBI:32195) is a organic molecular entity (CHEBI:50860) |
| tesamorelin acetate (CHEBI:754768) is a organic molecular entity (CHEBI:50860) |
| tesidolumab (CHEBI:757437) is a organic molecular entity (CHEBI:50860) |
| tesnatilimab (CHEBI:758037) is a organic molecular entity (CHEBI:50860) |
| tesrivetcel (CHEBI:759578) is a organic molecular entity (CHEBI:50860) |
| Testing submission (CHEBI:747006) is a organic molecular entity (CHEBI:50860) |
| Tet2-Et (CHEBI:229636) is a organic molecular entity (CHEBI:50860) |
| Tet2-Me (CHEBI:229637) is a organic molecular entity (CHEBI:50860) |
| Tet3-Butyl (CHEBI:229638) is a organic molecular entity (CHEBI:50860) |
| tetanus and gas gangrene antitoxins (CHEBI:753795) is a organic molecular entity (CHEBI:50860) |
| tetanus antitoxin (CHEBI:753120) is a organic molecular entity (CHEBI:50860) |
| tetanus immune globulin (CHEBI:749548) is a organic molecular entity (CHEBI:50860) |
| tetanus toxoid (CHEBI:753796) is a organic molecular entity (CHEBI:50860) |
| tetanus toxoid adsorbed (CHEBI:753797) is a organic molecular entity (CHEBI:50860) |
| tetracopper hexahydroxide sulphate (CHEBI:232855) is a organic molecular entity (CHEBI:50860) |
| tetracosanoyl carnitine (CHEBI:140753) is a organic molecular entity (CHEBI:50860) |
| tetracosatetraenoyl carnitine (CHEBI:230754) is a organic molecular entity (CHEBI:50860) |
| Tetracycline hydrochloride (CHEBI:35006) is a organic molecular entity (CHEBI:50860) |
| tetrafilcon a (CHEBI:753121) is a organic molecular entity (CHEBI:50860) |
| Tetrahydrobiopterin-4a-carbinolamine (CHEBI:140754) is a organic molecular entity (CHEBI:50860) |
| TETRAHYDROURIDINE (CHEBI:46208) is a organic molecular entity (CHEBI:50860) |
| Tetramisole hydrochloride (CHEBI:9496) is a organic molecular entity (CHEBI:50860) |
| Tetranor-12-HETE (CHEBI:746951) is a organic molecular entity (CHEBI:50860) |
| tetulomab tetraxetan lu-177 (CHEBI:757344) is a organic molecular entity (CHEBI:50860) |
| Tezacaftor (CHEBI:234517) is a organic molecular entity (CHEBI:50860) |
| tezemlimogene daxadenorepvec (CHEBI:758898) is a organic molecular entity (CHEBI:50860) |
| tezepelumab (CHEBI:755742) is a organic molecular entity (CHEBI:50860) |
| TG003 (CHEBI:233005) is a organic molecular entity (CHEBI:50860) |
| tgn-1412 (CHEBI:754120) is a organic molecular entity (CHEBI:50860) |
| thallous chloride (CHEBI:757644) is a organic molecular entity (CHEBI:50860) |
| thallous chloride tl 201 (CHEBI:749269) is a organic molecular entity (CHEBI:50860) |
| thaumatin (CHEBI:753122) is a organic molecular entity (CHEBI:50860) |
| thenoyltrifluoroacetone (CHEBI:234560) is a organic molecular entity (CHEBI:50860) |
| theonellasterol b (CHEBI:230556) is a organic molecular entity (CHEBI:50860) |
| thiamine cobalt chlorophyllin complex (CHEBI:753798) is a organic molecular entity (CHEBI:50860) |
| thienopyrrole (CHEBI:232751) is a organic molecular entity (CHEBI:50860) |
| Thiogalactoside (CHEBI:9552) is a organic molecular entity (CHEBI:50860) |
| Thioinosine (CHEBI:32217) is a organic molecular entity (CHEBI:50860) |
| Thiol-containing reductant (CHEBI:80696) is a organic molecular entity (CHEBI:50860) |
| thr-18 (CHEBI:758502) is a organic molecular entity (CHEBI:50860) |
| thr-184 (CHEBI:758869) is a organic molecular entity (CHEBI:50860) |
| threoninochenodeoxycholic acid (CHEBI:232201) is a organic molecular entity (CHEBI:50860) |
| threoninocholic acid (CHEBI:232256) is a organic molecular entity (CHEBI:50860) |
| threoninolithocholic acid (CHEBI:232182) is a organic molecular entity (CHEBI:50860) |
| threoninoursodeoxycholic acid (CHEBI:232274) is a organic molecular entity (CHEBI:50860) |
| threonylodeoxycholic acid (CHEBI:232220) is a organic molecular entity (CHEBI:50860) |
| Thrombin (CHEBI:9574) is a organic molecular entity (CHEBI:50860) |
| thrombin alfa (CHEBI:752897) is a organic molecular entity (CHEBI:50860) |
| thrombomodulin alfa (CHEBI:753603) is a organic molecular entity (CHEBI:50860) |
| thromboplastin (CHEBI:753158) is a organic molecular entity (CHEBI:50860) |
| Thudichumic acid (CHEBI:195357) is a organic molecular entity (CHEBI:50860) |
| thunbergol (CHEBI:192750) is a organic molecular entity (CHEBI:50860) |
| Thymosin alpha-1 (CHEBI:80287) is a organic molecular entity (CHEBI:50860) |
| Thymosin beta-10 (CHEBI:80289) is a organic molecular entity (CHEBI:50860) |
| Thymosin beta-4 (CHEBI:80288) is a organic molecular entity (CHEBI:50860) |
| thymostimulin (CHEBI:753123) is a organic molecular entity (CHEBI:50860) |
| thyroglobulin (CHEBI:749525) is a organic molecular entity (CHEBI:50860) |
| Thyroglobulin 3-Iodotyrosine (CHEBI:80692) is a organic molecular entity (CHEBI:50860) |
| Thyroglobulin 3,5-diiodotyrosine (CHEBI:80691) is a organic molecular entity (CHEBI:50860) |
| Thyroglobulin dehydroalanine (CHEBI:80694) is a organic molecular entity (CHEBI:50860) |
| Thyroglobulin L-thyroxine (CHEBI:80689) is a organic molecular entity (CHEBI:50860) |
| Thyroglobulin L-tyrosine (CHEBI:80693) is a organic molecular entity (CHEBI:50860) |
| Thyroglobulin triiodothyronine (CHEBI:80690) is a organic molecular entity (CHEBI:50860) |
| thyroid (CHEBI:753799) is a organic molecular entity (CHEBI:50860) |
| thyrotropin (CHEBI:749528) is a organic molecular entity (CHEBI:50860) |
| thyrotropin alfa (CHEBI:749567) is a organic molecular entity (CHEBI:50860) |
| tibrecovatein (CHEBI:759492) is a organic molecular entity (CHEBI:50860) |
| tibulizumab (CHEBI:756483) is a organic molecular entity (CHEBI:50860) |
| tidagixagene derxeparvovec (CHEBI:759405) is a organic molecular entity (CHEBI:50860) |
| tidutamab (CHEBI:757544) is a organic molecular entity (CHEBI:50860) |
| tifacogin (CHEBI:753719) is a organic molecular entity (CHEBI:50860) |
| tifalibep (CHEBI:760503) is a organic molecular entity (CHEBI:50860) |
| tifcemalimab (CHEBI:758920) is a organic molecular entity (CHEBI:50860) |
| tifuvirtide (CHEBI:753604) is a organic molecular entity (CHEBI:50860) |
| tigatuzumab (CHEBI:750157) is a organic molecular entity (CHEBI:50860) |
| tilactase (CHEBI:753720) is a organic molecular entity (CHEBI:50860) |
| tilatamig (CHEBI:760099) is a organic molecular entity (CHEBI:50860) |
| tilatamig samrotecan (CHEBI:760100) is a organic molecular entity (CHEBI:50860) |
| tilavonemab (CHEBI:757301) is a organic molecular entity (CHEBI:50860) |
| tildrakizumab (CHEBI:753629) is a organic molecular entity (CHEBI:50860) |
| tilmanocept (CHEBI:759760) is a organic molecular entity (CHEBI:50860) |
| tilrekimig (CHEBI:760385) is a organic molecular entity (CHEBI:50860) |
| tilsotolimod (CHEBI:757281) is a organic molecular entity (CHEBI:50860) |
| tilsotolimod sodium (CHEBI:757421) is a organic molecular entity (CHEBI:50860) |
| tilvestamab (CHEBI:758004) is a organic molecular entity (CHEBI:50860) |
| timbetasin (CHEBI:757812) is a organic molecular entity (CHEBI:50860) |
| timbetasin acetate (CHEBI:757813) is a organic molecular entity (CHEBI:50860) |
| timdarpacept (CHEBI:759473) is a organic molecular entity (CHEBI:50860) |
| Timepidium bromide (CHEBI:32226) is a organic molecular entity (CHEBI:50860) |
| Timnodonyl carnitine (CHEBI:140755) is a organic molecular entity (CHEBI:50860) |
| timolumab (CHEBI:757354) is a organic molecular entity (CHEBI:50860) |
| timrepigene emparvovec (CHEBI:757814) is a organic molecular entity (CHEBI:50860) |
| tindupepimut (CHEBI:760354) is a organic molecular entity (CHEBI:50860) |
| tinocabtagene autoleucel (CHEBI:759474) is a organic molecular entity (CHEBI:50860) |
| tinzaparin (CHEBI:760498) is a organic molecular entity (CHEBI:50860) |
| tinzaparin sodium (CHEBI:749522) is a organic molecular entity (CHEBI:50860) |
| tiomolibdate choline (CHEBI:757765) is a organic molecular entity (CHEBI:50860) |
| tiomolibdate diammonium (CHEBI:755878) is a organic molecular entity (CHEBI:50860) |
| tiomolibdate ion (CHEBI:749652) is a organic molecular entity (CHEBI:50860) |
| tiomolibdic acid (CHEBI:756932) is a organic molecular entity (CHEBI:50860) |
| tipapkinogene sovacivec (CHEBI:753655) is a organic molecular entity (CHEBI:50860) |
| tiplimotide (CHEBI:753791) is a organic molecular entity (CHEBI:50860) |
| tiprelestat (CHEBI:753328) is a organic molecular entity (CHEBI:50860) |
| Tirabrutinib (CHEBI:232544) is a organic molecular entity (CHEBI:50860) |
| tiragolumab (CHEBI:757473) is a organic molecular entity (CHEBI:50860) |
| tirnovetmab (CHEBI:758145) is a organic molecular entity (CHEBI:50860) |
| Tiron (CHEBI:9607) is a organic molecular entity (CHEBI:50860) |
| tisagenlecleucel (CHEBI:755258) is a organic molecular entity (CHEBI:50860) |
| tisilfocon a (CHEBI:753792) is a organic molecular entity (CHEBI:50860) |
| tislelizumab (CHEBI:757282) is a organic molecular entity (CHEBI:50860) |
| tisokinase (CHEBI:753118) is a organic molecular entity (CHEBI:50860) |
| tisotumab (CHEBI:757842) is a organic molecular entity (CHEBI:50860) |
| tisotumab vedotin (CHEBI:757283) is a organic molecular entity (CHEBI:50860) |
| tivanisiran (CHEBI:755823) is a organic molecular entity (CHEBI:50860) |
| tivanisiran sodium (CHEBI:759339) is a organic molecular entity (CHEBI:50860) |
| tividenofusp alfa (CHEBI:758011) is a organic molecular entity (CHEBI:50860) |
| tixagevimab (CHEBI:758171) is a organic molecular entity (CHEBI:50860) |
| tizetatug (CHEBI:760222) is a organic molecular entity (CHEBI:50860) |
| tizetatug rezetecan (CHEBI:760223) is a organic molecular entity (CHEBI:50860) |
| tm30339 (CHEBI:755464) is a organic molecular entity (CHEBI:50860) |
| TMC-151 (CHEBI:80119) is a organic molecular entity (CHEBI:50860) |
| TmdZLys (CHEBI:232672) is a organic molecular entity (CHEBI:50860) |
| TMP269 (CHEBI:230501) is a organic molecular entity (CHEBI:50860) |
| TMP778 (CHEBI:230502) is a organic molecular entity (CHEBI:50860) |
| TMP920 (CHEBI:230503) is a organic molecular entity (CHEBI:50860) |
| tnt-1b (CHEBI:754379) is a organic molecular entity (CHEBI:50860) |
| tnx-100 (CHEBI:754262) is a organic molecular entity (CHEBI:50860) |
| tobemstomig (CHEBI:759691) is a organic molecular entity (CHEBI:50860) |
| tobevibart (CHEBI:759318) is a organic molecular entity (CHEBI:50860) |
| tocilizumab (CHEBI:64360) is a organic molecular entity (CHEBI:50860) |
| tocofersolan (CHEBI:753119) is a organic molecular entity (CHEBI:50860) |
| tocopherols excipient (CHEBI:753793) is a organic molecular entity (CHEBI:50860) |
| tofersen (CHEBI:755937) is a organic molecular entity (CHEBI:50860) |
| tofersen sodium (CHEBI:756740) is a organic molecular entity (CHEBI:50860) |
| Tofisopam (CHEBI:32241) is a organic molecular entity (CHEBI:50860) |
| tol-101 (CHEBI:754348) is a organic molecular entity (CHEBI:50860) |
| Tolebrutinib (CHEBI:233436) is a organic molecular entity (CHEBI:50860) |
| tolevamer potassium sodium (CHEBI:753605) is a organic molecular entity (CHEBI:50860) |
| tolevamer sodium (CHEBI:753794) is a organic molecular entity (CHEBI:50860) |
| toll-like receptor 9 (CHEBI:758315) is a organic molecular entity (CHEBI:50860) |
| tolofocon a (CHEBI:753680) is a organic molecular entity (CHEBI:50860) |
| tolpovidone i 131 (CHEBI:753681) is a organic molecular entity (CHEBI:50860) |
| tolu balsam (CHEBI:753130) is a organic molecular entity (CHEBI:50860) |
| tolu balsam syrup (CHEBI:753606) is a organic molecular entity (CHEBI:50860) |
| tolu balsam tincture (CHEBI:753607) is a organic molecular entity (CHEBI:50860) |
| tomaralimab (CHEBI:757489) is a organic molecular entity (CHEBI:50860) |
| tominersen (CHEBI:757056) is a organic molecular entity (CHEBI:50860) |
| tomuzotuximab (CHEBI:757284) is a organic molecular entity (CHEBI:50860) |
| tonlamarsen (CHEBI:758918) is a organic molecular entity (CHEBI:50860) |
| tonlamarsen sodium (CHEBI:759023) is a organic molecular entity (CHEBI:50860) |
| tonogenchoncel-l (CHEBI:755543) is a organic molecular entity (CHEBI:50860) |
| TopBP1-IN-1 (CHEBI:233312) is a organic molecular entity (CHEBI:50860) |
| topsalysin (CHEBI:755002) is a organic molecular entity (CHEBI:50860) |
| toralizumab (CHEBI:753682) is a organic molecular entity (CHEBI:50860) |
| torapsel (CHEBI:753072) is a organic molecular entity (CHEBI:50860) |
| toripalimab (CHEBI:757285) is a organic molecular entity (CHEBI:50860) |
| torudokimab (CHEBI:758368) is a organic molecular entity (CHEBI:50860) |
| torulimogene lonferencel (CHEBI:759406) is a organic molecular entity (CHEBI:50860) |
| tosatoxumab (CHEBI:758000) is a organic molecular entity (CHEBI:50860) |
| tositumomab (CHEBI:749499) is a organic molecular entity (CHEBI:50860) |
| tositumomab 131i (CHEBI:755905) is a organic molecular entity (CHEBI:50860) |
| toussaintine A (CHEBI:232496) is a organic molecular entity (CHEBI:50860) |
| tovecimig (CHEBI:760224) is a organic molecular entity (CHEBI:50860) |
| tovetumab (CHEBI:754998) is a organic molecular entity (CHEBI:50860) |
| tozinameran (CHEBI:758316) is a organic molecular entity (CHEBI:50860) |
| tozorakimab (CHEBI:758371) is a organic molecular entity (CHEBI:50860) |
| tozuleristide (CHEBI:756505) is a organic molecular entity (CHEBI:50860) |
| TPT-172 (CHEBI:747460) is a organic molecular entity (CHEBI:50860) |
| TPT-260 (CHEBI:232979) is a organic molecular entity (CHEBI:50860) |
| tpx-4589 (CHEBI:759715) is a organic molecular entity (CHEBI:50860) |
| TR-Saponin A (CHEBI:230098) is a organic molecular entity (CHEBI:50860) |
| trabedersen (CHEBI:753325) is a organic molecular entity (CHEBI:50860) |
| trabikibart (CHEBI:759475) is a organic molecular entity (CHEBI:50860) |
| tracheal cytotoxin (CHEBI:233430) is a organic molecular entity (CHEBI:50860) |
| tradipitant (CHEBI:747212) is a organic molecular entity (CHEBI:50860) |
| trafermin (CHEBI:753096) is a organic molecular entity (CHEBI:50860) |
| tragacanth (CHEBI:753097) is a organic molecular entity (CHEBI:50860) |
| tralokinumab (CHEBI:750158) is a organic molecular entity (CHEBI:50860) |
| trans-Dec-2-enoyl-[acp] (CHEBI:10724) is a organic molecular entity (CHEBI:50860) |
| trans-Dodec-2-enoyl-[acp] (CHEBI:10725) is a organic molecular entity (CHEBI:50860) |
| trans-Hex-2-enoyl-[acp] (CHEBI:10727) is a organic molecular entity (CHEBI:50860) |
| trans-Hexadec-2-enoyl-[acp] (CHEBI:10729) is a organic molecular entity (CHEBI:50860) |
| trans-Tetradec-2-enoyl-[acp] (CHEBI:10735) is a organic molecular entity (CHEBI:50860) |
| transferrin aldifitox (CHEBI:753324) is a organic molecular entity (CHEBI:50860) |
| Translation Initiation Targets (CHEBI:189682) is a organic molecular entity (CHEBI:50860) |
| trastuzumab (CHEBI:231601) is a organic molecular entity (CHEBI:50860) |
| trastuzumab botidotin (CHEBI:759476) is a organic molecular entity (CHEBI:50860) |
| trastuzumab brengitecan (CHEBI:759579) is a organic molecular entity (CHEBI:50860) |
| trastuzumab corixetan (CHEBI:758738) is a organic molecular entity (CHEBI:50860) |
| trastuzumab deruxtecan (CHEBI:757286) is a organic molecular entity (CHEBI:50860) |
| trastuzumab duocarmazine (CHEBI:757585) is a organic molecular entity (CHEBI:50860) |
| trastuzumab emtansine (CHEBI:750159) is a organic molecular entity (CHEBI:50860) |
| trastuzumab envedotin (CHEBI:760101) is a organic molecular entity (CHEBI:50860) |
| trastuzumab imbotolimod (CHEBI:758888) is a organic molecular entity (CHEBI:50860) |
| trastuzumab mafodotin (CHEBI:760510) is a organic molecular entity (CHEBI:50860) |
| trastuzumab pamirtecan (CHEBI:760225) is a organic molecular entity (CHEBI:50860) |
| trastuzumab rezetecan (CHEBI:759407) is a organic molecular entity (CHEBI:50860) |
| trastuzumab vedotin (CHEBI:759720) is a organic molecular entity (CHEBI:50860) |
| traxivitug (CHEBI:759580) is a organic molecular entity (CHEBI:50860) |
| trc-093 (CHEBI:754195) is a organic molecular entity (CHEBI:50860) |
| trebananib (CHEBI:753522) is a organic molecular entity (CHEBI:50860) |
| trecovirsen (CHEBI:753333) is a organic molecular entity (CHEBI:50860) |
| trecovirsen sodium (CHEBI:753098) is a organic molecular entity (CHEBI:50860) |
| tregalizumab (CHEBI:750160) is a organic molecular entity (CHEBI:50860) |
| trehalose dihydrate (CHEBI:232797) is a organic molecular entity (CHEBI:50860) |
| tremacamra (CHEBI:753099) is a organic molecular entity (CHEBI:50860) |
| tremelimumab (CHEBI:753608) is a organic molecular entity (CHEBI:50860) |
| tremtelectogene empogeditemcel (CHEBI:759408) is a organic molecular entity (CHEBI:50860) |
| trenibotulinumtoxine (CHEBI:758013) is a organic molecular entity (CHEBI:50860) |
| trenonacog alfa (CHEBI:755080) is a organic molecular entity (CHEBI:50860) |
| Trepibutone (CHEBI:32255) is a organic molecular entity (CHEBI:50860) |
| trevogrumab (CHEBI:755604) is a organic molecular entity (CHEBI:50860) |
| trevotamig (CHEBI:760226) is a organic molecular entity (CHEBI:50860) |
| Tri-2,5-cyclohexadien-1-ylsilane (CHEBI:188673) is a organic molecular entity (CHEBI:50860) |
| trichinella extract (CHEBI:753724) is a organic molecular entity (CHEBI:50860) |
| Trichlormethine (CHEBI:82375) is a organic molecular entity (CHEBI:50860) |
| trichodion (CHEBI:68797) is a organic molecular entity (CHEBI:50860) |
| Trichomycin (CHEBI:35022) is a organic molecular entity (CHEBI:50860) |
| tridecactide (CHEBI:753320) is a organic molecular entity (CHEBI:50860) |
| tridecenedioic acid (CHEBI:233758) is a organic molecular entity (CHEBI:50860) |
| Triethyltin bromide (CHEBI:747845) is a organic molecular entity (CHEBI:50860) |
| trifluorinated methyl farnesoate (CHEBI:235477) is a organic molecular entity (CHEBI:50860) |
| triglycerides, medium-chain (CHEBI:753609) is a organic molecular entity (CHEBI:50860) |
| Trigoneoside XIIIa (CHEBI:230100) is a organic molecular entity (CHEBI:50860) |
| trikates (CHEBI:757738) is a organic molecular entity (CHEBI:50860) |
| trimedoxime bromide (CHEBI:233584) is a organic molecular entity (CHEBI:50860) |
| trimethyl(octadecyl)silane (CHEBI:137538) is a organic molecular entity (CHEBI:50860) |
| trimix (CHEBI:758503) is a organic molecular entity (CHEBI:50860) |
| trinecol (pullus) (CHEBI:753726) is a organic molecular entity (CHEBI:50860) |
| Tripamide (CHEBI:32264) is a organic molecular entity (CHEBI:50860) |
| Triptolide Analog (CHEBI:230923) is a organic molecular entity (CHEBI:50860) |
| triptorelin acetate (CHEBI:759756) is a organic molecular entity (CHEBI:50860) |
| tris(8-hydroxyquinolinato)gallium (CHEBI:757998) is a organic molecular entity (CHEBI:50860) |
| trk-950 (CHEBI:757853) is a organic molecular entity (CHEBI:50860) |
| troculeucel (CHEBI:759581) is a organic molecular entity (CHEBI:50860) |
| trolamine polypeptide oleate condensate (CHEBI:749490) is a organic molecular entity (CHEBI:50860) |
| trontinemab (CHEBI:758943) is a organic molecular entity (CHEBI:50860) |
| troplasminogen alfa (CHEBI:753331) is a organic molecular entity (CHEBI:50860) |
| trosunilimab (CHEBI:760102) is a organic molecular entity (CHEBI:50860) |
| trovocabtagene autoleucel (CHEBI:759477) is a organic molecular entity (CHEBI:50860) |
| trph-222 (CHEBI:757983) is a organic molecular entity (CHEBI:50860) |
| tru-015 (CHEBI:757287) is a organic molecular entity (CHEBI:50860) |
| trx-1 (CHEBI:754260) is a organic molecular entity (CHEBI:50860) |
| trx-518 (CHEBI:754225) is a organic molecular entity (CHEBI:50860) |
| Tryparedoxin (CHEBI:80649) is a organic molecular entity (CHEBI:50860) |
| Tryparedoxin disulfide (CHEBI:80650) is a organic molecular entity (CHEBI:50860) |
| Trypsin (CHEBI:9765) is a organic molecular entity (CHEBI:50860) |
| trypsin, crystallized (CHEBI:753747) is a organic molecular entity (CHEBI:50860) |
| tryptaminochenodeoxycholic acid (CHEBI:232211) is a organic molecular entity (CHEBI:50860) |
| tryptaminocholic acid (CHEBI:232266) is a organic molecular entity (CHEBI:50860) |
| tryptaminolithocholic acid (CHEBI:232193) is a organic molecular entity (CHEBI:50860) |
| tryptaminoursodeoxycholic acid (CHEBI:232286) is a organic molecular entity (CHEBI:50860) |
| tryptophanochenodeoxycholic acid (CHEBI:232208) is a organic molecular entity (CHEBI:50860) |
| tryptophanodeoxycholic acid (CHEBI:232226) is a organic molecular entity (CHEBI:50860) |
| tryptophanolithocholic acid (CHEBI:232188) is a organic molecular entity (CHEBI:50860) |
| tryptophanoursodeoxycholic acid (CHEBI:232282) is a organic molecular entity (CHEBI:50860) |
| ttp-607 (CHEBI:755578) is a organic molecular entity (CHEBI:50860) |
| Tubastatin A hydrochloride (CHEBI:747810) is a organic molecular entity (CHEBI:50860) |
| tuberculin (CHEBI:753171) is a organic molecular entity (CHEBI:50860) |
| Tuberoinfundibular peptide of 39 residues (CHEBI:80275) is a organic molecular entity (CHEBI:50860) |
| tucotuzumab celmoleukin (CHEBI:753610) is a organic molecular entity (CHEBI:50860) |
| tulathromycin (CHEBI:759897) is a organic molecular entity (CHEBI:50860) |
| tulisokibart (CHEBI:758937) is a organic molecular entity (CHEBI:50860) |
| Tulobuterol hydrochloride (CHEBI:32272) is a organic molecular entity (CHEBI:50860) |
| tumor necrosis factor receptor superfamily member 9 (CHEBI:757356) is a organic molecular entity (CHEBI:50860) |
| Tungsten carbide (CHEBI:82283) is a organic molecular entity (CHEBI:50860) |
| tuparstobart (CHEBI:758032) is a organic molecular entity (CHEBI:50860) |
| turenkibart (CHEBI:760227) is a organic molecular entity (CHEBI:50860) |
| turoctocog alfa (CHEBI:753278) is a organic molecular entity (CHEBI:50860) |
| turoctocog alfa pegol (CHEBI:759754) is a organic molecular entity (CHEBI:50860) |
| tusamitamab (CHEBI:759021) is a organic molecular entity (CHEBI:50860) |
| tusamitamab ravtansine (CHEBI:757517) is a organic molecular entity (CHEBI:50860) |
| tuvirumab (CHEBI:753172) is a organic molecular entity (CHEBI:50860) |
| Type 1 disialyl-paragloboside (CHEBI:140919) is a organic molecular entity (CHEBI:50860) |
| Type 1 monosialylgalactosylgloboside (CHEBI:140917) is a organic molecular entity (CHEBI:50860) |
| Type 2 monosialylgalactosylgloboside (CHEBI:140918) is a organic molecular entity (CHEBI:50860) |
| Type H1 glycolipid (CHEBI:9790) is a organic molecular entity (CHEBI:50860) |
| type iv cyanolipid 20:1(11z) ester (CHEBI:230694) is a organic molecular entity (CHEBI:50860) |
| typhoid vi polysaccharide vaccine (CHEBI:753748) is a organic molecular entity (CHEBI:50860) |
| typhus vaccine (CHEBI:753749) is a organic molecular entity (CHEBI:50860) |
| tyrosinase (CHEBI:758913) is a organic molecular entity (CHEBI:50860) |
| tyrosinochenodeoxycholic acid (CHEBI:232204) is a organic molecular entity (CHEBI:50860) |
| tyrosinocholic acid (CHEBI:232259) is a organic molecular entity (CHEBI:50860) |
| tyrosinodeoxycholic acid (CHEBI:232222) is a organic molecular entity (CHEBI:50860) |
| tyrosinolithocholic acid (CHEBI:232184) is a organic molecular entity (CHEBI:50860) |
| tyrosinoursodeoxycholic acid (CHEBI:232278) is a organic molecular entity (CHEBI:50860) |
| Tyrosyl-prolyl-leucyl-glycinamide (CHEBI:230096) is a organic molecular entity (CHEBI:50860) |
| U-92016A (CHEBI:232976) is a organic molecular entity (CHEBI:50860) |
| ubamatamab (CHEBI:758067) is a organic molecular entity (CHEBI:50860) |
| ublituximab (CHEBI:753332) is a organic molecular entity (CHEBI:50860) |
| Ubrogepant (CHEBI:234515) is a organic molecular entity (CHEBI:50860) |
| ucasareotide dasaroxetan (CHEBI:759582) is a organic molecular entity (CHEBI:50860) |
| ucb-6114 (CHEBI:758400) is a organic molecular entity (CHEBI:50860) |
| ucenprubart (CHEBI:759336) is a organic molecular entity (CHEBI:50860) |
| UDP-N-acetyl-α-D-muramoyl-L-alanyl-L-glutamate(4−) (CHEBI:142725) is a organic molecular entity (CHEBI:50860) |
| Ufenamate (CHEBI:32276) is a organic molecular entity (CHEBI:50860) |
| ulefnersen (CHEBI:758917) is a organic molecular entity (CHEBI:50860) |
| ulefnersen sodium (CHEBI:759024) is a organic molecular entity (CHEBI:50860) |
| uliledlimab (CHEBI:758396) is a organic molecular entity (CHEBI:50860) |
| Ulinastatin (CHEBI:230430) is a organic molecular entity (CHEBI:50860) |
| ulintoclax pegondrimer (CHEBI:760103) is a organic molecular entity (CHEBI:50860) |
| ulocuplumab (CHEBI:755084) is a organic molecular entity (CHEBI:50860) |
| ultevursen (CHEBI:758870) is a organic molecular entity (CHEBI:50860) |
| ulviprubart (CHEBI:758319) is a organic molecular entity (CHEBI:50860) |
| umedaptanib pegol (CHEBI:759478) is a organic molecular entity (CHEBI:50860) |
| umesolerbart (CHEBI:758941) is a organic molecular entity (CHEBI:50860) |
| umikibart (CHEBI:760104) is a organic molecular entity (CHEBI:50860) |
| umitrelimorgene autodencel (CHEBI:759409) is a organic molecular entity (CHEBI:50860) |
| umizortamig (CHEBI:759410) is a organic molecular entity (CHEBI:50860) |
| unasnemab (CHEBI:758373) is a organic molecular entity (CHEBI:50860) |
| UNC1999 (CHEBI:230504) is a organic molecular entity (CHEBI:50860) |
| undecoylium chloride iodine complex (CHEBI:749584) is a organic molecular entity (CHEBI:50860) |
| ungeremine (CHEBI:32277) is a organic molecular entity (CHEBI:50860) |
| unifocon a (CHEBI:753750) is a organic molecular entity (CHEBI:50860) |
| Unii-N8lrs5gbb6 (CHEBI:232605) is a organic molecular entity (CHEBI:50860) |
| upalsecovatein (CHEBI:759498) is a organic molecular entity (CHEBI:50860) |
| upanovimab (CHEBI:758527) is a organic molecular entity (CHEBI:50860) |
| UPF648 (CHEBI:747589) is a organic molecular entity (CHEBI:50860) |
| uprevstobart (CHEBI:759583) is a organic molecular entity (CHEBI:50860) |
| urabrelimab (CHEBI:758082) is a organic molecular entity (CHEBI:50860) |
| urelumab (CHEBI:750161) is a organic molecular entity (CHEBI:50860) |
| Urethane dimethacrylate (CHEBI:79946) is a organic molecular entity (CHEBI:50860) |
| Urocortin I (CHEBI:80295) is a organic molecular entity (CHEBI:50860) |
| Urocortin II (CHEBI:80296) is a organic molecular entity (CHEBI:50860) |
| Urocortin III (CHEBI:80297) is a organic molecular entity (CHEBI:50860) |
| Urodilatin (CHEBI:80231) is a organic molecular entity (CHEBI:50860) |
| urofollitropin (CHEBI:749510) is a organic molecular entity (CHEBI:50860) |
| urogastrone (CHEBI:753173) is a organic molecular entity (CHEBI:50860) |
| Uroguanylin (CHEBI:80236) is a organic molecular entity (CHEBI:50860) |
| urokinase (CHEBI:749515) is a organic molecular entity (CHEBI:50860) |
| urokinase alfa (CHEBI:753453) is a organic molecular entity (CHEBI:50860) |
| Urotensin I (CHEBI:80292) is a organic molecular entity (CHEBI:50860) |
| Urotensin II (CHEBI:80244) is a organic molecular entity (CHEBI:50860) |
| urtoxazumab (CHEBI:753073) is a organic molecular entity (CHEBI:50860) |
| usilnetug (CHEBI:759584) is a organic molecular entity (CHEBI:50860) |
| ustekinumab (CHEBI:749609) is a organic molecular entity (CHEBI:50860) |
| utigamglogene autogedtemcel (CHEBI:760228) is a organic molecular entity (CHEBI:50860) |
| utomilumab (CHEBI:755800) is a organic molecular entity (CHEBI:50860) |
| utreglutide (CHEBI:758739) is a organic molecular entity (CHEBI:50860) |
| uva ursi fluidextract (CHEBI:753751) is a organic molecular entity (CHEBI:50860) |
| uzatresgene autoleucel (CHEBI:760376) is a organic molecular entity (CHEBI:50860) |
| vaccinia immune globulin (CHEBI:753643) is a organic molecular entity (CHEBI:50860) |
| vaccinia virus, live modified (CHEBI:760287) is a organic molecular entity (CHEBI:50860) |
| vaccinia virus, modified encoding ebola virus glycoprotein and nucleoprotein (CHEBI:760293) is a organic molecular entity (CHEBI:50860) |
| vadacabtagene leraleucel (CHEBI:756502) is a organic molecular entity (CHEBI:50860) |
| vadastuximab (CHEBI:756506) is a organic molecular entity (CHEBI:50860) |
| vadastuximab talirine (CHEBI:756503) is a organic molecular entity (CHEBI:50860) |
| Valacyclovir hydrochloride (CHEBI:9919) is a organic molecular entity (CHEBI:50860) |
| valanafusp alfa (CHEBI:757028) is a organic molecular entity (CHEBI:50860) |
| valerian (CHEBI:753174) is a organic molecular entity (CHEBI:50860) |
| valerian extract, powdered (CHEBI:753452) is a organic molecular entity (CHEBI:50860) |
| Valine acylated putrescine (CHEBI:234022) is a organic molecular entity (CHEBI:50860) |
| valinochenodeoxycholic acid (CHEBI:232207) is a organic molecular entity (CHEBI:50860) |
| valinocholic acid (CHEBI:232262) is a organic molecular entity (CHEBI:50860) |
| valinodeoxycholic acid (CHEBI:232225) is a organic molecular entity (CHEBI:50860) |
| valinolithocholic acid (CHEBI:232189) is a organic molecular entity (CHEBI:50860) |
| valinoursodeoxycholic acid (CHEBI:232281) is a organic molecular entity (CHEBI:50860) |
| valoctocogene roxaparvovec (CHEBI:757054) is a organic molecular entity (CHEBI:50860) |
| valziflocept (CHEBI:757524) is a organic molecular entity (CHEBI:50860) |
| vamikibart (CHEBI:759710) is a organic molecular entity (CHEBI:50860) |
| Vancomycin hydrochloride (CHEBI:9932) is a organic molecular entity (CHEBI:50860) |
| vandortuzumab (CHEBI:755944) is a organic molecular entity (CHEBI:50860) |
| vandortuzumab vedotin (CHEBI:755906) is a organic molecular entity (CHEBI:50860) |
| Vaneic acid (CHEBI:197305) is a organic molecular entity (CHEBI:50860) |
| vangatalcite (CHEBI:753752) is a organic molecular entity (CHEBI:50860) |
| vanglusagene ensiparvovec (CHEBI:759028) is a organic molecular entity (CHEBI:50860) |
| vanilla (CHEBI:753175) is a organic molecular entity (CHEBI:50860) |
| vantictumab (CHEBI:754999) is a organic molecular entity (CHEBI:50860) |
| vanucizumab (CHEBI:755544) is a organic molecular entity (CHEBI:50860) |
| vanutide cridificar (CHEBI:753074) is a organic molecular entity (CHEBI:50860) |
| vapaliximab (CHEBI:753753) is a organic molecular entity (CHEBI:50860) |
| varfollitropin alfa (CHEBI:753323) is a organic molecular entity (CHEBI:50860) |
| varicella zoster virus envelope glycoprotein e (CHEBI:757405) is a organic molecular entity (CHEBI:50860) |
| varicella zoster virus, live attenuated (CHEBI:760271) is a organic molecular entity (CHEBI:50860) |
| varicella-zoster immune globulin (CHEBI:753754) is a organic molecular entity (CHEBI:50860) |
| variculatriene A (CHEBI:177893) is a organic molecular entity (CHEBI:50860) |
| varlilumab (CHEBI:755173) is a organic molecular entity (CHEBI:50860) |
| varnimcabtagene autoleucel (CHEBI:759411) is a organic molecular entity (CHEBI:50860) |
| varokibart (CHEBI:759412) is a organic molecular entity (CHEBI:50860) |
| Vasoactive intestinal peptide (CHEBI:80331) is a organic molecular entity (CHEBI:50860) |
| Vasopressin Dimer (CHEBI:234348) is a organic molecular entity (CHEBI:50860) |
| vasopressin tannate (CHEBI:749450) is a organic molecular entity (CHEBI:50860) |
| vatelizumab (CHEBI:750162) is a organic molecular entity (CHEBI:50860) |
| vatreptacog alfa (activated) (CHEBI:753307) is a organic molecular entity (CHEBI:50860) |
| vedolizumab (CHEBI:750163) is a organic molecular entity (CHEBI:50860) |
| vegetable oil, hydrogenated (CHEBI:753755) is a organic molecular entity (CHEBI:50860) |
| velafermin (CHEBI:753075) is a organic molecular entity (CHEBI:50860) |
| Velaglucerase alfa (CHEBI:747652) is a organic molecular entity (CHEBI:50860) |
| veligrotug (CHEBI:754182) is a organic molecular entity (CHEBI:50860) |
| velimogene aliplasmid (CHEBI:753611) is a organic molecular entity (CHEBI:50860) |
| velinotamig (CHEBI:760229) is a organic molecular entity (CHEBI:50860) |
| velmanase alfa (CHEBI:757435) is a organic molecular entity (CHEBI:50860) |
| veltuzumab (CHEBI:750164) is a organic molecular entity (CHEBI:50860) |
| venanprubart (CHEBI:759321) is a organic molecular entity (CHEBI:50860) |
| vensemaglutide (CHEBI:760230) is a organic molecular entity (CHEBI:50860) |
| vensobafusp alfa (CHEBI:759479) is a organic molecular entity (CHEBI:50860) |
| vepalimomab (CHEBI:753176) is a organic molecular entity (CHEBI:50860) |
| vepdegestrant (CHEBI:747473) is a organic molecular entity (CHEBI:50860) |
| vepoloxamer (CHEBI:755181) is a organic molecular entity (CHEBI:50860) |
| veratrum viride root (CHEBI:749463) is a organic molecular entity (CHEBI:50860) |
| verazine (CHEBI:230592) is a organic molecular entity (CHEBI:50860) |
| verbrinacogene setparvovec (CHEBI:758153) is a organic molecular entity (CHEBI:50860) |
| verekitug (CHEBI:759692) is a organic molecular entity (CHEBI:50860) |
| verenafusp alfa (CHEBI:760231) is a organic molecular entity (CHEBI:50860) |
| verlukast (CHEBI:746984) is a organic molecular entity (CHEBI:50860) |
| Verniceic acid (CHEBI:195344) is a organic molecular entity (CHEBI:50860) |
| verpasep caltespen (CHEBI:753612) is a organic molecular entity (CHEBI:50860) |
| verzistobart (CHEBI:759480) is a organic molecular entity (CHEBI:50860) |
| vesencumab (CHEBI:750165) is a organic molecular entity (CHEBI:50860) |
| vesicular stomatitis virus encoding ebola virus glycoprotein (CHEBI:760289) is a organic molecular entity (CHEBI:50860) |
| vesigenurtucel-l (CHEBI:755255) is a organic molecular entity (CHEBI:50860) |
| vesleteplirsen (CHEBI:760499) is a organic molecular entity (CHEBI:50860) |
| vestronidase alfa (CHEBI:755838) is a organic molecular entity (CHEBI:50860) |
| veverimer (CHEBI:757603) is a organic molecular entity (CHEBI:50860) |
| vevoctadekin (CHEBI:759585) is a organic molecular entity (CHEBI:50860) |
| vezocolmitide (CHEBI:760105) is a organic molecular entity (CHEBI:50860) |
| vgx-100 (CHEBI:757289) is a organic molecular entity (CHEBI:50860) |
| viagenpumatucel-l (CHEBI:755167) is a organic molecular entity (CHEBI:50860) |
| vibecotamab (CHEBI:757543) is a organic molecular entity (CHEBI:50860) |
| vibosameran (CHEBI:759048) is a organic molecular entity (CHEBI:50860) |
| vibostolimab (CHEBI:757231) is a organic molecular entity (CHEBI:50860) |
| vibrio cholerae toxin b subunit (CHEBI:760266) is a organic molecular entity (CHEBI:50860) |
| vibrio cholerae, inactivated (CHEBI:760267) is a organic molecular entity (CHEBI:50860) |
| vibrio cholerae, live attenuated (CHEBI:753852) is a organic molecular entity (CHEBI:50860) |
| vicatertide (CHEBI:759586) is a organic molecular entity (CHEBI:50860) |
| vididencel (CHEBI:759481) is a organic molecular entity (CHEBI:50860) |
| vidutolimod (CHEBI:759693) is a organic molecular entity (CHEBI:50860) |
| vifilcon a (CHEBI:753177) is a organic molecular entity (CHEBI:50860) |
| vifilcon b (CHEBI:753756) is a organic molecular entity (CHEBI:50860) |
| vilamakitug (CHEBI:759025) is a organic molecular entity (CHEBI:50860) |
| vilastobart (CHEBI:759587) is a organic molecular entity (CHEBI:50860) |
| vilobelimab (CHEBI:754373) is a organic molecular entity (CHEBI:50860) |
| viltolarsen (CHEBI:757485) is a organic molecular entity (CHEBI:50860) |
| vimekofusp (CHEBI:759667) is a organic molecular entity (CHEBI:50860) |
| vinafocon a (CHEBI:753178) is a organic molecular entity (CHEBI:50860) |
| vintesomeran (CHEBI:759499) is a organic molecular entity (CHEBI:50860) |
| Vinyl toluene (CHEBI:82552) is a organic molecular entity (CHEBI:50860) |
| vipalanebart (CHEBI:759311) is a organic molecular entity (CHEBI:50860) |
| vipivotide tetraxetan gallium (CHEBI:758407) is a organic molecular entity (CHEBI:50860) |
| vipivotide tetraxetan gallium ga-68 (CHEBI:758252) is a organic molecular entity (CHEBI:50860) |
| vipivotide tetraxetan lutetium (CHEBI:758094) is a organic molecular entity (CHEBI:50860) |
| viridofulvin (CHEBI:753166) is a organic molecular entity (CHEBI:50860) |
| vis-410 (CHEBI:758085) is a organic molecular entity (CHEBI:50860) |
| visepegenatide (CHEBI:759588) is a organic molecular entity (CHEBI:50860) |
| visilizumab (CHEBI:753738) is a organic molecular entity (CHEBI:50860) |
| vislarafusp alfa (CHEBI:760106) is a organic molecular entity (CHEBI:50860) |
| vispacabtagene regedleucel (CHEBI:760232) is a organic molecular entity (CHEBI:50860) |
| visugromab (CHEBI:758897) is a organic molecular entity (CHEBI:50860) |
| vitespen (CHEBI:753076) is a organic molecular entity (CHEBI:50860) |
| vittatine Trifluoroacetic acid (CHEBI:68310) is a organic molecular entity (CHEBI:50860) |
| vixarelimab (CHEBI:757839) is a organic molecular entity (CHEBI:50860) |
| vixticibart (CHEBI:760107) is a organic molecular entity (CHEBI:50860) |
| VM 44864 (CHEBI:141368) is a organic molecular entity (CHEBI:50860) |
| vobarilizumab (CHEBI:755934) is a organic molecular entity (CHEBI:50860) |
| vobramitamab (CHEBI:758740) is a organic molecular entity (CHEBI:50860) |
| vobramitamab duocarmazine (CHEBI:758049) is a organic molecular entity (CHEBI:50860) |
| vocimagene amiretrorepvec (CHEBI:753578) is a organic molecular entity (CHEBI:50860) |
| vofatamab (CHEBI:757290) is a organic molecular entity (CHEBI:50860) |
| Voglibose (CHEBI:32300) is a organic molecular entity (CHEBI:50860) |
| volagidemab (CHEBI:757619) is a organic molecular entity (CHEBI:50860) |
| volamcabtagene durzigedleucel (CHEBI:758741) is a organic molecular entity (CHEBI:50860) |
| volanesorsen (CHEBI:755410) is a organic molecular entity (CHEBI:50860) |
| volanesorsen sodium (CHEBI:755405) is a organic molecular entity (CHEBI:50860) |
| volenrelaxin (CHEBI:760360) is a organic molecular entity (CHEBI:50860) |
| volociximab (CHEBI:753077) is a organic molecular entity (CHEBI:50860) |
| volrubigene ralaparvovec (CHEBI:757589) is a organic molecular entity (CHEBI:50860) |
| volrustomig (CHEBI:758929) is a organic molecular entity (CHEBI:50860) |
| von willebrand factor human (CHEBI:757540) is a organic molecular entity (CHEBI:50860) |
| vonapanitase (CHEBI:755445) is a organic molecular entity (CHEBI:50860) |
| vonicog alfa (CHEBI:752915) is a organic molecular entity (CHEBI:50860) |
| vonlerolizumab (CHEBI:756504) is a organic molecular entity (CHEBI:50860) |
| vonsetamig (CHEBI:759482) is a organic molecular entity (CHEBI:50860) |
| vopikitug (CHEBI:758389) is a organic molecular entity (CHEBI:50860) |
| vopratelimab (CHEBI:757429) is a organic molecular entity (CHEBI:50860) |
| voretigene neparvovec (CHEBI:755766) is a organic molecular entity (CHEBI:50860) |
| vormatrigine (CHEBI:760233) is a organic molecular entity (CHEBI:50860) |
| vorsetuzumab (CHEBI:753621) is a organic molecular entity (CHEBI:50860) |
| vorsetuzumab mafodotin (CHEBI:753620) is a organic molecular entity (CHEBI:50860) |
| vorumotide (CHEBI:759483) is a organic molecular entity (CHEBI:50860) |
| vosoritide (CHEBI:755767) is a organic molecular entity (CHEBI:50860) |
| votucalis (CHEBI:753330) is a organic molecular entity (CHEBI:50860) |
| votumumab (CHEBI:753167) is a organic molecular entity (CHEBI:50860) |
| votumumab 99tc (CHEBI:755911) is a organic molecular entity (CHEBI:50860) |
| voxeralgagene autotemcel (CHEBI:759032) is a organic molecular entity (CHEBI:50860) |
| vrc-01 (CHEBI:758402) is a organic molecular entity (CHEBI:50860) |
| vrc-01ls (CHEBI:757541) is a organic molecular entity (CHEBI:50860) |
| vrc07-523ls (CHEBI:757984) is a organic molecular entity (CHEBI:50860) |
| vsv-gp128 (CHEBI:760500) is a organic molecular entity (CHEBI:50860) |
| VTP-50469 (CHEBI:232861) is a organic molecular entity (CHEBI:50860) |
| VU0463271 (CHEBI:232339) is a organic molecular entity (CHEBI:50860) |
| VUAA1 (CHEBI:232163) is a organic molecular entity (CHEBI:50860) |
| vudalimab (CHEBI:758089) is a organic molecular entity (CHEBI:50860) |
| vulinacimab (CHEBI:758021) is a organic molecular entity (CHEBI:50860) |
| vunakizumab (CHEBI:757521) is a organic molecular entity (CHEBI:50860) |
| vupanorsen (CHEBI:757604) is a organic molecular entity (CHEBI:50860) |
| vupanorsen sodium (CHEBI:757605) is a organic molecular entity (CHEBI:50860) |
| vurolenatide (CHEBI:758934) is a organic molecular entity (CHEBI:50860) |
| vusolimogene oderparepvec (CHEBI:758177) is a organic molecular entity (CHEBI:50860) |
| vutrisiran (CHEBI:757985) is a organic molecular entity (CHEBI:50860) |
| vutrisiran sodium (CHEBI:758876) is a organic molecular entity (CHEBI:50860) |
| W23-1006 (CHEBI:747372) is a organic molecular entity (CHEBI:50860) |
| wanjudiene (CHEBI:192984) is a organic molecular entity (CHEBI:50860) |
| wax, carnauba (CHEBI:754113) is a organic molecular entity (CHEBI:50860) |
| wax, emulsifying (CHEBI:753739) is a organic molecular entity (CHEBI:50860) |
| wax, microcrystalline (CHEBI:753034) is a organic molecular entity (CHEBI:50860) |
| wax, white (CHEBI:753035) is a organic molecular entity (CHEBI:50860) |
| wax, yellow (CHEBI:753641) is a organic molecular entity (CHEBI:50860) |
| wheat bran (CHEBI:753640) is a organic molecular entity (CHEBI:50860) |
| white lotion (CHEBI:753168) is a organic molecular entity (CHEBI:50860) |
| wild cherry syrup (CHEBI:753032) is a organic molecular entity (CHEBI:50860) |
| WIN 64338 hydrochloride (CHEBI:231367) is a organic molecular entity (CHEBI:50860) |
| WIN-35428 (CHEBI:232539) is a organic molecular entity (CHEBI:50860) |
| witch hazel (CHEBI:753642) is a organic molecular entity (CHEBI:50860) |
| witepsol (CHEBI:753033) is a organic molecular entity (CHEBI:50860) |
| wn-80e (CHEBI:757986) is a organic molecular entity (CHEBI:50860) |
| WNK463 (CHEBI:750706) is a organic molecular entity (CHEBI:50860) |
| Wollastonite (CHEBI:82553) is a organic molecular entity (CHEBI:50860) |
| wound matrix, small intestinal submucosa (CHEBI:753613) is a organic molecular entity (CHEBI:50860) |
| WP1066 (CHEBI:234609) is a organic molecular entity (CHEBI:50860) |
| wx-037 (CHEBI:755610) is a organic molecular entity (CHEBI:50860) |
| wx-554 (CHEBI:755483) is a organic molecular entity (CHEBI:50860) |
| x-82 (CHEBI:755621) is a organic molecular entity (CHEBI:50860) |
| X-Trp (CHEBI:10047) is a organic molecular entity (CHEBI:50860) |
| X5050 (CHEBI:230505) is a organic molecular entity (CHEBI:50860) |
| Xaa-Arg (CHEBI:10051) is a organic molecular entity (CHEBI:50860) |
| Xaa-His (CHEBI:10052) is a organic molecular entity (CHEBI:50860) |
| Xaa-Lys (CHEBI:10053) is a organic molecular entity (CHEBI:50860) |
| Xaa-ornithine (CHEBI:10054) is a organic molecular entity (CHEBI:50860) |
| xalnesiran (CHEBI:758742) is a organic molecular entity (CHEBI:50860) |
| xalnesiran sodium (CHEBI:759322) is a organic molecular entity (CHEBI:50860) |
| xanthan gum (CHEBI:753740) is a organic molecular entity (CHEBI:50860) |
| xanthochymol (CHEBI:70327) is a organic molecular entity (CHEBI:50860) |
| xelafaslatide (CHEBI:760234) is a organic molecular entity (CHEBI:50860) |
| xempritolimod (CHEBI:759413) is a organic molecular entity (CHEBI:50860) |
| xen-d0501 (CHEBI:755779) is a organic molecular entity (CHEBI:50860) |
| xen403 (CHEBI:755457) is a organic molecular entity (CHEBI:50860) |
| xeniaphyllene (CHEBI:192741) is a organic molecular entity (CHEBI:50860) |
| xenon xe 127 (CHEBI:749296) is a organic molecular entity (CHEBI:50860) |
| xenon xe 133 (CHEBI:749299) is a organic molecular entity (CHEBI:50860) |
| xentuzumab (CHEBI:757292) is a organic molecular entity (CHEBI:50860) |
| Xevinapant (CHEBI:197401) is a organic molecular entity (CHEBI:50860) |
| xirestomig (CHEBI:759589) is a organic molecular entity (CHEBI:50860) |
| xl-820 (CHEBI:755622) is a organic molecular entity (CHEBI:50860) |
| xl-844 (CHEBI:755381) is a organic molecular entity (CHEBI:50860) |
| xl550 (CHEBI:755615) is a organic molecular entity (CHEBI:50860) |
| xmab-2513 (CHEBI:757545) is a organic molecular entity (CHEBI:50860) |
| xmt-1536 (CHEBI:757293) is a organic molecular entity (CHEBI:50860) |
| xmt-1592 (CHEBI:759694) is a organic molecular entity (CHEBI:50860) |
| xtl-6865 (CHEBI:754232) is a organic molecular entity (CHEBI:50860) |
| xueguang1024 (CHEBI:139165) is a organic molecular entity (CHEBI:50860) |
| xylofilcon a (CHEBI:753169) is a organic molecular entity (CHEBI:50860) |
| Y-27632 dihydrochloride (CHEBI:232591) is a organic molecular entity (CHEBI:50860) |
| Yamanakanic acid (CHEBI:197306) is a organic molecular entity (CHEBI:50860) |
| yeast, dried (CHEBI:753741) is a organic molecular entity (CHEBI:50860) |
| yellow fever vaccine (CHEBI:753742) is a organic molecular entity (CHEBI:50860) |
| yersinopine(1−) (CHEBI:143224) is a organic molecular entity (CHEBI:50860) |
| yh-001 (CHEBI:758956) is a organic molecular entity (CHEBI:50860) |
| yh-003 (CHEBI:758957) is a organic molecular entity (CHEBI:50860) |
| Yhhu 3792 (CHEBI:195190) is a organic molecular entity (CHEBI:50860) |
| yttrium (CHEBI:758406) is a organic molecular entity (CHEBI:50860) |
| yttrium chloride y-90 (CHEBI:759738) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 capromab pendetide (CHEBI:754317) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 clivatuzumab tetraxetan (CHEBI:753651) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 epratuzumab (CHEBI:753743) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 epratuzumab tetraxetan (CHEBI:753614) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 ibritumomab tiuxetan (CHEBI:753615) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 labetuzumab (CHEBI:753744) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 labetuzumab tetraxetan (CHEBI:753616) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 tacatuzumab (CHEBI:753078) is a organic molecular entity (CHEBI:50860) |
| yttrium y 90 tacatuzumab tetraxetan (CHEBI:753617) is a organic molecular entity (CHEBI:50860) |
| yttrium y-90 (CHEBI:758259) is a organic molecular entity (CHEBI:50860) |
| Z-IETD-FMK (CHEBI:747567) is a organic molecular entity (CHEBI:50860) |
| Z-Isohalidrysone A (CHEBI:144084) is a organic molecular entity (CHEBI:50860) |
| zabilugene almadenorepvec (CHEBI:760235) is a organic molecular entity (CHEBI:50860) |
| zadoprubart (CHEBI:760236) is a organic molecular entity (CHEBI:50860) |
| zaftuclenegene piruparvovec (CHEBI:758743) is a organic molecular entity (CHEBI:50860) |
| zagotenemab (CHEBI:757445) is a organic molecular entity (CHEBI:50860) |
| zalfermin (CHEBI:759590) is a organic molecular entity (CHEBI:50860) |
| zalifrelimab (CHEBI:757314) is a organic molecular entity (CHEBI:50860) |
| zaloganan (CHEBI:759591) is a organic molecular entity (CHEBI:50860) |
| zaltenibart (CHEBI:760108) is a organic molecular entity (CHEBI:50860) |
| Zaltoprofen (CHEBI:32306) is a organic molecular entity (CHEBI:50860) |
| zalutumumab (CHEBI:752904) is a organic molecular entity (CHEBI:50860) |
| zamaglutenase (CHEBI:758744) is a organic molecular entity (CHEBI:50860) |
| zampilimab (CHEBI:758317) is a organic molecular entity (CHEBI:50860) |
| zamubafusp alfa (CHEBI:759920) is a organic molecular entity (CHEBI:50860) |
| zanidatamab (CHEBI:758162) is a organic molecular entity (CHEBI:50860) |
| zanolimumab (CHEBI:753079) is a organic molecular entity (CHEBI:50860) |
| zansecimab (CHEBI:758367) is a organic molecular entity (CHEBI:50860) |
| zedenoleucel (CHEBI:758374) is a organic molecular entity (CHEBI:50860) |
| zein (CHEBI:753150) is a organic molecular entity (CHEBI:50860) |
| zeleciment (CHEBI:759592) is a organic molecular entity (CHEBI:50860) |
| zeleciment basivarsen (CHEBI:759593) is a organic molecular entity (CHEBI:50860) |
| zeleciment rostudirsen (CHEBI:759594) is a organic molecular entity (CHEBI:50860) |
| zelenectide (CHEBI:759595) is a organic molecular entity (CHEBI:50860) |
| zelenectide pevedotin (CHEBI:759596) is a organic molecular entity (CHEBI:50860) |
| zelpultide alfa (CHEBI:758267) is a organic molecular entity (CHEBI:50860) |
| zen-3694 (CHEBI:760506) is a organic molecular entity (CHEBI:50860) |
| zendusortide (CHEBI:758745) is a organic molecular entity (CHEBI:50860) |
| zenocutuzumab (CHEBI:757449) is a organic molecular entity (CHEBI:50860) |
| zeripatamig (CHEBI:758313) is a organic molecular entity (CHEBI:50860) |
| zerlasiran (CHEBI:759414) is a organic molecular entity (CHEBI:50860) |
| zertomibgene cazparvovec (CHEBI:759921) is a organic molecular entity (CHEBI:50860) |
| zevorcabtagene autoleucel (CHEBI:758172) is a organic molecular entity (CHEBI:50860) |
| ziclumeran (CHEBI:759415) is a organic molecular entity (CHEBI:50860) |
| ziconotide acetate (CHEBI:750197) is a organic molecular entity (CHEBI:50860) |
| zifcasiran (CHEBI:759026) is a organic molecular entity (CHEBI:50860) |
| zifcasiran sodium (CHEBI:759027) is a organic molecular entity (CHEBI:50860) |
| zifibancimig (CHEBI:758945) is a organic molecular entity (CHEBI:50860) |
| zifogaptide (CHEBI:760109) is a organic molecular entity (CHEBI:50860) |
| zigakibart (CHEBI:758889) is a organic molecular entity (CHEBI:50860) |
| zilebesiran (CHEBI:758871) is a organic molecular entity (CHEBI:50860) |
| zilebesiran sodium (CHEBI:759037) is a organic molecular entity (CHEBI:50860) |
| zilganersen (CHEBI:758995) is a organic molecular entity (CHEBI:50860) |
| zilganersen sodium (CHEBI:758996) is a organic molecular entity (CHEBI:50860) |
| ziltivekimab (CHEBI:757184) is a organic molecular entity (CHEBI:50860) |
| zimberelimab (CHEBI:757298) is a organic molecular entity (CHEBI:50860) |
| zimislecel (CHEBI:759597) is a organic molecular entity (CHEBI:50860) |
| zimistobart (CHEBI:760378) is a organic molecular entity (CHEBI:50860) |
| zinc gelatin (CHEBI:753021) is a organic molecular entity (CHEBI:50860) |
| Zinc phosphide (CHEBI:81884) is a organic molecular entity (CHEBI:50860) |
| zinc-66(2+) (CHEBI:176618) is a organic molecular entity (CHEBI:50860) |
| zinlirvimab (CHEBI:757137) is a organic molecular entity (CHEBI:50860) |
| zinpentraxin alfa (CHEBI:757259) is a organic molecular entity (CHEBI:50860) |
| ziralimumab (CHEBI:753713) is a organic molecular entity (CHEBI:50860) |
| zirconium (89zr) girentuximab senvedoxam (CHEBI:760110) is a organic molecular entity (CHEBI:50860) |
| zirconium zr 89 crefmirlimab berdoxam (CHEBI:759346) is a organic molecular entity (CHEBI:50860) |
| zirconium zr-89-desferrioxamine-iab22m2c (CHEBI:758318) is a organic molecular entity (CHEBI:50860) |
| ZK 93423 hydrochloride (CHEBI:231362) is a organic molecular entity (CHEBI:50860) |
| ZL0420 (CHEBI:232047) is a organic molecular entity (CHEBI:50860) |
| ZN(II) Phthalocyanine tetrasulfonic acid (CHEBI:195320) is a organic molecular entity (CHEBI:50860) |
| zocaglusagene nuzaparvovec (CHEBI:759416) is a organic molecular entity (CHEBI:50860) |
| zodasiran (CHEBI:759344) is a organic molecular entity (CHEBI:50860) |
| zodasiran sodium (CHEBI:760355) is a organic molecular entity (CHEBI:50860) |
| zolacabtagene autoleucel (CHEBI:760386) is a organic molecular entity (CHEBI:50860) |
| zolbetuximab (CHEBI:754224) is a organic molecular entity (CHEBI:50860) |
| zolimomab aritox (CHEBI:753714) is a organic molecular entity (CHEBI:50860) |
| zooxanthellactone (CHEBI:230685) is a organic molecular entity (CHEBI:50860) |
| zopapogene imadenovec (CHEBI:760111) is a organic molecular entity (CHEBI:50860) |
| zorecimeran (CHEBI:758517) is a organic molecular entity (CHEBI:50860) |
| zorevunersen (CHEBI:758952) is a organic molecular entity (CHEBI:50860) |
| zorevunersen sodium (CHEBI:759323) is a organic molecular entity (CHEBI:50860) |
| Zotiraciclib (CHEBI:233411) is a organic molecular entity (CHEBI:50860) |
| zotresiran (CHEBI:759598) is a organic molecular entity (CHEBI:50860) |
| zovostotug (CHEBI:759484) is a organic molecular entity (CHEBI:50860) |
| zubotamig (CHEBI:760112) is a organic molecular entity (CHEBI:50860) |
| zunibergene rocparvovec (CHEBI:759922) is a organic molecular entity (CHEBI:50860) |
| zyh7 (CHEBI:755459) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142211) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142213) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142212) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142215) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142216) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142214) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:142349) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:142351) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(3−) (CHEBI:142350) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:142353) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:142354) is a organic molecular entity (CHEBI:50860) |
| α-N-acetyl-9-O-acetylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:142352) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142653) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142647) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142651) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142654) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142652) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142585) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142586) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-N-acetylneuraminosyl-(2→6)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142595) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-[α-N-acetylneuraminosyl-(2→6)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142627) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-(α-L-fucosyl-(1→3))-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142564) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142561) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142608) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142583) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→6)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142948) is a organic molecular entity (CHEBI:50860) |
| α-N-acetylneuraminosyl-(2→6)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142949) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142327) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142329) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142328) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142331) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142332) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142330) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142192) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142194) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142193) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142196) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142197) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142195) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:141970) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141973) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:141971) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141975) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141976) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141974) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144991) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144990) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144993) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144992) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144983) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144982) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144986) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144985) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142103) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142105) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142104) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142108) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142109) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142107) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144899) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144898) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144901) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144900) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144607) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144606) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144891) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144608) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:144604) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:144603) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:144765) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:144605) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142085) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142087) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142086) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142089) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142090) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142088) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:144814) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:144816) is a organic molecular entity (CHEBI:50860) |
| α-N-glycoloylneuraminosyl-(2→8)-α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:144815) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-(α-L-Fuc-(1→2))-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140837) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-(α-L-Fuc-(1→2))-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140838) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-(α-L-Fuc-(1→2))-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141197) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-(α-L-Fuc-(1→2))-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141198) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-(α-L-Fuc-(1→2))-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141199) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141022) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140777) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140778) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141037) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140759) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140760) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141036) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140744) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141035) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140818) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141042) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141007) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1)-N-acylsphinganine (CHEBI:140711) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)- β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140740) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140733) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141015) is a organic molecular entity (CHEBI:50860) |
| α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141017) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142644) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142289) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142292) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142291) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142294) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142295) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142293) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t20:0)(1−) (CHEBI:142296) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:142186) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:142188) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:142187) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:142190) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:142191) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:142189) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:142141) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:142143) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142142) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (CHEBI:142145) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:142146) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142144) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142631) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144820) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144819) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144821) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144839) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144838) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144841) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144840) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144826) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144825) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144828) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144827) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144679) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144681) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144680) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144573) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144572) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144682) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144574) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:141785) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141787) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:141786) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141789) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141791) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141788) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (d18:1(4E))(2−) (CHEBI:141778) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(2−) (CHEBI:141776) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141777) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141783) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141784) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141779) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144579) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144578) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144580) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:145065) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:145064) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:145068) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[N-acetyl-β-D-galactosaminyl-(1→4)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:145067) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:145058) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:145057) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:145060) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:145059) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144632) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144631) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144848) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144633) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144567) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144566) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144568) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-α-[L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144793) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphingosine (CHEBI:140620) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-acylsphingosine (CHEBI:140615) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144689) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144688) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144690) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1↔1')-ceramide (CHEBI:143594) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-(1→4)-β-D-galactosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:143595) is a organic molecular entity (CHEBI:50860) |
| α-D-galactosyl-β-D-galactosyldiacylglycerol (CHEBI:10239) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-(α-L-Fuc-(1→2))-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1)-N-acylsphinganine (CHEBI:140790) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-[α-L-Fuc-β-(1→2)]-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141021) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-(α-L-Fuc-(1→2)-β-D-Gal-(1→3)-β-D-GalNAc-(1→4))-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141193) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-(α-L-Fuc-(1→2)-β-D-Gal-(1→3)-β-D-GalNAc-(1→4))-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141194) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-(α-L-Fuc-(1→2)-β-D-Gal-(1→3)-β-D-GalNAc-(1→4))-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141195) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-(β-D-Gal-(1→3)-β-D-GalNAc-(1→4))-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141191) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140822) is a organic molecular entity (CHEBI:50860) |
| α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141044) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-[α-D-Gal-(1→3)]-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141106) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-[α-D-Gal-(1→3)]-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141107) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-[α-D-Gal-(1→3)]-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141110) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140831) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140832) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141039) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141098) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141099) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141100) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141019) is a organic molecular entity (CHEBI:50860) |
| α-L-Fuc-(1→2)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1)-N-acylsphinganine (CHEBI:140716) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142933) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142934) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142936) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-(N-acetyl-α-D-galactosaminyl-(1→3))-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142937) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142613) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-N-ceramide(d18:0) (CHEBI:144478) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144477) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141674) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141676) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141677) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141675) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141758) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(2−) (CHEBI:141759) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141761) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141762) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141760) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N- glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142220) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N- glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142222) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N- glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142221) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N- glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142224) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N- glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142225) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N- glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142223) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:141624) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (CHEBI:141626) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:141627) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:141625) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142923) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142924) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142926) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142927) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142609) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142910) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142911) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142902) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142903) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144919) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144918) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144921) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144920) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144914) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144913) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144916) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144915) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144548) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144767) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144549) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142896) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142897) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144640) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144722) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144641) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144766) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144642) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144875) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144877) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-[α-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144876) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142177) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142179) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142178) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142181) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142182) is a organic molecular entity (CHEBI:50860) |
| α-L-fucosyl-(1→3)-[β-D-galactosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142180) is a organic molecular entity (CHEBI:50860) |
| α-bromocinnamaldehyde (CHEBI:233277) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747109) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747108) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→2)-α-D-Manp-(1→3)-α-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747114) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747107) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→3)-α-D-Manp-(1→3)-α-D-Manp-(1→3)-α-D-ManpO[CH2]5NH2 (CHEBI:747110) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→4)-α-D-Manp-(1→4)-α-D-Manp-(1→4)-α-D-ManpO[CH2]5NH2 (CHEBI:747111) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-ManpO[CH2]5NH2 (CHEBI:747113) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-Manp-(1→6)-α-D-ManpO[CH2]5NH2 (CHEBI:747112) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-α-D-Manp-6P-1-O[CH2]5NH2 (CHEBI:747118) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-β-D-Manp-6P-(1→2)-α-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747120) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-β-D-Manp-6P-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747121) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-β-D-Manp-6P-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747119) is a organic molecular entity (CHEBI:50860) |
| α-D-Manp-(1→6)-β-D-Manp-6P-1-O[CH2]5NH2 (CHEBI:747122) is a organic molecular entity (CHEBI:50860) |
| α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(d16:1)(1−) (CHEBI:90465) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-[α-NeuAc-(2→6)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140719) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-[α-NeuAc-(2→6)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140721) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-[α-NeuAc-(2→6)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141012) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141102) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141103) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141104) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140717) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140718) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141011) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→6)-(α-NeuAc-(2→3))-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140792) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→6)-(α-NeuAc-(2→3))-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140793) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→6)-[α-NeuAc-(2→3)]-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141040) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→8)-α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140798) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→8)-α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140805) is a organic molecular entity (CHEBI:50860) |
| α-NeuAc-(2→8)-α-NeuAc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141041) is a organic molecular entity (CHEBI:50860) |
| α-NeuGc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141170) is a organic molecular entity (CHEBI:50860) |
| α-NeuGc-(2→8)-α-NeuGc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141174) is a organic molecular entity (CHEBI:50860) |
| α-NeuGc-(2→8)-α-NeuGc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141175) is a organic molecular entity (CHEBI:50860) |
| α-NeuGc-(2→8)-α-NeuGc-(2→3)-β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141176) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→3)-[β-D-GlcNAc-(1→6)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140704) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→3)-[β-D-GlcNAc-(1→6)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141032) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141065) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141067) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141066) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→6)-[β-D-Gal-(1→3)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140710) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→6)-[β-D-Gal-(1→3)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140709) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→6)-[β-D-Gal-(1→3)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141034) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)-[β-D-Gal-(1→3)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140707) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)-[β-D-Gal-(1→3)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140706) is a organic molecular entity (CHEBI:50860) |
| β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)-[β-D-Gal-(1→3)]-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141033) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142049) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142052) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142051) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142055) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142056) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142053) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:142069) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:142071) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(3−) (CHEBI:142070) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:142073) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:142074) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:142072) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:142063) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:142065) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(3−) (CHEBI:142064) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:142067) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:142068) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[N-acetyl-α-neuraminosyl-(2→6)]-N-acetyl-β-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:142066) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[α-N-acetylneuraminosyl-(2→6)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142951) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[α-N-acetylneuraminosyl-(2→6)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142952) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142596) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144652) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144651) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(SO3)-3-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142153) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(SO3)-3-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142155) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(SO3)-3-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142154) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(SO3)-3-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142157) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(SO3)-3-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142158) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-(SO3)-3-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142156) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141671) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141673) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141672) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(2−) (CHEBI:141651) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(2−) (CHEBI:141653) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(2−) (CHEBI:141654) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(2−) (CHEBI:141652) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(3−) (CHEBI:141743) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(3−) (CHEBI:141744) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(3−) (CHEBI:141746) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(3−) (CHEBI:141747) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→8)-N-acetyl-α-neuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(3−) (CHEBI:141745) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:141982) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:141984) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:141983) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:141986) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:141987) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:141985) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(1−) (CHEBI:142097) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0)(1−) (CHEBI:142099) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E))(1−) (CHEBI:142098) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0)(1−) (CHEBI:142101) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E))(1−) (CHEBI:142102) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-glycoloylneuraminosyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0)(1−) (CHEBI:142100) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:141620) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:0) (CHEBI:141622) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:141623) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:141621) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144749) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144751) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144750) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142589) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144685) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144684) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144687) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144686) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142899) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142900) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:145001) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:145000) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:145003) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:145002) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144597) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144596) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144906) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144598) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144701) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144715) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144714) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144593) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:144592) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144902) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144594) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144599) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144799) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144798) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144512) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144754) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144753) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142893) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142894) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144601) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144797) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-[α-L-fucosyl-(1→3)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144796) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144450) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144600) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144795) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144794) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144752) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144602) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:0) (CHEBI:144871) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144873) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-[β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144872) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d20:1(4E)) (CHEBI:144893) is a organic molecular entity (CHEBI:50860) |
| β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:144892) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140834) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140835) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141038) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140820) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141043) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141008) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140736) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141016) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphinganine (CHEBI:140783) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-N-acylsphingosine (CHEBI:140784) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141031) is a organic molecular entity (CHEBI:50860) |
| β-D-GalNAc-(1→3)α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1)-N-acylsphinganine (CHEBI:140712) is a organic molecular entity (CHEBI:50860) |
| β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-GlcpNAc6S-(1→3)-D-Galp (CHEBI:63852) is a organic molecular entity (CHEBI:50860) |
| β-D-GlcNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:0) (CHEBI:141181) is a organic molecular entity (CHEBI:50860) |
| β-D-GlcNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(d18:1(4E)) (CHEBI:141182) is a organic molecular entity (CHEBI:50860) |
| β-D-GlcNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-ceramide(t18:0) (CHEBI:141183) is a organic molecular entity (CHEBI:50860) |
| β-D-mannopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→3)-α-D-galactopyranosyl-diphospho-ditrans,octacis-undecaprenol(2−) (CHEBI:167469) is a organic molecular entity (CHEBI:50860) |
| β-citryl-L-glutamyl-L-glutamate (CHEBI:167458) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→3)-[β-D-Glcp-(1→6)]-β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747135) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→3)-[β-D-Glcp-(1→6)]-β-D-GlcpO[CH2]5NH2 (CHEBI:747133) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-[β-D-Glcp-(1→6)]-β-D-GlcpO[CH2]5NH2 (CHEBI:747134) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747128) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747126) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747125) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→6)-[β-D-Glcp-(1→3)-β-D-Glcp-(1→3)]-β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747136) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→6)-β-D-Glcp-(1→3)-β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747130) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→6)-β-D-Glcp-(1→3)-β-D-GlcpO[CH2]5NH2 (CHEBI:747129) is a organic molecular entity (CHEBI:50860) |
| β-D-Glcp-(1→6)-β-D-GlcpO[CH2]5NH2 (CHEBI:747131) is a organic molecular entity (CHEBI:50860) |
| β-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747117) is a organic molecular entity (CHEBI:50860) |
| β-D-Manp-(1→2)-α-D-Manp-(1→2)-α-D-ManpO[CH2]5NH2 (CHEBI:747116) is a organic molecular entity (CHEBI:50860) |
| β-endosulfan (CHEBI:232154) is a organic molecular entity (CHEBI:50860) |
| β-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142666) is a organic molecular entity (CHEBI:50860) |
| β-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142998) is a organic molecular entity (CHEBI:50860) |
| β-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-galactosyl-(1→3)-[α-L-fucosyl-(1→4)]-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142999) is a organic molecular entity (CHEBI:50860) |
| β-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(d18:1(4E)) (CHEBI:142994) is a organic molecular entity (CHEBI:50860) |
| β-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-galactosyl-(1→3)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide(t18:0) (CHEBI:142995) is a organic molecular entity (CHEBI:50860) |
| β-galactosylceramide (CHEBI:143593) is a organic molecular entity (CHEBI:50860) |
| β-glucosyl 6-β-glucosyloxy-indole-3-carboxylate (CHEBI:132675) is a organic molecular entity (CHEBI:50860) |
| β-glycerylphosphocholine (CHEBI:144950) is a organic molecular entity (CHEBI:50860) |
| ω-hydroxy-ultra-long chain fatty acylceramide (CHEBI:144784) is a organic molecular entity (CHEBI:50860) |
| ω-linoleoyloxy-O-ultra-long chain acylceramide (CHEBI:144785) is a organic molecular entity (CHEBI:50860) |
